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R2249 Effect of a probiotic dairy product containing Lactobacillus
casei Shirota on the gut microbiota in irritable bowel
syndrome: a randomised, placebo-controlled, double-blind
study
V. Vankerckhoven*, N. Hens, A. Thijssen, C. Lammens, S. Chapelle,
A. Vanderstraeten, D. Jonkers, C. Clemens, A. Masclee, H. Goossens
(Antwerp, Hasselt, BE; Maastricht, NL; Leiden, NL)
Objectives: It has been hypothesized that disturbances in the intestinal
ﬂora could be a factor in the onset and persistence of IBS complaints.
The aim of the study was to analyse the effect of Lactobacillus casei
Shirota (LcS) on the faecal ﬂora of IBS patients.
Methods: In a randomised, placebo controlled, double blind study, IBS
patients fulﬁlling the Rome criteria II were included. Patients took 2
bottles daily for 8 weeks, containing either LcS or placebo. Faecal
samples were collected before intervention (week −2/0,S1), at the end
of intervention (week 6/8,S2) and during follow-up (week 14/16,S3).
Microbial populations (Bacteroides, anaerobes, biﬁdobacteria, coliforms,
clostridia, and lactobacilli) were enumerated using quantitative plating.
Total bacterial counts were performed using FISH. Bacterial DNA was
analysed by quantitative Real-Time PCR for the detection of Atopo-
bium spp., Bacteroides-Prevotella-Porphyromonas group, Clostridium
coccoides-Eubacterium rectale group, Clostridium leptum subgroup,
Clostridium difﬁcile, Clostridium perfringens, Desulfovibrio desulfuri-
cans group, and Biﬁdobacterium spp. Statistical analysis was performed
using Mann-Whitney U tests or Paired Wilcoxon tests. P< 0.05 was
considered statistically signiﬁcant.
Results: No signiﬁcant differences in total bacterial counts were seen
between the treatment and placebo group. Using quantitative plating,
no signiﬁcant differences were seen for the different bacterial groups
between both groups. Signiﬁcantly lower bacterial counts were seen in
both groups for clostridia for S2 compared to S1 and S3. In the placebo
group, signiﬁcantly higher amounts of biﬁdobacteria and lactobacilli
were detected for S2 compared to S1. Using qRT-PCR, signiﬁcantly
lower counts for D. desulfuricans group were seen in the placebo group
compared to the treatment group. In the treatment group signiﬁcant
differences were seen only for S2 compared to S3, whereas in the placebo
group, no signiﬁcant differences were detected for the different bacterial
groups at the different sampling points. Analysis at the IBS subtype level
revealed differences in microbiota between the different subtypes.
Conclusions: Although signiﬁcant changes in the microbiota were seen
during intake of LcS in the treatment group, differences in microbial
populations between both groups were not signiﬁcant. Interestingly,
speciﬁc ﬁndings are likely to be associated with a speciﬁc IBS subtype
rather than with IBS in general.
R2250 H1N1 virus infection: review of chest radiographic ﬁndings
J.A. Parra*, J.L. Gonzalez, M. Gutierrez-Cuadra, J. Rodrı´guez-Cabello,
P. de Lucio, C. Farin˜as-Alvarez, G. Blanco, M.V. Sanjuan,
M.C. Farin˜as, I. Fidalgo (Santander, Torrelavega, ES)
Objective: To asses the chest radiography ﬁndings of patients with H1N1
Inﬂuenza virus infection.
Material and Methods: Review of radiological ﬁndings of 110 patients
with conﬁrmed inﬂuenza A virus infection admitted to two Hospitals
in Cantabria, Spain. The radiological ﬁndings were characterized by
pattern of opacities, lung distribution and, presence or absence of pleural
effusions or hiliar or mediastinal adenopahies.
Results: The initial radiography was abnormal in 39 (34%) patients,
but only 28 (25%) were related exclusively to the inﬂuenza A virus
infection. Characteristic imaging ﬁndings in these 28 patients included:
parenchymal consolidation 68%, consolidation plus ground glass 25%
and ground glass opacities in 7%. Seventeen patients had a diffuse
distribution of the opacities, in 61% it was bilateral, and lower and
middle zones were those most frequently affected. No pleural effusions
or pathological mediastinal lymph nodes were seen in this initial
radiography. Patients with abnormal chest X-ray were more frequently
men, smokers, had dyspnoea, pleuritic pain and diarrhoea.
Conclusions: Although more of patients with inﬂuenza virus A infection
showed normal chest X-ray, those with abnormal chest radiographies,
characteristically showed areas of consolidation with or without ground
glass affectation, bilateral and diffuse distribution, and predilection for
lower and middle zones. Pleural effusion or mediastinal adenopahty were
not ﬁndings seen in the initial radiography.
R2251 Surveillance of drug resistance of Mycobacterium
tuberculosis patterns in clinical sputum samples
C.D. Kalunga*, W. Muvwimi, M. Tembo (Lusaka, ZM)
Introduction: Chest diseases tb reference lab is responsible for ﬁrst
line anti tuberculosis drug testing and so this formed the backbone of
the study based on routine drug susceptibility testing. These drugs are
widely used in the world and tested for in rounds of proﬁciency testing
among reference laboratories. Drug resistance was probably the result of
a selective process by which non susceptible mycobacteria are singled out
through the elimination of the susceptible majority. Therefore the need
to determine the susceptibility and resistance patterns of mycobacterium
tuberculosis in 830 clinical samples sent for culture in the period between
2007 and 2010.
Objective: To determine the drug resistance patterns for mycobacterium
tuberculosis in clinical samples.
Methodology: This was a retrospective descriptive study conducted at
chest diseases laboratory between 2007 and 2010 and used data from the
data base 830 tuberculosis (tb) positive cultures of clinical samples from
new and retreatment patients using proportion methods were tested. Data
of the drug resistance survey conducted during this period was excluded.
Results: The total number of cultures examined was 830 between
2007 and 2010, showing drug resistance to one or more drugs in
mycobacterium tuberculosis strains from newly diagnosed and previously
treated patients in a continuing sample surveillance.
Total resistant strains was 209 (25.1%), mono resistance to streptomycin
22 (2.6%), isoniazid 33 (3.9%), rifampicin 27 (3.2%), ethambutol
2 (0.2%).
Resistance to two drugs included rifampicin and isoniazid [multi
drug resistance 49 (5.9%)], streptomycin and isoniazid 10 (1.2%),
streptomycin and rifampin 25 (3.01%), isoniazid and ethambutol
07 (0.8%), streptomycin and Ethambutol 01 (0.1%), Rifampicin and
Ethambutol 01 (0.12%).
Resistance to three drugs included streptomycin + isoniazid + rifampcin
36 (4.3%), isoniazid + rifampicin + ethambutol 0 (0%) streptomycin +
isoniazid + ethambutol 07 (0.8%).
Resistance to all four drugs included 0.7 (0.8%).
Conclusion: Resistance to rifampicin and isoniazid (mdr) 5.9%) showed
a rising trend and threatening to be a problem. Mono resistance to
isoniazid (3.9%) was in rising proportions.
Resistance to ethambutol and rifampicin and isoniazid 0%) marked the
least trend.
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R2252 Changes in biostructure of the microﬂora in adolescents
with inﬂammatory bowel disease
T. Gosiewski*, M. Strus, K. Fyderek, K. Kowalska-Duplaga,
A. Wedrychowicz, A. Pietrzyk, P. Heczko (Cracow, PL)
Objectives: The commensal bacterial ﬂora of the gastrointestinal tract
plays an important role in pathogenesis of inﬂammatory bowel disease
(IBD). We examined what is structure of bacterial microﬂora in the
colon in adolescents with Crohn’s disease (CD), ulcerative colitis (UC)
and control group.
Methods: Faecal samples were collected in three fractions from patients
with CD (n = 22), UC (n = 12) and control (n = 24) during preparation
to colonoscopy which was based on cleaning of the gastrointestinal
tract with: ﬁrst normal saline enema, oral administration of laxative
sodium phosphate (0.6−0.8ml/kg) and repeated normal saline enema
until clean, at least three enemas in whole preparation procedure. After
each preparatory step the large bowel intestinal contents were collected,
resulting in three fractions I, II and III. Samples were examined using
a quantitative culture technique and ﬂuorescent in situ hybridization
(FISH) method.
Results: Quantitative composition of the bacterial ﬂora was different
in the consecutive three faecal fractions of the study groups (Fig.
1a,b,d,e) but in patients from the control group the composition of
the bacterial ﬂora in the consecutive fractions was similar (Fig. 1c,f).
Statistical analyses showed that the total distribution of the studied
bacterial taxons in the contents, in all three faecal fractions in the given
disease group, as well as in the control group were characteristic for the
studied patient group and statistically signiﬁcant (p< 0.0001). Generally,
in the results obtained using the culture methods, the biggest differences
were noted for Biﬁdobacterium genus, which numbers decreased in the
consecutive, but remained stable and high in the control group. The above
differences were also demonstrated using FISH, but using hybridization
the percentages of biﬁdobacteria in the studied groups were not as high
(Fig. 1). Moreover, it showed that in the ﬁrst faecal fraction (transient
planktonic ﬂora) there is no statistical signiﬁcance for any of the analyzed
bacterial groups, both using the culture methods or FISH, but signiﬁcant
results were demonstrated in the II and III fractions for speciﬁc bacterial
groups.
Conclusions: Distribution of the bacterial ﬂora in the colon is layered,
what can be named biostructure. It means that one may identify
planktonic microﬂora and the ﬂora which comes in direct contact with
the mucus covering the colonic epithelium and exerts action on it.
R2253 SEM observations: pathogenesis of Candida infections in
a human skin model
A. Raz-Pasteur*, I. Berdicevsky (Haifa, IL)
Candida albicans, is regarded as the most common agent in fungal
infectios, but other Candida species have become a signiﬁcant cause of
infection. Scanning electron microscope (SEM) observations were used
to analyse the capability of C. albicans, C. tropicalis, and C. parapsilosis
to adhere to our human skin model which mimics the human skin in
vivo. The skin sections were inoculated with low (104ml-1) and high
(106ml-1) concentration of the yeasts for 1 and 5 days. The cells were
ﬁxed with glutaraldehyde and post ﬁxed with o5o4, dehydrated in serial
alcohol concentrations and viewed by SEM.
All three yeasts tested adhered to the skin but C. albicans covered
the entire skin surface to a higher extend than C. tropicalis and
C. parapsilosis, at the low concentration as well as the high one. Mucin
like material coated the blastocoridia mainly in C. albicans. After 5 days
of incubation all Candida species have shown bioﬁlm formation. These
results may give a partial explanation for the predominance in cutaneous
pathogenicity of C. albicans and explain why almost any C. albicans is
isolated from the skin.
R2254 Rapid identiﬁcation of ﬁve Candida species using Yeast
Trafﬁc Light PNA Fish
R.M. Humphries, P. Wollenberg, M.A. Lewinski, J. Dien Bard* (Los
Angeles, US; Kingston, CA)
Objectives: Candidemia are serious causes of morbidity and mortality,
particularly in the immunocompromised hosts. Although C. albicans
(CA) is still the most prevalent Candida spp. (CS) isolated from blood/
ﬂuid culture bottles (BFCB) at UCLA, other CS that are less susceptible
to ﬂuconazole (FLU) constitutes approximately 40% of all candidemias.
IDSA guidelines recommends selection of initial anti-fungal therapy
based on species identiﬁcation, therefore, rapid identiﬁcation of CS to
guide appropriate empiric therapeutics is warranted. This study evaluated
the performance of a rapid assay to identify CA, C. parapsilosis (CP),
C. tropicalis (CT), C. krusei (CK), and C. glabrata (CG) directly from
positive BFCB.
Methods: From March to November 2010, the Yeast Trafﬁc Light PNA
FISH™ kit (AdvanDx) was performed directly on yeast positive BFCB.
Peptide nucleic acid ﬂuorescent in situ hybridization (PNA FISH) was
also performed on a number of yeast isolates cultured on Sabouraud agar
(SAB). The assay targets the rRNA sequences of the ﬁve CS appearing as
green, yellow, and red for CA/CP, CT, and CK/CG, respectively. CA/CP
and CK/CG are differentiated by germ tube (GT) and rapid trehalose
assimilation. Conventional identiﬁcation methods were performed in
parallel for conﬁrmation.
Results: In the study period, PNA FISH was performed on a total
of 120 positive culture bottles and 11 SAB. 131 (100%) of yeast
specimens tested were correctly identiﬁed by PNA FISH as CA/CP
(24/31), CT (13), CK/CG (7/16) or other yeast (no ﬂuorescence). 91
(69%) of the isolates were deﬁnitively identiﬁed using the kit and
no cross-reactivity was seen with the other 34 specimens, including
C. dubliniensis, a ﬂuconazole resistant (R) yeast commonly misidentiﬁed
as CA. Of note, PNA FISH identiﬁed a mixed infection with CA and CG,
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an important ﬁnding since 40% of CG isolated at UCLA is R to FLU
(UCLA Antibiogram, 2009) and empiric therapy with an echinocandin
is preferred. Conventional methods would have been solely reported
CA from positive GT. Susceptibility testing by broth microdilution was
performed on 43 isolates and 4/9 (44%) CG was R to FLU.
Conclusions: The Yeast Trafﬁc Light PNA FISH™ kit identiﬁed
speciﬁc CS, directly from BFCB (1.5 h) or from colonies (24 h), with
100% sensitivity and speciﬁcity. Moreover, one mixed infection was
successfully detected. The ability to rapidly identify the majority of CS
is pertinent in selecting appropriate anti-fungal therapy.
R2255 Environmental pH changes, but not the LuxS signalling
pathway, regulates SpeB expression in M1 group A
streptococci
C. Chiang-Ni, P.X. Zheng, P.J. Tsai, W.J. Chuang, Y.S. Lin, C.C. Liu,
J.J. Wu* (Tainan, TW)
Objectives: The autoinducer-2/LuxS signaling pathway participates in
quorum-sensing in diverse bacterial species. In group A streptococcus,
LuxS has been shown to be involved in regulating expression of several
important virulence factors. Streptococcal pyrogenic exotoxin B (SpeB)
is a cysteine protease that has important roles in group A streptococcus
pathogenesis. In the present study, whether the autoinducer-2/LuxS
signaling pathway is participated in regulating speB expression in clinical
prevalent M1 strains were analyzed.
Methods: The speB expression of clinical M1 isolates A-20, GAS 602,
and their luxS isogenic mutants in different culture conditions were
analyzed by Northern hybridization and real-time RT-PCR. In addition,
the protease activities of these strains were analyzed by skim-milk agar
plates.
Results: We found that the supernatant harvested from an overnight
culture stimulated M1 strains to express speB. However, mutation of the
luxS gene in M1 strains or treating M1 strains with luxS mutant culture
supernatant did not affect speB expression, indicating that the LuxS
pathway is not involved in regulation of speB expression in M1 strains.
In addition, we found the acid property of culture broth can stimulate
M1 strains to express speB in the same LuxS-independent manner.
Conclusion: These results indicate that speB expression in M1 strains is
induced by environmental pH changes, but is not regulated by the LuxS
signaling pathway.
R2256 Role of Chlamydia infection in the pathogenesis of
vegetative state
J.I. Vaynshenker*, I.M. Ivchenko, L.A. Berezina, L.B. Kulyashova,
A.D. Korotkov, V.A. Zinserling, S.V. Medvedev (Saint Petersburg, RU)
Objectives: The treatment of patients in vegetative state is not
sufﬁciently elaborated. The primary injury of the brain leads to
autoaggresive damages of nervous tissue, suppressing immune response
and inﬂammatory process. The aim of the current research was to study
the special features of im-mune status of the patients in vegetative state
and the role of chlamydia infection in its mainten-ance.
Methods: 32 patients in vegetative state (23 males and 9 females aged
from 14 to 58 y.) with the period of unconscious state from 3.5 months
to 2 years were studied. All patients were examined using complex
neurological, neuroradiological, electrophysiological and immunological
methods. DNA, culture and serological methods were used for the
diagnostics of chlamydiosis.
Results: Diffuse atrophic processes without typical signs of demyeliza-
tion as well as glucose hypometabolism in different parts of brain were
revealed with neuroradiological methods in all patients. In most patients
were found the pathological changes in immune status: decreased number
of CD4+ cells (24 out of 32), disimmunoglobulinemia (30 out of
32), distortion of phagocytes function (30 out of 32) and decrease
of interferon production (29 out of 32). Speciﬁc antibodies against
C. trachomatis or C. pneumoniae were found in 25 patients, 10 of
them had cHSP 60 IgG. Five strains of C. trachomatis were isolated
on McCoy cells from cerebrospinal ﬂuid. In 4 cases of autopsy there
were found lesions due to Chlamydia with revealing the pathogen both
by PAS staining and immunoﬂuorescence. All patients with conﬁrmed
chlamydiases received speciﬁc antibacterial therapy, which allowed to
achieve notable improvement of communicative activity of patients. This
positive dynamics was observed during antibacterial treatment also later
(in 6 month–2 years). Improvement of glucose metabolism in some areas
of the brain was proved as well. According to “Glasgow Outcome Scale”
in 6 months–2 years good recovery was noted in 21% of patients.
Conclusion: The latent inﬂammatory immunopathological process
associated with chlamydia infection is present in patients in vegetative
state and should be taken in consideration during the examination and
treatment of these patients.
R2257 Herpes simplex virus inhibits spermatogenesis in murine
testis organotypic culture
V. Naumenko*, Y. Tyulenev, R. Klimova, L. Kurilo, L. Shileyko,
A. Kushch (Moscow, RU)
Objectives: Herpes simplex virus (HSV) is considered to contribute in
etiology of the male infertility, but the pathogenesis remains unclear.
Investigation of spermatogenesis is crucial for understanding the role
of infectious agents in male fertility disorders. Short-term culturing
of mice germ cells obtained from prepuberal mice before 10 days
postpartum (dpp) is suitable for analysis of spermatogonia differentiation
into spermatocytes, while pups testis before 19 dpp can be used for
modeling meiotic process in vitro. The aim of this study was to develop
organ culture system suitable for investigation of HSV inﬂuence on
murine spermatogenesis.
Methods: Testicular fragments from 9 dpp (Group I), 17 dpp (Group II)
pups and 20 weeks-old (Group III) DBA mice were cultured at 33ºC
for 6 days on the liquid-gas interface. DMEM supplied with 10%
serum, vitamins, insulin, transferrin, glutamine and pyruvate was used
for culturing. HSV-infected and uninfected fragments were analyzed by
morphological, virological and immunocytochemical methods.
Results: In Group I after 4 days of culturing we observed primary
spermatocytes in 19% of uninfected tubules, comparing with 8%
in infected ones (p< 0.05). In Group II pachytene spermatocytes
differentiated into round spermatids in 100% of intact tubules, while
HSV-infected cells passed through meiosis in 60% of tubules (p< 0.001).
In Group III we found decrease in number of tubules, containing
spermatocytes and round spermatids comparing with that of the control
(38% vs 63%, p< 0.001). Viral load in Group I was 22-fold higher than
in Group II and 40-fold higher than in Group III. Quantity of germ cells
containing viral antigens in Groups I, II, III was 90%, 70% and 5%,
respectively.
Conclusion: Culture system developed allow to investigate discrete
steps of normal spermatogenesis and abnormalities caused by infectious
factors. It was found that HSV disturbs spermatogonia differentiation and
meiosis and as a result population of spermatocytes and round spermatids
declines. Dramatic increase in viral yield and number of infected cells in
pups testis comparing with adult mice can be explained by the absence
of hemato-testicular barrier until 15−17 dpp.
R2258 Vibrio ﬂuvialis-stimulated secretion of interleukin-8 by
INT407 cells
G. Chowdhury*, G.P. Pazhani, T. Ramamurthy (Kolkata, IN)
Objectives: Vibrio ﬂuvialis is one of the causative agents of acute
diarrhoeal infection in Kolkata. However, mechanisms of pathogenesis
of this bacterium are not understood clearly as they did not harbour
any of the known virulence genes. In this study, we demonstrate that
V. ﬂuvialis strains can induce secretion of IL-8 from INT407 human
intestinal epithelial cells as detected by reverse-transcribed mRNA PCR
and the gene product secretion by IL-8 ELISA.
Methods: The cell-free culture supernatants of V. ﬂuvialis isolated from
acute diarrhoeal patients were assayed on INT407 cells. The infected
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and non-infected cells were incubated for different time periods. The
supernatants of culture medium collected at different time intervals were
lysed in Trizol and used in the IL-8 ELISA and RT-PCR. cDNA was
prepared from RNA by using the SUPERSCRIPT™ and RT-PCR was
performed by using the cDNA.
Results: We have shown that V. ﬂuvialis strains can induce IL-8
from INT407 cells. Incubation of the epithelial cells with V. ﬂuvialis
signiﬁcantly increased the levels of IL-8 mRNA in a time-dependent
manner, indicating that the induction of IL-8 production by V. ﬂuvialis
occurred at the mRNA level. In, RT-PCR, IL-8 mRNA expression was
evident in INT407 cells as early as 2 h and up to 24 h and G3PDH
demonstrated that the expression of transcripts for this constitutive
enzyme was unaffected (Fig). In ELISA, the IL-8 level of INT407 cells
was examined at various time intervals with V. ﬂuvialis infection. IL-8
secretion increased in up to 8 h (~755 pg/ml) (Fig. 1), and the amount of
secreted protein declined to 520 pg/ml at 24 h, indicating that the event
occurs in 4−8 h post infection.
Conclusion:We demonstrate that V. ﬂuvialis isolated from the diarrhoeal
patients can induce secretion of IL-8 by the INT407 cells. It is interesting
to note that these strains did not harbor any of the known virulence
gens markers associated with diarrhoea. Most these patients also had
blood in their stools. Recent studies have suggested that IL-8 secretion
may be an early signal for the acute inﬂammatory response following
bacterial infections. Our data suggest that secretion of IL-8 by intestinal
epithelial cells exposed to V. ﬂuvialis may be the initial signal for the
acute inﬂammatory response. We are also examining to elicit the cytokine
induction of other inﬂammatory response in intestinal epithelial cell lines
with following exposure to V. ﬂuvialis.
R2259 Antibiotic susceptibility pattern of Pseudomonas aeruginosa
isolates in patients with cystic ﬁbrosis
H. Fazeli*, R. Akbari, M. Sharare (Isfahan, IR)
Objectives: Pseudomonas aeruginosa accounts for about one half of all
pulmonary infections of cystic ﬁbrosis (CF) patients. Once established,
are difﬁcult to eradicate even with intensive antibiotic treatment, and
becomes predominant with age and predicts shortened CF survival. It is
important to monitor the antibiotic susceptibility pattern of P. aeruginosa
isolates to reduce morbidity and mortality in patients with cystic ﬁbrosis.
Methods: Patients with CF (median age 6/2 years) referred to Alzzahra
Medical Center in Esfahan between June 2003 and March 2008 were
included in the study. The diagnosis of CF was based on both clinical
and laboratory parameters. Fifty-nine CF patients were followed up
monthly in the Alzzahra Medical Center for evidence of P. aeruginosa
colonization of the respiratory tract. Antibiotic sensitivity of the mucoid
morphotype and nonmucoid morphotype was performed by using
the Kirby Bauer method and the following antibiotics; gentamicin,
ciproﬂoxacin, piperacillin, amikacin and ceftazidime (Hi Media, padtan
teb). P. aeruginosa ATCC 27853 served as the control strains.
Results: Antimicrobial susceptibility of the 21 P. aeruginosa CF
isolates was investigated by using 5 antibiotic and the resistance rates
according to NCCLS guidelines were as follows: Amikacin (9.5%),
Gentamicin (9.5%), Ciproﬂoxacin (14.2%), Piperacillin (19%) and
Ceftazidime (86%) (Fig. 1). The result showed that the majoritiy of
P. aeruginosa isolates were the most resistance to ceftazidime (86%).
Figure and Table will show at the full text.
Conclusions: Out of 11 resistance cases to at least one of four antibiotics
(GM, AN, PIP and CP), 9 (81.8%) isolates were mucoid that is higher
than in compared with two nonmucoid isolates (18.1%). 19 isolates
(90.5%) were found sensitive to gentamicin and amikacin. The 85.7%
of patients (6/7) harbored the isolates that was displayed resistance to
at least 2 antibiotics had repetitive hospitalization (at least two time).
The isolates of P. aeruginosa showed meaningful difference between
drug resistance to ceftazidime in compared to other antibiotics (PIP, CP,
AK, GM).
R2260 The culturability and virulence of Legionella cells during
desiccation
I. Gobin*, E. Pasic, M. Matesic, D. Rebic, D. Jurcic-Momcilovic,
M. Doric (Rijeka, HR)
Objectives: Legionellosis is a serious and sometimes fatal form of
pneumonia caused by the Legionella species. Most Legionella species
are found in aquatic environments where they have the ability to
reside and multiply in aquatic free-living amoeba. Some of species,
such as Legionella longbeachae, have the ability to grow in soil and
potting composts. The bacteria are transmitted to humans by aerosols
from natural and human-made aquatic environments or, in the case of
L. longbeachae infection, through exposure to contaminated potting soil.
The objective of this study was to assess the culturability and viability
of Legionella exposed to desiccation. Also, the role of Acanthamoeba
castellanii in possible resuscitation of viable but non-culturable (VBNC)
Legionella after desiccation was tested.
Methods: For desiccation study, bacteria were prepared in sterile water
and 5×20ml of bacterial suspension (~108 cfu/ml) were transferred in
96 wells plates and dried for 1 hour under laminar ﬂow hood. The plates
with dried Legionella, as well as plates with bacterial suspensions (wet
conditions) were stored at room temperature. Bacteria were rehydrated
and cultivated at different time points on BCYE agar. Bacterial viability
was assessed with the Bacterial Viability Kit LIVE/DEAD® BacLight™
dying before ﬂuorescent microscopy. At the same time, Legionella cells
exposed to desiccation were added to A. castellanii monolayers and
incubated for 48 hours.
Results: Both Legionella species could be cultivated on BCYE agar
only 24 hours after desiccation. Using ﬂuorescent microscope viable
Legionella cells could be detected up to 15 days of desiccation so bacteria
entered viable but non-culturable (VBNC) state. Our data show that
although L. pneumophila become non-culturable after desiccation, co-
culture with amoeba resuscitates the VBNC bacteria, with subsequent
intracellular proliferation within A. castellanii.
In conclusion, L. pneumophila and L. longbeachae exposed to
desiccation loss their culturability but remain viable and are able to
infect and proliferate in Acanthamoeba castellanii.
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R2261 BCG carrying ICL gene on plasmid shows increased
survival in mice
A.M. Szabo*, I. Faludi, A. Miczak (Szeged, HU)
Objectives: Tuberculosis is one of the most persistent human diseases.
No new anti-TB drugs have been introduced in the past 40 years, even
though their development becoming increasingly important to face new
challenges posed by multidrug resistant and extensively drug resistant
strains and by acute infection with Mycobacterium tuberculosis of HIV
positive patients. Isocitrate lyase (ICL) plays a pivotal role in the
persistence of M. tuberculosis in inﬂammatory macrophages and was
found to be important in virulence of many microbial pathogens.
Methods: TB-icl gene was ampliﬁed by polymerase chain reaction
(PCR) and cloned into the E. coli-mycobacterium shuttle plasmid
pMV262 to obtain recombinant shuttle plasmids pTB-icl. The plasmid
was electroporated into Bacillus Calmette-Gue´rin (BCG).
To compare the survival BCG and recombinant BCG (rBCG) were
injected to Apob(tm2Sgy)Ldlr(tm1Her/J) mice intraperitoneally either
with the rBCG or with BCG 106 colony forming units (CFU) in a
100 microliter total volume. Mice were sacriﬁced 10, 14, 21, 35 days
after the treatment. The titer of rBCG and BCG were determined from
homogenized lungs and spleens. Copy number of icl was determined by
qPCR.
Results: The titer of rBCG was 7 times higher than in BCG and after 21
days only rBCG could be demonstrated in both organs. Spleens were 3
times larger in rBCG infected mice. The copy number of this construct
was 29 in rBCG while in BCG was 1.
Conclusion: These data suggest that ICL plays a very important role in
the survival of mycobacteria and it gives potential to this enzyme as a
drug target against infections.
R2262 Role of cytokines in patients with arthritis and low back
pain brucellosis
A.R. Khalighi*, N. Saadati, R. Farid Hossainy, J. Tavakkol Afshari,
Sh. Kouhestani, B. Naghibzadeh (Mashhad, IR)
Objectives: Cytokines are secreted as the molecular products of different
cells in particular T-Lymphocytes which contribute in the processes
of immune responses. Therefore, the study may provide valuable
information regarding the function of cell mediated immunity (CMI)
in this disease.
Methods: This study was performed in the medical centers of Mashhad
University of Medical Sciences. 50 patients with Brucellosis & 50
normal samples were took part in this investigation. Diagnosis of the
disease was based on case history, clinical examinations & serological
tests.
Results: The levels of TNF-a, IL-2, IFN-g, IL-4 & IL-10 in serum
were measured using ELISA method. The levels of the random variables
IL-2 & IL-10 were tested by Kolmogorov Smirnov test & shown to be
normal (p< 0.05). Other cytokines including IL-4, IFN-g & TNF-a of
patients serum were not normal. The results indicated that the levels of
IL-10 in the sera of patients had increased (p< 0.001). IFN-g level had
increased in patients (p< 0.05). The level of IL-2 & IL-4 & TNF-a in
the sera of patients did’nt show any appreciable difference with those
of normal controls (p> 0.1). Kruskal-Wallis test showed a signiﬁcant
difference in IFN-g in both groups.
Conclusion: Our results would suggest a deﬁnite role of IFN-g & IL-10
in sera of the patients with arthritis & low back pain Brucellosis.
R2263 Frequency of virulence genes among different species of
Shigella isolated from Peruvian children under 2 years of age
A. Lluque, J. Ruiz*, A. Prada, T. Ochoa (Lima, PE; Barcelona, ES)
Objective: The aim of this study was to describe the presence and
frequency of 10 virulence genes in Shigella strains isolated from
Peruvian children under 2 years of age, with and without diarrhoea.
Methods: Ninety-nine Shigella spp. isolates were tested; 77 from
diarrhoea cases and 22 from healthy controls, from a cohort study in
Lima, Peru. The isolates were biochemically and serologically identiﬁed
as 66 S. ﬂexneri, 16 S. boydii, 14 S. sonnei and 3 S. dysenteriae.
The following virulence genes were studied by PCR: gene of virulence
related to serine protease autotransporters (SPATEs) (sigA, pic, sepA,
sat), Enterotoxins ShET 1 y ShET2 (set1A, set1B y sen) and genes
related to invasiveness (icsA, virA and ipgD).
Results: 75% of the strains analyzed presented sen, 69% sigA and 65%
sat genes. The most frequently genes found in diarrhoea cases were
icsA and virA (71%), sen (70%), and sat (68%); otherwise, the most
frequently in control cases were sen (95%), virA and icsA (91%), and
sigA (86%). sigA was most frequently in diarrhoea cases of S. sonnei
(100%) and control cases of S. ﬂexneri (93%) (p< 0.05).
The genes studied were found frequently in Shigella ﬂexneri strains. The
only strains that presented set1A y set1B in this study were S. ﬂexneri,
48% (25/52) diarrhoeae cases and 64% (9/14) control cases. No one case
of S. boydii, S. sonnei and S. dysenteriae presented sepA gen. 100% of
Shigella sonnei ampliﬁed sigA, 71% (10/14) sen, 64% (9/14) icsA, and
57% (8/14) virA and ipgD, in this group no one strain amplify sat. virA,
ipgD and icsA were present in all the three strains of S. dysenteriae
studied.
R2264 Phenotypic adaptation of Pseudomonas aeruginosa in two
different microenvirenments
V. Bayrakal*, I. Bahar (Izmir, TR)
Objective: Pseudomonas aeruginosa may show adaptive pathogenicity
according to microenviroment conditions. In this study, effect of
minimum inhibitory concentrations (MICs) and sub-MICs of gentamicin
(GN) and imipenem (IMP) treatment on P. aeruginosa which infected
HEp-2 and RD were determined.
Material and Methods: Potential phenotypic changes in P. aeruginosa
were determined by alkaline protease enzyme synthesis, quorum sensing
systems which las and rhl responses and bioﬁlm formation. Cellular
changes of HEp-2 (epithelial cell line) and RD (muscles cell line) were
determined by apoptosis, necrosis and nitric oxide responses following
infected by Pseudomonas aeruginosa PAO1 (lasI) and P. aeruginosa
PAO1 (wild type) strains (multiplicity of infection; m.o.i: 100:1) which
were treated by MIC, % 50 MIC and % 25 MIC concentrations of GN
and IMP following the infections, respectively.
Results: Bioﬁlm formation was detected in both cell lines following
infection by PAO1 (wild type) under the effect of all concentrations of
IMP whereas it was not detected in HEp-2 cell line under the effect of
50% MIC and 25% MIC of GN. Bioﬁlm formation was detected in both
cell lines which were infected by PAO1 (lasI) strain under the effect of
IMP and GN. The las system of the PAO1 (lasI) took place at MIC of GN
in RD cell lines and under the effect of 50% MIC and 25% MIC of IMP
in HEp-2 cell lines (conﬁrmed by PCR). The rhl system of the PAO1
(lasI) and these las and rhl systems of the PAO1 (wild type) took place
at MICs and sub-MICs concentrations of GN and IMP in both cell lines.
In PAO1 (wild type) and PAO1 (lasI) infected HEp-2 and RD cell lines
under the effect of GN and IMP concentrations showed apoptosis at a
rate of ninety percent. Nitric oxide responses were higher in PAO1 (lasI)
infected HEp-2 and RD cell lines, whereas alkalen protease responses
were positive in all groups.
Conclusions: Bacterial protein synthesis inhibitor and bacterial wall
synthesis inhibitor antibiotics create different microenvironments follow-
ing infected by different strains of P. aeruginosa. Cellular vitality and
secondary messenger responses of both cell lines changed while bacterial
phenotypic changes occurred also. This adaptation ability shows us the
real picture of the antibiotic-bacteria-microenvironment interactions in
translational clinical studies also.
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R2265 Antimicrobial activity of copper alloys compared to
aminoglycosides against multidrug-resistant bacteria
E. Kouskouni, I. Tsouma, I. Patikas, K. Karageorgou*, Z. Manolidou,
M. Tseroni, I. Agrafa, P. Efstathiou (Athens, GR)
Objectives: The emergence of multi-resistant bacteria against powerful
antibiotics and their transborder transmission constitute some of the most
threatening public health problems of the recent years. Metallic copper
alloys have recently attracted attention as a new antimicrobial agent, able
to minimize environmental contamination by pathogenic bacteria.
We investigated the efﬁcacy of a copper alloy (Cu63%-Zn37%) in
relation to aminoglycosides.
Methods:Multi-resistant bacteria, isolated from blood culture of patients
with signs of infection or fever appearing any time after 8 days
of admission into ICU, were selected. The samples were cultured
onto suitable culture media and bacterial isolates were identiﬁed
using standard methods. The isolated bacteria were: Escherichia coli,
Klebsiella spp, Acinetobacter baumannii, Pseudomonas aeruginosa,
Staphylococcus aureus, Enterococcus faecium.
Resistance genes were detected for up to 10 antibiotics, evaluated
with VITEK 2 System (bioMe´rieux) for identiﬁcation and antimicrobial
susceptibility test and the Minimum Inhibitory Concentration (MIC)
to determine the antimicrobial activity of a material against speciﬁc
bacteria and to control the activity of new antimicrobiological factors
were recorded and compared.
In the above procedure we used coupons (1x1cm) of copper alloys
containing (Cu63%-Zn37%) and Aminoglycoside discs.
Susceptibility testing was conducted by Kirby Bauer disc diffusion
method on “Miller Hinton Agar” in which an aminoglycoside disc was
placed at 3cm distance from the copper coupon. This procedure was
followed for each isolated pathogen.
Results: After 24-hour and 48-hour incubation periods, the inhibition
zone bacteria around the antibiotic disc as well as around the copper
coupon were recorded.
The inhibition zones of antimicrobial copper were equal to those
of aminoglycisides for E. coli and Klebsiella spp, were smaller for
Pseudomonas aeruginosa, and Enterococcus faecium and larger for
Staphylococcus aureus and Acinetobacter baumannii respectively.
Conclusion: The copper alloy exhibited antimicrobial activity against all
multidrug resistant bacteria studied. The inhibition zone of our speciﬁc
cooper alloy was increased, compared to that of aminoglycosides for
Staphylococcus aureus and Acinetobacter baumannii. It should be noted
that the reduction of bacterial load in a hospital where antimicrobial
copper is used, leads to drastic reduction of antibiotic use.
R2266 Decidual inﬂammatory mediators: implication in pre-term
labour with intrauterine infection
V. Castro-Leyva*, S. Giono-Cerezo, E. Hernandez-Andrade, A. Espejel-
Nun˜ez, J. Beltran-Montoya, G. Estrada-Gutierrez (Mexico City, MX)
Background: Increased risk of preterm labour has been linked to
cervicovaginal infection. Bacteria colonising the lower genital tract
may ascend to the gestational tissues, triggering an inﬂammatory
response mediated primarily by pro-inﬂammatory cytokines, matrix
metalloproteinases and prostaglandins.
Objective: The aim of this study was to determine if decidual cells
produce inﬂammatory mediators implicated in preterm labour during
intrauterine infection.
Methodology: Fetal membranes were obtained after caesarian section
from 10 healthy women with normal pregnancies at term with
no evidence of labour, and from 10 women with preterm labour
and conﬁrmed intrauterine infection [Ureaplasma urealyticum (2),
group B streptococci (3), Gardnerella vaginalis (3), Escherichia coli
(2)]. Decidua was scrapped and decidual cells were obtained and
cultured overnight. Secretion of anti-inﬂammatory cytokines (IL-2, IL-4,
IL-10), pro-inﬂammatory cytokines (IL-6, IL-8, IL-1b and TNF-a), and
matrix metalloproteinases (MMP-1, MMP-2, MMP-3, MMP-7, MMP-8,
MMP-9) was evaluated in the supernatants using the Bio-Plex System.
Additionally, prostaglandin E2 (PGE2) was measured by ELISA.
Results: We found a signiﬁcant increase of pro-inﬂammatory cy-
tokines and a signiﬁcant decrease of anti-inﬂammatory cytokines in
supernantants from decidual cells obtained from women with preterm
labour and intrauterine infection compared with women with normal
pregnancies. Likewise, secretion of MMP-1, MMP-8, MMP-9 and PGE2
was signiﬁcantly higher.
Conclusions: These results suggest that decidual cells promote a pro-
inﬂammatory microenvironment during intrauterine infection leading to
preterm labour.
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R2267 Clinical experience of use of taurolidine in varied complex
clinical cases
M. Qazi*, A. Guleri (Blackpool, UK)
Background: Taurolidine citrate [Taurolock™] is licensed as a medical
device. Literature reveals its predominant use as a venous line locking
system to prevent catheter line infections. Taurolidine has antimicrobial,
antimycotic, antiadherent and antiendotoxic properties. The antimicrobial
properties extend across multiresistant organisms. We present here
clinical experience of taurolidine use in four very complex varied cases
and an overview of taurolidine use at Blackpool Victoria Hospital.
Methodology: Case notes review of 10 cases over 2-years [ including
the complex cases] were undertaken.
Results: All cases were discussed between primary consultant and
Microbiologist. The patients included were treated in a variety of hospital
settings:including cardiology ward, cardiac intensive care unit, cardiac
high care, general surgical ward, surgical high care, intensive treatment
unit and general medical ward.
The 10-cases included 6-males [av age 59.2-years] and 4-females [av
age 57-years]. All cases were discussed between primary consultant
and Microbiologist. 70% [7/10] use as a line lock was for new (long
term) hickman lines following removal of previous infected line. 30%
was for salvage of colonised lines. Linelock use included haematology
patients on chemotherapy as well as surgical patients on total parenteral
nutrition. Average duration of use was 18-doses. 77.8% of patients
received simultaneous systemic antibiotics. In 33.3% of cases salvage of
colonised line with taurolidine failed and infected line was removed. In
66.7% there was successful outcome. 88.9% of patients were discharged
home after successful outcomes.
Complex cases: A complex surgical case with enterocutaneous ﬁstula,
over a dozen episodes of candidaemia, multiple central line infections
had a successful outcome with taurolidine locked hickman line.
Two complex thoracic cases with Pseudomonas infection had a
successful outcome following taurolidine pleural irrigation.
Complex case of aortic root graft re-infection with pseudomonas
underwent mediastinal irrigation before VAC dressing. Cases to be
presented.
Conclusion: Successful outcomes with taurolidine-citrate, licensed as a
medical device, ﬁnds its place in several case reports. Our complex cases
indicate its potential outside of its use as a line lock to prevent infections
in long term venous catheters. Further large randomised studies on
taurolidine citrate are required. Cases to be presented.
R2268 The polyclonal anti-TNF immune Fab AZD9773 neutralises
human TNF-a biological activity in vivo
P. Newham*, P. Ceuppens, J. Growcott (Macclesﬁeld, UK)
Objectives: AZD9773, comprising ovine-derived polyclonal anti-TNF-a
Fab fragments, is intended for intravenous infusion to treat severe sepsis
and septic shock. As AZD9773 is highly speciﬁc for human TNF-a,
preclinical in vivo studies were undertaken to assess its effect on recom-
binant human TNF-a (rhTNF-a)-induced lethality in D-galactosamine
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(D-gal)-sensitised mice and lipopolysaccharide (LPS)-induced endotox-
aemia in humanised TNF-a transgenic (Tg1278/TNF−/−) mice (Tgx
mice), respectively. D-CytoFab, an earlier experimental version of
AZD9773, demonstrated to have a clinical beneﬁt in patients with severe
sepsis and septic shock, was included as a comparator.
Methods: rhTNF-a-induced lethality: female BALB/c mice received
intraperitoneal (i.p.) rhTNF-a (5.9×105 IU/mouse), D-gal (18mg/mouse)
and 0–110 U/mouse D-CytoFab or AZD9773. Mouse survival was
monitored for 36 h. Endotoxemia: Tgx mice received high (845 U/kg)
and low (84 U/kg) i.p. doses of AZD9773 or D-CytoFab 2 h prior
to LPS challenge (10mg/kg, i.p.) and were sacriﬁced 2 h post-LPS
challenge, with terminal bleeds for AZD9773/D-CytoFab and serum
cytokine analyses. AZD9773 (0–850 U/Kg, delivered i.p. 2 h pre- i.p.
LPS dose) effects on human TNF-a and a large panel of serum
murine cytokines were determined 2 h post-LPS challenge. AZD9773,
D-CytoFab, human TNF-a, and mouse cytokines were determined by
enzyme-linked-immunosorbent assays.
Results: AZD9773 and D-CytoFab comparably (based on equivalent unit
dosing) protected BALB/c mice from human TNF-a induced mortality. In
the Tgx mice, high-dose AZD9773 or D-CytoFab signiﬁcantly reduced
LPS-induced serum human TNF-a and murine IL-6, 2 hours post-
LPS (p< 0.01). Similar effects on cytokine suppression were observed
when AZD9773 and D-CytoFab serum levels were unit normalised. LPS
challenge in Tgx mice resulted in the expression of 42 cytokines. Pre-
treatment (LPS −2 h) with AZD9773 resulted in a dose-related exposure
(measured 4 h post-i.p. dose). AZD9773 doses of 850 and 425 U/Kg
resulted in statistically signiﬁcant reductions in 29 and 22, respectively,
out of the 60 cytokines measured (including human TNF-a, IL-2, IL-4
and IL-6).
Conclusion: AZD9773 has been shown to be an effective anti-TNF-a
agent in two separate human TNF-a mouse models. AZD9773 biological
activity did not signiﬁcantly differ from that of D-CytoFab.
R2269 Hyperbaric oxygen and medical ozone as adjuvant therapy
in a murine model of streptococcal myositis
O¨. Coskun*, S. O¨ter, S. Sadir, O. Bedir, E. O¨ztas, B. Uysal, M. Seyrek,
C. Eyigu¨n (Ankara, TR)
Severe streptococcal infections lead to serious tissue damages. Myositis
is an example of these conditions. Systemic antibiotic therapy is the
principle course of treatment in necrotizing soft tissue infection. Clinical
trials have also shown Hyperbaric Oxygen (HBO) therapy to be effective
in streptococcal myositis patients. Ozone (O3), known as a cytotoxic
gas, has recently been shown to support immune system by activating
oxidative mechanisms and increasing pro-inﬂammatory cytokines.
In this study, we compared the effectiveness of antibiotherapy, HBO and
O3 application on bacterial growth and wound recovery in a murine
model of streptococcal myositis.
Forty-ﬁve male Sprague-Dawley rats were divided in ﬁve groups.
Myositis was caused by inoculation of 0.15ml 0.5 McFarland
streptococcus pyogenes to thigh region in the four groups other than
the Sham group. Normal saline was given to the rats in one of the four
groups as a control, whereas other three groups were treated by penicillin
G (98mg/kg in 0.25ml intraperitoneally 2X1), HBO (100% oxygen, 2,5
Atm. 90 min. 2X1) and ozone (1mg/kg 1X1 intraperitoneally).
At the seventh day, histological and bacterial investigations were done
on soft tissue specimens taken from thigh region. There was signiﬁcant
difference in response to therapy in all of the three groups compared to
control group (p< 0.05). Antibiotic and ozone groups were also more
successful than HBO (p< 0.05). Ozone group yielded better results than
that of antibiotic group (p< 0.05).
Our results conclude that Ozone therapy should be used in addition to
antibiotic treatment in serious infections such as myositis.
R2270 Limited value of MRI to detect apoptotic injury of the
hippocampus in experimental meningitis
J. Gitz Holler, L.V. Søgaard, C. Brandt, S. Leib, I. Rowland,
C. Østergaard* on behalf of ESCMID Meningitis Study Group − EMESG
Objective: Increased neuronal apoptosis in the hippocampus is a well
described brain pathological characteristic for pneumococcal meningitis
and is associated with learning difﬁculties in experimental models of the
disease (1). The present study hypothesized that in vivo measurement
of water diffusion (apparent diffusion coefﬁcient − ADC) in the
hippocampus of rats with pneumococcal meningitis could disclose the
risk of neuronal apoptosis.
Methods:Meningitis was induced by injecting rats i.c. with 106 CFU/ml
S. pneumoniae serotype 3 (n = 35) or beef broth (n = 8). The study
comprised of four experimental groups: I. meningitis; II. meningitis
with attenuated bacteremia (treated with speciﬁc antipneumococcal
antibodies); III. meningitis with early onset bacteremia (additional i.v.
injection of pneumococci); IV. broth injected controls (2).
MRI images were acquired 28 and 38 hours after infection using a SISCO
4.7T imaging system. T1W, T2W, quantitative diffusion and dynamic
MRI measurements were performed.
After imaging brains were harvested for histopathology. ADC maps
were calculated from images acquired with b-values of 0, 185, 740 and
1665 s/mm2. Regions of interest were drawn around the hippocampus
on 2 consecutive coronal brain slices and a mean ADC measured with
MIPAV (ﬁg. B). On histopathological specimens, neurons with apoptotic
morphology in the dentate gyrus of the hippocampus were scored. Image-
and specimen analysis was performed blinded to the experimental design.
For statistical analysis of correlations p< 0.01 was considered signiﬁcant.
Results: No association between hippocampus ADC and apoptosis
scores was found either including (Spearman Rank, Rho = 0.38,
p = 0.011) or excluding the very homogenous uninfected control group
(Rho = 0.019, p = 0.92), ﬁg. A. High ADC values was found in the
hippocampus of infected rats, and was signiﬁcantly increased among
all groups of infected rats compared to uninfected controls except the
attenuated bacteremia group (Kruskal-Wallis, p = 0.0001, Dunn’s post-
test p< 0.05). Similarly, apoptosis scores were signiﬁcantly increased
among infected rats compared to uninfected controls (p = 0.0002), ﬁg. C.
Conclusion: In vivo hippocampus oedema measured by ADC was
not correlated to the rate of neuronal apoptosis. For the evaluation of
apoptotic injury in the hippocampus, histomorphometry remains the gold
standard.
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R2271 Efﬁcacy of ertapenem, zosyn and tygacil in a mixed infection
rat intra-abdominal abscess model with ESBL E. coli
W. Weiss*, M. Pulse, P. Renick, P. Nguyen, J. Pierce, D. Valtierra,
M. Kukula, J. Simecka (Fort Worth, US)
Objectives: Complicated intra-abdominal infections (IAI) are among
the most common infections in general surgery with morbidity and
mortality rates as high as 59% and 21%, respectively. There is also an
increasing prevalence of resistant Enterobacteriaceae in these nosocomial
infections. The present study was conducted to evaluate the in vivo
efﬁcacy of ertapenem (ERT), Zosyn® (ZSN) and Tygacil® (TYG) in an
experimental intra-abdominal infection model in rats with Bacteroides
fragilis (Bf) and an extended spectrum b-lactamase (ESBL) producing
Escherichia coli (Ec) expressing CTX-M-15.
Methods: Cultures were grown on appropriate media and diluted in
either brucella broth for Bf or trypticase soy broth for Ec. Inoculums
of 107 CFU for Bf and 105 CFU for Ec were added to a size 1
gelatin capsule ﬁlled with sterile rat fecal contents. Capsules were
surgically implanted into the lower left quadrant of the abdomen of male
Sprague-Dawley rats and sutured closed. Treatment was administered
intravenously and initiated 4 hrs after implantation then continued twice-
a-day (bid) for three days with either 50mg/kg ERT, 700mg/kg ZSN or
25mg/kg TYG. Abscesses were aseptically removed 18−24 hrs after the
last administered dose, plated on appropriate media and conditions to
determine bacterial counts for both the Bf and Ec isolates.
Results: Susceptibility testing on the Bf and Ec isolates used in this
model demonstrated MICs of 0.03 and 0.03mgmL for ERT, 0.5 and
16mgmL for ZSN and 0.125 and 0.25mgmL for TGY, respectively.
Abscesses from the untreated control group exhibited mean log10 CFU
burdens of 8.86 for Bf and 9.44 for Ec on day 5. ERT treatment resulted
in mean log10 CFU reductions of 2.43 for Bf and 3.89 for Ec as
compared to the untreated controls. ZSN and TYG were less efﬁcacious
with log10 CFU reductions of 0.12 and -0.13 for ZSN and 0.23 and 0.40
for TGY against the Bf and Ec isolates, respectively.
Conclusions: The increased prevalence of ESBL producing Enter-
obacteriaceae and their role in complicated IAI points to the need
for more effective therapies against these antibiotic resistant bacteria.
Carbapenems, such as ertapenem, remain efﬁcacious for serious
infections such as IAI and further testing is warranted to optimize dosing
regimens for maximal efﬁcacy and determine the potential for selection
of antibiotic resistance.
R2272 Efﬁcacy of levoﬂoxacin and gentamycin against a
uropathogenic strain of Escherichia coli in a mouse urinary
tract infection model
M. Pulse*, P. Nguyen, J. Pierce, W. Weiss, J. Simecka (Fort Worth, US)
Objectives: Due to the continued need to evaluate antibiotics for the
treatment of urinary tract infections (UTIs), a mouse UTI model was
developed by our lab to determine the efﬁcacy of antibiotics against
uropathogenic Escherichia coli (UPEC). Here, we describe the efﬁcacy
of levoﬂoxacin and gentamicin against a susceptible UPEC isolate in the
animal model.
Methods: Female C3H/HeJ mice were placed on 5% glucose water
6 days prior to infection. Anesthetized animals were transurethrally
infected with a strain of E. coli that is uropathogenic but antibiotic
susceptible (gentamicin and levoﬂoxacin MICs of 0.5 and 0.06mgmL,
respectively) at 8.9 log10 CFUs per animal. Beginning 4 days after
infection, gentamicin and levoﬂoxacin were dosed subcutaneously (s.c.)
twice daily for 3 consecutive days. Kidneys, bladders, and urine were
collected 18 hours after the ﬁnal dose, and the tissue homogenates
(kidneys and bladders) and urine were plated for CFU counts. Efﬁcacy
was determined by comparing the mean CFU of treated groups to
untreated controls.
Results: The mean CFU counts in the kidneys and bladders of untreated
control animals increased from 5.4 and 5.2 log10 at 4 days post-infection
to 6.2 and 6.7 log10 after 7 days, respectively. The urine counts for
untreated controls (3.5 log10 CFU) remained unchanged on days 4 and
7. When compared to 7-day untreated controls, levoﬂoxacin dosed s.c.
at 0.03 to 2mg/kg over three days decreased mean log10 CFU counts in
kidneys by 2.0 to 2.8, bladders by 3.1 to 3.7, and urine by 0.1 to 0.8.
Similarly, s.c. doses of gentamicin ranging from 0.125 to 8mg/kg over
three days effectively reduced mean log10 CFU counts in kidneys and
bladders by 2.1 to 3 and 1.3 to 3.4, respectively. Additionally, the urine
counts in gentamicin treated animals were maximally decreased by 2.5
mean log10 CFU when compared to 7-day controls.
Conclusion: The mean CFU counts in the kidneys, bladders, and urine
of 4- and 7-day control groups suggested that a stable, ascending UTI
was established in the animal model. Dose responses for levoﬂoxacin
and gentamicin were observed, and while similar efﬁcacy results were
seen in the kidneys and bladders, a greater reduction in urine counts
was observed for gentamicin treated animals. These results suggest that
the described mouse model can be useful in evaluating and comparing
antibiotics that treat UTIs caused UPEC.
R2273 An invertebrate model of infection to evaluate virulence in
A. fumigatus
A. Gomez-Lopez*, J.L. Slater, L. Gregson, E. Cendejas, E. Mellado,
S.J. Howard, W.W. Hope, J.L. Rodriguez-Tudela, M. Cuenca-Estrella
(Majadahonda, ES; Manchester, UK)
Objectives: The impact of acquired resistance mechanisms on
Aspergillus fumigatus in terms of virulence and ﬁtness is not yet
well understood. Virulence of fungal pathogens has traditionally been
determined using lethal infections in mammalian hosts such as mice or
rats (the gold standard) although some have used an invertebrate host,
which has demonstrated almost complete correlation with mice. Here we
describe the use of Galleria mellonella as an alternative model to assess
differences in virulence between A. fumigatus wild-type strains and
different derived isogenic single mutants. Furthermore in vitro growth
rates of the different mutants were compared.
Method: A total of 9 A. fumigatus strains were studied, including
the parental strain (wild type for the gene encoding the azole target
cyp51A) and 8 different derived mutants strains with altered cyp51A
alleles (non-synonymous point mutations at codons 54, 98 and 220 in the
Cyp51Ap), which confer changes in antifungal drugs susceptibility. Ten
larvas of G. mellonella per group were infected with each strain (104 and
105 ufc/larva) in duplicate, incubated in plastic containers at 37ºC and
monitored daily for survival. Survival among groups was compared using
Mantel-Cox tests (GraphPad Software Inc, La Jolla, CA, USA). Growth
kinetics assays in solid (Potato Dextrose Agar and Minimal Medium)
and liquid media (RPMI2%glucose) were also performed in order to
better characterize the growth rate of these strains. Differences between
growth parameters were calculated and compared.
Results: Under the conditions used in this study, all the A. fumigatus
strains (wild type and mutants) were able to kill G. mellonella larvae
equally. All strains caused <15% or <30% mean survival of larvae 6
days post injection of 105 and 104 ufc/larva respectively. In addition, no
signiﬁcant difference in virulence between groups were detected between
the inocula size tested (P = 0.9 and P = 0.3 respectively). Results from the
in vitro growth experiments showed no signiﬁcant differences in radial
growth rate of the wild type compared to the mutant strains. The kinetic
evaluation of growth over time in liquid RPMI medium also supported
these ﬁnding.
Conclusions: Mutations involving cyp51 genes of A. fumigatus which
confer changes in susceptibility to azoles are not associated with
signiﬁcant alterations of virulence. G. mellonella could provide a
reproducible infection model for A. fumigatus in screening studies.
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R2274 Infectivity of Aerococcus urinae in an ascending urinary
tract infection mouse model
H. Holst, J.M. Andersen, N. Frimodt-Møller, B. Nu¨rnberg,
J.J. Christensen* (Copenhagen, Roskilde, Slagelse, DK)
Objective: Aerococcus urinae has recently been associated with urinary
tract infection (UTI). It resembles staphylococci in Gram stain and
a-haemolytic streptococci on blood agar. Strains have been recognized
worldwide, isolated from 0.3−0.8% of urine specimens and found
resistant to several antibiotics, used for treating UTI. Also, strains
have been isolated from blood from patients suffering from urogenic
bacteraemia/septicemia, often complicated with endocarditis. However,
the pathogenic potential of A. urinae in UTI has been questioned. We
therefore examined the pathogenic potential of A. urinae strains in a UTI
mouse model.
Materials: Six A. urinae strains were used; one blood-culture strain
and ﬁve urine strains. Outbred female albino mice (Ssc-CF1 mice) were
used. Trans-urethral inoculation of anesthetized mice was done with a
plastic catheter, which was gently inserted to the top of the bladder and
the bacterial suspension injected. Urine from each mouse was collected
by gentle compression of the abdomen. Mice were afterwards killed
by cervical dislocation, and organs (bladder, kidneys) were removed
aseptically and homogenized in PBS. The CFU/ml of urine, per bladder,
or per kidney were determined after 18 to 24 h of incubation at 35ºC
(lower detection limit was 50 CFU/ml).
Results: Three strains, were used to optimize conditions. These were
overnight growth on 10% DBA, inoculum volume of 200ml, 2 days
observation period and an inoculum of 2×108 CFU/ml. Afterwards
3 additional strains were included. Presence of bacteria were most
pronounced in the urine and to a lesser extent in bladder and
kidney tissue. All strains could be isolated from either urine, bladder
and/or kidney tissue after two days incubation, though a difference in
concentration of bacteria/ml and number of mice colonized/infected was
observed (Table 1). Prolonged infective episodes were not observed (2
strains; 1−2−3−4−7−14−21 days). A septicemic phase was not detected
by culture of blood drawn at various periods after inoculation (2 strains;
1−3−6−24h; 2−3−7−14−21 days).
Conclusion: All 6 strains of A. urinae examined could mostly be
detected from urine and kidney tissue, while bladder infection was less
obvious than seen for E. coli. This indicates a present but low pathogenic
potential of the strains in this model. A systemic spread of the bacterium
did not take place and the infection established was selﬂimiting.
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R2275 Activities of tigecycline and vancomycin
H. Aslan, N. Yapar* (Izmir, TR)
Objective: Today, intravenous catheters, the most common cause of
bloodstream infections, led to high mortality, prolonged hospitalization,
and increasing costs. Staphylococci constitute 75−90% of all catheter-
related infections. Coagulase-negative staphylococci are responsible for
35−50% of these infections and more adhesive to plastic catheters
than other microorganisms. Methicillin-resistant Staphylococcus aureus
(MRSA) is in the second place (15−20%) of the most common
factors after the coagulase-negative staphylococci. Treatment options for
catheter infections related to MRSA are restricted. Tigecycline is a broad-
spectrum, well tolerated, injectable and new glycylcycline antibiotic. In
this study, in an in vitro MRSA bioﬁlm model, we aimed to compare
the efﬁcacy of tigecycline and vancomycin.
Methods: Silicone disks were incubated in human plasma for 24 hours
and then in the suspension of MRSA for 24 hours for bioﬁlm formation.
Disks were exposed tigecycline and vancomycin for 24 hours and 5 days
of 4-hour daily in the model of antibiotic lock therapy. After incubation,
the disks were placed into saline solution for 15 minutes. Finally, the
tubes were vortexed and from each tube, 100-mL of the solution was
inoculated onto 5% sheep blood-Trypticase soy agar plates. The plates
were incubated overnight at 37ºC and the colonies were counted.
Results: Colony forming unit counts of MRSA decreased from 100 000
cfu/mL to 510 cfu/mL in the tigecycline group and from 100 000 cfu/mL
to 3 800 cfu/mL in the vancomycin group. The difference between
the vancomycin and tigecycline groups was statistically signiﬁcant
(p< 0,001). In antibiotic lock therapy tests, bacterial growth was not
detected on second day in tygecycline group and on ﬁfth day in
vancomycine group.
Conclusion: Under in vitro conditions, tigecycline is more effective
against MRSA bioﬁlms than vancomycin. This result suggests that
tigecycline can be a good treatment of choice for catheter-related
infections. However, its introduction to clinical use requires further
clinical studies.
R2276 Evaluation of bioﬁlms formation of standard ﬂuconazole-
resistant strain of Candida albicans on PVC and catheters
coated with TiO2 nanoparticles by XTT assay
F. Haghighi, S. Roudbar Mohammadi, P. Mohammadi* (Tehran, IR)
Objective: Candida albicans is the major fungal pathogen of
immunocompromised Patients. Nowadays fungal infections especially
candidiasis have signiﬁcantly increased. Limitations in treatment of
fungal diseases include drug resistance and side effects due to search
for a new antifungal agents and using replacement new compounds such
as nanoparticles. In this study fungal bioﬁlms formation of Fluconazole
resistant strain of C. albicans on PVC (Polyvinyl Chloride) and Catheter
coated with TiO2 (Titanium dioxide) nanoparticles was evaluated.
Methods: TiO2 nanoparticles were synthesized with sol-gel method and
hydrolysis of precursor Titanium tetrachloride and were assessed with
Scanning Electron Microscope (SEM). Small pieces of PVC and Catheter
were prepared (1 cm2) and coated with dip coating method. Candidal
bioﬁlms formation was formed in 12-well tissue culture plates. Standard
Fluconazole resistance strain of C. albicans (ATCC 76615), was used
for the bioﬁlms forming yeasts and cell suspension regulated at 1×106
cells/ml. The yeast cells were incubated for 2 h at 370C in 1ml of 1%
BSA then 80ml of C. albicans cell suspension was inoculated. The yeast
cells were allowed to adhere to the surface at 37ºC for 90 min. After
this time the discs were gently submerged with 4ml of YNB medium.
The plates were incubated at 370C for 48 h. After incubation, fungal
bioﬁlms formation samples were evaluated by standard XTT reduction
assays and SEM.
Results: Concentration of TiO2 solution was 7.03mg/ml 5.63×1020
particles/ml. Morphology and diameter properties of the TiO2 nanopar-
ticles with SEM showed that nanoparticles were spherical with diameter
between 40−65nm. Optical density of survival cells in coated samples
was less than control samples (not treated) and was determined for
PVC 0.158± 0.07 and Catheter 0.142± 0.01 in comparison of controls
0.253± 0.04 and 0.359± 0.05 in order. Data of treated samples showed
signiﬁcant difference with control samples (p< 0.05). Also the images
of SEM showed that fungal bioﬁlms didn’t form in coated samples.
Conclusion: According to our ﬁndings, coatings of TiO2 were showed
suitable antifungal activity in comparison of other antifungal agent. Thus
overall these results indicate that a potential therapeutic application of
TiO2 and further investigations need that it could be represent candidates
in elimination of Fluconazole resistance strains of C. albicans in ﬁeld
of medical especially in medical devices.
R2277 Detection of bioﬁlm formation among the clinical isolates
of Acinetobacter baumannii
A. Hassan*, J. Usman, F. Kaleem, M. Omair, A. Khalid (Rawalpindi, PK)
Introduction: Acinetobacter baumannii has emerged as a signiﬁcant
nosocomial pathogen, particularly in intensive care units. Ability of
this organism to form boﬁlms puts a further strain on the helath care
system. Acinetobacter baumannii growing in a bioﬁlm are associated
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with chronic and recurrent human infections and highly resistant to
antimicrobial agents.
Objective: We have conducted this study to detect the bioﬁlm formation
among Acinetobacter baumannii isolated from a tertiary care hospital.
Materials and Method: The study was carried out at the Department
of Microbiology, Army Medical College/National University of Sciences
and Technology, Pakistan, from June 2010 to November 2010. A
total of 110 A. baumannii isolated from various clinical specimens
were investigated for bioﬁlm production. Isolates were identiﬁed by
standard microbiological procedures (Gram’s stain appearance, colonial
morphology, catalase test, cytochrome oxidase reaction, motility, API
20NE). Isolated organisms were subjected to tissue culture plate method
and tube method for bioﬁlm detection.
Results: From the total 110 clinical isolates of A. baumannii, the tissue
culture plate method detected 22.7% as high, 41% moderate and 36.3%
as weak or non producers of a bioﬁlm. The tube method correlated well
with the TCP method for identifying strong bioﬁlm producers, but it was
hard to differentiate between moderate, weak and non-bioﬁlm producers
due to the changeability in observed results by different observers.
Conclusion: Frequency of bioﬁlm forming A. baumannii is high in our
set up. The tissue culture plate method is an accurate and reliable method
for detection of bioﬁlm formation in A. baumannii. Tube method cannot
be suggested as general screening test to identify bioﬁlm producing
isolates. TCP is an easy to do method which can be advised for detection
of resistant bacteria.
R2278 First results of bacteriological examination of bladder wall
in patients with recurrent lower urinary tract infections
and interstitial cystitis/painful bladder syndrome
L. Siniakova*, V. Zhukhovitsky, M. Sukhina, M. Shteinberg, N. Vinarova
(Moscow, RU)
Objectives: The aim of our study was to examine bladder wall in patients
with recurrent lower urinary tract infections (RLUTI) and interstitial
cystitis/painful bladder syndrome (IC/PBS) for the presence of infectious
agents to improve diagnosis and treatment of these diseases.
Materials and Methods: In 2010 in our clinic 33 women aged
19−53 years with RLUTI (n = 23) and IC/PBS (n = 10) had undergone
cystoscopy with biopsy and subsequent pathological and microbiologic
examination. The bladder mucosa was cultured for allocation of pure
culture and assessment of antibiotic resistance. The ability of isolated
cultures to form a bioﬁlm on abiogenic media was evaluated by
bacteriscopy and bacteriologically (analyzer “BioTrac 4250”).
Results: Microﬂora in bladder wall was isolated in the majority of
patients (n = 32) with severe symptoms despite the lack of bacteriuria in
a greater proportion of patients with RLUTI (n = 17) and IC/PBS (n = 9)
with inﬂammation and dysplasia. Mixed infection took place in 6
cases of IC/PBS. The representatives of the family Micrococcaceae
(Staphylococcus spp., Kocuria spp.) and gramnegative nonfermentative
rod-shaped bacteria of the genera Burkholderia, Flavimonas, Brevundi-
monas, Acinetobacter were elucidated. A monoculture was allocated in
3 patients. The microﬂora growth was 1×103−1×105 CFU/ml in all
23 patients with RLUTI. The same bacteria as well as Pseudomonas,
and Proteus mirabilis were allocated. Monoculture was also isolated
from three patients. Micrococci genus Kocuria, Staphylococcus and
Acinetobacter demonstrated the ability to form bioﬁlms in vitro.
Conclusions:
1. Identiﬁcation of pathogens in the bladder wall of patients with IC/PBS
conﬁrms the role of infection in the etiology and pathogenesis of this
disease.
2. Both pathology and microbiology examinations of biopsy samples
should be performed in patients with RLUTI.
3. Etiological treatment of patients with RLUTI should include bioﬁlm
penetrating drugs.
R2279 Quartz crystal microbalance − a useful tool for evaluation
of Pseudomonas aeruginosa bioﬁlm formation
G. Gula*, M. Swiatkowski, K. Waszczuk, J. Olszewski, Z. Drulis-Kawa,
J. Gutowicz, T. Gotszalk (Wroclaw, PL)
Objectives: Persistent of bacterial bioﬁlm type growth attached to
the biotic or abiotic surfaces is known problem for a few decades.
There are two main groups of methods used for evaluation of bacterial
community − colorimetric or ﬂuorescence assays and various types of
microscopy visualization. In this paper authors present a new tool for
analyzing bacterial bioﬁlm growth, based on crystal oscillators: quartz
crystal microbalances (QCM). Authors tested the method for two bioﬁlm
model Gram-negative strains Pseudomonas aeruginosa ATCC 27853 and
Pseudomonas aeruginosa PAO1.
Methods: QCM disc inside liquid cell was sterilized in an autoclave
before experiments. For the experiments, refreshed bacterial strains were
suspended in a Mueller Hinton broth (Becton Dickinson and Company,
Cockeysville, MD, USA) to an optical density equal to the McFarland
No. 5 (108 cells per milliliter). The culture was diluted 100-fold and
one milliliter of culture containing 106 cells was added to the ﬂow cell
containing QCM disc. Culture was measured in a QCM system for 5
days at 37ºC. As controls crystal violet assay and AFM visualization
was performed following to the presented technique.
Results: In the bioﬁlm type of growth three phases are identiﬁed:
adhesion, maturation and dispersion of bioﬁlm structures. In our
experiment additional phase − adaptation of the QCM disc to gold
surface was observed (Fig. 1). A rapid increase of frequency shift for
P. aeruginosa ATCC 27853 was reported after 20 hours of incubation.
Maximum of frequency shift (3000Hz) for this strain was observed
in 55th hour of the experiment. The similar phases of the bioﬁlm
growth characteristics were noticed for P. aeruginosa PAO1 strain. The
maturation phase of the bioﬁlm structure was observed in the 60th hour
after start of the test. Maximum frequency shift for PAO1 strain had a
value of ca. 1000Hz. During the experiment (5 days) the culture medium
was not refreshed and QCM discs were not prepared and ﬁxed before
measurements.
Conclusions: We have shown that quartz crystal microbalance can be
considered as a new useful tool for the evaluation of bacterial bioﬁlm
growth. Using this technique it is possible to recognize three phases
of bioﬁlm formation. Our results proved that presented measurement
system can be applied as a convenient method for real-time observation
of bacterial bioﬁlm formation.
R2280 Phenotypical and genetical analysis of bioﬁlm formation by
coagulase negative staphylococci
I. Liduma*, T. Tracevska, U. Bers, A. Zilevica (Riga, LV)
Coagulase-negative staphylococci (CoNS) are major nosocomial
pathogens. The most important property of CoNS is their ability to form
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bioﬁlm on the surfaces of foreign bodies introduced (implanted) into
the organism. The accumulative phase of bioﬁlm formation is linked
to the production of polysaccharide intercellular adhesin (PIA), which is
synthesized by icaADBC-encoded proteins. The accumulation associated
protein (AAP) encoded by aap is important genetic determinant of slime
production.
The purpose of this study was to investigate strains of CoNS using
phenotypical and genotypical methods.
Methods: 49 clinical group specimens of CoNS were isolated from
surgical wounds (10), blood culture (18) and intravenous catheters (21).
A control group of 12 CoNS specimens from nose epithelium of
healthy people was included. Appearance of icaA and aap genes was
tested by PCR. The Congo Red agar screening phenotypical method
was evaluated for rapid and accurate detection of slime production by
coagulase negative staphylococci. The microtiter plate assay described
by Christensen et al. with modiﬁcations was used in parallel.
Results: Both genes icaA and aap positive were detected in 9 (50%) of
18 blood samples, 2 (20%) of 10 surgical wound samples, 6 (28,6%)
of 21 catheter samples. In control group (12) only one of CoNS isolate
was positive for aap gene. Congo Red agar (1% glucose) demonstrated
that correlation between icaA, aap and speciﬁc phenotypical appearance
was only in 8 (13,1%) of 61 CoNS samples. In this study, the ability of
bioﬁlm formation was evaluated in 31 samples using microtiter plate (96-
well cell+ plate). Positive bioﬁlm formation was detected in 8 (53,3%)
of 15 central venous catheter and peripheral venous catheter samples,
and in 5 (31,2%) of 16 blood samples.
Conclusions: The data indicate that icaA and aap genes along with
phenotypical analysis (microtiter plate) are reliable methods for bioﬁlm
detection in coagulase negative staphylococci. The Congo Red agar (1%
glucose) screening could not be recommended for analysis of bioﬁlm
forming CoNS, due to high rate of heterogeneity of results.
R2281 Effects of human polymorphonuclear neutrophils alone
or in combination with three antipseudomonal antibiotics
against Pseudomonas aeruginosa bioﬁlms
A. Chatzimoschou*, E. Georgiadou, T. Walsh, E. Roilides (Thessaloniki,
GR; New York, US)
Objectives: P. aeruginosa (PA) is the main cause of chronic airway
infections in cystic ﬁbrosis (CF) patients. CF airway bacteria are rarely
eradicated by antibiotics due to their ability to form bioﬁlms (BFs).
Little is known about the antimicrobial activities of host phagocytes
and of antipseudomonal antibiotics (AAs) against PA BFs. We aimed to
examine the in vitro activities of 3 AAs [Amikacin (AMK), Ceftazidime
(CEF) and Ciproﬂoxacin (CIP)] alone and in combination with PMNs
against PA BFs and compare these activities to those of their planktonic
(PL) counterparts.
Methods: Six CF clinical isolates of PA, either susceptible to AMK
(AMKS), CEF (CEFS), CIP (CIPS) or resistant to AMK (AMKR), CEF
(CEFR), CIP (CIPR) were used. All isolates were grown by incubation
in cation-adjusted Mueller-Hinton broth in 96-well ﬂat-bottomed plastic
plates under constant shaking for 48h at 37ºC in order to form BFs.
PMNs from healthy donors at an effector-to-target (E:T) ratio of 1:10 or
1:20 were incubated further for 24h alone or in combination with 2, 8 or
32mg/l of AMK, CEF or CIP. Percent damage of BF or PL was assessed
by XTT assay. Synergy was concluded when the observed bacterial
damage was signiﬁcantly higher to the expected sum of damages;
whereas, antagonism was deﬁned when the observed bacterial damage
was signiﬁcantly lower to the expected sum of damages. ANOVA (n = 6)
with Dunnett’s test was performed.
Results: PMNs damaged BFs and PL in an E:T ratio-dependent pattern;
however, PMN-induced damage of BFs was signiﬁcantly lower than that
of PL even when PMNs were combined with each of the 3 AAs. BF
or PL damages of susceptible isolates were relatively higher than those
of resistant isolates. Synergy was observed when PMNs (at 1:10) were
combined with AMK (8 or 32mg/l) for both AMKR and AMKS isolates
in BF and PL cells. Antagonism was observed when PMNs (at 1:20) were
combined with CEF (2, 8 or 32mg/l) for AMKR, with CEF (8mg/l) for
AMKS, CIP (32mg/l) for CIPR and CIP (2 or 8mg/l) for CIPS.
Conclusions: PA BFs are more resistant than PL to the activities of
PMNs, of AAs alone and of the combinations of PMNs with the 3
AAs. Synergy is exhibited between PMNs and AMK against BFs of PA,
while antagonism is exhibited between PMNs and CEF or CIP. Even
high concentrations of AAs alone or in combination with PMNs do
not achieve eradication of PA, suggesting a possible mechanism of PA
persistence in the respiratory tract of CF patients.
R2282 Bioﬁlm-associated eye infections: an evaluation of the
published evidence
A. Kapaskelis, A. Karfopoulou*, D. Karageorgopoulos, M. Falagas
(Athens, GR)
Objective: Bioﬁlm-associated eye infections are increasingly being
recognized as a diagnostic and therapeutic problem. We sought to
systematically review the relevant published literature on the clinical
characteristics of these infections.
Methods: We searched in PubMed and Google Scholar to identify
articles that provided clinical data on patients with eye infections
associated with the presence of bacterial or fungal bioﬁlm, documented
by electron scanning microscopy.
Results: We identiﬁed 12 articles involving 15 cases of documented
bioﬁlm-associated eye infection. The infectious syndromes in regard
were infectious crystalline keratopathy (6 cases), keratitis (4 cases),
endophthalmitis (2 cases), corneal abscess (1 case), conjunctivitis (1
case), and conjunctivitis with scleritis and corneal perforation (1 case).
All 15 patients had prior ophthalmologic surgery. In 8 of the 15 patients,
the infection was associated with the presence of a foreign body; the
foreign body was a corneal suture (3 cases), intraocular lens (3 cases),
punctual plug (1 case) and soft contact lens (1 case). In the remaining 7 of
the 15 included cases, the bioﬁlm-associated eye infection developed on
native tissue; the presence of a bioﬁlm was documented in corneal biopsy
specimen in 5 cases, extracted corneal tissue in 1 case, and extracted
bacterial concretion in the remaining case. Various causative pathogens
were isolated. Treatment was eventually successful in all cases. In those
with a foreign body, cure was achieved only after foreign body removal.
Regarding the 7 cases with no foreign bodies, keratoplasty was required
in 3 cases and evisceration of the eye 1 case.
Conclusion: Our ﬁndings suggest that bioﬁlm-associated eye infections
can develop on both foreign bodies and native tissue. Most of the
published clinical cases refer to infections of the anterior hemisphere
of the eye and particularly the cornea. Yet, this could be related to
the diagnostic problems of the documentation of a bioﬁlm. Further
studies are need to better appreciate the particular characteristics of these
infections.
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R2283 Therapeutic drug monitoring of clindamycine in osteo
articular infections: inﬂuence of body-weight on the
pharmacokinetic variability
V. Pestre, V. Jullien*, E. Curis, L. Eyrolle, D. Archambaud, M. Karoubi,
P. Anract, J. Courpied, D. Salmon Ceron (Paris, FR)
Rationale and Objective: Clindamycin (CD), usually active against
Staphylococcus aureus, has been recommended as one of the antibiotic
to be used in combination (with vancomycine, rifampicin or quuinolone)
in osteo articular infections by several infectious diseases societies. Our
objective was to determine if the usual dosage of CD of 600mg TID
were adequate to obtain sufﬁcient concentrations in bone.
Method: A prospective study included all patients treated with IV or oral
CD from 11/2008 to 11/2010, for an osteo articular infection. CD peak
concentrations were measured 30 min after IV infusion or 1.5 h after oral
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dose. CD trough concentrations were measured between 7 and 9 h. The
target residual concentration in blood was set to 2mg/L, considering that
the breakpoint for S. aureus is 0.5mg/L, that the bone penetration of CD
is only around 30%, and that CD displays time-dependant activity.
Results: Values are given as mean (ﬁrst & third quartile). 58 patients, 31
male, 27 female, mean age 56 y-o, were included. The dosage of 600mg
TID of clindamycin led to a mean dose reported to weight 27.2mg/kg/d
(22.5−30). With this dose, the mean CD trough concentration was
2.06mg/L (0.60–3.15) and 63.5% of the dosages were <2mg/L. The CD
mean peak concentration was 7.86mg/L (5.78−9,33). Oral or IV regimen
did not lead to signiﬁcant differences in CD peak concentrations (8.62
vs 6.87mg/L; p = 0.09) as well as CD trough concentrations (2.19 vs
1.93mg/L, p = 0.73). A signiﬁcant correlation was evidenced between
the daily dose reported to weight and CD trough concentration (p = 0.04,
analysis of covariance, with time of measure as covariable). A trough
concentration over the target concentration of 2mg/L was obtained in
44% of the patients having a daily dose >25mg/kg/d and in 25% of the
patients with a dose <25mg/kg/d.
Conclusion: A clear relation was evidenced between CD through
concentrations and CD daily dose reported to weigh. The daily dosage
of clindamycin should not be uniform in all patients but reported to
weight and should reach at least 25mg/kg/d in order to reach sufﬁcient
concentrations in bone.
R2284 Moxiﬂoxacin concentrations in plasma and pancreatic
pseudocyst ﬂuid of patients with chronic pancreatitis
A. Ovsyankin, R. Kozlov*, A. Martinovich, S. Gerasimov, J. Tsuman
(Smolensk, RU)
Objectives: To estimate the concentrations of moxiﬂoxacin (MOX) after
single intravenous injection in blood plasma and pancreatic pseudocyst
ﬂuid samples obtained from patients with chronic pancreatitis.
Materials and Methods: A total of 26 blood samples and 27 pancreatic
pseudocyst ﬂuid samples were obtained from 26 surgical patients
with chronic pancreatitis complicated with pancreatic pseudocyst in
2008–2010. Blood samples were taken by venous puncture and
pancreatic pseudocyst ﬂuid samples were collected by ultrasound
controlled transcutaneous aspiration or during abdominal operation
at 3 hours after a single intravenous injection of moxiﬂoxacin
(400mg). MOX concentrations were determined using a reversed-
phase high-performance liquid chromatography (RP-HPLC) assay. The
chromatographic separation was achieved on Symmetry C18 column
(3.9x150mm) using a mixture of 15% acetonitrile, 85% 50 Mm
ammonium chloride, 7 Mm tetrabutylammonium hydroxide (pH 3.0
adjusted with citric acid) as the mobile phase with isocratic system
at a ﬂow rate of 1ml/min. Fluorescence detection was employed with
excitation at 287 nm and emission at 465 nm. Gemiﬂoxacin was used
as internal standard. Clinical samples were prepared by mixing aliquots
of plasma or pseudocyst ﬂuid with equal volumes of acetonitrile and
diluting the supernatant obtained after centrifugation 2-fold in water.
The assay was validated by analyzing spiked quality control samples and
showed accuracy and precision of ±3%, and linearity of determination
in the range of 0.125−4mg/l with correlation coefﬁcient of 0.9998.
Results: The MOX concentrations in pseudocyst ﬂuid samples of
patients ranged from 0.04 to 1.98 (mean±SD = 0.57±0.41) mg/l. The
corresponding MOX concentrations in plasma samples were 0.86 to 2.45
(mean±SD = 1.67±0.39) mg/l.
Conclusion: The concentrations of moxiﬂoxacin in pancreatic pseu-
docyst ﬂuid achieved 3 hours after a single 400mg iv injection were
generally lower than the corresponding concentrations in plasma but
exceeded the epidemiological cut-off MIC values for most bacterial
pathogens reported by EUCAST. These data indicate that moxiﬂoxacin
may potentially be effective for perioperative prophylaxis in patients with
chronic pancreatitis.
R2285 Risk factors to obtain low colistin peak-plasma
concentrations in patients with multidrug-resistant
Gram-negative bacterial infections
S. Luque*, L. Sorli, N. Berenguer, J.P. Horcajada, F. A´lvarez-Lerma,
H. Knobel, M. Montero, C. Segura, S. Grau (Barcelona, ES)
Objectives: Colistin use has remerged for the treatment of multidrug
resistant Gram-negative (MDR-GNB) infections but there is a lack of
information about the clinical and demographic patient’s characteristics
that could modify colistin plasma concentrations. The aim of the
study was to assess the risk factors to obtain a colistin peak plasma
concentrations (Cmax) lower than 1 mcg/ml in patients with MDR-GNB
infections treated with colistimethate sodium (CMS) at dosages used in
clinical practice.
Methods: Observational prospective pharmacokinetic study performed
in hospitalized patients with MDR-GNB infections treated with CMS.
Colistin Cmax (30 minutes after the end of the infusion) at steady-state
was obtained in all the studied patients and quantiﬁed using a validated
HPLC method. Data collected: age, gender, body mass index (BMI),
Acute Physiology and Chronic Health Evaluation II score (APACHE II),
gromerular ﬁltration rate at the beginning of CMS treatment (GFR),
presence of sepsis (SEP) or septic shock (SHOCK), total plasma
proteins (TPP), human serum albumin (ALB), CMS dose, colistin Cmax
and concomitant administration of vasoactive drugs and/or diuretics
(VASO/DIUR). In univariate analysis the differences between patients
with colistin Cmax higher or equal to 1 mcg/ml and those with Cmax
lower than 1 mcg/ml were assessed.
Results: 36 patients. Mean values: age 65.8 (SD 15.7) years; 30 (83.3%)
men; BMI: 25.0 (SD 5.3) kg/m2; APACHE: 9.5 (SD 4.6); 23 patients
(63.9%) with GFR higher or equal to 80ml/min; 19 (52.8%) SEP; 2
(5.6%) SHOCK; TPP: 5.5 (SD 0.90) g/dl; ALB: 2.7 (SD 0.5) g/dl; CMS
dose: 5.1 (SD 2.2) mg/kg; Cmax: 1.2 (SD 0.8) mcg/ml and VASO/DIUR:
14 (38.9%). Differences between patients with Cmax higher or equal to
1 mcg/ml versus those with Cmax lower than 1 mcg/ml are shown in
table 1.
Patients with a GFR higher or equal to 80ml/min presented a 7.150 times
higher risk to obtain a colistin Cmax lower than 1 mcg/ml. Additionally,
younger age was correlated with the achievement of lower colistin Cmax.
Conclusions: Younger patients with good renal function treated with
colistin for MDR-GNB infections present a higher risk to obtain
peak plasma levels far from the cut-off values for colistin bacterial
susceptibility, regardless of their gender, BMI and CMS administered
dose. In those patients the efﬁcacy of colistin should be narrowly
followed and colistin plasma concentrations during treatment should be
monitored.
R2286 The pharmacokinetics/pharmacodynamics of meropenem
in patients with febrile neutropenia and bacteraemia
S. Jaruratanasirikul* (Songkla, TH)
Objectives: The aim of this study was to compare the probability of
target attainment (PTA) and cumulative fraction of response (CFR) for
meropenem between administration by bolus injection and a 3 h infusion
in febrile neutropenic patients with bacteremia.
Methods: The study was a randomized three-way crossover in eight
febrile neutropenic patients with bacteremia. Each subject received
meropenem in three regimens consecutively: (i) bolus injection of 1
g every 8 h for 24 h; (ii) a 3 h infusion of 1 g every 8 h for 24 h; and (iii)
a 3 h infusion of 2 g every 8 h for 24 h. The Monte Carlo simulation
was performed to determine the probability of attaining a speciﬁc
pharmacodynamic target at various regimens. The CFRs were determined
for each regimen against each population of E. coli, Klebsiella spp.,
P. aeruginosa and Acinetobacter spp.
Results: The PTA for three regimens are listed in the table.
The predicted CFRs for PTA achieving a target of 40% T>MIC for
E. coli following the administration of meropenem by a bolus injection
of 1 g every 8 h, a 3 h infusion of 1 g every 8 h and a 3 h infusion of 2 g
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every 8 h were 97.03%, 99.88% and 99.96%, respectively. The predicted
CFRs for PTA achieving a target of 40% T>MIC for Klebsiella spp.
were 97.07%, 99.92% and 100%, respectively.
Conclusion: A 3 h infusion of 2 g of meropenem every 8 h resulted
in the highest PTA rates. The three regimens of meropenem had high
probabilities of achieving optimal impact against E. coli or Klebsiella
spp.
R2287 Urinary pharmacokinetics and bactericidal activity of
ﬁnaﬂoxacin (200 and 800mg) in healthy volunteers
receiving a single oral dose
F.M. Wagenlehner*, C.M. Wagenlehner, B. Blenk, H. Blenk, S. Schubert,
A. Dalhoff, W. Weidner, K. Naber (Giessen, Nuremberg, Kiel, Munich,
DE)
Introduction and Objectives: Finaﬂoxacin is a novel 8-cyano-
ﬂuoroquinolone under investigation for treatment of urinary tract
infections. In contrast to other ﬂuoroquinolones its antibacterial activity
is enhanced in an acidic environment. An acidic environment is
frequently found during infectious processes and in urine. The aim of this
phase 1 study was to investigate urinary concentrations as well as urinary
bactericidal titers (UBT) at different pH levels in healthy volunteers.
Material and Methods: Urinary concentrations and UBTs of
ﬁnaﬂoxacin 200 and 800mg single doses in 6 healthy volunteers were
measured up to 48 hours. Urinary concentrations were measured by a
HPLC-MS/MS method. UBTs were determined for a reference strain
and 9 selected clinical uropathogens at the pH of native, acidiﬁed (pH
5.5) and alkalinized (pH 8.0) urine.
Results: Mean maximum urine concentration of 200 and 800mg
ﬁnaﬂoxacin was 69.3mg/L (0 to 2 hours) and 150mg/L (4 to 8 hours).
Median UBTs were between 0 and 1: >2,048 and were in general
agreement with MIC of strains and urinary pH values. UBTs in alkaline
urine were signiﬁcantly lower compared with those in native or acidic
urine except for Enterococcus faecalis.
Conclusions: Finaﬂoxacin exhibited signiﬁcant bactericidal activity
against susceptible uropathogens. The urinary bactericidal activity of
ﬁnaﬂoxacin was enhanced in acidic urine and signiﬁcantly lower in
alkaline urine.
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R2288 Osteomyelitis associated to CTX-M-15-producing
Aeromonas hydrophila: ﬁrst description in Europe
M. Almagro*, D. Saez, S. Fernandez-Romero, F. Merino, J. Oteo,
J. Campos, J.L. Gomez-Garces (Madrid, ES)
Objective: We describe, to the best of our knowledgement, the ﬁrst case
of CTX-M-15-producing Aeromonas hydrophila.
Methods: A 37-year-old woman was hospitalised in May of 2009 for
an open fracture grade III of the right tibial pilon. External ﬁxator
were placed and Pseudomonas aeruginosa and Staphylococcus aureus
resistant to methicillin (SARM) were isolated from the wound. The
patient got better and two months later, the patient was discharged with
a treatment consisting on levoﬂoxacin+rifampin due to a new isolation
of SARM in the wound. In March of 2010, the patient returned to the
hospital with an acute clinical pictures of suppuration through an ankle
ﬁstula. A surgery resection of the distal end of the tibia, affected by
osteomyelitis, was done. The wound and surgical bone tissue specimens
were processed.
Results: Gram-negative bacillus was isolated from both, wound exudates
and bone samples. The isolate was identiﬁed as A. hydrophila by
both phenotypic and genotyopic methods. The isolate showed resistance
to ampicillin, cefazolin, cefotaxime, cefepime, gentamicin, tobramycin
and ciproﬂoxacin; decreased susceptibility to amoxicillin/clavulanic
acid, ceftazidime and aztreonam; and susceptibility to cotrimoxazole,
amikacin, piperacillin/tazobactam and carbapenems. Clavulanic acid
recovered the activity of cefotaxime and ceftazidime. The patient
was successfully treated with meropenem+amikacin. Standard PCR
conditions were used to amplify the genes blaTEM, blaSHV, blaCTX-M
and blaOXA; sequence analysis of PCR products obtained identiﬁed
TEM-1 and CTX-M-15 ESBL, no PCR products were obtained using
the remaining primers. This isolate had also the aac(6′)-Ib-cr and the
aac(3)-IIa aminoglycoside resistance genes.
Conclusions:
1. We present the ﬁrst known case of osteomyelitis associated to a CTX-
M-15-producing A. hydrophila isolate carrying also the blaTEM-1
gene, as well as genes conferring resistance to aminoglycosides,
aac(3)-IIa, and to aminoglycosides and ciproﬂoxacin, aac(6′)-Ib-cr.
2. This report conﬁrms the high dissemination capacity of the plasmids
carrying CTX-M-15, and other antibiotic resistance determinants,
not only between Escherichia coli or Klebsiella pneumoniae, as
demonstrated, but also between other Gram-negative species as
A. hydrophila.
R2289 Antimicrobial resistance of Escherichia coli clinical isolates
causing neonatal sepsis
S.M. Soto*, E. Guiral, J. Bosch, J. Vila (Barcelona, ES)
Objectives: Neonatal risk factors for invasive bacterial disease and its
diagnosis and therapy remain an important medical problem. Neonatal
meningitis and septicemia caused by Escherichia coli and Streptococcus
agalactiae are still major health problems in industrialized countries. The
objective of the present work was to evaluate the antimicrobial resistance
of E. coli strains causing early and late neonatal sepsis and to compare
them with E. coli strains isolated from healthy neonates.
Methods: Sixty-seven E. coli strains were included in the study (27 from
early neonatal sepsis, 40 from late neonatal sepsis and 28 from healthy
neonates). Samples from healthy neonates were obtained from ear and
pharyngeal swabs. Minimal inhibitory concentrations were determined
using the MicroScan-Negative MIC Panel Type 37 (NM37, Siemens).
Detection and characterization of determinants of resistance, integrons,
and gyrA and parC mutations were carried out by PCR and sequencing.
Results: No statically signiﬁcant differences were found in the
antimicrobial resistance between strains from early and late neonatal
sepsis. However, resistance to chloramphenicol and piperacillin was
signiﬁcantly more frequent among strains collected from sepsis than from
healthy neonates (p = 0.05 and 0.0004, respectively). No differences were
found among the resistance to the antimicrobial agents used to treat late
neonatal sepsis (amikacin, ceftazidime and imipenem). Only two strains
were found to carry BLEAS, one from early neonatal sepsis, which was
CTX-M14 and one from late neonatal sepsis (CTX-M15.) Fifty-eight
percent of strains from late neonatal sepsis were resistant to tetracycline
showing a high variety of resistance genes (tetA, B, C, D and G) whereas
only 37% of strains from early neonatal sepsis were resistant to this
antimicrobial agent. Twenty strains (30%) presented class-1 integrons
with different combination of gene cassettes. Finally, among the eight
strains resistant to ciproﬂoxacin, four presented mutations in the amino
acid codons Ser83Leu and Asp87Asn from the gyrA gene, two only
Ser83Leu and one Asp87Lys. Of these, ﬁve also presented a mutation
in the parC gene (Ser80Ile) and one also a mutation in the amino acid
codon Gly84Val.
Conclusions: E. coli strains causing neonatal sepsis were more resistant
to the antimicrobial agents studied than the strains collected from
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healthy neonates except in those related to ciproﬂoxacin and gentamycin
resistance.
R2290 Mechanisms of macrolide resistance in Polish Campylobacter
jejuni and C. coli strains isolated from chicken meat,
2006–2009
E. Rozynek, D. Korsak, W. Kaminska, E. Mackiw,
K. Dzierzanowska-Fangrat* (Warsaw, PL)
Objectives: Macrolides such as erythromycin and azithromycin have
been used as drugs of choice for the treatment of human campylobac-
teriosis. Studies conducted in Poland during 2003–2005 did not ﬁnd
macrolide resistance in Campylobacter isolates of chicken origin.
The aim of this study was to examine the prevalence and genetic
background of macrolide resistance in Polish strains of C. jejuni and
C. coli isolated from chicken carcasses during 2006–2009.
Methods: A total of 306 chicken meat specimens, obtained in selected
supermarkets in Warsaw from 2006 through 2009 were studied. Isolation
and identiﬁcation of Campylobacter sp. were performed according
to the International Organization for Standardization guideline 10272.
Susceptibility to erythromycin was determined by the E-test and the
disk diffusion method. The PCR-RFLP and sequencing were used for
the detection of A2074C and A2075G mutations in the 23S rRNA gene.
Modiﬁcations in the L4 and L22 ribosomal proteins were analysed using
PCR and sequencing. Inhibition of the efﬂux pump was determined
on Mueller-Hinton agar plates supplemented with phenyl-arginine-b-
naphthylamide (PAbN).
Results: A total of 208 Campylobacter strains were isolated (52 C. jejuni
and 156 C. coli). Nineteen isolates (9.1%) were found resistant to
erythromycin by the disk diffusion method, but only 12 (5.8%) were
resistant by the E-test method. The A2075G mutation in the 23S rRNA
gene was identiﬁed in 8 of 12 isolates displaying high-level resistance to
erythromycin, whereas the A2074G mutation was found in 1 isolate.
Sequence analysis of rplD and rplV genes of erythromycin-resistant
strains showed modiﬁcations in the L4 and L22 proteins only in few
isolates. The efﬂux pump inhibitor (PabN) increased the susceptibility
to erythromycin in 3 resistant isolates.
Conclusions: Erythromycin-resistance in Polish Campylobacter isolates
of chicken origin is mediated mainly by A2075G and A2074G mutations
in the 23S rRNA gene, whereas modiﬁcations in the L4 and L22 proteins,
and the efﬂux pump have only modest impact on macrolide-resistance.
The risk of transmission of resistant strains from animals to humans via
food chain requires constant monitoring of resistance in Campylobacter
clinical isolates.
R2291 Impact of the new EUCAST breakpoints and rules on
b-lactam susceptibility reporting for ESBL-producing
enterobacteria
G. Brigante*, S. Bracco, E. Mantengoli, N. Corbo, B. Pini,
G.M. Rossolini, F. Luzzaro (Lecco, Siena, IT)
Objectives: Production of extended-spectrum b-lactamases (ESBLs) is
the most important mechanism of resistance to b-lactam antibiotics
among Enterobacteriaceae. Based on the 2010 EUCAST criteria,
susceptibility results for penicillins, cephalosporins, and monobactams
should be reported as found in strains that produce ESBLs, when using
the lowered breakpoints. Our study aimed to evaluate the impact of the
new EUCAST breakpoints and rules on b-lactam antibiotic susceptibility
reporting for ESBL-producing enterobacteria.
Methods:We studied 262 ESBL-producing Enterobacteriaceae collected
at the Manzoni Hospital (Lecco, Italy) from January 2009 to June 2010:
Escherichia coli (n = 195), Proteus mirabilis (n = 50), and Klebsiella
pneumoniae (n = 17). Identiﬁcation and antimicrobial susceptibility were
determined using the Vitek2 automated system (bioMe´rieux, Marcy
l’Etoile, France). ESBL production was assessed using phenotypic tests
and conﬁrmed by molecular methods.
Results: In 64/262 cases (24.4%), at least one of expanded-spectrum
cephalosporins (cefotaxime, ceftazidime, cefepime) showed an MIC
value 1mg/L, thus being reported as susceptible according to current
EUCAST criteria. In 4/64 cases, these microorganisms had been obtained
from blood cultures. Similar percentages of low values were found
in E. coli (25.1%), P. mirabilis (22%), and K. pneumoniae (23.5%),
although some features differed depending on ESBL type. Concerning
tested drugs, ceftazidime (37/262, 14.1%) and cefepime (40/262, 15.3%)
showed similar values, whereas cefotaxime rarely had an MIC 1mg/L
(7/262, 2.7%).
Conclusions: Our data demonstrate that the adoption of the new
EUCAST interpretive criteria will result, in a high number of cases, in
categorization of ESBL producers as susceptible to expanded-spectrum
cephalosporins. In absence of outcome data demonstrating efﬁcacy
of expanded-spectrum cephalosporins in these cases, it would seem
advisable to keep informing clinicians about ESBL production in clinical
isolates from serious infections.
R2292 Aeromonas hydrophila resistant to carbapenems: discrep-
ancy in the results between E-test and microdilution method
P. Marı´n-Casanova, F. Galan-Sanchez*, I. Guerrero-Lozano,
P. Garcia-Martos, A. Garcia-Tapia, J. Oteo, M. Rodriguez-Iglesias
(Cadiz, Madrid, ES)
Objectives: A. hydrophila harbours several chromosomal b-lactamase
(CepH, AmpH and ImiH or CphA) that are regulated by blrA/blrB
and under selective pressure of certain antibiotics can be overexpressed
jointly. CphA is a metallo-b-lactamase (MBL) with moderate carbapene-
mase activity. The objective is to communicate the observed discrepancy
in carbapenems MIC values of clinical isolates of Aeromonas hydrophila
determined by E-test and commercial microdilution system.
Methods: Three strains of A. hydrophila isolated from CSF, BAS and
faecal specimen respectively were tested for antimicrobial activities of
imipenem, meropenem and ertapenem using commercial microdilution
system (Wider, Soria-Melguizo, Spain) and E-test (AB Biodisks)
following manufacturer’s indications. Phenotypical detection of ESBL,
AmpC, and modiﬁed Hodge’s test were done. CphA gene PCR and rep-
PCR were also performed.
Results: All the strains were considered carbapenems resistant by
commercial microdilution system and susceptible by E-test (0.5
McFarland). MIC’s values are shown in Table 1. E-test for imipenem
was repeated using a higher inoculum (4 MacFarland), obtaining MIC’s
values of 8mg/L. Neither ESBL nor Amp C were detected, and modiﬁed
Hodge’s test were negative. The cphA gene was identiﬁed in all strains.
The three isolates showed different rep-PCR patterns.
Conclusions: The MIC values obtained by microdilution do not correlate
with those obtained by the E-test method. Presence of MTB expression
encoded by cphA gene is better detected using higher inocula with
commercial microdilution systems than E-test. The bacterial density
in many infections is higher than that used in conventional MICs
determinations so, for Aeromonas spp. in vitro studies, particularly
E-test, is important to increased the inocula at least 4 McFarland to
obtain accuracy results.
R2293 Comparison of antagonistic activity of lactic acid bacteria
strains isolated from humans and food
M. Bodaszewska-Lubas*, D. Diep, M. Brzychczy-Wloch, T. Gosiewski,
M. Strus, P. Heczko (Krakow, PL; A˚, NO)
Objectives: Lactic Acid Bacteria (LAB) species are common bacteria
in the environment. Often, LAB are isolated, among others, from food,
human colon but foremost from human vagina. Streptococcus agalactiae
(GBS) is one of the coexistent components of the vaginal microﬂora and
it can trigger newborn infection. Metabolites with antagonistic properties
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of LAB protect against multiplication of pathogenic microorganisms
as well as of GBS. Therefore, the aim of the study was to assess of
sensitivity of GBS strains in relation to capsular polysaccharides of GBS
to antagonistic activity of chosen LAB strains isolated from vagina and
food.
Methods: The antagonistic properties of L. plantarum (n = 3), L. fermen-
tum (n = 2), L. gasseri (n = 2), L. rhamnosus (n = 2) originating from the
vagina of healthy women and control bacteriocin-producing strains such
as L. plantarum C11, L. sakei DSMZ 6333, L. lactis ATCC 11454 and
L. rhamnosus GG ATCC 53103 were tested. In the antagonism study,
26 strains of GBS from human sources belonging to Ia, Ib, II, III or
V serotypes were used as indicator bacteria. Antagonism between LAB
and GBS was tested in a mixture of ﬂuid 24 h cultures and the results
were determined quantitatively by serial dilutions in 3 time intervals (10
min, 2 h, 4 h).
Results:
1. Most investigated strains of LAB have an ability to inhibit the growth
GBS within 2 h after application.
2. L. plantarum strains were the most effective LAB strains isolated
from vagina against GBS, on the other hand L. fermentum showed
the weakest inhibitory activity against GBS strains.
3. The L. plantarum C11 control strain isolated from fermented
cucumber, displayed comparable antimicrobial activity against GBS
as L. plantarum strains originating from vagina.
4. Statistically signiﬁcant relationship was conﬁrmed for sensitivity of
GBS serotypes to vaginal LAB and control LAB effect. GBS strains
with serotype III were the least sensitive to LAB activity and the most
sensitive were GBS strains belonging to serotypes V and II.
5. The control strains isolated from food, such as L. sakei DSMZ 6333
and L. lactis ATCC 11454 did not show antimicrobial activity against
GBS strains.
Conclusions: LAB control strains isolated from food were less effective
against GBS than LAB strains isolated from vagina. More studies are
needed to elucidate the antibacterial property of vaginal L. plantarum
as the producer of antimicrobial substances and the opportunity of its
application as a probiotic preparation.
R2294 Detection of OXA-48-encoding plasmid in a clinical strain
of Enterobacter cloacae isolated in Spain
F. Galan-Sanchez*, P. Marin-Casanova, P. Aznar-Marin, E. Foncubierta,
P. Garcı´a-Martos, A. Garcı´a-Tapia, M. Rodriguez-Iglesias (Cadiz, ES)
Objectives: The global spread of ESBLs has driven therapeutic choice
towards carbapenems and lead to emergence of carbapenem resistance
mechanisms. Carbapenemases now represent a public health challenge.
Class D OXA-48 is one of the few members of this family with
carbapenem-hydrolyzing activity. They are involved in outbreaks in
various geographical regions, in particular in countries from the eastern
and southern Mediterranean region. We described the ﬁrst strain of
Enterobacter cloacae with a plasmid-encoded bla OXA-48 gene in Spain.
Methods: In September 2010 an Enterobacter cloacae strain with
reduced susceptibility to imipenem was isolated from sputum specimen
corresponding to a 77 years-old man with global chronic respiratory
failure exacerbation. Antimicrobial susceptibility tests were determined
by a commercial microdilution system (Wider, Soria Melguizo)
following manufacturer’s indications. MICs of carbapenems were also
performed by using the E-test method, and interpreted according to the
CLSI standard. Phenotypic detection of carbapenemases was determined
using modiﬁed Hodge’s test (MHT). Molecular analysis of plasmid-
encoded b-lactamases genes was performed using Check Carba ESBL
(Check-Points, Hain Lifescience), a new molecular rapid system based
in microarray platform with objective analysis by software.
Results: The strain was resistant to all the tested cephalosporins,
including cefepime, and MICs by Etest for imipenem and meropenem
were 2mg/L and 8mg/L respectively. MHT was positive. Results by
Check-Point Carba ESBL showed the simultaneous detection of bla
OXA-48, bla CTX-M9 and bla SHV-12 like.
Conclusions: The class D b-lactamases OXA-48 conferring decreased
susceptibility to carbapenems has been reported from Klebsiella
pneumoniae and Escherichia coli. However, its origin seems to be in
Shewanella and other environmental Enterobacteriaceae. We report the
ﬁrst detection of OXA-48 in a clinical strain of Enterobacter cloacae in
southern Spain. Since this plasmid confers a low level of resistance to
carbapenems, clinical laboratory detection of OXA-48-producing strains
may be difﬁcult and can be very useful the molecular detection by rapid
methods as microarray systems.
R2295 Klebsiella pneumoniae carbapenemase in Ontario, Canada:
continuous surveillance of a worldwide disseminated
b-lactamase
N. Tijet*, O. Lastovetska, S. Lo, S. Patel, R. Melano (Toronto, CA)
Objective: The ﬁrst Klebsiella pneumoniae carbapenemase (KPC)
was detected in Ontario, Canada, in 2008 at the Ontario Public
Health Laboratories (OPHL), the provincial reference laboratory in
antimicrobial resistance. Since then, the OPHL has been performing a
continuous surveillance of carbapenemase-producing Enterobacteriaceae
in the province. The goal of this study was to characterize the blaKPC
positive isolates received at the PHL during the period of April 2008-
September 2010.
Methods: Antimicrobial susceptibility proﬁles of the blaKPC-positive
isolates (conﬁrmed by PCR) were determined using Etest (Clinical and
Laboratory Standards Institute guidelines, 2010). Molecular screening of
other b-lactamase genes in these KPC-producing isolates was performed
by PCR (blaTEM, blaSHV, blaOXA-1-like, blaCTX-M groups 1, 2
and 9, blaVEB, blaPER, blaGES blaOXA-48-like, blaIMP, blaVIM,
blaNDM-1, and 6 groups of blaAmpC genes). The molecular typing
of the blaKPC positive isolates was determined by pulse-ﬁeld gel
electrophoresis (PFGE) and multi-locus sequence typing (MLST). The
blaKPC genetic platforms were analyzed by PCR-cartography.
Results: 15 clinical isolates (1 per patient) were detected as blaKPC
positive during the study period: 4 from 2008, 3 from 2009, and 8 from
2010. The isolates (all K. pneumoniae) were submitted by 6 different
hospital laboratories, most of them from the Great Toronto Area (n = 13).
The susceptibility proﬁle is shown in the Table. Broad MIC ranges for
ertapenem (3 to32mg/ml), meropenem (1 to32mg/ml) and imipenem
(1.5 to 32mg/ml) were observed. As expected, all the strains were
positive for blaKPC (mostly blaKPC-2) and blaSHV. Thirteen of them
were also positive for blaTEM, and 2 for blaOXA-1-like. No other
b-lactamase genes were detected. All the isolates were closely related by
PFGE (the proﬁles exhibited >80% similarity). By MLST, 13 isolates
belonged to the sequence type (ST) 258, and the 2 remaining to the
ST437, which is closely related to ST258 (6 identical loci and the 7th −
tonB − differing by 4 point mutations). By PCR-cartography, blaKPC
genes were identiﬁed on Tn4401 transposon, variants a (11 isolates) and
b (4 isolates).
Conclusion: Since August 2008 to September 2010, only 15 multidrug
resistant K. pneumoniae KPC-producers were detected at OPHL.
According to the typing data, the slow dissemination of blaKPC in
Ontario is consequence of a clonal spread of ST258 or related.
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R2296 Correlation between rifampicin consumption and resistance
among Acinetobacter baumannii causing infections at a
university hospital
A. Gutie´rrez*, E. Garcı´a, M. Gil, J. Lepe, M. Go´mez, J. Cisneros,
J. Pacho´n (Seville, ES)
Objectives: To study the evolution of resistance to rifampicin by
A. baumannii in the years 2008 and 2009, and consumption of rifampicin
during the years 2007 and 2008 and analyse their correlation.
Methods: Retrospective ecological study conduced in a teaching
hospital, with two centers, General Hospital and Traumatology Hospital,
which was analysed a) the use of rifampicin since January 2007 to
December 2008, by determining the deﬁned daily dose (DDD/100
patient-days); and b) the development of resistance to rifampicin by
A. baumannii since January 2008 to December 2009, by number of
clinical isolates of rifampin resistant A. baumannii/1000 patient-days.
(MIC >16mg/L according to the French Society of Microbiology). These
tests have been performed globally and inpatient areas. We analyzed the
difference between consumption, MIC50 and MIC90, in the mentioned
period, by Mann-Whitney test. The evolution of the rate of resistance
was tested by X2 test. Finally we have analysed the association between
consumption of rifampicin and the resistance rate by Spearman Rho test.
Results: The consumption of rifampicin in 2007 and 2008 was 0.85 and
1.11 DDD/100 patient-days in the Hospital. In intensive care units, 0.43
and 2.37 DDD/100 patient-days. Medical and surgical services was 0.88
and 1.01 DDD/100 patient-days in the same years. During the years
2008 y 2009 were identiﬁed 171 and 310 strains of A. baumannii in
clinical samples.
Conclusions: The data suggest the existence of correlation between the
rifampicin consumption and resistance among A. baumannii causing
infections at ICUs.
R2297 A nonsense mutation in MutS associated with a
hypermutable phenotype in a clinical isolate of
Enterococcus faecalis
C. Arpin*, B. Ba, L. Coulange, C. Andre´, C. Quentin (Bordeaux, FR)
Introduction: Mutations in the DNA Mismatch Repair (MMR) genes,
mutSL (equivalent to hexAB locus of pneumococci), have been
associated with hypermutability phenotypes in various bacterial species
and may play a signiﬁcant role in the antibiotic resistance emergence.
Objectives: The mutator frequency of 233 consecutive non-redundant
Enterococcus faecalis isolates collected in a 2001 extra-hospital survey
was investigated.
Methods and Results: To detect mutators, a ﬁrst approach was based on
an agar diffusion method using a fosfomycin disk, and the identiﬁcation
of hypermutable strains was achevied by counting the “squatter” colonies
growing in the inhibition zone after 24 h of incubation. Four strains
(Ef1468, Ef1473, Ef1497 and Ef1591) with more than 50 Colony
Forming Units within the fosfomycin inhibition area were considered
as mutators. Their mutation frequency was evaluated on agar medium
with or without rifampicin. The rates were comprised between 2.2×10−5
to 7.3×10−6 (SD, 2.4×10−5 to 7.3×10−6), i.e. at least 100-fold higher
than ﬁve other tested strains taken at random in the collection, including
the E. faecalis strain ATCC 29212 (frequency, <10−9). The mutators
were isolated from urine (Ef1468, Ef1473 and Ef1497) or sperm ﬂuid
(Ef1591). The analysis of mutSL was investigated for Ef1497 by PCR
ampliﬁcation and sequencing experiments. Five (A321T, A323S, A397E,
K415N, I800S) and three (A437V, A440E, A495T) amino acid (aa)
substitutions in MutS (858 aa) and MutL (710 aa) respectively, were
identiﬁed in comparison to the reference sequence (GenBank accession
no. AE016830). In addition, a nonsense mutation of the arginine at
position 341 led to the inactivation of MutS; this mutation was associated
with the hypermutability of Ef1497.
Conclusions: The mutator frequency in a clinical population of
E. faecalis was 1.7%. In a previous study, we have shown that linezolid
mutants emerged more readily from Ef1497 than from E. faecalis ATCC
29212 (Ba et al., 2010, Antimicrob. Agent Chemother., 54:1443−52).
Hypermutation capability of strains should be detected by the simple
agar diffusion method using a fosfomycin disk, prior to a prolonged
antibiotic monotherapy treatment. Our study gives the ﬁrst evidence of
an association of a MMR gene inactivation with a mutator phenotype in
a clinical E. faecalis strain.
R2298 Class 1 integrons and associated resistance gene cassettes
among enteropathogenic Escherichia coli
S. Najibi, B. Bakhshi*, M. Sattari, M. Alebouyeh, M. Tajbakhsh
(Tehran, IR)
Objectives: Infectious diarrheal diseases is recognized as the second
cause of mortality among infectious diseases in children less than ﬁve
years. Enteropathogenic Escherichia coli (EPEC) play an important role
as a causative agent of children diarrhea. Integrons are DNA elements
known to carry genetic cassettes responsible for antibiotic resistance.
The objective of this study was to investigate the presence and resistance
gene cassette content of class 1 integron among Enteropathogenic E. coli
isolated from patients referred to Tehran hospitals.
Methods: In this study, 300 stool samples were collected and
Enteropathogenic Escherichia coli was detected using biochemical and
serological methods and conﬁrmed by PCR ampliﬁcation of eae, stx1
and stx2 genes. Isolates with eae+/stx1−/stx2− genotype were deﬁned as
EPEC and subjected to further analysis. Class 1 integron was investigated
with primers speciﬁc for the conserved integrase gene (int). The variable
resistance gene cassettes were ampliﬁed and sequenced.
Results: During the study period 28 cases of Enteropathogenic
Escherichia coli strains was detected and serotype O86 and O127 were
appeared as dominant serotypes. Twenty two strains (79%) appeared to
harbor class 1 integron among which the variable region was deﬁned
to be dfrA7, aadA1, dfrA1/aadA1, dfrA12/aadA2 which related to
amplicons of approximately 750, 1000, 1700 and 2000 bp in sizes,
respectively.
Conclusion: The presence of class 1 integron in 79% reveals that, this
genetic element plays a very important role in the transfer of antibiotic
resistance among the strains studied and may transfer resistance to
aminoglycosides and trimetoprim to other Gram-negative bacteria.
R2299 Is colistin resistance in Klebsiella pneumoniae associated
with mutations in the BasRS two component regulatory
system?
D. Plachouras*, I. Galani, Z. Chrysouli, F. Kontopidou, T. Panagea,
M. Souli, G. Petrikkos (Haidari, GR)
Objectives: Colistin resistance in Salmonella enterica has been asso-
ciated with mutations in the PmrAB two component regulatory system
that controls the composition of the outer membrane lipopolysachharide.
The mechanism of recently described colistin resistance in Klebsiella
pneumoniae clinical strains has not been elucidated. BasRS, the
homologue system to PmrAB in K. pneumoniae, was studied.
Methods: Colistin resistant K. pneumoniae strains isolated in clinical
and surveillance specimens of 10 patients, who were on colistin
treatment, as well as sensitive strains isolated from the same patients
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before colistin use, were included in the study. Exact MICs for colistin
were determined by the E-test strip. Sensitive and resistant isolates were
epidemiologically studied by repetitive extragenic palindromic (REP)-
PCR methodology. The basR and basS genes from the respective resistant
and susceptible isolates were ampliﬁed by PCR and sequenced. The
primers used were designed by WebPrimer to amplify a 653 bp internal
fragment of BasR (5′-TGT-CGA-TGT-TGT-TAG-CCA-GCA-3′, 5′-AGT-
CAT-TGA-AGA-CGA-TGC-GCT-3′)and a 1097 bp internal fragment
of BasS (5′-TCA-ATG-GGT-GCT-GAC-GTT-CT-3′, 5′-TGG-CTC-TGT-
TTG-CAA-CTG-3′). The ampliﬁed DNA’s were sequenced on both DNA
strands, by Euroﬁns MWG (Ebersberg, Germany) and analyzed for
aminoacid substitutions by the BLAST program (National Center for
Biotechnology Information, Bethesda, US).
Results: Only clonally related pairs of isolates (susceptible and resistant)
were included in the study. MICs of the colistin resistant isolates ranged
between 16 and 48mg/L while susceptible isolates had MICs of 0.38 to
1mg/L. One colistin resistant strain with an MIC of 48mg/L harboured a
substitution of glycine to serine (G→ S) at codon position 53 in the basS
gene compared to the susceptible strain isolated from the same patient.
In all other cases no signiﬁcant differences were observed between the
genes from the susceptible and resistant strains.
Conclusion: The mutation observed in the basS gene of one resistant
isolate has already been described in the homologue gene pmrA of
a colistin resistant laboratory strain of Salmonella enterica. However
mutations in the two component regulatory system BasRS in clinical
isolates do not explain most of the cases of colistin resistance in
Klebsiella pneumoniae strains.
R2300 Mutations in penicillin-binding protein 1 is responsible
for high-level methicillin resistance in a Staphylococcus
lugdunensis isolate
A. Liakopoulos*, K. Chatzigeorgiou, K. Tarpatzi, L. Zerva, E. Petinaki
(Larissa, Athens, GR)
Objective: To investigate the mechanism of high-level methicillin-
resistance in a Staphylococcus lugdunensis isolate.
Materials and Methods: The microorganism was isolated from blood
culture of a patient with endocarditis. Identiﬁcation to the species level
was performed by the Vitek 2 System and was veriﬁed by a molecular
method based on fbl gene. Susceptibility testing to various antimicrobial
agents was assessed by the Vitek 2 system, while the MICs values were
determined by Etest. The production of penicillinase was performed
by the nitrocephin disk test, while the presence of mecA gene was
detected by PCR. In order to detect mutations in PBP1 and PBP4 genes,
ampliﬁcation followed by sequencing analysis was done and the results
were compared with those obtained from a clinical S. lugdunensis strain
susceptible to oxacillin (MIC: 0.75mg/L).
Results: The isolate, despite the high-level resistance to oxacillin (MIC:
256mg/L), did not carry the mecA gene, while no overproduction
of penicillinase or mutation of PBP4 were detected. However some
mutations were found in PBP1: an alteration in the 482 position (L482P)
and an insertion in 570 position of four aminoacids (SAYG). These
mutations were not found in the susceptible strain. As b-lactams bind
to the penicillin-binding motif KTG in the transpeptidase region, that
is located in 582 position, alterations in or around the motif possibly
confer resistance due to reduced afﬁnity to b-lactams.
Conclusions: This is the ﬁrst report for mutations in PBP1 resulting in
high-level methicillin-resistance in a clinical S. lugdunensis isolate.
R2301 Molecular characterisation of ﬂuoroquinolone-resistant
Escherichia coli causing septic diarrhoea in calves in Italy:
emergence of a multi-resistant O78 clonal group
A. Marchese*, E. Coppo, R. Barbieri, S. Zoppi, C. Pruzzo, F. Rossi,
S. Bergagna, A. Dondo, E. Debbia (Genoa, Turin, IT)
Objectives: The emergence of antibiotic-resistant epidemic clones
among animals should be monitored since clonal relatedness among
certain O serogroup strains (i.e. E. coli O78) capable of causing
disease in different hosts, humans included, has been shown and,
although different molecules are employed, cross-resistance exists among
ﬂuoroquinolones used in human and veterinary medicine.
An increased incidence of enroﬂoxacin-resistant E. coli associated with
septic diarrhoea in calves was recently observed in northern Italy (from
14.3% in 2002 to >30% in 2007). The aim of this study was to investigate
this phenomenon.
Methods: A total of 47 consecutive E. coli isolates exhibiting reduced
susceptibility to enroﬂoxacin (intermediately resistant or resistant)
causing septic diarrhoea in calves from 45 large-scale farms during
2006–2007, were studied. Phylogenetic group, antibiotic susceptibility
and O serogroup were determined with RAPD and PFGE typing
providing additional discrimination.
Results: The majority (97.8%) of microorganisms (46/47) carried
resistance to two or more additional drugs with the pattern:
ﬂuoroquinolone–ampicillin–co-trimoxazole– tetracycline–gentamicin–
thiamphenicol being the most represented (24/47; 51.0%). Plasmid-
mediated extended-spectrum and AmpC b-lactamases including plasmid-
mediated ﬂuoroquinolone resistance genetic determinants were not
detected. Third generation cephalosporins emerged as the most active
antimicrobial agents tested (97.9% of susceptible strains).
Conclusion: Overall, 37 different RAPD proﬁles and 18 different O
serogroups could be distinguished among the typable strains indicating
a substantial heterogeneity and suggesting the occurence of several
independent selection events. However, approximately one fourth (11/47)
of the strains belonged to serogroup O78 and PFGE revealed that the
majority (7/11) of these were clonally related, indicating the selection of
a O78 clonal group.
Since animals have been suggested as a possible source of serogroup
O78 E. coli infections in humans, further studies are needed to clearly
determine the zoonotic potential of these strains.
R2302 Molecular characterisation of plasmids encoding
CTX-M-15 b-lactamases from Klebsiella pneumoniae strains
in the Moroccan community
A. Barguigua, M. Bouchakour, M. Talmi, K. Zerouali, F. El Otmani,
M. Timinouni* (Casablanca, El Jadida, MA)
Objectives: The Morocco, like other countries worldwide, has a growing
problem with CTX-M b-lactamase producing Enterobacteriaceae. The
present study sought to characterize blaCTX-M-15-containing plasmids
associated with Klebsiella pneumoniae CTX-M-15 isolates recovered in
Moroccan community.
Methods: We characterized the multidrug resistance region sequences
of three plasmids that encode CTX-M-15 b-lactamases in Klebsiella
pneumoniae strains isolated in three Moroccan cities; Casablanca
(plasmid A), El Jadida (plasmid B) and Settat (plasmid C). Conjugative
mating was attempted on agar. MICs were determined by E-Test method.
Antibiotic resistance genes and integrons were identiﬁed by PCR and
sequenced.
Results: Conjugative transfer of cefotaxime resistance was achieved
in all strains. blaCTX-M-15 was carried by a 125 kb plasmid. In
addition the plasmid A harboured the following 6 antibiotic resistance
genes conferring resistance to seven antibiotic classes: blaOXA-1,
blaTEM-1, aac(6′)-Ib-cr, catB4, tet(A), and the qnrB genes; the plasmid
B carried blaTEM-1 consistently, also blaOXA-1, catB4, aac(6′)-Ib-cr,
and tet(A). By contrast plasmid C carried blaOXA-1, catB4, aac(6′)-Ib-
cr, and tet(A). The blaCTX-M-15 gene presented the following genetic
environment: ISEcp1-blaCTX-M-15-orf477 and blaTEM-1b -TnpA-
ISEcp1-blaCTX-M-15-orf477.
Conclusions: To our knowledge, this is the ﬁrst description of genetic
environment of CTX-M-15 gene in K. pneumoniae from a Moroccan
community. The plasmids encoding CTX-M-15 conferred similar multi-
drug resistance phenotypes, suggesting that they may share a similar
genetic scaffold. Both shared features with plasmids encoding CTX-
M-15 b-lactamases in Escherichia coli from Canada.
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R2303 Macrolide resistance and in vitro selection of antibiotic
resistance in different human isolated Lactobacillus strains
V. Rodighiero*, E. De Vecchi, R. Mattina, T. Celeste, M. Toscano,
L. Drago (Milan, IT)
Objectives: Spreading of antibiotic resistance is of concern due to the
increasing rate of isolation of multiresistant pathogens. Since commensal
bacteria can transfer determinants of resistance to pathogens, studies on
resistance should include lactic acid bacteria, especially those intended
for use as probiotics. We performed this study aiming to evaluate the
capability of some antibiotics to select for resistance in lactobacilli.
Methods: Strains of Lactobacillus acidophilus (n = 13), Lactobacillus
plantarum (n = 9), Lactobacillus crispatus (n = 6) and Lactobacillus casei
(n = 12) isolated from human feces were included.
Amoxicillin/clavulanate, erythromycin and tetracycline were tested.
Minimum Inhibitory Concentrations (MICs) were measured with the
microdilution broth method. Susceptibility was determined according to
breakpoints established by EFSA.
The frequency of spontaneous mutations was calculated as the number
of colonies grown on antibiotic-containing agar plates per inoculum.
Selection of resistance was performed at 4× and 8× MIC and
peak serum concentration (Cmax). Susceptible isolates were serially
subcultured onto agar plates containing a linear gradient of each
antibiotic. Bacteria were exposed to ten consecutive passages on
antibiotic-gradient plates, then to ten passages on antibiotic-free plates.
Acquisition of resistance was deﬁned as >4-fold increase in MIC.
Stable mutants with reduced susceptibility to erythromycin were analysed
by PCR to detect the presence of erm and mef genes.
Results: Resistance to macrolides was observed in 16 strains (8 of them
harboured the ermB gene) and to tetracycline in 11 strains; all strains
were susceptible to amoxicillin/clavulanate.
Frequencies of mutation of susceptible strains (n = 26) were lower at
8× than at 4× MIC. Tetracycline showed the highest frequencies of
mutations.
After multi-step selection an increase in MICs was generally observed.
Such change was stable only in some strains. All tested antibiotics
could select stable resistance in all species. Molecular characterization
of resistant mutants did not lead to detection of erm nor mef genes.
Conclusions: Our results suggest that a decrease in susceptibility
following exposure to antibiotics might occur in some lactobacilli. So,
evaluation of the ability to acquire resistance to common antibiotics
should be performed in parallel with investigations on the presence of
resistance determinants in strains intended for human and animal use.
R2304 The active component, which mimics the role of
b-lactam antibiotics in the b-lactam antibiotic-induced
vancomycin-resistant MRSA
S. Ikeda*, H. Hanaki, Y. Ikeda-Dantsuji, H. Matsui, M. Iwatsuki,
K. Shiomi, T. Nakae, K. Sunakawa, S. Omura (Tokyo, Kanagawa, JP)
Background: Patients who suffer from MRSA infection are often
coinfected with Gram-negative bacteria, and they are likely to be
treated with a combination of vancomycin (VAN) and b-lactam
antibiotics. However, this combination therapy causes the emergence
of VAN-resistant MRSA, designated as b-lactam antibiotic-induced
VAN-resistant MRSA (BIVR), which traps a large amount of VAN
and lower free drug concentration in the mi-lieu. b-Lactam antibiotics
inhibit peptidoglycan synthesis and promote the expression of autolysin
resulting in the release of large amounts of peptidoglycan fragments into
the extracellular milieu. We hypothesized that peptidoglycan fragments
generated by the action of b-lactam antibiotics and autolysins were
incorporated into the cytoplasm for recycling and promote synthesis
of nascent lipid-II, an analogy to the case in Escherichia coli. Thus,
we searched active compound(s), which mimics the role of b-lactam
antibiotics in the induction of the BIVR phenomenon.
Method: The BIVR strain K744 was used for the indicator cells in
the BIVR assay. The compounds tested for the induction of BIVR
phenomenon were either prepared from peptidoglycan fragments or the
synthetics. The compounds to be tested were impregnated on a paper
disc with a diameter of 8mm, and that was placed on the VAN agar
plate streaked with the K744 cells. The plates were incubated overnight.
If the test compound was active, the indicator BIVR cells grow around
a paper disc forming a hollow, of which diameter was measured. The
non-BIVR cell show no growth zone due to the presence of VAN.
Results: The puriﬁed muropeptide, GlcNAc-MurNAc-L-Ala-D-isoGln-
L-Lys-(Gly4)-D-Ala-Gly2 and GlcNAc-1, 6-N, O-diacetyl-MurN-L-Ala-
D-isoGln-L-Lys-(Gly4)-D-Ala-Gly2 at 75mg per disc yielded 17.5 and
11.5mm, respectively, of the K744 growth zone. The Gly4 peptide
was not essential for the activity. The BIVR inducing activity was
undetectable by GlcNAc-MurNAc-L-Ala-D-isoGln, MurNAc-L-Ala-D-
isoGlu-L-Lys and L-Ala-D-isoGlu-L-Lys.
Conclusion: We concluded that the active compound was composed of
the GlcNAc-MurNAc glycan chain and the L-Ala-D-isoGln-L-Lys-D-
Ala-Gly2 peptide.
R2305 Report of transmission of VIM-producing Enterobacter
cloacae in a university hospital in Ireland
C. Ludden, M. Corcoran, D. Killeen, D. Keady, M. Da Costa,
M. Cormican, D. Morris, T.W. Boo* (Galway, IE)
Objective: Emergence of carbapenem-resistant Enterobacteriaceae
(CRE) has become a signiﬁcant public health threat. Within this diverse
group, VIM-producing Enterobacter cloacae is increasingly reported
in countries such as Greece and Spain. In this report, we evaluate
the evidence for transmission of carbapenem-resistant E. cloacae in a
cardiothoracic intensive care unit (CT-ICU).
Methods: Clinical, infection control and microbiological data were
collated. Clinical specimens were cultured by rountine methods. Patients
(rectal swab) and the environment were screened for CRE. Isolates
were identiﬁed by Vitek 2 and susceptibility testing was performed by
CLSI disc diffusion. Evaluation for carbapenemase was conducted using
the modiﬁed Hodge test (MHT), metallo-b-lactamase (MBL) Etest and
synergy testing. PCR detection of carbapenemase genes and analysis of
Xba1-restricted PFGE banding patterns were also performed.
Results: Carbapenem-resistant E. cloacae were cultured from sternal
wounds of 2 patients within a 6-day period. Both patients had received
broad-spectrum antibiotics but neither had a history of recent travel.
Their respective stays in the CT-ICU had overlapped for 11 days.
Both were treated with appropriate antibiotics while aggressive infection
control measures were instituted. CRE was not isolated from other
patients, the hospital environment or medical equipment at that time. The
isolates were resistant to b-lactams (including carbapenems), gentamicin
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and tobramycin, but susceptible to ciproﬂoxacin, amikacin and colistin.
Phenotypic carbapenemase screening methods yielded positive but often
inconsistent and subtle results. PCR conﬁrmed the presence of blaVIM
in both isolates, while PFGE demonstrated indistinguishable banding
patterns.
Conclusions: This is the ﬁrst report of the emergence of VIM-producing
E. cloacae in Ireland. Sternal wound infections by such organisms
were also not previously reported. Clinical and molecular data indicated
that cross-transmission of carbapenem-resistant E. cloacae in CT-ICU
was likely. Laboratory detection of VIM-producing Enterobacteriaceae
remains challenging, while the need for active surveillance in high-
risk patients warrants further consideration. The report highlights the
therapeutic and infection control challenges posed by these organisms,
and reiterates the importance of prudent antibiotic usage and aggressive
infection control measures.
R2306 Integron carriage of ESBL-producing Klebsiella
pneumoniae from bloodstream infections: a 2-year study
B.N. Belgode* (Puducherry, IN)
Introduction: Integrons are mobile genetic elements capable of gene
capture and expression via site-speciﬁc recombination and the action of
a promoter. Integrons play a major role in the dissemination of antibiotic
resistance genes and are commonly associated with members of the
family Enterobacteriaceae.
Objectives: To ﬁnd out the incidence and the classes of integron
associated with ESBL producing Klebsiella pneumoniae isolated from
blood stream infections.
Materials and Methods: This study was carried out on 256
K. pneumoniae isolates over a period of two years. Antimicrobial
susceptibility was tested for 14 antibiotics. ESBL detection was done
as per CLSI followed by a multiplex PCR. Integrase gene PCR was
done to detect class 1, class 2 integrons; similarly for class 3 and class 4
integron using speciﬁc primers. Sequencing was done for representative
number of strains.
Results: Out of the 256 isolates, 167 (65.2%) were ESBL producers.
blaSHV (77.2%) and blaCTX-M (85.6%) were the most common. Of
the 167 ESBL positive isolates, 121 (72.4%) carried class 1 integron; 51
(42.1%) isolates carried class 2 integron. Both class 1 and class 2 were
found in 33 (27.2%) and none had class 3 or class 4 type. Sequencing
and blasting results conﬁrmed their identities. The drug resistant rates of
integron positive isolates were 23% higher compared to integron negative
strains.
Conclusions: A higher percentage of class 2 integrons association with
ESBL strains is being noted for the ﬁrst time from our region, also the
co-existence of both class 1 and class 2 types increases the higher risk of
multidrug resistant gene transfer rates. These ﬁndings strongly suggest
that integrons have a major role in the dissemination of ESBL mediated
resistance among nosocomial isolates of K. pneumoniae.
R2307 Prophages induction by mitomycin C in Helicobacter
pylori clinical isolates and its association with resistance to
antimicrobial agents
T. Alarcon*, E. Aznar, M. Espinola, A. Somodevilla, M. Lopez-Brea
(Madrid, ES)
Objective: The aim of this study was to detect the presence of prophages
by the induction of its lytic cycle after culturing clinical isolates in
the presence of low concentrations of mitomycin C and determine its
association with the resistance to antimicrobial agents.
Methods: 47 H. pylori strains were studied. They were obtained from
gastric biopsies following standard methodology. Strains were stored
at −80ºC until used. TIGR 26695 was used as negative control as
no prophage was detected in its genome. Amoxicillin, clarithromycin,
rifampicin, ciproﬂoxacin, tetracycline, metronidazole resistance was
determined by E-test following standard methodology.
For prophage induction, H. pylori strains were subcultured on recently
prepared blood agar plates containing 5 ng/ml Mitomycin C, 10mg/l
vancomycin and 5mg/l amphotericyn B. After 2 to 5 days incubation,
plates were examined for the presence of growth inhibition plaques.
Results: Porphage induction was observed in 15 out of 47 strains
(31.9%) (not in TIGR) by detection of inhibition plaques after culture
on mitomycin C containing blood agar plates. The following resistance
percentages were detected: 4.2% to amoxicillin, 44.7% to clarithromycin,
10.9% to rifampicin, 4.3% to ciproﬂoxacin, 2.1% to tetraciclin and
27.6% to metronidazole.
Percentage of resistance was analyzed in 2 groups (strains with or
without prophages) Resistance was higher in the group with prophages
for the following antimicrobial agents: amoxicillin (6,6% vs 3,1%),
clarithromycin (53,3% vs 40,6%), ciproﬂoxacin (7,1% vs 3,1%) and
metrronidazol (33,3% vs 25%). Resistance was lower in the group with
prophages for the following antimicrobial agents: rifampicin (7,1% vs
12,5%) and tetracycline (0% vs 3,1%).
Conclusions: (1) Mitomycin C containing blood agar plates is an
easy method to detect prophage carriage among H. pylori strains.
(2) A high percentage of H. pylori strains showed prophage detected by
mitomycin C induction and (3) the presence of these prophages seems to
be associated with a higher percentage of resistance to the antimicrobial
agents most frequently used to treat infection produced by H. pylori.
R2308 The ﬁrst isolation and treatment of an OXA48
carbapenemase-producing E. coli in the UK
S. Thomas*, R. Hill (Manchester, London, UK)
Objective: To identify the resistance mechanism and determine
appropriate antibiotic treatment for a patient whose blood and abdominal
ﬂuid isolated an E. coli resistant to ertapenem and the cephalosporins,
with borderline imipenem and meropenem resistance. To highlight
problems with detection and difﬁculties with treatment of multi drug
resistant Gram negative organisms.
Methods: Following hospitalisation for an MI in Egypt, requiring ITU
care in The Nile Hospital, the patient was repatriated via air-ambulance
to Wythenshawe Hospital for cardiac rehabilitation and subsequently
developed an acute abdomen secondary to cholycystitis. Laporotomy
and cholecystectomy were carried out and cultures from blood and drain
ﬂuid isolated a resistant E. coli.
Routine in-house antibiotic susceptibility testing of the isolates was
undertaken by VITEK. Resistance was conﬁrmed by the Reference
Laboratory who carried out MICs to cephalosporins, carbapenems,
aminoglycosides, tigecycline and other agents by agar dilution. Potential
carbapenemase activity was examined by a plate assay (Clover Leaf test),
followed by enzyme identiﬁcation by PCR.
Results: A pure growth of E. coli with reduced carbapenem
susceptibility was isolated. MICs of carbapenems were ertapenem = 8,
meropenem = 1 and imipenem = 2. The isolate was clover leaf positive
for carbapenemase activity and PCR identiﬁed an OXA48. The isolate
was pan-b-lactam-resistant due to a CTX-M, seen by the MIC of
Cefotaxime potentiated from >256 to 1, whilst ceftazidime fell from 32
to 1. The isolate was sensitive to tigecycline, which the patient received
for 10 days resulting in full recovery. A detailed travel history revealed
visits to Tunisia, Spain and Portugal but no travel to Greece or Turkey,
during the past 5 yrs.
Conclusion: OXA48 has not previously been identiﬁed in an E. coli in
the UK. Detection of this carbapenemase is problematic as resistance to
ertapenem may be the only indicator, yet the MIC of ertapenem can be
readily raised by impermeability alone, making its use as a single maker
uncertain. Dissemination of OXA48 has to date, been geographically and
species restricted and not previously associated with E. coli or with travel
to Egypt. Tigecycline concentrates well in the gall bladder and should
be considered for sensitivity testing in these circumstances; however
concerns remain around the achievement of adequate serum levels of the
agent in patients with severe sepsis with a single conﬁrmed pathogen.
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R2309 Study on drug resistance of Mycobacterium tuberculosis and
mycobacteria other than tubercle bacilli strains to oﬂoxacin
and ciproﬂoxacin isolated from patients admitted to
research centre for TB and pulmonary diseases, Tabriz, Iran
A. Raﬁ*, R. Moaddab (Tabriz, IR)
Objectives: Study and evaluation of effectiveness of second line drugs
against mycobacterial strains has become more important in the past few
years, particularly due to the outbreak caused by multi-drug resistant
(MDR) strains of Mycobacterium tuberculosis (MT). The aim of this
study was to evaluate the in-vitro susceptibility of M. tuberculosis (MT)
and mycobacteria other than tubercle bacilli (MOTT) strains to the two
main second line anti-mycobacterial agents (ciproﬂoxacin and oﬂoxacin).
Methods: In this study, in-vitro activities of oﬂoxacin and ciproﬂoxacin
against totally 100 mycobacterial strains including 90 Mycobacterium
tuberculosis strains (40 strains resistant and 50 strains sensitive to
the ﬁrst line drugs) and 10 mycobacteria other than tubercle bacilli
strains (all strains resistant to the ﬁrst line drugs) were investigated by
proportional method on Lowenstein-Jensen (LJ) medium.
Results: Out of 90 M. tuberculosis strains, 50 strains that were sensitive
to the ﬁrst line drugs were diagnosed as susceptible to oﬂoxacin and
ciproﬂoxacin. Of other 40 strains which were resistant to the ﬁrst line
drugs, only one strain was resistant to oﬂoxacin and 2 strains were found
to be resistant to ciproﬂoxacin. Of 10 mycobacteria other than tubercle
bacilli strains, 4 strains were resistant to oﬂoxacin and 3 strains were
found to be resistant to ciproﬂoxacin.
Conclusion: The ﬁndings of this study showed that oﬂoxacin
and ciproﬂoxacin could be effectively used against Mycobacterium
tuberculosis strains and also mycobacteria other than tubercle bacilli
strains.
R2310 Staphylococcus aureus faecal carriage among healthy
humans in Spain. Detection of livestock-associated genetic
lineages ST398 and ST133 in methicillin-susceptible isolates
D. Benito*, C. Lozano, E. Go´mez-sanz, M. Zarazaga, C. Torres
(Logron˜o, ES)
Objectives: To determine the rate of S. aureus faecal carriage in healthy
humans in Spain and to perform the genetic characterization of recovered
isolates.
Methods: Fecal samples of 96 healthy humans were recovered in
La Rioja (Spain) during September-December 2010. Samples were
inoculated into Mannitol-Salt-agar and ORSAB plates for S. aureus
and methicillin-resistant S. aureus recovery, respectively. Isolates were
identiﬁed by biochemical methods and nuc-gene PCR. Antibiotic
susceptibility proﬁle was determined by disk-diffusion method for 18
antibiotics. S. aureus isolates were submitted to spa- agr- and MLST
typing. The presence of 9 antibiotic resistance genes (msrA, msrB,
mphC, ermA, ermB, ermC, ermF, ant-4′, mupA) and 11 virulence factor
genes (lukF/lukS-PV, lukE-lukD, lukM, tst-1, eta, etb, hlA, hlB, hlD,
hlG, hlgv) were studied by PCR.
Results: S. aureus was recovered in 14 of 96 studied samples (14,6%),
all of them being methicillin-susceptible (MSSA). A very high diversity
of spa-types was detected among our isolates (t084, t002, t209, t012,
t021, t216, t136, t3495, t571), types t084 and t002 being detected in two
samples, each one. MLST was performed for isolates with spa-types
t571 and t3495, and sequence types ST398 and ST133, respectively,
were identiﬁed. Isolates were susceptible to most of antibiotic tested
with some exceptions: erythromycin-clindamycin (3 isolates, with ermC
with/without ermA+mphC), tobramycin and mupirocin (1 isolate with
ant(4′) + mupA genes). All 14 MSSA were negative for lukF/lukS-
PV genes encoding Panton-Valentine leucocidin. The lukDE gene was
identiﬁed in 5 isolates. Interestingly, strain ST133 harboured the lukDE
+ lukM genes. Five isolates were tst-1 positives (35% of all MSSA).
Others virulence factors detected were (number of isolates): hlA(14),
hlB(9), hlD(14), hlG(6), and hlG2(8).
Conclusions: A high prevalence and a high clonal diversity of MSSA
isolates were identiﬁed. As far as we know, this is the ﬁrst detection of
MSSA ST133 in faecal samples of healthy humans.
R2311 Antimicrobial resistance and vancomycin heteroresistance
of MRSA strains from a tertiary hospital in Greece
T. Panayea*, M. Souli, I. Galani, I. Karantani, H. Giamarellou,
G. Petrikkos (Athens, GR)
Methicillin resistant S. aureus strains cause a variety of infections
that are sometimes difﬁcult to treat and are spread both in hospital
environment and community. Vancomycin heteroresistance (hVISA) is
mainly observed among these strains.
Objectives: To detect antimicrobial resistance and hVISA prevalence of
MRSA isolates and examine vancomycin MIC through time.
Methods: 155 MRSA non-duplicate isolates were isolated in the Clinical
Microbiology and Infectious Diseases Laboratory during 1/1/2008
to 30/6/2010. Samples were:116 wounds and abscesses (74.8%), 29
blood (18.8%), 5 intravascular catheters (3.2%) and 5 ﬂuids (4 synovial,
1 pleuritic) (3.2%). The majority of patients were hospitalised
(33.5% internal medicine wards, 14.2% surgical wards, 7.1% ICU)
while 45.2% were outpatients. Identiﬁcation and susceptibility testing
was performed by automated system (AS) (Phoenix BD) according to
CLSI guidelines. All strains’ MIC to vancomycin and teicoplanin was
further tested by Etest (AB Biodisk). E-test macromethod was used to
detect hVISA strains.
Results: Resistance rates of MRSA strains were: eryth 62%, clind
47.1%, cipr 45.8%, gent 31.6%, rif 29%, trim-sulf 14.2%, quin-dalf
2.6%, mup high-level 1.9%. MIC to fusidic ac was 4 for 69% of
the strains (only EUCAST brpoint: R 2). Inducible MLSB phenotype
was detected in 10% of the strains. There were no resistant strains to
vancomycin, teicoplanin and linezolid. MICs to vanc and teic determined
by E-test were higher than those of the AS. Vanc 1 was detected in
97.4% (AS) and 33.5% (E-test) of the strains and teicoplanin 1 in
94.8% (AS) and 81.9% (E-test) of the strains. MIC results by E-test
were: vanc MIC50 = 1.5, MIC90 = 2 (range 0.5−3, one strain with MIC= 3
was not conﬁrmed to be a VISA isolate by broth microdilution, nor
was hVISA), teic MIC50 = 0.75, MIC90 = 1.5 (range 0.25−6). There
was a transient increase (p< 0.05) in vanc MIC during 1/7/2008 to
30/6/2009.13 of 155 strains (8.4%) were hVISA. Among these 13
isolates, 8 were recovered from wounds and abscesses, 4 from blood, and
1 from intravascular catheter, while four of the patients were outpatients.
Vanc MIC range was 0.75−2 (1 st = 0.75, 2 st = 1, 8 st = 1.5, 2 st = 2).
Conclusion: hVISA phenotype is not uncommon among MRSA isolates.
Strains with vanc >1 should be tested for such a phenotype. Further
studies using population analysis are needed to establish the prevalence
of such strains, their antimicrobial resistance and infections clinical
outcome.
R2312 ESBL-Escherichia coli fading away
J.M. Sahuquillo-Arce, H. Perpin˜a´n, A. Rodriguez, A. Iranzo*,
C. Armero, A. Lo´pez-Quilez, F. Gonza´lez, M. Gobernado (Valencia, ES)
Objective: To study the evolution and pattern of consecutive urinary
tract infections (UTI) caused by Escherichia coli in patients from the
Comunitat Valenciana, Spain.
Methods: Urinary isolates were obtained from January 2007 to
December 2008. Microbial identiﬁcation and antimicrobial susceptibility
testing were performed according to each laboratory standard procedures
and conforming to CLSI antimicrobial susceptibility criteria, either
by regular biochemical reactions and agar diffusion susceptibility
tests or automated methods. Data were retrieved from the Comunitat
Valenciana Microbiological Surveillance Network (RedMIVA), which
daily compiles and analyzes information from 25 microbiology
laboratories that manage more than 90% of the total population
(5,029,601 people).
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ESBL-Escherichia coli (EEC) was deﬁned as an E. coli resistant to third
generation cephalosporins but susceptible to amoxicillin clavulanate.
Thus, most TEM, SHV and CTX-M-type enzymes (molecular class
A enzymes or functional group 2be from the Bush-Jacoby-Medeiros
classiﬁcation) were taken into account.
ITU were considered different if time between two episodes was greater
than 15 days or the isolate presented different susceptibility patterns
affecting ESBL classiﬁcation.
In vitro growth competitions were carried out ﬁvefold by placing the
same inoculum of two isolates of E. coli (EEC vs. E. coli with no
antimicrobial resistance) into 10ml of thioglicolate (TG). Then, aliquots
were sub-cultured every day for both re-growth in 10ml TG and colony
identiﬁcation.
Results: The total number of urinary isolates analyzed was 70,827
belonging to 49,304 different patients. Of these isolates, 5,161 (7.3%)
were categorized as EEC. The number of different ITU was 64,472,
4,403 (6.8%) by EEC, and 1701 were discarded because they took place
at the end of the study period during the fourth consecutive ITU.
The mean time from an EEC ITU to another EEC ITU was 43 days,
while the mean time from an EEC ITU to a non-EEC ITU was 75 days.
Growth competitions showed a greater than 99% decreased in the EEC
population after 5 days.
Conclusions: Our data suggests that, given the time and in the absence
of antimicrobial pressure, E. coli with fewer antimicrobial resistances
will outgrow EEC, probably due to a better ﬁtness of the isolate.
R2313 Antimicrobial susceptibility pattern among Acinetobacter
calcoaceticus-baumannii complex in a Saudi Arabian
hospital
S. Al Johani*, H. Balkhy (Riyadh, SA)
Objective: To examine patterns of antimicrobial susceptibility in
Acinetobacter calcoaceticus-baumannii isolates to commonly used drugs
at a tertiary care hospital in Riyadh, Saudi Arabia.
Methods: A retrospective study was carried out at King Fahad National
Guard Hospital (KFNGH) between 2008 and 2010. Organisms were
identiﬁed and tested by the automated identiﬁcation and susceptibility
system (MicroScan Walk away 96, Siemens®) and the Antibiotic
susceptibility testing were conﬁrmed by the Etest (AB Biodisk, Sweden).
The procedural details interpretations were as recommended by the
Clinical laboratory standards Institute (CLSI).
Results: Between 2008–2010, a total of 2552 isolates of Acinetobacter
baumannii (A. baumannii) were available for analysis. The organism
showed high rates of resistance to Pip-Tazo (81% of isolates),
Imipenem (66%), Meropenem (83%), Gentamicin (68%), amikacin
(65%), ceftazidime (82%), cefepime (70%), ciproﬂoxacin (80%) and
colistin 19%. Multidrug resistance was observed in (65−75%) of
Acinetobacter species isolates.
Conclusion: Antimicrobial resistance in Acinetobacter baumannii is a
major emerging problem particularly in the intensive care unit, Strict
infection control measures, judicious prescribing of antibiotics, antibiotic
stewardship programs and antibiotic cycling should be adopted to
control infections due to these bacteria in patients admitted to intensive
care Continuous monitoring of antimicrobial susceptibility and strict
adherence to infection prevention guidelines are essential to eliminate
major outbreaks in the future.
R2314 Multicentre evaluation of in vitro activity of
tigecycline against extended-spectrum b-lactamases and
multidrug-resistant Enterobacteriaceae clinical isolates
C. Caneiras*, F. Calisto, R. Moura, M. Augusto, G. Da Silva, J. Melo
Cristino, A. Duarte (Lisbon, Coimbra, PT)
Objectives: Tigecycline is an antibiotic used in clinical setting where
multidrug resistance (MDR) and extended spectrum b-lactamases
(ESBL) production is prominent. Due to the constant potential of
emergency of resistance, long term survey studies are needed. The aim
of this study was to assess the activity of tigecycline against MDR and
ESBL Enterobacteriaceae isolates during a period of ten years.
Methods: A total of 155 isolates, Escherichia coli (n = 92) and Klebsiella
pneumoniae (n = 63), were collected at 5 hospitals in Portugal (1999–
2010). Susceptibilities to antimicrobial agents were determined by disk
diffusion and interpreted according to CLSI guidelines: tigecycline,
imipenem, ciproﬂoxacin, gentamicin, amikacin, ampicillin, cefotaxime,
ceftazidime, cefepime and amoxicillin/clavulanic acid. Tigecycline MICs
were performed by Etest. The ESBLs were identiﬁed by PCR with
speciﬁc primers for bla-CTX-M, bla-TEM and bla-KPC gene.
Results: According to the breakpoints proposed by CLSI, 25% of
K. pneumoniae and 13% of E. coli ESBL-producing were nonsusceptible
to tigecycline. Higher prevalence of intermediate susceptibility was
found (Klebsiella 63% and E. coli 44%). Longitudinal analysis showed
no increase in tigecycline resistance over the 10-years study period
and was not inﬂuenced by the presence of CTX-M- and TEM-type
enzymes. However for the ﬁrst time in Portugal it was identiﬁed a
KPC-3 E. coli resistant to tigecycline and nine K. pneumoniae isolates
producing KPC-3 showed reduced activity (33%). MDR and ESBL-
producing E. coli had tigecycline MIC90 3mg/l and K. pneumoniae
isolates had tigecycline MIC90 2mg/l. The analysis of tigecycline
MICs showed a poor correlation with values obtained and disk zone
diameters, 38% of the MIC results are concordant. The discordant data
occur mostly in the intermediate/susceptible zones.
Conclusion: Tigecycline showed good activity against MDR and ESBL
isolates. However, the high frequency of isolates in intermediate category
found and the discordant correlation between MICs and inhibition zone
diameters, suggest that further selective pressure will lead to an overall
reduced susceptibility to tigecycline in Enterobacteria. For instances, the
tigecycline resistance found in KPC-3 isolates collected in 2010 may
indicate an indiscriminate use of tigecycline. These results indicate that
the use of tigecycline in hospital setting should be carefully controlled
to avoid the emergence of resistance.
R2315 Comprehensive analysis of telavancin activity against
staphylococcal isolates from Europe (2009–2010), including
strains with reduced susceptibility to vancomycin
R. Mendes*, H. Sader, D. Farrell, R. Jones (North Liberty, US)
Objectives: To assess telavancin (TLV) and comparator activities against
staphylococci, including strains with decreased susceptibility (S) to
vancomycin (VA) and teicoplanin (TE), from Europe (EU). TLV is
approved in the United States (US) and Canada for the treatment of
adults with complicated skin and skin structure infections (cSSSI). This
drug is also under review for the treatment of complicated skin and soft
tissue infections in EU and nosocomial pneumonia in the US and EU.
Methods: 3 868 S. aureus (SA) and 1 003 coagulase-negative staphylo-
cocci (CoNS) were collected from 33 sites in 12 countries, including
Turkey and Israel. Isolates were submitted to a central laboratory and
identiﬁcation performed by standard algorithms and Vitek 2. Strains were
S tested by CLSI methods (M07-A8, 2009). EUCAST criteria (2010)
were applied, when available.
Results: SA were from SSSI (41.0%), bacteremia (35.3%), and
respiratory tract infections (13.0%), while the majority (68.2%) of
CoNS were from bacteremia. TLV (MIC50/90, 0.12/0.25mg/L) was
2-fold more potent than daptomycin (DA; MIC50/90, 0.25/0.5mg/L)
and 4- to 8-fold more active than VA (MIC50/90, 1/1mg/L) and
linezolid (LZ; MIC50/90, 1/2mg/L) against all SA. Similar results were
noted for CoNS. 1.6 and 1.0% of SA had higher VA (>1mg/L; all
2mg/L) and TE MICs (2−8mg/L), while 47.6 and 31.0% of CoNS had
elevated VA (2−4mg/L) and TE MICs (4mg/L), respectively. Rates
of SA with VA MICs >1mg/L varied among countries (0.7−5.1%),
being lowest in Poland and highest in Switzerland. TLV (MIC50/90,
0.25/0.5mg/L) showed higher MICs (2-fold) against SA with decreased
S to glycopeptides compared with strains with lower VA and TE MICs
(MIC50/90, 0.12/0.25mg/L). No differences in the TLV MIC50/90 values
were noted against SA from different years, countries or infection sources
(MIC50/90, 0.12/0.25mg/L). Consistent TLV (MIC50/90, 0.12/0.25mg/L)
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activity was observed against CoNS, regardless of country of origin or
glycopeptide S.
Conclusions: TLV exhibited higher potency (at least 2-fold) than
direct comparators (VA, DA and LZ). SA with decreased S to
glycopeptides showed higher TLV MICs, although all strains were
inhibited (0.5mg/L) at concentrations below the FDA breakpoint for
SA (1mg/L). The TLV activity against SA and CoNS suggests this
drug as an option for staphylococcal infections, including those caused
by strains with decreased S to glycopeptides.
R2316 Antibiotic susceptibility of Escherichia coli strains causing
community-acquired urinary tract infection
M. Espı´nola*, A. Garcı´a, A´. Somodevilla, M. Martı´nez, A. Guiu,
A. Correa, M. Lo´pez-Brea (Madrid, ES)
Escherichia coli is involved in 85% of community-acquired urinary
tract infections (UTIs). For this reason, it is important to know its
antimicrobial susceptibility patterns in order to give an appropriate
empiric treatment of UTIs.
The aim of this study is to evaluate the antibiotic resistance of E. coli
strains isolated in community-acquired UTIs, and to see the prevalence
of extended-spectrum b-lactamase (ESBL) producing strains in the
community.
Methods: 2598 E. coli isolates were collected from outpatients with
clinical evidence of community-acquired UTIs during the period January
to November 2010 in a hospital in Madrid, Spain. Urine samples were
cultured in CLED agar and incubated at 37ºC for 48 hours. UTIs were
deﬁned as the culture of a single organism from a midstream urine
specimen at 105 colony forming units per milliliter. Identiﬁcation and
antibiotic susceptibility tests were made by the routinely used automated
system MicroScan (Siemens). Additionally, susceptibility tests were
performed by disk diffusion method according to standard procedures.
For the study, reduced susceptibility to 8 antibiotics commonly
used in UTIs (amoxicillin, amoxicillin/clavulanic acid, cefuroxime,
norﬂoxacin, ciproﬂoxacin, trimethoprim/sulfamethoxazole, fosfomycin
and nitrofurantoin) was evaluated. In addition, extended-spectrum
b-lactamase (ESBL) production was examined; a ratio of 8 or greater
for the ceftazidime to ceftazidime-clavulanic acid minimal inhibitory
concentrations (MICs) and the cefotaxime to cefotaxime-clavulanic acid
MICs was considered ESBL-positive.
Results: 2598 E. coli isolates were obtained, 179 of which (6,9%)
produced an extended-spectrum b-lactamase. Isolates presenting reduced
susceptibility to the different antibiotics evaluated are shown in the table
attached.
Conclusion: This study shows the increasing prevalence of ESBL-E. coli
in community-acquired infections, being almost 7% of the E. coli strains
isolated positive for ESBL.
High resistance rates are obtained for quinolones (norﬂoxacin and
ciproﬂoxacin) in both, ESBL and not ESBL producing E. coli. For this
reason, these antibiotics should not be used for the empiric treatment
of community-acquired UTIs in our country. However, low resistance
rates are shown for nitrofurantoin and fosfomycin, in both ESBL and
not ESBL E. coli, which suggests that these antibiotics may be a good
option in the empiric treatment of UTIs.
R2317 High-level antimicrobial non-susceptibility rates among
environmental bacteria isolated from Iztuzu Beach in
Dalyan, Turkey
M. Ozturk*, E. Oryasin, O. Guclu, B. Bozdogan (Aydin, TR)
Introduction: Antimicrobial resistance level is high among pathogen
bacteria especially hospitals. The aim of this study was to determine
antimicrobial susceptibility levels of environmental bacteria from a
national park in Turkey.
Materials and Methods: A total of 72 bacteria were deﬁned by 16S
rRNA sequencing (Figure 1). The antimicrobial susceptibilities of 72
bacteria isolated were investigated to penicillin, ampicillin, lincomycin,
erythromycin, vancomycin, ciproﬂoxacin, gentamicin, tetracyclin, and
chloramphenicol by agar diffusion MIC method. Strains with high
MICs for lincomycin, chloramphenicol and penicillin were tested for
inactivation by Gots’ test. b lactamase positive strains were tested for
ESBL production. All strains with high level MICs for gentamicin,
tetracyclin, and chloramphenicol were studied for the presence of known
gene by PCR. Gram positive bacteria were tested for the presence of
erytromycin, and vancomycin resistanve genes. The following genes were
tested for their presence: ermA, ermB, ermC, vanA, tetA, aac-aph and
cat.
Results: Among isolates high MIC rates were 76.3%, 75%, 70.8%, 68%,
54.1%, and 47.2% for ampicillin, penicillin, gentamicin, chlorampheni-
col, tetracycline, and ciproﬂoxacin, respectively among all isolates. MIC
values were evaluated for lincomycin, erythromycin and vancomycin
among Gram (+) bacteria which showed 88.6%, 45.4%, and 15,9% high
level MICs, respectively. Gots’ test showed that, 35 isolates inactivates
penicillin and only one isolate inactivates chloramphenicol. Among
b-lactamase (+) strains one was ESBL producer. Of 20 isolates with
high level erythromycin MICs 2 had ermB, 1 ermC, and 0 ermA. Of 51
isolate with high gentamicin MICs only 1 had aac-aph. Of 39 tetracyclin
resistant isolates 4 had tetA and 2 had tetM genes but 33 were negative
for both. Of 21 vancomycin resistant isolates 1 had vanA. The vanA (+)
isolate was E. faecium and ST type of this strain was close to 17 with
one allele difference.
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Conclusions: Antimicrobial resistance is one of the main public health
problem. The use of antimicrobials select resistance strains in hospitals
but also the dispersion of antimicrobials to the nature may cause
selection of resistance in the nature. Our study showed presence of high
level antimicrobial non-susceptibility among environmental isolates in
a natural park. The effect of environmental resistant strains on public
health should be evaluated.
R2318 Increase of antibiotic resistance in S. aureus isolates from
mastitis milk of Sicilian dairy farms: a seven-year survey
M.C. Emanuele*, D. Vicari, M. La Giglia, M. Bivona, R. Bosco,
M. Vitale (Palermo, IT)
Objectives: Antimicrobial agents are widely used in animal husbandry
for treating infectious diseases and ensuring animal welfare and good
quality food production. It is well known that antimicrobial usage
can select for resistant forms of bacteria and resistant strains can be
exchanged between humans, animals and other ecosystems. To the aim
of monitoring resistance against selected antimicrobial agents commonly
used in sheep producing milk, a survey was carried out on S. aureus
strains isolated from milk of animals with mastitis problems in seven
years from 87 farms.
Methods: 172 strains of Staphylococcus aureus were isolated and
collected from milk during 2002–2008 in sicilian livestocks with
big problems of ovine mastitis. The isolates in fact were used to
prepare autogenous vaccine at the IZS of Sicily. They were tested
for antimicrobial susceptibility by disk diffusion test (DDT) against
the following agents: ampicillin (AMP 30mcg), amoxicillin+clavulanate
(AMC 30mcg), enroﬂoxacin (ENR 5mcg), eritromycin (ER 15mcg),
penicillin (P 10UI), tetracycline (TE 30mcg), vancomycin (VA 30mcg),
oxacillin (OX 1mcg), oxytetracycline (OT 30mcg) according to CLSI
guidelines.
Results: As shown in the table 1, the number of clones resistant to
AMP, AMC, P and Te, OT, the antimicrobials commonly used in animal
husbandry, increased during 2002 to 2008. The resistance to ER was
also found (19−20%). A low level of OX resistance was detected,
with a decrease from 2002–2005 to 2006–2008. A double increase in
tetracycline resistence is shown and an substantial increase in OT was
also observed.
The presence of mecA gene was investigated by PCR and resulted in
a 10% of positive clones with similar percentages in the 2 considered
periods. None of them showed resistance to VA and ENR.
Conclusion: The ﬁnding of a general increasing trend in antibiotic
resistance against the selected drugs implies that the selective pressure
has acted in the ecosystem favouring the espansion of resistant clones;
for this reason is important the monitoring of drug resistance in food
animals and a prudent usage of antibiotics in the veterinary ﬁeld, to
avoid major risk for increase drug resistance in the human population.
R2319 Evolving molecular epidemiology of Enterobacteriaceae
resistant to expanded-spectrum cephalosporins in Italy:
one-year results of a large, multicentre, observational study
E. Mantengoli, F. Luzzaro, T. Di Maggio, G. Brigante, B. Pini, A. Goglio,
L. Ferrari, P. Pecile, M. Tinelli, E. Tacconelli, R. Cauda, G.M. Rossolini*
(Siena, Lecco, Bergamo, Cremona, Florence, Lodi, Rome, IT)
Objectives: Italy is among the countries reporting increasing resistance
rates to expanded-spectrum cephalosporins (ESCs) in Enterobacteri-
aceae. Production of extended-spectrum b-lactamases (ESBLs) and
AmpC-type b-lactamases (CBLs) remain the major mechanisms of ESC
resistance. We report here on the molecular epidemiology of ESBL- and
CBL-producing enterobacterial isolates collected during one-year in a
large, multicentric study recently conducted in Italy.
Methods: Five Italian Medical Centres consecutively enrolled patients
with infections caused by Escherichia coli, Klebsiella pneumoniae
or Proteus mirabilis with reduced susceptibility to ESCs (cefotaxime
and/or ceftazidime MICs >1mg/L) during the period 2007–2008. ESBL
production was conﬁrmed using the double-disk synergy test. ESBL
and CBL determinants were characterized by DNA hybridization and
conﬁrmed by PCR and sequencing. Clonal relatedness was investigated
by RAPD.
Results: A total of 444 cases of infection caused by Enterobacteriaceae
with reduced susceptibility to ESCs were enrolled (268 by E. coli, 74 by
K. pneumoniae and 102 by P. mirabilis). ESBL production was conﬁrmed
in 396 (89%) of isolates, CBL production was observed in all ESBL-
negative P. mirabilis. Among the ESBL producers, CTX-M-type enzymes
were overall the most prevalent (80% overall, 91% in E. coli, 90%
in Klebsiella, and 12% in Proteus) and mostly (95.8%) belonged in
group 1 (CTX-M-1 and CTX-M-15). However, CTX-Ms of groups 2
(1.1%, CTX-M-2) and 9 (3.1%, CTX-M-14 and CTX-M-27) were also
detected. Other ESBLs included TEM- and SHV-type variants (10%
and 4.7% overall, respectively, including TEM-92, TEM-72 and SHV-
12, SHV-2a). All CBLs belonged in the CMY-2 lineage, being totally
represented by CMY-16. Clonal heterogeneity was observed among the
ESBL producers of each species, although clonal expansion phenomena
caused by CTX-M-producing E. coli ST131 were observed. All CBL-
producing P. mirabilis isolates were clonally related with each other.
Conclusions: In comparison with previous studies, a remarkable
evolution of the molecular epidemiology of ESC-resistant Enterobac-
teriaceae was observed in Italy. CTX-M-type enzymes have become the
predominant ESBLs, with enzymes of group 2 and 9 also emerging,
while CMY-2-like CBLs now signiﬁcantly contribute to ESC resistance
in P. mirabilis.
R2320 Further increase in carbapenem-, amikacin-, and
ﬂuoroquinolone-resistant isolates of Acinetobacter spp. and
P. aeruginosa in Korea: KONSAR study 2009
K. Lee, M. Kim, J. Kim, H. Hong, J. Kang, J. Shin, Y. Park, D. Yong,
S. Jeong, Y. Chong* on behalf of the KONSAR group
Objective: The increasing prevalence of carbapenem-, amikacin-, and
ﬂuoroquinolone-resistant Acinetobacter spp. and P. aeruginosa are of
particular concern in Korea. We analyzed resistance trends of E. coli,
K. pneumoniae, Acinetobacter spp. and P. aeruginosa in Korean hospitals
(HOSP) and clinics.
Methods: Antimicrobial susceptibility was determined by participating
laboratories (Labs) either by CLSI disc diffusion or commercial broth
microdilution methods. The data collected from 24 HOSPs and two
commercial Labs (CLAB) servicing secondary-care HOSPs and clinics
were analyzed, excluding those from Labs with poor performance.
Results: Contrary to our expectations, typical nosocomial pathogens,
Acinetobacter spp. and P. aeruginosa, comprised a large proportion
of CLAB isolates. We were also surprised that most resistance rates
were higher for CLAB isolates. Trends of resistance in 2007 vs. 2009
for HOSP isolates were: ceftazidime-resistant E. coli 8% vs. 17%,
ceftazidime-resistant K. pneumoniae 29% vs. 33%; imipenem-resistant
Acinetobacter spp. 22% vs. 51%; and imipenem-resistant P. aeruginosa
21% vs. 26%. A previous study showed that the majority of imipenem-
resistant Acinetobacter spp. was mediated by OXA carbapenemase
production. Among the HOSP Acinetobacter spp. isolates in 2007 and
2009, ﬂuoroquinolone-resistance rose from 48% to 67%, and amikacin-
resistance rose from 37% to 48%. Comparison of the data from six
>1000-bed HOSP showed signiﬁcantly higher imipenem-resistant rates
among ICU isolates than non-ICU isolates: Acinetobacter spp. 74% vs.
53%, and P. aeruginosa 39% vs. 20%.
Conclusion: Ceftazidime-resistant E. coli and K. pneumoniae were
also prevalent among CLAB-tested isolates. Imipenem-, amikacin- and
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ﬂuoroquinolone-resistant Acinetobacter spp. increased further in both
HOSPs and CLABs. Imipenem-resistant isolates were more prevalent
among ICU isolates. We are confronted with a worsening problem in
treating Acinetobacter spp.-infected patients and controlling resistance.
R2321 Evaluation of tigecycline activity in clinical isolates
D. Kofteridis, S. Maraki, D. Dimopoulou*, A. Valachis, J. Papadakis,
G. Samonis (Heraklion, GR)
Objectives: Resistance to antimicrobial agents is emerging in a wide
variety of nosocomial-acquired pathogens. Tigecycline, a glycylcycline
antimicrobial, is a newer treatment option for emerging single- or
multidrug-resistant Gram-positive cocci (GPC) and Gram negative bacilli
(GNB). The purpose of the present study was to determine the in vitro
activity of tigecycline against clinical isolates of various pathogens.
Material and Method: A total of 3240 non-duplicate clinical isolates
collected from hospitalized patients during 2009, were evaluated by
the disk diffusion method. The isolates were classiﬁed as tigecycline
susceptible and resistant based on FDA breakpoints. Isolates with
intermediate resistance to tigecycline have been included in the resistant
group.
Results: Tigecycline activity against all GPC and GNB isolates tested
is shown in the table.
Conclusion: The present data show that tigecycline has excellent activity
against all Gram positive and Gram negative organisms tested, with the
important exception of Acinetobacter spp. that are showing alarming
resistance rates to tigecycline in the area of Crete.
R2322 Susceptibility pattern of H. pylori after treatment failure
L. Rasmussen*, J. Alimoradi, A. Boschian, L.P. Andersen (Copenhagen,
Glostrup, DK)
Objectives: According to the Maastricht III Consensus, H. pylori test
and treat is the strategy of choice in most H. pylori infected patients
and PPI combined with amoxicillin and clarithromycin/metronidazole
is recommendated as ﬁrst line treatment. There is a growing concern
regarding antibiotic resistance in H. pylori, which can result in treatment
failure. The aim of this study was to evaluate the susceptibility pattern
of H. pylori strains after treatment failure in Danish patients.
Methods: 50 clinically isolated H. pylori strains were susceptibil-
ity tested by E-test for amoxicillin, metronidazole, ciproﬂoxacin,
levoﬂoxacin, clindamycin, erythromycin, clarithromycin, rifampicin,
tetracycline and meropenem.
The bacteria were grown and susceptibility tested according to the
manufacturer.
Results: 74% of the strains were resistant to metronidazole, 54% were
resistant to clindamycin and clarithromycin and 52% were resistant to
erythromycin while 36% of the strains were resistant to all those 4
antibiotics at the same time. All strains were susceptible to amoxicillin,
ciproﬂoxacin, levaﬂoxacin, tetracycline and rifampicin.
Conclusion: This study shows a high rate of resistance to the most
commonly used antibiotics and a high rate of multiresistant strains
in patients with treatment failure. This suggests that antimicrobial
susceptibility testing should be done after the ﬁrst treatment failure.
R2323 Retrospective study of microbiological cultures during the
last two years from intensive care unit
E. Ismirli*, N. Kostoglu, P. Kasviki, R. Zilidu, I. Xuris (Giannitsa, GR)
Objectives: To study the results of cultures of patients, who had been
hospitalized in intensive care unit (I.C.U.) during the last two years The
specimens were from bronchial lavages, urine, rectum, central venous
catheters, blood, traumas and pharyngeal smears.
Methods: The specimens were cultivated in chocolate, blood, McConkey
No2 and Chapman agars. in 35−37º for 24 h. The identiﬁcation and
control of sensitivity were performed by mini API test and diffusion
disk test by Kirby-Bauer according to the CLSI standards.
Results: From the 1145 cultures of the period (24/7/2009−24/7/2010),
815 were negative, and 330 were positive. From the 1350 specimens
of period (24/7/2008–24/7/2009) 805 were negative and 545 positive.
We isolated in the period (24/7/2008−24/7/2009) the following bacterial
species Pseudomonas aeruginosa 104 (19,0%) K. pneumoniae 169
(31,00%) Acinetobacter baumannii 120 (22,0%) E. coli 28 (5,13%)
S. aureus 32 (5,8%) Stenotrophomonas maltophilia 11 (2,01%), Kleb-
siella oxytoca 9 (1,6%) Proteus mirabilis 39 (7,15%) Staphylococcus spp
40 (7,3%) Candida spp. 146 (26,7%) Candida albicans 89 (16,3%) En-
terococcus spp. 5 (0,9%). During the period (24/7/2009−24/7/2010),the
following bacterial species were isolated: Pseudomonas aeruginosa 51
(15,4%), K. pneumoniae 33 (10%), Acinetobacter baumannii 12 (9,6%),
E. coli 12 (3,6%), S. aureus 11 (3,3%), Stenotrophomonas maltophilia
11 (3,33%), Klebsiella oxytoca 9 (2,72%), Proteus mirabilis 4 (1,2%),
Staphylococcus spp 17 (5.1%), Candida spp. 110 (33,3%) Candida
albicans 21 (6,3%), Enterococcus spp. 10 (3,0%). The resistance to
antibiotics for K. pneumoniae was the following: Ampicillin/Sulbactam
52%, Piperacillin/Tazobactam 42%, Amikacin22%, Meropenem 16%,
Imipenem 15%. The resistance for Acinetobacter baumannii was
the following: Amikacin 75%, Meropenem 74%, Imipenem 76%,
Piperacillin/Tazobactam 80%, Ticarcillin/Clavulanic Acid 82%, Ampi-
cillin/Sulbactam 84%, Colistin 0%.
Conclusions: The most common isolated microorganism from the
Gram(−) negatives, during the period (2008–2009) was K. pneumoniae
with second A. baumannii, while the period 2009–2010 ﬁrst was
Pseudomonas aeruginosa with second K. pneumoniae. First from the
Gram(+) positive microorganisms, was S. aureus. Infections due to
Candida spp. are an increasingly important complication in hospitalized
patients in I.C.U. The resistance of Acinetobacter baumannii to
antibiotics raises great concern.
R2324 Activity of ceftaroline against European isolates from
complicated skin and skin structure infections collected in
2008–2009
I. Morrissey*, A. Leakey, J. Ambler (Fordham, UK; Waltham, US)
Objective: Ceftaroline (CPT) fosamil, the prodrug of the active
compound CPT, is a broad-spectrum, parenteral cephalosporin recently
approved in the USA for the treatment of acute bacterial skin and skin
structure infections and community-acquired bacterial pneumonia. The
aim of this study was to determine CPT activity against complicated
skin and skin structure infection (cSSSI) isolates from Austria, Bulgaria,
Czech Republic, France, Germany, Greece, Ireland, Italy, Poland,
Portugal, Russia, Slovakia, Spain, Switzerland, the Netherlands, Turkey
and the UK.
Methods: 103 European centres submitted 2708 bacterial isolates
causing cSSTIs in 2008–2009. These were re-identiﬁed and CPT (plus
numerous comparator) MICs determined by CLSI broth microdilution
at a central laboratory.
Results: Summary CPT MIC data are shown in the Table [cefuroxime
(FUR) data are shown as a reference].
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Conclusions: These data from a large collection of European isolates
conﬁrm the broad-spectrum activity of CPT against cSSSI pathogens.
CPT is unique among clinically available cephalosporins, having good
activity against methicillin-resistant Staphylococcus aureus (MRSA),
methicillin-resistant coagulase-negative staphylococci, in addition to
moderate activity against Gram-negative bacteria.
R2325 Carbapenem-resistant klebsiella pneumoniae isolates in a
Greek hospital
T. Skalidis*, C. Silleli, A. Partheni, Z. Tsetri, G. Gerontara,
M. Saloustrou, M. Flessas, P. Karabogia-Karaﬁllidis (Athens, GR)
Objectives: To evaluate the frequency and phenotype resistance to
carbapenems of K. pneumoniae isolates from clinical samples in the
General Hospital of Athens “PAMMAKARISTOS”.
Methods: During one year period 105 strains of K. pneumoniae were
isolated. Susceptibility tests were performed by Kirby-Bauer method,
MIC determination by automated system (Microscan, Siemens) and
E-test method, according to CLSI standards Phenotypic detection of VIM
enzymes was based on CD synergy test with Meropenem and EDTA and
of KPC enzymes on the combination of modiﬁed Hodge test and the CD
synergy test with Meropenem and boronic acid.
Results: From a total of 105 K. pneumoniae isolates, 14 (14/105, 13.3%)
exhibited reduced susceptibility to carbapenems (MIC range: 2−16)
and were isolated from cultures of urine (n = 8), blood (n = 2), wounds
(n = 2), catheter tips (n = 1) and bronchial secretions (n = 1) of patients
with haematologic malignancies (6), solid tumors (1), cardiovascular
diseases (3) and surgical patients (4). Five strains (5/14, 35.7%) were
KPC-producers, four (4/14, 28.6%) were VIM-producers, one (1/14,
7.2%) was co-producing both carbapenemases, two (2/14, 14.25%)
produced KPC and ESBL and two (2/14, 14.25%) produced VIM and
ESBL. The distribution of isolates was as follows: Internal Medicine
unit (9), surgical units (4), Neurology (1). All strains were sensitive to
gentamycin and tigecycline, 2 were resistant to tetracycline.
Conclusion: Phenotypic method is very helpful in detecting
carbapenemase-producing K. pneumoniae isolates and in limiting the
spread of multiresistant strains. All K. pneumoniae strains with reduced
susceptibility to carbapenems should be monitored for production of
VIM and/or KPC enzymes.
R2326 Distribution of bloodstream infection pathogens over time
at an Australian tertiary hospital
A.K. Aung*, M.J. Skinner, T. Dharmadasa, R. Tay, A.C. Cheng
(Melbourne, AU)
Objectives: Previous studies have demonstrated signiﬁcant changes in
the distribution of bloodstream infection (BSI) pathogens over time with
Gram-positive pathogens becoming more prevalent than Gram-negatives
since the 1970s. It is also recognised that there is a shift to Gram-negative
pathogens with increasing age. This study describes the trends in BSI
pathogens and antimicrobial susceptibility over 9 years at an Australian
adult tertiary referral hospital.
Methods: Positive blood cultures from 1st January 2001 till 31st
December 2009 were reviewed. Duplicate isolates (within 14 days of the
primary culture) and patients <20 years of age were excluded. Patients
in haematology (including bone marrow transplantation), respiratory
(including lung transplant and cystic ﬁbrosis), oncology and burns
units were also excluded as they represented heterogeneous populations.
Coagulase negative Staphylococci (CNS) were excluded as it was not
possible to retrospectively differentiate between true infections and
contamination.
Results: We found an overall decline in blood culture positivity rate
from 9.48 to 4.80 per 1000 admissions. Similarly, the proportion of
positive cultures also decreased from 2.6% to 1.5%. Overall, Gram-
positive pathogens were isolated in 48.9% of patients (S. aureus 24.0%,
Enterococcus spp. 7.1%, S. viridans 3.6%) compared to Gram-negative
pathogens in 45.5% of patients (E. coli 20.3%, Klebsiella spp. 6.9%,
Pseudomonas spp. 3.8%). There was a trend to an increasing proportion
of Gram-negative pathogens during these 9 years. However, age speciﬁc
proportions of Gram-positives and Gram-negatives remained similar,
suggesting this relates to overall aging of the hospital population. The
proportion of S. aureus isolates that were methicillin-resistant (MRSA)
declined from 54.0% to 27.5%. In Gram-negatives, susceptibility to
gentamicin and third generation cephalosporins by Enterobacteriaceae
remained stable. Ceftazidime resistance also remained stable, suggesting
no increase in extended spectrum b-lactamase (ESBL) producing
organisms.
Conclusions: Our study demonstrated important trends in epidemiology
of BSI pathogens over time and their impact on choices of appropriate
antimicrobial therapy, particularly for the elderly hospital inpatient
population. b-lactams, gentamicin and quinolones all remain effective
antibiotics for our patient population.
R2327 Acinetobacter resistance to antimicrobial agents: a
prospective study in Iran
D. Yadegarynia*, F. Abbasi, M. Khalili-azad, S. Asadi, M. Ahmadzadeh,
S. Gholamin, L. Gachkar, S. Kazemi (Tehran, IR)
Objective: Acinetobacter species have become increasingly resistant to
antibiotics over the past several years and currently present a signiﬁcant
challenge in treating these infections. They are important cause of
nosocomial infections.
Methods: In a prospective study we evaluated 100 positive cultures of
Acinetobacter from 100 patients in different wards of seven tertiary care
hospitals in Tehran, Iran in a 6 months period in 2009. PCR was used
to determine the species of Acinetobacter. E-test and Disk diffusion
method was used to determine the resistance of isolated Acinetobacter
baumannii and non-baumannii. Antimicrobial sensitivity to following
antibiotics was analyzed: ceftazidime, cefepime, amikacin, imipenem,
piperacillin-tazobactam, tigecycline and colistin.
Results: In our study 89% of isolated Acinetobacter was baumannii and
11% was non-baumannii. 70% of samples were isolated from male and
30% from female patients. The most incriminated wards were intensive
care and burn units with a high prevalence of pneumonia and wound
infection due to acinetobacter. The most frequently sites of infection were
wound, respiratory tract, blood stream, urinary tract, cerebrospinal ﬂuid
and brain abscess. Acinetobacter was isolated from respiratory secretion
in 38%, wound in 29%, tip of catheter in 14%, urine in 8%, blood
in 4%, CSF in 4%, pleural ﬂuid in 2% and brain abscess in 1% of
samples. Acinetobacter was resistant to amikacin in 100%, to ceftazidime
in 100%, to cefepime in 94.5%, to piperacillin-tazobactam in 83% and
to imipenem in 64% of all the samples. Sensitivity to colistin was 100%
and to tigecycline was 74.5% in our study.
Conclusion: Prevalence of cephalosporins and carbapenems resistant
acinetobacter is high in our study. Colistin and tigecycline are best
choices for treatment of acinetobacter. High prevalence of nosocomial
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infections and presence of multidrug resistant Acinetobacter specially
in ICU patients require developing new strategies for control of
acinetobacter infection.
R2328 Resistance associated with extended-spectrum b-lactamases
production by strains isolated from infections in neonatal
intensive care units in Poland
A. Chmielarczyk*, J. Wo´jkowska-Mach, D. Romaniszyn,
M. Brzychczy-Wloch, E. Helwich, P.B. Heczko (Cracow, Warsaw, PL)
Objectives: Newborns in NICUs are at high risk for infections. The
most important risk factors are invasive devices and frequent use
of antimicrobials. The project aims to analyze epidemiological and
microbiological infections with Gram negative etiology occurring in
children with low birth weight (LBW) in a Polish NICUs.
Methods: Data collection was made prospectively from 01–12.2009
from a group of 910 LBW newborns. They were monitored from <1 500
g until discharge >1 800 g or death. Surveillance included main types
of infections: bloodstream infections-BSI, pneumonia-PNU, necrotizing
enterocolitis-NEC and others.
In 2009, 93 of Gram negative strains were isolated from 41 patients. 57
isolates were from PNU, 21 from BSI, 15 from others.
Species were determined in the Vitek automatic system, drug resistance
was determined by disc diffusion method (according to EUCAST). Genes
for b-lactamases SHV, TEM and CTX-M were identiﬁed with PCR.
Results: The incidence density per 1000 patient days was 27,1. The
most common infection (regardless of the type of microorganism) was
BSI: 43% of all and PNU: 38,8%.
Among the infections caused by Gram negative rods, the late onset
infections (>2 days) dominated − 76%. 30% of them were PNU
associated with MV, 8,45% with the use of NCPAP. 7% of BSI were
associated with CVC and 4% with PVC.
The dominant species among the isolates were E. coli − 30, others
were: Enterobacter sp. − 18, Klebsiella sp. − 24, Serratia sp. − 8, non-
fermentative bacilli − 13.
Resistance to ceftazidime and cefotaxime was detected in 13% for
EC, 31% for Klebsiella, 72% for E. cloacae. Resistance to 4 tested
carbapenems was 6% for EC, 12,5% for PAR, the other strains were
susceptible. All tested isolates were susceptible to tigecycline.
24 isolates of all (25,8%) showed the ESBL phenotype: Enterobacter
10, Klebsiella 8, E. coli 5 and Serratia 1. Only one ESBL+ isolate came
from an early respiratory tract infection. 20 ESBL+ strains carried the
blaCTX-M gene, 5 of them also had blaSHV and blaTEM genes. The
remaining 4 ESBL+ strains did not had blaCTX-M gene but had both
blaSHV and blaTEM.
Conclusion: Resistance due to production of ESBLs appears mainly
in late infections. This has most likely occurred because of selection
pressure imposed by the intensive use of broad spectrum antibiotics
and/or because of plasmid mediated acquisition of resistance. One way
to limit the spread of resistance would be the rational use of antibiotics
for controlling ESBL+ strains infection.
R2329 Risk ranking predicted environmental concentrations of
antimicrobial residues as a result of human consumption
using regression analysis
S. Harris*, E. Cummins (Dublin, IE)
Objectives: The primary objective of this study was to determine
leading factors inﬂuencing the presence of antimicrobial residues in the
environment and to rank their predicted environmental concentrations
(PEC).
Methods: A mechanistic model is presented for determination
of antimicrobial presence in the environment (EXCEL 2003 with
@Risk 5.0® add-on). The model was tested for six main groups of
antimicrobials consumed in Europe: penicillins (PEN), b-lactams (BET),
tetracyclines (TET), macrolides (MAC), quinolone/ﬂuoroquinolones
(Q/F) and sulfonamides/trimethoprim (S/T). The model simulates the
release of antimicrobials into the environment by integrating the effects
of antimicrobial use, metabolism, degradation, and dilution. Each input
variable was uniﬁed and assigned a probability density to represent
inherent uncertainty and variability in the parameter. The Monte Carlo
simulation model resulted in probability distributions of PECs for each
antimicrobial group. Using regression analysis, resulting PECs were
ranked in relation to resistance potential, chronic and acute toxicity and
hazard quotient (HQ).
Results: The model simulated the mean PEC of PEN, BET, TET, MAC,
Q/F and S/T (Table 1). Degradation was the main input inﬂuencing PEN
PEC, usage was foremost for BET and S/T, while metabolism was the
most critical input for TET, MAC and Q/F PECs. Q/F expressed the
highest rate of resistance formation potential (57%). BET expressed a
moderate HQ (2.02) with all remaining antimicrobials expressing a low
HQ. No antimicrobial group was predicted to express toxicity in the
environment.
Conclusion: The observed results infer that current antimicrobial
use can lead to levels in the environment which may increase
resistance formation. The legislation of new antimicrobials should
consider metabolism, as it will greatly inﬂuence levels emitted into the
environment.
The in-depth understanding of antimicrobial presence in the environment
is lacking; speciﬁcally, with regard to lower limits of minimum inhibitory
concentrations acting as selectors for resistance formation. The use of
ECOSAR® for antimicrobial toxicity reference values is limited as the
bacteria targeted by antimicrobials are phylogenetically distinct from the
cyanobacteria used to calculate the EC/LCsub50 values. The results and
limitations presented here accentuate the need for further research into
antimicrobials in the environment and the development of antimicrobial
resistant strains.
R2330 In vitro activity of tigecycline against bacterial pathogens
from Tigecycline Evaluation and Surveillance Trial (TEST
Program 2010) in Hong Kong
C.C. Lee, K.T. Wong, R.W. Lai, T.K. Ling* (Hong Kong, HK)
Objectives: Tigecycline is the ﬁrst of the glycylcycline antimicrobial
active against a wide range of bacterial pathogens. We have participated
in the global Tigecycline Evaluation and Surveillance Trial (TEST) to
study the in-vitro activity of tigecycline. This report summarizes the
antimicrobial susceptibility of bacterial pathogens collected in 2010.
Methods: A total of 135 Gram-negative and 65 Gram-positive isolates
were collected in the Prince of Wales Hospital. MICs were determined
using microdilution trays purchased from TREK Diagnostics Systems,
East Grinstead, UK and interpreted using CLSI guidelines.
Results: Tigecycline MIC90 were all smaller than or equal to 1mg/L
against Gram-positive isolates including Staphylococcus spp. (n = 25),
Enterococcus spp. (n = 15), Streptococcus pneumoniae (n = 15) and other
Streptococcus spp. (n = 10). Tigecycline MIC90 were smaller than or
equal to 2mg/L against most of the Gram-negative isolates including
E. coli (n = 25), Klebsiella spp. (n = 25), Enterobacter spp. (n = 25),
Serratia spp. (n = 10) and H. inﬂuenzae (n = 15) but with MIC90 = 8mg/L
against Acinetobacter spp. (n = 15) and >16mg/L against P. aeruginosa
(n = 20). The percentages of resistance of different antibiotics against
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Gram-negative and Gram-positive bacteria are shown in Table 1 and 2
respectively. Shading denotes % resistance value smaller than or equal
to 10%.
Conclusion: Tigecycline showed excellent activity against all Gram-
positive and Gram-negative isolates but less active against Acinetobacter
spp. and P. aeruginosa.
R2331 Invasive Streptococcus mitis and Streptococcus oralis:
penicillin and macrolide resistance mechanisms in patients
with haematological malignancies
A. Ergin*, O¨. Ko¨seoglu Eser, G. Hasc¸elik (Ankara, TR)
Objectives: Penicillin resistance concomitant with erythromycin resis-
tance is a risk factor in the mortality of patients with S. mitis and
S. oralis bacteremia. The aim of the study was to determine penicillin
and macrolide resistance mechanisms in invasive S. mitis and S. oralis
bacteremia strains isolated from patients that have haematological
malignancies.
Methods: S. mitis (n:23) and S. oralis (n:17) isolates from blood
cultures of patients (n:40) with haematological malignancies were
included in the study. Isolates were identiﬁed with BD Phoenix
system. Penicillin and erythromycin susceptibilities were performed with
E-test. Vancomycin, clindamycin, cefotaxime, levoﬂoxacin and linezolid
susceptibilities were determined by broth microdilution. Penicillin and
erythromycin resistance genes, pbp1a, pbp2b, pbp2x, ermB and mefA/E
were ampliﬁed using PCR method. BamHI restriction enzyme was used
for discrimination of mefA and mefE.
Results: Patient age range was 42−84. Twenty of fourty patients were
women. Thirty of the patients have diagnosed as myelogeneous (n:22)
and lymphoblastic leukaemia (n:8). Fifteen of the patients have died
due to solid cancers. Fourteen (35%) and eighteen (45%) strains were
resistant to penicillin (MIC 4mg/L) and erythromycin (MIC 4mg/L),
respectively. Rate of resistance to clindamycin and cefotaxime were
32.5% and 22.5%. All the isolates were susceptible to vancomycin,
levoﬂoxacin and linezolid. Five of penicillin resistant isolates carried
pbp2b and three carried pbp2x genes. Among erythromycin resistant and
intermediate (n:23) isolates,16 exhibited ermB and 7 mefE genotypes.
Conclusion: Erythromycin resistance is highly due to ermB and
followed by mefE genes and penicillin susceptibility can partially
be explained by the presence of pbp2b and pbp2x genes among
our isolates. It is important to be aware of high level resistance of
penicillin and erythromycin in S. mitis and S. oralis in patients with
haematological malignancies as an emerging threat since susceptible
empirical antibiotics may not reduce overall mortality.
R2332 Trend of antimicrobial susceptibility of P. aeruginosa isolates
from UTI and RTI of Japanese hospital participating in
the levoﬂoxacine surveillance group during 1994–2010
O. Akira*, I. Yoshikazu, T. Kazuhiro, Y. Keizo on behalf of the the
Levoﬂoxacin Surveillance group
Objectives: Pseudomonas aeruginosa has become ploblematic because
of an outbreak of multidrug-resistant clone producing metallo-
b-lactamases (MBLs). We have already been taken nationwide surveil-
lance for FQ and other antimicrobials resistance against many bacterial
clinical isolates since 1994 in Japan. In this study, we report surveillance
data for P. aeruginosa isolates from patients with urinary tract infection
(UTI) and with respiratory tract infection (RTI) collected between 1994–
2010.
Methods: A total of 7,019 clinical isolates (3,232 isolates from UTI and
3,787 isolates from RTI) were collected from 92 centers participating
in the Levoﬂoxacin Surveillance group during 1994–2010 in Japan.
Antimicrobial susceptibility testing by broth microdilution methods was
based on Clinical and Laboratory Standards Institute (CLSI) guidelines
that were updated annually as revised documents were published.
Results and Discussions:
1. UTI; The ‘Susceptible’ rate for levoﬂoxacin has particularly increased
over time (from 41.8% in 1994 to 74.2% in 2010). Although the cause
of this increase is obscure, recent request for strict observance of the
dosing period is probably implicated because drug use reviews do not
show any decrease of the amount of levoﬂoxacin used nationwide
in the ﬁeld of urology. Amikacin and ceftazidime also showed a
gradual increase of the ‘Susceptible’ rate. The susceptibility for
imipenem remained unchanged. The rate of 4 drugs resistant isolate
to levoﬂoxacin, ceftazidime, amikacin and imipenem was about 1%
until 1998, however increased to 4.6% abruptly in 2000 and then
shifted at the level of approximately 4%.
2. RTI; The ‘Susceptible’ rate to levoﬂoxacin, amikacin, ceftazidime and
imipenem has been maintained constantly at a level of approximately
80%, 97%, 88% and 70%, respectively. The rate of 4 drugs resistant
isolate to levoﬂoxacin, ceftazidime, amikacin and imipenem was in a
moderate increase in comparison with that in UTI.
3. Metallo-b-lactamase; The rate of metallo-b-lactamase producing
isolates from UTI and RTI was 8.0% in 2002, 7.2% in 2004 and
5.6% in 2007 (UTI), and 1.5% in 2002 1.0% in 2004 and 2.2% in
2007 (RTI), respectively.
R2333 Detection of extended-spectrum b-lactamases in clinical
isolates of Pseudomonas aeruginosa
Y. Alikhani*, Z. Karimi tabar, P. Karami, A. Zamani, S. Farajnia
(Hamadan, Zanjan, Tabriz, IR)
Objectives: Pseudomonas aeruginosa is a leading cause of nosocomial
infections worldwide. The infections can be particularly severe in
patients with impaired immune systems. The infections of this agent
are frequently difﬁcult to treat because of both the natural resistance
of the species and its ability to acquire further resistance mechanisms
to multiple groups of antimicrobial agents. Resistance of P. aeruginosa
strains to the broad-spectrum cephalosporins may be mediated by the
extended-spectrum b-lactamases (ESBLs). The aim of this study was to
determination of P. aeruginosa antibacterial resistance patterns and the
prevalence of ESBLs producing strains as PER-1 and VEB genes.
Methods: In our study, a total of 106 clinical isolates of P. aeruginosa
were studied. The isolates were collected from two university hospitals
in Hamadan, Iran, during 7 month (2009), to assess the current levels
of antimicrobial susceptibility. The susceptibility of the investigate
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P. aeruginosa isolates to 12 antimicrobial agents was determine by the
disc diffusion method on Mueller Hinton agar plates and was interpreted
according to the Clinical an Laboratory Standards Institute (CLSI)
recommendation. ESBLs producing strains have detected by combined
disk test and the presence of PER-1 and VEB genes by PCR.
Results: The antibiotic resistance rates against the broad-spectrum
cephalosporins and monobactames were: cefepime 97%, cefotaxime
92.5% ceftazidime 51%, and aztreonam 27%. Ciproﬂoxacin (91.5%),
imipenem (84.9) and meropenem (82.07) were the most effective anti-
pseudomonal agents. The results revealed that 94 (88.7%) of the isolates
were multidrug resistant and 60 (58.25%) of the isolates were ESBL
positive. Sixteen (26.6%), 9 (15%) and 3 (5%) strains among 60 ESBL-
producing strains ampliﬁed blaPER-1, blaVEB and blaPER-1/blaVEB
respectively.
Conclusion: This study highlights needs to establish antimicrobial
resistance surveillance networks for P. aeruginosa to determine the
appropriate empirical treatment regimen. Bacterial strains resistant to
most classes of antibiotics will continue to emerge unless inappropriate
uses of drugs are decreasing a continuous education of infection control
practices maintained. The high prevalence of multidrug resistance and
production of ESBLS in P. aeruginosa isolates in patient conﬁrm that
Protocols considering these issues should be considered in hospitals.
R2334 A trend of drug-resistant Streptococcus pneumoniae at
King Chulalongkorn Memorial Hospital, Thailand
P. Techawaleekul* (Bangkok, TH)
Objectives: To determine the epidemiologic, clinical, and microbiologic
data of infections caused by drug-resistant Streptococcus pneumoniae
(DRSP) in adult patients.
Patients and Methods: A retrospective study of all adult patients with
pneumococcal infections who were hospitalized at King Chulalongkorn
Memorial Hospital, Bangkok, Thailand, was carried out from January
1, 2008 to December 31, 2009. In addition, a trend of prevalence of
penicillin- and cephalosporin-non-susceptible S. pneumoniae (PNSP and
CNSP) from 1997 to 2009 in our institute was analyzed.
Results: Of 86 pneumococcal isolates, there were 70 (81.40%), 5
(5.81%), and 11 (12.79%) patients with pneumonia, primary bacteremia,
and meningitis, respectively. There were 56 (65.11%) males and
30 (34.89%) females with the mean age of 62 + 10 years (range
15–101 years). Of 70 patients with pneumonia, there were 67
(95.70%), 3 (4.30%), 0 (0%), 70 (100%), 0 (0%), and 0 (0%)
of penicillin-susceptible S. pneumoniae (PSSP), penicillin-intermediate
S. pneumoniae (PISP), penicillin-resistant S. pneumoniae (PRSP),
cefotaxime-susceptible S. pneumoniae (CSSP), cefotaxime-intermediate
S. pneumoniae (CISP), and cefotaxime-resistant S. pneumoniae (CRSP),
respectively. Of 5 patients with primary bacteremia, there were 5 (100%)
and 5 (100%) of PSSP and CSSP, respectively. Of 11 patients with
meningitis, there were 7 (63.64%), 4 (36.36%), 10 (90.91%), 1 (9.09%),
and 0 (0%) of PSSP, PRSP, CSSP, CISP, and CRSP, respectively. All
isolates were susceptible to vancomycin. A trend of prevalence of
meningitis caused by PNSP and CNSP from 1997 to 2009 in our institute
is summarized in Table.
Conclusions: There is a relatively high prevalence of infections caused
by PNSP and CNSP in adult patients in our institute. This emphasizes
an urgent need to strengthen both appropriate use of antimicrobials and
strict infection control measures to help reduce the occurrence of DRSP.
Molecular epidemiology of resistance genes,
strains and serotypes
R2335 Penicillin and macrolide resistance mechanisms in invasive
Streptococcus pneumoniae isolates before introduction of
PCV7 in Ankara, Turkey
O¨. Ko¨seoglu Eser*, H. Uludag Altun, D. Gu¨r, G. Hascelik (Ankara, TR)
Objectives: In this study, macrolide resistance mechanisms and the
diversity of PBPs 2b, 2x and 1a of invasive Streptococcus pneumoniae
(SP) isolates identiﬁed from patients admitted to Hacettepe Hospitals
before the introduction of heptavalent pneumococcal conjugate vaccine
(PCV-7) in Turkey between 1996 and 2008 was investigated.
Methods: Invasive SP clinical isolates were collected from children
and adults admitted to Ihsan Dogramaci Children’s Hospital and Adult
Hospital of Hacettepe University. Antimicrobial susceptibility testing
of all isolates were performed for six antimicrobial agents; penicillin
(PEN), ceftriaxone (CRO), levoﬂoxacin (LEV), erythromycin (EM),
clindamycin (CD) and vancomycin (VAN) by broth microdilution method
according to “Clinical Laboratory Standards Institute, CLSI”. Serotypes
were determined by Quellung reaction with speciﬁc antisera for SP.
Isolates with MIC 0.125mg/ml were examined for the PBP genes
pbp2b, pbp2x ve pbp1a by PCR. Resistance genotypes of EM resistant
isolates (MIC 0.5mg/ml) were determined by a multiplex erm(B)/mef
PCR method for SP. RFLP analysis was done to differentiate mefA/E
genes.
Results: Of the 182 nonduplicated pneumococcal isolates, 59 were
obtained from children and 123 from adults. Of these, 32 were
cerebrospinal ﬂuid (CSF) and 150 were blood isolates. In 16 of CSF
isolates (50.0%), MICs for PEN were 2mg/ml. EM resistance (MIC
0.5mg/ml) was found in 23 (12.6%) isolates, of these 11 were resistant
to both EM and CD. In EM resistant isolates, 10 (43.5%) had ermB gene,
two (8.7%) had mef E gene. In 55 isolates with PEN MIC 0.125mg/ml,
27 (49.1%) had pbp2x, pbp2x and pbp1a together, four (7.3%) pbp2x
and pbp2b, three (5.5%) pbp2b, one pbp2x and pbp2b, one pbp2B and
pbp1a and one pbp1a. In all isolates, resistance for LEV was 1% and 0
for CRO and VAN. In the paediatric age group, 17 different serotypes
and in the adult group, 23 different serotypes were observed. The most
frequent serogroups in both age groups were 6, 3, 23, 9 and 5.
Conclusions: Although there was no resistance for PEN among the
blood isolates, PEN resistance was high among the CSF isolates. The
major serotype associated with PEN resistance in CSF isolates was
serotype 23F. Analysis of PBP genes showed predominancy in pbp2B.
The predominant mechanism of macrolide resistance is associated with
the erm(B) gene with strains showing co-resistance to clindamycin in
the majority of cases.
R2336 Co-dissemination of antibiotic and copper resistance genes
in large conjugative plasmids of enterococci from different
ecological niches
E. Silveira, A.R. Freitas, T.M. Coque, L. Peixe, C. Novais* (Porto,
PT; Madrid, ES)
Objectives: tcrB, a copper resistance (CuR) gene, has been identiﬁed
among enterococci from several geographical regions but data supporting
its co-transference with genes encoding antibiotic resistance (ABR)
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are scarce. Our goal was to analyze the occurrence of tcrB among
enterococci from different ecological niches and to characterize the
genetic context of this gene.
Methods: We analyzed 214 E. faecalis-Eﬂ, 266 E. faecium-Efm, 23
E. gallinarum, 4 E. casseliﬂavus, 37 E. hirae, 97 Enterococci sp from
hospitalized humans (H, n = 103); healthy humans (HV, n = 125), poultry
(P, n = 129), piggeries environment/swine (PE, n = 232) and sewage/
river (SR, n = 52) recovered from different Portuguese areas (1997–
2007). Genes coding for CuR and ABR were searched by PCR. Mating
assays were performed for 45 representative tcrB+ isolates in the
presence of tetracycline, erythromycin, vancomycin or gentamicin, using
different receptor strains. Clonality was studied by PFGE (SmaI)/MLST.
Co-localization of tcrB and ABR genes was assessed by S1 PFGE
hybridization.
Results: tcrB was detected in 15% (98/641) of isolates (26% PE, 15%
SR, 11% HV, 9% P, 3% H; 59 Efm, 14 Eﬂ, 25 other species). It
was co-transferred with ABR genes (ermB-20; vanA-7; tetM-5; tetL-2;
aac(6′)-Ie-aph(2′′)-Ia-1). A polyclonal population was detected among
tcrB+ representative isolates. Among Efm, 32 PFGE types corresponded
to CC17 (ST18, ST393, ST431); CC5 (ST5, ST185, ST150) and also
ST432, ST434 and ST432. Ten Eﬂ PFGE types were detected. A few
common strains were identiﬁed within and between niches (PFGE A-PE
and H). tcrB was located on plasmids of 90–120kb in Eﬂ and 120–300kb
in Efm. The tcrB gene was located alone (5Efm PE, HV; 1Eﬂ P) or with
vanA (1Efm; PE), tetL (2Efm PE, HV), tetM (3Efm PE, HV), ermB
(2Efm PE, SR; 2Eﬂ PE, P), tetL+ermB (5Efm PE, HV), tetM+ermB
(2Efm PE, SR), tetM+tetL (1Eﬂ P), vanA+tetM+ermB (1Efm PE),
tetM+tetL+ermB (6Efm PE, HV, SR). In 14 isolates tetM, tetL, ermB or
aac(6′)-Ie-aph(2′′)-Ia were located in other plasmids (25−90Kb), which
co-transferred with those of tcrB (n = 4).
Conclusions: The co-transference of tcrB with other ABR genes located
in the same or different plasmids suggest that the intensive use of copper
in some niches might favour the selection of ABR enterococci. Both
plasmid transfer and clonal expansion play important roles in the spread
of tcrB.
R2337 Evaluation of L6 ribosomal protein alterations in fusidic
acid-resistant Staphylococcus aureus: ﬁtness cost and
time-kill analysis
M. Castanheira*, R. Jones, L. Woosley, R. Mendes, G. Moet, D. Farrell
(North Liberty, US)
Objectives: To evaluate ﬁtness cost and activity by time kill experiments
on three S. aureus (SA) clinical strains displaying elevated fusidic acid
(FA) MIC values (4−8mg/L) and L6 ribosomal protein (RP) alterations.
L6 RP (encoded by fusE) has been recognized as a FA secondary action
site and L6 mutations have been described in FA-resistant (R) SA small
colony variant laboratory mutants.
Methods: Three SA clinical strains showing FA-R MIC values were
identiﬁed in 2008 and 2009. Two strains were detected from one hospital
during a surveillance study and one strain was isolated following FA
therapy. MIC values were determined by CLSI broth microdilution
method (M07-A8, 2009). Isolates were screened for known FA-R
mechanisms by PCR and sequencing. Clonality was assessed by PFGE
and spa typing. Growth rate studies were performed Q30 min for 10h.
Time kill analyses were performed over 48h and tested FA at 8X MIC
and at the clinical trough plasma level (80mg/L).
Results: SA clinical strains showing FA-R (MIC, 4−8mg/L) were
screened for the presence of fusB, fusC, and fusD, as well as mutations
in fusA, yielding negative results. All three SA showed fusE alterations.
Two SA clinical strains were recovered from different patients in
Michigan and possessed a 22 amino acid deletion in fusE starting at
position 78 (compared to SA Mu50). These strains were shown to be
identical by two typing methods, and belonged to USA300 clone. A
third strain (FA MIC, 8mg/L) recovered after FA therapy had a stop
codon in L6 at position 77. This strain had identical PFGE and spa
typing results as the pre-treatment isolate (FA MIC, 0.12mg/L). SA
displaying L6 RP alterations did not reach log phase in 10h (very slow
generation times), while controls [NSR384 (USA300) and pre-treatment
strain] demonstrated a mass doubling time of 90 min. Time kill studies
showed rapid killing at the clinical trough plasma level for all FA-R
clinical strains and controls.
Conclusions: L6 alterations have not been described in SA strains from
patient infections. In this study, three SA clinical strains displaying
L6 RP alterations were associated with modest elevation of FA MICs,
but possess a remarkable difference in ﬁtness cost. Furthermore, under
experimental conditions, simulated FA plasma trough levels attained in
vivo killed these R mutant strains.
R2338 Carbapenem-resistant Acinetobacter baumannii in burn
unit from hospital in Krakow, Poland
P. Paluchowska, P. Nowak, A. Budak* (Krakow, PL)
Objectives: Nosocomial infections remain the main cause of morbidity
and mortality in burn patients. Infections caused by A. baumannii have
emerged as a signiﬁcant problem reported in burn units. A. baumannii
strains are usually resistant to multiple antimicrobial agents including
carbapenems which represent an important option for the treatment
of Acinetobacter infections caused by multidrug-resistant isolates. The
most common mechanism responsible for carbapenem-resistance are
carbapenem-hydrolysing-b-lactamases belonging to molecular class D
(OXA enzymes) and also may be associated with the presence of an
insertion sequence (ISAba1). The aim of the study was detection of:1)
OXA encoding genes; 2) presence of ISAba1.
Methods: A total of 32 A. baumannii strains were collected from 2007–
2010 in burn unit (BU) of Specialized Hospital in Krakow, Poland.
All strains selected to this study were carbapenem-resistant and were
isolated from single patients. Identiﬁcation and susceptibility testing
were performed by VITEK-2 Compact (bioMe´rieux, Poland) according
to CLSI criteria. Multiplex PCR described by Woodford et al. (2006) was
applied for detection of OXA carbapenemases encoding genes (blaoxa-
51-like, blaoxa-24-like and blaoxa-23-like). All strains were also tested
for the presence of 549-bp fragment containing a portion of ISAba1.
Results: Antibiotic resistance rate to piperacillin was 100%, piperacillin-
tazobactam 94%, ceftazidime 91%, cefepime 94%, imipenem 100%,
meropenem 100%, gentamicin 100%, ciproﬂoxacin 100% but was only
3% to tobramycin and 25% to amikacin. All carbapenem-resistant
isolates contained intrinsic gene encoding b-lactamase belonging to
OXA-51-like group. The isolates were also found to encode blaOXA-
23-like and blaOXA-24-like genes respectively in 28 (88%) and 2 (6%).
ISAba1 insertion sequence gene was detected in all tested strains.
Conclusions: Carbapenem resistance in tested isolates might be
associated with: 1) expression of acquired oxacillinases belonging
to OXA-23-like and OXA-24-like groups; 2) extended expression of
intrinsic oxacillinases belonging to OXA-51-like group supported by the
presence of insertion sequence ISAba1.
R2339 Mutations in the quinolone resistance-determining region
of gyrA gene of Arcobacter butzleri
A. Gonza´lez*, J. Nigri, V. Herna´ndez, R. Gonza´lez, M.A. Ferru´s
(Valencia, ES)
Objectives: Arcobacter butzleri has been associated with human
infection. Fluoroquinolones are potential drugs for treatment. However,
there is evidence of increasing resistance to these antimicrobial agents.
This resistance may occur due to mutations in a quinolone resistance-
determining region (QRDR) of the gyrA gene. Therefore the goal of this
study was to look for the mutations associated with quinolone resistance
in Arcobacter isolates.
Methods: Forty-four A. butzleri isolates and the reference strain A. but-
zleri DSM 8739 were used in this study. Arcobacter susceptibility to
ciproﬂoxacin and levoﬂoxacin was determined by disc diffusion tests
(BD, USA) and E-test® strips (AB BIODISK, Sweden). As there is not
any recommendation about antibiotic resistance of arcobacters, the disc
diffusion breakpoints and the minimum inhibitory concentration (MIC)
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values were determined as recommended by the Clinical and Laboratory
Standards Institute (CLSI®) for campylobacters. All the isolates were
subsequently analysed in order to determine the presence of mutations
in the QRDR of gyrA gene. For that purpose, a 344-bp fragment of
gyrA gene of Arcobacter spp. was ampliﬁed using F-QRDR (5′-TGG
ATT AAA GCC AGT TCA TAG AAG-3′) and R2-QRDR (5′-TCA TMG
WAT CAT CAT AAT TTG GWA C-3′) primers. Finally, PCR products
were puriﬁed and sequenced on both strands by Sistemas Geno´micos S.
L. (Valencia, Spain).
Results: Among the 44 isolates tested, 31 were sensitive and the
remaining 13 were considered to be resistant to both antibiotics. A
disc diffusion zone of 6mm and a MIC value 4mg/mL indicates
resistance. The MIC values with respect to ciproﬂoxacin and levoﬂoxacin
ranged from 0.064 to 0.38mg/mL and 0.094 to 0.5mg/mL, respectively
for the sensitive isolates. The 13 resistant isolates presented MICs
ranging from 8 to 32mg/mL for both antibiotics. The sequencing of the
344-bp PCR product revealed a mutation in position 254 of the gyrA
gene in the 13 resistant Arcobacter isolates. This C-254 to T mutation
could be the cause of quinolones resistance as this change was absent
in all the susceptible isolates.
Conclusion: This study shows high rates of quinolone resistance in
arcobacters that was always associated to one mutation in the QRDR
region of the gyrA gene. The increasing resistance to this class of
antibiotics could be a public health concern as they have been reported
to be the most commonly used and best performing ﬂuoroquinolones
against arcobacters.
R2340 Multidrug-resistant Acinetobacter baumannii blood isolates:
evaluation of susceptible antibiotics, metallo-b-lactamase
production and distribution of oxacillinase genes
A. Ergin*, O¨. Ko¨seoglu Eser, N. Pakasticali, G. Hasc¸elik (Ankara, TR)
Objectives: The aim of this study was to evaluate antimicrobial
susceptibility, metallo b-lactamase production (MBL) and dissemination
of oxacillinase genes among multidrug resistant (MDR) invasive
Acinetobacter baumannii isolates obtained in Hacettepe University
Hospital between 2009–2010.
Methods: A total of 40 MDR A. baumannii invasive isolates were
included in the study. Species identiﬁcation was performed by use
of BD Phoenix system. Susceptibility against piperacillin (PIP),
tazobactam (TZP), amikacin (AN), gentamicin (GM), imipenem (IMP),
meropenem (MER), cefotaxime (CTX), ceftazidime (CAZ), cefepim
(FEP) ciproﬂoxacin (CIP), levoﬂoxacin (LEV) was determined with
broth microdilution method. Colistin (CL), tigecycline (TGC) and
doripenem (DOR) susceptibility were performed by E-test. MBL
production was determined by the combined disk test with IMP-0.1M
EDTA. An increase in zone diameter of 4 for 0.1M IMP-EDTA disks
was considered positive for MBL production. OXA genes, 23-like, 24-
like, 51-like and 58 were ampliﬁed by multiplex PCR assay.
Results: Twelve of the patients (30%)were from intensive care units
(ICU). Colistin (97.5%), tigecycline (95%) were the most susceptible
antibiotics tested. Carbapenem resistance rate was 95% (n:38) for IMP
and MER and 90% (n:36) for DOR among the isolates. MIC90 values for
the isolates were >64mg/ml for PIP, >64/4mg/ml for TZP, >32mg/ml for
AN, >8mg/ml for GM, >8mg/ml for IMP, >8mg/ml for MER, >32mg/ml
for CTX, >16mg/ml for CAZ, >16mg/ml for FEP, >2mg/ml for CIP,
>4mg/ml for LEV, 0.38mg/ml for CL, 2mg/ml for TGC, >32mg/ml for
DOR, respectively. Among 40 A. baumannii isolates, 2 (5%) yielded
positive results for MBL production by 0.1M IMP-EDTA disk test.
Oxacillinase genes were detected in 39 (97.5%) of the isolates. The
occurence of OXA genes was: blaOXA-23 (n:27, 67.5%), blaOXA-58
(n:4, 10%) and blaOXA-51 (n:39, 97.5%). None yielded blaOXA-24.
Conclusion: This study shows that carbapenemase resistance is highly
due to blaOXA-23 gene among our MDR A. baumannii invasive isolates.
As the treatment alternatives gets restricted for MDR A. baumannii,
reevaluation of carbapenems and other antibiotics is mandatory.
R2341 Molecular detection of class 1 integron associated
antimicrobial gene cassettes in multidrug-resistant
Salmonella serovars isolated in Iran
M.R. Aghasadeghi*, S.D. Siadat, B. Rajaei, F. Badmasti, N. Sepehri Rad,
R. Sabohi, S. Javadian, M.R. Razavi, S. Najar Peerayeh, S.M. Zahraei,
R.A. Khavari-Nejad, S.M. Sadat, A. Moshiri, A. Rahimi (Tehran, IR)
Objective: High levels of multidrug resistance are normally associated
with mobile genetic elements that encode speciﬁc resistance genes.
Among these genetic elements are the integrons, which are structures that
can integrate and express resistance genes. Integrons play an important
role in the capture and expression of exogenous genetic material.
Methods: Eighty ﬁve epidemiologically unrelated clinical isolates of
Salmonella.spp were collected from different provinces of Iran through
2008–2009. All isolates were serotyped comprising four serovars (A, B,
C, D) and tested for the antimicrobial susceptibility for several antibiotic.
All isolates were screened for the presence of class 1 integron using
primers speciﬁc for intI1 gene. The gene cassettes inserted in the variable
region of class 1 integrons were ampliﬁed using 5′-CS and 3′-CS primer
pairs. The PCR products were extracted from agarose gel and puriﬁed
with the High Pure PCR Product Puriﬁcation Kit. According to the
size of IVR ampliﬁed, one representative band of each group were
sequenced and compared with the GenBank sequences using online
BLAST software ww.ncbi.nlm.nih.gov/BLAST. Following this analysis,
sequences were submitted to the EMBL/GenBank database.
Results: Forty isolates (47.05%) which were resistant to at least 4
antimicrobial agents considered as MDR Salmonella serovars. Of the
85 isolates, 58.82% (50 isolates) presented class 1 integrons. 68%
(34 cases) of these isolates were multidrug resistance. PCR assays
and DNA sequencing of internal variable regions (IVRs) of class 1
integron characterized four gene cassette arrays including dhfr7 (0.8
kb), aadA1 (1kp), blaP1 (1.2 kb),dhfr7-aadA1 (1.6 kb) with eight IVR
distribution patterns in MDR isolates. The nucleotide sequences of
aadA1 gene, the dhfr7 gene, the blaP1 gene, the dhfr1-aadA1 gene
cassette and the aadA1 gene in the class 1 integrons have been deposited
in the NCBI GenBank sequence databases under the accession numbers
HQ132374,HQ132376,HQ132377,HQ132378, HQ132375 respectively.
Conclusion: High frequency of MDR Salmonella serovars demonstrates
that antimicrobial selection pressure is widespread in our clinical
settings. Detection of class 1 integron carrying gene cassettes
which confer resistance to different classes of antibiotics such as
aminoglycosides,b-lactams and trimethoprim conﬁrms that integron-
mediated antimicrobial gene cassettes are common in MDR Salmonella
serovars isolated in Iran.
R2342 Molecular and phenotypical analysis of non-typable
Salmonella enterica serovar typhimurium clinical isolates
V. Majta´n*, L. Majta´nova, J. Majta´n (Bratislava, SK)
Objectives: The objectives of this study was molecular and phenotypical
analysis of Salmonella enterica serovar Typhimurium clinical isolates,
which did not react with the typing phages (nontypable).
Methods: A total 131 isolates were collected and analysed. The
isolates were characterized using antimicrobial susceptibility testing,
PCR determination of class 1 integrons and SGI1, DNA sequencing
for class 1 integrons as well as macrorestriction analysing (PFGE) and
bioﬁlm production.
Results: A high frequence of multidrug resistance to antimicrobial
agents (78.6%) was detected. Two multidrug resistance patterns were
the most frequent in nontypable isolates: isolates with ampicillin,
streptomycin, sulﬁzoxazole and tetracycline (R-type ASSuT) [38.9%]
and isolates with ampicillin, streptomycin, sulﬁzoxazole, sulphamethox-
azole, tetracycline and trimethoprim (R.type ASSuSxTTTMP) [19.8%]
resistance patterns. Class 1 integrons were detected only in ten (7.6%) of
the multidrug-resistant isolates. The results demonstrated the presence
of both SGI1-borne resistance genes and class 1 integrons in three
isolates only. After treatment of genomic DNA with XbaI, we observed
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macrorestriction proﬁles which were grouped into ten patterns. Most of
the isolates belonged to X1 (34.9%) and X2 (31.0%) PFGE patterns.
With regard to bioﬁlm production of isolates studied, all isolates were
positive in different degree of production, except of two isolates.
Conclusion: This study shown that the nontypable S. Typhimurium
isolates were characterized by multidrug antimicrobial resistance
encoded by class 1 integrons in some of them. PFGE analysis suggested
presence of the multiple clones of nontypable clinical isolates of this
serovar.
This work was supported by Ministry of Health of the Slovak
Republic under the project “Molecular analysis of antibiotic resistance
of nontyphoid salmonella serovars”.
R2343 Emm types distribution of macrolide-resistant GAS from
pharyngitis patients in Serbia
I. Gajic*, V. Mijac, I. Lazarevic, M. Stanojevic, N. Opavski (Belgrade,
RS)
Objective: Group A streptococci (GAS), are the most common cause
of bacterial pharyngitis. Penicillin remains the ﬁrst line therapy for
GAS infections, but in the case of allergy, macrolides are used instead.
However, resistance to these antibiotics among GAS population is in
rise in many European countries. The distribution of resistance pheno/
genotypes as well as the prevalence of different emm types among
macrolide resistant strains varies considerably in different regions and
with time.
Therefore, the aim of this study was to investigate phenotypes, genotypes
and emm type distribution among macrolide resistant GAS isolates from
pharyngitis patients in Serbia.
Methods: Fifty one GAS isolates exhibiting macrolide resistance
were collected from various regions from Serbia in the period
2008–2009. Phenotypes of erythromycin resistance (M, iMLS and
cMLS phenotype) were evaluated by triple disk diffusion test with
erythromycin, clindamycin and spiramycin, as previously described. The
corresponding resistance genes: mefA, ermA, and ermB were detected
using PCR ampliﬁcation. The emm genotypes were determined by PCR
with “all M” primers following a previously published protocol by
Podbielski and co-workers.
Results: Out of 51 GAS isolates, the majority (71%) harbored mef A,
25% had ermA, while, ermB was rarely encountered (4%). All strains
with M phenotype had mef A gene. Out of 13 iMLS isolates, all were
ermA positive, and one harbored additionally mefA gene. ErmB was
present in 2 out of 3 strains with cMLS phenotype. Emm genotyping
revealed the presence of 5 different emm types: emm 75 (47%), emm 77
(25%), emm 12 (24%), emm 28 (2%) and emm118 (2%). The relation
of emm types and particular resistance mechanisms could be observed:
all emm 75 type isolates were mefA positive and all emm 77 isolates
were ermA positive. Emm 12 was encountered among isolates harboring
mefA as well as in one ermA positive strain and one cMLS strain that
harbored none of the tested genes. Erm B positive strains were of emm
28 and emm 118 types.
Conclusion: Our data show the predominance of efﬂux mediated
resistance (mefA) and homogenous emm type distribution among
macrolide resistant GAS in Serbia. Genotypes associated with resistance
were mainly emm 75 and emm 77.
R2344 A comprehensive study on mechanisms of imipenem resis-
tance in Acinetobacter baumannii clinical isolates in Taiwan
H.-Y. Lee*, R.-C. Chang, L.-H. Su, T.-Y. Lin, C.-H. Chiu (Taoyuan, TW)
Objectives: A total of 82 A. baumannii clinical isolates from two
teaching hospitals in Taiwan in December of 2006 and 2009 were
collected and examined in order to elucidate current resistance
mechanisms.
Methods: The minimum inhibitory concentrations (MIC) of imipenem,
ceftazidime, and ceftriaxone were checked by E-test analysis to these
isolates. Primers speciﬁc for resistance genes (blaIMP-1, blaVIM-1,
blaVIM-2, blaOXA-23, blaOXA-24, blaOXA-40, blaOXA-54, blaOXA-
58, blaOXA-51, blaADC) and upstream regions of insertion sequences
(ISAba1, ISAba2, ISAba3, ISAba4 or IS1008) were designed for PCR
ampliﬁcation and sequence identiﬁcation. All 62 A. baumannii isolates
in 2009 were genotyped by pulsed-ﬁeld gel electrophoresis (PFGE). The
30-day mortality data of patients with isolates in 2009 were collected.
Results: The upstream ISAba1 was found in 53 isolates with blaOXA-
23, including Tn2006 (ISAba1–blaOXA-23–ISAba1, n = 47) and Tn2008
(ISAba1–blaOXA-23, n = 6), and in 9 isolates with blaOXA-51-like.
All these isolates expressed full resistance to imipenem (MIC >32)
(Table 1). ISAba3-blaOXA-58-ISAba3 was found in 3 isolates and
offered 2 isolates with resistance to imipenem (MIC >12). In the
contrast, without upstream ISAba1, or ISAba3, isolates with OXA-type
b-lactamases were all susceptible to imipenem. The upstream ISAba1
found in 50 isolates with blaADC-25 and the upstream ISAba1 or
ISAba3 found in other 3 isolates with OXA-type b-lactamases offered
these isolates with full resistance to both ceftriaxone and ceftazidime.
Isolates with the combination of upstream ISAba1 or ISAba3 and OXA-
type b-lactamases or blaADC-25 showed more resistant to imipenem,
ceftazidime and ceftriaxone than those without such combination (all
P< 0.001). Forty-one PFGE genotypes were found in 62 isolates in
2009. Tn2006 were found in 19 genotypes (46.3%) that is signiﬁcantly
more than ISAba1–blaOXA-51 (12.2%, 5/41) (P = 0.001). The 30-day
mortality rate was signiﬁcant lower in patients infected by isolates
with ISAba1–blaOXA-51-like (0%, 0/6), compared with isolates with
ISAba1–blaOXA-23 (50%, 17/34) (P = 0.030).
Conclusion: Displacing ISAba1–blaOXA-51 which was the main
resistant mechanism to imipenem in A. baumannii in 1993–2007, Tn2006
with higher ability of spreading to different PFGE genotypes and
correlation with higher mortality, became the predominant imipenem
resistance mechanism in A. baumannii in Taiwan.
R2345 Types of b-lactamases in pathogenic Enterobacteriaceae,
resistant to ampicillin, in Saint Petersburg and north-west
region of Russia
E.P. Barantsevich*, N.S. Kozlova, N.E. Barantsevich (Saint Petersburg,
RU)
Objectives: The aim of the present study was to determine the presence
of different types of b-lactamases in pathogenic Enterobacteriaceae
(Salmonella spp. and Shigella spp.) strains, resistant to ampicillin,
isolated in Saint-Petersburg and North-West region of Russia.
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Methods: Resistance to ampicillin was studied on Muller-Hinton agar
(Oxoid, GB) by dilution techniques. Isoelectric focusing and PCR were
used to reveal the presence of b-lactamases, their number and types
in pathogenic Enterobacteriaceae species (51 Salmonella spp. and 62
Shigella spp. strains), resistant to ampicillin.
Results:MIC of ampicillin in 113 strains of Salmonella spp. and Shigella
spp. varied from 32 to >512 mcg/ml: in 7.1% MIC was 32 mcg/ml, in
32.7% − 64 mcg/ml, in 53.1% − 128 mcg/ml, in 7.1% − >512 mcg/ml.
All the strains produced one (77%) or more (23%) b-lactamases of
different types. There were 4 types of b-lactamases with isoelectric
points (pI) 5.4 (TEM-1), 5.7 (PSE), 7.0 (OXA-1) and 7.6 (SHV-1)
detected. Predominant types of enzymes, responsible for the resistance
to ampicillin, were OXA-1 (52.2%) and TEM-1 (46.0%). Frequency of
other types of b-lactamases was lower: 17.7% for SHV-1 and 8.0% for
PSE.
Totally ten spectrums of b-lactamases were detected. The prevalence of
one enzyme production in the studied strains was revealed − OXA-1
(39.8% strains) or TEM-1 (25.7%). The combination of two enzymes −
TEM-1+SHV-1 or TEM-1+OXA-1 produced 9.7% and 8.8% of strains
respectively. The other combinations of enzymes were revealed only in
1−2 strains. Few strains produced only one enzyme − PSE or SHV-1 −
6.2% and 5.3% respectively. Only one strain (S. enteritidis) produced
three types of enzymes (TEM-1+OXA-1+SHV-1).
Conclusions:
1. The resistance to ampicillin in Salmonella spp. and Shigella spp. in
St. Petersburg and North-West region of Russia was mostly due to
production of one type of b-lactamase.
2. The predominant types of b-lactamases were OXA-1 and TEM-1.
3. The most widespread combinations of these enzymes, detected in
18.5% strains, were TEM-1+SHV-1 and TEM-1+OXA-1.
R2346 Nasal Panton-Valentine leukocidin-positive Staphylococcus
aureus carriage in skin and soft tissue infections
T. Demir*, N. Coplu, H. Bayrak, M. Turan, T. Bu¨yu¨kgu¨c¸lu¨, D. Caliskan,
B. Yalcin, U. Cinar, N. Atakan, Z. Karahan, B. Esen (Kirsehir, Ankara,
Mersin, Karabuk, TR)
Objectives: PVL toxin is commonly associated with community
acquired-S. aureus isolates with a wide range of diseases including skin,
soft tissue and pulmoner infections, as well. The aim of this study is to
assess the prevalence of PVL toxin co-carriage both in wound and nasal
samples.
Methods: Nasal and wound samples of 125 patients admitted to
outpatient clinics were evaluated for PVL toxin carriage in the study
period, between 2007–2008. Oxacillin, cefoxitin disk diffusion tests,
oxacillin screen agar test and PCR methods were used for methicillin
resistance detection. PVL and mecA gene detection was performed by
PCR. Data were compared by the chi-square test, Fisher’s exact test with
SPSS 15.0. P values of <0.05 were considered statistically signiﬁcant.
Results: Among 115 S. aureus (92 wound, 23 nasal swab) strains,
11 wound and one (4.3%) nasal S. aureus were deﬁned as methicillin
resistant S. aureus (MRSA). Nasal S. aureus, MSSA, MRSA prevalence
were as; 18.4%, 17.6%, 0.8%. 14 patients were S. aureus carriers both
in wound and nasal sample. 14 wound, 2 (8.7%) nasal sample were PVL
toxin positive, none of which were MRSA. Among wound samples PVL
positive strains were isolated from froncule (71.4%), abscess (21.4%)
and carboncule (7.1%). PVL toxin carriage was found to be associated
with fronculosis (p< 0.05) but statistically signiﬁcant relationship was
not identiﬁed between PVL positivity and age, gender. Among PVL
positive nasal samples one was from froncule and the other from
carboncule. Two patients with nasal PVL positive S. aureus were found
to have PVL positive S. aureus in wound sample showing the similar
antimicrobial susceptibility pattern (one was resistant only penicillin, the
other penicilin and erytromycin).
Conclusion: PVL toxin carriage is not alarming in our country, but
routine surveillance should be performed for methicilin resistance and
PVL carriage for all isolates on available laborotories to prevent the
dissemination of these isolates.
R2347 Eight-year surveillance of imipenem non-susceptible clinical
isolates in Klebsiella pneumoniae in Taiwan
L. Ma* (Miaoli County, TW)
Objective: The aim of this study was to investigate the mechanism of
resistance and clonality among 29 imipenem-non-susceptible K. pneu-
moniae isolates collected between 2002 and 2009 from a nationawide
surveillance.
Methods: Twenty-nine imipenem non susceptible K. pneumoniae
isolates were obtained from seven medical centers and thirteen
regional hospitals between 2002 and 2009. Laboratory investigation
of the K. pneumoniae included antimicrobial susceptibility testing,
resistance gene (include class A carbapenemaseIMI,SME,GES,KPC;
class B metallo b-lactamase IMP, VIM, NDM; AmpC enzymes
CMY,DHA; Class D oxacillinase, ESBL genes CTX-M, SHV,TEM)
by PCR ampliﬁcation and DNA sequencing, genotyping by pulse-ﬁeld
gel electrophoresis (PFGE), and outer membrane protein (OmpK35,
OmpK36) analysis by SDS-polyacrylamide gel electrophoresis.
Results: Eleven isolates had blaIMP-8 alleles, whereas blaCMY-2 and
blaDHA-1 alleles were detected in 1 and 11 isolates, respectively. All
isolates had either blaCTX-3, blaCTX-M-15 blaCTX-M-14 or blaSHV-
12 ESBL genes. SDS-PAGE of outer membrane proteins showed
22 isolates lack or greatly diminished expression of OmpK35 or
OmpK36. Pulsed-ﬁeld gel electrophoresis of XbaI-restricted genomic
DNA revealed one closed related cluster among four blaIMP-8 positive
isolates.
Conclusion: In conclusion, non-imipenem susceptible among K. pneu-
moniae in Taiwan were largely by class B metallo-b-lactamase IMP-8
and by production of plasmid-mediated AmpC b-lactamases along with
lack or greatly diminished expression of OmpK35 and OmpK36 porins.
R2348 Molecular epidemiology of CTX-M-14 ESBL E. coli from
cattle and humans in England and Wales
N.G. Coldham*, M. Stokes, J. Cottell, L. Randall, H. Wearing, L. Snow,
M. Wootton, R. Howe, L.J. Piddock, C. Teale (Addlestone, Birmingham,
Cardiff, UK)
Objectives: The molecular epidemiology of an outbreak CTX-M-14
ESBL E. coli on a dairy farm in Wales was investigated to determine the
geographical dissemination, linkage to this farm following the dispersal
of the cattle to other holdings and presence in the human population.
Risk factors for CTX-M E. coli on cattle farms were also investigated.
Methods: Pat samples from cattle on selected farms were screened for
CTX-M E. coli using Chromagar CTX and sequence typed (Randall
et al., 2008). A contemporaneous, year long passive surveillance study
was used to assess the geographical dissemination of CTX-M E. coli
by the analysis of cattle and sheep diagnostic faecal samples (n = 113)
submitted to local VLA regional laboratories in Wales. A network
analysis approach was used to investigate the dissemination of the CTX-
M-14 E. coli from the outbreak farm using the cattle tracing system.
The CTX-M-14 isolate from the outbreak farm was compared to human
CTX-M-14 isolates (n = 19) from Wales using a multiplex PCR (Cottell
et al., 2011) for the plasmid (pCT) bearing the CTX-M-14 from that
farm.
Results: Geographical analysis revealed that the CTX-M gene from
veterinary sources was widespread in the study area and predominantly
CTX-M-15 (n = 7) not CTX-M-14 (n = 3). The prevalence of CTX-M
E. coli in the population of farms (n = 17) linked to the outbreak
farm was 59% compared with 37% in the control farms (n = 48) and
no statistically signiﬁcant linkage was observed. However, there was
a signiﬁcant (P< 0.05; OR 4.4) association between the presence of
CTX-M E. coli on cattle farms and the use of 3rd/4th, but not 1st/2nd,
generation cephalosporins. Analysis of the human CTX-M-14 isolates
revealed that some isolates from humans (n = 3) had similar plasmid
backbone genes to pCT.
Conclusions:While the CTX-M gene was present in the study area there
was no evidence for linkage of the CTX-M-14 to the outbreak farm. A
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similar plasmid to that from the outbreak farm (pCT) was found in
CTX-M-14 E. coli isolates from humans. The role of 3rd/4th generation
cephalosporins in the selection of CTX-M E. coli on cattle farms is
being further investigated.
R2349 Serotyping of Streptococcus pneumoniae strains isolated in
Algeria
H. Tali-Maamar*, R. Laliam, C. Bentchouala, Dj. Touati, M. Azzam,
W. Amhis, R. Belouni, F. Smati, Kh. Rahal (Algiers, Constantine, Tizi
Ouzou, Blida, DZ)
Objectives: The aim of this work is the study of Streptococcus
pneumoniae serotypes isolated in many algerian cities, their distribution
by localisation site, and the evaluation of the theoretical coverage for
conjugate vaccines.
Methods: Our study was performed on 256 strains of Streptococcus
pneumoniae, collected from January 2001 to July 2010. These isolates
came from various samples: CSF (Cerebrospinal ﬂuid) (n = 104); blood
(n = 36), ascitic, pleural, peritoneal and gastric ﬂuid (n = 14); nasal, throat
and ear swabs (n = 61); lung samples (n = 25) and ﬁnally, ﬁstulae (n = 16).
Among these strains, 45.6% came from children, of which 33.3% were
under 5 years of age. The strains were identiﬁed using the usual tests. For
serotyping, we use the latex particle agglutination (Statens Serum Institut
Pneumotest-Latex), and the capsular swelling test using monovalent sera
(Statens Serum Institut).
Results: The most common serotypes were: 14 (19,5%), 23F (9,7%),
6B (9,3%), 19F (5,4%) and serotype 1 (5%). The frequency of these
serotypes in invasive sites in children under 5 years is 14 (31.25%), 23F
(10.4%), 19F (8.3%), 6B (6.25%) and serotype 1 (4.2%). The theoretical
coverage of invasive infections in children under 2 years is 61.5%,
69.2% and 76.9% for the 7-valent, 10-valent and 13-valent conjugate
vaccines, respectively. This coverage represent 63.5%, 64.9% and 68.9%,
respectively for each vaccine, against pneumococcus non susceptible of
penicillin (PNSP).
Conclusion: The national consensus for the treatment and management
of bacterial meningitis requires updating. Numerous publications
describe the variation over time of circulating serotypes of Streptococcus
pneumoniae. The differences noted between the two studies conducted
in Constantine (1994) and Algiers (2000), and the present study we
are presenting reveal the need to establish a pneumococcal infection
monitoring program in Algeria. Effort is required to increase the number
of samples and their quality in order to extend sampling for a more
representative epidemiological study.
R2350 Activity of daptomycin against staphylococcal blood isolates.
Glycopeptide tolerance and comparison of vancomycin
MICs determined by broth microdilution and E-test
J. Picazo*, C. Betriu, I. Rodrı´guez-Avial, E. Culebras, F. Lo´pez-Fabal,
M. Go´mez on behalf of the VIRA study group
Objectives: To assess the activity of daptomycin and fourteen
comparator agents against staphylococcal blood isolates, to evaluate
vancomycin and teicoplanin tolerance and the incidence of heterogeneous
glycopeptide-intermediate (hGISA) isolates, and to investigate the
presence of the cfr gene in the linezolid nonsusceptible strains.
Methods: The activity of daptomycin and fourteen comparators was
evaluated against 702 staphylococcal blood isolates (316 methicillin-
susceptible Staphylococcus aureus [MSSA], 187 methicillin-resistant
S. aureus [MRSA], and 199 coagulase-negative staphylococci [CoNS])
recently collected in 41 Spanish medical centers. Vancomycin minimum
inhibitory concentrations (MICs) determined by the Etest were compared
with those obtained by the reference broth microdilution method.
Results: Daptomycin exhibited good activity against the majority of
the isolates and only two (0.3%) isolates were nonsusceptible to this
antibiotic. Nonsusceptibility to linezolid was observed in two MRSA
isolates and in 16 CoNS. The cfr gene was detected in seven (38.8%)
of these 18 isolates. Vancomycin and teicoplanin tolerance was 9.6%
and 21.9%, respectively, in MRSA isolates. We detected the hGISA
phenotype in 5.8% of MRSA isolates and in 0.3% of MSSA isolates.
Vancomycin MICs by the Etest were slightly higher than those obtained
by broth microdilution, mainly for S. aureus. Most of the differences
in MIC observed between the methods were of only one dilution.
Daptomycin retained activity against isolates that were not susceptible to
linezolid, teicoplanin, or quinupristin-dalfopristin, and was highly active
against hGISA isolates (daptomycin MICs, 0.25−0.5mg/ml).
Conclusion: Daptomycin represents an alternative in the treatment of
serious infections caused by multiresistant staphylococci.
R2351 Performance of a new modiﬁed NucliSENS EasyQ® MRSA
assay with community-associated Danish MRSA strains
M. Mølvadgaard* (Aalborg, DK)
Objectives: Several commercial assays have been developed for rapid
detection of MRSA colonization with nasal swabs, but genetic variations
within the SCCmec cassette poses a constant challenge to the primer
design. NucliSENS EasyQ® MRSA (bioMe´rieux) is an ampliﬁcation-
based method which simultaneously detects the mecA gene and a speciﬁc
cassette junction conﬁrming the presence of the SCCmec cassette
integrated in the S. aureus chromosome. A selection of different MRSA
strains was previous tested with the ﬁrst version of the assay and only
11 out of 15 strains were correctly identiﬁed as MRSA at that time
(ECCMID 2010 − Ab. Nr. 2145). Among others the assay failed to detect
clonal complex (CC) 398 (ST398) associated to livestock animals and
constituting an emerging problem in both Denmark and The Netherlands.
A rapid test for screening and identiﬁcation of these livestock-associated
strains could have important implications for surveillance and infection
control initiatives. The objective is to evaluate the performance of a new
modiﬁed version with the collection of community-associated Danish
MRSA strains tested previously.
Method: MRSA isolates were obtained from residents in North Jutland,
Denmark and were characterized genetically by spa typing and clustered
into spa CC groups (www.ridom.de) as part of the Danish national
surveillance program maintained by Statens Serum Institut. Cultures of
MRSA strains were processed according to the manufacturer’s guidelines
for positive controls and analysed on the EasyQ instrument, a NASBA-
based platform.
Results: 15 MRSA strains representing 10 different CCs [numbers in
brackets]: CC1 [1], 5 [3], 8 [1], 22 [2], 30 [1], 59 [1], 72 [1], 88
[3], 97 [1], and 398 [1]) were all positive with the new version of
the NucliSENS EasyQ® MRSA assay. These results supersede the ones
previously obtained with the ﬁrst version where 4 strains failed the test
(CC5 [1], CC59 [1], CC97 [1], and CC398 [1]). The test was easy to
perform and was conducted in 3 hours.
Conclusion: The NucliSENS EasyQ® MRSA assay is a very rapid test
and easy to perform. In the current epidemiological situation in Denmark
the assay should identify correctly the prevalent clonal complexes
including CC398. An extensive trial with samples from community-
dwelling Danes including persons in close contact with livestock animals
is warranted.
R2352 Resistance to macrolides in Corynebacterium striatum
J. Navas*, J. Agu¨ero, C. Salas, J. Calvo, I. Pe´rez del Molino,
M. Gonza´lez-Carrero´, L. Martı´nez-Martı´nez (Santander, ES)
Objectives:
– Analyze the activity of two macrolides (erythromycin and spiramycin)
and clindamycin against 74 Corynebacterium striatum clinical strains
isolated at the hospital Marque´s de Valdecilla, Santander, between
2005 and 2009.
– Phenotypic detection of macrolide resistance.
– Detection of the gene(s) associated with the resistance phenotype.
– Mapping the region surrounding the resistance gene(s) to know if it
is associated with a transposable element.
– Assay the transferability of the resistance gene(s) to Escherichia coli.
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Methods: Susceptibility of C. striatum strains to erythromycin and
clindamycin was analyzed by Etest (AB BIODISK, Solna, Sweden). For
spiramycin the disk diffusion method was used. The type of resistance
of the C. striatum strains was elucidated by the double disc diffusion
test. The gene(s) associated with resistance were isolated by PCR with
primers speciﬁc for ermX and mef genes. The region surrounding the
resistance gene(s) in two representative C. striatum isolates was cloned
by inverse PCR using primers designed from the sequence of their ermX
alleles. The transferability of the resistance gene(s) from two C. striatum
strains to E. coli was assayed by electroporation and conjugation.
Results: We analyzed a collection of 74 C. striatum from clinical
specimens responsible for cases of wound infections, skin ulcers and
pneumonia. 64 C. striatum were resistant to erythromycin, 64 to
clindamycin and 62 to spiramycin; 62 were resistant to both erythromycin
and clindamycin; 60 isolates were resistant to the three compounds.
The gene ermX was detected in 62 of the 64 C. striatum resistant to
erythromycin and clindamycin. This gene was also found in one isolate
sensitive to the three compounds. Preliminary results indicate that in our
C. striatum isolates the gene ermX is chromosomic and does not take
part of transposon Tn5432.
Conclusion: Our study revealed a high incidence of resistance to two
macrolides and clindamycin in C. striatum clinical strains isolated at
hospital Marque´s de Valdecilla, Santander, Spain. First results show that
in our C. striatum collection the ermX gene is chromosomic and is not
associated to transposon Tn5432.
R2353 IRT associated phenotypes might mask inhibitor-resistant
CTX-M b-lactamases mutants
A. Ripoll*, M.C. Turrientes, R. Canto´n, M. Tato, L. Martı´nez-Martı´nez,
F. Baquero, J.C. Gala´n (Madrid, Santander, ES)
Objectives: Unlike TEM and SHV, b-lactam plus b-lactamase inhibitor
(BBLIs) resistant variants among CTX-M enzymes have not hitherto
been described in the clinical setting. These variants may exist but
their phenotypic patterns could be confused with those of IRT or IR-
SHV. The objectives of this work were: i) to test if an automatic
susceptibility testing system (Wider) and blind expert analysis might
identify different CTX-Ms harbouring different laboratory-introduced
mutations conferring increased MICs to BBLIs; ii) to compare the
efﬁciency to detect IR-CTX-M enzymes when using CLSI or EUCAST
breakpoints.
Methods: 14 constructions of hybrid plasmids containing 3 wild-
type CTX-M genes and 11 CTX-M laboratory-obtained coding for
enzymes resistant to inhibitors were transformed into 4 isogenic
E. coli laboratory strains with porin membrane alterations: MKW505
(wild-type), KAEC5 (ompC::Kn), MH621 (ompF::lacZ) and KAECF5
(ompF::lacZ; ompC::Kn). Wild-type CTX-Ms were CTX-M-1, CTX-
M-2 and CTX-M-14 and mutated CTX-M belonged to these CTX-Ms
but carrying changes (S130G, S237G and K234R) that we previously
described conferring increased BBLI MICs.
Results: All wild-type CTX-Ms into the four genetic backgrounds
were correctly detected by Wider and expert personnel. Those six
mutated CTX-Ms carrying S130G were classiﬁed by Wider as IRT (with
and without overexpression of TEM) or ESBL (2 cases) while expert
personnel as IRT (2), overexpression of TEM (1), overexpression of
SHV (1) and ESBL (2). Those three mutated CTX-Ms-K234R and two
CTX-Ms-S237G mutants were classiﬁed as ESBL with Wider and expert
personnel. Using current breakpoints, reference CTX-Ms were always
identiﬁed as ESBL, except KAECF5-CTX-M-1 which was classiﬁed as
IR phenotype with EUCAST breakpoints. All variants were coincidently
identiﬁed as IRT in CTX-Ms-S130G and as ESBL in CTX-Ms-K234R
and CTX-Ms-S237G when using both CLSI and EUCAST breakpoints.
Interestingly, CTX-M-14-K234R and CTX-M-35-S130G were classiﬁed
as IR-ESBL when using EUCAST but not with CLSI breakpoints.
Conclusions: Not a single IR-CTX-M phenotype was detectable either
by the automatic system or the blind expert analysis, suggesting that these
IR-CTX-M variants could be overlooked in the clinical microbiology
setting. When using current breakpoints, EUCAST detected more IR-
CTX-M-ESBL phenotypes than CLSI. This result suggests that EUCAST
must be considered as reference to detect these IR-CTX-M mutants in
the future.
R2354 Carbapenemase-producing Pseudomonas aeruginosa in
French intensive care units
D. Fournier*, M. Robert-Nicoud, P. Ple´siat and the GESPAR Group
Objectives: A multicenter, prospective, observational study was
conducted in June 2010 to determine the prevalence of carbapenemase-
producing P. aeruginosa in patients hospitalized in French intensive care
units (ICUs).
Methods: Thirty hospital bacteriology departments participated in this
study. All of the non-duplicate ICU isolates of P. aeruginosa with
imipenem MIC >4mg/L were collected and sent to the coordinating
center (Besanc¸on). Drug MICs were determined by the microplate
dilution method (Sensititre®). Carbapenemases were detected among the
ceftazidime-resistant isolates (MIC >8mg/L) by double disc synergy
tests (ceftazidime-EDTA, imipenem-clavulanate) and PCR targeting
carbapenemase-encoding genes from Ambler classes A, B and D.
Results: One hundred and ﬁve P. aeruginosa isolates were collected
from 26/30 participating centres (median: 4 isolates; range: 1−10). Seven
isolates (6.7%) from 5 hospitals harbored a class B metallo-b-lactamase
(MBL): 1 VIM-1, 4 VIM-2, 1 VIM-4, and 1 novel IMP-type enzyme
(IMP-29). Five of these isolates exhibited a high level resistance to the 3
carbapenems tested (MICs 128mg/L) whereas 2 strains (producing
either IMP-2 or IMP-29) turned out to be moderately resistant to
imipenem (MIC of 32mg/L). No class A or D carbapenemases were
found in the collection. Among the 98 remaining strains (93.3%), the
decreased susceptibility to imipenem (MIC from 6 to 64mg/L) was
attributed to alteration or loss of porin OprD. In these impermeability
mutants, the activity of meropenem and doripenem was generally better
than that of imipenem (MICs from 2 to 16 times lower).
Conclusion: Seven % of the imipenem non-susceptible P. aeruginosa
isolated in French ICUs produce a MBL. This prevalence is lower than in
some other European countries. Nevertheless, the epidemic potential of
these broad-spectrum b-lactamases should incite ICUs and microbiology
laboratories to strengthen surveillance measures to prevent their spread.
R2355 AmpC b-lactamases in Escherichia coli and Klebsiella
pneumoniae blood isolates
O¨. Ko¨seoglu Eser*, Y. O¨cal, B. Sener, G. Hascelik (Ankara, TR)
Objectives: Detection of plasmid mediated AmpC b-lactamase produc-
ing organisms is important to ensure effective therapeutic intervention
and optimal infection control. However, detection of these enzymes is a
challenge for laboratories since there is no reliable method for the routine
detection of plasmid mediated AmpC enzymes. This study was aimed
to investigate the prevalence of plasmid mediated AmpC b-lactamases
in E. coli and Klebsiella spp. in a university hospital in Turkey.
Methods: Among a total of 1317 blood E. coli and Klebsiella spp.
isolated from the blood cultures of patients admitted to Hacettepe
University Hospital between 2007–2010, 40 K. pneumoniae(n = 30)
and E. coli(n = 10) isolates which were found to be resistant to
cefoxitin (FOX) by BD Phoenix system were included in the study.
The antimicrobial susceptibility of the isolates were determined by
disk diffusion method according to the CLSI guidelines. AmpC and
ESBL production were conﬁrmed with combined disk diffusion test
in combination with or without boronic acid (BA) and clavulanic acid
(CA). Multiplex PCR was performed in all isolates for the detection
of plasmid-mediated blaMOX, blaCIT, blaDHA, blaACC, blaFOX and
blaEBC ampC genes.
Results: Of the 40 FOX resistant isolates, 32 (80%) were found
resistant to FOX by disk diffusion method. The rates of susceptibility to
imipenem, cefepime, aztreonam, ciproﬂoxacin, cefotetan, ceftazidime,
cloxacillin, cefotaxime, cefpodoxime, amoxicillin-clavulanic acid and
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amikacin were 90.0%, 27.5%, 47.5%, 50.0%, 75.0%, 42.5%, 97.5%,
25%, 30%, 2.5% and 92.5%, respectively. Phenotypic AmpC b-lactamase
production was found in 15 (37.5%) and ESBL production in 18
(45%)of the isolates with cephalosporin/BA/CA and cephalosporin/BA
disk diffusion test. Plasmid-mediated ampC genes; blaCiT and blaEBC
was found in two K. pneumoniae isolates (6.7%), only one being
phenotypically positive for AmpC production.
Conclusion: Plasmid mediated AmpC prevalence was 6.7% among
blood Klebsiella isolates in our center. These results emphasized
that clinical laboratories should consider testing the presence of
plasmid mediated AmpC b-lactamases particularly in cefoxitin resistant
Klebsiella spp. and continuous surveillance of these enzymes is
necessary in terms of improved hospital infection control and therapeutic
options. These data also highlighted the use of molecular analysis
to verify the presence of plasmid-mediated AmpC in Gram negative
pathogens.
R2356 Molecular characterisation and epidemiology of a
carbapenem-resistant Enterobacteriaceae outbreak in a
tertiary care centre, Istanbul
M. Yilmaz*, S. Aydin, B. Mete, H. Nazik, B. Ongen, R. Ozaras,
N. Saltoglu, A. Mert, R. Ozturk, F. Tabak (Istanbul, TR)
Introduction: Bacteria from clinical and non-clinical settings are
becoming increasingly resistant to conventional antibiotics. The increase
in resistance of Gram-negative bacteria is mainly due to mobile genes
on plasmids encoding carbapenem-hydrolyzing b-lactamases that can
readily spread through bacterial populations. Here we describe a long
lasting nosocomial outbreak of carbapenem-resistant Enterobacteriaceae
strains expressing OXA-48.
Objectives: Between 2002 and 2010, we identiﬁed 42 Enterobacteriaceae
strains that are resistant to any of the carbapenems in a 1500 bed
university hospital. The aim of the study was to identify the resistance
mechanisms for carbapenems in these strains and to check for clonal
dissemination.
Methods: All the strains (29 Klebsiella pneumoniae, 6 Escherichia
coli, and 7 Enterobacter spp.) were nonrepetitive clinical isolates
from the Infectious Diseases and Clinical Microbiology Laboratory
of Istanbul University, Cerrahpasa Medical Faculty. The strains were
identiﬁed with the API 32GN system. Carbapenemase- and extended-
spectrum-b-lactamase (ESBL)-encoding genes were identiﬁed by PCR
experiments using previously designed primers for blaTEM, blaSHV,
blaCTX-M, blaOXA-48, and blaVEB followed by sequencing. Isolates
belonging to the same species were compared by pulsed-ﬁeld gel
electrophoresis. Transferability of b-lactamase genes were studied by
conjugation experiments using an azide-resistant E. coli J53 as the
recipient.
Results: All the carbapenem resistant strains isolated produced OXA-
48, a class D oxacillinase with signiﬁcant carbapenem-hydrolyzing
activity. Many of the strains coproduced various b-lactamases (SHV-
12, CTX-M-15 and TEM-1). Conjugation experiments were successful
with K. pneumoniae isolates and all the transconjugants had decreased
susceptibility to carbapenems. Isolates of the same species belonged to
different pulsotypes.
Conclusion: The present work indicated that dissemination of the
blaOXA-48 gene is not driven by the dissemination of a single
clone but by dissemination of the blaOXA-48-carrying plasmid among
Enterobacteriaceae during the last decade in our hospital. Since OXA-
48 confers by itself a low level of resistance to carbapenems, clinical
laboratory detection of OXA-48-producing strains may be difﬁcult and
the problem may actually be much bigger than it seems.
R2357 Are ready-to-eat salads an important vehicle of pathogenic
and commensal bacteria resistant to antibiotics?
J. Campos, L. Peixe, J. Moura˜o, J. Pires, A. Silva, C. Costa, H. Nunes,
N. Pestana, C. Novais, P. Antunes* (Porto, PT)
Objectives: The increase demand for fresh fruits and vegetables is
causing an expansion of the market share for minimally processed
vegetables along with recognized food safety problems. We analyzed
the microbiological quality of Portuguese ready-to-eat salads (RTS) and
their role in the spread of bacteria carrying antibiotic resistance (ABR)
genes.
Methods: RTS (n = 50; 7 brands; split or mixed leaves, carrot, cornmeal)
were collected in 5 of the main supermarkets (2010). The evaluation
of microbiological load and quality followed the international standard
methods for counting aerobic mesophilic, coliforms, Enterococcus sp
and detection of Salmonella sp or Listeria monocytogenes. Samples were
also plated in different culture media with/without AB before and after a
pre-enrichment step. ABR was studied by agar diffusion method (CLSI)
and ESBL expression by double disk synergy test (DDST). Species were
identiﬁed by PCR (Gram positive), API ID32GN or 16rRNA (Gram
negative). ABR genes, integron types and E. coli phylogenetic groups
were searched by PCR and clonality by MLST in speciﬁc isolates.
Results: A high number of RTS presented poor microbiological quality
(86% for aerobic mesophilic, 74%-coliforms, 4%-E. coli), but no
pathogens. Different ABR phenotypes and genotypes were seen to
both Gram positive and Gram negative bacteria. E. coli detected in 13
samples (n = 26; phylogenetic groups A-7, B1−10, B2−1, D-8) presented
resistance (%) to tetracycline (73; tetA and/or tetB), streptomycin (50;
aadA), sulfametoxazole (46; sul1 and/or sul2), trimethoprim (46; dfrA1
or dfrA12), ampicillin (46; blaTEM), nalidixic acid (27), ciproﬂoxacin
(8) or chloramphenicol (4). Two integron types (dfrA1 + aadA, dfrA12 +
aadA) were detected in 11 isolates. Multidrug resistant E. coli (n = 2; D)
belonged to the widespread ST69; the fumC alleles of other E. coli were
highly diverse and identiﬁed as 8, 48, 65 and 100. DDST gave a positive
test for 2 Raoultella sp (2 samples) carrying an ESBL identiﬁed as
SHV2. Among enterococci (n = 108) ABR (%) was seen for tetracyclines
(6; tetM and/or tetL), erythromycin (3; ermB), nitrofurantoin (1) or
ciproﬂoxacin (1).
Conclusions: The present study positions RTS within the spectrum
of ecological niches that may be reservoirs/vehicles for ABR bacteria/
genes with clinical interest (e.g. E. coli-B2 or ST69; ESBL) being these
ﬁndings worthy of attention as their spread to humans by ingestion
cannot be dismissed.
R2358 Plasmid diversity among vancomycin-resistant and
vancomycin-susceptible Enterococcus spp. (1991–2010)
M. Lo´pez*, A.P. Tedim, F. Baquero, C. Torres, T.M. Coque (Logron˜o,
Madrid, ES)
Objectives: Mobile genetic elements (MGE) of E. faecalis and
E. faecium have been recently analyzed in detail, but little is know
about MGE in other enterococcal species. The aim of the study was
to search the plasmid diversity among unfrequent enterococcal species
of Enterococcus recovered from different hosts in Spain for a 20 year
period.
Methods: We studied 31 Enterococcus spp isolates recovered from
hospitalized and healthy humans, animals and waste water (1996–2010).
They included 17 E. durans (10 VSE, 7 vanA), 5 E. hirae (4 vanA and
1 vanB2), 7 E. avium (7 VSE), 2 E. casseliﬂavus (2 vanC)), Typing of
van-Tns was performed by PCR based assays. Plasmid characterization
included determination of size and content (S1-PFGE), and identiﬁcation
of relaxases (rel), rep initiation proteins (rep), or toxin-antitoxin systems
(TA) by using PCR-typing methods, hybridization and sequencing.
Results: Isolates contained 1−3 plasmids/cell ranging from 25kb to
250kb. They belong to different families of: i) RCR (32% pEF1071, 6%
pEFNP1), ii) small tetha replicating (6% reppCIZ, <5% reppEF418),
Inc18 (48% reppRE25, 29% reppVEF, 10% repInc18) RepA_N (26%
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reppAD1, <5% reppRUM, 48% reppLG1), and pHTb-like (10%).
Relaxases from plasmids pAD1, pLG1 and pRUM plasmids were rare
(all <5%). TA systems w-e-z (52%), Axe-Txe (32%) and parpAD1
(16%) were detected. pUSA02, pAD1 and pLG1 were mostly detected
among E. durans and E. hirae. pEF1071 pRE25, and pAD1 were
predominant among vancomycin resistant isolates. All but one vanA
isolates harboured the complete Tn1546 backbone. One E. hirae strain
contained a Tn1546 truncated by a IS19-like insertion within vanX-vanY.
Conclusions: These data constitute the ﬁrst report of MGE in Enterococ-
cus spp. and demonstrates the presence of plasmids widely disseminated
among E. faecium and E. faecalis among these species. Differences
among species might mirror ecological background. Enrichment of
certain plasmid groups among VRE suggests acquisition from an
external source.
R2359 Molecular characterisation of Enterococcus faecalis
plasmids from clinical isolates in Spain, 2001–2009
A.P. Tedim*, A.C. Miranda, P. Ruiz-Garbajosa, A.R. Freitas,
M.V. Francia, F. Baquero, T.M. Coque (Madrid, ES; Oporto, PT;
Santander, ES)
Objectives: The population structure of Enterococcus faecalis (Efc)
causing nosocomial infections is comprised of few clonal complexes
as CC2, CC9 and CC87. Although resistance to ﬁrst line antibiotics
(aminoglycosides, macrolides, glycopeptides) is associated with either
Tn and/or plasmids, little is known about the plasmid diversity among
Efc. The aim of this study was to evaluate the plasmid content of Efc
isolates from our institution in 2001 and 2009, situated in an area with
low prevalence of enterococci resistant to glycopeptides and high levels
of aminoglycosides.
Methods: We studied 68 Efc clinical isolates from infected and
colonized patients (37 blood, 28 faecal, 3 wounds) recovered in 2001
and 2009. They are representative isolates of invasive and non-invasive
strains from our hospital during both periods. Antibiotic susceptibility
was determined by CLSI microdilution. Clonality was established by
SmaI-PFGE and MLST. Plasmid characterization included determination
of size and content (S1-PFGE), and identiﬁcation of relaxases (rel),
rep initiation proteins (rep) and toxin-antitoxin systems (TA) by PCR,
sequencing and hybridization.
Results: Efc strains studied were classiﬁed in 47 PFGE-types and
38 STs which clustered into CC9 (n = 11, 16%), CC2 (n = 10, 15%),
CC16 (n = 9, 13%), CC25 (n = 5, 7%) and CC21 (n = 4, 6%). They were
highly resistant to erythromycin (72%), tetracycline (59%), streptomycin
(47%), gentamicin (37%), ciproﬂoxacin (35%) and chloramphenicol
(18%). All were susceptible to glycopeptides. Plasmid content of Efc
isolates was variable (1−3/cell; 20–100 kb), those ranging from 40 to
60 kb being predominant. They belong to different plasmid families: i)
RCR/thetha (15% reppS86/pAMa1; 21% relpS86/pAMa1); ii) repA_N
(62% reppAD1, 10% reppAM373, 62% relpAD1, 32% relpCF10,
10% par) iii) Inc18 (18% repInc18, 22% reppRE25, 19% relpRE25,
<5% relpEF1). Modules from small theta replicating plasmids (pCIZ2,
pEF418 and pEF1071) were rarely found (<5%). Similar rep and rel
content was observed among isolates for each CC. Mosaic plasmids
containing rep and/or rel from different families were identiﬁed.
Conclusions: Most Efc isolates harboured mosaic plasmids associated
with the repA_N family. The inﬂuence of particular plasmids or plasmid
modules in the success of major Efc lineages and in the distribution of
antibiotic resistance genes among different clonal lineages of the same
or different enterococcal species remains to be established.
In vitro antibacterial susceptibility and drug
interaction studies
R2360 In vitro fosfomycin activity against extended-spectrum
b-lactamase producing Escherichia coli related urinary
tract infections
T. Demir*, M. Turan, T. Bu¨yu¨kgu¨c¸lu¨ (Kirsehir, Karabuk, TR)
Objectives: Extended spectrum b-lactamase (ESBL) producing E. coli
disseminated worldwide as an important cause of both nosocomial and
community-acquired urinary tract infections (UTI). Increasing resistance
rates to antimicrobials among these isolates limit the choice of treatment.
The aim of this study was to evaluate invitro activity of fosfomycin in
ESBL-producing E. coli isolates recovered from UTI.
Methods: Between November 2008-December 2010, 169 E. coli strains
(115 outpatient, 54 inpatient; 47 male, 122 female; ranging 1−93
years) isolated from UTI were included in the study. Susceptibilities to
fosfomycin (FF), amoxicillin-clavulanic acid (AMC), gentamicin (CN),
amikacin (AK), piperacillin-tazobactam (TPZ), ciproﬂoxacillin (CIP),
trimethoprim-sulphametoxasole (SXT), imipenem (IMP), ertapenem
(ERT) and meropenem (MEM) were analysed using Kirby Bauer disk
diffusion method according to CLSI. Double disk synergy test and
combined disk diffusion tests with ceftazidime-clavulanic acid and
cefotaxime-clavulanic acid were used to determine ESBL production.
Two different periods were analysed for ESBL positivity and fosfomycin
resistance: from November 2008-December 2009 and January-December
2010.
Results: The rates of ESBL producing strains isolated from inpatients
and outpatients were 68% v 32%, respectively. Among these isolates, the
resistance rate to fosfomycin was 3.0% (n = 5), and two (1.2%) isolates
showed intermediate susceptibility. Nosocomial isolates displayed higher
resistance rates for fosfomycin than community strains (7.4% v 2.6%,
OR= 2.987; 95%CI = 0.64–13.84; p = 0.144). The prevalence of
fosfomycin resistance rate among ESBL-producing E. coli increased
from 1.4% in the ﬁrst study period to 6.1% 2010 (p = 0.241).
Additionally, ESBL-producing E. coli infections in community increased
from 40.9% to 59.1% in 2010.
Conclusion: In the present study high susceptibility rates to fosfomycin
was observed for ESBL producing E. coli strains suggesting that it
may be a good alternative for the treatment of community acquired
and nosocomial UTI related with ESBL producing E. coli. Additionally,
SXT and ciproﬂoxacin resistance is in an alarming position among ESBL
producing isolates.
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R2361 Use of ampicillin to predict susceptibility of ampicillin-
susceptible but penicillin-resistant isolates of Enterococcus
faecalis to other b-lactam antibiotics
C. Barata*, N. Conceic¸a˜o, L. Souza, L. Silva, R. Molina, A. Oliveira
(Uberaba, BR)
Enterococcus resistance to b-lactam antibiotics is a serious problem
because it prevents bactericidal synergism obtained by association
of these drugs with aminoglycosides. Currently, CLSI (Clinical and
Laboratory Standards Institute) recommends that susceptibility to
penicillin or ampicillin can predict susceptibility to amoxicillin,
imipenem and piperacillin, but susceptibility to ampicillin should not
be used to predict susceptibility to penicillin. Therefore, the aim of
the present study was to determine the resistance proﬁle of isolates
ampicillin-susceptible, penicillin-resistant of E. faecalis to amoxicillin,
imipenem and piperacillin. The resistance proﬁle was determined by
Etest (AB Biodisk, Sweden) and by disk diffusion and broth dilution
methods, according to CLSI guidelines. A total of 59 E. faecalis isolates
recovered from different clinical specimens of hospitalized patients were
included in this study. All of them were susceptible to ampicillin and
resistant to penicillin according to the results obtained by disk diffusion
method using Oxoid disks. Ampicillin susceptibility was conﬁrmed
for all isolates by using Etest and broth dilution test, while penicillin
resistance was conﬁrmed for 44 (74.6%) and 36 (61.0%) of the 59
isolates according the results obtained by those two tests, respectively.
Regarding to the other b-lactam antibiotics, 3 (5.1%) isolates were
resistant to amoxicillin, 32 (54.2%) to imipenem and 37 (62.7%) to
piperacillin by disk diffusion test. Using broth dilution test, there were
no E. faecalis isolate resistant to amoxicillin, while 10 (16.9%) isolates
were resistant to imipenem and 55 (93.2%) to piperacillin. In conclusion,
we demonstrated that the in vitro results obtained for ampicillin by
broth dilution test might accurately predict the in vitro susceptibility of
amoxicillin. Differently, the results obtained for ampicillin using either
disk diffusion or broth dilution tests were not concordant with that
for piperacillin and imipenem. Therefore, our results suggest that it is
necessary to reevaluate the use of ampicillin results to predict the in
vitro susceptibility to piperacillin and imipenem.
R2362 Evaluation of daptomycin activity in Staphylococcus aureus
isolates with decreased susceptibility to vancomycin
S. Ferreira*, A. Paradela, R. Diaz, S. Rocha, E. Ramalheira (Aveiro, PT)
Objectives: Daptomycin belongs to a new class of antibiotics and is
approved for use in the treatment of complicated skin and soft-tissue
infections (SSTI) caused by Gram-positive bacteria. Staphylococcus
aureus is the most common Gram-positive microorganism isolated from
patients with these infections. The aim of this work was to evaluate
the activity of daptomycin in Staphylococcus aureus isolates with a
vancomycin MIC of 1mgmL.
Methods: During a two months period, thirty S. aureus with a
vancomycin MIC of 1mgmL were collected in the Hospital Infante
D. Pedro EPE and included in this study. The strains were collected
from SSTI, bloodstream and urinary tract infections. The isolates were
identiﬁed by the Vitek 2 system (CLSI guidelines) and Advanced
Expert System (VITEK 2 AES) (BioMe´rieux, Marcy L’Etoile, France).
Vancomycin MIC was determined by the automated method and
conﬁrmed by Etest strips (AB Biodisk). Daptomycin Etest strips
were used according to the manufacturer’s instructions to determine
daptomycin MIC.
Results: Among the thirty S. aureus isolates collected, twenty-two
(73%) exhibited a metacillin resistant phenotype and eight (27%)
were found to be metacillin sensitive. Most of the isolates were
collected from bloodstream infections, followed by SSTI and urinary
tract infections. Twelve isolates (40%) exhibited a MIC higher than
1mgmL to daptomycin. The higher MIC obtained had a value of 3mgmL
and the lowest a value of 0.125 mgmL.
Conclusions: Daptomycin is not yet in use in the Portuguese hospitals,
however and despite breakpoints for resistant phenotype are not
established, this work shows that daptomycin can be an alternative
to vancomycin, as therapeutic option for the treatment of S. aureus
infections. Moreover, the decreased susceptibility to vancomycin
exhibited by the metacillin sensitive isolates requires surveillance.
R2363 In vitro activity of tigecycline and colistin against
multi-drug-resistant Acinetobacter baumannii
S. Aljohani*, A. Al Othman, F. Al Dughaishim (Riyadh, SA)
Objectives: Tigecycline (TIG) is a member of the glycylcycline class
of antibiotics with a broad spectrum of activity which includes several
Gram-positive and Gram-negative bacteria. Colistin (polymyxin E) is a
polymyxin antibiotic produced by certain strains of Bacillus polymyxa
var. colistinus. Also, Colistin is a mixture of cyclic polypeptides colistin
A and B. Colistin is effective against most Gram-negative bacilli
and is used as a polypeptide antibiotic. It is one of the last resort
antibiotics for multidrug resistant pathogens Pseudomonas aeruginosa,
and Acinetobacter.
In this study we evaluate the in-vitro activity of TIG against Multidrug
resistant Acinetobacter spp.
Methods: A total of 506 carbapenem resistant isolates of Acinetobacter
spp isolated in our centre were studied Isolates were recovered from
blood cultures, body ﬂuids, catheters tips, pus, bronchial secretions and
urine samples in a two year period, from January 2009 till November
2010. The identiﬁcation and susceptibility testing was performed via the
MicroScan Walkaway (Siemens). The TIG and Colistin susceptibility
testing performed using Etest strips (AB Biodisc, Sweden) according
to CLSI guidelines. The EUCAST Enterobacteriaceae breakpoints were
used to interpret Tigecycline and colistin MIC results for A. baumannii.
Results: Of the 506 isolates, 420 isolates exhibit an MIC less the 4mg/L
(Susceptible range) which represent 83.00%. There are 86 resistant
isolates (16.99%). Of the resistant strains; there were 8 samples exhibit
very high level of resistance MIC 256mg/L, and 12 isolates has MIC
equal to 4mg/L and the rest fall between 6mg/L and 24mg/L. In our
study, all these isolates have susceptibility to amikacin at 21%, to
cefepime at 0.6%, to imipenem 2.00% and to colistin 98.00%.
Conclusion: Tigecycline maintains potent in vitro activity against highly
resistant Acinetobacter spp. As for A. baumannii, there is a decreased
susceptibility but it may be an alternative treatment option when other
agents are excluded due to multidrug resistance. Due to the possibility
of gaining resistance, it is essential for a hospital to remain aware of the
susceptibility patterns of this new agent.
R2364 Effect of carbon dioxide on susceptibility testing of
serogroup 19A Streptococcus pneumoniae
J.P. Bruin*, B.M. Diederen, E.P. IJzerman, J.W. Mouton (Haarlem,
Nijmegen, NL)
Objectives: Routine use of susceptibility testing with disk diffusion and
E-tests for detecting antibiotic resistance is essential for the treatment
of pneumococcal infections. For 19 A Streptococcus pneumoniae there
is an ongoing concern because increasing numbers of strains within
this serotype exhibit high-level resistance to multiple drug classes. We
investigated the effect of incubation under ambient atmosphere and the
effect of carbon dioxide against 4 antimicrobials by using the E-test and
disk diffusion test.
Methods: MICs and zone diameter of 50 serogroup 19A Streptococcus
pneumoniae were determined against the antimicrobials erythromycin,
azithromycin, clarithromycin and clindamycin. E-tests and disk diffusion
tests were performed on two different media incubated at ambient
atmosphere and 5% CO2 at 35ºC. Interpretation of susceptibility were
determined according the guidelines recommended by the CLSI and
EUCAST. The MICs and zone diameter were read after 1 day of
incubation at 35.
S706 21st ECCMID/27th ICC, Abstracts accepted for publication only
Results: Elevated MICs and smaller zone diameters were noted
for the two different methods (CLSI and EUCAST) and all the
tested antimicrobials in the presence of CO2. Geometric mean MIC
values generated by CLSI method increased in CO2 by 1.85, 3.84,
1.98 and 1.78, and by EUCAST method 1.83, 3.39, 1.94 and 1.62
log2 dilutions for erythromycin, azithromycin, clarithromycin and
clindamycin, respectively; the noted differences in smaller diameter
zones (mm) were by CLSI method is 3.4, 7.1, 4.2 and 5.7 and by
EUCAST method 4.8, 8.4, 5.0 and 6.3.
Conclusion: Incubation conditions have an effect on the MIC and disk
diffusion results for Streptococcus pneumoniae serogroups 19A. We can
expect that incubation conditions are also of inﬂuence for Streptococcus
pneumoniae serogroups other than 19A. Further investigation is needed.
R2365 In vitro susceptibility of ceftobiprole, vancomycin and
fosfomycin against recent clinical bloodstream isolates of
methicillin-resistant Staphylococcus aureus in the General
Hospital of Vienna
C. Kratzer*, C. Dungl, S. Tobudic, K. Karaca, N. Kreischitz,
W. Graninger (Vienna, AT)
Objectives: Since 1961 methicillin-resistant Staphylococcus aureus
(MRSA) has spread worldwide and has become a leading cause of
nosocomial infections. The aim of the present study was to evaluate the in
vitro susceptibility of recent MRSA-isolates against the ﬁfth generation
cephalosporin ceftobiprole compared to the standard anti-MRSA agents
vancomycin and fosfomycin.
Methods: We tested 103 recent clinical MRSA strains, isolated from
the blood of septic patients hospitalized to the General Hospital of
Vienna. A single isolate per patient was accepted. Minimal inhibitory
concentrations (MICs) of ceftobiprole, vancomycin and fosfomycin were
determined using broth microdilution method according to the guidelines
of the Clinical Laboratory Standard Institutes (CLSI).
Results: The MIC50 and MIC90 values for MRSA were 2mg/ml and
4mg/ml for ceftobiprole, 1mg/ml and 2mg/ml for vancomycin, 4mg/ml
and 16mg/ml for fosfomycin, respectively. According to the breakpoints
established by CLSI and EUCAST, a single isolate was resistant to
ceftobiprole, another isolate was resistant to vancomycin, whereas seven
isolates showed in vitro resistance to fosfomycin.
Conclusions: Ceftobiprole and vancomycin demonstrated potent in vitro
activity against MRSA blood-stream isolates with 99% susceptibility
compared to less activity of fosfomycin with a MRSA resistance rate of
6.9%.
R2366 Prospective study of antimicrobial resistance of
H. inﬂuenzae in Russia: trends in 2010
R. Kozlov*, O. Sivaya, N. Ivanchik, I. Otvagin for the PEHASus project
group
Objectives: To estimate antimicrobial resistance of Haemophilus
inﬂuenzae in different regions of Russia from 2003 to 2010.
Methods: This study was conducted in Central, Volga, Urals, Siberia
regions of Russia from 2003 to 2010. Identiﬁcation of the strains was
done on the basis of colony morphology on chocolate agar, Gram stain,
bacitracin resistance (10 IU). Susceptibility to 11 antimicrobials was
performed according to CLSI with usage Haemophilus Test Medium
broth prepared on the basis of cation-adjusted Mueller-Hinton broth with
13ml of the hematin stock solution, 5 g of yeast extract and 3ml of a
nicotinamide adenine dinucleotide (NAD) stock solution (50mg of NAD
dissolved in 10ml of distilled water, ﬁlter sterilized). Microtiter plates
were incubated for 24 h at 35ºC and 5% CO2. Breakpoints were those
of Clinical and Laboratory Standards Institute (CLSI 2010).
Results: A total of 691 of non-duplicated clinical H. inﬂuenzae were
included to the study for 2003–2010. Respiratory samples (sputum, BAL,
sinus aspirate, middle ear and pleural ﬂuid) were the the main sources
of strains − 87.3% in 2003–2005 and 90.7% in 2006–2010.
The susceptibility testing results are presented in the Table.
Conclusions: Thus b-lactams (amoxicillin, amoxicillin/clavulanic acid,
ceftibuten, ceftriaxone), azithromycin, clarithromycin, respiratory ﬂuo-
roquinolones retain their high in vitro activity against haemophili, thus
continue to serve as the ﬁrst line of choice for treatment of infections
caused by H. inﬂuenzae in Russia.
R2367 In vitro activity of tigecycline against methicillin-resistant
Staphylococcus aureus, vancomycin resistant Enterococcus
faecalis and extended-spectrum b-lactamases producing
Klebsiella pneumoniae
N. Skarmoutsou*, D. Dimitriadi, M. Kehagia, K. Stamoulos,
M. Drivala, M. Martsoukou, E.M. Fakiri (Athens, GR)
Objectives: Tigecycline is a newly introduced glycylcycline with a
broad spectrum activity against both Gram (+) and Gram (−) bacteria
and anaerobes as well, that gained approval initially for treatment of
complicated skin, soft tissue and intra-abdominal infections and latest
for community acquired pneumonia. The objective of the present study
was to investigate the in vitro activity of tigecycline against a range of
resistant clinical isolates included MRSA, VRE and K. pneumoniae.
Methods: A total of 250 different clinical isolates were tested. The
isolates included 50 MRSA strains, 50 VRE and 150 K. pneumoniae
strains, of which 30 produced ESBL, 45 ESBL and KPC, 35 ESBL
and MBL, 28 MBL, 8 KPC and 4 ampC b-lactamases. All strains were
recovered from blood stream infections, skin and skin structure infections
and community acquired lower respiratory tract infections, from patients
treated in ICU (64%), Internal Medical Wards (28%) and Surgical Wards
(8%) in a general hospital the last two years. Species identiﬁcation
and initially susceptibility testing of the isolates was performed using
the Wider system (Soria), while phenotypic detection of the production
of extended spectrum b-lactamases ESBL, ampC-b-lactamases, metallo-
b-lactamases MBL and carbapenemases KPC, was performed by the
double disk synergy test, the combined disk test, the two-sided E-test
and the modiﬁed Hodge Test on M. H. agar. Tigecycline susceptibility
was determined using the E-test method following the manufacturer’s
guigelines (bioMerieux, Sweden). Sensitivity and resistance breakpoints
for tigecycline were determined according to FDA guidelines. S. aureus
ATCC29213, E. faecalis ATCC29212 and E. coli ATCC 25922 were
used as QC.
Results: Tigecycline MICs (mg/L) ranged from: 0.032−0.5 (MRSA),
0.032–0.25 (VRE), 0.38−12 (ESBL K. pneumoniae), 0.75−6 (ESBL+
KPC K. pneumoniae), 0.38−8 (ESBL+MBL K. pneumoniae), 0.5−8
(MBL K. pneumoniae), 0.75−8 (KPC K. pneumoniae) and 0.5−6
(ampC K. pneumoniae). MICs 50/MICs 90 were respectively 0.094/0.25,
0.064/0.125, 1.0/6.0, 1.5/4.0, 1.0/6.0, 1.5/6.0, 1.5/4.0 and 1.0/6.0.
Conclusions: The in vitro activity of tigecycline, according to the
current breakpoints established by FDA, was considered active against all
MRSA and VRE isolates. Furthermore it seems to provide a promising
alternative choice for treatment of infections caused by several extended
spectrum b-lactamases producing K. pneumoniae, as its sensitivity ranges
overall between 70−85%.
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R2368 In vitro activity of doripenem against imipenem and/or
meropenem non-susceptible isolates of Pseudomonas
aeruginosa from a university hospital, Bangkok, Thailand
T. Chadlane*, P. Santanirand (Bangkok, TH)
Objective: Pseudomonas aeruginosa is an important causative agent
of nosocomial infections. Treatment of hospital acquired P. aeruginosa
infection has become more difﬁcult and complicated and usually
required broad spectrum antibiotics such as carbapenem. Currently,
the carbapenem resistant strains of P. aeruginosa are more recognized
among hospital-acquired isolates. This has limited the choice of effective
antibiotics. The objective of the study was to evaluate the in vitro
activity of doripenem, a new anti-pseudomonal carbapenem against the
imipenem and/or meropenem non-susceptible P. aeruginosa.
Method: A total of 171 clinically isolated P. aeruginosa which showed
non-susceptible to either IPM or MEM were tested against doripenem.
The MICs of imipenem, meropenem and doripenem were determined by
broth microdilution using THANF customized panel (Trek, UK). The full
range MIC of doripenem was tested with E-test method.
Results: The organisms were divided into groups according to the results
of imipenem and meropenem as susceptible (S), intermediate (I) or
resistant (R). The MIC50 and MIC90 of each group were compared. The
overall MIC ranged from 1 to >32mgml. The double resistant isolates
(n = 59) revealed the MIC50 and MIC90 of doripenem at >32mgml.
In contrast, isolates with a combination of one resistance and one
intermediate (n = 51) showed the MIC90 of doripenem at 4mgml and
the majority (82.35%) of these isolates had the MIC at the same point
as MIC90. Although the imipenem susceptible and the meropenem
susceptible groups revealed the similar MIC90 at 4mgml, the meropenem
susceptible group tended to have lower doripenem MIC50 (2mgml).
This occurred in both imipenem susceptible and intermediate groups.
The MICs of all isolates from double intermediate and the imipenem
susceptible groups were at 4mgml.
Conclusion: The above data of doripenem has showed that this
new carbapenem could be an alternative choice for the treatment of
imipenem/meropenem non-susceptible P. aeruginosa infectiom.
R2369 In vitro efﬁcacy of tigecycline, minocycline and colistin
against multidrug-resistant Acinetobacter baumannii
A. Hassan*, J. Usman, F. Kaleem, M. Omair, A. Khalid (Rawalpindi, PK)
Introduction: Acinetobacter baumannii has now got itself established
as a very common and difﬁcult to treat nosocomial pathogen. Its ability
to develop resistance against the major groups of antibiotics limits
therapeutic options. Very few antibiotics can be reliably used against
this resistant organism.
Objective: We have conducted this study to ﬁnd out the efﬁcacy of
tigecycline, minocycline and colistin against MDR A. baumannii
Materials and Method: The study was carried out at the Department
of Microbiology, Army Medical College/National University of Sciences
and Technology, looking after an 1100 bedded tertiary care hospital.
Routine clinical specimens were received from various wards. A. bau-
mannii was identiﬁed using standard microbiological procedures. MDR
was deﬁned as isolates simultaneously resistant to aminoglycosides,
carbapenems and ﬂuoroquinolones Minimum inhibitory concentration
was performed by using E-strips (AB-Biodisk) of colistin, minocycline
and tigecycline for each isolate. Results were interpreted by using SPSS
version 17.0.
Result: A total of 100 MDR A. baumannii were tested. Colistin found
out to be the most effective among the three antibiotics tested. All
the isolates were susceptible to colistin. Minocycline was better in
activity than tigecycline against MDR A. baumannii. 94% isolates were
susceptible to minocycline and 80% were susceptible to tigecyclien.
Conclusion: Colistin and minocycline, cost effective antibiotics, can
be reliably suggested against infections caused by MDR A. baumannii.
Emerging resistance against Tigecycline and its high cost hinders its use
as ﬁrst choice.
New antimicrobials
R2370 A preliminary quantitative assessment of anti-Helicobacter
pylori activity of xanthone derivatives
E. Karczewska*, K. Klesiewicz, N. Szkaradek, A. Gunia, H. Marona,
A. Budak (Krakow, PL)
Objectives: The aim of the study was to determine anti-H. pylori activity
of a series of 14 xanthone derivatives. They were substituted in different
position in xanthone structure i.e. 2, 3, 4 and 6, 2 and 6 or 2 and 7.
They possessed among other piperazine, pyridine, aminoalkanol, allyl,
methylamine, ethylamine, alkoxy, fenoxy or carbamyl moiety, some of
them had also chlorine atom(s) in their structure.
Methods: Disc diffusion procedure (Kirby-Bauer method) was used for
primary screening of susceptibility H. pylori clinical strain isolated from
a patient and ATCC 43504 H. pylori strain to the xanthone derivatives
(in concentration 10mg/ml).
In addition compounds giving an inhibition zone ranged from 11mm to
45mm in diameter were chosen to quantitative assay to establish the
lowest concentration that inhibits growth of the H. pylori strain (MIC).
Bacterial suspension of H. pylori was adjusted to yeld approximately
1.0×108 CFU/ml and plated on Mueller Hinton agar with 5% horse
blood and NAD plates (Oxoid). A stock solution (10mg/ml) of each
substance was appropriately diluted in DMSO to obtain the required
concentrations of 1mg/ml, 200mgml, 100mgml and 50mgml. Filter paper
discs were placed on the inoculated agar surfaces and impregnated with
10 ul of each sample solution. Antibacterial activity was expressed as
the mean of inhibition diameters (mm) produced by the substances. The
lowest concentration required for growth inhibition of H. pylori strain
was regarded as MIC.
Result: The results were very similar for two examined strains. Most
of the tested compounds were active against both. H. pylori strains at
the concentration of 10mg/ml (stock solution). Two substances exhibited
more than 40mm wide grown inhibition zone, 1 − 39mm, 2 − from 29
to 30mm, 7 − from 12 to 20,5mm. 2 of the presented substances were
classiﬁed as nonactive.
MIC of the xanthones ranged from 10mg/ml to 50mgml. Most potent
activity with MIC value of 50mgml was characteristic for 3 compounds.
Conclusion: Performed research on anti-H. pylori activity of the series of
xanthone derivatives, it could be stated that: chlorine atom as well as allyl
moiety are favorable, substitution in the xanthone structure in position 2
is more favorable than in position 3 and 4 and carbonyl group in a side
chain is responsible for the partial loss of activity. Further studies will
be necessary to investigate the effect of these active compounds.
Epidemiology of MRSA, VRE and other
Gram-positives
R2371 Changing molecular epidemiology of vancomycin-resistant
enterococci in a Chinese hospital between 2003 and 2009
Y.M. Liu*, B. Cao, L. Gu, H. Wang (Beijing, CN)
Objective: To investigate the molecular epidemiology of vancomycin
resistant enterococci (VRE) in our hospital.
Methods: We examined a total of 98 clinical VRE isolates cultured
from patients admitted to Beijing Chao-Yang hospital from June 2003
to December 2009. Minimal inhibitory concentrations (MICs) were
determined by the agar dilution method. The vancomycin-resistant genes
including vanA, vanB were ampliﬁed by multiplex PCR. Isolates were
characterized by pulsed ﬁeld gel electrophoresis (PFGE) and multilocus
sequence typing (MLST). The vanA gene cluster and the distribution of
the virulence markers were investigated using PCR.
Results: Of the 98 VRE, there were 81 E. faecium and 17 E. faecalis.
Ampliﬁcation of vanA and vanB showed that the vanA gene was
exclusive to E. faecium isolates while vanB gene was unique to
E. faecalis isolates. Our results indicate that single clone of E. faecalis
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(VREfs) is responsible for the vancomycin-resistance from 2003 to
2007. All 17 VREfs were genotyped as ST4. After 2007, VREfs was
completely replaced by VREfm which has since been the predominant
species in our hospital. Vancomycin-resistant E. faecium (VREfm)
were found to have a polyclonal distribution and thus appear to have
originated from several different sources (Fig. 1). VREfm isolates were
heterogeneous in their vanA cluster types and in the presence of virulence
genes. All VREfm isolates were ampicillin- and levoﬂoxacin-resistant,
and the majority (88.9%) of VREfm possessed the esp gene. MLST
revealed ﬁve novel STs and one new allele in VREfm. We observed
incongruence between genotype and phenotype in 21% of VREfm
isolates.
Conclusion: Our ﬁndings indicate that the dissemination of the vanA-
containing VREfm isolates might be due to either clonal dissemination or
horizontal transfer of a resistance gene cluster, but the dissemination of
the vanB-containing VREfs isolates support clonal dissemination. VRE
appears to be in an evolutionary ﬂux in our hospital.
R2372 Detection of Panton-Valentine leukocidin by real-time
polymerase chain reaction in methicillin-resistant
Staphylococcus aureus producers isolated in clinical samples
B. Castro*, M. Hernandez, Y. Pedroso, M. Ramos, M. Cuervo,
A. Tenorio, M. Lecuona (La Laguna, ES)
Objectives: The aim of this study is to detect by real time
polymerase chain reaction (RT-PCR) the Panton-Valentine leukocidin
(PVL) produced by methicillin resistant Staphylococcus aureus (MRSA)
isolated in clinical samples of patients in a University Hospital.
Methods: During 2008, 416 MRSA were isolated in clinical samples
(56) or nasal swabs of an active surveillance (416) corresponding to
patients joined in our hospital. The identiﬁcation and susceptibility
patterns were performed by VITEK II (BioMerie`ux) and MRSA were
classiﬁed according to our pulse ﬁeld electrophoresis (PFGE) patterns.
RT-PCR for detection of PVL genes was performed in 56 MRSA
isolated in clinical samples using lukS-PV and lukF-PV primers with
iQTMSYBR®Green Supermix (BIORAD) in iQTM5 Real Time PCR
detection system (BIORAD). All these 56 cases of MRSA were classiﬁed
in hospital and community colonization or infection.
Results: In 2008, 56 MRSA were isolated in clinical samples (31 swabs,
10 blood, 7 bronchial aspirates, 3 sputum, 2 catheter, 2 abscess and 1
surgical swab). These isolates produced 20 (35.7%) hospital infections,
17 (30.4%) community infections, 16 (28.6%) hospital colonization, 2
(3.6%) community colonization and 1 (1.8%) contamination. RT-PCR
detected 6 (12%) MRSA PVL producers, 5 (83.4%) were community
infections (1 ST5-MRSA IVA clone, 1 ST22-MRSA-IV, 1 ST36-MRSA-
II, 1 ST8-MRSA-IV and 1 ST88-MRSA-IV clone) and 1 (16.6%)
was a hospital infection (1 ST5-MRSA-IVA clone). Of 5 community
infections 4 (80%) were infections of tissue and soft skin and 1 (20%)
was an infection of surgical site, the hospital infection was a primary
bloodstream infection.
Conclusion: PVL is a cytotoxin that causes leukocyte destruction and
tissue necrosis. In our hospital, a 12% of MRSA isolates in clinical
sample were PVL producers and a high percentage was related with
community infections associated to tissue and soft skin infections as
in others studies but also a low percentage was related with hospital
infections. According to MRSA clones, PVL is usually produced by
community acquired MRSA (CA-MRSA) clones as we found in our
study. RT-PCR is a rapid procedure to detect the presence of PVL MRSA
producers isolated in clinical samples related to community infections.
R2373 Validation of Copan MRSA-B broth for MRSA detection
by culture and by Xpert MRSA/SA/nasal assay
A. Squassina*, E. Privitera, L. Conter, R. Botrugno, S. Castriciano
(Brescia, IT)
Objectives: Enrichment broths are increasing the sensitivity of detecting
MRSA when screening colonized patients prior hospital admission or to
critical care wards. Copan produced a new Liquid Base Microbiology
(LBM) device, the MRSA-B, consists of a 2ml tube of enrichment broth
and can be used for pooling samples for MRSA collected from different
sites from the same patient. The objective of this study is to validated
the Copan MRSA-B for the detection of MRSA and MSSA by culture
and by Xpert MRSA_SA_NASAL assay (XMSN) (Cepheid).
Methods: Simulated samples were prepared by inoculating MRSA-B
tubes with MRSA ATCC (43300) and MSSA ATCC (6538SA) strains
and tested by culture and by XMSN assay. 0.5 McFarland dilution of
MRSA and MSSA strains were prepared from fresh cultures and diluted
to 0.5:104 and 0.5:105 in PBS. 200 ul of each dilution were used to
inoculated 2ml sets of MRSa-B5 tubes and tested at 0 times and after 2,
4 and 6 hours incubation at 350 C. Aliquots of 100ul from each MRSA
and MSSA inoculated tube were plated in Mannitol salt agar after all
incubation times and conditions. Colonies were counted and recorded
after 24 hours plate incubation at 350 C. To enhance the sensitivity of
XMSN assay the 200 ul and the pellets generated from centrifuging
1.0ml and 1.5ml of broth were also tested. Negative vial broths were
also tested. The XMSN assay testing was done as per package insert
procedure.
Results: In the culture results for the ﬁnal dilution of 0.5:105 there were
change in the number of CFU/100 was noted up to 2 hours incubation
with the MRSA and MSSA enrichment broth samples, but 9 and 27 fold
increases after 4 and 6 hours for the MRSA but not for the MSSA. In
the XMSN assay there was an increase in the 200 ul (and 1ml pellet)
by 1.7 (4.4), 7.8 (3.4) and 11.8 (2.6) CT from 0T to 2, 4, and 6 hours
incubation respectively. No MSSA was detected when testing for MRSA.
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The MRSA dilution of 0.5:106 had very few colonies in culture up to
6 hours but the pellet of 1.5ml of the broth after 2, 4, and 6 hours
incubation there was an increase of 1.7, 3.6 and 4.8 in CT. There was
no interference, inhibition or cross-reaction with MSSA in the XMSN
assay.
Conclusions: The Copan MRSA-B enrichment broth increases the
number of MRSA colonies 27 folds and 11 CT in the XMSN assay
after 6 hours incubation. The sensitivity of the XMSN assay is increased
when using the pellet from centrifuging 1.0 or 1.5ml of the MRSA-B
enrichment broth.
R2374 Which role for MRSA screening in the intensive care unit?
P. Stano*, M. Avolio, R. De Rosa, M. Modolo, A. Camporese
(Pordenone, IT)
Objectives: Several recent studies have shown that active surveillance
for Methicillin-resistant Staphylococcus aureus (MRSA) colonization in
ICU (Intensive Care Unit) patients may decrease MRSA transmission
and/or infection, by isolation, decolonisation of positive cases and hand
hygiene programs. A potential role for active MRSA surveillance in
ICU, has been recently proposed, as a guide for antibiotic treatment in
patients suspicious of being infected with MRSA, by using a care bundle
approach.
Methods: From March 2009 through September 2010, a total of 376
patients were screened for MRSA nasal carriage at admittance to ICU.
All nasal swabs were analyzed by molecular test (GeneXpert MRSA,
Cepheid), able to amplify by real-time PCR the target sequence for
MRSA at the SCCmec-orfX junction. The results were available in
the LIS (Laboratory Information System) from specimen receipt in the
laboratory, within the same day.
Results: Of the 376 patients admitted during the study period, 26 (7%)
were colonized with MRSA and 350 were MRSA negative. During the
ICU hospitalization, MRSA infection was more likely to develop in
MRSA carriers (8/26, 30%) compared with non-MRSA carriers (1/350,
0.3%). Our data showed an increased relative risk for developing MRSA
infection in the ﬁrst group compared to the other, therefore a strongly
association between MRSA colonization and subsequent MRSA disease.
Conclusion: Our data suggest that MRSA colonization in ICU patients
is a risk for development of subsequent MRSA infections and that nasal
MRSA screen appears a potential predictor of the infection, conﬁrming
the role of a documented MRSA colonization as a useful determinant
for empirical MRSA antimicrobial coverage in ICU patients, in a care
bundle approach.
R2375 Hospital-associated Methicillin-resistant Staphylococcus
aureus in Germany: epidemic but not really multi-resistant
F. Layer*, C. Cuny, U. Nu¨bel, W. Witte (Wernigerode, DE)
Objectives: As National Reference Centre for Staphylococci we perform
long term molecular typing on representative samples of Methicillin-
resistant Staphylococcus aureus (MRSA) isolates from German hospitals
and thus following the dynamics of emergence and spread of hospital
associated MRSA (HA-MRSA) clones.
Methods: The respective isolates were sent to the Reference Centre for
further characterisation. The antimicrobial susceptibility, the presence
of several resistance and pathogenicity associated genes, the spa- and
multilocus sequence-type were analyzed.
Results: From 1991 to 2000 the incidence of HA-MRSA increased
from ~2% to >20%. During this time clonal lineages (ST247, ST228)
disappeared, and among newly emerging clonal lineages ST225 and
ST22 became particularly prevalent. These strains exhibit a less broad
resistance proﬁle: OXA, ERY, CLI, CIP, MFL (mecA, ermA/ermC,
mutations parC, gyrA).
Resistance to other classes of antibiotics is still not frequent:
(ST22/ST225) DAP 0,2/1,7%; FOS 0/0%; FUS 1,9/0%; GEN 0/4,8%;
LNZ 0/0,5%, MUP 0/0%, RAM 1,7/4,5%; TGC 0/0%; TPL 0/0%;
VAN 0/0%. Of particular interest are isolates exhibiting resistance to
daptomycin and in parallel the GISA phenotype (not observed so far).
MRSA ST225 represent a subpopulation of MRSA CC5 which evolved
from MRSA ST5 in the USA ~20 years ago and became epidemic in
Central European hospitals after 2002 (Nu¨bel et al., PLoS Pathog., 2010).
MRSA ST22, already known as “EMRSA 15” in the UK, became
epidemic in Central Europe after 1996. It presents an epidemic
subpopulation of S. aureus/MRSA ST22 spreading in hospitals. CA-
MRSA ST22 (PVL-positive) represents a separate subpopulation (Kurth
et al., unpublished data).
Obviously there is also an “import” of MRSA known to be epidemic in
other European countries (e.g. ST36, UK; ST239, South-East-Europe;
ST125, Spain). However, these cases are sporadic.
Also infections caused by CA-MRSA ST398 are rare so far (1,68%).
Conclusions: As shown by the results from the EARSS/Seqnet study
particular HA-MRSA clonal lineages are obviously widely disseminated.
However, in certain geographical areas a few lineages predominate. The
reasons for different epidemiology in different environments are not
known so far. The frequent resistance to macrolides/lincosamides and
ﬂuoroquinolones besides all b-lactames reﬂects the consumption volume
of antibiotics in German hospitals. In cases of calculated therapy a
number of options are left.
R2376 Antibiotic resistance proﬁles and molecular epidemiological
characteristics of Staphylococcus aureus isolates in
Changsha, south China
M. Zou*, R. Zhou, X. Fan, F. Hu, W. Liu, W. Wu, X. Li (Hunan,
Shanghai, CN)
Objectives: Increasing prevalence of Staphylococcus aureus, particularly
methicillin-resistant S. aureus (MRSA) has been reported in China.
The aim of the present study is to investigate the drug resistance
characteristic, the genetic background and the molecular epidemiological
characteristic of S. aureus in Changsha, south China.
Methods: Between December 2006 and December 2008, a total of
293 clinical isolates of S. aureus were collected from 11 representative
hospitals in Changsha and then identiﬁed by Vitek-2 system. All the
isolates were veriﬁed as S. aureus and MRSA by PCR ampliﬁcation
of femA and mecA gene respectively. K-B disk method was used to
test drug sensitivity of S. aureus to 23 commonly used antibiotics.
Chromogenic cephalosporin spot test was applied to detect b-lactamase.
Pulsed-ﬁeld gel electrophoresis (PFGE) was performed for genotypic
and homologous analysis of 115 isolates randomly selected from the
original 293 clinical S. aureus isolates.
Results: Among the 293 strains, 273 (93.2%) were b-lactamase test
positive. Resistant rates to penicillin and ampicillin were the highest
(both 96.6%). All the isolates were susceptible to tecoplanin, vancomycin
and linezolid. All the stains exhibited 93 antimicrobial-resistant proﬁles
to the 23 antibiotics tested. The PX1 type included 47 (16.0%) strains
and the PX2 type included 35 (11.9%) strains, which accounted
28.0% (82/293) of all, were the primary epidemic antimicrobial-resistant
proﬁles. 190 (64.8%) were MRSA and 103 (35.2%) were MSSA.
The resistant rates of MRSA to 18 antibiotics were higher than
MSSA (P< 0.05). The MIC range of OXA and FOX was 0.125mg/ml–
>256mg/ml and 2mg/ml–>256mg/ml respectively. Both of their MIC50
and MIC90 were 256mg/ml. Of all the 115 clinical S. aureus isolates,
39 PFGE types were demonstrated. PFGE type A with the incidence of
48.7% (56/115), from 8 hospitals (8/11), was the predominant genotype.
55 (55/56) strains with PFGE type A were MRSA. The next was PFGE
type L with the incidence of 4.3% (5/115). PFGE type A included 13
subtypes from A1 to A13, and the subtype A1 is the predominant type
and epidemic clone with the incidence of 22.6% (26/115).
Conclusion: S. aureus in Changsha is multiple resistant to commonly
used antimicrobial agents and has a high resistant rate to methicillin.
PFGE type A outbreak at clinical isolates of S. aureus occurred in
Changsha and A1 subtype is the predominant epidemic clone.
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R2377 Risk factors for developing reduced vancomycin susceptibil-
ity and methicillin resistance among episodes of Staphylo-
coccus aureus bacteraemia (SAB) in an intensive care unit
R. Zaragoza*, S. Sancho, R. Gonza´lez, C. Lloret, F. Puchades,
A. Artero, J. Camarena, J. Nogueira (Valencia, ES)
Objectives: The aims of this study were to describe the vancomycin
susceptibility levels of Staphylococcus aureus bloodstream infections
(SAB) in critically ill patients, to know the prevalence of methicilin-
resistant episodes (MRSA), to know their prognosis and ﬁnally to deﬁne
clinical risk factors independently associated to the development of RVS
and MR among ICU-SAB.
Methods: From 1995 to 2010, 503 patients with a clinically signiﬁcant
bacteremia were prospectively evaluated in an intensive care unit of
a university hospital, specially SAB. MRSA (oxacilin MIC4mg/ml)
and RVS (MIC >1mg/ml) were deﬁned by E-Test® method. Clinical
and microbiological variables were studied. Several multivariate analysis
were performed to determine clinical risk factors independently
associated to the development of RVS and MR among ICU-SAB.
Results: Ninety (17.8%) of 503 ICU bacteraemias were caused by
SAB and 32.2% of them was MRSA. RVS were detected in 48,8%
of the cases. The global and related mortality rate for SAB was 53.3%
and 18.8%. Global mortality rates were signiﬁcantly higher in MRSA
episodes (68.9% vs 45.9%; p = 0.04). whereas RVS episodes showed
higher related mortality rates (27.2% vs 10.8%; p = 0.04). Age (OR
1.04; CI95% 1.01–1.08; p = 0.01), previous use of corticosteroids (OR
5.23; CI95% 1.08–25.2; p = 0.03), polimicrobial bacteraemia (OR 5.31;
CI95% 1.22–23.1; p = 0.02) were factors independently associated to
RVS episodes whereas the presence of phlebitis (OR 0.12; CI95% 0.02–
0.76; p = 0.02) was a protective factor for these episodes. On the other
hand only the previous use of corticosteroids (OR 4.53; CI95% 1.04–
19.7; p = 0.04) and nosocomial origin (OR 6.71; CI95% 1.34–33.6;
p = 0.02) were independently associated to MR episodes.
Conclusions: 1 in 3 of SAB in ICU was caused by MRSA and almost
half presented RSV. Both MR and RVS episodes were associated to
an increased mortality rates in ICU patients. Age, previous use of
corticosteroids, polimicrobial bacteraemia, and the absence of phlebitis
were identiﬁed as risk factors for developing RVS in ICU-SAB and only
nosocomial origin and previous use of corticosteroids were related to
MR episodes in this study.
R2378 A research for methicillin-resistant Staphylococcus
aureus originated from foods: several methods for the
detection, occurrence, enterotoxigenic characteristics, and
epidemiologic typing method
Z. Salehipour*, M.M. Soltan Dallal, S. Agha Amiri, T. Abedi Mohtasab,
M. Pourmand, T. Zahraei Salehi, A. Rahimi Forushani (Tehran, IR)
Objectives: The purpose of this study was a research for Methicillin-
resistant staphylococcus aureus originated from foods based on pheno
and genotypic methods.
Methods: 93 S. aureus isolates from 913 food samples were investigated
for the detection of methicillin resistance using mecA speciﬁc PCR,
oxacillin agar screen and disk diffusion, penicillin binding protein 2
(PBP2) latex agglutination, b-lactamase production and MIC tests. The
MRSA strains were characterized by the antimicrobial susceptibility,
production of type A-D staphylococcal enterotoxins (SEs) and toxic
shock syndrome toxin1 (TSST1), as well as biotyping and molecular
typing based on the x-region of the protein A (spa) and the coagulase
(coa) genes.
Results: Out of the 93 S. aureus isolates, eight were mecA positive while
phenotypic tests showed a discrepancy in comparison with each other.
The majority of MRSA isolates were PBP producers and Multi-resistant.
All TSST1 producing MRSA were SE producers. Out of the 12 MRSA
isolates, eight were belonged to human biotype; three belonged to NHS
and one to bovine biotype. Ampliﬁcation of polymorphic spa and coa
genes revealed three and ﬁve distinct types, respectively.
Conclusion: Food is an important vector for transmission of antibiotic
resistance to human. Some MRSA isolates recovered from different
sources showed genetic and phenotypic similarity in the patterns
obtained, suggesting that contamination with human origin has been
occurred during food handling.
R2379 High diversity of Panton-Valentine leukocidin-positive
MSSA clones circulating in Italy
A. Sanchini*, M. Monaco, G. Gattuso, M. Tinelli, A. Pantosti (Rome,
Mantova, Lodi, IT)
Objectives: Both MSSA and MRSA PVL-positive strains can cause
serious and recurrent infections in subjects without risk factors living
in the community. In this work we focus the attention on the
characterization of the PVL-positive MSSA strains, responsible for
outbreak and sporadic infections in Italy.
Methods: During the period 2005–2010, twenty-two PVL-positive
MSSA were collected. The isolates have been sent to the National
Laboratory by different Italian hospital laboratories on the basis of the
type and the severity of the infections that appeared typical of PVL-
positive strains.
The presence of nuc (species conﬁrmation), PVL and toxic shock
syndrome toxin 1 (TSST-1) genes were detected by PCR. Molecular
typing techniques such as agr typing, spa typing and Multi-Locus
Sequence typing (MLST) were performed. Clonal Complexes (CCs)
were determined by using eBurst software.
Results: All the isolates were conﬁrmed as PVL-positive MSSA.
Fourteen isolates were from skin and soft tissue infections (SSTIs),
4 from nasal carrier, 2 from necrotizing pneumonia, one each from
an ORL infection, sepsis and osteomielitis. One of these isolates was
the strain responsible for an hospital-community outbreak in 2005.
Molecular typing revealed that isolates belonged to all the four known
agr alleles (from 1 to 4), to 16 different spa type and to 12 different
sequence type (ST). Following eBurst analyses, the related STs were
grouped in CCs except for ST1209 that was a singleton. The isolates
belonged to 9 different genetic lineages. The most common were
CC121/agrIV and CC30/agrIII (6 isolates each). The other lineages
were: CC5/agrII, ST1209/agrIII and CC22/agrI (2 isolates each) and
CC1/agrIII, CC78/agrIII, CC152/agrI and CC8/agrI (1 isolate each).
Three strains were TSST-1 positive: both the ST1209/agrIII strains and
one CC30/agrIII.
Conclusions: This study showed the great variety of the PVL-positive
MSSA clones circulating in Italy, with CC121/agrIV and CC30/agrIII
being the most commons. Differently from other countries, we did not
ﬁnd strains belonging to the common CC80/agrIII clone. A new lineage
was found (ST1209/agrIII) which also was TSST-1 positive. Further
studies should be done to evaluate the circulation and the characteristics
of PVL-positive MSSA since it can cause serious infections similarly to
its counterpart, PVL-positive MRSA.
R2380 Demonstration of the hypervirulent ST17 clone of
Streptococcus agalactiae in Hungary
S. Kardos, M. Fu¨zi, K. Kristo´f, K. Nagy, O. Dobay* (Budapest, HU)
Objectives: Streptococcus agalactiae (Group B streptococcus, GBS) is
well established as a major human pathogen causing serious infections
primarily in neonates but affecting also adults. The screening of pregnant
women for GBS prior to delivery is performed in many European
countries but has not been introduced in Hungary. In addition, no data
on the clonal distribution and virulence of GBS has been reported in
Hungary to date.
Methods: 110 strains of GBS, isolated from pregnant women or
newborns, at the Central Bacteriology Laboratory of Semmelweis
University between 2009–2010, were genetically characterised. The
strains were identiﬁed by routine biochemical tests and by PCR detection
of the GBS speciﬁc dltR gene. The serotypes of the isolates were
determined with the Pastorex latex agglutination test which distinguishes
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types I, II and III, and the genetic relatedness of the strains was
determined by PFGE.
Results: In the examined period, out of all cervical or vaginal exudates,
20.7% proved to be GBS positive. 9.5% of the newborns were colonised
(ears or throat), and only 0.4% had GBS in the blood. The hypervirulent
ST17 clone was detected in 46.2% of GBS+ women and 35.6% of GBS+
newborns. Generally, serotype III was most prevalent (56%), type I was
isolated in 18% (mostly from the ears of newborns) and type II in only
7%. The vast majority of the ST17 strains (36/58) were also of type III.
The ST17 strains belonged to 4 clearly distinguishable PFGE clones, but
were generally closely related to one another.
Conclusions: Serotype III was shown to be the most prevalent in
neonatal colonisation or asymptomatic carriers also in Hungary. The
ST17 clone of GBS identiﬁed by multi locus sequence typing (MLST) is
recognised as a hypervirulent international clone associated mainly with
invasive neonatal infections. ST17 comprised 46.2% of asymptomatic
carriers among the pregnant women, and could be transmitted to the
newborns at high rates, with a potential of causing severe neonatal
infections. These results emphasize the necessity of a regular screening
during pregnancy also in Hungary.
R2381 Surveillance of Staphylococcus aureus carriage in healthy
young adults in Hungary
K. Laub*, Sz. Kardos, K. Nagy, O. Dobay (Budapest, HU)
Objectives: The carriage of pathogenic bacteria such as Staphylococcus
aureus in healthy individuals is well known, with a 25−30% prevalence.
In this study we surveyed the nasal carriage of students of a medical
university, who already attend hospital wards, so they can be a potential
source of infection. This is the ﬁrst study of this kind in Hungary.
Methods: Eighty-eight S. aureus isolates were collected from the nasal
passages of the students attending Semmelweis University, Budapest,
Hungary. The species identity was conﬁrmed by colony morphology,
catalase test, Pastorex test (Bio-Rad) and nucA PCR. MRSA strains
were screened by mecA PCR. The antibiotic sensitivity was determined
by E-test, applying the EUCAST breakpoints. The genetic relatedness
of 56 strains was examined by PFGE.
Results: Altogether 300 3rd-year students (205 Hungarian and 95 non-
Hungarian) were sampled on a voluntary base. The overall S. aureus
carriage rate was 29.3%, little higher among the Hungarians (31.7%)
than in the non-Hungarian group (24.2%). On one occasion carriage
of two unrelated strains was detected. Out of the 88 strains, only
2 carried the mecA gene, but these had oxacillin MICs of only
0.75 and 2mg/L, respectively. The strains were fully sensitive to
gentamicin, ciproﬂoxacin and vancomycin. There were 9 isolates with
high-level (MIC 256mg/L), and 3 with low-level (MIC = 12−32mg/L)
erythromycin resistance. Only 1 isolate was resistant to clindamycin.
Based on the PFGE pattern, 3 clones comprised approximately half of
the strains (15, 14 and 6 strains, respectively), but the rest were rather
diverse.
Conclusions: The S. aureus carriage rate correlates well with
international data. Luckily there were only 2 MRSA strains (2.3%).
The one with the higher MIC (the EUCAST breakpoint is >2mg/L)
was highly resistant also to erythromycin, but the other strain was fully
sensitive to all tested drugs. The other isolates were generally very
sensitive, which is characteristic in the case of carried pathogens. The
strains proved to be genetically more diverse than the usual MRSA
populations, with only a few smaller clones, indicating the presence of
several independent strains. This, and the dissimilarity of isolates within
the same groups, indicate that there is no extensive exchange between
the students ﬂora.
R2382 Detection of pili in clinical and carried isolates of
Hungarian Streptococcus pneumoniae
A. To´thpa´l*, D. Itzkovitz, Sz. Kardos, K. Nagy, O. Dobay (Budapest, HU)
Objectives: In 2006, presence of pili on the surface of Streptococcus
pneumoniae (pneumococcus) was discovered and it was shown to
enhance adhesion to epithel cells. In the case of pneumococcus, carriage
in the nasopharynx (esp. children) is the initial step of subsequent
invasion. According to the literature, 20−30% of strains possess pili,
and these are restricted to certain serotypes, especially the so-called
vaccine-types (i.e. included in the pneumococcal conjugate vaccines).
In the present study, we wanted to determine the presence of pili in
Hungarian pneumococcal strains, for the ﬁrst time.
Methods:We have tested 100 clinical strains, isolated at different routine
laboratories in Hungary between 2002–2008, as well as 156 strains
that derived from healthy children attending day-care centres (2009–
2010), all well characterised earlier. Boiled bacterial colonies were used
as template. We have used previously described primers for the PCR
detection of pili.
Results: Among the clinical strains, the pilus was present in 24 cases
(24.0%). Seven of these derived from invasive infections, and the rest
from respiratory specimens. Half of them came from small children
(<4,5 y), and half from adults (41−84 y). The majority of the strains
was resistant (R) to macrolides, and had elevated MICs to penicillin
(0.25−1.5mg/L). Their serotypes were: 6 (n = 11), 14 (n = 7), 19F (n = 3),
11A (n = 2) and 23F (n = 1). Among the carried isolates, only 15.4%
(n = 24) were pilus positive. These were of the following serotypes: 6
(n = 10), 19F (n = 6), 14 (n = 3), 19A (n = 2), 15B (n = 1), 3 (n = 1) and
18C (n = 1). Although the majority of the carried strains was sensitive
to antibiotics, nearly half of the pilus + strains was also R to macrolides
and non-susceptible to penicillin. Out of the 24 children, only 2 were
previously vaccinated with Prevenar.
Conclusions: The rate of pilus positive clinical strains correlates well
with international data, but it was signiﬁcantly lower in the carried
strains. This suggests that pili are required more for invasion rather than
merely for colonisation. Very probably there is no direct correlation
between pili and resistance, but rather we found pili only in certain
resistant serotypes. These were almost all (45/48) vaccine-types (with
the dominance of serotype 6), except for 3 strains (11A or 15B). The
conjugate vaccines seem to be quite effective in preventing colonisation
with pilus positive strains, hence preventing subsequent invasion in the
body.
R2383 Meticillin-resistant Staphylococcus aureus ST22 outbreak
in a French neonatology unit
E. Martin, A. Tristan, M. Bes, K. Bellemin, F. Vandenesch, J. Etienne,
O. Claris, G. Lina, O. Dumitrescu* (Lyon, FR)
Objectives: Meticillin-resistant Staphylococcus aureus (MRSA) has
been diffusing in French ICUs and long-term care facilities. Here we
report a MRSA outbreak in the Neonatology unit of our hospital and the
emergence of the ST22 MRSA clone in French hospitals.
Methods: Patients admitted to the Neonatology unit of the HFME
hospital in Lyon were screened weekly for MRSA carriage in the
feces. Strains isolated on chromogenic agar for MRSA detection as
well as MRSA isolated from various infections in neonates were fully
characterized by using macro-array Staphy-Type from Clondiag (Alere),
MLST typing and for the antibiotic susceptibility proﬁle.
Results: From January to August 2010 the prevalence of MRSA carriage
and infection among neonates admitted to our hospital was extremely low
(2 MRSA strains were isolated from the feces and one MRSA strain
was isolated from a surgical wound infection). During the ﬁrst week of
September, one MRSA strain was isolated from blood culture from one
neonate who deceased from septicemia. From September to December
no other MRSA infection was detected but MRSA gut-carriage was
diagnosed in 23 other neonates. All 26 isolated strains displayed the
same antibiotic susceptibility proﬁle: oxacillin and levoﬂoxacin resistant.
Genotyping results showed that the strains belong to two different clones.
The ﬁrst 3 strains isolated (from January to August) were agr1, SCCmec
type IV, harbored enterotoxin A gene and belong to the ST8 Lyon
clone. The 23 MRSA strains isolated from September to December were
agr1, SCCmec type IV, harbored enterotoxins C, L and collagen binding
protein genes and belong to the ST22 EMRSA-15 clone.
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Conclusions: Previous data account for MRSA diffusion in French
hospitals, most isolated strains belonging to the ST8 Lyon clone. We
report here a MRSA outbreak in a Neonatology unit and the emergence
of ST22 MRSA clone in a French hospital. Our observation raises the
question of the competition between these two MRSA clones. Further
survey may clarify whether ST22 would displace the Lyon clone and
spread more efﬁciently in our hospitals.
R2384 Molecular characterisation of methicillin-resistant
coagulase-negative staphylococci isolated from patients of
cardiovascular and neonatal centres in Moscow
O. Dmitrenko*, O. Voronina, M. Kunda, A. Ankirskaya,
L. Lubasovskaya, D. Popov, A. Gintsburg (Moscow, RU)
Objectives: Coagulase-negative staphylococci (CoNS) are now recog-
nized as the aethiological agents of an important range of infections in
humans. Most countries have reported an increase in CoNS infections in
hospitalized patients that are resistant to methicillin and other antibiotics.
Despite of it information of population structure and global epidemiology
of Staphylococcus epidermidis and some other CoNS is scare. The goal
of investigation was to analyze collection of CoNS from diverse clinical
origins using molecular genotyping.
Methods: CoNS isolates were recovered from the blood (36), umbilical
wound (10), conjunctivitis (33), urine (1), pulmonary tissue (2) in 2009–
2010. Antimicrobial susceptibility was determined by standard methods.
Species identiﬁcation was carried out by ampliﬁcation and sequencing of
tuf gene. S. epidermidis isolates were analyzed by multilocus sequence
typing (MLST) by protocol, as described by Thomas J.C. et al. (2007).
MLST of Staphylococcus haemolyticus isolates was performed using
original primers sets. Structural components of staphylococcal cassette
chromosome mec (SCCmec) were tested by PCR additionally.
Results: Identiﬁcation of CoNS at the species level indicated that
S. epidermidis was the most common species with 46 isolates, followed
by S. haemolyticus (18), Staphylococcus hominis (10), Staphylococcus
warneri (7), Staphylococcus pasteuri (1). 69 (84.2%) isolates were
methicillin-resistant. Among S. epidermidis isolates 24 ST were
discovered, including 5 new. New alleles for 5 analysing genes were
discovered two. ST59 was predominated (41.3%. isolates). S. epidermidis
isolates carried SCCmec IV, composite variant SCCmec (mecB+,
ccr1,+ccr2) or unusual patterns with two mec gene complexes (class
A and class B). Among S. haemolyticus isolates 9 St were recovered.
Isolates carried modiﬁed SCCmec type IV (ccr2+, comlex mec class B
1kbp), or elements SCCmecV (ccr5+). SCCmec in 42.7% isolates were
not typable. The predominant SCCmec type found among S. hominis
isolates was a new type with ccr1 and class mec typeA.
Conclusion: Only 4 species (S. epidermidis, S haemolyticus, S. hominis,
S. warneri were prevalent (98.8%) among tested collection of coagulase-
negative staphylococci. High level of genetic diversity of S. epidermidis
and S. haemolyticus isolates were discovered. Isolates S. epidermidis
ST59 were epidemic in neonatal center and aethiological agent of
different forms of infectious process. CoNS may serve as reservoir of
new types SCCmec.
R2385 Clinical and molecular features of methicillin-resistant
Staphylococcus aureus causing bacteraemia in Andalucı´a,
Spain
L.E. Lo´pez-Corte´s*, C. Velasco, M. De Cueto, F.J. Caballero,
J.M. Gil-Bermejo, C. Natera, J. Corzo, A. Martı´n-Aspas, J.M. Lomas,
J. Ferna´ndez-Rivera, E. Nun˜o, T. Pe´rez-Corte´s, S. Vergara, J. Pacho´n,
J. Rodrı´guez-Ban˜o, A´. Pascual (Seville, Cadiz, Jerez de la Frontera, ES)
Background: Some changes in the molecular epidemiology of MRSA
has been reported in Spain during the last decade. Whether the clinical
features of MRSA bloodstream infections (BSI) are different according
to molecular proﬁles of the isolates has not been extensively studied.
Methods: A multicenter cohort study of patients with BSI due to
MRSA was performed from 2008 to 2010 in 10 hospitals in Andalucı´a,
Spain. Antimicrobial susceptibility was assessed by broth microdilution
and E-test. Isolates were characterized by PFGE after SmaI digestion,
SCCmec typing, agr typing, spa typing with BURP analysis, and clonal
complex assignment.
Results: 99 cases were included (data were collected retrospectively
in 36 and prospectively in 64). Complete clinical data are currently
available for 81; 51 (63%) were hospitalized in medical, 20 (25%)
in intensive care units, and 10 (12%) in surgical wards. According
to Friedman’s criteria, acquisition was classiﬁed as nosocomial in 47
(57%), healthcare-associated in 28 (35%), and community in 7 (9%).
The Charlson index was 2 in 65%, and 42% had a Pitt score >2. The
most frequent source was an intravascular catheter infection (43%). BSI
was considered as complicated in 26 patients (33%); 36 patients (44%)
met 1 criteria for therapeutic failure; BSI-related mortality was 31%
(25 patients). All 100 isolates were studied. There were 14 different
antibiotic resistance patterns, with combined resistance to ciproﬂoxacin,
tobramycin and erythromycin being the most prevalent (29%). By broth
microdilution, MIC of vancomycin was <1 and 2mg/ml for 84% and
6% of the isolates, respectively; by E-test, it was 1, 1.5 and 2mg/ml
in 56%, 39% and 5%, respectively. Regarding daptomycin, only 2%
of the isolates showed a MIC >1mg/ml by microdilution although all
the isolates showed a MIC 0.5mg/ml by E-test. Eighty percent of the
isolates were grouped into 5 clusters by PFGE (groups A to E) with the
following characteristics: A (9 isolates), spa t008, agrI, and SSCmecIV;
B (9 isolates), spa t148 and t3092, agrI y SCCmecIV; clusters C, D and E
(61 isolates), predominantly spa t067 and t002, agrII, and SSCmecIV.
Acquisition, predisposing features, source of BSI, complicated BSI or
mortality were similar among the 5 clusters.
Conclusion: Isolates of MRSA causing BSI in our area are grouped into
5 clusters, in which SSCmecIV, agrII and spa t067 predominated. We
were unable to ﬁnd signiﬁcant epidemiological or clinical differences or
trends among the clusters.
R2386 Molecular epidemiology and characterisation of CA-MRSA
selected according to the CDC criteria
M. Gonza´lez, C. Seral*, Y. Sa´enz, S. Salvo, M.J. Gude, N. Porres-Osante,
M.C. Rubio, C. Torres, F.J. Castillo (Zaragoza, Logron˜o, ES)
Objectives: Community-associated MRSA (CA-MRSA) has become a
worldwide phenomenon. In this study, we investigated the molecular
epidemiology and the antibiotic resistance mechanisms of CA-MRSA
selected from clinical specimens according to the CDC criteria.
Methods: 34 non-duplicated outpatient isolates were classiﬁed as CA-
MRSA (July 2009 to July 2010) in our institution. Identiﬁcation
and susceptibility testing was carried out by WIDER® system and
disk diffusion method. All isolates were genotyped by PFGE/SmaI
and spa, SCCmec and agr typing. The presence of genes encoding
PVL and resistance genes: methicillin (mecA), erythromycin (ER)
and clindamycin (CC) (ermA, ermB, ermC and msrA), gentamicin
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(GM), kanamycin, amikacin and tobramycin (TO) (aac(6′)-Ie-aph(2”)-
Ia, ant(4′)-Ia and aph(3′)-III) and tetracycline (TE) were performed by
PCR.
Results: A high diversity of PFGE patterns was observed in CA-
MRSA. Resistance to ER, CC, TO, GM and TE was 52.9%, 14.7%,
73.5%, 26.4% and 8.8%, respectively. ER resistance genes detected were
msrA (32.3%), ermC (8.8%), msrA+ermC (8.8%) and ermA (2.9%).
The msrA gene was found in isolates with macrolide-streptogramine
(MS) resistance phenotype and ermC, ermA or msrA+ermC genes in
those with MLSBc or MLSBi resistance phenotypes. Aminoglycoside
resistance genes detected were ant(4′)-Ia (61.8%), aac(6′)-Ie-aph(2”)-Ia
(2.9%), aph(3′)-III (2.9%) and aac(6′)-Ie-aph(2”)-Ia+aph(3′)-III (5.9%).
Five (14.7%) strains were PVL positive.
SCCmec type IVc was detected in 27 strains (79.4%), type V in 3 (8.8%)
and 4 strains were type I, II, IVa and non-typeable, respectively. The agr
type II was identiﬁed in 28 strains (82.3%), agr type I in 3 (12%),
agr type III in 2 (5.8%) and one strain was non-typeable. The spa-type
t067 was the predominant (64.7%) followed by t002 (8.8%). spa type
t067 and t002, normally grouped in clonal-complex CC067 and CC5
(sequence-types ST125 and ST228), are responsible for more than half
of nosocomial MRSA infections in Spain. Single strains were typed as
t008, t019, t024, t116, t127, t314, t548, t1084 and t2220.
Conclusion: Five of 34 selected CA-MRSA carried PVL gene and
corresponded to spa types classically community-associated: t024 (ST8-
USA300), t019 (ST30), t008 (ST8-USA300), t314 (ST121) and t127
(ST1- USA400). The remaining 29 CA-MRSA corresponded to spa
types more associated to the hospital environment what suggests the
interchange of genetic lineages of MRSA among community and hospital
niches.
R2387 No signiﬁcant increase of colonisation rate but
diversiﬁcation of methicillin-resistant Staphylococcus aureus
strains among children in the community
E. Sze´kely*, A. Man, A. Mare, F. Toma, L. Lorinczi (Taˆrgu-Mures, RO)
Objectives: We compared methicillin-resistant Staphylococcus aureus
(MRSA) strains’ characteristics and colonization rates among children
attending kindergartens in Tg Mures, Romania, in two study periods
three years apart. We also examined the strains’ relatedness with MRSA
clinical isolates obtained from hospitalized patients.
Methods: Sampling was performed randomly and after the parents’
informed consent. Nasal swabs were collected and placed in transport
medium. After enrichment S. aureus strains were identiﬁed by
conventional methods. Multiplex PCR was applied for the detection of
nucA, mecA and lukS-lukF-PV genes. Pulsed-ﬁeld gel electrophoresis
was performed for determining clonal relations. Pulsotypes were
compared to a database of clinical isolates recovered from hospitalized
patients.
Results: The study was conducted in 16 kindergartens, in 2007 and 2010.
During the ﬁrst period 186 children out of 2900 were enrolled, while
in the second period 189 children out of 2695. S. aureus colonization
rate was 49% (40−57%, 95%CI) in 2007 and 44% (38−52%, 95%CI)
in 2010. MRSA colonization rate was 2.3% (0−5%, 95%CI) and 3.4
(1.5−4.9%, 95%CI) in 2007 and 2010, respectively. All MRSA strains
identiﬁed by conventional methods were conﬁrmed by the molecular
methods. None of the MRSA strains harboured genes encoding for
Panton-Valentine leukocidin. MRSA strains isolated in 2007 belonged
to the same clonal type. Five distinct pulsotypes were recorded in 2010.
MRSA strains endemic in the hospital setting were not found in children.
On the contrary, community strains were sporadically recovered among
hospital clinical isolates.
Conclusion: There was no signiﬁcant increase in MRSA colonization
rate between the two periods, although a diversiﬁcation of circulating
strains was recorded. Hospital strains were not disseminated in children
collectivity, while community strains were present among hospitalized
patients.
This work was partially supported by CNCSIS-UEFISCDI, project
number 1180 PNII-Idei, code 1570/2008.
R2388 Staphylococcus aureus carriage in physicians attending
three national meetings about infectious diseases
J.P. Stahl*, A. Mignon, J.C. Lucet, M. Marmiesse, C. Rabaud,
P. Berthelot, H. Dupont (Grenoble, Paris, Nancy, Saint Etienne,
Amiens, FR)
SA (Staphylococcus aureus) SARM and/or SAMS)) carriage in
physicians caring for weakened patients is not well documented and
could be a concern. We investigated it among microbiologists, infectious
diseases, hygiene and intensive care physicians attending their national
annual meetings (namely JNI for infectious disease physicians and
microbiologists, SFAR for intensive care physicians, and JNHH for
hygiene physicians).
Methods: Volunteer physicians were recruited during the meetings.
The anonymous screening (nasal swab) was performed using nasal
MRSA/SA Xpert test (Cepheid), an automatized PCR test, feasible
in less than 2 minutes, focusing on SCCmec (staphylococcal cassette
chromosome), mecA (meticilline re´sistance gene), and spA (speciﬁc of
SA species) targets.
Results: We performed 293 tests during SFAR meeting, 152 during JNI,
and 120 during JNHH. 32% of volunteers in SFAR meeting were positive
for SA, including 8% of MRSA, 34,2% and 2,4% in JNI, 27,5%, and
1,6% in JNHH. We did not reveal any difference according to the type
of structure and number of patients’ beds. 50% of SA carriers in JNI
were in close contact with potentially weakened patients, and 51,2% in
SFAR meeting. 73% of SA carriers identiﬁed during the SFHH meeting
reported to be potentially in contact with patients at risk for MRSA
acquisition, but they were not in charge of patients’ care.
Conclusion: One third of volunteer physicians, essentially working
closely with compromised patients, was positive for SA in a
nasal screening test. The MRSA rate was small but the targeted
decontamination in healthcare workers should be debated, due to its
consequences for patients.
R2389 Presence of methicillin-resistant Staphylococcus sciuri in
nasal swab specimens obtained from hospitalized patients
and healthcare workers
I. Cirkovic*, M. Svabic-Vlahovic, B. Jovanovic, S. Stepanovic
(Belgrade, RS)
Although Staphylococcus sciuri is only occasionally isolated from
humans, less is known about the carriage of this bacterium in humans,
especially methicillin-resistant S. sciuri. The aim of the present study
was to provide the analysis of carriage of methicillin-resistant S. sciuri
in hospitalized patients and healthcare workers (HCWs).
Nasal swab were taken from 195 hospitalized and 105 HCWs at
the Clinical Center of Serbia in Belgrade. Oxidase positive colonies
of staphylococci were further identiﬁed as S. sciuri by BD Phoenix
Automated Microbiology System. Methicillin resistance was conﬁrmed
by PCR for mecA gene. Susceptibility to antibiotics was performed by
disk diffusion method in accordance to the CLSI recommendations.
Determination of SCCmec types was done by previously described
protocol for mec class and ccr type (Kondo et al., 2007). PFGE was
performed as described previously (Bannerman et al., 1995).
Among 195 hospitalized patients and 105 HCWs, 12 (6.1%) and 4 (3.8%)
respectively were colonized with methicillin-resistant S. sciuri. All 16
isolates (100%) were resistant or intermediate resistant to two or more
antibiotics beside b-lactam antibiotics, i.e. they were multidrug resistant.
All tested strains were susceptible to trimethoprim/sulfamethoxazole,
vancomycin, linezolid, and pristinamycin, while 15 (93.8%) were
resistant to gentamicin, 15 (93.8%) to kanamycin, 15 (93.8%) to
tobramycin, 1 (6.2%) to erythromycin, 1 (6.2%) to clindamycin and
the remaining 15 (93.8%) were intermediate resistant to clindamycin,
2 (12.5%) to ciproﬂoxacin, 1 (6.2%) was resistant to rifampin and 1
(6.2%) was intermediate resistant to rifampin, 1 (6.2%) to tetracycline,
4 (25%) to chloramphenicol, 1 (6.2%) to mupirocin, and 12 (75%)
were intermediate resistant to fusidic acid. PFGE analysis revealed 11
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pulsotypes within the population of methicillin resistant S. sciuri strains.
Isolation of methicillin-resistant S. sciuri of the same PFGE cluster B,
and E, from different individuals in different hospitals and different
wards indicate successfuly spread of this bacterium. All isolated strains
had mec type A and ccr type 3.
Carriage of methicillin-resistant S. sciuri among hospitalized patients
and HCWs was determined to be surprisingly high, 5%,. Carriage
was higher in hospitalized patients, 6.1%, than in HCWs, 3.8%.
Isolated methicillin-resistant S. sciuri strains has different genotypic and
phenotipyc characteristics.
R2390 Characterisation of Staphylococcus spp. isolated from
wounds
E.P. Pereira*, M.R. Barreira, M.L. Cunha (Botucatu, BR)
Objectives: Identify the presence of Staphylococcus spp in wounds
of patients attended primary care units, in the city of Botucatu, the
characterize the staphylococcal cassette chromosome mec (SCCmec).
Methods: This study included 103 isolates from 86 patients treated
between March to November 2010. The samples were submitted for
identiﬁcation and detection of resistance by the diffusion method with
oxacillin, cefoxitin, penicillin, levoﬂoxacin, clindamycin, erythromycin,
gentamicin, sulfametazol/trimethoprim, tigecycline, fusidic acid, quin-
upristin/dalfopristin, linezolid and vancomycin and the characterization
of SCCmec by multiplex PCR in samples with mecA gene.
Results: Of the 103 samples studied, 61 (59.2%) were identiﬁed as
Staphylococcus spp, these 41 (67.2%) were identiﬁed as S. aureus and
20 (32.8%) were identiﬁed as coagulase-negative staphylococci (CNS).
The mecA gene was found in four (9.7%) isolates of S. aureus and 12
(60%) isolates of CNS. The characterization of SCCmec revealed for
S. aureus 1 (25%) sample type 3 and 3 (75%) type II and to CNS,
8 (66.6%) samples were characterized as type III, 4 (33.3%) samples
as type IV. The drug sensitivity test disk showed only 3 (5%) strains
were sensitive to all drugs, 25 (41%) were resistant to only one drug,
12 (19.7%) strains were resistant to two drugs, 8 (13.1%) were resistant
to three drugs and 13 (21.3%) strains were resistant to more than four
drugs. All strains of CNS resistant to more than four drugs were positive
to gene mec A, and two samples carrying the gene were sensitive to the
oxacillin disc diffusion method, revealing heteroresistance.
Conclusion: The results from this study shows a high number
of Staphylococcus resistant to oxacillin, with a predominance of
staphylococcal cassette chromosome type III in CNS and type II in
S. aureus, common in hospital strains and inserted in the community
explained by being chronic wounds and patients with a history of
multiple hospitalizations over of life. There were great similarities
between strains of Staphylococcus found and the sensitivity of the drugs
tested, when comparing samples found in the same basic health unit,
which may indicate the presence of a possible clone of Staphylococcus
in several patients. The results also call attention to the high rate
of multidrug resistance found in strains isolated these patients with
predominance of SCCmec type III which complicates the treatment these
infections.
R2391 Monitoring of antibiotic resistance of S. aureus in patients
with knee or hip joint replacement in 2007–2009
S.A. Bozhkova*, V.L. Razorenov, O.V. Shneider, T.M. Petrova (Saint
Petersburg, RU)
The incidence of an orthopedic implantrelated infection is 1.5% to
2.5% for primary knee or hip replacements and 3.2% to 5.6% for
revision surgeries. The essential role in development paraprosthetic joint
infections (PJI) belongs to Staphylococcus aureus (S. aureus). This
bacteria has entered the spotlight as a globally pervasive drug-resistant
pathogen. When dealing with prosthetic joint infections (PJI) there is
often a need to start empirical antibiotic therapy. The constant monitoring
of resistance chosen pathogen allows in good time to correct the schemes
an antibiotic therapy that brings about increasing of its efﬁciency. The
present prospective study was performed to evaluate the frequency of
detection S. aureus as etiology factor of PJI and conduct the test of its
antibiotic resistance. Methods. We examined the records of 938 isolates
is chosen from tissue and ﬂuid samples from 618 patients with PJI from
2007 to 2009. Antibiotic sensitivity S. aureus was tested by agar dilution
method. Resalt. S. aureus was the most common pathogen in PJI during
these years. The frequency of S. aureus was 42.0%, 38.8% and 38.1%
accordingly for 2007, 2008 and 2009 year. The prevalence of methicillin-
resistant S. aureus (MRSA) almost did not changed (32.8%, 30.3% and
30.4% for each speciﬁed year accordingly).
Figure 1 summarizes results of dynamic analysis antibiotic resistance
S. aureus in PJI. None of these strains was vancomycin and linezolid
resistant. More than 90% isolates were sensitive to fuzidic acid,
trimethoprim-sulfamethoxazole, rifampicin and fosfomycin. Resistance
rates of S. aureus to the antibacterial agents, respectively, were
as follows: less than 20% isolates were resistant to erythromycin,
lincomycin, more than 20% to ciproﬂoxacin, gentamycin, amoxicillin/
clavulanate, The highest resistance rate of S. aureus was detected to to
penicillin-G (more than 80%). Ciproﬂoxacin, lincomycin, amoxicillin/
clavulanate, rifampicin show gradual reduction of activity against
S. aureus.
Conclusions: S. aureus account for about 40% of cases PJI. MRSA
was cultured in 1/3 of cases with no relevant difference whithin years.
Vancomycin and linezolid are 100% effective against S. aureus and could
be used for empirical therapy for orthopedic implantrelated infection in
acute cases. The b-lactam antibiotics, ﬂuoroquinolones and gentamycin
can be used for staphylococcus infection therapy only in case of
previously conﬁrmed isolate sensitivity.
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R2392 Detection of ESBL-producing Enterobacteriaceae during
2008–2010, in Aveiro, Portugal
S. Ferreira*, A. Paradela, R. Diaz, S. Rocha, E. Ramalheira (Aveiro, PT)
Objectives: The emerging changes in the resistance phenotype of ESBL-
producing Enterobacteriaceae are becoming a serious problem. The
aim of the present study was to screen for ESBL-producers among
Escherichia coli and Klebsiella pneumoniae isolates, recovered from
patients in Hospital Infante D. Pedro, Aveiro-Portugal.
Methods: From January 2008 until December 2010 E. coli and K. pneu-
moniae ESBL-producing isolates were collected in the Hospital Infante
D. Pedro, EPE, central Portugal. The identiﬁcation and susceptibility
proﬁle of the isolates were performed with the Vitek2 system (according
to CLSI guidelines) and Advanced Expert System (VITEK 2 AES)
(BioMe´rieux, Marcy L’Etoile, France). ESBL producers were conﬁrmed
by Etest® (AB Biodisk) ESBL with Cefotaxime/Cefotaxime + Clavulanic
acid and Ceftazidime/Ceftazidime + Clavulanic acid strips, according to
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manufacturer’s instructions. PCR, nucleotide sequencing and sequence
analysis were employed to identify b-lactamases.
Results: From a total of 15843 clinical isolates, 222 Escherichia coli and
263 Klebsiella pneumoniae, with an ESBL phenotype were detected. The
isolates were collected mainly from the urinary tract, blood and bronchial
secretions. The Advanced Expert System identiﬁed 108 isolates in 2008,
175 in 2009 and 202 isolates in 2010 with ESBL-positive phenotype.
483 bacterial isolates were further investigated. The PCR revealed that
CTX-M group was the most prevalent in both species.
Conclusions: The presence of ESBL in clinical specimens is be-
coming common in our region, however there were two tendencies
occurring among the Enterobacteriaceae studied. The occurrence of
ESBL-producing K. pneumoniae in our hospital has increased from
approximately 20% (1:5) in 2008 to more than 50% (1:2) in 2010. On
the other hand, the occurrence of ESBL-producing E. coli has decreased
in the last year. Nevertheless the percentage of producing isolates is
still considerable and requires surveillance. CTX-M is the dominating
enzyme group in both E. coli and K. pneumoniae. The presence of
ESBL’s among the isolates highlights the importance of routine detection
of ESBL producers. CTX-M-group is plasmid mediated and, therefore,
can represent a dissemination problem, as these genes can be easily
mobilised between strains or even species.
R2393 Incidence of ESBL-producing E. coli and K. pneumoniae
strains from 2006 to 2010 in two German teaching hospitals
B. Grabein, M. Hoeck, B. Wiedemann* for the EPICENTER Network
Objectives: ESBL producing E. coli and K. pneumoniae strains are a
serious problem as these strains often leave little therapeutic options
especially in intensive care units. We analysed these strain in two big
teaching hospitals in Germany to see whether their number is still
increasing.
Methods: The two laboratories participate in the network using
the automated BD PHOENIX-systems measuring MICs. The BD
EPICENTER Data-Management-System is used for the evaluation of
the data in the laboratory and for the transfer of the data for joint
analysis. Copy strains are excluded. Quality control assays are routinely
performed. For this study we analysed the ESBL production in all E. coli
and K. pneumoniae strains isolated in a period from 2006 to 2010
with the associated BD-expert system, as the Phoenix shows excellent
performance in ESBL detection (Maurine A. Leverstein-van Hall, et al.:
J Clin Microbiol. 2002 October; 40(10): 3703).
Results: We looked at more than 34000 E. coli and K. pneumoniae
strains for ESBL production (see table). With about 12% ESBL
producing strains the incidence in K. pneumoniae strains was nearly
identical in both laboratories. Two % higher were the ESBL producing
strains in E. coli UTI isolates of laboratory B as compared to
laboratory M.
We observed a steady increase in the number of ESBL producing strains
in E. coli (6 to 15%) and K. pneumoniae (8 to 21%) from 2006 to
2009 only. In 2010 however the incidence decreased for 3% in E. coli
and K. pneumoniae. The selected blood isolates for E. coli showed a
permanent increase on a lower level until 2010 (3 to 9%).
Conclusion: As far as the incidence of ESBL producing strains
is concernd, differences in both laboratories were negligible for
K. pneumoniae. The incidence of ESBL producing E. coli strains was
slightly higher in Lab B. E. coli blood isolates showed a lower rate of
ESBL producing strains. The data might imply that we already changed
the trend of increase, what needs careful observation.
R2394 Antimicrobial resistance in Escherichia coli and Klebsiella
pneumoniae from Singapore: a proliferation of plasmids
T.Y. Tan*, L.Y. Hsu, T.H. Koh, Q.C. Lau, P. Krishnan, R. Jureen, N. Tee,
R. Lin (Singapore, SG)
Objectives: This study was conducted to survey antimicrobial resistance
trends and the distribution of resistance genes in Escherichia coli and
Klebsiella pneumoniae isolates from Singapore.
Methods: Antimicrobial susceptibility data were collected from
microbiology laboratories of ﬁve participating healthcare institutions.
Categorical susceptibility was analysed by WHONET software, and
converted into incidence-density rates based on inpatient-days. For
detailed bacteriological testing, a small subset of bacterial isolates
were collected from 2007–2009. Minimum inhibitory concentrations
to multiple antibiotics were determined by microbroth dilution.
Phenotypic screening in Enterobacteriaceae for extended-spectrum
b-lactamases (ESBL), AmpC enzymes and metallo-b-lactamase enzymes
was performed by disc diffusion. The genotypic distribution of ESBL,
plasmid-borne ampC genes and plasmid-borne qnr genes (quinolone
resistance) was determined by multiplex PCR. Clonal typing on a subset
of E. coli and K. pneumoniae isolates was performed by pulsed-ﬁeld gel
electrophoresis (PFGE).
Results: Routine laboratory data demonstrated rising incidence-density
of ceftriaxone and quinolone resistance in E. coli, but falling incidence-
density for K. pneumoniae. Detailed susceptibility testing demonstrated
that ESBL genes were present in 23% of E. coli, predominantly CTX-M
(91%) and TEM (17%). The corresponding ESBL rate was 30% in
K. pneumoniae isolates, predominantly CTX-M (82%) and SHV (13%)
genes. Plasmid borne ampC genes were present in 8% and 5% of E. coli
and K. pneumoniae respectively, with DHA-like and CMY-like genes
detected. Plasmid-mediated qnr genes were detected in 10% and 23% of
E. coli and K. pneumoniae, respectively. PFGE typing showed greater
clonal diversity in ceftriaxone resistant isolates of E. coli, but some
limited clonal clustering for ceftriaxone-resistant K. pneumoniae isolates.
Conclusion: Antimicrobial resistance to quinolones and third-generation
cephalosporins was high in E. coli and K. pneumoniae isolates, with a
high level of plasmid-mediated resistance genes. Resistance trends to
quinolones and cephalosporins showed divergent results for E. coli as
compared to K. pneumoniae.
R2395 Prevalence study of clinically signiﬁcant Gram-negative
pathogens depending on the consumption of antibiotics in
two large cancer hospitals in Moscow, Russia
N. Dmitrieva, A. Sokolov, S. Mitrokhin, I. Petukhova, M. Zubkov,
Z. Grigoryevskaya, D. Tsvetkov, S. Dyakova*, I. Ryabova, N. Bagirova
(Moscow, RU)
Objective: To study prevalence of multidrug- (MDR) and pandrug-
resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa,
and ESBL-producing Klebsiella pneumoniae and E. coli and to correlate
the data with the consumption with cephalosporins (CEPH) and
carbapenems in NN Blokhin Cancer Research Center (CRC) of Russia
and Moscow Cancer City Hospital no. 62 (MCCH).
Methods: CRC has 1.120 beds vs 600 beds in MCCH. From 01.01.till
01.12.2010 (11 months) 17,320 and 19,548 cancer patients were treated
in CRC and MCCH, and total numbers of bed-days were 349,654
and 184,218, respectively. Average number of bed-days per patient was
20,2 vs 13,6 in CRC and MCCH, and average number of pretreatment
bed-days per patient was 6,4 vs 3,7 days, respectively. In both clinics
identiﬁcation and susceptibility testing was performed with VITEK-2
System.
Results: A total of 2,512 bacterial and fungal strains in CRC and
1,696 strains in MCCH were isolated. P. aeruginosa accounted for
10.3% (259/2512) in CRC vs 6.1% (103/1696) in MCCH (p< 0.0001).
MDR-strains of P. aeruginosa were 23.2% (60/259) in CRC vs 11.6%
(12/103) in MCCH (p< 0.001). PDR P. aeruginosa accounted for 49.4%
(128/259) in the CRC vs 24.2% (25/103) in MCCH (p< 0.0001).
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A. baumannii accounted for 8.8% (221/2512) in CRC vs 2.0% (34/1696)
in MCCH (p< 0.0001) and MDR A. baumannii (sensitive only to
colistin) accounted for 77.8% (172/221) in CRC vs 41.2% (14/51) in
MCCH (p< 0.0001). The number of ESBL-producing K. pneumoniae
accounted for 62.1% (74/119) versus 69.7% (76/104) (p> 0.05) and
E. coli (ESBL) was 37.0% (94/254) vs 26.8% (39/145) (p< 0.002),
respectively. The ratio of aforementioned strains to the number of
patients in CRC was 2−4 times higher than in MCCH (except
K. pneumoniae).
The consumption with carbapenems and 4th-generation CEPH was
signiﬁcantly higher in CRC: 13.9 vs. 0.8 DDDs/1000 patient-days (PD)
for carbapenems; 55.4 vs. 8.6 DDDs/1000 PD for cefepime. On the
contrary, consumption with 3rd-generation CEPH was higher in MCCH:
5.9 vs. 18.9 DDDs/1000 PD for ceftriaxone; 0 vs. 6.7 DDDs/1000 PD
for ceftazidime. Total consumption with antipseudomonal CEPH was
55.4 vs. 15.3 DDDs/1000 PD, respectively.
Conclusions: The rate of MDR and PDR P. aeruginosa and
A. baumannii (isolated from patients) was higher in CRC associated
with the higher average number of bed-days and pretreatment bed-days
and massive consumption with antipseudomonal antibiotics, including
carbapenems. In MCCH ESBL-producers are the main problem.
R2396 Multi-resistant Enterobacteriaceae in a private hospital in
London: mechanisms of resistance and epidemiology
H. Bligh, S. Maharjan, H. Dhanji, R. Pike, J. Riley, R. Thomson,
N. Woodford, G. Scott* (London, UK)
Objectives: The London Clinic delivers care to a mixed clientele of UK
and International patients. It has an active Intensive Care Unit (ICU) and
Oncology Unit with some stem cell but no solid organ transplantation.
Observing a number of signiﬁcant infections with Enterobacteriaceae
sensitive only to amikacin and carbapenems, we prospectively examined
ﬁrst isolates from 24 patients collected over 8 months in 2009. We were
concerned about the risk of cross infection and the frequency of such
isolates and whether empirical therapy of febrile patients should be with
a carbapenem rather than the more conventional piperacillin-tazobactam,
ceftazidime or ciproﬂoxacin with or without gentamicin.
Methods: The 24 isolates were identiﬁed to species level and underwent
detailed susceptibility testing using disc diffusion, agar dilution MIC
determination and automated “Walkaway Microscan™” methods. PCR
was then used to detect the presence of CTX-M groups, and Escherichia
coli isolates underwent PCR for phylogrouping.
Results: Samples from outpatients, inpatients, and ICU grew 11
Escherichia coli, 9 Klebsiella spp. and 4 Enterobacter cloacae isolates.
33% of the isolates were from urine, 33% from wounds and sputa, 21%
from ICU screening swabs and 13% from blood cultures. 11/24 isolates
(3 E. coli, 5 Klebsiella spp, 3 E. cloacae) were from patients with contact
with ICU. The patients from whom the 24 strains were isolated originated
from the Middle East (13), UK (9) and Nigeria (2). The average interval
from admission to detecting the ﬁrst signiﬁcant isolate was between 0
and 85 (mean 13, median 2 days). PCR showed that 20 of the 24 isolates
belonged to CTX-M group 1, potentially CTX-M-15s by inference of the
MICs. Care in ICU was a signiﬁcant risk factor for the ﬁnding of CTX-M
ESBL producing pathogens (p< 0.05). Phylogrouping of the 11 E. coli
strains revealed 2 group A, 6 group B1, 3 pathogenic group D, and no
pathogenic B2 strains.
Conclusions: MICs, PCR and phylogrouping of the 24 isolates suggest
that despite the proﬁle of sensitivity being consistently to only
amikacin and carbapenem, that this proﬁle was created by expression of
heterogeneous resistance mechanisms, which would preclude concerns
about cross infection. Further work to characterise the CTX-M group 1
ESBL cluster and molecular environment of these genes could clarify
the resistance mechanisms and origins of these strains.
R2397 Colonisation and infection with multidrug-resistant
Enterobacteriaceae in a neonatal intensive care unit: a
surveillance study
M. Papadimitriou*, E. Koemtzidou, A. Doudoulakakis, J. Kapetanakis,
E. Lebessi, A. Tsakris (Athens, GR)
Objectives: Infections from Gram-negative bacteria are responsible for
considerable morbidity and mortality in neonatal intensive care units
(NICUs).
Surveillance study of multidrug-resistant (MDR) Enterobacteriaceae was
performed in a 30-bed, university-afﬁliated, level III-IV NICU of a
tertiary paediatric hospital in Athens, Greece.
Methods: All neonates, admitted to the NICU during Dec 2007–
May 2009, with no MDR pathogens in their bacterial ﬂora upon
admission were included. Surveillance cultures for the detection of
MDR bacteria consisted of throat and rectal swabs, taken upon
admission and weekly thereafter until discharge. Culture of samples
and identiﬁcation of organisms were made by standard methods.
Antimicrobial susceptibilities of isolates and phenotypic detection of
ESBLs were determined according to the CLSI guidelines.
Results: The study included 493 neonates. During hospitalization in
the NICU, 27 neonates (5.5%) were colonized with ESBL-positive
Escherichia coli, 32 (6.5%) with ESBL-positive Klebsiella pneumoniae,
16 (3.2%) with ESBL-positive Enterobacter cloacae and 19 (3.9%) with
AmpC-hyperproducing E. cloacae. Duration of hospitalization prior to
colonization with the above pathogens was 7–111 days (median 31 d),
7–104 d (median 23 d), 6−57 d (median 16 d) and 5–248 d (median
17 d), respectively. Analysis of monthly incidence revealed: 1) a minor
epidemic with ESBL-producing E. coli in Jan 2008 (n = 11); 2) a cluster
of cases with ESBL-producing K. pneumoniae during Feb–Mar 2008
(n = 7) and a probable epidemic in Feb–May 2009 (n = 10); 3) a minor
epidemic with ESBL-producing E. cloacae between Dec 2007 and
Feb 2008 (n = 10); 4) a cluster of cases with AmpC-hyperproducing
E. cloacae in Feb 2009 (n = 5). In total, seven episodes of invasive
infection occurred (one due to ESBL-producing E. coli and six due
to ESBL-producing K. pneumoniae).
Conclusion: Regular surveillance of colonization/infection with MRD
pathogens permits prompt implementation of infection control measures,
targeted at minimization of spread and avoidance of epidemics.
R2398 Outbreak of Enterobacter cloacae ESBL(+) colonisation in
a neonatal intensive care unit in Greece
A. Doudoulakakis, A. Nika, P. Giakkoupi, M. Papadimitriou,
A. Papaioannou, J. Kapetanakis, A. Vatopoulos, E. Lebessi* (Athens, GR)
Objectives: Enterobacter cloacae has emerged as an important
nosocomial pathogen in neonatal units. The aim of this study was to
investigate a massive colonization of neonates with ESBL producing
E. cloacae in a 30-bed, university-afﬁliated, level II-IV Neonatal
Intensive Care Unit (NICU) at a large pediatric hospital in Athens.
Methods: Routine surveillance cultures for the detection of multidrug
resistant bacteria at the throat and rectum of the neonates at admission
and weekly until discharge is a standard practice in our NICU.
Environmental samples are collected during suspected outbreaks.
Clinical and environmental samples are processed according to classic
microbiologic methods and the susceptibility to antimicrobials are tested
according to the CLSI guidelines. ESBLs are detected by phenotypic
methods. Molecular typing of isolates is determined by PFGE after
digestion of genomic DNA with XbaI.
Results: On August 2010 seven neonates were found colonized with
ESBL producing E. cloacae as opposed to only 5 neonates found
colonized during their NICU stay (NICU-acquired cases), and one
neonate colonized upon admission (referred case) during the last 12
months. A nosocomial outbreak due to ESBL(+) E. cloacae was then
highly suspected, and a one-day survey was performed on 2/9/2010.
Twenty out of 26 neonates were found colonized with ESBL(+)
E. cloacae reported. Environmental samples were all found negative.
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Three neonates developed bacteremia due to ESBL(+) E. cloacae during
the study period, but only one, suffering from serious underlying
conditions died.
PFGE analysis of 10 epidemic strains plus 4 epidemiologically unrelated
E. cloacae isolates proven >85% similarity among the epidemic strains,
a fact consistent with nosocomial spread.
Strict infection control measures, such as hand hygiene, patient cohorting
and shuting down the NICU for new admissions, were established.
Continuous surveillance over the next weeks showed a steady decline
in the number of colonized neonates, and on 16/11/2010 only 2 out of
18 hospitalized were found colonized.
Conclusion: Continuous surveillance was an important tool in early
identifying the outbreak, whereas the implementation of proper infection
control measures resulted in containment of the outbreak in a short period
of time.
R2399 First identiﬁcation of KPC-2 producing Klebsiella
pneumoniae in the Czech Republic and in vivo selection of
colistin resistance during the therapy
J. Hrabak*, J. Niemczykova, E. Chudackova, M. Fridrichova,
V. Studentova, D. Cervena, P. Urbaskova, H. Zemlickova (Plzen,
Ostrava, Prague, CZ)
Objectives: The occurrence of carbapenemase producing Gram-negative
bacteria is of high clinical interest as they can hydrolyze most b-lactam
agents including carbapenems recognised as antibiotics of choice in
ESBL or acquired AmpC producers usually resistant to other antibiotics.
The resistance to carbapenems, generally very rare in Klebsiella
pneumoniae strains in the Czech Republic, is predominantly caused by
an alteration of the cell wall, together with a production of extended-
spectrum and/or AmpC b-lactamases. At the end of 2009, the ﬁrst
putative KPC-producing isolates of K. pneumoniae was submitted for
conﬁrmation to the National Reference Laboratory for Antibiotics of the
National Institute of Public Health in Prague. The isolates were obtained
from one patient.
Methods: MICs of 24 antibiotics were determined according to
EUCAST recommendation. b-lactamases were identiﬁed by isoelectric
focusing followed by PCR and sequencing of b-lactamase genes. The
gene environment of blaKPC-2 was determined by PCR mapping and
sequencing of the amplicons. Isolates were compared by PFGE after
the restriction with XbaI endonuclease and multilocus sequence typing
(MLST).
Results: The isolates of K. pneumoniae (ST258) were obtained from a
wound swab, decubitus and urine from patient formerly hospitalized in
a Greek hospital. The carbapenemase was identiﬁed as a KPC-2 with
a gene located on Tn4401a traspozon variant. The resistance to colistin
developed after 20-days long therapy with this drug, but after this single
isolation, the KPC-2 producing strain disappeared.
Conclusion: This is the ﬁrst description of the KPC-producing
K. pneumoniae in the Czech Republic in patient with a travel history
in Greece − the country with an endemic KPC. Despite the history of
travel to the countries with the endemic KPC situation (Greece, USA,
Israel) no import of KPC strain to the Czech Republic was noticed during
past years.
This work reported here has been supported by the research project
grants NS9717−4/2008 and NT11032−6/2010.
R2400 Nosocomial outbreak of Pseudomonas aeruginosa in adult
inpatients: multidrug- vs. non-multidrug-resistant strains
J.L. Navarro*, A. Somodevilla, M.C. Martı´nez, J.M. Azcona, S. Agudo,
T. Alarco´n, M. Lo´pez-Brea (Madrid, ES)
Objective: Pseudomonas aeruginosa (PA) is an emerging opportunistic
pathogen that can easily exhibit multidrug-resistance (MDR). It is
intrinsically resistant to many antibiotic classes and can readily acquire
new mechanisms. Higher rates of death, prolonged hospitalization and
rising costs have been associated with MDR-PA. Comparison of MDR
rates among institutions is not always possible because there is no
agreement to deﬁne MDR in PA. We use here a modiﬁed MDR criterion
from Paterson et al. to make it more operational. The aim of this study
was to compare epidemiological features between MDR and non-MDR-
PA infection rates within an outbreak at a University Hospital in Madrid.
Methods: An observational retrospective study of 822 PA isolates from
369 adult inpatients was conducted for one year. All kind of samples
were obtained. Colonization and infection were not distinguished. We
studied 10 drugs: ceftazidime (CAZ), cefepime (CPE), piperacillin-
tazobactam (TZP), imipenem (IMI), meropenem (MER), ciproﬂoxacin
(CIP), gentamycin (GEN), tobramycin (TOB), amikacin (AKA) and
colistin (COL). Susceptibility was tested by a broth microdilution
method, using CLSI breakpoints to interpret. MDR was deﬁned as a
decreased susceptibility to two or more of the six following items: (1)
CPE and/or CAZ; (2) IMI and/or MER; (3) TZP; (4) CIP; (5) AKA
and/or [GEN and TOB]; (6) COL. Qualitative variables are expressed as
proportions, compared using Chi-square test and quantiﬁed by odds-ratio
(OR) with 95% conﬁdence. P-values lower than 0.05 were considered
signiﬁcant.
Results: Globally, 296 (36.0%) isolates were considered MDR according
to the MDR criterion. Among ﬁrst isolates, 95 (25.7%) were MDR. No
signiﬁcant difference in gender was found between MDR and non-MDR-
PA (p = 0.17). An increased rate of MDR-PA was shown in patients
under 70 years (mainly in the 5th decade, p = 0.03). PA isolates were
specially high at ICU, Neumology, Internal Medicine, Haematology and
Nephrology departments, but only Haematology dpt. (OR= 5.55 [2.43–
12.81], p< 0.0001) showed a statistically signiﬁcant difference of MDR
over the rest.
Conclusions: (1) A very high rate of MDR-PA isolates was found within
the outbreak. (2) Although PA isolation rate is higher in males, no
difference has been found between MDR and non-MDR. (3) Among
patients infected by PA, young ones have a higher likelihood of being
infected by a MDR-PA than older. (4) Haematology dpt. had the highest
rate of MDR strains.
R2401 Genetic dynamics of the emerging Salmonella enterica
serotype 4,5,12:i- (monophasic variant of S. typhimurium)
in Portugal
P. Antunes*, J. Mourao, L. Dias, L. Ferreira, L. Peixe (Porto, PT)
Objectives: A marked increase in the prevalence of the serotype
4,5,12:i-, a monophasic variant of S.Typhimurium, has been noted
worldwide in recent years. Our goal was to assess clonal relationships
and to characterize antibiotic and/or biocide resistance in Portuguese
isolates from different sources.
Methods: We studied 132 isolates (2002–2010) from humans (n = 115),
food (n = 9), environment (n = 4) and piggeries (n = 4). The serotype
was conﬁrmed by PCR (ﬂjA, ﬂjB, hin and ﬂjA-ﬂjB). Antibiotic
susceptibility to 10 antibiotics was tested by disk diffusion method
(CLSI). Characterization of antibiotic and biocide resistance genes and
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class 1 integrons were done by PCR, RFLP and sequencing. Clonality
was established by MLST in representative isolates.
Results: All but 2 isolates (99%) were resistant to antibiotics of which
94% were multidrug-resistant (MDR, 2−8 antibiotics). They expressed
resistance to sulfametoxazole (Su, 92%; sul1, sul2 and/or sul3),
tetracycline (T, 91%; tetA and/or tetB), streptomycin (S, 88%; aadA
and/or strA-strB), ampicillin (A, 67%; blaTEM), chloramphenicol (C,
45%; cmlA1 and/or ﬂoR), trimethoprim (Tr, 35%; dfrA12), gentamicin
(G, 27%; aac(3)-IV), nalidixic acid (4%) or kanamicin (3%). Three
major groups of isolates mostly associated with 3 genotypes could be
identiﬁed: (i) ASSuT type (n = 48; blaTEM, strA-strB, sul2 and tetB),
also carrying the pcoD copper efﬂux gene and assigned to the ST34 (SLV
of ST19); (ii) MDR (3−8 antibiotics) type (n = 45), being more frequent
the phenotype ACGSSuTTr (n = 27; blaTEM, cmlA1, aac(3)-IV, aadA,
sul1-sul2-sul3, tetA and dfrA12;) carrying an unusual class 1 integron
with estX-psp-aadA2-cmlA1-aadA1 associated to qacH, IS440 and sul3,
and in addition a class 1 integron of 2000 bp (dfrA12-orfX-aadA2) or an
empty one with qacEdelta1 and sul1 in the 3′CS, and belonging to the
worldwide spread ST19 and DT104/U302 phagetype. (iii) CSSuTTr type
(n = 15; cmlA1, aadA, sul3, tetB and dfrA12), carrying a class 1 integron
with the dfrA12-orfF-aadA2-cmlA1-aadA1 gene cassettes associated to
an unusual 3′ sequence region with qacH, IS440 and sul3 and belonging
to ST19.
Conclusions: This is the ﬁrst study characterising the S. enterica
serotype 4,5,12:i- in isolates from Portugal. The spread of three MDR
genotypes belonging to worldwide spread clonal lineages in association
with biocide resistance determinants (pcoD, qacEdelta1 and/or qacH)
might account for the recent emergence and success of this serotype.
R2402 Efﬁcacy of fosfomycin in the extended-spectrum b-lactamase
producing Enterobacteriaceae infections
M. Palacian, C. Marne, A. Rezusta*, G. Martin, M. Revillo (Zaragoza,
ES)
Objectives: To document fosfomycin susceptibility compared with other
antibiotics used for urinary tract infections caused by extended-spectrum
b-lactamase (ESBL) producing Escherichia coli and Klebsiella spp.
Methods: A retrospective study of ESBL-producing E. coli and
Klebsiella spp strains isolated from clinical samples of patients attended
in the Hospital Universitario Miguel Servet (hospitalized and outpatients)
over a ﬁve-year period (2005 to 2009) was performed.
Isolates were identiﬁed and tested for antibiotic susceptibility by mi-
crodilution system (MicroScan Walkaway® Siemens). ESBL production
was conﬁrmed by the double-disk diffusion method according to CLSI
standards.
Results: Antibiotic susceptibility against fosfomycin was tested in 516
strains of E. coli, 47 of K. pneumoniae and 7 of K. oxytoca.
95.54% of E. coli ESBL-producing isolates were susceptible to
fosfomycin. Similarly, 68.08% of K. pneumoniae isolates and 100% of
K. oxytoca isolates were susceptible to fosfomycin.
Gentamicin susceptibility data was 88.57% of E. coli isolates, 39.21%
of K. pneumoniae and 60% of K. oxytoca isolates. Most of the strains
were ciproﬂoxacin resistant (80.81% of E. coli isolates, 77.27% of
K. pneumoniae and 36.84% of K. oxytoca).
Cotrimoxazole shows similar resistance in the three species, 55.86%,
60% and 44.44% in E. coli, K. pneumoniae and K. oxytoca isolates
respectively.
Conclusions: The high susceptibility rates and the absence of variation
during the period study, indicates that fosfomycin can be considered
an important oral treatment option in urinary tract infections by ESLB-
producing strains.
R2403 Molecular characterisation of blaVIM-2-producing
Pseudomonas aeruginosa clinical isolates from Portugal
S. Quinteira*, F. Grosso, L. Peixe (Vila Nova de Famalica˜o, Porto, PT)
Objectives: Pseudomonas aeruginosa is an important etiological agent
of nosocomial infections frequently exhibiting multidrug resistance.
Metallo-b-lactamase (MBL)-producing strains are emerging worldwide,
with VIM-2 exhibiting particular relevance in Europe. Dispersion of
integrons carrying blaVIM-2, clonal spreading and the association
of MBL genes with transposons may contribute to the observed
dissemination rates. Our aim was to analyze the population structure
of blaVIM-2-carrying P. aeruginosa clinical isolates.
Methods: From our collection of carbapenem-resistant P. aeruginosa
isolates (2005–2008), derived from ﬁve hospitals in North and Centre
of Portugal, all blaVIM-2-producing P. aeruginosa isolates were
characterized (n = 12). Antibiotic susceptibility was determined by the
agar diffusion method and E-test (CLSI). Class 1 integrons were
characterized by PCR and sequencing. Clonal relatedness was studied
by PFGE (XbaI and SpeI) and MLST (http://pubmlst.org/paeruginosa).
Results: All P. aeruginosa isolates showed a multidrug-resistant
phenotype including resistance to imipenem (MIC >32mg/L), amino-
glycosides and ciproﬂoxacin. They carried blaVIM-2 as a gene cassette
inserted in 5 different class 1 integrons: In56, In58, In100, In102
(ORF11, aacA4, aacC1, blaVIM-2) and In103 (aacA7, blaVIM-2,
aacA4). In58 was the most frequent, found in 8 isolates. blaVIM-2 gene
was found to be chromosomal and/or plasmid located.
All isolates were clonally unrelated corresponding to 12 PFGE types.
On the other hand, 8 different sequence types (STs) were found: ST111
(n = 2), ST175 (n = 1), ST179 (n = 3), ST235 (n = 1), ST253 (n = 2),
ST260 (n = 1), ST282 (n = 1), and ST815 (n = 1). No close relationships
(single or double locus variants) were observed among these STs. Most
blaVIM-2 producing strains were assigned to widespread STs as ST111,
ST179 or ST235, which is the founder of the international Clonal
Complex 11 containing MBL isolates.
Conclusions: This is the ﬁrst report characterizing the population
structure of VIM-2-producing P. aeruginosa isolates in Portugal. Our
data indicate that these isolates belong to an extremely polyclonal
population with no apparent common ancestry. Further studies are
imperative to follow-up the relevance of speciﬁc clones in the
dissemination of blaVIM2 carrying isolates.
R2404 Clinico-epidemiological characteristics of tularaemia cases:
a tertiary hospital experience, Turkey
M. Demirelli*, T. Sari, F. Temoc¸in, A. Yazan, C. Bulut, G. Tuncer
Ertem, F. Erdinc¸, B. Oral, N. Eren Tu¨lek (Ankara, TR)
Francisella (F.) tularensis, Gram-negative, aerobic, facultative intracel-
lular bacterium have been distinguished to date: F. tularensis subsp.
tularensis, holarctica, mediasiatica and novicida. F. tularensis has been
detected in more than 200 animal species, with rabbits, hares, small
rodents (e.g. voles, ﬁeld mice) and semi-aquatic animals etc. Tularemia
is a re-emerging disease in our country recently.
In here, we evaluated the clinico-epidemiological characteristics of our
patients with tularemia.
Method: Prospective review of clinical records of patients diagnosed
with tularemia admitted to our hospital in Ankara, from January to
December 2010.
Case deﬁnition: Patient with suggestive clinical course and epidemiol-
ogy (coming from the epizootic area) and positive serology (antibodies
to Francisella tularensis >1/160).
Results: 22 patients (13males, 9 females) with a mean age of 41
years were included to the study. Nine patients were living in endemic
areas of turkey and thirteen patients had travelled to the endemic
areas. Among 21 cases, contaminated food or water were the most
commonly noted exposures (ten patients were consumed spring water),
and one had tick bite exposures Thirteen patient reported being exposed
to a rat which lived around patients houses. The clinical symptoms
period of patients ranged from 10 to 45 days. The ﬁnal diagnosis
of 20 patients was glandular tularemia, whereas two of them were
oculoglandular tularemia. 4 had suppurated lymph nodes. Fourteen of
the 22 patients were hospitalized (median duration: 4 days [range:
1−27 days]). History of antibiotic use was available for all patients.
18 of patients had been treated with a b-lactam or b-lactam/b-lactamase
inhibitors antibiotics those are considered ineffective against tularemia.
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Among 3 patients initially treated with streptomycin monotherapy and
one of the patient was treated with streptomycin and ciproﬂoxacin
combination. Epidemiological and clinical ﬁndings of patients were
summarized in Table 1.
Conclusions: Tularaemia should be considered in the differential
diagnosis of patients with fever, pharyngitis, conjunctivitis, and cervical
lymphadenopathies. Hence, early diagnosis and treatment of tularaemia
are important, every clinicians must be aware of diseases.
R2405 Multidrug-resistant Acinetobacter baumannii: study of
clonally related isolates spread in an Italian single center
institution over a four-year period (2007–2010)
P. Gaia*, M. Tejada, S. Marzocca, A. Moroni, G. Fugazza,
R. Migliavacca, P. Micheletti, E. Costa (San Donato Milanese, Pavia, IT)
Objectives: Acinetobacter baumannii (Ab) is an opportunistic pathogen
associated with severe hospital infections. In order to better control Ab
spread, it’s necessary to assess the multidrug resistance and implement
measures to prevent the transmission in the critical divisions.
The aim was to control Multidrug-Resistant (MDR) Ab spread in
S. Donato Hospital, Northern Italy. We investigated the epidemiology
of MDR Ab clinical isolates, with a focus on the mechanisms of
carbapenem and aminoglycoside resistance.
Materials and Methods: 106 non replicate Ab strains were collected
between January 2007 and December 2010 from different samples; Ab
strains identiﬁcation and their susceptibility were performed by Vitek2
Compact automated system. Molecular identiﬁcation at the species
level was performed by PCR ampliﬁcation of blaOXA-51-like allele.
Susceptibility to imipenem (IP) was tested by standard disk diffusion
method, also in presence of EDTA, and by Etest MBL in according to
CLSI 2010 breakpoints. PCR analysis was performed for detection of
resistance gene and genotyping was carried out by multiplex PCR and
PFGE.
Results: Ab strains distribution in the wards was: 32.7% in Post-
Surgery Intensive Care Unit, 30.6% in General Intensive Care and Stroke
Unit, 10.2% in Pneumology, 8.2% in Cardiac Surgery, 8.2% in General
Surgery, 6.1% in Oncology/Medicine, 2% in Endocrinology and 2%
in Urology. All strains resulted resistant to cefotaxime, ceftazidime,
cefepime, amikacin, gentamicin, tobramycin, levoﬂoxacin, ciproﬂoxacin,
IP and meropenem (MP). 49/106 were found to be carbapenem
resistant. Isolates, showing amikacin MIC values ranging 2−8mg/ml,
displayed a double growth alone in disk diffusion test and exhibited
heteroresistance to amikacin by Etest. IP and MP MICs were >16mg/ml;
all Ab strains were susceptible to colistin. OXA-23 carbapenemase and
ArmA methylase production were the main mechanisms responsible of
carbapenem and aminoglycoside resistance. The Ab strains belonged
to a single clone and were related to pan-European clone II (RUH134).
Multiplex-PCR showed that isolates belonged to the sequence type Group
1, related to European clone II.
Conclusion: Our data show that the spread of MDR Ab is becoming a
substantial problem in our hospital; moreover, the results emphasize the
need to adopt surveillance programs to prevent colonization and infection
by MDR Ab in the hospital settings.
R2406 Incidence, evolution and antibiotic resistance of
multidrug-resistant microorganisms in urinary tract
infections: 2000–2009
J. Lozano Serra*, C. Sainz de Baranda Camino, J. Galan Ros, L. Robles
Fonseca, M. Martinez Serrano, M. Crespo Sanchez (Albacete, ES)
Objectives: To determine the epidemiology of urinary tract infections
(UTIs) by multiresistant microorganism isolation in hospitalized patients
and the community diagnosed at the Hospital Universitario (Albacete,
Spain) from 2000 to 2009; to study antimicrobial susceptibility to the
drugs commonly used in such infections.
Methods: 292,291 urine samples were processed for aerobic culture by
standard methods from January 2000 to December 2009. Identiﬁcation
and antimicrobial sensitivity testing were performed with the commercial
Wider® system (Soria Melguizo). The criteria proposed by the CLSI
were followed to detect multidrug resistance mechanisms. We considered
multidrug-resistant Pseudomonas aeruginosa (MRPA) with resistance
to 3 or more antibiotics of the following: ceftazidime, carbapenems,
quinolones and aminoglycosides; and multiresistant Acinetobacter
baumannii (MRA) when the isolate was sensitive to only tigecycline
and colistin.
Results: Of all the urine samples tested, 51,990 (18.0%) were positive.
Of these, (1,240; 2.4%) some MDR microorganism was isolated, 1,102
(88.8%) were extended-spectrum b-lactamase-producing Enterobacteria
(ESBL), 84 (6.8%) were meticilin-resistant Staphylococcus aureus
(MRSA), 28 (2.2%) were MRPA and 26 (2.2%) were MRA. Within
the ESBL-producing Enterobacteria we found 996 (90.3%) Escherichia
coli, 90 (8.1%) Klebsiella spp. and 12 (1.0%) Proteus spp.
Multidrug-resistant isolates increased from 3 in 2000 to 274 in 2009 in
both inpatients and the community. Of the 1,240 total patients, 1,188
(95.8%) were adults and 52 (4.2%) were children; 62.4% were women.
The antimicrobial resistance rates of ESBL-producing enterobacteria
were: nalidixic acid 77.6%, ciproﬂoxacin 64.8%, cotrimoxazole 60.0%,
gentamicin 22.0%, nitrofurantoin 7.8%, fosfomycin 4.2% and amocillin-
clavulanate 27.6%. No carbapenem resistant strains were found.
Conclusions: We observed an increase in the incidence of UTIs through
multiresistant pathogens during the study period, both in inpatients
and in patients with infections acquired in the community. Among
inpatients, the highest incidence corresponded to the Internal Medicine
and Geriatric Departments. ESBL-producing Enterobacteria were the
most frequently isolated multiresistant organisms. Carbapenems and
aminoglycosides could be the best choice for empiric treatement in
hospitalized patients. Quinolones and cotrimoxazole should not be
recommended due to the high resistance rates observed.
R2407 Frequency of extended-spectrum b-lactamase in Escherichia
coli and Klebsiella spp. and Proteus spp. over a ﬁve-year
period in a university hospital, Spain
M. Palacian, C. Marne, A. Rezusta*, M. Monforte, C. Villuendas,
G. Martin, M. Aı´sa, M. Marco, M. Hernandez, M. Revillo (Zaragoza, ES)
Objectives: To study the prevalence of extended-spectrum b-lactamase-
producing (ESBL) Escherichia coli, Klebsiella spp and Proteus spp
strains during the period 2005–2009.
Methods: A retrospective study of ESBL-producing E. coli, Klebsiella
spp and Proteus spp strains isolated from clinical samples of hospitalized
and outpatients attended in the Hospital Universitario Miguel Servet of
Zaragoza (Spain) from 2005 to 2009 was performed.
Isolates were identiﬁed and tested for antibiotic susceptibility by mi-
crodilution system (MicroScan Walkaway® Siemens). ESBL production
was conﬁrmed by the double-disk diffusion method according to CLSI
standards.
Results: In our study 27887 E. coli, 4422 K. pneumoniae, 1042
K. oxytoca, 1852 P. mirabilis and 45 P. vulgaris strains were isolated.
The prevalence of ESBL-producing Enterobacteriaceae is shown in
table 1. ESBL-producing strains were more frequently isolated from
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urine samples: 92.94% of E. coli, 64.10% of K. pneumoniae, 41.86% of
K. oxytoca and 100% of Proteus spp strains.
Conclusions:
1. During 2009 isolation of EBSL-producing E. coli. been increased.
2. E. coli remains the most frequent isolated species with this
characteristic.
3. The punctual increase in 2006 of ESBL K. oxytoca was due to an
outbreak in an intensive care unit.
R2408 High-throughput DNA sequencing of resistance plasmids:
a powerful approach to identify resistance and virulence
features
L. Villa*, C. Carta, A. Garcı´a-Ferna´ndez, D. Fortini, A. Carattoli
(Rome, IT)
Introduction: High-throughput DNA sequencing of resistance plasmids
allows a very quick determination of plasmid content. By this novel
approach it is possible to identify the major characteristics of resistance
and virulence and to trace the evolution of speciﬁc plasmid families,
recognizing their basis for virulence, host range, transferability and
stability.
We sequenced plasmids identiﬁed in Klebsiella pneumoniae (KP) of
nosocomial origin that were i) untypable by PCR-Based Replicon Typing
(PBRT); ii) relevant being characteristic of epidemic clones.
Materials and Methods: A procedure was devised to simultaneously
pyrosequence multiple plasmids by the 454 GS-FLX Titanium, using
MID-TAG barcoded primers in large volume emPCR (Roche, Italy).
Mobile DNA elements associated with resistance genes, regions
implicated in replication and plasmid host ranges, maintenance (toxin-
antitoxin, plasmid partitioning and exclusion properties) and transfer
were annotated.
Results:
i. The majority of the plasmids carrying blaSHV-12 gene are classiﬁed
as untypable being negative to the most common replicons of
Enterobacteriaceae. One of these plasmids belonged to the novel
IncR plasmid family. This plasmid family was characterized
by a novel replicase gene that we previously identiﬁed in a
Salmonella Montevideo from The Netherlands associated to the
qnrS1 gene (Garcı´a-Ferna´ndez et al. 2009). The novel fully
sequenced IncR-SHV-12 plasmid confers resistance to b-lactams
and cephalosporines (blaSHV-12, blaTEM-1, blaOXA9), but also
to mercuric ions, aminoglycosides (strA-strB, aacA4, aadA1) and
sulphonamides and is negative for the conjugative transfer locus,
suggesting in trans mobilization mediated by co-resident plasmids.
ii. The entire plasmid content of two KP ST258 strains (one multi-
drug resistant and one susceptible) was determined. The resistant
strain was positive for the carbapenemase KPC-3 located on plasmid
pKpQIL, previously identiﬁed in ST258 from Israel (NC_014016).
The susceptible ST258 contained virulence-like plasmids of the
FIIK type that likely contributed to the successful spread of this
clone, independently by the acquisition of antimicrobial resistance
genes.
Conclusions: Since plasmids can be considered as “genomes” within
the bacterial genome, a fully sequence approach may help to identify
the characteristics enhancing the successful spread of speciﬁc plasmid
families, but also the ability of plasmids to support the host survival and
spread.
R2409 Extended virulence proﬁle of major UPEC clones from
different origins and geographical locations
Aˆ. Novais*, J. Pires, L. Peixe (Porto, PT)
Objectives: Speciﬁc UTI-causing E. coli clones have been linked to the
emergence and spread of AbR genes but the complete virulence proﬁle
of these UPEC clones has only been assessed for a few lineages.
Methods: Our collection includes 104 B2-ST131 (n = 29), D-ST393
(n = 12), D-ST69 (n = 10), D-ST405 (n = 11), A-ST10 complex (n = 18),
A-ST23 complex (n = 13), B1-ST155 (n = 6) and B1-ST359 (n = 5)
isolates, representing isolates from a 19 year period (1991–2010),
different origins (62% hospital, 13.6% healthy volunteers, 13.6%
animals, 8.7% outpatients and 1% environment) and locations (n = 89,
8 EU countries; n = 4 Korea; n = 11 USA). Of these, n = 46 were UTI-
isolates and n = 60 were ESBL/AmpC producers. Clonal relatedness was
assessed by PFGE/MLST and phylogroups were identiﬁed by PCR.
Screening for 33 UPEC virulence factors (VFs) including adhesins,
toxins, siderophores, polysaccharide coatings and others (PAI, usp, ibeA)
was performed by PCR as described. ExPEC isolates were identiﬁed by
a previously described criterium.
Results: ﬁmH (90%), iutA (78%) and traT (71%) were found within
all STs. The number of VFs varied: ST131 or ST393 (n = 18); ST69,
ST405 or ST10 (n = 11−14); ST155 or ST359 (n = 7). Common virulence
proﬁles were established for each UPEC clone rather than for UTI-
causing isolates. ExPEC isolates (n = 55, 53%) belonged to all ST393,
all ST69 and most ST131, which were enriched in kpsMTII, iutA and iha.
ExPEC identiﬁed in nearly half ST23 and occasionally other STs had pap
alleles (papEF, papGIII or papC) and/or kpsMTII besides iutA. ST393
and ST69 were also signiﬁcantly enriched in pap alleles. Frequency of
usp (53%), sat (55%) and fyuA (58%) was high, though with varible
distribution: a) fyuA and sat among D and B2-EC and ST23/ST10,
respectively; b) usp among ST131, ST10, ST23 and ST359 (54% of
these were CTX-M-14 or CTX-M-15 producers). On the other hand,
speciﬁc VFs were only found in particular STs: i) PAI (31%) mostly
within ST131 and ST405; ii) cvaC (12%) was conﬁned to ST23 complex,
ST155 and ST359; iii) ibeA (4%) was only identiﬁed in ST131 non-
CTX-M-15 producers (TEM-4, TEM-24 or CTX-M-1); iv) sfa/doc (3%)
was found in ST155 and v) afa/dra (2%) was detected in ST131 isolates.
Conclusion: Consistent VFs proﬁles were found within STs, and
differences could not be explained by origin, pathogenesis or AbR
proﬁle. A and B1 UPEC proﬁle was linked to the presence of ﬁmH
(adhesion), iutA (iron uptake), traT (surface exclusion) colV (colicin)
and/or usp.
R2410 Outbreak of ertapenem-resistant widespread
Enterobacteriaceae clones in a Portuguese hospital
Aˆ. Novais*, C. Rodrigues, R. Branquinho, P. Antunes, G. Ribeiro,
L. Peixe (Porto, Coimbra, PT)
Objectives: The emergence of carbapenem resistance among ESBL-
producing isolates has been increasingly reported worldwide. We
aimed to characterize a recent outbreak of ertapenem (ERT)-resistant
Enterobacteriaceae isolates from a Portuguese hospital.
Methods: ERT-R (n = 15, MIC = 3−>32mgml, IMI and MER suscep-
tible) and ERT-S (n = 16, presumptive ESBL-producers) K. pneumoniae
(KP, n = 21), E. coli (EC, n = 7), E. asburiae (Eas, n = 1), E. aerogenes
(Eae, n = 1) and E. cloacae (Ecl, n = 1) isolates were studied (March-
August 2010). b-lactamase production was evaluated by phenotypic
tests, IEF, PCR (blaKPC, blaNDM, blaVIM, blaIMP, blaOXA, blaGES,
blaAmpC, blaTEM, blaSHV and blaCTX-M genes) and sequencing.
False positives obtained for carbapenemase production phenotypic
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assays were conﬁrmed spectrophotometrically. Strain identiﬁcation and
antibiotic susceptibility testing were performed by standard methods.
Clonal analysis included PFGE, MLST and identiﬁcation of E. coli
phylogroups. Plasmid content and blaCTX-M-15 location were assessed
by S1-PFGE. Presence of class 1 integrons, sul (sul1, sul2 and sul3)
and qnr (qnrA, qnrB, qnrS) genes was searched as described. Porins
(ompK35, ompK36, ompC, ompF, omp35 and omp36) were investigated
by PCR and sequencing, and SDS-PAGE.
Results: Seven ERT-non-S clones (3 KP, 1 EC, 1 Eas, 1 Eae and 1
Ecl, MIC 4−>32mgml), mostly producing ESBL/AmpC were detected.
A MDR KP-ST15 epidemic clone (n = 19, 3 PFGE-types, 63% urology-
transplant unit, sul2+) was the most frequently identiﬁed throughout
the whole period and included ERT-S (n = 10, PFGE A and B) and
ERT-R (n = 9, PFGE B and C, MIC 3−32mgml) CTX-M-15 encoding
isolates, bla within 50−70Kb plasmids. KP-ST14 and KP-ST45 (n = 1
each, MIC 12mgml) were sporadic non-ESBL producers. A CTX-
M-15-producing EC-B2-ST131 clone [n = 5 isolates/5 PFGE, ERT-R
(MIC= 32mgml) and ERT-S, different units] was detected at the end
of the period (06/07.2010), bla located in 130Kb plasmids. One ACT-2
carbapenem-R Eae, one TEM-24-producing Ecl (MIC 4mgml) and one
Eae (MIC >32mgml) clones were also identiﬁed (03/04.2010). Different
porin alterations were observed among ERT-R clones. qnrB (1 KP, 1
EC), qnrA (1Ecl) and class 1 integrons (dfrA25, dfrA17-Delta-aadA5
and aacA4) were sporadically detected.
Conclusion: This study reveals a complex allodemic scenario asso-
ciated with the emergence of ertapenem resistance among different
ESBL/AmpC Enterobacteriaceae widespread clones in Portugal.
R2411 Characterisation and clonal analysis of Klebsiella
pneumoniae sequence type 258 KPC-2 positive isolates
responsible for a nosocomial outbreak in northern Italy
T. Giani, R. Musumeci, S. Bramati*, R. Piazza, M.M. D’Andrea,
M. Manenti, C.E. Cocuzza, G.M. Rossolini, F.E. Vigano` (Siena, Monza,
IT)
Objectives: KPC are an important group of b-lactamases given their
spreading in nosocomial settings among Enterobacteriaceae. KPC-2
and -3 are the wider disseminated, found mostly on plasmids in
K. pneumoniae. KPC-positive K. pneumoniae (KPC-KP) have been
reported in many European countries. After the ﬁrst description of a
KPC-KP in Italy in 2009 only few reports has been published. Here
we report on the second Italian outbreak, discussing on clinical and
molecular features.
Methods: 22 K. pneumoniae isolates collected during 2010 at the San
Gerardo Hospital in Monza were analyzed as representative of 58 isolates
involved in the outbreak. Antibiotic susceptibility tests were performed
with Vitek 2. MICs for imipenem and meropenem were conﬁrmed
by Etest for isolates that were positive for carbapenemase production
(detected by phenyl boronic acid test). Clonal distribution were assessed
by rep-PCR, RAPD, PFGE and MLST. Selected isolates were subjected
to PCR analysis and sequencing to detect the pattern of resistance
determinants.
Results: The 22 investigated isolates showed a MDR phenotype being
susceptible only to colistin, gentamicin and tigecycline. Results of
genotyping techniques were all concordant and showed that all but
one isolates were clonally related and belonged to ST 258. All isolates
were conﬁrmed to be blaKPC-2 positive by sequencing. In addition the
investigated strains were positive for blaCTX-M-15 and all but one to
blaSHV-12 ESBLs. 36 additional isolates showing the same phenotypic
pattern were presumed to be related to the epidemic cluster.
Conclusion: Before November 2009 at the San Gerardo Hospital no
KPC-KP strains has been isolated. During the studied period, 22 clonally
related KPC-KP were obtained. Isolates belonged to ST 258 as the
ﬁrst described Italian KPC-KP. This clone is the major responsible
of worldwide spreading of these resistance determinants. Molecular
analysis demonstrated the presence in all isolates of blaKPC-2, and
blaCTX-M-15 and in all but one of blaSHV-12 b-lactamase. The only
KPC-KP isolate not clonally related to the outbreak clone, was positive
for blaSHV-1 determinant and was obtained from a patient transferred
from another Hospital. This different clone represent an exception in the
Italian epidemiological scenario where all described KPC-KP belonged
to ST258. The rep-PCR approach here described appear to be a rapid
and robust technique to investigate clonal relationship of KPC-KP.
R2412 Colonisation sites of extended-spectrum b-lactamase-
producing enterobacteria
L. Papst*, K. Seme, P. Gabrijel, B. Beovic (Ljubljana, SI)
Objectives: Detection and isolation of patients colonised with ESBL-
producing bacteria is an important measure to prevent transmission of
resistant bacteria in hospitals. In a prospective study we wanted to
determine the anatomical sites of ESBL-producing Escherichia coli and
Klebsiella pneumoniae.
Methods: Patients colonised or infected with ESBL-producing bacteria
were included in a prospective study from November 2009 to November
2010. Rectal swab, urine culture, and throat swab were performed in each
patient. Wound swabs were obtained in patients with wound, and sputum
was collected in patients with productive cough. Sample collection
was repeated every 3 months. Collected samples were inoculated on
chromogenic agar selective for ESBL-producing bacteria. Disc diffusion
method was done for K. pneumoniae and/or E. coli isolates to assess
antimicrobial susceptibility proﬁle for each isolate.
Results: 89 sample collections were done in 42 patients. Patients,
28 males and 14 females, were 24 to 94 years old (62 years on
average). 4 patients were on immunosuppressive therapy, 5 had a chronic
cardiovascular disease, 3 were diabetics on insulin, 2 patients had chronic
kidney failure and 3 had a chronic respiratory illness. 26 patients were
colonised with K. pneumoniae, 6 patients with E. coli, in 10 patients both
were isolated. At least one sample was positive for ESBL-producing
bacteria on 73 occasions. Rectal swab was positive on 68 (93.2%),
throat swabs on 22 (30.1%) and urine cultures on 25 (34.2%) occasions.
Sputum culture was performed 11 times, 6 (54.6%) were positive. Wound
swabs were positive in 50% (9/18 samples taken). On 5 occasions
(in 4 patients), in which rectal swab was negative, ESBL-producing
K. pneumoniae was isolated only from urine. In 3 out of these 4 patients
rectal swabs from initial sample collections were positive, together with
urine, throat or wound swabs. 6 to 12 months later, however, urine was
the only positive site, in 1 of the patients even on 2 subsequent occasions.
Conclusions: Our results have shown that rectal swabs are positive in
most patients colonised with ESBL-producing E. coli and K. pneumo-
niae. We can assume that rectal swab is an appropriate method for routine
screening for colonisation with E. coli and K. pneumoniae producing
ESBL. However, in some patients the urine may at least transitory be
the only positive site.
R2413 Epidemiology of bloodstream infections caused by
Enterobacter cloacae isolates producing the VIM-1 metallo-
b-lactamase in a neonatal unit of a tertiary Greek hospital
I. Daniil, E. Voulgari, N. Rekliti, M. Kimouli*, K. Ranellou, G. Vrioni,
D. Petropoulou, A. Tsakris (Piraeus, Athens, GR)
Objectives: Enterobacter cloacae isolates, which produce metallo
b-lactamases (MBLs) are regarded as an emerging clinical threat.
Infections by such pathogens involving neonates remain uncommon. We
analyzed clinical characteristics and outcomes of bloodstream infections
due to VIM-producing E. cloacae in preterm neonates who were
hospitalized in the neonatal unit of a tertiary hospital in Greece.
Methods: During a one-year period (Jan 2010-Dec 2010), neonates
presented bloodstream infections due to E. cloacae which exhibited
reduced susceptibility to carbapenems were studied. Bacterial isolates
were identiﬁed by Vitek 2 (bioMe´rieux). MICs were determined by
E-testing (AB Biodisk). Phenotypic testing was performed using the
modiﬁed Hodge test, the combined EDTA disk test and boronic acid
potentiation disk tests. PCR was used to screen for carbapenemase
genes (blaVIM, blaIPM and blaKPC) as well as for ESBL (blaCTX-M,
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blaTEM, blaSHV) and plasmid-mediated AmpC genes. DNA sequencing
was used to identify the MBL type gene.
Results: During the study, ﬁve premature neonates had bloodstream
infection due to carbapenem-non-susceptible E. cloacae. The isolates
exhibited variable carbapenem MICs ranging for imipenem from
1−4mg/ml, meropenem 1−16mg/ml and ertapenem 0.5−8mg/ml.
All isolates remained sensitive to tigecycline and colistin, while two
were resistant to gentamicin. Phenotypic tests were indicative of MBL
production. PCR was used for the veriﬁcation and identiﬁcation of the
carbapenemase; it conﬁrmed the presence solely of the blaVIM gene in
all isolates. DNA sequencing and BLAST search identifying blaVIM-1
gene. Of the 5 neonates, 4 were female and one male, their mean age
of gestation was 27.6±2.5 w and their mean weight was 0.974±0.218
kg. Three of the 5 neonates had been exposed to carbapenems during
their hospitalization prior to the reported bloodstream infection. Clinical
records of these premature neonates were analyzed and the attributable
mortality rate was 40%.
Conclusion: The study showed that premature neonates represent a
group of patients especially vulnerable to life threatening infections due
to MBL-producing E. cloacae isolates. Carbapenem MICs tend to be
variable for these strains and early detection remains a challenge for
the laboratory. The timely implementation of infection control strategies
is an absolute necessity in order to prevent the spread of these MDR
bacteria.
R2414 Dissemination of bla(DHA-1) genes by a putative ICE
among isolates of Enterobacteriaceae
C. Mata*, F. Navarro, E. Miro´, T. Walsh, M. Toleman (Barcelona,
ES; Cardiff, UK)
Objectives: DHA-1, an inducible acquired AmpC b-lactamase, confers
resistance to most b-lactams except cefepime and carbapenems.
Since a previous study displaying the genetic context of a well
characterized collection of 30 DHA-1 producers showed that donors
and transconjugants of two of these isolates of Escherichia coli carried
bla(DHA-1) on multiple plasmids as well as on the chromosome, one of
these isolates was selected for further analyses to better understand the
element mobilizing bla(DHA-1).
Methods: To check if results obtained by the ﬁrst study were
reproducible, we repeated the conjugation assays and picked up 25
independent transconjugant colonies, selected with ceftazidime and
rifampin. The plasmid and chromosomal location of bla(DHA-1) in the
parental and the 25 transconjugants selected was then investigated by
S1 and Xba1 digestion of the entire DNA followed by pulsed ﬁeld
gel electrophoresis (PFGE) and probing with 32P labelled bla(DHA-1)
probes.
Results: S1-PFGE and hybridisation analyses with bla(DHA-1) probe
among the donor and the 25 transconjugant colonies analysed revealed
that bla(DHA-1) genes were carried on plasmids in the donor and six of
the 25 transconjugants tested, but also on the chromosome in all cases.
Moreover, multiple hybridisation bands were observed when hybridising
the Xba1-PFGE with bla(DHA-1) in all transconjugants.
Conclusions: Acquired AmpC b-lactamases has recently been described
mobilised by integrative conjugative elements (ICEs). These elements
are capable to transfer themselves from chromosome to chromosome
via conjugation. As bla(DHA-1) was present on the chromosome of the
donor and was transferred to the chromosome of all 25 transconjugants,
we hypothesize that an ICE could be involved in the mobilisation the
bla(DHA-1) genes in these E. coli isolates.
R2415 Interactive MLST database management using the
BioNumerics® plugin, as illustrated on Campylobacter
B. Pot*, J. Dombrecht, J. Goris, K. Janssens, P. Vauterin, L. Vauterin
(Sint-Martens-Latem, BE)
Multi Locus Sequence Typing (MLST) is a method to discriminate mi-
crobial isolates through the partial sequencing of selected housekeeping
genes. The BioNumerics® software is widely used for the storage and
analysis of MLST sequences. With the use of an adapted plugin tool,
BioNumerics automatically assembles and processes sequence trace ﬁles,
connects to the online MLST database, and retrieves corresponding allele
numbers, sequence types as well as available clonal complex information.
In the case of Campylobacter jejuni and C. coli (http://pubmlst.org/
campylobacter/) 4378 proﬁles are available (24/02/2010) linked to 43
clonal complexes.
Using the BioNumerics® Minimum Spanning Tree (MST) we illustrate
the interrelation of these clonal complexes. MST’s are well-known in
the context of mathematical topology. When a set of distances is given
between n samples, a minimum spanning tree connects all samples
in such a way that the summed distance of all branches of the tree
is minimal. With the principle of maximum parsimony (MP), MST
shares the idea that evolution should be explained with as few events
as possible. In contrast to MP, a “classical” MST does not allow the
creation of hypothetical nodes, relying on all states present in the sampled
dataset to explain the relationships and evolution. Therefore, MST is
only applicable in studies focusing on a very short evolutionary time
frame (micro-evolution) and for complete datasets. The MST algorithm
presented here allows the creation of hypothetical nodes when the total
distance of the tree is reduced by a user-deﬁned number of events. In the
context of MLST, hypothetical nodes are usually missing allelic types
for which a number of single locus variants (SLVs) are present in the
dataset. Introducing hypothetical allelic types has proven to produce
more reliable models in non-complete sampled datasets. Additionally,
to select the MST that has the most probable evolutionary interpretation
among multiple equivalent solutions (degenerate trees), BioNumerics®
has editable priority rules for tie handling adopted from the BURST
program (http://www.mlst.net).
The data ﬂow will be illustrated through the processing of MLST trace
ﬁles from C. jejuni and C. coli isolates. An UPGMA dendrogram for a
mixture of MLST proﬁles of C. jejuni and C. coli, based on similarities
calculated by the categorical coefﬁcient, will be compared to a Minimum
Spanning Tree obtained using the same data.
R2416 Molecular-epidemiological analysis of nososcomial
carbapenem-resistant Klebsiella spp. by automated
rep-PCR and MALDI-TOF
M. Trevino*, D. Navarro, G. Barbeito, C. Garcı´a-Riestra, J. Llovo,
M.L. Pe´rez del Molino, M.A. Garcı´a-Zabarte, B.J. Regueiro (Santiago
de Compostela, ES)
Objective: Fast techniques for routine strain typing in the clinical
microbiology laboratory are useful tools. We report the results
of a comparative study between automated rep-PCR and whole-
cell matrix-assisted laser desortion ionization-time of ﬂight mass
spectrometry (MALDI-TOF MS) for molecular-epidemiological analysis
of nososcomial carbapenem-resistant Klebsiella spp.
Methods: Thirteen Klebsiella spp (9 K. oxytoca and 4 K. pneumoniae)
nosocomial isolates that were VIM-1 metallo-b-lactamase producers
were analyzed by automated rep-PCR (DiversiLab System) and MALDI-
TOF MS AXIMA. Species identiﬁcation was performed by Vitek 2
System and by MALDI-TOF. Antimicrobial susceptibility testing of
isolated bacteria were assayed using Vitek 2 System and Etest. DNA
array was used for detection of KPC and, TEM, SHV and CTX-M
extended spectrum b-lactamase. The detection of blaVIM-1 gene was
done by PCR and sequencing.
Results: All Klebsiella spp isolates except one K. oxytoca had the
blaVIM-1 gene and all K. pneumoniae had, also, blaSHV gene associated
to ESBL production. Rep-PCR using DiversiLab system showed higher
discriminatory power than MALDI-TOF spectra analysis for strain
typing.
Conclusions: The combined use of MALDI-TOF for species identiﬁca-
tion and DiversiLab System for clonal strain typing may be a useful tool
for fast and accurate management of nosocomial outbreaks.
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R2417 European Surveillance of Antimicrobial Consumption
(ESAC): trends in systemic azole consumption in hospital
care in Europe
N. Adriaenssens, S. Coenen, A. Versporten*, A. Muller, P. Zarb,
H. Goossens and the ESAC Project Group (Antwerp, BE)
Objectives: To describe trends in systemic azole consumption in hospital
care in Europe from 2005 till 2009 in the context of increased prevalence
of azole-resistant species.
Methods: Within ESAC (www.esac.ua.ac.be) adopting the anatomic
therapeutic chemical (ATC) and deﬁned daily dose (DDD) methodology,
data on hospital use of all 14 antimycotics (12) and antifungals (2) for
systemic use (ATC J02 and D01B), aggregated at the level of the active
substance, were collected for 2005–2009, and use was expressed in DDD
(WHO ATC/DDD, version 2010) per 1000 inhabitants per day (DID).
Only countries for which validated data were available for at least three
years, were included in the analysis.
Results: Data were available for 15 countries. Total systemic azole
use in hospital care on average represented 75% of the total hospital
antimycotic and antifungal use in all countries except in Croatia (72%),
Malta (68%) and Ireland (46%). In 10 out of 15 countries, total systemic
azole use in hospital care increased on average >5% each year between
2005 and 2009. In France, it declined on average >5% each year.
In Hungary, Ireland, Luxembourg and Slovenia no such changes were
observed. In 2009, ﬂuconazole was the most frequently used azole in
hospital care in all countries except in Slovakia (ketoconazole). In 2009,
azole consumption more than doubled in hospital care in Denmark,
Finland, Latvia and Croatia compared to 2008.
Conclusion: Our study demonstrates a trend of increased systemic azole
use in hospital care in Europe contrasted by a decreasing use in France.
These trends are mainly driven by ﬂuconazole use, and call for closer
monitoring of antimycotic and antifungal use and resistance.
R2418 Stability and administration of cefotaxime in glucose 10%
in continuous infusion in neonates
A.A. van Boekholt*, H.W. Huntjens-Fleuren, G.P. Gerrits,
B.A. Semmekrot, M.E. den Hollander, J.W. Mouton (Nijmegen, NL)
Objective: Cefotaxime is a widely used antibiotic in the treatment of
neonatal infection. Dosing of b-lactam antibiotics by continuous infusion
has been suggested to improve treatment outcome, as compared to
intermittent infusion. However, continuous infusion is critical in neonates
because of ﬂuid and salt restriction. Glucose 10% is often used as
a nutrient supply in neonates and could at the same time serve as a
good solvent for cefotaxime. Yet, stability data of cefotaxime in glucose
10% are lacking, restraining pediatricians from continuous infusion of
cefotaxime. We investigated the stability of cefotaxime in glucose 10%.
Method: Cefotaxime was dissolved in glucose 10% in a concentration
of 80mg/ml and stored at room temperature. Cefotaxime levels were
measured every sixty minutes for eight hours and after 24 hours using
a validated High Performance Liquid Chromatography (HPLC) method.
All measurements were performed in duplicate. Values estimated for
each sample at subsequent time points were calculated as percentages
of the initial concentration. Recovery below 90 percent of the initial
concentration was deﬁned as signiﬁcant loss, using worldwide standards.
Results: The relative concentration time curve is shown in ﬁgure 1. After
24 hours, the cefotaxime concentration declined to 98.1% (SEM 1.65),
indicating that cefotaxime is stable for at least 24 hours in glucose 10%.
Conclusion: Even after 24 hours, cefotaxime does not decrease to the
90% limit of stability in a concentration of 80mg/ml when dissolved in
glucose 10%. Glucose 10% is a good solvent for cefotaxime allowing
continuous infusion with changes of infusion bags only once a day.
This facilitates optimal treatment, allows glucose supplementation and
reduces nursing staff workload.
R2419 Congruence of suspected clinical diagnosis in the origin of
the bacteraemia and ﬁnal diagnosis. Is it important in the
prognosis evolution of bacteraemia?
J.M. Ruiz Giardı´n*, J. Ortiz, J. Sanmartı´n, C. Jime´nez, N. Cabello,
A. Barrios, R.M. Martı´n, I. Garcı´a, J. Jaquetti (Fuenlabrada, ES)
Objective: Analysis of diagnostic accuracy of the suspected origins
of the bacteremias and the prognostic inﬂuence of the type of
microorganism, adquisition, empirical treatment and origin of bacteremia
in the evolution to death.
Material and Methods: A retrospective study of bacteremia diagnosed
during 2 years in a South Hospital in Madrid, analyzing suspected origin,
ﬁnal origin, acquisition, microorganism, empirical therapy and evolution
to death.
Results: 326 bacteremia were analyzed. Congruence between diagnosis
suspected/deﬁnitive origin of nosocomial bacteremia was 80,26% (61/76)
with a difference of 19,7% (95%CI 10,7% to 28,6%), Sig: <0,001.
Congruence between diagnosis suspected/deﬁnitive origin of community
bacteremia was of 81,3% (192/236) with a difference of 18,6% (95%CI
15,6% to 30,6%), Sig: <0,001. Bacteremias of respiratory origin had a
percent of apropriate empiric diagnosis of 93,5% while that of vascular
origin, only 56%.
S. pneumoniae had a percent of apropriate empiric diagnosis of
91,6%, while non-fermentative Gram-negative bacilli 60% and coagulase
negative Staphylococcus 52,1%.
Mortality was 2,95 CI 95% (1,01 to 4,29) fold higher in bacteremic
inadequate empirical antibiotic treatment. The mortality in the group
receiving inadequate antibiotic therapy was 19,7%. Difference between
both groups was 9,1% CI 95% (0,8% to 19%) Sig: 0,042. The difference
in mortality between the group with right and wrong suspected diagnosis
of origin of bacteremia was 3,45% CI 95% (−0,6% to 13,5%) Sig: 0,47.
OR 1,33 (95%CI 0,59 to 2,99).
Conclusions: Clinicians have a high degree of suspicion about correct
original focus of bacteremia, higher in the respiratory origin and lowest
in those of vascular origin, and these data are consistent with the type
of microorganism. The degree of success does not affect the overall
mortality of bacteremia but empirical treatment does it.
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R2420 Colistin by inhalation: superior for the treatment of
nosocomial pneumonia associated with multidrug-resistant
Pseudomonas aeruginosa as compared to parenteral
administration? A retrospective observational study
R. Naesens*, E. Vlieghe, W. Verbrugghe, P. Jorens, M. Ieven (Edegem,
BE)
Objective: To investigate the outcome of patients treated with colistin
either by IV or inhalation therapy for nosocomial pneumonia associated
with multidrug-resistant (MDR) Pseudomonas aeruginosa.
Methods: A retrospective study of 20 intensive care patients with
a pneumonia associated with MDR P. aeruginosa receiving colistin
sulphomethate sodium (Colistineb®) between 2007 and 2009 was
performed. A strain was considered multidrug-resistant if it was resistant
to at least 6 of the following antibiotics: piperacillin-tazobactam,
ceftazidime, cefepime, meropenem, aztreonam, ciproﬂoxacin, and
amikacin. The administration mode, predicted mortality based on the
SAPS3 score, SOFA score at onset of the colistin treatment, clinical
and microbiological response, and mortality during the episode of the
infection were analysed. The non parametric Kruskal-Wallis and Fisher’s
Exact test were used for statistical analysis of respectively the predicted
mortality/SOFA score and mortality rate.
Results: Six patients received colistin by inhalation only, 5 were
treated only parenterally, and 9 by a combination of both administration
modes. All patients received concomitant be`talactam therapy. The mean
predicted mortalities were respectively 72%, 68%, and 69% (p = 0.91).
SOFA scores at the onset of the treatment were also comparable
(p = 0.87). Clinical response was favourable in all patients receiving
colistin by inhalation (6/6) and in 40% (2/5) of the patients receiving
colistin parenterally (p = 0.06). In the patients with colistin administered
both via inhalation and parenterally, clinical response was favourable in
78% of the patients (7/9) (p = 0.27 as compared to the treatment group
receiving colistin only parenterally). When all patients with inhalation
therapy were compared to the group without inhalation therapy, a
favorable clinical response was present in respectively 87% and 40%
(p = 0.06). In none of the patients, the Pseudomonas spp. was eradicated
from the follow-up cultures.
All patients in the parenterally treated group died. None of the patients
receiving colistin by inhalation, and 3 of 9 patients of the combination
group eventually died (p = 0.002 and p = 0.03 respectively as compared
to the group receiving colistin only parenterally).
Conclusion: Aerosolized colistin could be beneﬁcial as adjunctive
treatment for the management of pneumonia associated with MDR
P. aeruginosa.
R2421 A point-prevalence study on surgical antibiotic prophylaxis
in a tertiary care hospital and evaluation of the use of the
surgical prophylaxis guide
Z. Kocak Tufan, C. Bulut*, E. Kaya Kilic, C. Sonmezer, S. Altun,
F. Temocin, N. Tulek, S. Kinikli, A. Demiroz (Ankara, TR)
Objectives: Inappropriate use of antimicrobial drugs is associated
with increased hospital expenditure, emergence of resistant bacteria
and unnecessary side-effects. Concerning this, antibiotic stewardship is
among the main concerns of the hospital infection control programmes.
A “surgical antibiotic prophylaxis guide” was established in our
hospital in 2008. The aim of this study was to investigate the point
prevalence of antibiotic prophylaxis in surgery clinics and to evaluate
the appropriateness of the antibiotic use.
Methods: The study was conducted in the Ankara Training & Research
Hospital, a 670-bed tertiary care teaching hospital. The hospital contains
23 operation rooms and over 15.000 operations are performed within a
year. On the 16th of December 2010 infectious diseases consultants went
to the operation rooms of eight surgery clinics (Plastics & reconstructive
surgery, general surgery, ophthalmology, ear-nose-throat, orthopaedics,
urology, obstetrics & gynaecology (O&G) and neurosurgery) and
investigate the prophylactic antibiotic regimen before the surgeries. The
duration of the intended use of antibiotics after the surgeries was also
included in the questionnaire.
Results: Seventy-two of 196 hospitalized surgery patients were
underwent different kind of surgeries. 50 of them (69.4%) were
using prophylaxis. Cefazolin (45.8%), sulbactam-ampicillin (11.1%)
and ceftriaxone (6.9%) were the most frequent antibiotics used for
prophylaxis. In four patients (5.6%) combined antibiotics (metronidazole
plus any antibiotics above) were used. 30.6% of the patients did not
get any prophylaxis. The mean duration of the antibiotic use was 2.7
(1−22) days and the intended use of the antibiotic prophylaxis after the
surgeries was 3.8 (1−10) days. 45 (62.5%) of the antibiotic prophylaxis
regimens were inappropriate according to the guidelines. The reasons for
the inappropriateness were as follows: wrong antibiotic (8.9%), wrong
doses and duration (84.4%) and no antibiotics in spite of the need (6.7%).
Conclusion: The current study showed a high percentage of inappro-
priate surgical prophylaxis regimens in our hospital. The main problems
about the inappropriate prophylactic antibiotic use were the dose and the
duration (84.4%). The chosen antibiotic was 91.1% right. As conclusion
we suggest that the hospital infection control programmes must include
the follow up of the use of established guidelines, just introducing them
seems to be not efﬁcient.
R2422 Therapy approach and problems in treatment of tularaemia
patients in Serbia
M. Djordjevic-Spasic*, V. Kostic, B. Lako, A. Potkonjak (Nis, Novi
Sad, RS)
Objectives: The ﬁrst epidemic of tularemia in South-eastern Serbia
happened in 1999. During a 10 years period, from 1999. till 2008, 151
patients were hospitalized and treated. The purpose of the study was to
analyze and determine the best therapy choices in patients suffered from
tularemia.
Methods: Before hospitalization 16.5% were not treated, 58.8% were in-
adequately treated, 10.3% were adequately treated and 14.4% unknown.
An average duration of disease before hospitalization was 35 days.
Antibiotic monotherapy was administrated to 53 patients: gentamicin
(27 patients), ciproﬂoxacin (11), amikacin (8), streptomycin (5) and
doxycycline (2 patients). Combined (polyvalent or successive) antibiotic
therapy was administrated to 98 patients: gentamicin and ciproﬂoxacin
(66 patients), gentamicin and doxycycline (18), ciproﬂoxacin and
doxycycline (2), gentamicin, ciproﬂoxacin and doxycycline (12 patients).
Results: The biggest success in treatment (75% cured) was noticed in
patients after combination of gentamicin, ciproﬂoxacin and doxycycline,
then combination of gentamicin and ciproﬂoxacin (71%), then monother-
apy of gentamicin (68%) and combination of gentamicin and doxycycline
(67% cured). In comparison to number of treated patients, the biggest
success in treatment (71%) had the combination of gentamicin and
ciproﬂoxacin, then monotherapy of gentamicin (68%).
Outcome of medicamentosus treatment: 92 patients (61%) of 151
were totally cured. The complications happened in 59 patients (39%):
1. abscessing of lymph nodes with or without ﬁstulisation at 36 patients
(23.8), 2. relapse − 12 patients (8%), 3. both complications at 11
patients (7.2%) (graphic 1). The relapses included recidivante lymph
node enlargement or intake more than one lymph nodes. Final outome
after conservative and radical treatment was total curing of 143 patients
(94.7%) and residual persistant lymphadenopathy at 8 patients (5.3%).
Conclusion: Reasons for appearance of complications during therapy of
tularemic patients:
1. inadequate initial antibiotic treatment
2. late onset of adequate antibiotic therapy
3. possible appearence of resistant species of F. tularensis in the region
of South-eastern Serbia.
Early, forehand treatment restrains the colliquation of lymph nodes,
recurrence of disease and dissemination of infection. Early diagnosis
and treatment are crucial for prevention of complication and complete
curing.
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R2423 Impact of an antimicrobial stewardship program in a
second level hospital
H. Monzon*, M. Salvado´, M. Estelrich, A. Gaso´s, C. Serrano,
F. Montaner (Martorell, ES)
Objective: There is a variety of methods to improve antimicrobial
appropriateness in hospitals. The aim of our study was to investigate
the inﬂuence of an antimicrobial stewardship program on antibiotic use
at the Hospital Sant Joan de De´u de Martorell.
Methods: The study was conducted in a 132 bed-hospital. Antibiotic
consumption was monitored one year prior (2008) and one year
during (2010) the antimicrobial stewardship program. During 2009,
internal protocols were reviewed and actualized. The antibiotic
working group included a clinical pharmacist, a microbiologist and an
attending infectious disease physician who provided clinical backup.
This group met once a week and checked the indication, dose,
frequency and duration of restricted antibiotics (including carbapenems,
voriconazole, vancomycin, piperacillin-tazobactam, linezolid, cefepime,
aztreonam, liposomal amphotericin and amikacin). When needed, the
group contacted the physician in charge in order to improve the
treatment. Antibiotic utilization was measured in deﬁned daily doses
(DDD)/100 bed days. Multiresistant bacteria comprising multidrug
resistant P. aeruginosa, methicillin resistant Staphylococcus aureus,
extended spectrum b-lactamase and AmpC b-lactamase producing
Klebsiella and E. coli strains were selected from all the cultures of
P. aeruginosa, Staphylococcus aureus, E. coli and Klebsiella spp.
Results: Total antimicrobial consumption in 2008 was 74.5 DDD/100
bed days in front of 86.75 DDD/100 bed days in 2010. After
implementation of the program, use of restricted antibiotics decreased
from 10.11 DDD/100 bed days in 2008 to 9.26 DDD/100 bed days in
2010. Seventy three interventions were performed related to: antibiogram
susceptibility (34), treatment duration (18), incorrect diagnosis (16) and
wrong dose (5). Meropenem and piperacillin-tazobactam were the most
overused antibiotics.
Multiresistant bacteria increased from 5.76% in 2008 to 7.45% in 2010.
Conclusions: Although total antimicrobial consumption and multiresis-
tant bacteria increased in 2010, the implementation of a multidisciplinary
antibiotic working group reduced the use of restricted antibiotics.
R2424 Fosfomycin and multi-resistant bacteria
A. Dinh*, J. Salomon, J. Bru, L. Bernard (Garches, Annecy, Tours, FR)
Objective: For several years, antimicrobial resistance rates among
bacteria have continued to rise, with limited therapeutic options due
to the shortage of new antimicrobial agents. This situation has led to
renewed interest in old antibiotics such as fosfomycin. We evaluate
efﬁcacy and safety of fosfomycin on resistant bacteria especially in
critically ill patients.
Method: Retrospective study evaluating the use and efﬁcacy of
fosfomycin as the only covering drug for 27 infections due to multi
resistant bacteria.
Results: Twenty seven patients (15 males, 12 females, mean age
was 60 year (range 18−81)). Indications for antibiotherapy was lung
infections for 15 patients (53.5%), complicated urinary tract infections
(UTI)for 8 (28.5%), abdominal infections for 3 (10.7%) and bacteraemia
without onset for 1. Four (4/27) patients had positive blood culture, 18
(18/27) were admitted to intensive care unit (18/27) and 11 (11/27)
presented septic shock. Infections were monomicrobial (85.7% n= 23)
or plurimicrobial (14.3% n= 4). The main identiﬁed bacteria were
P. aeruginosa (n = 22), then Stenotrophomonas maltophilia (n = 4). Mean
global treatment duration was 16.8±7.0 days (lung infection 22±6.8,
complicated UTI 14.0±2.13, and abdominal infection 19.6±9.1).
22 (85.7%) patients were cured and 5 died, 12 (12/15) patients with
lung infection were cured, 2 (2/3) for abdominal sepsis, 8 (8/8) for
complicated UTI. The patient with bacteraemia without onset died during
ﬁrst month after sepsis. No adverse events possibly due to fosfomycin
were reported.
Concerning monomicrobial infection due to P. aeruginosa, 15 (15/16)
patients have favourable outcome. Fosfomycin seems to be an excellent
choice for infections due to resistant Pseudomonas aeruginosa.
Conclusion: Our study included a high number of critical situations with
67.9% of patients admitted to intensive care unit and 39.2% involving
septic shock. Considering resistant bacteria and critical situations, the
global outcome was attractive.
Parenteral fosfomycin combined with another antibiotic appears to be
safe and effective treatment for severe infections caused by resistant
bacteria sensitive only to this antibiotic. A further beneﬁt is its low
(~3%) and stable rate of resistance in countries in which it has been
in use for a long time. This should be conﬁrmed by further studies to
substantiate this ﬁnding.
R2425 UK registry experience of the treatment of infective
endocarditis with daptomycin
A. Guleri* on behalf of the UK EU-CORE group
Objectives: To describe the real world clinical experience of the use of
daptomycin (DAP) for the treatment of infective endocarditis in the UK.
Methods: A retrospective non-interventional review of patients (pts)
receiving DAP in 8 UK institutions participating in the European
Cubicin® Outcomes Registry and Experience (EU-CORESM) during the
ﬁrst 2.5 years of the registry. Efﬁcacy was evaluated by the investigator
at the end of DAP therapy as cured, improved, failure and non-evaluable.
Data were collected on demographics, antibiotic usage, microbiological
and clinical outcomes and adverse events from pts treated between
January 2006 and August 2009. Patients (pts) were categorised by
severity (complicated and uncomplicated) and the anatomical site of the
primary infection. All pts included in the registry had received at least
one dose of DAP.
Results: 51 pts with a mean age of 61 yrs were treated. The majority
of pts had signiﬁcant underlying disease (86%). 55% had left-sided IE.
Both sides were involved in 16%, 14% had right-sided and 14% foreign
body involvement. Prior antibiotics had been received by 84% pts, with
the reason for discontinuation of therapy being loss of susceptibility/
resistance in 46% pts. Cultures were obtained for the primary infection
in 94% pts. Staphylococcus aureus was the most frequently isolated
organism (31%), followed by and coagulase-negative staphylococci
(14%) and Streptococcus spp (8%) Heart valves were replaced in 22%
pts, but there was no surgical intervention in the majority of pts
(72%). Mean duration of therapy was 21 days and 63% of pts received
concomitant antibiotics. DAP 6mg/kg 24h was the most frequently used
dose. Clinical outcomes were success, deﬁned as ’cure plus improved’
(73%), failure (4%) and non-evaluable (23%). Adverse events were
reported regardless of study drug relationship and were experienced by
29% of pts. The mean time to clinical improvement was 6 days. Therapy
was stopped because of an adverse event in 12% pts.
Conclusions: Despite the number of prior antibiotic failures and multiple
comorbidites in these pts the overall clinical success rate in this UK
population was 73%. There is emerging evidence that DAP is being
used to treat infections caused by other Gram-positive species that are
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of increasing importance in IE, particularly where treatment options may
be limited. The data from the current series adds to the body of evidence
for the efﬁcacy of DAP in left-sided IE.
R2426 Nebulised antibiotics for the treatment of patients with
non-cystic ﬁbrosis bronchiectasis with chronic Pseudomonas
aeruginosa colonisation
J.R. Donado*, B.C. Jime´nez, M.E. Fuentes, J.M. Ruiz-Giardin,
V. Valeri-Busto, M.A. Racionero, E. Prats, N. Cabello, J.V. Sanmartı´n,
A. Barrios, A. Zapatero (Madrid, ES)
Objectives: To describe the effect of nebulized antibiotics (NA) on
hospital admissions and length of hospital stay in patients with non-cystic
ﬁbrosis bronquiectasis (BQ), chronically colonized by Pseudomonas
aeruginosa (PA) during the last 5 years.
Methods: Retrospective case review of BQ patients with PA isolated
from sputum at least twice during the year prior to NA administration
and a minimum 6-month follow-up. Main outcomes were number of
hospital admissions and length of stay before and after NA. Data on
clinical, microbiological and functional changes and tolerability was also
collected.
Results: Seventeen patients were included (9 men), median age 69.7
years, average follow-up 753 days (range 183–1824). Initial treatment:
tobramycin (TOB) in 9 patients, colistin (COL) in 7 and gentamicin
(GEN) in 1. Nine patients received more than 1 NA during follow-up,
resulting in a total of 31 NA courses: 16 with COL (average dose:
2.875.000 U/day), 14 with TOB (average dose: 442.857mg/day), 1 with
GEN (320mg/day). Average treatment duration was 492.47 days (range
100–971).
Subjective clinical improvement after NA was described by 12 patients
(70.5%) and microbiological eradication of PA was conﬁrmed in 7
patients (41.2%), though there was 1 relapse. NA did not result in clinical
improvement in 2 patients, though it was well tolerated. Three patients
did not tolerate any of the NA administered (at least COL and TOB).
Table 1 shows the reduction in mean number of admissions/year and
mean lenght of stay/year in days after NA onset for all patients. A
statistically signiﬁcant reduction is observed when PA is eradicated.
On the whole, 8 patients presented side effects at any time during
treatment (47%), mainly bronchospasm (60%).
Side effects that prompted treatment interruption were observed during
15 NA courses: 6 with COL (40%), 8 with TOB (53.3%) and 1 with
GEN.
Conclusions:
1. NA resulted in clinical improvement in 70.5% of BQ patients and in
eradication of PA in 41.2%.
2. NA reduced number of admissions and length of stay per year in
all patients. A statistically signiﬁcant reduction was observed in
patients that achieved PA eradication, in whom NA prevented nearly
2 admissions per year.
3. Side effects were observed in 47% of patients and 17.6% did not
tolerate any NA.
R2427 Trends in regional outpatient antibiotic prescription data
and interventions in the Dutch-German EURSAFETY
HEALTH-NET project
A. Jurke*, M. Flume, A. Kintrup, R. Ko¨ck, I. Daniels-Haardt,
A.W. Friedrich (Mu¨nster, Dortmund, DE)
Increasing prescription of broad-spectrum antibiotics is regarded to
facilitate selection of multiresistant germs. Surveillance of outpatient
antibiotic use might contribute to the efforts made for preventing
the spread of Methicillin-resistant S. aureus (MRSA) within regional
networks. In the EURSAFETY HEALTH-NET, this issue has been
addressed by offering training sessions on MRSA and antibiotic
awareness to general practitioners in cooperation with the Association of
Statutory Health Insurance Physicians Westphalia-Lippe (KVWL) which
represents the German part of the EUREGIO and other regions in North
Rhine-Westphalia. Furthermore, in 2006, a possibility for reimbursement
of MRSA eradication therapy in outpatients has been created. We present
data comparing the use of selected antibiotics in outpatient care of
medical doctors in the EUREGIO to those in other KVWL regions.
Regional data for outpatient prescription of antibiotics (based on Deﬁned
Daily Doses (DDD)) were collected by the KVWL and analyzed for the
years 2002 to 2009. In order to compare the prescription of different
antibiotics like ﬂuoroquinolones or mupirocin in the EUREGIO to the
whole KVWL region, we used the Cochrane Armitage Trend Test.
Altogether, a total of 12.2 DDD/day per 1,000 inhabitants (DID) were
prescribed in 2002, followed by 12.9 DID, 12.9 DID, 14.4 DID, 13.8
DID, 14.4 DID, 14.7 DID and 14.8 DID from 2003 to 2009, respectively.
From 2002 to 2009 the percentage of prescriptions of all antibiotics and
of ﬂuorochinolones decreased signiﬁcantly in EUREGIO relating to the
whole KVWL region. In contrast, the number of mupirocin prescriptions
increased signiﬁcantly more in EUREGIO than in KVWL region.
As desirable, the medical doctors in the EUREGIO region tends to more
prudent antibiotic use. The increasing number of mupirocin prescription
among outpatients reﬂects the growing demand and, facilitated by
new refunding possibilities, the increasing implementation of MRSA
eradication therapy in outpatient care. Regional trends which may reﬂect
effects of interventions can be observed in routine data.
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R2428 Haemophilus inﬂuenzae and Haemophilus haemolyticus
identiﬁcation and serotyping by molecular methods
H. Farghali, J. Bruin, E. IJzerman, R. Jansen* (Haarlem, NL)
Isolates of the non-pathogenic Haemophilus haemolyticus from respi-
ratory samples are often misclassiﬁed as non-typeable H. inﬂuenzae
because bacteriological techniques are not sufﬁcient to distinguish these
two closely related species. The presence of H. haemolyticus among
the H. inﬂuenzae isolates hampers studies on the pharyncheal ﬂora
and limits the use of Slide Agglutination SeroTyping (SAST), since
H. haemolyticus may give false positive results.
Objectives: The development of a novel protocol for the distinction
of the two Haemophilus species and the subsequent serotyping of
H. inﬂuenzae isolates by molecular methods.
Methods: The protocol consists of two parts: a PCR to distinguish
between H. inﬂuenzae and H. haemolyticus using the 7F3 epitope of
the ompP6 gene, followed by PCRs on the bexA and capsular genes for
serotyping.
Results: Among 386 isolates from vaccinated children, we found 18%
H. haemolyticus isolates and 82% H. inﬂuenzae. The latter species was
conﬁrmed by the presence of the iga gene, a marker for H. inﬂuenzae.
By SAST we found that all the H. haemolyticus isolates reacted falsely
with the serotype a antiserum, while as expected the bexA and capsular
genes were absent in these isolates.
Conclusions: The distinction of the two Haemophilus species by the
ompP6 PCR and the subsequent serotyping of H. inﬂuenzae gives
unequivocal results that will aid studies on the pharyncheal ﬂora.
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R2429 A 37 kDa/83 kDa RNase L isoform ratio could be used as
a biochemical marker for chronic brucellosis patients
M.J. Castan˜o*, L. Moreno, E. Navarro, R. Serrano, R. Calero, J. Solera
(Albacete, ES)
Objectives: Chronic brucellosis (CB) and chronic fatigue syndrome
(CFS) are characterized by a collection of non-speciﬁc symptoms
and long-lasting fatigue. Of note, there are no objective clinical and
diagnostic ﬁndings in both CB and CFS. A low-molecular-mass (37 kDa)
isoform of RNAse L has been described in peripheral blood mononuclear
cell (PBMC) extracts and the ratio of two isoforms of RNAse L (37
kDa/83 kDa) has been proposed as a potential biochemical marker of
CFS (Tiev et al., 2003). To our knowledge, the RNase L has never been
analyzed in CB patients.
The aim of this study was to determine the ratio of the 37kDa/83KDa
isoforms in CB patients and compare the results with healthy well-
matched volunteers.
Methods: The CB group consisted of 9 patients (5 women and 4 men;
mean standard deviation (SD) age: 49±9 years) that had been diagnosed
with brucellosis between ﬁve and 35 years prior to the study. Two of
the CB patients had focal disease (one spondylitis and one multifocal
motor neuropathy). The remaining 7 subjects had non-speciﬁc symptoms
such as fatigue, malaise, arthralgia and/or myalgia. Five of the 9 CB
patients had been diagnosed of CFS. The control group consisted of
7 matched healthy volunteers (4 women and 3 men; mean standard
deviation (SD) age: 31±3 years). PBMCs were isolated by density-
gradient centrifugation. Target proteins were probed using a Western
Blot procedure.
Results: PBMC extracts from all subjects give rise to a major 83 kDa
and a minor 37 kDa polypeptide band. The ratio of RNase L isoforms
(37 kDa/83 kDa) of 0.4 used as a cut-off, allowed discrimination of CB
patients from controls with high sensitivity (88.9%), speciﬁcity (85.7%),
a positive prognostic value (88.9%) and a negative prognostic value
(85.7%). The mean amount of the ratio of RNase L isoforms (37 kDa/83
kDa) in chronic brucellosis patients (0.84) was higher than in healthy
subjects (0.22) (P< 0.05).
Conclusion: The chronic brucellosis patients are more likely to show
a higher ratio of the two isoforms of RNAse L (37 kDa/83 kDa) than
the healthy subjects. A high 37 kDa/83 kDa ratio of the RNase L could
distinguish CB patients from healthy subjects.
R2430 Rapid molecular detection of S. aureus nasal colonisation
among patients undergoing urgent surgery
D. Schwartz*, O. Shalom, E. Dor, B. Avidor, Y. Carmeli (Tel Aviv, IL)
Objectives: Recent publications suggest that 20−30% of surgical site
infections are caused by S. aureus, and half of these arise from
endogenous ﬂora. This study evaluates rapid molecular identiﬁcation of
S. aureus nasal carriage from patients undergoing urgent surgery.
Methods: The study was carried out in Tel-Aviv Medical Center from
9.5–30.11.2010. Patients were selected from different surgical wards:
neurosurgery, thoracic, orthopedic, vascular and plastic surgery. Nasal
swabs from the patients were collected using a double swab; one swab
was used for molecular testing on GeneXpert (Xpert MRSA/SA Nasal
Assay − Cepheid) and the other was used for conﬁrmatory culture on
solid (chromagar MRSA II and 5% sheep blood) and liquid medium
(brain heart Infusion broth).
Results: 174 patients were sampled. 54 patients (31%) were found to
be cariers of S. aureus by molecular testing: 49 (28%) MSSA, 5 (2.9%)
MRSA. Compared to routine culture the sensitivity and speciﬁcity of the
molecular testing were 94% and 95% respectively; the positive predictive
value (ppv) and negative predictive value (npv) were 89% and 98%.
13 patients had invalid results on initial molecular testing. On repeated
molecular testing (with the swab used initially for culture) only 3 had
invalid results.
Conclusion: Xpert MRSA/SA Nasal Assay is capable of rapid and
accurate detection of MSSA and MRSA nasal colonization. Further
studies are needed in order to reduce invalid results.
R2431 Clinical usefulness of a PCRQ assay in a case of chronic
brucellosis with multifocal motor neuropathy
E. Navarro*, M.J. Castano, B. Rallo, J.M. Pardal, J. Solera (Albacete,
ES)
Objective: To test the clinical usefulness of a quantitative real time
PCR (PCRQ) assay for the diagnosis of one chronic brucellosis (CB)
case with multifocal motor neuropathy (MMN).
Patient and Methods: Blood, serum and a cerebrospinal ﬂuid (CSF)
sample from one patient with MMN were analyzed by a PCRQ assay to
detect and quantify Brucella melitensis DNA (Navarro et al. Clin Infect
Dis. 2006 May 1; 42(9): 1266−73).
Case report and Results: A 44-years-old man, veterinarian. In 1990
he pricked with a Rev-1 B. melitensis strain and experienced clinical
features compatible with acute brucellosis with positive serology for
Brucella spp. He received doxycycline (Dox) for 45 days. Eight months
later he developed a MMN. In December 2002, he started treatment
with rifampicin (RFP) for 40 days, followed by cyclophosphamide for
6 months, coinciding with improvement of the left hand mobility. In
June 2006, he consulted the Internal Medicine Department because he
considered that his neuropathy was related to the initial brucellosis
episode. Serology was positive for the RB, Coombs (1/40) and
Brucellacapt (1/40) tests. The PCRQ assay was positive in blood
(461copies/ml) and negative in serum. In November 2002, he received a
new treatment with Dox+RFP for 8 months, with transient improvement
of symptoms and the electromyogram. During the 3 years follow-up,
we analyzed 49 samples (24 blood, 24 serum and a CSF sample).
The CSF sample was negative for both serology and the PCRQ
assay. Three months after completion of the treatment, the patient
resumed it for 6 months, because he considered that his clinical
improvement was associated with antimicrobial therapy. During the
second treatment period 10 samples (5 blood, 5 serum) were analyzed
by PCRQ. Only one serum sample was positive with 1125copies/ml.
Blood samples were negative. In the last year post-treatment follow-up,
we analyzed 12 samples (6 blood, 6 serum) which were all negative by
PCRQ. Conventional serology showed no detectable antibody titers and
Brucellacapt test showed a titer of 1/40. Nowadays, the patient remains
with severe loss of strength in his left hand and right foot and continues
receving doses of intravenous IgG monthly.
Conclusion: This may be the ﬁrst report of CB with MMN as
neurological complication described, thanks to the high sensitivity and
speciﬁcity of a PCRQ assay.
R2432 Cloning, expression and puriﬁcation of truncated form of
Flagellin, N-terminal (1–161), of Pseudomonas aeruginosa
in Escherichia coli
F. Dakterzada*, A. Mohabati Mobarez, M. Habibi Roudkenar,
M. Forouzandeh Moghadam (Tehran, IR)
Introduction: Pseudomonas aeruginosa is an opportunistic bacterium
that has high antibiotic resistance. Immunoprophylaxy and immunother-
apy may be considered as desirable ways for control and treatment
of Pseudomonas aeruginosa infections. Flagellin is a main virulence
factor. There is high homology and cross reaction among ﬂagellin of
Pseudomonas aeruginosa strains. N-terminal domain of ﬂagellin plays an
important role in attachment to TLR5. It also may play an important role
in the induction of protective immune responses. This study was aimed
to produce rN-terminal ﬂagellin(1−161). In future, its immunological
effect would be evaluated on animal and compared with native ﬂagellin.
Materials and Methods: The coding sequence of ﬂagellin N-terminal of
Pseudomonas aeruginosa 8821M was isolated by PCR and cloned into
pET28a vector. E. coli BL21 (DE3) strain was used as an expression
host. The recombinant protein was puriﬁed by Ni-Sepharose resin. The
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Antigenicity of protein was evaluated by western blot analysis by using
of antibody against native ﬂagellin.
Results: Expression of ﬂagellin gene in the host produced considerable
amount of protein. Single band of the recombinant protein was observed
in SDS-PAGE after puriﬁcation that indicates high pure protein. Result
of western blot analysis showed that antibody against native ﬂagellin can
identify recombinant protein.
Conclusion: Pure recombinant N-terminal ﬂagellin(1−161) was pro-
duced and further characterized by native antibody of ﬂagellin by
our methods. It would be expected the recombinant protein induce
immunological responses against ﬂagellin in an animal model.
R2433 Development of a new diagnostic tool for the detection of
Chlamydophila pneumoniae and Mycoplasma pneumoniae
in a duplex real-time PCR
M. Bertrand*, M. Vignoles, J. Bes, S. Magro, C. Barranger, M. Joannes
(Verniolle, FR)
Objectives: Chlamydophila pneumoniae and Mycoplasma pneumoniae
are important and common causes of community-acquired pneumoniae.
The highest incidence of C. pneumoniae and M. pneumoniae infections
is among schoolchildren 5 to 14 years old. Symptoms may be mild,
nonproductive persistent cough, malaise, and fever, but more severe
illness occurs when the lower respiratory tracts is affected, given rise
to acute bronchitis and pneumoniae. The agents causing respiratory
infections are difﬁcult to distinguish clinically, since many bacterial
and viral infection share clinical features, including symptoms. It is
therefore important to ﬁnd a sensitive and effective way to identify
these agents and propose the appropriate antibiotic therapy. Currently
culture and serological conﬁrmation of the diagnosis of C. pneumoniae
and M. pneumoniae are difﬁcult and time-consuming. Real time PCR,
sensitive speciﬁc and rapid technology, is an effective alternative. We
propose a new real-time PCR based diagnsotic tool for C. pneumoniae
and M. pneumoniae diagnosis.
Methods: Nucleic acids were extracted from nasopharyngeal specimens
by using easyMag (bioMe´rieux) or MagNA Pure Compact (Roche)
extraction systems. Puriﬁed nucleic acids were added to the ready-to-
use Chla/Myco pneumo r-gene™ ampliﬁcation premix. C. pneumoniae
and M. pneumoniae were distinguished in a duplex single reaction tube.
Ampliﬁcation was performed on ABI7500 Fast, Bio-Rad CFX96 or
Roche LC480 platforms.
Results: On QCMD European Proﬁciency Panel 2010, the 12
positive/negative samples were correctly identiﬁed with Chla/Myco
pneumo r-gene™. All positives were detected, including weak pos-
itives (0,049IFU/100mL for C. pneumoniae and 50CCU/100mL for
M. pneumoniae). Analytical Sensitivity study on C. pneumoniae and
M. pneumoniae samples was performed in respiratory specimens.
Speciﬁcity study showed no cross reaction with other respiratory bacteria
or viruses.
Conclusion: The high quality associated with its compatibility with
the major extraction and real time PCR platforms allows an immediate
integration of Chla/Myco pneumo r-gene™ in most routine diagnostic
laboratories.
R2434 Preliminary clinical study using a multiplex blood PCR for
rapid detection of bacterial and fungal pathogens in ICU
patients with presumed sepsis
G. Vrioni*, I. Daniil, V. Mamali, M. Kimouli, D. Mylona-Petropoulou,
K. Themeli-Digalaki, A. Tsakris (Athens, Piraeus, GR)
Objectives: Sepsis is a serious medical condition that requires rapidly
administered, appropriate antibiotic treatment. The rapid detection of
pathogens in blood is critical for a favourable outcome of patients with
suspected sepsis. Although blood culture (BC) is considered the criterion
standard for diagnosis of bloodstream infection, it take three or more
days for ﬁnal pathogen identiﬁcation and antimicrobial susceptibility
testing. In this observational study, the clinical impact of a commercially
available multiplex PCR system in ICU patients with suspected sepsis
was been analysed.
Methods: Blood samples from patients with presumed sepsis were
cultured with the Bactec 9240 system (Becton Dickinson, Heidelberg,
Germany) and blood in EDTA from the same patients subjected to
analysis with the LightCycler SeptiFast M(grade) Test (LC-SF; Roche
Diagnostics, Mannheim, Germany) at two tertiary care centres. LC-
SF test is a multiplex, real-time PCR system allowing detection of 16
pathogens at the species level and four groups of pathogens at the genus
level (Gram-positive, Gram-negative and fungal microorganisms). For
samples with PCR-detected pathogens, the actual impact on clinical
management was determined by chart review. Furthermore a comparison
between the time to a positive blood culture result and the LC-SF result
was made.
Results: From 33 patients, 24 (73%) yielded concordant negative and 7
(21%) concordant positive results. In one patient two more pathogens
were detected with molecular method (E. coli in blood cultures vs
E. coli/S. maltophilia/C. albicans in LC-SF assay) and one patient was
LC-SF positive only (negative blood cultures vs P. aeruginosa in LC-SF
assay). LC-SF results were obtained in 7−15 h, in contrast to the 24−72 h
required for blood culture. According to the LC-SF results, initial therapy
was inadequate in ﬁve patients, and antibiotic treatment was changed.
Conclusion: This rapid, multiplex pathogen detection LC-SF system
complemented traditional culture-based methods and offered some added
diagnostic value for the timely detection of causative pathogens having
a relevant impact on clinical management for a subset of patients with
clinically suspected sepsis.
R2435 A seven-year survey of pertussis incidence in the capital
city of Soﬁa, Bulgaria
N. Brankova*, V. Levterova, S. Panaiotov, K. Tankova, T. Kantardjiev
(Soﬁa, BG)
Bordetella pertussis, the causative agent of whooping cough is endemic
in Bulgaria despite extensive nationwide vaccination since 1950s.
Objectives: Goal of this study was to investigate the incidence of
pertussis infection among children and adults in the capital city of Soﬁa,
Bulgaria for a seven years period.
Methods: Since seven years the National reference laboratory in
molecular microbiology started molecular diagnosis of pertussis. As
target PCR marker we selected pertussis toxin gene. 162 bp ampliﬁed
fragment was detected on agarose gels. DNA was extracted from
nasopharyngeal swab samples by automated robot system. A total of
2227 samples were analyzed. Samples from patients clinically suspected
for pertussis were analyzed.
Results: A total of 2227 samples were analyzed for pertussis by PCR.
Of these 496 samples were positive and 1731 negative for pertussis.
Positive samples represent 22.3%. The capital city of Soﬁa has about
1.3 million inhabitants. The incidence of pertussis illness is estimated to
be 38.1 patients per 100.000 inhabitants.
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Conclusions: Children in Soﬁa have high immunization coverage.
Acellular vaccination is applied since April 2010. Whole cellular vaccine
was previously applied. Highest prevalence of pertussis incidence is in
group age 0−3 years.
R2436 Evaluation of the GenoType® CDiff for detection of
Clostridium difﬁcile-DNA and the multiplexed identiﬁcation
of toxins and different ribotypes from stool specimens
U. Eigner*, M. Holfelder, A. Fahr, M. Weizenegger (Heidelberg, DE)
Objectives: The purpose of this study was to evaluate the new
PCR based Clostridium difﬁcile (CD) assay GenoType® CDiff (Hain
Lifescience, Nehren, Germany). This assay is able to identify Clostridium
difﬁcile, toxins A and B, the binary toxin cdtA/B, and the highly pathogen
and virulent ribotypes 078, 126 and 027. The detection is done in a line
probe format (DNA-strip).
Methods: DNA isolation from stool was performed with an automated
nucleic acid puriﬁcation instrument (GenoXtract) and the GXT Stool
Extraction Kit (Hain Lifescience). The GenoType® CDiff assay was
performed according to manufacturer’s instructions.
Results: 175 stool samples positive with the Glutamate dehydrogenase
(GDH) antigen test (C.diff Check™-60-EIA, Techlab, Blacksburg, VA,
U.S.A.) were compared to results from an EIA for the detection of
toxin A and B (Premier™ TOXINS, A&B, Meridian, Saco, ME, U.S.A.)
performed on cultured CD colonies and directly from stool. EIA based
toxin detection directly from stool had a sensitivity of 73% and a NPV
of 29%.
In 167 GDH positive and culture positive stool specimens C. difﬁcile was
conﬁrmed in 161 cases by PCR (sensitivity 96%). Eight GDH positive
stool specimens remained negative when cultured.
152 samples were congruent positive by PCR and tox EIA (culture +
direct testing), 17 were congruent negative and 4 only positive by the
EIA. Two samples were excluded (sensitivity toxin-PCR 97%, speciﬁcity
100%, PPV 100%, NPV 81%).
The GenoType® Cdiff assay was able to identify ribotype O27 in 9
specimens and in 2 specimens 078/126.
Conclusions: The GenoType® Cdiff assay for the direct detection
of Clostridium difﬁcile and major ribotypes from stool shows rapid,
sensitive and speciﬁc results. The DNA isolation is fully automated. The
turnaround time (including hands on time) is approximately 1.5 hours for
DNA isolation, 2 hours for ampliﬁcation and 2 hours for hybridization.
The assay provides more information (ribotypes, toxins, binary toxins
and Moxiﬂoxacin resistance) as any presently available commercial CD
test.
R2437 Molecular conﬁrmation of resistance to ﬁrst- and
second-line antituberculosis drugs using GenoType
MTBDRplus and GenoType MTBDRsl assays
D. Lemus*, Y. Alvarez, R. Dı´az, I. Valde´s, M. Echemendı´a, A. Martin,
P. Van der Stuyf, J.C. Palomino, E. Montoro (Havana, CU; Antwerp, BE)
Objective: To detect mutations in genes associated with resistance to
ﬁrst and second line antituberculous drugs in multidrug resistant (MDR)
clinical isolates of M. tuberculosis.
Methods: GenoType MTBDRplus and GenoType MTBDRsl assays were
used according to the instructions of the manufacturer in 22 Cuban
clinical isolates of M. tuberculosis previously reported as MDR by
Proportion Method (PM) and Nitrate Reductase Assay (NRA). These
methods were also used to detect resistance to second line drugs.
Results: 13 strains had mutations associated with resistance to isoniazid
and only one showed a wild type pattern for katG gen. Mutations in
rpoB gen were found in 95.45% of MDR strains. Resistance to oﬂoxacin
was found in one strain showing mutations in the gyrA gen. 4 out 5
strains considered resistant to kanamycin by phenotypic methods, reveal
mutation in rrs gen. For capreomycin, 80% of resistant strains had
mutations related with resistance to this drug. Five strains had mutations
in embB gen but only 40% were phenotypically resistant to ethambutol
(EMB). Otherwise one EMB-resistant strain showed a wild type pattern
to embB gen.
Conclusion: Genotype MTBDRplus is a very useful tool for MDR
resistance detection while GenoType MTBDRsl assay is a promising
test for rapid identiﬁcation of the most common mutations involved in
resistance to second line drugs.
R2438 Molecular detection of bacterial bloodstream infections:
the SepsiTest™ assay
A. Nieman*, E. de Jong, B. Beishuizen, A. Koek, P.H. Savelkoul,
R.P. Schade (Amsterdam, NL)
Objectives: Implementation of rapid molecular diagnostics in blood-
stream infections could signiﬁcantly improve speed of diagnosis,
and thereby outcome. Current molecular tests directly on whole
blood samples have suboptimal sensitivity, due to the use of small
volumes. Larger volumes show an inhibitory effect of human DNA.
The Sepsitest™-assay (Molzym, Germany) incorporates a pre-test
enrichment method, which selectively eliminates human cells. This may
lead to an increase in input volume and subsequent diagnostic sensitivity.
We investigated the use of this assay in a cohort of patient with sepsis
on the ICU.
Methods: We analysed 55 septicaemic patients on the ICU in whom
blood cultures (BC) were taken. Together with the BC (n = 90), an
additional blood sample (EDTA) was taken from the same sample
site, for analysis with the Sepsitest™-assay (ST). The assay consists
of a pre-test-enrichment on 1ml EDTA-sample, followed by bacterial
lysis and DNA-isolation, and subsequent ampliﬁcation using 16S-
based universal primers for Gram-negative and Gram-positive bacteria.
Amplicons are detected by agar-based gel-electrophoresis. In accordance
with instructions of the manufacturer, EDTA-samples were analysed in
duplicate, and a sample was considered positive if at least one of the
duplicates was positive.
Results: Of the 90 BC, 5 (6%) yielded positive results; S. aureus (n = 1),
E. faecalis (n = 3), and CNS with E. faecalis (n = 1). Bacteraemia was
diagnosed in 3/50 (6%) of the patients. ST was positive in 11/90 (12%)
of the samples. Compared to BC, sensitivity was 80% (4/5 positive
BC). In total 2/3 patients (66%) with positive BC was positive with ST.
Seven patients had positive ST and negative BC. In all of these patients,
the clinical suspicion of bacterial infection was high, and 3 of them
showed positive BC during septicemia, but at another time point when
no EDTA-samples had been taken for this study. These results might
therefore represent additional yield of the Sepsitest™-assay. Sequencing
of amplicons is currently being performed, to provide species-speciﬁc
results and control for false-positive results.
Conclusions:
– The Sepsitest™-assay can be used in clinical practice for molecular
analysis directly on blood samples.
– Implementation of the assay may provide additional detection of
bacteraemic patients, but results have to be evaluated with sequence
results.
– Gel-based analysis is applicable, but may be troublesome to implement
in the routine workﬂow.
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R2439 Development of novel multiplexed molecular assays for
detection of respiratory viruses using room temperature
stable reagents, the AmpliVue™ inﬂuenza A/B and
AmpliVue™ hMPV/RSV assays
H. Liang, J. Stockwell, V. Armendarez, J. Carpenter, T. Ott, T. Pack,
R. Kelly, R. Lollar, N. Nasser*, T. Ranalli, T. Stenzel (San Diego, US)
Background and Objectives: Respiratory Infections cause signiﬁcant
morbidity and mortality in both developed and developing countries.
Inﬂuenza A and B (Flu A&B), RNA viruses of the family Orthomyx-
oviridae, spreads in regular epidemics resulting in the deaths of more
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than 250,000 people worldwide annually. Human respiratory syncytial
virus (RSV) is a negative single-stranded RNA virus of the family
Paramyxoviridae. RSV is the major cause of lower respiratory tract
infection and hospital visits during infancy and childhood. Human
metapneumovirus (hMPV) is a negative single-stranded RNA virus of
the family Paramyxoviridae, and may be the second most common cause
(after RSV) of lower respiratory infection in young children. Utilizing
proprietary chemistries and processes, we have developed novel, room
temperature stable reagents for use in our AmpliVue Taqman®-based,
multiplexed, rt-PCR assays for the detection of Flu A&B or hMPV/RSV.
As an added beneﬁt, the AmpliVue™ assays provide a simpliﬁed
workﬂow, signiﬁcantly reducing the number of end-user manipulations
required to perform testing. These attributes allow for more widespread
and reliable use of molecular diagnostics in the detection of respiratory
viruses. In this report, we describe the initial studies performed with
these reagents on both the Applied Biosystems® 7500 FastDx and the
Cepheid® SmartCycler.
Methods and Results: Testing was performed on cultured isolates or
clinical specimens to establish initial performance of the assays. RNA
was extracted on either a NucliSENS® easyMag® or Roche MagNA Pure
Compact and 5 ul of each sample was added to reconstituted master mix.
Each cultured inﬂuenza A and B isolate was detected; 19/19 and 14/14,
respectively. Clinical specimens analyzed for the presence of either RSV
A, RSV B or hMPV were able to detect 10/10 RSV A, 13/13 RSV B,
and 26/26 hMPV. Speciﬁcity was 100% for all samples evaluated. Initial
analytical sensitivity tests for the various viruses indicated detection
limits less than 50 TCID50/ml and/or 10vp/mL for each target. Testing
with isolates of other common viruses and bacteria conﬁrmed that these
reagents are not cross reactive with other common respiratory pathogens.
Conclusion: Results from these studies indicate that our room
temperature stable reagents, coupled with the simpliﬁed workﬂow for
our AmpliVue molecular assays, provides end-users with sensitive and
speciﬁc assays for the detection of Flu A&B and hMPV/RSV.
R2440 Quantitative PCR for detection and monitoring of active
CMV infection in routine diagnostics
N. Zotos, C. Gartzonika, H. Sakkas, D. Papamichail, C. Boboyianni,
E. Kapsali, E. Papapetrou, E. Priavali, A. Makis, L. Bourantas,
A. Mavridis, S. Levidiotou* (Ioannina, GR)
Objectives: Infections with CMV are usually asymptomatic or related
with harmless symptoms. Severe problems occur if fetuses, transplant
patients, or patients under immunosuppressive therapy get infected. The
aim of this study was to investigate the impact of quantative PCR for
diagnosis and monitoring of an active CMV infection.
Methods: A total of 138 patients were enrolled in this study, 72
males and 66 females aged 30 days to 72 years. Both children (n = 16)
and adults (n = 122), immunocompetent (n = 40) and immunosupressed
(n = 98), hospitalized with clinical suspicion of CMV infection, in the
University Hospital of Ioannina, Greece, were screened for CMV-IgM
antibody (AxSYM, Abbott) and CMV-DNA (COBAS AMPLICOR,
Roche). Viral load and clinical data was also investigated.
Results: The conﬁrmation of CMV infection by the two methods was
obtained in 14 patients. One hundred four patients were positive for
CMV-IgM and negative for CMV-DNA. Antibodies for HSV, VZV
or EBV were also detected in some of them. By performing PCR,
20 extra cases of active infection were diagnosed, for which no
antibodies could be detected. This translates to a 15% rise in the number
of diagnoses of active CMV infection as compared with serological
approach. The CMV-DNA positive patients were 6 children and 28
adults. The major underlying disease was haematological malignancies
(14/34). Pneumonitis was the most common clinical presentation (20/34).
Overall, the median viral load was 2255 copies/ml (472–58700), while
in them with CMV mononucleosis was 583 copies/ml (472–874). The
overall mortality rate was 12% and major cause was respiratory failure.
Eighteen of the 34 PCR positive patients received ganciclovir. Treatment
led to a marked decrease in CMV DNA copy number. The median time
interval necessary to obtain a negative result after implementation of
treatment by PCR was 27 days.
Conclusion: Quantative PCR CMV assay is rapid, and linear for
quantifying CMV viral load, and it seems to be useful in the
diagnosis and management of affected patients for predicting disease
and monitoring response to antiviral therapy and can serve as surrogate
markers for antiviral resistance and clinical relapse in these patients.
Compared with traditional serologic assays that detect antibodies to
CMV, Q-PCR offers a signiﬁcant advance through the direct detection
of viral DNA, which is independent of a functioning humoral immune
system.
R2441 Detection of HSV1 and HSV2 DNA from external
anogenital lesion specimens using the BD Viper™ System
in extracted mode
L. Miller*, D. Yursis, B. Biederman, J. Harris, L. Keller (Sparks, US)
Objective: To characterize the performance of the new BD ProbeTec™
Herpes Simplex Viruses (HSV1&2) Qx Ampliﬁed DNA Assays* using
swab specimens collected from external anogenital lesions expressed into
BD™ Universal Viral Transport medium (UVT) or equivalent Copan
Universal Viral Transport Medium (UTM-RT) System.
Methods: The BD ProbeTec Herpes Simplex Viruses (HSV1&2) Qx
Ampliﬁed DNA Assays were designed to be compatible with transport
via the Swab Diluent for the BD ProbeTec CT/GC Qx Ampliﬁed DNA
Assays (Qx Swab Diluent) and BD UVT or Copan UTM-RT collection
devices. This study focused on evaluating performance of the HSV
assays using simulated specimen comprising 0.5mL BD UVT medium
added to a pre-ﬁlled Qx Swab Diluent Tube. Samples were pre-warmed,
and then loaded directly onto the BD Viper System for DNA extraction
and ampliﬁcation.
Results: The analytical limits of detection (95% proportion positive) for
the HSV1 Qx and HSV2 Qx assays using clean BD UVT medium were
estimated to be 24 viral particles (vp)/mL and 88 vp/mL, respectively.
The limits of detection for the assays in the presence of external
anogenital swab specimen matrix were estimated to be 17 vp/mL and 127
vp/mL for HSV1 Qx and HSV2 Qx, respectively. Both assays were shown
to be tolerant to common exogenous and endogenous substances that may
be present in external anogenital lesion specimens, including but not
limited to blood, mucus, semen, leukocytes and various prescription and
over-the-counter medications. In addition, both assays were found not to
cross-react with a variety of bacteria, viruses and fungi that could be
found in external anogenital lesion specimens. Stability of HSV DNA
in simulated external anogenital swab specimens was demonstrated at
ambient, refrigerated and frozen temperatures in both the original UVT
specimen and once diluted in the Qx Swab Diluent.
Conclusion: The BD ProbeTec Herpes Simplex Viruses (HSV1&2)
Qx Ampliﬁed DNA Assays* offer excellent analytical sensitivity and
robust performance for the detection of HSV1 and HSV2 DNA from
external anogenital swabs expressed into BD UVT medium. The BD
Viper System software allows the user to test both CT/GC specimens and
HSV1/HSV2 specimens within the same Viper run, providing workﬂow
ﬂexibility.
*Product not for sale, for investigational use only in the US.
R2442 Comparative evaluation of two commercial HCV genotype
tests: Versant assay (LiPA) 2.0 versus 1.0
M. Munoz, A. Moreno*, M. Iborra, C. Salvador, M. Segovia (Murcia, ES)
Background: HCV genotyping is used to predict the response to
antiviral therapy and also to optimize the duration of treatment. The
5-untranslated region (5-UTR) is the region of choice for routine
genotyping of HCV. However, due to its high level of conservation,
the 5-UTR is limited in its ability to discriminate genotype 6 from
genotype 1 and subtypes within genotypes 1, 2, 3, 4, and 6. The newly
developed Versant HCV genotype assay (LiPA) 2.0 (Versant 2.0) uses
sequence information from both the 5-UTR and the core region, allowing
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distinction between HCV genotype 1 and 6 and between subtypes a and
b of genotype 1. Previously, Versant HCV genotype assay (LiPA) 1.0
(Versant 1.0) only used sequence information of 5-UTR. In this study,
the results of both genotyping assays were evaluated.
Methods: A total of 556 HCV-positive samples (EDTA plasma) were
genotyped using the Versant 2.0 according to the manufacturer’s
instructions. For the comparison study, Versant 1.0 was used. HCV RNA
was extracted by using the NucliSENS® easyMAG™ (BioMe`rieux). In
each extraction run, positive and negative controls were included. Only
interpretable results by both assays were included in the study. Only
differences found at the genotype 1 and subtypes 1a and 1b level were
taken into account. The Versant 2.0 was considered the reference method.
Results: Table 1 gives an overview of the results of the comparison study
after testing by both assays. The correlation rate of both tests was 85.8%
(477/556). Results from 79 specimens (16.2%) were discordant between
the two assays, being the genotype 1a the most difﬁcult to discriminate
by the Versant 1.0 (40 samples).
Discussion: Versant 2.0 showed an improvement in identifying the
correct subtype of genotype 1. This improvement can be attributed
to the additional information available from the core region of the
HCV genome. As the clinical management of patients infected by
genotype 1a and 1b is equal, disagreements among both tests may present
epidemiological consequences but at least Versant 1.0 errors do not affect
treatment dosage and duration.
R2443 Prevalence of human papillomavirus in cervical samples
from sexually active young women: a cross-sectional
age-stratiﬁed study
E. Frati*, S. Bianchi, D. Colzani, A. Zappa, R. Rinaudo, G. Orlando,
E. Tanzi (Milan, IT)
Objectives: This cross-sectional study aimed at the identiﬁcation of HPV
infection prevalence in sexually active young women aged 14−26 years −
target of HPV vaccination programme − residing in Northern Italy.
Methods: 651 cervical swabs were collected from women aged 14−26
years. The population was age-stratiﬁed in 4 groups: (1) 14−17 years,
(2) 18−20 years, (3) 21−23 years, and (4) 24−26 years.
Samples were centrifuged at 3500xg for 15′ to obtain the cell pellet. DNA
extraction was carried out by a commercial kit (NucliSENS®miniMAG®,
BioMe´rieux, France) and the ampliﬁcation of a L1 gene fragment (450
bp) was performed by degenerated primers pair. Genotyping was carried
out through restriction fragment length polymorphism technique using 3
restriction enzymes (RsaI, HaeIII, DdeI, Recombinant Enzyme, BioLabs
Inc, New England).
Results: The overall prevalence of HPV infection was 25.8% (168/651).
The age-stratiﬁed prevalence of HPV infection was: 41.3% in women
aged 14−17 years; 18.2% in those aged 18−20 years; 35.5% in women
aged 21−23 years, and 37.6% in those aged 24−26 years.
The prevalence of genital high-risk HPV was 78.9% in group 1, 82.8%
in group 2, 83.3% in group 3, and 93.1% in the last group. HPV-16 was
detected in 32/651 (4.9%) cervical swabs and HPV-18 in 6/651 (0.9%)
samples.
Conclusion: The high prevalence observed in women aged 14−17 years
is probably due to both the increased susceptibility of this population
and an early sexual debut, major risk factor for the acquisition of
HPV infection. A characteristic ascending age-speciﬁc curve of infection
prevalence was observed in the other 3 groups. These data support the
existence of an inverse relationship between age and HPV infection
prevalence. In addition, vaccination of this whole population would have
prevented about 6% of occurred infections.
R2444 HPV prevalence in adolescent population at the beginning
of immunisation policy in northern Italy
E. Tanzi*, S. Bianchi, E. Frati, D. Panatto, M. Martinese, A. Zappa,
C. Zotti, R. Gasparini (Milan, Genoa, Turin, IT)
Objective: The recent introduction of vaccination against HPV in
adolescent girls in Italy has focused the attention on the virological
surveillance in this age group. Since HPV is one of the major pathogen
sexually transmitted worldwide, it will be important to extend the
surveillance also to the adolescent males, who could be the next target
of the immunization strategy. This study aimed at evaluating the HPV
infection prevalence in adolescents both females and males. On purpose,
a molecular assay based on urine samples, easy to collect and acceptable
for this young individuals, was applied for the detection and genotyping
of HPV-DNA.
Materials and Methods: 545 urine samples were collected from
adolescents (14−17 years) attending community clinics, youth centres
of the local sanitary units or day clinics in Northern Italy in the
period spanning from September 2009 to July 2010. Analysed subjects
were 233 females (mean age 15.3 years) and 312 males (mean age
15.4 years). Samples were centrifuged at 3500xg for 20′ to obtain the
cell pellet. DNA extraction was carried out using a commercial kit
(NucliSENS®miniMAG®, BioMe´rieux, France) and the ampliﬁcation of
a L1 gene fragment (450bp) was performed by degenerated primers.
Genotyping was performed by restriction fragment length polymorphism
technique using 3 restriction enzymes (RsaI, HaeIII, DdeI, Recombinant
Enzyme, BioLabs Inc, New England).
Results: HPV-DNA was detected in 2% (11/545) of analysed samples.
In particular, in 3.9% (9/233) and in 0.6% (2/312) of samples collected
from female and male adolescents, respectively. Both high and low-
risk genotypes were identiﬁed: high-risk HPV-16 (11.1%) and HPV-66
(11.1%), low-risk HPV-70 (33.3%), HPV-6 (22.2%), HPV-11 (22.2%)
and HPV-87 (11.1%). Among female adolescents, 8 infections were
due to a single genotype and 1 was sustained by HPV-16/HPV-70 co-
infection. The two infections found in male subjects were sustained by
HPV-70.
Conclusions: These data show that HPV infection is present in 14−17
years old subjects, more frequently in females than in males. These
infections were supported both by high- and/or low-risk genotypes and,
among these, 45% (5/11) could now be preventable by the available
vaccines that include one or two types found (HPV-6 and HPV-16).
Molecular testing on urine sample seems to be a good alternative to
those conducted on cervical swab, especially for very young women.
Finally, this method seems to be applicable also to the male population.
R2445 Molecular diagnosis for human herpesvirus in critical
patients affected by pneumonia
C.I. Palermo*, G. Castiglione, E. Panascia, R. Russo, C.M. Costanzo,
C. Franchina, D. Zappala’, G. Scalia (Catania, IT)
The aim of this study was the evaluation of the often underestimated
potential role of herpes viruses in the onset or inauspicious evolution
of respiratory pathologies in critical patients. We analyzed 158
bronchoalveolar washes from patients hospitalized with severe acute
respiratory pathologies at the intensive care units of some hospitals in
Catania, Sicily, Italy.
S732 21st ECCMID/27th ICC, Abstracts accepted for publication only
For the retrospective study we used viral isolation methods and Real-
Time PCR, respectively, for viral replication activity and the clinical
signiﬁcance expressed in terms of viral load, correlated with the days
the patients were on assisted ventilation until the time of the analysis.
In 57.6% (91/158) of the samples DNA was found of at least one, though
often two or more, of the herpes viruses (HSV1, VZV, CMV, EBV,
HHV7). In particular: 19% (30/158) were HSV1, 10.7% (17/158) CMV,
16% EBV (26/158) and 46% (68/158) HHV7; there was no positivity for
VZV. Based on the data relative to the ﬁnding of viral nucleic acid and the
duration of mechanical ventilation, a statistically signiﬁcant association
was found only for HSV1 DNA with assisted ventilation of more than
7 days (p< 0.05). The increase of the viral load, in some cases, was
directly proportional to the days on assisted ventilation reaching a value
of 108 gEq/ml for HSV1, compared to 102–104 gEq/ml for CMV and
EBV.
The prevalence of herpes viruses, and above all the ﬁnding of HSV1,
accompanied by a substantial viral load, would conﬁrm the importance
that these viruses could have in the onset of respiratory pathologies in
immunocompromised subjects. Therefore, the introduction of tests for
the detection of the above mentioned viruses in diagnostic protocols
would favor early diagnosis and correct therapy that could reduce the
rate of mortality in critical long-term patients affected by respiratory
pathologies who need assisted ventilation.
R2446 A etiology of bronchiolitis in hospitalised children in south
eastern Spain
C. Salvador-Garcia, A. Moreno-Docon*, J.A. Pin˜ero,
M.A. Iborra-Bendicho, S. Alfayate, M. Segovia-Hernandez,
M. Sanchez-Solis (Murcia, ES)
Objectives: Bronchiolitis is the most common respiratory disease in
children under 2 years-old and a major cause of hospitalization in
young children, especially during the winter. Respiratory syncytial virus
(RSV) is the leading cause of bronchiolitis. During the epidemic period,
over 90% of diagnosed cases are caused by this virus. However, the
incorporation of new molecular techniques such as RT-PCR in the last
decade has enabled the detection of other additional viral agents. The aim
of this study was to investigate the prevalence and etiology of respiratory
viruses, as well as ascertain the involvement of mixed viral respiratory
infections in children hospitalized during the winter of 2008–2009 in
south-east of Spain.
Methods: It was a prospective study during the bronchiolitis season
(December-April). Children below 18 months-old admitted to the
hospital for a ﬁrst bronchiolitis episode were included. The study
excluded all infants with previous episodes of bronchiolitis as well as
those bronchiolitis cataloged as acquired in the hospital. Nasopharyngeal
aspirate were collected. It was performed a reverse transcription
polymerase chain reaction (RT-PCR) (CLART®PneumoVir, Genomica)
for the detection of 16 respiratory viruses including RSV A and B;
inﬂuenza virus (Flu) A, B, and C; coronavirus (229E), adenovirus
(ADV), rhinovirus (RV), parainﬂuenza (PI) 1−4; metapneumovirus
(hMPV)A and B; bocavirus (hBoV) and enterovirus (echovirus).
Results: 235 children were included. The mean age was 3.4 months
(mean±SD months, 3.4±3.3 months), range 8 days-17 months of which
78.7% were under 5 months-old. A total of 287 viruses were detected in
NA from 204 infants (86.8%). Respiratory syncytial virus was the virus
detected more frequently (56.4%) followed by rhinovirus. Co-infections
were found in the 36% of children. The most common associations were
respiratory syncytial virus A with rhinovirus (Figure1).
Conclusions: This study showed that respiratory viruses were detected in
most of the children below 18 months-old hospitalized with bronchiolitis
and that 36% of them showed a mixed infection. 3/4 of the children
had infection by RSV, whereas the frequency of infection with other
respiratory viruses was low and mainly associated to mixed infections.
R2447 Epidemiology of viral infections in acute respiratory
illnesses in children
M.L. Modolo*, V. Carnelutto, T. Lucchese, S. Zamparo, M. Avolio,
R. De rosa, P. Stano, A. Camporese (Pordenone, IT)
Objectives: Acute children respiratory infections (ACRI) are a common
reason for consulting general practitioners. In most cases the aetiology
is unknown, yet most result in an antibiotic prescription. The objective
was to study the epidemiology of respiratory virus infections and in
particular to determine the virus-speciﬁc positivity rates and seasonality
in pediatric age for respiratory virus infections over a 15 month period
in Pordenone (ITALY), using a multiplex real-time PCR assay to detect
multiple viruses in the same reaction.
Methods: A total of 195 nasopharyngeal specimens were collected from
symptomatic pediatric inpatients (average 3 years) between November
2008 and January 2010. Each specimen was split into two aliquots,
one aliquot was processed by using multiplex real-time PCR test
and the second was tested for adenovirus using a nested PCR.
Total nucleic acid was extracted using the BioMerieux easyMAG.
Multiplex real-time PCR test was performed using Dia-ResRNAVir-050
(DIAGENODE) for detection of Inﬂuenza A virus (IA) and Inﬂuenza
B virus (IB), Respiratory Syncytial Virus (RSV), Metapneumovirus
(MPV), Rhinovirus (RVs) and Parainﬂuenza virus (PIV) 1, 2, 3 and
4. Adenovirus was detected by nested PCR (NANOGEN).
Results: Of the 195 specimens tested, 158 (81.02%) were positive for
at least one respiratory virus including: 64 (32,8%) RSV (A or B), 34
(21,4%) Rhinovirus, 23 (11,8%) Flu A or B, 15 (7.8%) Parainﬂuenza
(1−4), 11 (5,6%) Adenovirus and 11/185 (5,9%) Metapneumovirus. Most
pediatric patients (86,6%) was pre-school age. All patients RSV and
MPV (38,5%) positive were less than 4 years of age. We have seen
a dual respiratory virus infection in 11/195 (5,6%) patients and only
one triple virus infection. In terms of seasonal distribution, RVs were
distributed across the majority of months. RSV peaks were between
December 2008 and March 2009. IA infections were distributed from
January and February 2009, with another “atypical” peak between
October and December 2009, including Inﬂuenza A/H1N1v. IB showed
a peach activity in March and April. PIVs peaked in November 2008
and October 2009. MPV peaked between the end of winter and spring
months. Adenovirus infections were distributed in winter and spring
months.
Conclusion: The molecular assay has increased our understanding of
the epidemiology of respiratory viral infections and should assist us in
the diagnosing the etiology of respiratory tract infections in individual
and in outbreak situation.
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R2448 Presence of rhinovirus and enterovirus in patients with
suspected inﬂuenza A/H1N1 infection
A. Tenorio*, B. Gomez, B. Castro, L.A. Arroyo, S. Campos, M. Lecuona
(La Laguna, ES)
Objective: To determine the presence of rhinovirus and enterovirus in
patients with suspected inﬂuenza infection during the 2009 A/H1N1
inﬂuenza pandemic.
Methods: During the peak incidence of H1N1 inﬂuenza in our hospital
(last week of October 2009), a total of 91 patients were diagnosed
with inﬂuenza according to strict clinical criteria. Nasal aspirates were
collected and stored at −80ºC. DNA extraction was performed with the
automated system Maxwell 16MDX (Promega, USA) using 200ml of
sample. All the samples were ﬁrst tested for inﬂuenza A (H1N1 and
H3N2) and inﬂuenza B using a real-time RT-PCR (Applied Biosystems,
USA) with primers published by CDC. Then, all the samples were
simultaneously screened for rhinovirus and enterovirus using a real-time
RT-PCR (PrimerDesign, UK).
Results: A total of 91 patients (47 men and 44 women), ranging from
0 to 81 years, were prospectively included in the study. Of the 91 nasal
aspirates, 43 were positive for inﬂuenza A/H1N1 (47,3%), 10 were
positive for rhinovirus (11%), 3 were positive for enterovirus (3,3%)
and the remaining 37 were negative (40.7%). All the samples were
negative for H3N2 and inﬂuenza B. Overall, 54 out of 91 samples
(59,3%) were positive for any of the viruses tested. In addition, two
different patients were coinfected by A ﬂu - rhinovirus and enterovirus-
rhinovirus. These coinfections represented 3,7% of the overall positive
samples. The average age and range of the infected patients were as
follows: for H1N1, 33 years (SD±20.1) and 0−76 years, respectively;
for rhinovirus, 28 years (SD±23.7) and 0−69 years respectively; and for
enterovirus, 25.7 years (SD±22.4) and 0−42 years, respectively.
Conclusions: Our results showed the involvement of other respiratory
viruses in patients with inﬂuenza-like illness. Thus, a notable proportion
of rhinovirus infection was found in a collection of patients diagnosed
with inﬂuenza during the peak incidence of H1N1 pandemic. These
data would suggest a potential indication for rhinovirus detection in
acute respiratory diseases. Regarding age and gender distribution of the
infected patients, no signiﬁcant differences were found for all the viruses
tested.
R2449 Comparison of HIV and HCV viraemia counts obtained
with Roche Cobas®Amplicor HIV-1 or HCV Monitor® and
Cobas® TaqMan® HIV-1 or HCV respectively following a
NucliSENS® easyMag™ (bioMe´rieux) extraction
M.-L. Tritten, R. Lienhard*, C. Glassey, H.H. Siegrist (La
Chaux-de-Fonds, CH)
Objectives: Our objective was to validate the viraemia results
obtained with the new Roche HIV-1 Cobas® TaqMan® and HCV
Cobas® TaqMan® Test platforms following an extraction with
NucliSENS®easyMag™ instead of the High Pure manual extraction
recommended by the manufacturer.
Methods: Ninety-seven plasma samples from HIV patients and
37 plasma samples from HCV patients whose viraemia counts were
obtained with Roche Cobas® Amplicor HIV-1 Monitor® Test v1.5 and
Cobas® Amplicor HCV Monitor® Test, respectively, were tested with the
new Roche Cobas® TaqMan® HIV and Cobas® TaqMan® HCV Tests.
Five hundred microlitres of each of the 134 samples were extracted with
the speciﬁc B protocol on the NucliSENS®easyMag™ (bioMe´rieux)
instrument. The results obtained with the two different platforms were
then compared.
Results: Fifty-three out of the 97 HIV plasmas yielded viraemia counts
lying within the linearity limits of both methods. The linear regression
analysis for these samples generated a R2 (square of correlation
coefﬁcient) of 0.95 comparable with the R2 (0.94) given by Roche for
Cobas® Amplicor HIV-1 Monitor® and Cobas® TaqMan® HIV with
High pure extraction. Regarding the HCV test all 37 samples yielded
results within linearity limits with both methods and the R2 was 0.97.
Regarding HIV tests we could observe that the two tests were poorly
correlated for the detection of viraemia counts below the lower limit of
quantiﬁcation (kappa correlation coefﬁcient: 0.39).
Conclusions: From these results we conclude that an extraction of
plasma samples with the NucliSENS® easyMag™ instrument can be
used with both the Cobas® TaqMan® HIV and Cobas® TaqMan®
HCV platforms instead of the High Pure manual extraction, avoiding
cumbersome work and long manual hands-on time without signiﬁcant
changes in ﬁnal results.
R2450 Human papillomavirus prevalence and types among women
in Herzegovina
S. Jakovac*, B. Tutisˇ (Mostar, BA)
Objectives: Human papillomavirus (HPV) is a group of small DNA
viruses that cause warts and certain cancers and precancers of the skin
lining the lower genital tract and mouth. The genital HPV types can be
divided into two broad groups (low-risk and high-risk HPVs) depending
upon their association (or lack of association) with cancers of the lower
genital tract. Genital HPV is very common. It is the most common viral
sexually transmitted infection (STI) and is likely to be the most common
STI overall. The aim of this study was to investigate the prevalence of
HPV DNA, to determine HPV types distribution among women in 3
Cantons in Herzegovina and prevalence of hr HPV infection in different
age groups of women (women over 30 years and under 30 years).
Methods: A total of one hundred sixty (n = 160) women were
retrospectively evaluated between March 2009 and December 2010.
Abbott RealTime polymerase chain reaction was used to detect the
presence of HPV types in cervicovaginal samples obtained from patients
during gynecologic examination. Abbott RT hr HPV test was performed
on the m 2000 rt PCR instrument and was designed to identify 14 hr
HPV genotypes: 16, 18 and other high risk types (31, 33, 35, 39, 45,
51, 52, 56, 58, 59, 66 and 68).
Results: Eight (n = 8) of the women were excluded from the study
because of the incomplete data and a total of 152 women were used for
the ﬁnal analysis. Forty-ﬁve patients (29.6%) were found to be infected
with a genital HPV. As expected, viral prevalence was higher among
women younger than 30 years of age (15.8%) in comparison to those
aged 30 or older (13.8%). The rate of o HPV types were as follows:
16 (37.8%), 18 (8.9%) i other (53.3%). Coinfection with multiple HPV
types had one woman. The largest number of positive samples was from
Herzegovina-Neretva Canton.
Conclusion: Our results indicated that HPV infections represent a
signiﬁcant public health concern in Herzegovina. Detailed knowledge
of HPV type circulating patterns in speciﬁc local geographical areas is
essential for appropriate implementation of screening, prevention, and
surveillance campaigns.
R2451 Contribution of inﬂuenza viruses, human metapneumovirus
and respiratory syncytial virus to acute respiratory
infections in children in northern Greece, 2008–2010
G. Gioula*, E. Chatzopoulou, M. Exindari, A. Melidou,
D. Chatzidimitriou, F. Chatzopoulou, N. Malisiovas (Thessaloniki, GR)
Objectives: Inﬂuenza viruses, respiratory syncytial virus (RSV) and
human metapneumovirus (hMPV) are the most common pathogens that
cause acute respiratory disease in children. The aim of this study is to
present the contribution of the above three pathogens to inﬂuenza-like
illness (ILI) in children (aged <6 years old) during 2-year (2008–2010)
inﬂuenza seasons in N. Greece.
Materials and Methods: 430 pharyngeal swabs from children younger
than 6 years, presented as ILI infections during the last two inﬂuenza
seasons (2008–2009 and 2009–2010) were examined for inﬂuenza A and
B, RSV and hMPV, by one step Real-time RT-PCR.
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Results: Inﬂuenza viruses were detected in 122 (28,3%) of the 430
spesimens, RSV in 45 (10,4%) samples and hMPV in 28 (6,5%). RSV
and inﬂuenza viruses’ co-infections were observed in eight cases, RSV
and hMPV co-infections in four cases and hMPV with inﬂuenza viruses
was found in one case. The majority of the patients (67,7%) were
between 3 and 6 years old.
Conclusion: Our results demonstrate that inﬂuenza viruses, RSV and
hMPV contribute to ILI presenting infections at a rate of 45,2% in
children younger than 6 years old.
Molecular mycology
R2452 A quick and low-cost PCR-based assay for detection of
Candida DNA from blood culture bottles: a pilot study
A.S. Melo*, H. Xafranski, A.C. Padovan, A.S. Nishikaku, M.R. Briones,
A.L. Colombo (Sao Paulo, BR)
Differences in susceptibility of Candida species to antifungal drugs make
identiﬁcation to the species level important for clinical management of
candidaemia. Molecular tests are not yet standardized or available in
most clinical laboratories, although they can reduce the time required for
species identiﬁcation, as compared to the conventional methods. To cut
laboratory costs and improve diagnostic accuracy, different molecular
methods have been proposed, including DNA extraction protocols to
produce pure DNA free from PCR inhibitors.
Objective: To identify Candida species causing candidaemia by
analyzing fungal DNA from blood culture bottles positive for yeasts
using a low cost-effectiveness assay.
Methods: For DNA extraction an “in house” protocol based on
organic solvent extraction was tested. Additional steps of liquid nitrogen
incubation followed by mechanical disruption were processed for
complete cells lysis. The purity of extracted DNA was evaluated. Fifty
blood culture bottles positive for yeasts were processed. PCR assays
ampliﬁed ITS region of rDNA gene. The amplicons of twenty samples
were sequenced and these sequences were submitted for comparison
on Genbank database (NCBI) for species identiﬁcation. Molecular yeast
identiﬁcation was compared to results provided by conventional methods.
Results: The organic solvent extraction protocol showed good repro-
ducibility on the amount of DNA extracted, pure DNA and high
PCR sensitivity (10 pg of C. albicans DNA and 90% ampliﬁcation
on PCR assay). Therefore, this method was used to analyze all
clinical samples available. The molecular species identiﬁcation showed
100% concordance to the conventional culture. However, the molecular
method could identify one sample with mixed infection caused by
C. albicans and C. glabrata, while the conventional culture identiﬁed
just C. albicans. Moreover, 3 samples identiﬁed as C. parapsilosis by
the classical method were molecularly identiﬁed as C. orthopsilosis, a
species belonging to the C. parapsilosis complex.
Conclusions: Organic DNA extraction, PCR assay and sequencing could
efﬁciently identify mixed infections, as well as Candida species that only
can be molecularly identiﬁed. This test can be easily implemented in
routine laboratories providing earlier and low cost species identiﬁcation
when compared to the traditional methods. The organic DNA extraction
was 4-fold less expensive than protocols using commercial kits.
Support: FAPESP 2007/08575−1.
Molecular typing
R2453 Use of modiﬁed PCR ribotyping for detection of Clostridium
difﬁcile ribotypes directly in stool samples
S. Janezic*, I. Strumbelj, E. Pal, M. Rupnik (Maribor, Murska Sobota, SI)
Objectives: Clostridium difﬁcile infections represent signiﬁcant burden
for health care system with small and large outbreaks constantly being
present in hospital environment. Some of the PCR ribotypes were lately
associated with outbreaks and with increased mortality and morbidity:
027, 078, 017 and 053. It is therefore important to recognize these
ribotypes as rapid as possible. Standard typing method in Europe
is culturing of C. difﬁcile from faecal sample and subsequent PCR
ribotyping. Here we describe for the ﬁrst time the modiﬁcation of PCR
ribotyping that can be used for direct detection in stool samples and its
use during emergence of PCR ribotype 027 in a single hospital.
Methods: For direct PCR ribotyping from stool sample we have modiﬁed
existing primers described by Bidet et al. (1999) to increase speciﬁcity
for C. difﬁcile. A total of 50 C. difﬁcile culture positive and 43
negative stool samples from the routine laboratory were then used
for validation of the method. DNA was isolated from faecal sample
and PCR ribotyping was performed with Bidet and with new primers.
Additionally, ﬁve stool samples from general hospital, which were
detected as “C. difﬁcile positive, presumptive 027/NAP1” by Cepheid
Xpert C. difﬁcile assay were submitted to the reference laboratory for
ribotype 027 conﬁrmations.
Results: Direct PCR ribtyping from stool samples was possible in 37 out
of 50 C. difﬁcile positive samples using new primers. Other 13 samples
were negative (n = 9) or the banding pattern was too weak to be analyzed
(n = 4). In 36 out of 37 cases PCR ribotype determined directly from the
stool was identical as PCR ribotype of the strain isolated from the same
stool sample (sensitivity 0.72−36 out of 50 positive samples). All, but
one C. difﬁcile culture negative samples were negative on direct PCR
ribotyping with modiﬁed primers. In contrast, 30 out of 43 C. difﬁcile
negative samples reacted with Bidet primers. All ﬁve Cepheid Xpert
“C. difﬁcile positive presumptive 027/NAP1” samples were conﬁrmed
as ribotype 027 by direct ribotyping as well as conventional ribotyping
of the cultured isolate.
Conclusion: The direct culture-independent PCR ribotyping of C. difﬁ-
cile is a useful and rapid method for detection of emerging strains and
outbreak identiﬁcation.
R2454 Genotyping of atypical Vibrio cholerae eltor strains from
Siberia and Far Eastern region of Russia
L. Mironova, S. Balakhonov, V. Polovinkina, A. Kozhevnikova,
L. Urbanovich, M. Afanas’ev* (Irkutsk, RU)
Objectives: A feature of the seventh cholera pandemic during last
decades is a replacement of typical El Tor (ET) biotype strains to an
altered ET biotype possessing determinants of cholera toxin (CT) of
the classical (CL) biotype. The new strains are common in endemic
areas and demonstrate higher pathogenic properties. The purposes of this
study included revealing and molecular-epidemiological characteristic of
atypical V. cholerae strains isolated in Siberian and Far Eastern regions
of Russia.
Methods: Sample set included a toxigenic V. cholerae strains (n = 32)
from patients and environmental samples, isolated during outbreaks and
sporadic cases of cholera in 1970s and 1990s. Twenty nine strains
belonged to ET biotype, including 19 and 8 strains isolated in Siberia
and at the Far East during 1990s and 1970s, respectively. Two ET strains
from European part of Russia and three CL strains were used as external
group for comparison. V. cholerae eltor M-878 and V. cholerae cholerae
569B were used as a control. Biovar-speciﬁc identiﬁcation of tcpA, rstC,
rstR, hlyA, rtxA, rtxC genes and TLC-element were carried out by PCR
as described previously. Allele-speciﬁc PCR (AS-PCR) for detection of
ctxB genomovars was fulﬁlled according to Morita et al. (2008). Standard
sequencing procedure of ctxB gene was performed for conﬁrmation of
AS-PCR results and for detection of numbers of ToxR-binding repeats
in the zot-ctxA intergenic region.
Results: Among total ET strains isolated during 1970s CT ET biotype
gene (ctxB3) was revealed. ET strains isolated in 1990s harbored CT
CL biotype gene (ctxB1). At the same time all these strains had ET
biotype-speciﬁc genetic determinants. Among nearly all ET strains we
observed four ToxR-binding repeats in the zot-ctxA intergenic region.
ctxB1 strains demonstrated heterogeneous TCL and rstR pattern: part of
TCL+ strains harbored rstREL, part of TCL+ and all TLC− strains had
both rstREl and rstRCL.
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Conclusion: Three genotypes of atypical ET strains imported
from different regions were revealed (ctxB1TLC+rstRET+rstRCL−;
ctxB1TLC+rstREL+rstRCL+ and ctxB1TLC−rstREL+rstRCl+). Analy-
sis atypical ET genotypes allowed to conclude a consecutive acquisition
of genetic determinants from CL biotype and formation of more
pathogenic clones.
R2455 Molecular typing of rotaviruses, isolated on the territory
of Ukraine
S. Soloviov, O. Trokhimenko, I. Dzyublyk* (Kiev, UA)
Objective: Diarrheal diseases can be caused by viruses that belong to
different species, but rotaviruses are most often the cases of severe
diarrhea with fatal consequences. The aim of the present study was
the investigation of rotavirus circulation among children under 5 years
old, hospitalized with severe diarrhea in different regions of Ukraine and
rotavirus genotype identiﬁcation.
Methods: Stool specimens were selected from 600 young children under
5 year old, hospitalized in 6 Ukrainian regions: South, North, West, East,
Center and Kyiv from 2006 to 2009. The detection of rotaviruses group A
was performed by chromatographic immunoassay (CITO TEST ROTA,
CerTest Biotec. S.L., Spain). All specimens positive for rotaviruses
were conﬁrmed and identiﬁed by RT-PCR (AmpliSens® Rotavirus-290,
InterLabService, Russia).
Results: It was shown that proportion of severe diarrhea, caused by
rotaviruses in 5 regions of Ukraine in the period of study was: in
the East − 10% in the South − 44,5% in the North − 24,8% in the
West − 45,4%, in the Center − 21,1%. The winter-spring seasonality
was conﬁrmed, and it was found that in the age group of children under
3 years the average frequency of rotavirus identiﬁcation was the highest
and amounted to 70,1±4,0%. As a result among 210 positive samples it
was detected G-genotype in 182 cases (86,7%) and P-genotype in 176
cases (83,8%). P-genotype and G-genotype were not identiﬁed in 3,3%
and 4,3% of samples, respectively. In 5,7% of samples both genotypes
were not identiﬁed. It was shown that during each epidemic season from
2006 to 2009 in Ukraine G1P[8] was the dominant genotype, which
varied from 30% to 80% of all positive samples. The second most
distributed genotype was G4P[8] (40%), third − genotype G3P[8] (25%),
and the fourth − G2P[8] (11%). During the epidemic period 2006–2009
in Kiev, for the ﬁrst time genotype G9P[8] was identiﬁed in 5% of cases.
Thereafter it was found seldom during 2007, then appeared in rare cases.
In some clinical samples multiple genotypes were identiﬁed: G1P[8] +
G3; G1P[8] + G2; G3P[8] + G4. Genetic variant G2P[4] was the cause
of rare cases of diarrhea during the studied period.
Conclusions: For the ﬁrst time the features of rotavirus group A
circulation in Ukraine among children under 5 years old were shown. The
obtained data of the major rotavirus genotypes has a great importance in
deciding the implementation of speciﬁc prevention of rotavirus diarrhea
in Ukraine.
R2456 Cost-effectiveness of PCR versus culture for MRSA in
hospitals: evaluation of the published evidence
O. Kakisi, E. Vouloumanou*, P. Rafailidis, M. Falagas (Athens, GR)
Objectives: The much decreased turnaround time of PCR tests has
still controversial impact on MRSA infection rates in hospitals. MRSA
rapid diagnosis however does not only concern screening but severe
life threatening infection diagnosis as well. The cost effectiveness for a
variety of important clinical outcomes of PCR for MRSA in hospitals
has not been sufﬁciently evaluated. We sought to systematically review
all studies in the English literature that evaluate the comparative cost
effectiveness of MRSA molecular testing versus traditional methods and
report the associated ﬁndings.
Methods: A literature search was performed in PubMed, Scopus and the
NHS Economic Evaluation Database. Quality evaluation of the selected
articles was performed using a standardized instrument for the quality
of economic analyses.
Results: Eleven studies were identiﬁed comparing molecular assays for
MRSA over traditional culture and/or chromogenic agars for a total
of 22757 patients. 4/6 cost-effectiveness studies found that PCR incurs
higher costs but better outcomes while 1/6 found multiplex PCR cost
effective among 31 methods when length of ICU stay is <2 days. 1/6
found PCR not cost effective. 3/4 cost-beneﬁt studies found PCR for
MRSA cost saving, and 1/4 found PCR not cost saving in an existing
search and destroy policy. One cost utility analysis reported that PCR
leads to important mortality reduction at a low cost/LYS, due to an
under the hour change in empirical antibiotics. Factors that determine
cost effectiveness in various settings are the baseline prevalence rate
of MRSA, applying screening and pre-emptive isolation to high-risk
patients, the availability and cost of isolation and last but not least, the
assay characteristics and individual test costs.
Conclusion: The use of PCR instead of culture screening for MRSA
is found to be cost effective and/or cost-saving particularly in surgery.
The signiﬁcant beneﬁts are less isolation, less overall hospital stay,
more infections avoided, timely and cheaper treatment choices and
lower mortality. Although more studies are urgently needed, especially
in severe infections diagnosis, infection control teams for MRSA in
hospitals can be preliminarily informed about the particulars of the cost
effectiveness of molecular assays over traditional techniques according
to each hospital’s settings.
R2457 Genomic changes in the populations of Bordetella pertussis
strains isolated in Poland before and after the 1990s
E. Mosiej*, M. Zawadka, E. Augustynowicz, A. Lutynska (Warsaw, PL)
Objectives: The aim of the study was the evaluation of genomic diversity
differences among B. pertussis strains collected from patients before and
after the 90-ties in respect to vaccine strains used for production of the
DTP vaccine.
Material and Methods: In the study, two collections consisting of
29 and 111 B. pertussis clinical isolates originated from 1960–1977
and 1995–2005 periods, respectively and six historical (A/63, 21/60,
7/60, 25593/65, 1326/62, 60623/67) and three current (606/67, 186/65,
629/65) vaccine strains were investigated. EUpertstrain Pulsed-Field Gel
Electrophoresis (PFGE) procedure with XbaI was applied and compared
with PFGE procedure with AﬂII enzyme. The obtained PFGE proﬁles
were analyzed using GelCompar software. The UPGMA algorithm was
used as the clustering method, with 2% band tolerance and 1.5%
optimization settings with the Dice coefﬁcient. PFGE proﬁles obtained
for clinical isolates and vaccine strains were compared to B. pertussis
PFGE reference strains.
Results: Among 111 strains isolated in the period from 1995–2005, 59
PFGE-XbaI and 64 PFGE-AﬂII proﬁles were identiﬁed. In the period
1960–1977, 18 PFGE-XbaI and 24 PFGE-AﬂII proﬁles were found
among 29 strains. B. pertussis strains from 1960–1977 typed with PFGE-
XbaI, were classiﬁed into 2 clusters: A and B, and 2 groups: III and IV.
The same set of strains typed with PFGE-AﬂII, were found in 3 clusters:
Aﬂ-A, Aﬂ-B and Aﬂ-III. B. pertussis strains isolated within 1995–2005,
typed with PFGE-XbaI, were found in the groups III, IV and V and
in clusters A and C. All currently used vaccine strains were found in
the group III. In the period from 1995–2005, compared with the period
from 1960–1977, frequency of strains belonging to groups III and IV
and cluster A increased, new group V and new cluster C have been
found and cluster B has disappeared. According to PFGE-AﬂII results,
new clusters: Aﬂ-C, Aﬂ-D, Aﬂ-E and Aﬂ-IV have been recognized and
cluster Aﬂ-B has disappeared. In the period 1995–2005 genetic similarity
has not changed signiﬁcantly.
Conclusions: The study showed that genetic similarities of B. pertussis
strains coming from 1995–2005 and 1960–1977 do not differ signiﬁ-
cantly and represent level 80.5–81.8% for PFGE-XbaI and 77−79% for
PFGE-AﬂII. Optimized PFGE-AﬂII system has been found as potential
additional tool for discrimination among closely related B. pertussis
isolates.
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R2458 Clonality of Escherichia coli isolates that cause repetitive
urinary tract infections in patients with spinal cord injury
U. Demirpek, Z. Erdem, O. Yildiz, B. Bozdogan* (Aydin, TR)
Introduction: Recurrent infections are not low among urinary tract
infections (UTI). One of the most important complications for patient
with spinal cord injury is urinary tract infections. Recurrence rate of UTI
among these patients are very high. One of the main questions is if these
recurrent infections are due to the same clone or different clones. The
aim of this study was to evaluate clonality of infectious agents isolated
from urinary samples of patients with spinal cord injury.
Materials and Methods: A total of 68 E. coli isolates from 23 patients
were included to present study retrospectively. Of 23 patients 13 were
women (56,5%) and 10 men (43,5%). All patients had at least 3 samples.
The antimicrobial susceptibilities of recurrent infection agents were
tested by disk diffusion method. Clonality was tested by PFGE. Total
DNA was restricted with XbaI and DNA fragments were separated using
CHER DR III.
Results: Among 23 patients 21 were infected with the same clone at
least twice. Among these patients 50% were women and 50% were
men. Of 68 E. coli isolates from 23 patients, were 9 days minimum
and 200 days maximum. Of 22 clones 12 were ESBL positive. A total
of 31 isolates were among 12 ESBL clones. Clones isolated from women
were relatively lower (56,5%) than from men (43,5%).
Discussion: The present study showed high rates of clonal urinary tract
infections among patients with spinal cord injury. Further studies are
needed to evaluate risk factors for recurrent urinary tract infections
among patients with spinal cord injury.
Diagnostic/laboratory methods (other than
molecular)
R2459 Legionella pneumophila detection and viability evaluation
by ﬂow cytometry
I. Faria-Ramos*, A. Cardoso, S. Costa-de-Oliveira, J. Santos-Antunes,
J. Barbosa, A.G. Rodrigues, C. Pina-Vaz (Porto, PT)
Objectives: Legionellosis occurs through inhalation of contaminated
aerosols expelled by wet cooling systems or hot water distribution
systems of healthcare facilities. Despite the prolonged incubation period,
culture remains the standard diagnostic method. Alternative methods
like antigen detection and molecular techniques are expensive, often
unavailable and give no information regarding Legionella pneumophila
viability, which can be of minor importance in clinical specimens but of
major impact in water samples and therefore in public health security.
Considering its high mortality rate and the need of speciﬁc treatment, the
development of a rapid, sensitive and speciﬁc method for L. pneumophila
detection is crucial. Also, distinction between viable and non-viable cells
in water is warranted. Therefore, we propose a ﬂow cytometry protocol
for L. pneumophila detection in clinical and water samples and viability
evaluation in the latter.
Methods: L. pneumophila, ATCC33155, was used for protocol opti-
mization. Fifty respiratory samples and twenty water samples previously
analysed by immunoﬂuorescence were screened by ﬂow cytometry. All
samples were stained with a speciﬁc antibody MONOFLUO™ Anti-
L. pneumophila (BioRad, California) (green-530nm), which reacts with
an external membrane protein found in all known L. pneumophila
serogroups, and with Propidium iodide (red-FL3) to evaluate bacteria
viability in positive water samples, where the analysis was made before
and after killing bacteria by heat. Flow cytometry analysis was performed
on FACSCalibur Cytometer (BD Biosciences, Sydney). Speciﬁcity was
studied by mixing L. pneumophila with suspensions of E. coli, S. aureus
and C. albicans type ATCC strains, according to the same protocol.
Results: L. pneumophila cells displayed an intense green ﬂuorescence,
indicating bacteria recognition by speciﬁc antibody. Dead cells showed
high intensity of ﬂuorescence in both channels, FL1 and FL3. A
100% correlation was achieved between immunoﬂuorescence and ﬂow
cytometry assay, in both clinical and water samples. Viability assessment
was successful.
Conclusion: Flow cytometry proved to be a sensitive and a speciﬁc
method to detect L. pneumophila and simultaneously to assess its
viability. Furthermore, while it has been used in the detection of
Legionella in environmental specimens and experimental systems, this
is the ﬁrst time that this technique is applied to detect L. pneumophila
in clinical specimens.
R2460 Antimicrobial suseptibility of Aspergillus, Candida and
Fusarium species isolated from keratitis in eastern India
S. Saha*, D. Banerjee, A. Khetan, J. Sengupta (Midnapore West,
Kolkata, IN)
Purpose: To ﬁnd out the antifungal drug sensitivity pattern of common
fungi responsible for cases of fungal keratitis in Eastern India and to
provide better guidance for appropriate choice of antifungal drugs.
Methods: A retrospective, noncomparative study of 25 commonly
selected fungal keratitis patients for antifungal susceptibility between
August 2008 to July 2010.
Results: Amphotericin B and Natamycin were sensitive to all selected
species isolated for susceptibility test. Amphotericin B had a lowest MIC
against Fusarium sp. Voriconazole was the most effective antifungal
with lowest MIC against all Aspergillus sp isolated from fungal keratitis
except Candida sp. Aspergillus, Candida and Fusarium were insensitive
to ﬂuconazole and miconazole. Ketoconazole had a best MIC against
Candida.
Conclusion: Voriconazole is still the ﬁrst choice in the treatment of
mould keratitis. Disk diffusion method might be a practical method for
preliminary assessment of in vitro antifungal susceptibility testing.
R2461 Assessment of mycoplasma duo kit culture system for
the detection of Mycoplasma hominis and Ureaplasma
urealyticum in cervicovaginal secretions
N. Hanafy* (Alexandria, EG)
Objective: Comparing results of a commercially available selective
culture system for isolation of Mycoplasma hominis and Ureaplasma
urealyticum with their detection using PCR ampliﬁcation.
Materials and Methods: Two endo-Cervical swabs have been collected
from each case of a cohort of 40 infertile females attending fertility
centers for management of infertility (group A), and from a control
group of 40 multiparus females attending contraception clinic (group
B). One swab have been subjected to culture for isolation of urogenital
mycoplasmas using a commercially available selective culture system
(Bio-Rad, USA) and the other sample was eluted in a buffer for
PCR ampliﬁcation using speciﬁc primers for Mycoplasma hominis and
Ureaplasma urealyticum.
Results: Using PCR, 19 of group A and 9 of group B were positive for
Mycoplasma hominis while 12 of group A and 8 of group B were positive
for Ureaplasma urealyticum. According to Duo kit results, 5 cases of
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groupA and one of control group B were positive for Mycoplasma
hominis while 10 and 8 cases were positive to Ureaplasma urealyticum
in group A and B respectively. The sensitivity of Duo kit culture system
in relation to PCR was found to be 89.47% and the speciﬁcity was 90.48.
Conclusion: Our study conﬁrm the reliability of Mycoplasma Duo kit
culture system for diagnosis of genitourinary colonization of the female
genital system with Mycoplasma hominis or Ureaplasma urealyticum.
Also we report a higher sensitivity than the PCR.
R2462 Review of the Tuberculosis External Quality Assessment
(EQA) programme in Zambia from 2005 to 2008
C. Kalunga* (Lusaka, ZM)
Introduction: The NTP has been conducting quality assurance through
the reference laboratory for the past four years to determine quality
improvement in Tb control. Quality improvement is a process by which
the components of smear microscopy diagnostic services are analyzed
with the aim of looking for ways to permanently remove obstacles to
success.
Direct sputum smear microscopy remains the most cost effective tool
for diagnosing patients with infectious tuberculosis and for monitoring
their progress on treatment. The case detection rate for Zambia is 58%
and falls short of the target of detecting 70% of all infectious cases of
TB.
Speciﬁc objectives:
1. To evaluate blinded rechecking results
2. To examine proﬁciency testing outcomes
3. To determine the solutions provided during on site evaluation
Methodology: This was a retrospective descriptive study, using the
quarterly reports and the data collected by the Chest Diseases Reference
laboratory from nine provincial hospitals between 2005 to 2008.
Results: Copperbelt had (15), Eastern (4), Northern (3) Southern
(4),UTH (7) Central (0) and Western (5), Luapula (2) North-Western (2)
errors.
The data for 2007: North-western (25) High False Negatives, 15 (6LFN,
4HFP, 2LFN) Southern and Central 28 (12HFP, 12LFP, 4LFP).
The data for 2008: There were (9) Arthur Davison Hospital, UTH and
Kasama General hospitals. Seven (7) Kitwe, Central, Mansa General.
Kabwe General (6).
On-site evaluation: No laboratory communication network which
resulted in inefﬁciency in results transmission and feedback. Lack of
adequate work space and ventilation in 90% of the laboratories.
Conclusion: The laboratory performance was above the expected major
errors. Proﬁciency testing outcomes were below 70% case detection in
Zambia.
R2463 Comparison of the performance of IFA, CFA, and ELISA
assays for the serodiagnosis of Q fever by quality assessment
D.W. Notermans*, T. Herremans, B. Hogema, J. Galema, M. Peeters,
M. Nabuurs, P. Schneeberger, M. Wegdam-Blans, A. Horrevorts, I. van
Loo, B. Vlaminckx, J. Berkhout, D. Raoult, J. Stenos, W. Nicholson,
H. Bijlmer (Bilthoven, Amsterdam, Nijmegen, Tilburg, Den Bosch,
Veldhoven, Maastricht, Nieuwegein, Venlo, NL; Marseille, FR;
Geelong, AU; Atlanta, US)
Objectives: Serology is important in diagnosing Q fever. Different tests
are available and comparability is not always clear. A quality assessment
for various Q fever tests was performed by comparing IFA, CFA and
ELISA, using serum samples from patients from a large outbreak in the
Netherlands.
Methods: A total of 25 serum samples were included from negative
controls, acute Q fever patients, and a serial diluted high positive sample.
Thirteen laboratories participated: eight from the Dutch Q fever endemic
area, two Dutch national laboratories and three reference laboratories
from outside The Netherlands. Six labs performed CFA, 9 performed
IFA, of which three were in-house assays, and 5 performed ELISA.
Results: IFA, ELISA and CFA values between laboratories using the
same methods were within close range and all three methods correctly
identiﬁed the Q fever patients. In house and commercial IFAs were well
comparable quantitatively. In titres reached some differences could be
observed.
All tests were reasonably speciﬁc (92–100%), however the sensitivity
showed more variation. IFA was the most sensitive test for both phase
1 and 2, with a sensitivity of 100% if IgG and IgM responses were
combined. For phase 2 antibodies the CFA performed well (100%) but
the sensitivity for phase 1 was only 61%. The phase 1 IgG ELISA
was more sensitive (67%) than phase 1 CFA, while phase 2 IgG and
IgM ELISAs were less sensitive than CFA (using the manufacturer’s
instructions).
Discussion: The higher sensitivity of the IFA was supported in the serial
dilution, however these observations were based on a limited number of
samples and should be reﬁned using a larger set of sera. The IFA appears
the method of choice if high sensitivity is required (e.g. early phase of
illness). ELISAs can be an alternative or for screening of large sample
numbers.
R2464 The utilisation of gluconic acid in certain strains of
Acinetobacter baumannii
B. Lopes, A. Hamouda, S. Amyes* (Edinburgh, UK)
Objective: A characteristic feature of glucose oxidizing acinetobacters
is their ability to produce a brown pigment in blood agar. The aim of
this study was to evaluate the nature of brown pigment produced by
Acinetobacter baumannii.
Methods: Two (A/B) A. baumannii strains were isolated from diabetic
patient and identiﬁed by blaOXA-51-like PCR and restriction analysis
of 16S and 23S r-RNA spacer sequences using AluI and NdeII. MICs
were estimated by BSAC guidelines. Isosensitest (IST)/M9 glucose broth
was used for the growth of strains. Growth of the strains was monitored
over 48 hour period using IST broth having gluconic acid concentration
range from 0.1 to 4%. The inhibitory activity of the pigment produced
by strain A was checked by the ditch plate method.
Results: The MICs for Imipenem, meropenem, ceftazidime and
cefepime were 0.5, 0.5, 8 and 4mg/L respectively for both strains. Both
the strains were positive for blaoxa-51-like and blaADC but negative for
blaoxa-23/40/58 and metallo-b-lactamases. Strain A produced a brown
pigment in presence of gluconic acid. It also grew better than strain B
over a period of 48 hours in the presence of IST broth containing
gluconic acid concentrations ranging from 0.1 to 4%. Neither strain
produced pigment in M9 glucose medium. When gluconic acid is added
in excess, it increases the pigment in strain A. The brown pigment
produced by strain A did not have any inhibitory effect against S. aureus
NCTC6571, Ps. aeruginosa NCTC10662, A. baumannii ATCC19606 and
E. coli NCTC10418. The glucose dehydrogenase enables both the strains
to form 6-phosphogluonate which is free to enter the Entner-Doudouroff
pathway hence there is no pigment production seen in both the strains
when M9 glucose broth is used. On the other side human blood being
enriched with nutrients including gluconic acid helps strain A to survive
better by converting gluconic acid to 2,5 diketogluconate which leads to
the formation of brown pigmentation.
Conclusion: The survival of A. baumannii A in gluconic acid enriched
medium helps it to survive better than A. baumannii B. Excess gluconic
acid in strain A leads to brown pigmentation which may offer protection
against antioxidant stress. The results show that strain A has multiple
routes of metabolism which offers it better chance for survival than
strain B.
R2465 Rapid identiﬁcation and antimicrobial susceptibility testing
of Gram-negative bacilli directly from positive blood
cultures using Vitek2
S. Iyer*, M. Reed, A. Stacey, N. Virgincar (Reading, UK)
Objectives: Prompt empirical antimicrobial treatment, after blood
culture is recommended for optimal management of sepsis. Rapid
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pathogen identiﬁcation (ID) and antimicrobial susceptibility testing
(AST) results permit early streamlining of the empirical antimicrobial
treatment to the pathogen-directed treatment with potential healthcare
beneﬁts.
We compared, using the Vitek 2 automated system, ID and AST of
Gram-negative bacilli (GNBs) from positive blood culture by ‘direct’
inoculation from blood culture broths with the ‘indirect’ inoculation
from pure subcultures to improve the turnaround time of microbiological
analysis.
Methods: Between May-October 2010, 97 consecutive GNBs from 64
monomicrobial positive blood cultures (33 sets in 2/2 and 31 sets in
1/2 bottles) were included in the study. Vitek 2 GN ID and AST
N142 (Enterobacteriaceae) cards were ‘directly’ inoculated with bacterial
suspensions, prepared by differential centrifugation of the positive blood
culture broth at 160Xg 5min, to separate blood cells and 650Xg
10min to pellet bacteria. Vitek 2 GNID, AST N142 and N 143 (Non-
Enterobacteriaceae) were also ‘indirectly’ inoculated from overnight
subcultures, following manufacturer’s instructions. The ‘indirect’ method
results were considered the ‘gold standard’. API ID system was used if
the GNB was not identiﬁed by the Vitek 2. Discrepant AST results were
interpreted as: a ‘very major error’ if the result of the direct method was
susceptible (“S”) and that of the ‘Indirect’ method was resistant (“R”);
a major error was the opposite. All other discrepancies were considered
minor errors.
Results: Of the 97 GNBs, 95 (98%) were identiﬁed by the indirect
method vs. 90 (93%) by the ‘direct’ method. The two methods concor-
dantly identiﬁed 95.4% (83/87) of the Enterobacteriaceae and 100% (6/6)
of the Pseudomonas aeruginosa isolates. Nine valid isolate-antibiotic
comparisons were possible between ‘direct’ AST N142 and ‘indirect’
AST N143 for Non-Enterobacteriaceae vs. 19 for Enterobacteriaceae.
For 92 GNBs (Enterobacteriaceae [n = 87], P. aeruginosa [n = 5]), a total
of 1698 valid isolate-antibiotic combinations were compared between the
‘Direct’ AST N142 and, ‘Indirect’ AST N 142 and N143 cards. Overall,
the rates of the ‘very major’, ‘major’, and ‘minor’ errors were: 0.35%
(6/1698), 1% (18/1698) and 1.3% (22/1698) respectively.
Conclusions: Direct inoculation of the Vitek 2 is rapid and reliable for
ID and AST of the GNBs from the positive blood cultures.
R2466 Bloodstream infections: is there a seasonal variation?
S. Baka*, D. Makri, A. Spathi, I. Patikas, S. Kotsali, A. Lykas,
D. Koutras, E. Logothetis, V. Genimata, E. Kouskouni (Athens, GR)
Objectives: Seasonal variation in rates of infection with certain
microorganisms has already been described with a higher incidence rate
during the warmest months than the remainder of the year. The aim of
the study was to detect seasonal variation, if any, in the recovery rate
of different pathogens from the positive blood cultures obtained from
patients of our hospital.
Methods: All the bloodstream infections reported during the last ﬁve
years were included in the study. After incubation in a continuously
monitoring blood culture system (BACTEC 9050, Becton Dickinson,
USA), positive blood-cultures were inoculated onto appropriate plates
for standard aerobic and anaerobic cultures and incubated at 370 C
for 24h and 48h, respectively. A Gram-stained smear was examined
under microscope to obtain valuable information about the types of
microorganisms present. The isolated pathogens were identiﬁed using
the automated system VITEK 2 (BioMerieux, Marcy l’Etoile, France).
Results: No seasonal variation was observed in the isolation of
Staphylococcus aureus and the coagulase-negative staphylococci. In
contrast, an increase in the isolation of enterococci and Candida species
during the warm months of the year was noted. Speciﬁcally, 52.2% of
enterococci and 60.8% of Candida species were isolated during June-
September or 68.5% and 70.3%, respectively, during May-September.
The same was true for Acinetobacter baumannii, Escherichia coli and
Klebsiella pneumoniae. For these microorganisms, the 75.0%, 52.2%
and 45.3%, respectively, of the isolates were recovered during June-
September or 76.6%, 56.7% and 57.2%, respectively, during May-
September.
Conclusions: Our data suggest a seasonal variation with an increase of
the bloodstream infections caused by enterococci, some Gram-negative
rods and Candida species during the warm months of the year.
R2467 Evaluation of Copan SL-solution for pre-treatment of lower
respiratory samples for bacterial culture inoculation on the
automated Walk away specimen processor (WASP)
A. Bielli*, A. Berlingeri, E. Mirone, M.P. Landini (Bologna, IT)
Objectives: Respiratory specimens (RS) contains a lot of mucus that
must be dissolved before plating. Copan has introduced to the market
the SL-Solution (SL), a ready to use tubes with 1.0ml of mucus
dissolving solution. The objectives of our study were to compare: 1)
the performance of SL versus Sputasol (SP) (Oxoid) for pre-treatment
of RS; 2) manual plating versus automated plating before implementing
RS inoculation on the Walk away specimen processor (WASP).
Method: 166 RS were tested: 31 expectorates (ESP), 83 bronchial
aspirates (ABR), 44 bronchoalveolar lavages (BRL) and 8 Pharyngo-
Nasal Aspirates (AFN). 31 ESP and 8 AFN were tested in duplicate,
one sample was prepared using a 1:1 (vol/vol) ratio (RS/SP), vortexed
and incubated for 30 minutes at 35ºC, the other sample was prepared
by transferring 1ml of specimen to a tube of SL to obtain a 1:1 ratio
(RS/SL). The other 127 samples were tested in duplicate: un-treated
and SL treated. Ten microliters of RS treated or untreated samples were
manually plated, samples in SL tubes were loaded on the WASP and
processed following the WASP protocol (Vortex at 2500 RPM for 30
seconds and plated with 10 ul loop). All samples were incubated as
per laboratory SOPs at 24 and 48 hours for semi-quantitative bacteria
growth.
Results: Among the 166 samples processed, 100 were positive (30
ESP and AFN, 70 ABR and BRL) and 66 had no signiﬁcant growth;
no qualitative differences were noted between manual and automated
streaking on the WASP. In the 30 ESP and AFN positive, pre-treated
with SP and SL, there was 100% agreement for bacteria and fungi strains
isolation and 93% agreement (28/30) when analyzing the bacterial load,
77% agreement (23/30) for the fungi.
Manual plating of untreated ABR and BRL vs. SL pre-treated (diluted
1:2) had 100% agreement for isolated bacteria and fungi and 91%
agreement (64/70) for bacterial load, 89% agreement (62/70) for the
fungi. A 99% agreement (76/77) was noted in the semi quantitative
evaluation of bacteria (manually vs. Wasp-plated). The loads differences
of 1 log in SL that were noted mainly with Candida, may due to the
1:2 SL dilution factor uneven sampling and inconsistency evaluation for
seeding in quadrants.
Conclusions: Copan SL-Solution demonstrated an excellent perfor-
mance and results agreement compared to the Sputasol with both manual
and WASP plating. It’s easy to use, doesn’t require a pre incubation step
and samples in SL tube can be loaded directly on the WASP.
R2468 Quantitative comparison of new liquid-based transport
swabs for aerobic and anaerobic organism recovery
H. Gough*, C. Yates, F.M. Awadel-Kariem (Stevenage, UK)
Background: The development and introduction of automation to
inoculate and streak samples in Microbiology laboratories, will lead to a
move from gel based transport swabs to liquid based transport systems.
Objectives: To compare and evaluate the survival of fastidious organisms
in two liquid based transport swabs (Copan Eswab® and Medical Wire
S® swabs) against two gel based systems (Copan M40 and Medical Wire
Transwab®). The Eswab® has a ﬂocked swab in 1mL of modiﬁed liquid
Amies, and is designed to elute the entire sample into the medium. The
S® swab is foam tipped in 1mL of liquid Amies.
Method: The study was based on CLSI procedure M40-A using the
quantitative elution method for the liquid based swabs and the roll
plate method for the gel swabs, to evaluate performance. Suspensions
of Neisseria gonorrhoeae ATCC 43069, Haemophilus inﬂuenzae ATCC
10211, Streptococcus pneumoniae ATCC 6305, Streptococcus pyogenes
Diagnostic/laboratory methods (other than molecular) S739
ATCC 6305, Fusobacterium nucleatum ATCC 25586, Prevotella
melaninogenica ATCC 25845 and Peptostreptococcus anaerobius ATCC
27337 were prepared by diluting 0.5 McFarlane solutions, made from
fresh cultures. The swabs, in triplicate, were inoculated by immersion
in 100mL of the suspensions for 10 seconds. Recovery was measured
by quantitative plate counts after 0, 24, and 48 hours storage at room
temperature.
Results: After 24 hours P. anaerobius, S. pneumoniae and S. pyogenes
were recovered from all swabs. F. nucleatum, P. melaninogenica and
N. gonorrhoeae were recovered from the Eswabs® and Copan gel swabs
only. H. inﬂuenzae was recovered from both the Eswab® and the S®
swabs. At 48 hours only S. pyogenes was recovered from all swabs.
P. anaerobius, F. nucleatum, P. melaninogenica and H. inﬂuenzae were
recovered from the Eswabs but not the S swabs. N. gonorrhoeae was
not recovered from any swabs after 48 hours.
The highest number of organisms recovered was consistently achieved
with the Eswab®.
Conclusions: The best results were obtained by the Eswab®; which
showed superior recovery of all the organisms, compared to the others
tested. It would be an acceptable transport system for these fastidious
organisms. It is also suitable for use with automated inoculation systems.
R2469 Rickettsial infections during 2000–2010 in northern Greece
P. Siasios*, N. Tseniklidou, A. Kandili, A. Kaftantzi, M. Rigkos,
D. Karabaxoglou, A. Kansouzidou (Thessaloniki, GR)
Background: Rickettsiae are a group of bacteria that cause disease in
both animals and humans. The cause of Mediterranean spotted fever is
Rickettsia conorii, transmitted to humans by the dog tick Rhipicephalus
sanguineus. Rickettsia mooseri is the cause of mourine or endemic
typhus and is transmitted to humans by the rat ﬂea Xenopsylla cheopis.
Purpose: The aim of the study was to determine the prevalence
of rickettsial infection among patients with clinically suspected
rickettsiosis. Also the distribution among several demographic variables,
including sex, age, and season during the period 2000–2010 was
evaluated.
Methods: Serum samples were collected from 903 patients (537 males,
366 females aged 10 months to 85 years old) and tested by indirect
immunoﬂuorescence assay (Rickettsia conorii Spot IF, Rickettsia mooseri
Spot IF, bioMerieux) for the detection of IgM and IgG antibodies. All
serum samples were tested in a 1/40 initial dilution. Intense ﬂuorescence
of the Rickettsiae situated in or outside the cells was considered positive
reaction. End-point titers were obtained by serial dilution on positive
specimens. Sera showing a typical pattern of ﬂuorescence at titers of
1:80 for IgG and/or for IgM antibodies were considered positive. In
64 patients a second serum sample was tested for seroconversion or a
fourfold titre increase.
Results: Of the total 903 patients, IgM and IgG antibodies to rickettsiae
were found in 250 patients. Antibodies to R. conorii were detected in 210
patients (84%), 115 males (54.8%) and 95 females (45.2%). In addition
antibodies to R. mooseri were found in 40 patients (16%), 26 males
(65%) and 14 females (35%). Difference in prevalence of antibodies to
rickettsiae between age groups in men was not signiﬁcant. However, the
highest prevalence of antibodies to rickettsiae was observed in women
aged >40 years old. Rickettsial infections are signiﬁcantly seasonal,
with most cases appearing during summer months. Patients from the
prefectures of Kavala and Xanthi demonstrated a high prevalence of
antibodies to rickettsiae.
Conclusions: Data show a wide distribution of R. conorii in Northern
Greece and indicate the low frequency of R. mooseri. Men are affected
more often than women. Increased incidence of disease occurs during
the summer months, especially in Eastern Macedonia and Thrace.
R2470 Evaluation of Liaison® Biotrin Parvovirus B19 kits for IgG
and IgM antibody detection
A. Cardentey-Reyes*, C. Liesnard, M.L. Delforge (Brussels, BE)
Objectives: The purpose of this study was to compare the LIAISON®
Biotrin Parvovirus B19 chemiluminescent immunoassay (CLIA) kit’s
performance to the Biotrin Parvovirus B19 Enzyme Immunoassay (EIA).
Methods: 273 serum samples were collected from patients with different
antibody status according to Biotrin EIA: 112 IgG positive-IgM negative
samples, 51 IgM positive samples and 110 IgG negative samples.
Potential cross-reactions were evaluated using 45 serum samples from
patients with other infectious diseases (n = 30) or immunological
pathologies (n = 15). LIAISON® results were compared with those
obtained with the Biotrin Parvovirus B19 EIA. Discordant results
between LIAISON® and EIA were conﬁrmed by Biotrin Parvovirus B19
Immunoﬂuorescent Assay (IFA).
Results: Of the IgG positive-IgM negative group we found one sample
was IgM positive by LIAISON®, negative by IFA. Of the IgM positive
group, two sera were negative by LIAISON®. One was conﬁrmed
negative and one was weakly positive by IFA. Of the IgG negative group
no discrepancies were found between the two tests. Of the potentially
cross-reactive IgM samples, 2 were positive with LIAISON®, one of
them was negative with EIA but both were positive with IFA. One showed
doubtful results with the three methods. All those three false positive
samples came from patients with acute CMV infection. Coefﬁcients of
variation for interassay variability for IgG and IgM antibodies were 4.5%
and 4%, respectively.
Conclusions: The agreement between LIAISON® and Biotrin EIA was
100% for IgG. Concerning IgM we observed 3 discrepancies, of which
1 was conﬁrmed by IFA. We can conclude that the fully automated
LIAISON® Biotrin Parvovirus B19 CLIA kits showed a good agreement
with Biotrin EIA for detection of IgG and IgM antibodies.
R2471 Increase of efﬁciency of antigen p24 HIV-1 detection
I. Sharipova*, M. Levina, V. Puzyrev, A. Obriadina, A. Burkov,
T. Ulanova (Nizhny Novgorod, RU)
Background: Antigen p24 is detected in blood serum at early stages
of HIV-infection as a result of virus replication and at later stages
of infection, when anti-p24 concentration decreases, and the antigen
becomes detectable again. When antibodies to HIV are revealed, antigen
p24 is often no longer detectable as a result of formation of a complex
between the antigen and antibodies in blood. All existing commercial
kits detect only the free p24 antigen, and their sensitivity level unable
to determine low concentrations of p24 antigen that is required for early
diagnosis of HIV infection.
The purpose of the work is the study of diagnostic efﬁciency of detection
of free and bound HIV-1 p24 antigen by the modiﬁed kit “DS-EIA-HIV-
Ag-screen”. An increase the sensitivity at antigen HIV-1 p24 detection is
achieved by dissociate the immune complex and detecting total antigen
p24 HIV-1 in patients’ samples.
Materials: Method for the dissociation of immune complex and
preserving the free HIV p24 antigen was developed. The samples were
treated with glycine hydrochloride to dissociate the immune complexes,
followed by neutralization with TRIS-hydrochloric acid. Reagents for
immune dissociation designed for use with the kit of the “DS-EIA-HIV-
Ag-screen”.
The following categories of sera were used in the work: 43 sera positive
in EIA and PCR and indeterminate in the immunoblot (IB), 107 well
deﬁned and positive in the IB reaction sera from HIV-infected patients.
Results: At testing 43 blood sera samples positive in EIA, PCR
and indeterminate in the IB, antigen p24 is detected in 31 samples
(72%) using the kit “DS-EIA-HIV-Ag-screen” and in 37 samples (86%)
using the modiﬁed kit. At testing of 107 the samples from HIV-
infected patients, conﬁrmed in the IB reaction, antigen p24 is detected
in 8 samples (7.48%) using the kit “DS-EIA-HIV-Ag-screen” and
additionally in 11 samples after the dissociation of immune complex. The
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total number of samples positive for p24 among samples with conﬁrmed
HIV infection by IB is 19 (17, 76%).
Conclusion: The dissociation of the p24 immune complexes is a simple
method to increase the proportion of HIV samples with p24 antigen. The
greatest percentage of overall detection of antigen p24 HIV-1 is detected
in the sera with indeterminate or negative result of the IB and may be
valuable in diagnosing HIV infection.
R2472 Using MALDI-TOF Biotyper 2 for identiﬁcation of clinical
isolates of undetermined species by routine methods
E. Besse`de*, S. Ben Amor, E. Sifre´, F. Me´graud (Bordeaux, FR)
Objectives: Routine identiﬁcation of clinical isolates is performed in our
laboratory using an automated Phoenix identiﬁcation system (Becton
Dickinson) and various API strips (bioMe´rieux). In the absence of
identiﬁcation, sequencing of 16S rRNA gene is performed. The aim
of this study was to include the MALDI-TOF Biotyper 2 identiﬁcations
in our protocol before sequencing in order to evaluate its efﬁcacity.
Methods: Since May 2010, all strains not identiﬁed by the phenotypic
methods were tested by MALDI-TOF (Ultraﬂex III, Bruker Daltonics,
Bremen) at the genomic platform of the University Victor Segalen
Bordeaux 2 since the laboratory does not currently have a mass
spectrometer on site to test all strains routinely.
All strains for which the biologist asked complementary identiﬁcation
1) from May to July 2010 isolates were placed in an Eppendorf tube
containing a water-ethanol mixture, then, an extraction was performed
before testing on the Ultraﬂex III. 2) since August, the extraction was
eliminated and the bacteria were subcultured the day before testing
directly deposited on the target.
Results: A total of 170 strains were tested on the Ultraﬂex III: 94 strains
(55%) were identiﬁed with a score above 2.00, 37 strains (22%) were
identiﬁed with a score between 1.70 and 1.99 and for 39 strains (23%)
a score below 1.70 was obtained. Finally, an identiﬁcation was obtained
for 77% of the bacterial isolates, avoiding sequencing. Moreover, even
if for 23% of strains, no valid identiﬁcation was obtained (low score), in
practice the identiﬁcations given by the MALDI-TOF mass spectrometer
often helped the biologist in orienting the identiﬁcation and carrying out
additional tests before performing the sequencing.
Conclusion: In conclusion, after 6 months of this protocol, more than
75% of bacteria thus treated were identiﬁed and all biologists are
convinced of the contribution of spectrometry in clinical bacteriology.
Valuable time is saved and in some cases the therapeutic management
of patients has been modiﬁed and adapted quickly to the results given
by mass spectrometry.
R2473 Performance of two commercial antigen tests for the
diagnosis of respiratory syncytial virus on respiratory
paediatric specimens
E. De Witte, H. Goossens, M. Ieven* (Edegem, BE)
Objectives: Rapid antigen detection assays for the respiratory syncytial
virus (RSV) antigen are widely available with large differences in
performance characteristics, sensitivities varying between 59% and 97%
(Henrickson KJ and Hall CB. Pediatr Infect Dis J., 2007 Nov; 26(11
Suppl): S36−40). We evaluated the performance of two commercially
available immunochromatographic assays: the BinaxNOW RSV and
Clearview RSV (Inverness Medical).
Methods: One hundred paediatric nasopharyngeal aspirates were
collected and stored during the winters 2007–2010 in the University
Hospital of Antwerp and were used for the evaluation of the BinaxNOW;
75 of these specimens were also tested with the Clearview RSV. The
results of these rapid assays were compared to the combination of
immunoﬂuorescence (IF) directly on the specimens and/or culture on
inoculated Hep2 shell vials followed by IF after two days of incubation
(VC), which was considered as the gold standard. True positives were
deﬁned as positive for either IF and/or VC.
Results: Of the 100 samples tested, 49 were found positive (49%) for
RSV with either IF and/or VC. The sensitivity and speciﬁcity of the
Clearview and the BinaxNOW assay were 77.1% and 92.5%, 87.8%
and 98.0% respectively (table 1). There was no signiﬁcant difference in
sensitivity (P = 0.3) and speciﬁcity (P = 0.3) between the two assays.
Conclusion: These easy to perform RSV antigen tests, which have a
comparable performance, facilitate urgent testing outside batched runs or
outside normal laboratory working hours. In order to increase sensitivity,
negative results should be conﬁrmed by IF.
R2474 Access® HIV combo: clinical evaluation of sensitivity and
speciﬁcity on serum and plasma samples
A. Gautheret-Dejean*, F. Descamps, S. Gre´aume, C. Chandelier,
R. Falcou-Briatte, M. Maniez-Montreuil (Paris, Lille, Bois-Guillaume,
Marnes-la-Coquette, FR)
Objectives: The diagnosis of infection with human immunodeﬁciency
virus 1 and 2 (HIV-1, HIV-2) is based on the detection of antibodies
(Ab) to HIV-1/-2, and, during the stage of primary infection, the
detection of p24 antigen or HIV-1 viral RNA. The objectives were
to assess the performance of the Access HIV combo assay (Bio-Rad)
on Access 2 system (Beckman Coulter) in terms of speciﬁcity and
sensitivity on serum and plasma samples. This study was performed in
three laboratories: Virology Department from Pitie´-Salpeˆtrie`re hospital,
laboratory “CQFD” from the EFS Nord de France (EFS-1) and
laboratory “Non-The´rapeutique” from the EFS Normandie (EFS-2).
Methods: The hospital tested on the one hand, speciﬁcity on 510 serum
samples from routine, 200 serum samples from pregnant women and
29 serum samples from patients infected by HTLV-I, and, on the other
hand, sensitivity on 103 plasma samples (patients followed for HIV-1
infection using viral load) and 8 serum samples from routine, 209
serum samples from patients at the chronic stage of HIV-1 infection
(Genotypes: subtypes A, B, C, D, F, G, H, J, K, 14 different CRFs and
group O), 86 serum samples from patients recently contaminated by
HIV-1 (pre- or per-seroconversion), and 75 serum samples from patients
infected by HIV-2. Results were compared with those obtained with
ELISA combined (p24 Ag/Ab to HIV-1/-2) or kit of third generation
(Ab to HIV-1/2) according to the period of initial testing.
EFS-1 and EFS-2 tested speciﬁcity on 2551 and 2561 serum samples
from blood donors, respectively. Those samples were negative for
HIV testing using the routine method (Prism®/Abbott or Genscreen™
ULTRA HIV Ag-Ab/Bio-Rad).
Results: Speciﬁcity at hospital was 99.80% for fresh serum samples,
100% for serum samples from pregnant women and patients infected by
HTLV-I. Speciﬁcity was 100% for EFS-1 and EFS-2 on blood donor
samples. Overall speciﬁcity was 99.98% for all blood donor and patient
samples from the three sites.
Sensitivity was 100% for serum samples from patients during chronic
stage of HIV infection and 97.7% during primary infection.
Conclusion: The clinical evaluation of Access HIV combo on Access 2
system showed an excellent speciﬁcity for HIV testing for blood donors
and hospital patients. All patients infected by HIV-1 or -2, at the chronic
stage of the infection, were also identiﬁed as positive. These performance
are fully suitable for HIV screening in private or hospital laboratory.
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R2475 Detection of antibodies to Campylobacter jejuni antigens
in children with Guillain-Barre´ syndrome by ELISA with
four different antigen preparations
N. Rokosz, W. Rastawicki, K. Zacharczuk*, R. Gierczynski (Warsaw, PL)
Objectives: Campylobacter jejuni is the organism that has most
frequently been described in association with Guillain-Barre´ syndrome
(GBS). Although infections with C. jejuni are recognized mainly by
culture, serodiagnosis is often useful tool in diagnosis of neurological
complications and reactive arthritis occurred after intestinal campylobac-
teriosis. Many various bacterial antigens have been used for the detection
of C. jejuni speciﬁc antibodies. In this study we evaluated ELISA with
four different antigen preparations for serological diagnosis of C. jejuni
infections in patients with GBS.
Methods: Sera were obtained from six pediatric patients (age range 4−16
years old; two males and four females) which met the established clinical
criteria for GBS. A few weeks before the development of neurological
symptoms all the six patients had a diarrhea episodes. Paired serum
specimens were obtained from 2 patients. For control of speciﬁcity
and sensitivity of different ELISA we used sera from culture-positive
C. jejuni patients and from blood donors. The serological tests for
C. jejuni were performed using one commercial ELISA (Mikrogen) and
three home-made ELISA tests, with whole-cell antigen (Virion/Serion),
LPS antigen and whole-cell antigen prepared according to method
described by Strid and colleagues.
Results: The cut-off limit of serum antibodies in home-made ELISA was
set at mean antibody titre determined in the sera of 100 blood donors
exceeded by three standard deviations. IgG antibodies, in diagnostically
signiﬁcant level, were presented in 4 patients by all four ELISA tests. We
observed signiﬁcant decrease of IgG antibodies titre in serum samples
obtained from two patients in chronic phase of disease. ELISA with LPS
antigen and ELISA with whole-cell antigen (Virion/Serion) diagnosed
the IgM antibodies in four patients. On the other hand the presence of
IgA was diagnosed only in serum samples obtained in the acute phase
from two patients by commercial ELISA and ELISA with LPS antigen.
Conclusion: The results of our study showed that serological
investigation may be a useful tool for identiﬁcation of C. jejuni infections
in patients with post-infectious neurological complications. Therefore,
development of a worldwide available, standardized ELISA assay which
can be used in serological diagnosis of C. jejuni infections, and its
complications such as GBS, is needed.
R2476 Analysis of recombinant Echinococcus granulosus antigen B
for serological diagnosis of Echinococcosis by enzyme-linked
immunosorbent assay
E. Kalantari*, B. Kazemi, N. Mosaffa, M. Bandehpour (Tehran, IR)
Objectives: Echinococcosis or hydatid disease is a zoonotic infection
caused by larval (metacestode) stages of cestodes belonging to the
Echinococcus, family Taeniidae. Echinococcus granulosus causes human
cystic echinococcosis which is an important public health problem
in many regions of the world. There are some problems in primary
diagnosis such as cross-reaction with sera from patients with other
parasitic disease in serological tests. The use of an appropriate source
of antigenic material is a very important and crucial point in the
improvement of the serodiagnostic features such as enzyme-linked
immunosorbent assay (ELISA) method.
Methods: We expressed and puriﬁed recombinant AgB of Echinococcus
granulosus and used as antigen in ELISA method. Serum samples were
given from 36 cystic hydatid disease patients that have been conﬁrmed
by surgical operation as well as 36 healthy individuals sera were tested by
ELISA method using recombinant AgB and compared with commercial
kit (Euroimmun) for speciﬁcity and sensitivities value. The sensitivity of
91.66% and speciﬁcity of 90.16% were determined by homemade kit.
Results: In this study, recombinant EgAgB (24 kDa) was expressed and
puriﬁed. The puriﬁed protein was coated onto ELISA microplates and
tested in an anti-IgG ELISA with sera from patients with or without
CHD and healthy individuals.sensitivity and speciﬁcity of ELISA test
in 36 positive samples and 51sero negative samples were estimated
respectively in order as 91.66% and 90.16%.
Conclusion: Overally we came to this conclusion that our results have
conﬁrmed the previous studies regarding the detection value of the
recombinant antigen. Although our ﬁndings are in common with other
previous studies in case of high Speciﬁcity and sensitivity of this antigen
for hydatidosis diagnosis with ELISA test as well. Therefore, the puriﬁed
recombinant AgB in this study is one of the desirable Ag for the fast and
accurate diagnosis of hydatidosis. Therefore, performing this method on
more samples and doing more wide researches make it possible to reach
more valuable and conclusive results.
R2477 Evaluation of spreading bacteria using manual method
versus InoqulA®
J. Rydback*, M.H. Walder, I. Tjernberg (Malmo¨, SE)
Introduction: Traditionally, clinical samples are manually inoculated
and spread onto agar plates by lab technicians using plastic or
platinum loops. The most common streaking pattern is the four-quadrant
pattern. The aim of this procedure is to isolate discrete colonies for
further identiﬁcation and antibiotic susceptibility testing. KIESTRA Lab
Automation (Drachten, The Netherlands) has developed an instrument
where the spreading of the samples is performed by beads in an
electromagnetic ﬁeld.
The aim of this study was:
– to compare the number of discrete colonies obtained by manual
spreading with automatic spreading performed by InoqulA®
– to study the variation and reproducibility of discrete colonies created
by InoqulA®
Methods: Bacteria from two different species were selected, Enterococ-
cus faecalis ATCC 29212 and Escherichia coli ATCC 25922. Inoculums
of each species were prepared by suspending the bacteria in Phosphate
Buffered Saline (PBS) to a density of McFarland 0.5 using VITEK®
2 Densicheck (bioMe´rieux). The suspension of E. faecalis was used
undiluted and the suspension of E. coli was diluted 1/10. The ﬁnal
inoculum spread on each plate were 108 and 107 respectively. Agar
plates used was a cromogenic agar called UriSelect 4 (BioRad).
Five skilled lab technicians were asked to participate in the study and
each lab technician inoculated two plates of each bacterial suspension.
The same suspensions were used to inoculate the plates with the
InoqulA®. All plates were inoculated with 10 mL using a pipette.
For the manual spreading, plastic loops and the four-quadrant pattern,
was used. The plates were incubated in ambient air at 35ºC for 16 hours
before discrete colonies were counted.
Results: InoqulA® produced three times as many discrete colonies of
E. coli and ﬁve times as many discrete colonies of E. faecalis than the
manual method (Table 1).
For both E. faecalis (ﬁg. 1) and E. coli (ﬁg. 2) the amount of discrete
colonies isolated by manual spreading varied between different lab
technicians. There was also a noticeable variation in number of discrete
colonies produced by InoqulA®.
Conclusions:
– InoqulA® produced a greater amount of isolated bacterial colonies
than manual streaking.
– The number of isolated colonies obtained by manual spreading varies
between different lab technicians.
– Reproducibility and evaluation of different InoqulA® streaking pattern
needs to be further studied.
R2478 Association of H. pylori infection with recurrent abdominal
pain based on H. pylori Stool Antigen
F. Ghahramani, T. Eqbal Eftekhaari* (Bandar-Abbas, IR)
Introduction: Chronic Abdominal Pain of childhood and adolescent is a
common disturbance of patients and their Families. Considering different
etiologies of abdominal pain, the role of Helicobacter pylori is unclear.
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Method: This study was case-control and prospective from 1387–1388,
carried out in Bandar Abbas. 50 patients aged 4−16 years suffering from
recurrent abdominal pain (RAP) over 3 months which interfered with
their normal life style were selected randomly. 50 healthy preschool
and school children with same age were selected as control group.
Demographic data were collected in a questionnaire. After physical
examination, both groups were checked for Helicobacter pylori stool
antigen test (HPSA).
Results: 58% (29) patients were female. 14% in case group suffering
from RAP and 10% in control group had a positive HPSAg and 1 person
(2%) had a borderline result. HPSAg was more positive in males, and
not related to age, route of delivery child was born or the family history
of peptic ulcer disease. HPSAg result did not differ signiﬁcantly in case
or control group. Initiation of supplemental feeding after 6 months was
a strong risk factor for h.pylori infection.
Discussion: Association of H. pylori infection with recurrent abdominal
pain is not fully conﬁrmed and other causes of recurrent abdominal pain
should be completely evaluated.
R2479 Review of the requests for rapid urinary antigen test for
diagnosis of pneumococcal community-acquired pneumonia
from the emergency unit
A. Ganuza, A. Gil, C. Ezpeleta*, I. Tordoya, E. Fernandez, J.J. Garcia
(Pamplona, ES)
Objectives: The aim of this study is to know how many of the requests
for rapid urinary antigen test for diagnosis of pneumococcal community-
acquired pneumonia (cap) meet the criteria for cap which had been
previously given by the Hospital (fever, presence of 2 symptoms of a
lower respiratory tract infection combined with a new inﬁltrate on chest
radiography).
Methods: During one year (2008) data of cap deﬁned criteria were
recorded from every adult patient of who the test was requested.
Fever was deﬁned as the temperature was above 38.1ºC. Not only the
emergence of a new inﬁltrate on chest radiography but it was made
prior to the request of the test was recorded. Clinical symptoms of lower
respiratory tract infection recorded were: malaise, cough, dyspnea and
chest pain. Data was recorded and entered into a computer database.
Results: During the period of study 1085 test were requested from the
emergency unit to the Laboratory. Only for 227 (20.92%) of the patients
a temperature above 38.1ºC was detected, 291 (28.82%) had respiratory
symptoms and for 392 (36.1%) patients the chest x-ray was made prior
to the test although only in 153 (14.1%) of them a new inﬁltrate could
be demonstrated. The number of positive test was 129 (11.86%) and for
398 (36.68%) of the patients who the test was requested it did not meet
any of the criteria.
Conclusions: The rapid urinary antigen test for diagnosis of pneumococ-
cal community-acquired pneumonia has been widely validated in adults.
However in our Hospital it is being using in many patients who don’t
meet the request criteria given by the Hospital. Probably it is due to
several factors; The test can be demanded from the laboratory request
form along other urine test in a very easy way and that an important
number of physicians working at the emergency unit are in their
training period from many different medical and surgical specialities and
probably they do not know exactly what are the criteria for application
the test given by the Hospital.
It would be interesting to know the number of patients diagnosed of cap
with a positive test for who the empirical treatment for cap was adjusted
after receiving the result of the test, although it was not included in the
aim of this work.
R2480 Diagnostic vaule of procalcitonin for infection or
noninfection in patients with systemic inﬂammatory
response syndrome
H.X. Ning*, D.D. Li, C.M. Tao, T.T. Wang, X.H. Bi (Chengdu, CN)
Objective: The aim of this study is evaluation of procalcitonin role
in the diagnosis infection and non infection patients with systemic
inﬂammatory response syndrome (SIRS) patients using meta-analysis.
Methods: The Cochrane Library, PubMed, Ovid, Springerlink, CBM,
CNKI, VIP, EMBASE, ISI, and Wanfang Chinese Periodical Database
were searched systematically for relevant studies from January 1966
to September 2010. The language of the researches wasn’t limited.
Inclusion criteria were established based on validity criteria for
diagnostic research. Subsequently, the characteristics of the included
articles including study background, design information and diagnostic
parameters were extracted. Statistical analysis was performed by
employing Meta-DiSc 1.4 and SPSS 12. 0 software. To check for
publication bias, a funnel plot, using Egger’s linear regression method,
was constructed. Heterogeneity of the included articles was tested for
selecting proper effect model (ﬁxed effects or random effects model) to
calculate pooled weighted, sensitivity, speciﬁcity and 95% conﬁdence
intervals (CI). Summary receiver operating characteristic (SROC) curve
was made and the area under the curve (AUC) and Q* index was
calculated. Finally, sensitivity analysis and comparison of sensitivity
among different groups were performed.
Results: 20 articles (6 English articles, 11 Chinese articles and 1other
language articles) were included ﬁnally, with 1258 total patients. No
signiﬁcant heterogeneity and no publication bias was observed The
sensitivity and speciﬁcity of PCT for the differentiation of infectious
versus non-infectious systemic inﬂammatory response syndrome were
0.76 (95%CI = 0.73–0.79) and 0.8 (95%CI = 0.77–0.83) respectively.
The area under summary receiver operating characteristic (SROC) curve
was 0.85.
Conclusions: Serum measurements of PCT may be valuable in
differentiating between on-infectious SIRS sepsis and infectious SIRS,
the latter including sepesis.
R2481 Comparative study of the ability of two swab transport
systems to maintain viability of clinically important
organisms at controlled room temperature
H. Lopardo*, D. Borgnia, A. Mastroianni (Buenos Aires, AR)
Introduction: Appropriate conservation of specimens is one of the
most critical steps in the microbiological study of infectious diseases.
Objective. The aim of the present study was to compare the ability of two
extendedly-used swab transport devices with Stuart medium: (1) Copan
Venturi Transystem® (Copan Italia Spa, Brescia, Italy) and (2) Eurotubo
(Deltalab, Rubı´, Barcelona, Spain).
Materials and Methods: The NCCLS (Now CLSI) published recom-
mendations were followed (NCCLS. Quality control of microbiological
transport systems, M40-A, Vol. 23 No. 34, Wayne, PA, USA, 2003).
In a volume of 0.1ml appropriate concentrations (approximately 105
and 104 CFU/ml) of each Streptococcus pyogenes ATCC 19615,
Haemophilus inﬂuenzae ATCC 10211, Neisseria gonorrhoeae ATCC
43069, or Streptococcus pneumoniae were absorbed by the two different
swabs. Swabs were held in transport tubes for 10 minutes, 24h and
48h at room temperature (25.1–28.0 oC) before streaking chocolate agar
plates (Britania, Buenos Aires, Argentina). All tests were performed in
triplicate. Colonies were counted in a blinded way by one of us (HL)
and averaged.
Results: By reading the CFU/ml at subsequent time points, we observed
the decline in viability for each organism in each kind of device as can
be seen in the Table.
Conclusions: Signiﬁcant differences were observed between the two
systems, being Copan the most effective device for maintaining the
viability of these selected strains.
Conﬂict of interests: Nothing to declare.
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Table. Average change in cfu (log10) comparing with the zero time
counts for each speciﬁc device
Organism (UFC/ml) Eurotubo (UFC/ml)
T=0 T=24 T=48 T=0 T=24 T=48
N. inﬂuenzae 100% 17.5% 13.5% 100% 0 0
N. gonorrhoeae 100% 2.5% 0.1% 100% 0 0
S. pyogenes 100% 100% 100% 100% 5.0% 1.9%
S. pneumoniae 100% 100% 34.9% 100% 0 0
R2482 Oxoid Brilliance® agar, a new rapid chromogenic medium
for the screening of methicillin-resistant Staphylococcus
aureus from clinical isolates − an evaluation
D. O’Brien*, A. Mc Dermott, S. Mulligan (Dublin, IE)
Objectives: Meticillin resistant Staphylococcus aureus (MRSA) is one
of the major contributors to healthcare associated infection. Although
PCR techniques are a faster method for MRSA detection with same
day results, chromogenic agars are a lot cheaper and more efﬁcient
for use in a routine clinical laboratory. This study sought to evaluate
the effectiveness of Oxoid Brilliance® Agar, a new rapid chromogenic
medium for the screening of MRSA from clinical isolates.
Methods: 448 screening swabs (nasal, groin and wound sites if present)
taken on patient admission were analysed for the presence of MRSA.
The ﬁrst 200 swabs were inoculated onto Oxoid Brilliance® agar (Oxoid)
and MRSA ID agar (Biomerieux). The remaining 248 swabs were
inoculated onto 3 agars; Oxoid Brilliance agar (Oxoid), MRSA ID®
agar (Biomerieux) and chromID® (Biomerieux). Presumptive MRSA
colonies were tested for latex agglutination using a Pastorex latex kit
(Biorad). Colonies positive for latex agglutination were inoculated onto
a DNAse agar plate (Oxoid) and were also tested using the cefoxitin 10
microgram disc diffusion sensitivity test according to the British Society
for Antimicrobial Chemotherapy guidelines.
Results: From the 448 samples tested, 17 isolates were positive overall
for presumptive MRSA. Sensitivity and speciﬁcity were calculated for
each media at the incubation time points 18, 20, 24 and 48 hours
(Table 1). No false positives for Oxoid Brilliance® within 24 hours were
noted. Oxoid Brilliance® was shown to be more sensitive than the other
the agars at the earlier time point of 18−24 hours.
Conclusion: In this study, Oxoid Brilliance® agar was shown to be
superior to the other agars for the detection of MRSA at the earlier
time point of 18−24 hours. Oxoid Brilliance® agar has the potential
to cut down on turnaround times by detecting MRSA within 24 hours
compared to 48 hours as seen with most other chromogenic agars.
This has major implications on cost, infection prevention and control
measures and treatment strategies within healthcare facilities.
R2483 Miniaturised g-IFN assay for diagnosis of congenital
toxoplasmosis
V. Meroni*, M. Gobbi, L. Piccoli, F. Genco, L. Bollani (Pavia, IT)
Objective: Diagnosis of congenital toxoplasmosis at birth, even with the
most sensitive serological test is possibile in only 70−80% of newborn
that must be followed until one year of age. Furthermore treated babies
could be serologically negative. In our laboratory immunological test like
stimulation index and Cd25 markers have been employed for many years
in all doubtful cases; but these tests are time consuming and expensive.
In this study we employed a commercial test: Quantiferon CMI Assay
(Cellestis-Australia) less expensive, more rapid and easier to perform to
the diagnosis of congenital toxoplasmosis.
Methods: 180 eparinized samples (1ml) were obtained from 126 patients
referred to outpatients of Neonatal and Intensive Care unit of IRCCS
Foundation San Matteo Policlinic Pavia Italy as at risk for congenital
toxoplasmosis. Serum was used for serology (IgGVIDAS, IgM ISAGA
Biomerieux − Marcy l’Etoile France; Toxok IgA Diasorin Saluggia
Italy; LDBIO IgG/IgM western Blot − Lyon France) and replaced with
the same amount of RPMI (S-US). The test Quantiferon CMI was
performed according manufacturer’s instruction on a smaller amount of
blood (900ml instead of 3000ml) and the results were expressed in IU
according a standard curve. Toxoplasmic antigen was kindly provided
by Diasorin.
Results: Eighty patients were recorded as negative at the ﬁrst sampling
and all but one were true negative in the follow-up. Ten newborn
scored positive and all of them were congenitally infected. No one
switched negative under treatment in further controls. For 36 newborn
test results were undetermined (32 because of inadequate response to
phytoemoagglutinine, 4 for an aspeciﬁc activation).
Conclusion: These preliminary data according with a previous paper by
Peyron et al. suggest that also this commercial test could be useful in
early diagnosis of congenital toxoplasmosis and in all cases in which
serological test cannot solve diagnostic problems.
R2484 The role of infection in morbidity newborns in critical
conditions with brain damage
I.B. Dmitrieva*, E.A. Chernevskaya, N.V. Beloborodova (Moscow, RU)
Objectives: The prenatal hypoxia is the leading of nervous system
patology on one side and infectious processes with tendency of
generalization on the other side. We use a tandem of markers in intensive
care newborns: PCT − a biomarker of a bacterial infection and S100B −
a marker of brain damage.
Methods: 31 newborns (3−6 days) in ICU transported from maternity
clinic. The gestational age was 28−40 weeks. PCT and S100 serum levels
were measured by Elecsys immunoassay.
Results: 13 newborns (42%) were with HIE and 18 (58%) with
IVH. Patients with IVH was with pre-natal pneumonia in 10 (77%)
cases and in 9 (69%) necrotizing coloenteritis. Whereas at patients
with HIE an aspiration pneumonia is prevailed (11. 61%). Necrotizing
coloenteritis is diagnosed in 4 (22%) cases. PCT level was1.54 ng/ml
after hospitalization (0.377–4.81) and exceeded 2 ng/ml in 15 cases.
Level PCT didn’t differ in groups. At the same time patients with
IVH have positive hemoculture in 8 (61.5%) cases, than at patients of
compared group − 4 (22.2%) (p = 0.05). At the same sample S100B
0.325 (0.26–0.45) pkg/l. 0.448 (0.253–0.764) pkg/l from newborns with
IVH, 0.301 (0.244–0.336) pkg/l with HIE (p = 0,05). The level of S100B
is directly correlate with PCT level (r = 0.51).
Subsequent assay was made by 18 patients. PCT was 0.39 (0.192−1.1)
ng/ml. In 9 cases PCT have normalized after initially levels more than
2 ng/ml level. In other cases decreased of PCT level before treatment
was more than 50%. While S100B remained the same 0.347 (0.192–
0.438) pkg/l and has raised at 8 patients from 0.299 (0.170–0.418) pkg/l
to 0.488 (0.202–0.843) pkg/l (p = 0.05) (5 newborns were with IVH, and
6 has developed the convulsive syndrome).
In eight cases the level of S100B decreased from 0.480 (0.270–0.630)
to 0.223 (0.133–0.307). The gestational age of these patients was 36
(36−39) weeks. Only one patients was IVH. Initial level PCT in this
group was 3.92 (1.5–14.5) ng/ml. Whereas in group with raised S100B,
it was 0.97 (0.28–4.07) ng/ml (p = 0.05).
Conclusions: The tandem of biomarkers allows to start an adequate
antibacterial therapy rapidly for newborns in ICU. Monitoring this
markers allows to carry out differential diagnostics in cases of an
aggravation of clinical condition, to prevent the exceeded escalation
antibacterial therapy at suspected bacterium etiology while the processes
of CNS damage are prevalence.
R2485 The Walk-Away specimen processor (WASP): a ﬁrst
European evaluation
S. Nys*, L. Waumans, K. Magerman, R. Cartuyvels (Hasselt, BE)
Objective: Finding trained technicians specialized in Microbiology
nowadays is difﬁcult in Belgium. Microbiology has been, up till
now, one of the most labour intensive disciplines of the Clinical
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Laboratory. However, recent developments as automation of planting and
identiﬁcation with MALDI-TOF technology initiated an unimaginable
revolution.
We evaluated the WASP™ instrument (Copan Diagnostics Inc.) for its
accuracy of planting liquid samples.
Methods: Accuracy of the loop content (1mL and 10mL) of the WASP
was compared with a calibrated 50 mL pipet using a ten times dilution
series of a 0.5 McFarland suspension of 3 ATCC strains (E. coli 25922,
P. aeruginosa 27853 and E. faecalis 29212) according to guidelines of
the American Society for Microbiology.
Every inoculation was performed in triple on blood agar plates and the
experiment was repeated four times.
For the implementation of the WASP in the routine microbiology
laboratory, results of the inoculation of ﬁfty urine samples and ﬁfty
MRSA-screening samples by the WASP were compared with results of
manual inoculation. For urine samples, 1mL was planted on blood agar
and McConkey agar plates in a four quadrants streaking pattern. Ten mL
of the MRSA screening samples (eSwab) was planted on a chromogenic
agar and inoculated in TSB salt enrichment medium. After overnight
incubation, enrichment broths were planted onto chromogenic agar plates
both by WASP and manually.
Results: The quantitative evaluation of the automated streaking of the
1mL loop showed that plates inoculated by the WASP had 10 times more
colonies growing after overnight incubation as compared to the plates
inoculated with 50mL using the calibrated pipet. This was the same for
all three ATCC strains and after a correction was made for the cfu/mL
of the initial 0.5 McFarland suspension. Although there were numeric
differences between colony count of plates inoculated by WASP and
manually, no differences in clinical interpretation was observed.
Testing of the clinical samples will be continued in the next weeks.
Conclusion: Although the WASP is a very promising automated
instrument for planting and streaking of bulk samples like urines and
MRSA-screening samples in microbiology laboratories, a conscientious
validation is recommended before the implementation in daily routine.
R2486 Identiﬁcation of anaerobic bacteria by MALDI-TOF mass
spectrometry
S. Vega Castan˜o, L. Ferreira, M. Gonza´lez Avila, F. Sa´nchez Juanes,
M.I. Garcı´a Garcı´a, S. Rodrı´guez, J.E. Garcı´a Sa´nchez, J.M. Gonza´lez
Buitrago, J.L. Mun˜oz Bellido* (Salamanca, ES)
Objectives: Anaerobic bacteria remain an important group of human
pathogens. Most of them are fastidious microorganisms, and their
identiﬁcation by conventional, biochemical methods is frequently tedious
and inaccurate. MALDI-TOF mass spectrometry is a fast and reliable
technology for microorganism identiﬁcation, which has been shown
useful for microorganisms identiﬁcation both from culture and from
some samples. We have compared the correlation between biochemical
identiﬁcation and MALDI-TOF mass spectrometry (ME) for anaerobic
bacteria identiﬁcation.
Methods: 133 clinical isolates, previously identiﬁed by biochemical
methods were evaluated: 82 Bacteroides fragilis, 9 B. ovatus, 2 B. caccae,
2 B. stercoris, 2 B. uniformis, 2 B. vulgatus, 10 Porphyromonas
asaccharolytica, 6 Prevotella bivia, 4 P. intermedia, 1 Prevotella
corporis, 1 P. melaninogenica, 3 Prevotella spp, 2 Parabacteroides
distasonis, 2 Clostridium perfringens, 1 Biﬁdobacterium spp, 1
Fusobacterium varium, 1 Fusobacterium spp, 1 Eggerthella lenta and 1
Veillonella spp.
Species were identiﬁed using the Rapid 32A® system (bioMerieux,
Marcy L’Etoile France) according the manufacturer instructions. MALDI
TOF mass spectrometry was performed with an Autoﬂex III MS
MALDI-TOF device (Bruker Daltonics GmbH, Leipzig, Germany).
Results: Correlation between both methods, to the genus and species
levels, appear in Table 1.
Conclusions: Both methods show a good correlation in Bacteroides
species, especially at the genus level, but correlation is quite worse for
other genera such as Prevotella and Porphyromonas.
R2487 Diagnosing bloodstream infection by MALDI-TOF mass
spectrometry
K.A. Bode*, S. Klein, C. Ko¨hler, S. Zimmermann (Heidelberg, DE)
Sepsis is caused by a variety of different groups of infectious etiologies.
Early and adequate antimicrobial therapies correlate with positive clinical
outcomes. In recent years matrix-assisted laser desorption-ionization
time of ﬂight (MALDI-TOF) mass spectrometry ﬁngerprinting has
become a powerful tool in the microbiological diagnostic. The direct
identiﬁcation of microorganisms from a positive blood culture can
shorten the diagnostic signiﬁcantly enabling an earlier speciﬁc therapy.
Aim of the study was to compare two different methods of sample
preparation for the MALDI-TOF directly from a positive blood culture
versus the conventional culture, the current gold standard.
In the ﬁrst part of the study 192 positive blood cultures have
been investigated by using tubes with separator gels (BD) to enrich
microorganisms in the serum followed by the standard ethanol/formic
acid protein extraction for the preparation of the bacterial extracts. In the
second part of the study MALDI Sepsityper Kit from Bruker Daltonic
has been used for the preparation of the bacterial extracts out from
132 positive blood cultures. 75% of Gram-negative bacteria and 60%
of Gram-positive bacteria were correctly identiﬁed using the separator
tubes compared to the cultures on species level. Using the MALDI
Sepsityper Kit from Bruker Daltonic 95% of Gram-negative bacteria
and 68% of Gram-positive bacteria were correctly identiﬁed. The overall
identiﬁcation Biotyper score in both studies was signiﬁcantly higher
for the Gram-negative (Septityper 2,2 and BD 2,0) compared to the
Gram-positive bacteria (Septityper 1,8 and BD 1,7). An alteration of the
algorithm for the interpretation of the Biotyper score for Gram-positive
bacteria increases the rate of identiﬁcation of the germ about 12−18%.
The hands-on time is higher for the method using the tubes with separator
gels.
Thus, both protocols are suitable methods for the analysis of blood stream
infection with better results observed with Brukers Daltonic Sepsityper
Kit.
R2488 Plasma levels of N terminal pro-brain natriuretic peptide
and biomarkers of sepsis (procalcitonin and C-reactive
protein) in critically Ill patients of intensive care units
S. Arampatzi*, E. Protonotariou, K. Thisiadou, C. Chanonidou,
A. Kalikaki, V. Tsavdaridou, M. Karamouzis, E. Diza (Thessaloniki, GR)
Objectives: Natriuretic peptides compose a family of peptides that
present diuretic and vasoconstrictive properties and are associated with
left heart ventricle functions. Especially, the amino ending end of brain
natriuretic peptide (NT-proBNP) is secreted by heart ventricles due to
their dilatation in heart failure. High levels of NT-proBNP are also
observed during bacterial infection and sepsis. Procalcitonin (PCT) is a
calcitonin propeptide, which levels increase in serious bacterial infection
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and sepsis, and C-reactive protein (CRP) is an acute phase protein.
The purpose of our study was to evaluate NT-proBNP, PCT and CRP
serum levels in patients with documented infection that were hospitalized
in Intensive Care Units (ICUs) and their correlation with the isolated
microorganism and the site of the infection.
Methods: We mearured NT-proBNP, PCT and CRP serum levels in 30
hospitalized patients in ICUs of AHEPA University hospital. Patients
presented 31 infection episodes, conﬁrmed with cultures. NT-proBNP
levels were determined with electroluminescence (Expected Values
<100 pg/ml), PCT levels with chemoilluminescense (Expected Values
<0.5 ng/ml) and CRP with nephelometry (Expected 0.0−0.8mg/dl).
Results: Increased levels of NT-proBNP and CRP were observed in
all episodes while increased PCT values were found only in 16 (53%)
episodes. The highest levels were observed for NT-proBNP in respiratory
truck infections and bacteremias, for PCT in respiratory infections and
bacteremias and for CRP in bacteremias and venous catheter infections.
Statistically, signiﬁcant correlation was observed between NT-proBNP
and CRP (p< 0.01), while no correlation was observed between NT-
proBNP and PCT or between CRP and PCT. No signiﬁcant correlation
was observed between the isolated bacteria and NT-proBNP, PCT or CRP.
In respiratory truck positive cultures it was found statistically signiﬁcant
correlation between NT-proBNP and CRP (p< 0.01) and also between
PCT and CRP (p< 0.05).
Conclusions:
1. NT-proBNP levels are signiﬁcantly correlated with CRP levels in
severe infections.
2. There is no signiﬁcant correlation between the isolated bacteria from
positive cultures and NT-proBNP, PCT or CRP.
R2489 Inconsistent results of amoxicillin/clavulanic acid
susceptibility tests with gradient test strips from three
different manufacturers in rapid growing anaerobes
C. Schillerwein, F. Geppert, H. Feichtinger, W. Ruppitsch,
M. Grassberger* (Vienna, AT)
Objectives: Since we repeatedly observed inconsistent results regarding
susceptibility of rapid growing anaerobes to amoxicillin/clavulanic acid
using different gradient test strips, we set out to systematically compare
test strips from three manufacturers in order to identify possible
discrepancies.
Methods: Commercially available gradient test strips for amox-
icillin/clavulanic acid from three manufacturers were compared:
Lioﬁlchem (MIC Test Strip), AB bioMe´rieux (ETest®) and Oxoid
(M.I.C.Evaluator™). The initial experiment was carried out on 30
isolates of Bacteroides fragilis, 18 isolates of Prevotella bivia and two
isolates of Parabacteroides distasonis (total n = 50). The experiment was
replicated with 9 isolates of B. fragilis, 4 isolates of P. bivia and one
isolate of P. distasonis (total n = 14) using new batches of test strips.
Since divergent results in the ﬁrst experiment were observed mainly
with isolates that expressed at least one resistance gene (as tested
by PCR), only such isolates were used in the replication experiment.
Plates (Brucella agar, Becton Dickinson) were prepared with Mc Farland
turbidity standard 1. Following application of the test strips, agar
plates were incubated at 37ºC in an anaerobic system for 48 hours.
After recording the MIC value, susceptibility was determined using the
breakpoints established by EUCAST.
PCR for resistance genes and additional species veriﬁcation of each
isolate using 16s rDNA sequencing was performed by the Austrian
Agency for Health and Food Safety (AGES). For quality control the
ATCC strain 25285 of B. fragilis was used.
Results: In 12 out of 64 tested isolates inconsistent results regarding
susceptibiliy to amoxicillin/clavulanic acid were documented (see table).
These isolates also expressed at least one resistance gene. Strips from
Lioﬁlchem consistently produced the highest MIC values, while strips
from AB bioMe´rieux yielded the lowest.
Conclusion: Our results demonstrate, that gradient test strips from
different manufacturers may yield contradictory results regarding
susceptibility. Possible explanations for this ﬁnding include different
diffusion times of the diagnostic reagents, different materials of the
test strips (Lioﬁlchem uses paper strips, the two other companies
use synthetic strips) or instability of the diagnostic reagents (possibly
clavulanic acid). These ﬁndings need further attention in order to make
appropriate clinical decisions.
R2490 The diagnostic and prognostic value of procalcitonin in
patients with systemic inﬂammatory response syndrome
and septic shock symptoms
A. Keskin, S.D. Akduman*, N. Piskin, H. Aydemir, G. Celebi,
G. Mungan, F. Kokturk, N. Oztoprak Cuvalci (Zonguldak, TR)
Objective: We evaluated the diagnostic and prognostic value of
procalcitonin (PCT) in patients with sepsis.
Methods: The study was conducted in Zonguldak Karaelmas University
Hospital, Turkey between February, 2009 and February, 2010. A total
of 94 patients (ages ranging between 22 and 75) with systemic
inﬂammatory response syndrome (SIRS) due to noninfectious etiology
(n = 17), sepsis (n = 51), severe sepsis (n = 15), septic shock (n = 11) were
included. Patients were followed for 14 days. PCT levels were recorded
on days 1 (T1), 3 (T3), 7 (T7) and 10 (T10). The value of PCT in terms
of differential diagnosis between SIRS due to other causes and sepsis,
prognostication, identifying the severity of illness and patients at risk of
deterioration was evaluated.
Serum PCT levels were measured with the VIDAS®B.H.R.A.M.S PCT
test (Biomerieux, Marcyl Etoile, France) on the Minividas Analyzer
(Biomerieux, Ponte A Ema, Italy) using Enzyme-linked Fluorescent
Assay.
Results: On T1 PCT was higher in patients with sepsis, than patients
with SIRS due to noninfectious etiology (p< 0.001). PCT levels
increased signiﬁcantly with the severity of illness. The highest levels
were observed in patients with septic shock (P< 0.001). Patients who
died during the follow up period were grouped as “nonsurvivors”.
Patients who were alive at the end of 14 days (n = 57) or discharged
with cure (n = 8) in this period were grouped as “survivors”. A total of
29 patients died in the ﬁrst 10 days, so PCT levels on T10 for these
patients were not available. PCT levels were higher in nonsurvivors on
T0, T3 and T7 (p< 0.001, p = 0.001, p= p< 0.019 respectively). The
change in PCT levels in time was analyzed. A signiﬁcant decrease was
observed in survivors in whom PCT values on T1, T3, T7, T10 were
available (n = 57) (p< 0.001).
At a cut-off value of 0.07ng/ml on T0, the negative predictive value
(NPV) of PCT for differentiating sepsis from SIRS due to non infectious
etiology was 100.0% with 95.7% accuracy. When 17 patients with SIRS
were excluded, for 77 patients with sepsis NPV of PCT for mortality
were as follows:
On T3, at a cut-off value of 0.7ng/ml, NPV: 91.0% accuracy: 70.6%
On T7, at a cut-off value of 3ng/ml, NPV: 97.5%, accuracy: 84.3%
Conclusion: We think that PCT is an important marker guiding the
clinician in the differential diagnosis of sepsis and prognostication.
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R2491 Differentiating between mastitis through Acute phase pro-
teins in different dairy animals in sub-tropical agro-climate
K. Behera*, T.K. Mohanty, S.S. Layek, A. Kumaresan, T. Patbandha
(Haryana, IN)
Objectives: Mastitis continues to be a costly disease in modern dairy
farming and detection at subclinical stage is of immense worth both in
terms of animal health and economy. The present study was undertaken
to evaluate potential value of Acute Phase Proteins (Serum Amyloid
A and Haptoglobin) in detecting clinical and subclinical mastitis and
their correlation with pH and electro-conductivity in Zebu (Sahiwal),
Holstein-Friesian Cross and Murrah buffaloes.
Methods: In the present study plasma Acute Phase Proteins (Serum
Amyloid A-SAA and Haptoglobin-Hp) were measured (Life Diagnostics
Inc., USA) and their correlation with pH and electro-conductivity of
milk in 200 cows of each breed of Sahiwal, HF Crossbred and Murrah
buffaloes. The subclinical and clinical mastitis cases were conﬁrmed by
Californian Mastitis Test.
Results: The haptoglobin levels in the subclinical, clinical and healthy
cases were 2.4±0.77, 1.69±0.94 and 0.17±0.02mg/l. The SAA levels
in subclinical, clinical and healthy cases were 1.427±2.04, 2.58±1.09
and 0.03±0.04mg/l. The milk electro-conductivity of healthy, subclinical
and clinical mastitis in Sahiwal cows was 5.25±0.19, 7.13±0.53 and
7.94±0.91 mS/cm in crossbred cows was 5.88± 0.23, 6.96±0.76 and
7.67±1.13 mS/cm and in Murrah was 5.44±0.35, 6.42±0.72 and
7.54±1.02 mS/cm, respectively. The milk pH of healthy animals was
6.55±0.19, 6.68±0.23 and 6.64±0.35, subclinical mastitis 6.63±0.27,
6.79±0.34 and 6.78±0.41 and mastitis was 6.93±0.37, 7.17±0.43
and 7.09±0.29, in Sahiwal, Crossbred and Murrah respectively. The
correlation coefﬁcient between Hp and Electroconductivity was 0.87 in
subclinical and 0.94 in clinical cases and SAA electro-conductivity was
0.73 and 0.91.
Conclusion: In our experiment, haptoglobin proved to be a better
indicator of mastitis. The higher level of Hp in subclinical mastitis than
clinical may be due to the chronic nature of the subclinical cases. Both
the APP’s showed a very correlation with the electrical conductivity.
Hence as APP’s are biomarkers for mastitis, it can be concluded that the
electroconductivity can be a good predictor of mastitis.
R2492 Performance evaluation of the Access® HIV combo assay
on the UniCel® DxI 800
E. Roux, N. Groleau, C. Chandelier, F. Margotteau, C. Stoia,
D. Duhamel, B. Roussel, C. Bonchamp, V. Potelle, D. Nogues, M. Cottin,
R. Falcou-Briatte*, O. Flecheux (Marnes la Coquette, Steenvoorde, FR)
Objectives: A new automated HIV combo assay has been developed
by Bio-Rad for the qualitative detection of HIV-1 p24 antigen and
antibodies to HIV-1 (groups M-N-O) and HIV-2 using the UniCel DxI
800 Immunoassay system (Beckman Coulter). The purpose of this study
was to evaluate the performance of this new assay in terms of sensitivity,
speciﬁcity and precision.
Methods: All studies were performed on UniCel DxI 800 immunoassay
system. The analytical sensitivity was estimated by dilution study of
the AFSSAPS panel and the NIBSC Panel 90/636 (WHO standard).
The clinical sensitivity was evaluated by testing 62 subtype and variant
samples, 289 commercial positive samples, 199 hospital patient samples
and 61 seroconversion panels (including 131 early seroconversion
samples). The clinical speciﬁcity was studied with 2,552 samples from
blood donors, 1,969 selected negative hospital patient samples and 617
non selected hospital patient samples. The precision study has been
studied following CLSI EP5A2 guidance by the analysis of 13 samples:
a negative sample, 2 low positive samples, a medium positive sample
for HIV-1, HIV-2, HIV-1-O and HIV-1 antigen.
Results: The speciﬁcity was found to be 100% on blood donor samples,
99.85% on selected negative hospitalized patient samples and 100% on
non selected hospitalized patient samples.
The analytical sensitivity obtained with the NIBSC 90/636 was equal to
1.1 IU/mL. It was estimated at 20.60 pg/mL with the AFSSAPS panel.
The clinical sensitivity for all positive samples including HIV-1-M, HIV-
1-O, HIV-1-N, HIV-2 antibodies and HIV-1 antigen was 100%. The
seroconversion sensitivity gave performance in accordance with the state
of the art as 131 early seroconversion samples were all detected.
Intra-assay and inter-assay precisions were found below 10% with
positive samples.
Conclusion: The evaluation of the Access HIV combo on the
highest throughput UniCel DxI immunoassay system showed excellent
performance in terms of global speciﬁcity, analytical sensitivity, clinical
sensitivity and precision. This new Access HIV combo is fully suited
for the screening of HIV, in hospitals or private laboratories.
R2493 Prognostic, economic and epidemiological signiﬁcance of
p24 antigen for early detection of HIV infection
D. Neshumaev*, L. Ruzaeva, I. Olkhovskiy, N. Shevchenco,
M. Vinogradova, I. Sharipova, T. Ulanova (Krasnoyarsk, Nizhny
Novgorod, RU)
Background: In Russia for screening purposes assays for simultaneously
detection of anti-HIV and antigen p24 HIV-1 are used. The conﬁrmation
of screening positive results carried out by immunoblot assays (IB) only.
IB are not intended for detection of presence p24 antigen. Therefore
there is problem with conﬁrmation screening result at early stage of
seroconversion. The aim of this study was to develop optimal algorithm
of diagnostics of HIV infection.
Materials: The work was done on the basis of the Regional Centre of
AIDS Prevention from 01.01.2007 to 01.01.2010. All sera (n = 4271)
with IB indeterminate and negative results were additionally tested in
high sensitive EIA for p24 antigen detection. The majority of these
samples (57%) were also evaluated for viral load. Cost-effectiveness of
analysis included the calculation of the cost of identifying one case of
HIV infection. The reliability of differences was determined by Mann-
Whitney’s criterion.
Results: Out of 4271 analyzed sera with IB indeterminate and negative
results, antigen p24 was detected in 4,5% and 2,5% respectively. In p24
positive samples, viral load was detected in 98%. More than in 25%
of cases, the viral load exceeds the sensitivity level of the used assay
(>750000 copies/ml). A median was more than 100,000 copies/ml in
samples with indeterminate IB results and more than 300000 copies/ml
in samples with negative IB results. HIV-status was conﬁrmed in 58%
of tested patients. The median time until conﬁrmation by IB was 107
days. 40% of patients with indeterminate and negative IB results did not
come for the repeat testing. A few of false-positive results (2%) were
due to the errors of pre-analytic phase.
The cost of identifying one case of HIV infection is $420 when
used currently available algorithm of diagnostics of HIV infection. The
additional testing for p24 allows to save about $10 due to a larger number
of identiﬁed cases.
Conclusion: The additional analysis of samples with indeterminate or
negative IB result for p24 antigen, can detect HIV infection in average on
107 days earlier. Each detected case of early seroconversion can prevent
1−3 cases of a HIV of an infection. Thus, additional testing on p24
allows not only lowering total cost of revealing of each case of HIV
infection, but also will allow slowing spread of epidemic.
R2494 Pathogens isolated from central vascular catheters in
patients with positive blood cultures
S. Baka*, S. Kotsali, A. Panopoulou, I. Patikas, I. Tsouma, A. Spathi,
A. Lykas, E. Logothetis, D. Makri, E. Kouskouni (Athens, GR)
Objectives: The use of central vascular catheters (CVC) was introduced
in practice more than 60 years ago and become essential to modern
medical practice, especially in the intensive care units (ICU). The aim
of this study was to evaluate the etiology of CVC-related infections in
patients with positive blood cultures.
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Methods: Catheter tips from patients hospitalized during January 2008
to October 2010 were processed using the semiquantitative method and
blood cultures were incubated in the automated BACTEC 9050 System
(Becton Dickinson, USA). The positive blood cultures and the CVC were
cultured under standard conditions. The identiﬁcation of the isolated
microorganisms and their susceptibility to different antimicrobial agents
was performed using the automated system VITEK 2 (BioMerieux,
Marcy l’Etoile, France).
Results: During the study period, samples from 127 CVC obtained
from different patients were evaluated (42 in 2008, 58 in 2009 and
27 in 2010). Positive cultures were found in 115 (90.6%) of cases [39
(92.9%) in 2008, 50 (86.2%) in 2009 and 26 (96.3%) in 2010]. Blood
cultures were available from all patients studied. Out of the 115 positive
CVC cultures, 96 (83.5%) yielded the same microorganism as from
the blood culture, while in 19 (16.5%) cases a different pathogen was
isolated in the blood culture. Out of the 96 cultures yielding the same
pathogen with the blood cultures, Gram-negative bacteria as well as
Gram-positive cocci were isolated in the same percentage, 48%, while
the remaining 4% was represented by fungi. Resistance to glycopeptides
among staphylococci and enterococci was not detected, whereas 60% of
Gram-negative bacteria were resistant to b-lactams.
Conclusions: In the majority of cases, the same microorganisms were
isolated from both CVC and blood cultures.
R2495 Acute phase DMSA renal cortical scintigraphy for
identifying dilating vesicoureteral reﬂux in children with
a ﬁrst febrile urinary tract infection: a diagnostic test
accuracy meta-analysis
E. Mantadakis*, E. Vouloumanou, G. Georgantzi, A. Tsalkidis,
A. Chatzimichael, M. Falagas (Alexandroupolis, Athens, GR)
Objective: Controversy exists regarding the type and/or sequence of
imaging studies needed during the ﬁrst febrile urinary tract infection
(UTI) in young children. Several investigators claim that since acute
phase Tc-99m dimercaptosuccinic acid (DMSA) renal scan results are
abnormal when there is dilating vesicoureteral reﬂux (VUR), a normal
DMSA scan makes voiding cystourethrography (VCUG) unnecessary
in the primary examination of infants with UTI. We aimed to evaluate
the accuracy of acute phase DMSA scan in identifying dilating (grades
III-V) VUR documented by VCUG in children with a ﬁrst febrile UTI.
Methods: We performed a diagnostic test accuracy meta-analysis of
relevant studies identiﬁed through the PubMed and Scopus databases.
Two separate analyses, patient-based and renal units-based, were
performed.
Results: Overall, 13 cohort studies were identiﬁed. Nine studies involved
patients <2 years old, 3 children 16 years, and 1 involved exclusively
neonates. Females constituted 22% to 85% of the involved children.
Pooled (95% conﬁdence intervals) sensitivity and speciﬁcity of DMSA
scan was 79% and 53%, respectively for the patient-based analyses (8
studies) and 60% and 65% for the renal units-based analysis (5 studies).
The respective areas under the hierarchical summary receiver operating
curves were 0.67 and 0.66. Marked statistical heterogeneity was observed
in both analyses, as indicated by an I2 index value of 91% and 87%,
respectively.
Conclusion: Acute phase DMSA renal scan cannot be recommended as
replacement for VCUG in the evaluation of young children with a ﬁrst
febrile UTI.
R2496 Cytomegalovirus immunity and infection in ﬁrst trimester
pregnant women in Greece
E. Katsantoni*, N. Kastrinios, D. Karakalpakis, P. Petropoulos,
E. Charvalos for the IASO group
Aim: The aim of this study was to assess immunity to Cytomegalovirus
(CMV) and infection in pregnant women in Greece.
Methods and Subjects: In this study, we present data of pregnant women
from years 2008 & 2009 in the 1st semester of pregnancy based on a total
of 4440 samples. CMV infection in pregnant women was identiﬁed in
our laboratory by a diagnostic algorithm utilizing CMV IgG, IgM, CMV
IgG avidity (Abbott Axsym and VIDAS BioMe´rieux) and home-made
PCR.
Results: For 2008, 60.2% of the women tested were CMV IgG
seropositive, 1.0% CMV IgM positive and only 19% of the latter were
tested with CMV IgG avidity and 3.8% with PCR. For 2009 63.5%
seropositive for CMV IgG, 1.1% positive for CMV IgM and 4.3% tested
with CMV IgG avidity and none with PCR. In addition, 35% of women
without antibody titers for both IgG & IgM were re-tested in 2008 and
23.2% in 2009 respectively.
Conclusions: The follow-up of pregnant women was found to be
inadequate. It seems that ﬁnancial issues could be the reason for this.
Comparing the two years, we observed that despite the homogeneous
distribution of the number of samples which were tested per trimester,
a signiﬁcant decrease in the number of the IgM positive samples in the
3rd trimester of the year, (4.7% for 2008 & 8.8% for 2009) was possibly
due to the increase of outbreaks in this period of the year.
Methods for antibacterial susceptibility
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R2497 Direct detection of Mycobacterium tuberculosis drug
resistance by nitrate reductase assay
D. Lemus*, Y. Milian, N. Mirabal, M. Echemendı´a, A. Martin, P. Van
der Stuyf, J.C. Palomino, E. Montoro (Havana, CU; Antwerp, BE)
Objective: The aim of this research was to evaluate the performance of
the direct nitrate reductase assay (D-NRA) for detection of resistance to
the ﬁrst line antituberculous drugs.
Methods: The D-NRA was performed in 174 smear positive sputum. We
used Lo¨wenstein-Jensen (LJ) medium with 1mg/mL of KNO3 and with
or without isoniazid (INH), streptomycin (STR), ethambutol (EMB),
rifampicin (RMP) and nicotinamide (NIC) at critical concentration of
0.2, 4, 2, 40 and 1000mg/mL, respectively. Previous to the D-NRA
sputum samples were decontaminated and part of the decontaminated
suspension was diluted 1:10. For each sample, 0.2ml of the undiluted
suspension was inoculated into LJ medium containing KNO3 and the
antituberculous drugs, and 0.2ml of the 1:10 dilution was inoculated
into three drug-free LJ medium tubes containing KNO3. The tubes were
incubated at 37ºC. After 14 days of incubation, 0.5ml of freshly prepared
Griess reagent was added to one drug-free tube. If any color appeared,
the drug containing tubes were developed. Else, the other tubes were
reincubated, and the procedure was repeated at day 21 or 28. An isolate
was considered resistant if the drug-containing tube produced a color
identical or greater than growth control.
PM was performed in 100 isolated strains with the recommended critical
concentration for INH, STR, EMB and RMP. PZase activity was assayed
in 100 isolated strains by the Wayne assay using Dubos agar. The pink
color indicates the enzymatic hydrolysis of the PZA into free POA, so
that a strain was considered susceptible to PZA.
The MedCalc software program was used to calculate the sensitivity and
the speciﬁcity using the results obtained by PM and Wayne Assay as a
reference.
Results: Of the 174 samples evaluated by D-NRA, only 100 of them
were evaluated by the indirect PM and Wayne Assay. D-NRA results
were obtained at day 14 for 33 specimens, for 40 specimens at day
21 and the remaining 27 specimens at day 28. The sensitivity of the
D-NRA was 73.33%, 93.91%, 85.71% and 54.55% for INH, STR, RMP
and NIC, respectively; for EMB the D-NRA don‘t identiﬁed resistant
results. Speciﬁcity was 97.65%, 97.40%, 97.94%, 100% and 98.88% for
INH, STR; EMB, RMP and NIC, respectively.
Conclusion: The D-NRA is simple to perform, rapid and cost-
effective tool for the ﬁrst line antituberculous drugs resistance detection.
Nevertheless, additional studies are requires to improving its sensitivity
almost for INH and RMP.
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R2498 Microarray-based assay for the rapid detection of
genes encoding extended-spectrum b-lactamases and
carbapenemases of A, B and D classes
M.M. Ulyashova*, M.Y. Rubtsova, Y.I. Halilova, M.V. Edelstein,
I. Alexandrova, A.M. Egorov (Moscow, Smolensk, RU)
Objectives: The production of b-lactamases is the predominant cause
of resistance to b-lactam antibiotics in Gram-negative bacteria. To
date, more than 700 b-lactamases have been described. Among them
extended-spectrum b-lactamases (ESBLs) are the most widespread and
clinically signiﬁcant enzymes which are active against practically all
penicillins and cephalosporins. During last years the clinical value of
carbapenemases of molecular classes A, B and D increased noticeably.
So far as many clinical isolates produce more than one b-lactamase and
due to the high diversity of these enzymes their determination at the
molecular level ensures adequate information for the identiﬁcation of
antimicrobial resistance. In the present research we have developed the
technology of oligonucleotide microarray with horseradish peroxidase
(HRP)-based detection for the identiﬁcation of genes encoding ESBLs
and carbapenemases of A, B and D classes.
Methods: Speciﬁc oligonucleotide probes were designed to determine
b-lactamase type and important mutations responsible for the broadening
of substrate speciﬁcity or resistance to inhibitors. The method of
DNA microarray consisted of several steps involving DNA extraction,
ampliﬁcation and labeling of target DNA with biotin by two multiplex
PCRs and the subsequent hybridization of a PCR product with speciﬁc
oligonucleotide probes immobilized on porous membrane support.
After hybridization biotin in DNA duplexes was developed with the
streptavidin–HRP conjugate followed by colorimetric detection of the
enzyme.
Results: Careful optimization of oligonucleotide probes and hybridi-
sation conditions ensured speciﬁc identiﬁcation of all control isolates
producing ESBLs and carbapenemases in a single array.
The method developed has been applied successfully for the detection
of ESBL and carbapenemase genes in a series of clinical isolates of
Enterobacteriaceae, Pseudomonas spp. and Acinetobacter spp.
Conclusion: DNA microarray technique offers the identiﬁcation of a
pathogen antibiotic resistance at the molecular level and is proposed
as a useful tool for epidemiological investigation of ESBL- and
carbapenemase-producing microorganisms.
The work was supported by the Russian Federal Programme “National
Technological Resources 2007–2011” (Contract GP/07/442/NTB/K).
R2499 The Brucella blood agar for disk diffusion antimicrobial
susceptibility testing of the Bacteroides fragilis group?
U.S. Justesen*, T.K. Danielsen, E. Matuschek, G. Kahlmeter (Odense,
DK; Va¨xjo¨, SE)
Objectives: The EUCAST disk diffusion antimicrobial susceptibility
testing method for fastidious organisms is based on the Mueller-Hinton
fastidious agar (MH-F). In a pilot study, most anaerobic bacteria did
not grow well enough on MH-F to permit antimicrobial susceptibility
testing. We decided to investigate whether or not the Brucella Blood
Agar supplemented with hemin and vitamin K (BBA), recommended for
antimicrobial susceptibility testing of anaerobic bacteria with gradient
strips, might also be suited for disk diffusion.
Methods: Bacteroides fragilis ATCC 25285 and Bacteroides thetaio-
taomicron ATCC 29741 were tested with E-test gradient strip
(piperacillin/tazobactam, meropenem, metronidazole and clindamycin)
on BBA according to the manufacturer’s instructions. The corresponding
disk (EUCAST disk strength) was included on each plate. Twelve plates
were incubated at 37ºC in an anaerobe environment (10% CO2, 10% H
and 80% N2) for 24 hours with each antimicrobial agent on two different
days for intra and inter day variability. E-test results were compared
with the acceptable ranges for the two strains (reference agar dilution
testing, CLSI guideline M11-A7). Twelve plates with disks only were
also incubated at 35ºC.
Results: All E-test results were within acceptable ranges and the intra
and inter day variability was 1 dilution step. Zone diameter mean and
range are shown in Table 1 (n = 12).
The maximum difference between two means was 2.9mm and the
maximum range was 5.5mm. Overall, growth was better and zones
smaller at 37ºC than at 35ºC.
Conclusion: Only a small intra and inter day variability was observed
with disk diffusion on BBA with the tested antimicrobial agents. Whether
this small variability can be reproduced with clinical isolates and
whether resistant isolates can be separated from wild type zone diameter
distributions of the Bacteroides fragilis group remains to be investigated.
Also the impact of different temperatures needs to be evaluated further.
Table 1.
R2500 Veriﬁcation of the 2009−10 EUCAST Cephalosporin
Breakpoints for Enterobacteriaceae Using Sensititre® MIC
Susceptibility Microdilution Panels
K. Doing*, E. Estes (Bangor, US)
Objectives: In 2009 EUCAST published revised breakpoints for the
interpretation of antimicrobial susceptibility tests; some of which
were further modiﬁed in 2010. The new breakpoints described for
Enterobacteriaceae lowered the susceptible criteria for multiple drug
classes, including the cephalosporins. Using disk diffusion (DD) and
frozen microdilution panels as reference methods, we evaluated the
accuracy of the Sensititre® GN4F standard MIC panel (Trek Diagnostic
Systems, Cleveland, OH, USA) using current EUCAST interpretative
breakpoints.
Methods: Susceptibility testing was performed on 55 enteric Gram
negative enteric bacilli. Bacteria from ﬁve different genera, comprised
of wild-type (n = 30) and ESBL positive strains of E. coli and
K. pneumoniae (n = 25) were included. MIC and DD testing were
performed simultaneously using the same inoculum, followed by
18−24 hours of incubation in ambient air or within the Automated
Reader and Incubation System (ARIS). The MIC distributions for
ceftriaxone, ceftazidime, and cefepime for ESBL positive isolates were
also examined.
Results: The MIC dilutions spanned a larger range on the frozen MIC
tray compared to the GN4F standard panel; however, the S, I, R,
interpretations of the MIC values and DD results were the same for all
isolates tested. The distribution of the MICs for ESBL positive isolates
varied, and ranged from 0.5 to >64mgmL for ceftriaxone (AXO), 1 to
>32mgmL for ceftazidime (TAZ), and 0.12 to >32mgmL for cefepime
(FEP).
Conclusions: A Sensititre standard microdilution panel was evaluated
against a reference frozen microdilution tray and DD. Accurate
determination of MICs and subsequent S, I, R reporting using
the new EUCAST interpretative breakpoints were achieved with the
Sensititre GN4F panel. Using the current breakpoints, all ESBL isolates
tested resistant to ceftriaxone or ceftazidime; one ESBL strain tested
susceptible to AXO, while three were susceptible to TAZ, and seven
strains yielded FEP MICs of <1 and would be considered susceptible.
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R2501 Performance of a new MicroScan WalkAway panel for
detection of oxacillin resistance in a French nationwide set
of staphylococci isolated from bacteraemia
O. Gallon, P. Pina, A. Gravet, F. Laurent, B. Lamy, J.M. Delarbre,
F. Doucet-Populaire, J.W. Decousser* for the College de Bacteriologie
Virologie Hygiene Study Group
Objectives: Detection of Oxacillin resistance (OR) in staphylococci is a
daily challenge for clinical laboratories. Erroneous in vitro susceptibility
results could lead to therapeutic failure or inadequate antimicrobial
selection pressure. Cefoxitin (FOX) testing is now currently used for this
purpose. We evaluated the performance of a new MicroScan WalkAway
panel (Siemens, Sacramento) including FOX, and the disk diffusion
method (DDM) for the detection of OR.
Methods: A set of 217 non-duplicates isolates of Staphylococcus
aureus (n = 167) and Coagulase Negative staphylococci (CNS, n = 50)
was collected in 2007 from a nationwide study through the French
College de Bacteriologie Virologie Hygiene network interesting in
clinically signiﬁcant bacteraemia. Identiﬁcation was performed using
gyrB PCR, mass spectrometry (Axima Assurance, Shimadzu) or 16S
RNA sequencing. The detection of mecA gene was considered as
the gold standard for OR detection. Phenotypic detection of OR was
performed according to EUCAST guidelines excepted for moxalactam
(MOX) (French ofﬁcial criteria: susceptible to oxacillin if diameter
>24 and resistant if <23mm) using (i) the FOX DDM, (ii) the MOX
DDM, (iii) the MicroScan WalkAway PC30 panel which contained
oxacillin MIC determination and an additional FOX TEST (4 mgmL);
each strain was categorized as OR if the oxacillin MIC was superior
to the EUCAST breakpoint or if the FOX TEST was positive (i.e.
yielded a growth). The panels was automatically run according to the
manufacturer’s instructions. ATCC25923 and 43300 were used as quality
control strains.
Results: OR was detected by PCR in 31% of S. aureus (52/167)
and 66% of CNS (33/50), this last group consisted of S. epidermidis
(34/50), S. haemolyticus (8/50), S. hominis (5/50), S. capitis (2/50) and
S. schleiferi (1/50). Considering the mecA PCR as the gold standard, the
sensibility, speciﬁcity, Positive Predictive and Negative Predictive Value
were respectively for S. aureus 88.5%, 100%, 100% and 95% for the
FOXdm, 98.1%, 100%, 100% and 99.1% for the MOXdm, and 98.1%,
100%, 100% and 99.1% for the PC30 panel including the FOX Test. The
corresponding results obtained for CNS were 87.9%, 100%, 100% and
81% for the FOXdm, 100%, 100%, 100% and 100% for the MOXdm
and 100%, 88.2%, 94.2% and 100% for the PC30.
Conclusions: The new Microscan PC30 panel used with the Walk Away
system is a highly accurate method for OR detection in clinical relevant
staphylococci.
R2502 Comparison of phenotypic and genotypic tests used for
determining methicillin resistance in Staphylococcus aureus
isolates
T. Demir*, N. Coplu, H. Bayrak, M. Turan, T. Bu¨yu¨kgu¨c¸lu¨, H. Iakar,
N. Balaban, D. C¸aliskan, B. Yalcin, U. Cinar, E. Guner, M. Eksioglu,
N. Atakan, B. Esen (Kirsehir, Ankara, Mersin, Karabuk, TR)
Objectives: The heterogenous expression of methicillin resistance in
S. aureus make the phenotypic testing difﬁcult and slow. The aim of this
study was to compare the results of phenotypic and genotypic methods
used for methicillin resistance, determine susceptibilities to antibiotics
used for skin and soft tissue infections.
Methods: 92 outpatient and 150 inpatient S. aureus strains isolated from
skin and soft tissue infection included in the study. The patients were
classiﬁed as community acquired and hospital acquired by CDC criteria.
Methicillin resistance was determined by oxacillin and cefoxitin disk
diffusion (DD), then conﬁrmed with oxacillin salt screen agar test, and
mecA PCR. Susceptibility test to antimicrobials including clindamycin
(CLI), erythromycin (ERY), gentamicin (GEN), penicillin (PEN),
mupirocin (MUP), rifampin (RIF), tetracycline (TET), trimethoprim-
sulphametoxasole (SXT), teicoplanin (TEC) were determined. Data were
compared by the chi-square or Fisher’s exact test, using SPSS 15.0.
Results: mecA was detected in 11 outpatient, 66 inpatient. HA strains
showed higher positivity than CA-strains (44%, 12%) (5.79; 2.85–
11.74, p = 0.001). Oxacillin, cefoxitin DD test, oxacillin screen agar test
exhibited sensitivities of 98.7%, 98.7%, 100% and speciﬁcity 96.9%,
97.5% and 96.9%, respectively. Based on mecA gene and patient data
242 S. aureus were classiﬁed as; 81 CA-MSSA, 84 HA-MSSA, 11 CA-
MRSA, 66 HA-MRSA. Five isolates were true CA-MRSA. All isolates
were susceptible to TEC. 3 CA, 2 HA were high level resistant to
MUP. MRSA isolates were more likely to be resistant to antibiotics
except MUP, FA compared with MSSA. mecA positive strains were
more resistant to ERY (10.3;4.09–27.5), CLI (10.6;3.63–24.35), TET
(28.3;12.1–66.4), GEN (35.5;16.7–75.5), and RIF (98.7;35.7–272.6) than
mecA negative strains (p = 0.001).
Conclusion: This study showed that with the highest sensitivity and
speciﬁcity oxacillin salt screen agar test and cefoxitin DD test could
be used for methicillin resistance detection as an alternative for mecA
PCR. Mupirocin and fusidic acid may be still therapeutic choices fort
he treatment of skin and soft tissue infections.
R2503 Comparison of E-test, Vitek2, and Wider for detection of
VIM-producing Enterobacteriaceae with the updated CLSI
and EUCAST breakpoint systems
I. Pena*, I. Rodriguez-Avial, C. Rodrı´guez-Avial, J. Picazo (Madrid, ES)
Objective: The aim of this study was to compare the performance
of Etest, Vitek2 and Wider in detecting metallo-b-lactamase (VIM)-
producing Enterobacteriaceae using the updated CLSI and EUCAST
clinical breakpoints as well as EUCAST epidemiological cut-off
(ECOFF) values.
Methods: A total 23 VIM-producing Enterobacteriaceae (12 K. pneu-
moniae, 8 K. oxytoca, 2 S. marcescens and 1 E. cloacae) were isolated in
our hospital from January 2009 to November 2010. Etest (bioMe´rieux)
with imipenem (IPM) and meropenem (MEM) was performed. Further,
all strains were tested with the VITEK2-system (bioMe´rieux) with the
AST N-114 card containing IPM and MEM, and microdilution Wider
system (Panel C095−31/W/REV2. Fco. Soria Melguizo, Madrid, Spain).
Results: Susceptibility testing results obtained by each method are
shown in the Table. With Etest and CLSI criteria, 8 strains were
interpreted as susceptible to MEM and applying EUCAST criteria 1 and
14 strains were interpreted as IPM and MEM susceptible respectively.
With Vitek2 and CLSI, 1 and 19 strains were IPM and MEM susceptible
whereas with EUCAST 2 and 22 respectively. The Wider system failed
in detecting 8 carbapenemase producers when using MEM with CLSI
and EUCAST criteria. Five additional failures were observed with IPM
and EUCAST. Only one strain had MICs below the IMP and MEM
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ECOFFs using the VITEK-2 system. With the other methods all strains
were detected using these epidemiological cut-offs.
Conclusions: The new CLSI breakpoints performed better that the
EUCAST clinical ones in detecting VIM-producing Enterobacteriaceae.
However the current breakpoints still do not capture all carbapenemase-
producing isolates. This is important because standard doses of
carbapenems for treatment of isolates with these MICs could be one
reason for the selection of highly resistant strains.
R2504 Anaerobic infections and susceptibility to antimicrobial
agents in a Portuguese hospital
F. Carneiro*, A. Read, M. Monteiro, M. Soares, V. Alves (Matosinhos, PT)
Objectives: Anaerobic bacteria have been established as causing a
number of serious human infections. Due to their fastidious nature, they
are difﬁcult to isolate from infectious sites and are often overlooked.
Increasing resistance to several antibiotics has been reported in the
last decades. The aims of the study were to analyze the prevalence
of anaerobes and to evaluate the antimicrobial susceptibility in various
clinical specimens in our hospital.
Methods: During the year of 2009, 136 anaerobic strains were
identiﬁed from 2113 clinical specimens. After elimination of duplicates
100 strains were studied (CLSI M-39). The samples were inoculated
in Schaedler broth (enrichement media) and cultured on brucella
anaerobic agar. Initial identiﬁcation was made by Gram staining,
colony morphology, hemolysis, pigment formation, special-potency
antimicrobial agent disks (Becton, Dickinson and Company, USA)
and by using the API 20A system (BioMerieux, France). The
susceptibility (MIC) for amoxicillin/clavulanic acid (AMC), imipenem
(IMP), metronidazole (MET) and clindamycin (CLIN) was determinated
with E-test (Biomerieux, France) and interpreted according to clinical
breakpoints from the CLSI M11− A7, 2007.
Results: Of 100 anaerobic strains studied, 60% were Bacteroides fragilis
group; 18% were other Gram-negative (Prevotella, Porphyromonas,
Veillonella) and 22% Gram-positive (Peptostreptococcus spp., Propi-
onibacterium, Biﬁdobacterium, Clostridium, Eubacterium, Actinomyces)
anaerobes. Table 1 presents the antimicrobial susceptibility. The infection
sources of the samples were: head and neck (2%), lung and thorax
(7%), abdomen (38%), soft tissue and extremities (40%), obstetric-
gynecological (9%) and surgical wound (4%).
Conclusion: As expected, the most abundant anaerobic species isolated
were Bacteroides fragilis group (60 strains), which comprised 60% of
the total anaerobes isolates. Gram-positive occurred in lower number
(22%). More than a half of anaerobes were isolated from intraabdominal
and soft tissue infections. All strains of Bacteroides fragilis group were
susceptible to MET, the IMP was the second choice with 98,30% of
susceptibility. Antimicrobial susceptibility testing suggests MET and
IMP as a useful spectrum of activity against all isolates and are good
alternatives for empiric therapy in our hospital.
R2505 Antibiotic sensitivity testing with InoqulA® according to
EUCAST new recommendations
M.H. Walder*, J. Rydback, I. Tjernberg (Malmo¨, SE)
Introduction: EUCAST new disc diffusion test for routine antimicrobial
susceptibility testing (AST) on Mueller Hinton (MH) agar is a
standardized method to be used in microbiological laboratories. The
EUCAST method requires that the inoculum is conﬂuent. We combined
the EUCAST AST guidelines using InoqulA® (Kiestra Lab Automation,
Drachten, The Netherlands). InoqulA® is an instrument for automatic
plate inoculation where the spreading is performed by magnetic beads
and the spreading patterns can be customized for different agars and
purposes.
The aim of this study was to optimize the spreading performed by
InoqulA® and to ﬁnd the ideal pattern for susceptibility testing on
MH agar according to EUCAST guidelines, by varying the volume of
the inoculum and the length and location of the primary streak. We
also wanted to compare the results of InoqulA® spreading with manual
spreading.
Method: 160 routine isolates from the following species were tested;
60 E. coli, 10 P. mirabilis, 10 K. pneumoniae, 10 Enterobacter spp,
10 P. aeruginosa, 40 S. aureus, 15 E. faecalis and 5 E. faecium. The
bacteria were cultivated on blood agar incubated in 35ºC ambient air
for 18−22 hours. Suspensions of McF 0,5 and McF <0,1 density were
prepared from each isolate. All suspensions were also manually spread
on MH agar with cotton swabs. After incubation inhibition zones were
then measured.
Results: The most ideal spreading pattern to create evenly spread growth
and uniform circular inhibition zones was pattern 5 with 1mm distance
between the laps and a full length primary streak. 50 mL of the McF
0,5 suspensions were sufﬁcient for all species except Enterococcus spp
which required an inoculum volume of 75mL. Less inoculum than 50mL
increased the diameter of the inhibition zones. Inoculums with a density
of McF< 0,1 yielded larger inhibition zones than inoculums of McF 0,5
density. This had an effect on the SIR-interpretation for some antibiotic-
bacteria combinations.
Conclusions:
1. It is possible to use InoqulA® for inoculation and spreading of
agar plates for susceptibility testing according to the new EUCAST
guidelines.
2. There is no signiﬁcant difference in SIR-interpretation of the included
species when comparing inhibition zones after manual spreading and
after spreading by InoqulA®
3. Using inoculums of much lower density than recommended increases
the size of the inhibition zone, which has an effect on the SIR-
interpretation for some antibiotic-bacteria combinations.
R2506 Rapid susceptibility of Enterobacteriaceae to ciproﬂoxacin
using ﬂow cytometry
R. Nogueira, I. Faria-Ramos*, J. Barbosa, M.J. Espinar,
A.G. Rodrigues, C. Pina-Vaz (Porto, PT)
Objectives: Increasing resistance to quinolones on Enterobacteriaceae,
the most important causes of nosocomial and community acquired
infections, have been documented. They constitute the main therapeutic
choice, often empirically made to overcome the delayed susceptibility
test. A quick test based on ﬂow cytometry was developed to analyze
the susceptibility to ciproﬂoxacin, an antimicrobial agent which inhibits
DNA gyrase and blocks DNA replication.
Methods: A total of 30 susceptible and resistant strains of Escherichia
coli, Klebsiella pneumoniae were screened for ciproﬂoxacin by VITEK
2 automate system (BioMe´rieux, Paris) and additionally by Etest
(BioMe´rieux, Paris). E. coli ATCC 25922 was used as control. Bacterial
cells were incubated in ﬁltered Muller-Hinton broth until exponential
phase and then exposed to 1, 2 and 4 micrograms per milliliter of
ciproﬂoxacin (S-Aldrich) for 0.5, 1 and 2 hours. Several ﬂuorescent dyes
were tested in order to obtain the best approach to the subject: Propidium
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Iodide (S-Aldrich) (FL3- 650 nm) a nucleic acid staining, which only
penetrates on cells with severe lesion of the membrane i.e. dead
cells; Bis-(1,3-dibutylbarbituric acid) trimethine oxonol (DiBAC4(3))
(S-Aldrich) (FL1- 530 nm), a lipophilic anion able to diffuse across
depolarized membranes; and SYBR Green I (Molecular Probes) (FL1-
530 nm) ﬂuorescent dye that binds to double stranded DNA. Flow
cytometric analysis was performed after staining with those probes in
the dark for 30 minutes. Conventional colony-forming units (CFU) assay
was performed from the suspensions analyzed by Flow Cytometry.
Results: Propidium Iodide and DiBAC4(3) were not able to discriminate
Susceptible and Resistant strains after the tested incubation time. SYBR
Green I was able to clearly discriminate between susceptible strains,
presenting a decrease in ﬂuorescence intensity in a drug concentration
and time dependent manner only on susceptible strains when compared
to the viable non-treated bacterial cells even after 0.5 hour treatment.
Correlation between conventional CFU assay and Flow Cytometry was
successfully achieved.
Conclusion: One hour versus 24−48 hours was enough to characterize
the susceptibility to ciproﬂoxacin staining with SYBR Green I. Flow
cytometry proved to be an excellent and accurate method representing
an alternative approach to evaluate the susceptibility of bacteria to
ciproﬂoxacin.
R2507 Use of the MicroScan Walkaway system for the
detection of extended-spectrum b-lactamase production by
Enterobacteriaceae
L. Phee*, T. Linehan, E. Yusuf-Adam, D.W. Wareham (London, UK)
Objectives: The detection of extended spectrum b-lactamases (ESBLs)
in the laboratory has led to a rise in the use of carbapenems worldwide.
Many laboratories now rely on automated systems to perform this
task, and the reliability of their results is of crucial importance. Here,
we assessed the performance of one such system − the MicroScan
WalkAway system (Siemens) and panel NM36 as a screening tool for
the detection of ESBL production by a range of enterobacteriaceae.
Methods: We collected 105 consecutive enterobacteriaceae isolates
which were reported as either ‘ESBL positive’ or ‘possible ESBL’ on
the NM36 panel. Isolates were further identiﬁed by MALDI-tof (Bruker)
mass spectrometry analysis. Combined disc diffusion tests (cefpodoxime
and cefepime +/− clavulanate) were used to conﬁrm ESBL production
and all isolates were then further characterised using multiplex PCR
methods to detect genes encoding TEM, SHV, OXA, CTX-M, PER,
VEB and plasmidic ampC enzymes.
Results: Of the 105 isolates, 84 were reported as ESBL producers, and
21 ﬂagged by MicroScan as ‘possible ESBL’ producers, 72/84 were
identiﬁed as Escherichia coli, 7/84 Klebsiella spp, 3/84 Enterobacter
spp, 1/84 Citrobacter spp, and 1/84 Proteus spp. 90% (76/84) of those
called positive by MicroScan were also positive by combined disc testing.
Of the 8 negative by disc diffusion, 6 were also negative for all genes
detected by PCR. Of the ‘possible ESBL producers’, 90% (19/21) were
negative in the disc assay, and 12 of these were also negative by PCR
for all b-lactamase genes tested. Of note the identiﬁcation of organisms
ﬂagged as ‘possible ESBL’ producers differed from those conﬁrmed as
positive − 7/21 Enterobacter spp, 6/21 Escherichia coli 2/21 Klebsiella
spp, 2/21 Proteus spp, 2/21 Morganella spp, 1/21 Citrobacter spp, and
1/21 Serratia spp.
Conclusion: The MicroScan NM36 panel was effective at identifying
common ESBL phenotypes in E. coli and Klebsiella species. Isolates
identiﬁed as ‘possible’ ESBL producers should be further investigated
using phenotypic disc tests or molecular methods, particularly if they
are not members of the genus Klebsiella or E. coli.
R2508 Comparison of genotypic and phenotypic susceptibility
testing in multidrug-resistant Gram-negative bacteria
B. Schulte*, S. Barth, I.B. Autenrieth, G. Lu¨dke (Tu¨bingen,
Holzgerlingen, DE)
Objectives: Multidrug-resistant gramnegative bacteria (MDR) became
an emerging problem throughout Europe within the last years. To prevent
transmission of these bacteria especially in the hospital setting and
to start earlier with an appropriate antibiotic therapy new and rapid
molecular-based diagnostic tools are needed.
Here we compared results from conventional phenotypic antibiotic
susceptibility testing with newly developed PCR based genotypic
methods to estimate the beneﬁt of such new tools in future.
Methods: A set of 237 clinical isolates was selected (196 Enterobac-
teriaceae, 41 non-fermenter). 193 of these clinical isolates exhibited a
MDR phenotype. MDR was deﬁned as resistance to at least 3 antibiotic
classes or an ESBL phenotype. Genotypic testing was carried out by a
multiplex PCR assay system targeting 3 classical b-lactamases (ambler
class A) and 2 families of plasmid coded ampC genes (ambler class C).
Moreover a surrogate marker for multidrug resistance was included in
the assay. The complete assay comprises genes coding for 17 different
pathogens and 22 resistance markers.
Results: 237 clinical isolates were investigated with the new multiplex
PCR assay system. No false positive results of non-MDR phenotypes
were observed. In 151 of the 170 (89%) Enterobacteriaceae and 20
of the 23 (87%) non-fermenter included in this study the MDR
phenotype was conﬁrmed. Occurrence of genes coding for b-lactamases
in Enterobacteriaceae are species speciﬁc. Interestingly, the presence of
more than one b-lactamase gene is very common and the combinations
are also species speciﬁc. Furthermore, detection of the MDR surrogate
marker shows a strong correlation with an ESBL phenotype in
Enterobacteriaceae. In the Acinetobacter baumannii isolates included
in this study this marker was suitable to predict a resistance to
aminoglycosides, whereas the correlation in Enterobacteriaceae was
poor.
Conclusion: Genotypic antibiotic susceptibility testing demonstrates a
rapid and therefore valuable tool to quickly detect MDR. Faster detection
should help to accelerate the implementation of hygienic measures and
to select the appropriate antibiotic therapy in time.
R2509 Implementation of EUCAST in a clinical laboratory: a
piece of cake?
S. Nys*, E. Willems, R. Cartuyvels, L. Waumans, K. Magerman
(Hasselt, BE)
Objective: EUCAST aims to set European breakpoints for antimicrobial
resistance and to streamline methods of antimicrobial susceptibility
testing (AST) to increase the comparability of results from different
laboratories.
In our laboratory AST was performed by micro-broth dilution on
Phoenix™ and disk diffusion (DD) according to CLSI guidelines. At
the moment BD Diagnostics discontinued production of certain non-
EUCAST panels, we decided to implement EUCAST-guidelines and
breakpoints for DD and automatic testing at the same time.
This study describes the draw-backs encountered during the implemen-
tation of these guidelines in a routine microbiology laboratory.
Methods: The EUCAST DD manual (EUCAST DD-Manual v. 1.0
18−12–2009) was used for the validation of the AST with EUCAST
breakpoints.
The checklist to facilitate implementation of AST with EUCAST
breakpoints (v. 1.0 25−08–2010) was used to guide the implementation.
Results: Although in 2008 a National Antimicrobial Committee was
founded for a nationwide validation of the implementation of EUCAST
methodology, no Belgian validation data for DD and Phoenix were
available at the moment of our implementation.
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Besides, breakpoints for several antibiotics tested in our lab are lacking in
EUCAST-guidelines e.g. temocillin for Enterobacteriaceae, ceftazidime
for Acinetobacter and erythromycin for Enterococci.
Practical issues encountered included the unavailability of some of the
required disks and plates from some companies at the moment of
implementation. Also, Phoenix EUCAST-panels do not all ﬁt completely
into EUCAST-strategy as some antibiotic ranges do not include the
new breakpoints recommended e.g. erythromycin for enterococci and
rifampicin for staphylococci.
Due to these issues, a complete quality control testing on 20 consecutive
days had to be performed using ATCC strains 25922, 27853, 29213,
29212, 49619 and NCTC strain 8468. Zone diameters were measure
daily by 2 trained microbiologists and compared to ranges provide by
EUCAST (Tables of QC targets and ranges v. 1.3 21−12–2010).
The implementation of the technicians (read a correct antibiogram
3 days in a row) required more than 4 days and is still ongoing
(increasing). Most problems are seen with PSAE and meropenem, STAU
and penicillin, ENFA and ampicillin, SRPN and penicillin and oxacillin
and HAIN.
Conclusion: The implementation of EUCAST guidelines for perfor-
mance and interpretation of AST in a routine microbiology laboratory
is no piece of cake!
R2510 New immunochromatographic assays for detection of
methicillin resistance and identiﬁcation of S. aureus directly
on primary culture or blood culture bottles in a few minutes
F. Laurent*, C. Tellini, A. Marocco, J.-P. Rasigade, M.-E. Reverdy,
S. Tigaud, F. Vandenesch, G. Lina, A.-M. Freydiere (Lyon, FR)
Objective: Evaluation of:
– Clearview Exact PBP2a™ (CPBP2a) (Alere) for detection of PBP2a
directly on primary cultures in 5 minutes.
– BinaxNOW Staphylococcus aureus™ (BNSA) and BinaxNOW
PBP2a™ (BNPBP2a) (Alere) for SA identiﬁcation and methicillin
re´sistance (MR) detection directly on blood culture bottles in 30
minutes.
Methods: Prospective study of CPBP2a: 333 consecutive staphylococcal
strains were tested from primary plates.
Evaluation and prospective study of BNSA and BNPBP2a: Evaluation:
17 strains representative of MRSA clones circulating through the world
were inoculated into artiﬁcial blood cultures (BacT/Alert FA and FN with
10ml fresh human blood, 100 CFU/vial) and incubated in the BacT/Alert
automat. Prospective study: 58 clinical blood culture bottles positive for
Gram-positive cocci were included.
All immunochromatographic results were compared with phenotypic
results (Vitek or Phoenix®). Any discrepant result was checked by PCR.
Results: Test CPBP2a: 329 tests were interpretable. For SA (MSSA,
n = 216; MRSA, n = 30), Se, Sp, PPV and NPV were 90%, 100%, 100%
and 98.6%, respectively. For coagulase negative staphylococci (CNS)
(MSCNS, n = 23; MRCNS, n = 60), Se, Sp, PPV NPV were 70%, 100%,
100%, 56%. No false positive was observed for SA and for CNS. For
MRSA and MRCNS isolates not detected on primary culture, the test was
positive for all MRSA and for 14 of 18 MRCNS after subculture. Two
out of the 4 remaining MRCNS were detected after induction (around
cefoxitin disc) and 2 could not be retested.
Tests BNSA and BNPBP2a: Evaluation: for BNSA, 1 out of the 34 blood
culture bottles (17 pairs aero/ana) remained negative. For BNPBP2a, all
strains were positive for PBP2a. Prospective study: for BNSA, Se, Sp,
PPV and NPV were 100%, 93.1%, 87.8%, 100%, respectively. All SA
were accurately detected while 4 CNS yielded false positive results. For
BNPBP2a, Se, Sp, PPV and NPV were 100% for SA (MSSA, n = 27;
MRSA, n = 2) while for CNS Se, Sp, PPV NPV were 75%, 90%, 93.8%,
64.3%, respectively.
Conclusion: For SA, CPBP2a presents relevant PPV and NPV, enabling
early consideration of the MR directly on primary culture. For CNS,
the test has an acceptable PPV but a low NPV and improvement would
probably require an optimization of the protocol.
For BNSA and BNPBP2a, evaluation study as well as preliminary results
from the prospective study appears promising.
Public health and community-acquired
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R2511 Clinical and laboratory characteristics of patients with
measles for the period February-June 2010
A. Petrov*, N. Vatev, M. Stoycheva, M. Pishmisheva, I. Boev,
C. Venchev (Plovdiv, BG)
Introduction: Measles as a highly infectious disease that can result
in serious complications returned in Bulgaria. Launched in 2009 a
major outbreak covered the majority of the population in the Roma
districts of Plovdiv and the region. The reasons for this vary from
high-risk populations unimmunized for cultural or religious beliefs to
low knowledge of the means of transmission and severity of measles.
Objectivity required accepting the fact that infectious diseases and
responsibility of them challenge the health system to increase the
immunization coverage up to 95%.
Material and Methods: During February and July, incl. 2121 cases
of measles were registered and 1969 of them were hospitalized in the
University Clinic of Infectious Diseases, town of Plovdiv. Laboratory
tests were conducted on the standard methodology; virus and serological
parameters were investigated in Regional Public Health Institute. The
data were statistically processed with SPSS 14 analysis system, using
parametric methods in Gaussian distribution and nonparametric when
needed. As a signiﬁcant difference interval was accepted p< 0.05,
guaranteeing 95% conﬁdence.
Results and Discussion: The highest incidence of measles was repotted
during April and May, 34.3% of hospitalized patients. Mainly medium–
heavy forms of disease were observed. 65% of treated were children
between 1 to 18 years. Measles complicated with pneumonia was found
in 504 patients − 25.6%. Pronounced respiratory failure and need of
oxygen therapy had 59 fellows. Antibiotics received all complicated
cases. X-Ray control was achieved in 74.3% of lung-affected. We
observed complications of the nervous system in 7 patients, aged 8
months to 52 years. Measles, complicated with meningitis − two cases,
viral encephalitis − 4 and one 8 years old boy with meningomyelitis.
Conclusion: Outbreak of measles in Plovdiv and the region in 2010
once again put reasonable challenges of organizational, ﬁnancial, legal
and social–legal aspect to epidemiologists and infectious diseases in
particular and the healthcare system in the country as a whole. The
neurological complications were rare − in analyzing study 0.36% with
benign ending.
R2512 Helicobacter pylori in inﬂammatory bowel disease and
colorectal cancer patients
I. Chudzicka-Strugala*, T.M. Karpinski, A. Szkaradkiewicz,
R. Marciniak, M. Drews, B. Zwozdziak (Poznan, PL)
Objectives: Recently, Helicobacter pylori proved to be capable to
colonise colonic tissue and, due to this, it may have a protective effect
against the development of inﬂammatory bowel disease (IBD). The study
aimed at evaluation of cagA-positive and cagA-negative H. pylori strain
manifestation in active IBD and colorectal cancer (CRC) patients.
Methods: The study was conducted in 44 hospitalized adult patients.
Employing standard clinical, radiological, endoscopic and histopatho-
logical criteria, 3 study groups were distinguished. Group 1 included 19
patients with active ulcerative colitis (UC). Group 2 included 10 patients
with active Crohn’s disease (CD). Group 3 included 15 patients with
CRC. The standard surgical treatment was applied in all the patients.
The study material involved homogenized colonic tissue. DNA was
isolated using QIAamp DNA Mini Kit (Qiagen). Helicobacter pylori and
cagA gene of H. pylori were identiﬁed using PCR-Helicobacter pylori
diagnostic kits (DNA Gdansk). PCR was conducted using Mastercycler
gradient (Eppendorf). Positive and negative controls were used. Positive
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result of Helicobacter pylori identiﬁcation involved presence of 262 bp
PCR product, positive identiﬁcation of cagA gene involved presence of
445 bp PCR product.
Results: In Group 1 H. pylori infection was disclosed in 6 patients
(31.6%), but in only a single case cagA-positive H. pylori was identiﬁed.
In Group 2 only a single patient (10%) carried cagA-negative H. pylori
infection. In turn, in Group 3 infection with H. pylori was detected
in 8 patients (53.3%) and in ﬁve of them cagA-positive H. pylori was
identiﬁed. In parallel, cagA-positive H. pylori infection was shown to
signiﬁcantly more frequent in CRC patients than in patients with IBD
(p = 0.0317).
Conclusion: In patients with IBD infections with cagA-negative
H. pylori strains prevail, which may carry no pathogenic signiﬁcance. On
the other hand, in CRC infections with cagA-positive H. pylori strains
prevail, which seems to be involved in development of colorectal cancer.
R2513 Spread of blood-borne viruses among conscripts of the
Bulgarian army
G. Popov*, K. Mekushinov (Soﬁa, BG)
Objectives: Contact with blood of battleﬁeld casualties, injection drug
use, tattoo, piercing and sharing of personal hygiene items play an
important role in the transmission of blood-borne infections among
military personnel. The purpose of this study was to determine the
prevalence of the main four blood-borne infections and to examine the
risk factors among conscripts of the Bulgarian army.
Methods: Anonymous cross-sectional data were collected from May
2009 to November 2010 from recruits who voluntary agreed to
participate in the study and who completed a self administrated
questionnaire. A blood sample was taken from each subject and tested
in order to detect anti-HBc, HBsAg, anti-HCV, anti-HDV and anti-HIV
by enzyme-linked immunosorbent assay (ELISA).
Results: In this study, 504 army conscripts at the age of 18−28
(20.1±6.8) were enrolled. 71 (14.1%) (95% conﬁdence interval 8.6%
to 18.8%) had antibody to hepatitis B core antigen, 21 (4.2%) (95%
conﬁdence interval 2.8% to 6.4%) were positive to hepatitis B surface
antigen, 12 (2.4%) (95% conﬁdence interval 1.8% to 2.6%) were anti-
hepatitis C positive, 9 (1.8%) (95% conﬁdence interval 0.9% to 2.8%)
had antibody to hepatitis D and 0 (0%) were positive to antibody to HIV.
Conclusions: Although this population theoretically had a low risk for
HBV, HCV and HDV infection, these results are higher than expected in
accordance with the age range. It has not been found any recruits positive
to HIV. Based on the prevalence of serological markers we recommend
vaccination against HBV infection after prevaccination screening.
R2514 Prevalence and correlates of hepatitis C virus infection
among inmates of Bulgarian prisons
G. Popov*, K. Plochev (Soﬁa, BG)
Objectives: To determine the prevalence and predictors of hepatitis C
virus (HCV) infection and associated risk factors for this infection among
inmates of Bulgarian prisons.
Methods: This study was carried out in 2009, among inmates of the
ﬁfth biggest Bulgarian prisons (men n = 367 and women n = 131) and
a juvenile correctional institution (n = 86). Anonymous cross-sectional
data was collected from prisoners who agreed to participate in the study
and who were interviewed using a standard questionnaire including
demographic, imprisonment history and HCV related risk behaviors
items. Thereafter, the blood drawn from the participants were tested
for anti-HCV antibodies and HCV-RNA. Discarded serum samples were
tested also for a presence of hepatitis B core antibodies (anti-HBc),
hepatitis B surface antigen (HBsAg), hepatitis D antibodies (anti-HDV)
and antibodies to human immunodeﬁciency virus (HIV).
Results: A total number of 498 (74% male and 26% female) inmates
participated in our study. The overall rate of antibody positivity to HCV
among inmates was 25.6%. Among male inmates 32.6%, and among
female inmates 20.2% were anti-HCV positive. The most important risk
factor for HCV infection was injection drug use. Total number of i.v.
drug abusers (IDA) and non-i.v. drug abusers (NIDA) was 142 (28.5%)
and 109 (21.9%), respectively. Of all IDAs, 61.4% and of NIDAs, 26.5%
had serological evidence of HCV infection. In addition, anti-HBc rates
were 59.2%, HBsAg 32.4%, anti-HDV 9.4% and anti-HIV 0.6%.
Conclusion: The seroprevalence of HCV infection among prisoners
comparing with the general population in Bulgaria, is very high (25.6%
vs. 1.1%). These data indicates that this infection is common among both
men and women entering prisons in Bulgaria. However, male inmates are
much more likely to be infected with HCV. Our results emphasize the
importance of policies to prevent transmission of viral hepatitis during
and following incarceration.
R2515 A bacteriologic study of diabetic foot ulcers
S. Baka*, S. Kotsali, A. Spathi, A. Lykas, I. Tsouma, A. Panopoulou,
I. Tsirba, D. Koutras, V. Genimata, E. Kouskouni (Athens, GR)
Objectives: Diabetic foot ulcers are frequently complicated by infection
which represents an important cause for hospitalization, enhancing
the risk for subsequent amputation. Usually these infections are
polymicrobial in nature so correct and early isolation and identiﬁcation,
as well as prompt initiation of appropriate antibiotic therapy are
important steps toward a successful outcome. This study was undertaken
to identify the pathogens associated with diabetic foot infections in our
hospital.
Methods: A total of 283 consecutive patients were included in the
study during the period January 2007 to October 2010. Only diabetic
patients presenting with foot infection and who did not receive antibiotics
for the past 30 days were included in the study. Clinical specimens
collected from patients were inoculated onto appropriate plates for
standard aerobic and anaerobic cultures and incubated at 370 C for 24h
and 48h, respectively. A Gram-stained smear from the specimen was
examined under microscope to obtain valuable information about the
types of microorganisms present. The isolated pathogens were identiﬁed
using the automated system VITEK 2 (BioMerieux, Marcy l’Etoile,
France).
Results: The mean age of the patients was 60.2 years (range 33−78)
with 165 (58.3%) of them being males and 118 (41.7%) females.
A total of 501 pathogens were isolated: 191 aerobic Gram-positive
cocci representing 38.1% of all pathogens, 221 (44.1%) aerobic Gram-
negative rods, 82 (16.4%) anaerobic bacteria and 7 Candida isolates
(1.4%). Staphylococcus aureus was more frequently isolated among the
Gram-positive cocci (60.9%), Proteus mirabilis was more frequently
isolated among the Gram-negative rods (31.4%) and Bacteroides species
represented the 86.4% of all anaerobic bacteria isolated. One hundred
and thirty-eight (48.8%) patients had one microorganism, 65 (23.0%)
had 2 pathogens, 32 (11.3%) had 3, 25 (8.8%) patients had 4 pathogens
and 7 (2.5%) patients had 5 pathogens isolated from their foot ulcers.
Conclusion: In our study group diabetic foot infections were mostly
monomicrobial. The most frequently isolated microorganisms from the
ulcers were S. aureus, P. mirabilis and Bacteroides species. Constant
awareness of isolated pathogens in these infections is essential for the
optimal management and a successful outcome of diabetic foot ulcers.
R2516 Inﬂuenza A/H1N1 in Libya: implementation during
pandemic inﬂuenza
O. Elahmer, A. Abudher, A. Bashein, M. Smeo, F. Alkhattali,
A. Alkorbaa, M. Elshweidi, A. Abubaker, W. Elkayekh, A. Zorgani,
H. Ziglam* (Tripoli, LY)
Objective: To analyse the epidemiology and clinical characteristics of
novel inﬂuenza A (H1N1). In March 2009 H1N1 inﬂuenza virus began
its inexorable spread around the world. The National Centre for Diseases
Prevention and control (NCDC) in Libya performs on-going inﬂuenza
surveillance and tracking of patients in Libya. We also evaluated the
performance of our diagnostic tools for the detection of H1N1 2009.
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The aim is to describe the NCDC experience and lessoned learned from
H1N1 pandemic.
Methods: Surveillance and investigation procedures were modiﬁed in
accordance with NCDC policy. From the outset of the outbreak and
until March 15, 2010, all suspected cases of inﬂuenza A/H1N1 were
investigated and laboratory veriﬁed. Starting December 1, 2009, lab
conﬁrmation was reserved for severely ill patients or those at high risk of
complications. All hospitalized cases were monitored and tracked daily.
We also evaluated a new rapid inﬂuenza diagnostic test (the Remel Xpect
Flu A&B test) for the pandemic (H1N1) 2009 virus, using real-time RT-
PCR for 684 samples which randomly selected and were negative by
rapid test.
Results: The ﬁrst A/H1N1 2009 cases were identiﬁed by the surveillance
system in the ﬁrst week of July 2009. The timeline showed epidemic
peak occurred in November 2009. In the six months from July to March
2010, there were 1192 conﬁrmed cases of H1N1 in Libya. During the
peak of the pandemic period, 35% of samples collected from patients
with inﬂuenza like illness (ILI) were reported to be positive for inﬂuenza;
95% of those positive for inﬂuenza were H1N1. At this time there was
an increase in the rates of patient visits to outpatient clinics for ILI,
especially in the age group 0−18 years old (54%) and in residents of
Tripoli, The capital of Libya. However, 99% of patients are less than 65
years old.
The Sensitivity of Remel Xpect Flu A&B test to the pandemic inﬂuenza
(H1N1) 2009 were 41%.
Discussion: Data indicate spread particularly to younger populations,
expressing non-speciﬁc respiratory symptoms. NCDC surveillance
system provided a valid picture which facilitated how to deal with the
inﬂuenza epidemic.
The low sensitivity value of the rapid test during these outbreaks
highlights the limitations of using this test alone to establish diagnosis
and aid clinical management.
R2517 Outbreak of Shigatoxin producing Escherichia coli
O174:H2 infections, Austria, 2010
S. Schlager, C. Kornschober, M. Wassermann-Neuhold,
A. Luckner-Hornischer, J. Stirling, F. Allerberger*, B. Springer (Graz,
Innsbruck, Vienna, AT)
Objectives: Shigatoxin producing Escherichia coli (STEC) are an
important cause of foodborne disease. It is transmitted to humans
primarily through consumption of contaminated food, such as raw or
undercooked ground meat products and raw milk. We report on the ﬁrst
occurrence of STEC O174:H2 in Austria.
Methods: Biochemical identiﬁcation, serotyping and virulence testing
were done at the National Reference Centre for Escherichia coli. A
descriptive investigation was performed in order to describe the outbreak
and to identify the outbreak genesis.
Results: The outbreak involved 7 persons (6 male). The index isolate was
from a 46 year old, previously healthy male, who had a fecal specimen
taken under intensive care for haemolytic uraemic syndrome (HUS) on
April 13 in Graz. The second isolate was from a 46 year old Tyrolean
patient (specimen received on April 28); this patient suffered from
discharge of slime and bowel irregularities, following watery diarrhea.
The patient attended a book fair in Graz 5 days before onset of illness in
Innsbruck. He and two working colleagues consumed appetizers (bred
with various handmade spreads) at some of the exhibition booths. The
two colleagues fell ill with diarrhea (one in Innsbruck, one in Munich,
Germany) but had not stool specimens tested. Another stool isolate (June
10) was from a 66 year old male treated for HUS in Vienna. A fourth
isolate was from this latter patient’s wife (age 63), who developed bloody
diarrhea three days after her husbands discharge from hospital. A ﬁfth
stool isolate was from a 92 year old patient with diarrhea from Graz
(specimen received May 12). All ﬁve isolates were sorbitol-fermenting,
positive for stx1, stx2 and hlyA, but negative for eae. Analyses by PFGE
using XbaI as restriction enzyme yielded patterns indistinguishable from
each other, but clearly different from ﬁve other STEC O174:H2 provided
by the German National Consulting Laboratory on HUS and 48 disease
associated Austrian STEC isolates from 2010.
Conclusion: Our report emphasizes that stool samples from patients
with HUS must be tested by other techniques than sole use of Sorbitol-
MacConkey media. Direct person-to-person transmission underlines
the importance of instructing family members about the need for
post-defecatory handwashing. For ﬁve of the six remaining patients,
consumption of an unidentiﬁed contaminated handmade spread produced
and distributed in the Graz area is the likely source of infection.
R2518 Expression of virulence hallmarks in Escherichia coli
aquatic strains submitted to different stress conditions
E. Panus, N. Rosoiu, C. Bleotu, L. Dacalu, M. Popa, C.M. Chiﬁriuc*
(Constanta, Bucharest, RO)
Purpose: To investigate the expression of 11 virulence factors (VF)
of 100 E. coli aquatic strains isolated from Black Sea in different
conditions.
Material and Methods: Cell-associated (i.e. adhesion to HeLa cells)
and soluble (i.e. lecithinase, lipase, gelatinase, caseinase, amylase,
aesculin hydrolysis, DN-ase, lisindecarboxilase, hemolysin, and CAMP
test performed in the presence of Staphylococcus aureus ATCC 25923
and Rhodococcus equi ATCC 6939) VF were investigated at different
temperature (22ºC, 37ºC, 44ºC), salinity, pH and glucose concentration,
in aerobic and respectively, anaerobic conditions. The genes encoding
for VF which remained negative, were detected by multiplex PCR for
Ecp/dA − lipase and EchelD − DN-ase and by simple PCR for Ech/yB −
a-hemolysin.
Results: The adherence ability, siderophores, amylase and caseinase
were better expressed at 37ºC. At 0% NaCl only amylase and
siderophores, at 2% and 3% NaCl the amylase was better expressed and
at 6% NaCl, siderophores and caseinase showed the best expression,
thereafter, the VF expression gradually decreasing till 10% NaCl. The
adherence to HeLa cells was decreased by higher salinities. The tested
strains proved high resistance to a broad range of pH from 5 to
9.6. The amylase and caseinase were better expressed at pH 9.6 and
siderophores at pH 7. The higher glucose concentrations (3%) inhibited
the expression of amylase and caseinase. The incubation conditions
exhibited no inﬂuence on the VF expression. The molecular detection
of VF genes evidenced the Ecp/dA in 82% and EchelD in 85% of the
tested strains. The densitometric analysis of the electrophoretic bands
obtained in multiplex PCR showed different intensities, suggesting that,
in a number of cases, the lipase or DN-ase genes could be lost in a great
percent in the bacterial population.
Conclusion: Our results proved the high adaptation ability of aquatic
enterobacterial strains to different stress conditions and the expression
of virulence determinants even in limiting environmental conditions,
demonstrating the role of these parameters in the preservation of the
virulence gene pool in water.
R2519 Evaluation of one-sample testing of self-obtained vaginal
swabs and ﬁrst-catch urine samples separately and in
combination for the detection of Chlamydia trachomatis
by two ampliﬁed DNA assays in women visiting a sexually
transmitted disease clinic
L. van Dommelen*, N. Dukers-Muijrers, F.H. van Tiel, E.E. Brouwers,
C.J. Hoebe (Maastricht, Geleen, NL)
Objective: Chlamydia trachomatis (CT) detection in both self obtained
vaginal swabs (SVS) and ﬁrst-catch urine (FCU) in two separate assays,
results in the highest sensitivity. In most laboratories however, one-
sample testing is performed for reasons of cost efﬁciency. To further
improve one-sample testing, we assessed the laboratory performance
of three different testing approaches to ﬁnd the most sensitive one-
sample test procedure: SVS versus FCU versus a combined specimen of
FCU/SVS.
Methods: All women visiting a STD clinic above the age of 16 were
asked to participate in the study. Each client was asked to take a FCU
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and a SVS with a dual swab. The FCU, SVS and FCU/SVS combination
were tested for CT by Strand Displacement Ampliﬁcation assay (SDA) of
Becton Dickinson (ProbeTec ET system, Maryland, USA) or Polymerase
Chain Reaction (PCR) by Roche Diagnostics Inc. (Cobas Amplicor
system, California, USA). Clients with at least one out of three sample
types (SVS, FCU, SVS/FCU combination) tested positive for CT by
NAAT, were regarded as CT positive (comparison standard).
Results: In total 791 females were included and CT prevalence was
12% (96/791). The CT detection rate for SVS, FCU and SVS/FCU
combination were 94%, 90% and 94%, respectively, if results of NAAT
by SDA and by PCR were analyzed together. The detection rate was
not signiﬁcantly different between any of the sample types, when tested
solely. Discordance in NAAT results within the different sample types
was found in 16 out of 96 CT positive results.
Conclusion: Our results show that the detection rate of SVS/FCU
combination is equal to that of FCU or SVS alone. SVS is an acceptable
and feasible specimen for females. Moreover, SVS is the most cost-
effective sample type for a STD clinic population We can therefore
conclude that SVS is the specimen of choice to detect CT in females.
R2520 Characteristics of an outbreak of pandemic H1N1 2009
among healthcare personnel
J. Chung*, S. Cho, S. Choi, M. Lee, M. Jeon (Seoul, Cheonan, KR)
Objectives: During an outbreak of pandemic H1N1 2009, healthcare
personnel (HCP) were thought to have substantial risk for acquirng
inﬂuenza for their frequent and close interaction with infected patients.
This study was performed to investigate the characteristics of an outbreak
of pandemic H1N1 2009 among HCP.
Methods: A multicenter survey of HCP was conducted in 4 general
hospitals of the Republic of Korea between July and August 2010. All
were assigned to local inﬂuenza centers by the Korean government during
the outbreak.
Results: The questionnaires were distributed to 4555 HCP and those
of 3365 (73.9%) were responded. Of the study HCP, 578 (17.2% of
3365) received diagnostic tests for pandemic H1N1 2009 and 141 had
positive results (4.2% of 3365; range, 3.8−4.6%). More than a quarter
of HCP (27.6%) had inﬂuenza-like illness (ILI) during the outbreak.
Independent risk factors for ILI were female gender, <40 years of age,
presence of chronic diseases associated with inﬂuenza complications, and
working in inﬂuenza outpatient, non-inﬂuenza outpatient and emergency
departments. The preventive effect of isolation precaution was not shown
prominently. HCP with pandemic H1N1 2009 more frequently had the
infection among their household members than those without. Whereas
pandemic H1N1 2009 tended to be transmitted from the hospital to the
household through HCP who were directly involved in patient care, it
did from the houshold to the hospital through HCP who had a infected
child or adolescent within their households.
Conclusion: ILI and pandemic H1N1 2009 was frequently observed
among HCP and the type of facility where HCP had worked principally
was one of the most important determinants for ILI. Inﬂuenza outpatient
and emergency departments were the highest risk for ILI of HCP. During
an inﬂuenza pandemic, infection control measures should be educated
and implemented for HCP who are actively involved in inﬂuenza patient
care, to prevent themselves and their households from the infection.
R2521 Predisposing factors for Streptococcus mutans septicaemia
S. Hotti*, L. Gro¨nholm, P. Laine, C. Lindqvist, R. Rautemaa (Helsinki,
FI)
Objectives: Streptococcus mutans, a viridans group streptococcus and
the primary etiological agent of dental caries, is rarely identiﬁed as
the cause of streptococcal sepsis or infective endocarditis (IE) by
conventional methods. The use of molecular methods allows species
level analyses of the etiology of systemic infection complications of oral
origin. This study describes ten patient cases of S. mutans septicaemia
identiﬁed by sequence-based methods.
Methods: This retrospective, population-based cohort study comprises
patients with S. mutans identiﬁed in blood cultures during 2002–2007 at
our hospital in Helsinki. Characteristics of hospital stay recorded were
diagnostic methods, supportive treatment, C-reactive protein levels, white
blood cell (WBC) counts, body temperature, length of stay (LOS), need
for intensive care, antimicrobial therapy and outcome. Dental records
were obtained from public and private dentists. Medical records were
veriﬁed by telephone interview of the patient during years 2006–2007.
Results: Ten patients (8 men, 2 women) were included with matched
controls. The mean age was 49.8 (24−77) years. IE (9/10) was the most
common distant site infection, one patient developed spondylitis. All
patients had some predisposing condition for distant site infection: mitral
valve insufﬁciency (5/10), bicuspid aortic valve (3/10), atrioventricular
septal defect (1/10) and discus protrusion (1/10). Five patients had
had a preceding dental procedure, which in most cases was removal
of dental plaque and calculus (4/10). None of the patients received
antibiotic prophylaxis preoperatively. All ten patients had active oral
infection foci, most often untreated periodontitis (5/10), likely to cause
spontaneous bacteraemia. Patients reported more childhood infections
than the controls (p = 0.01). WBC counts (10(3)/mL) on admission were
median 8.0 (4.5–10.6) and at maximum 9.9 (5.5–33.6). LOS was 27 days
in median (9−75).
Conclusion: Patients with predisposing medical conditions seem to be
more susceptible for distant site infections caused by S. mutans. The
major predisposing factor in our study material was cardiac structural
abnormality. All these patients subsequently developed IE as a distant site
infection. The results highlight the importance of oral health in patients
with cardiac abnormalities and support the use of antibiotic prophylaxis
during dental care of oral infection foci in these patients, especially if
colonised with S. mutans.
R2522 “The body gets used to them”: patients’ interpretations of
antibiotic resistance and the implications for containment
strategies
L. Brookes-Howell*, G. Elwyn, K. Hood, F. Wood, L. Cooper,
H. Goossens, M. Ieven, C. Butler (Cardiff, UK; Antwerp, BE)
Background: Antibiotic resistance is a term that is frequently used
by clinicians in their discussions with patients. However, patients and
clinicians may not share the same assumptions about the meaning of
this term.
Objective: We aimed to explore patients’ interpretations of the term
‘antibiotic resistance’ and to consider the implications for strategies to
reduce the overuse of antibiotics.
Design: Qualitative interview study.
Participants: 121 adult patients from nine European cities who had
recently consulted a primary care clinician with symptoms of Lower
Respiratory Tract Infection (LRTI).
Approach: Semi-structured interviews were conducted with participants
following their consultation. Data were subject to Framework Analysis.
Results: The dominant theme in all networks was that antibiotic
resistance arose from having or developing a ‘resistant body’, where the
barrier to antibiotic effectiveness was individual loss of responsiveness.
Less commonly, patients correctly conceptualised antibiotic resistance
as a property of bacteria. Nevertheless, the over-use of antibiotics was a
strong central concept in almost all patients’ explanations, whether they
viewed resistance as located in either the body or in bacteria.
Conclusions: Most patients were aware of the link between antibiotic
use and antibiotic resistance. The identiﬁcation of the misinterpretation
of antibiotic resistance as being located in the body could lead to
clinician-patient discussions and public health interventions which are
much clearer about the location and mechanism of antibiotic resistance,
explaining the transferability and societal relevance rather than focusing
on individualised risk, thereby emphasising the public health argument
for the prudent use of antibiotics.
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R2523 Enteroaggregative Escherichia coli as a possible cause of
sporadic diarrhoea in children from Romania
C. Usein*, D. Tatu-Chitoiu, S. Ciontea, M. Baltoiu, M. Nica,
M. Damian (Bucharest, RO)
Objectives: Diarrhoea remains one of the main sources of morbidity and
mortality in the world and enteroaggregative Escherichia coli (EAEC)
have been increasingly recognized as an emerging pathogen, causing
diarrhoea in both developing and industrialized countries. In Romania,
the real contribution of EAEC to diarrhoea disease burden is not
known because of the lack of routine EAEC detection protocols in
clinical microbiological laboratories. The aim of the present study was
to determine the prevalence of faecal carriage of EAEC in Romanian
children with sporadic acute diarrhoea.
Methods: E. coli isolates originating in stool samples, collected during
diarrheal episodes from 477 children, under ﬁve years of age, previously
found negative for enteric pathogens such as Salmonella spp., Shigella
spp., Yersinia enterocolitica, Campylobacter spp. and other diarrheagenic
E. coli pathotypes, were included in the study. From each specimen,
one biochemically conﬁrmed E. coli isolate was screened by PCR
for the presence of EAEC-associated genes aat, aggR, aap and astA.
EAEC isolates were evaluated, using a PCR-based protocol, for their
phylogenetic background and tested for antimicrobial susceptibility by
the disk diffusion methods.
Results: The molecular approach revealed that 41 (8.6%) E. coli
isolates carried at least two of EAEC-associated genes targeted. The
most frequently detected genes were aat (40 isolates) and aap (38
isolates). Twenty-nine isolates harboured concurrently aat, aggR, and
aap genes. Almost half of these carried also astA gene. Most of the
EAEC isolates derived from phylogenetic group A (29 isolates), while
the rest belonged to groups B2 (6 isolates), D (4 isolates) and B1 (2
isolates). Twenty-four EAEC isolates expressed resistance, of which ﬁve
were extended-spectrum b-lactamase producers. All EAEC isolates were
ﬂuoroquinolone susceptible.
Conclusion: This study revealed that EAEC pathotype might be a
signiﬁcant cause of sporadic diarrhoea among children in Romania. Our
results provide additional support for the reconsideration of the local
diagnostic and surveillance strategies.
R2524 The occurrence of selected intestinal helminthoses in
marginalised group of Roma living in settlements
M. Hala´nova´*, L. Cisla´kova´, P. Jurisˇ, I. Papajova´, P. Jarcusˇka,
P. Rudohradska´ (Kosˇice, SK)
Material dimension of poverty in Roma national minority is particularly
noticeable in the sphere of living. Especially, in the segregated
settlements with illegal huts (mostly built of wood, iron waste, ﬂat metal
stock and other materials obtained from waste dumps or surrounding
countryside), devastated environment and with no access to basic
infrastructure such as electricity, tap water (they mostly use water wells
or streams), sewerage system and waste disposal what in many cases
has inﬂuence on bad health status and troubles with hygiene. According
to the Ofﬁce of Government Plenipotentiary for Roma issue in Slovakia
there is approximately 680 Roma settlements at present. These are often
located in rural communities without the necessary basic infrastructure.
According to several studies in many settlements, which are often built
on loose soils are lacking in their drinking water, sewage, waste pits and
landﬁlls, sanitary facilities and lack of garbage disposal.
The settlements are concentrated in a small area with a large number of
people (about 500 000 people) whose health status is unsatisfactory.
The aim of our work was to study the occurrence of helminthoses
in Roma children population in selected areas of Eastern Slovakia,
especially from Roma settlements (Michalovce, Presˇov, Vranov nad
Toplou, Secovce) and Lunik IX (Kosˇice).
In total, 246 stool samples from children aged 0−14 years were
examined.
For detection of parasites was used coprological method Paraprep L
(DiaMondial, France).
The helminth eggs were detected in 19.9% of examined children, at
which Ascaris sp. (18.3%) and Trichuris sp. (5.3%) eggs dominated.
The highest positivity was detected in children in the age group 6−14
years (27.1%).
Low standard of housing, communal and personal hygiene, lack of
drinking water and sanitation in Roma settlements increases the risk
of oro-faecal infections.
Indirectly to faecal contaminated environment shows the high prevalence
of enteronematodes. The occurrence of epidemiologically low-risky
parasitoses in Roma population in Slovakia suggests low hygiene
standard in Roma settlements.
This work was partially supported by the Agency of the Slovak Ministry
of Education for the Structural Funds of the EU, under project ITMS:
26220120058 (80%)and by VEGA MSˇ SR No. 1/0412/09 and No.
2/0147/10.
R2525 Neural involvement in brucellosis: clinical classiﬁcation,
treatment and outcomes
Y. Demiroglu*, T. Turunc, S. Karaca, Z. Arlier, H. Aliskan,
S. Colakoglu, H. Arslan (Adana, TR)
Aim: The aim of this study was to describe and to categorize different
clinical pictures of patients with neurobrucellosis in our clinic, and to
present demographical and laboratory data about the patients.
Material and Methods: Hospital records, between 2003 and 2009, of
about 430 patients with brucellosis were followed and retrospectively
reviewed in our clinic.
Results: Out of 430 patients, 19 (4.4%) had neurobrucellosis. These
patients were classiﬁed into four groups: Meningitis group (n = 14; 13
cases of subacute-chronic meningitis and one case of acute meningitis),
Encephalomyelitis group (n = 3; one case of meningoencephalomyelitis,
one case of cerebellar abscess, and one case of transverse myelitis),
Polyradicular group (n = 1; one case of Miller Fisher Syndrome), and
others (n = 1; one case of intradural abscess).
Ten patients (52.6%) were female, and nine patients (47.4%) were male
and the mean age of the patients was 48.8 years. About 47.4% of the
patients had fever, 26% of the patients had neck stiffness, and 5%
of the patients were in an unconscious state. Out of 19 patients, 18
underwent lumbar puncture (LP). According to cerebrospinal ﬂuid (CSF)
analyses, the mean leukocyte count was 113/mm3, the mean glucose
level was 45mg/dl, and the mean protein level was 123mg/dl. Standard
tube agglutination test showed brucellosis in all patients who underwent
LP. Microorganisms were detected in four patient’s blood culture and
one patient’s CSF culture. There were cranial nerve involvements in
ﬁve cases. The most frequent was the sixth cranial nerve involvement.
Out of 19 patients, 3 recovered with sequels (paraparesis, hearing
loss, dementia, and sphincter dysfunction) and 16 patients recovered
completely.
Conclusion: Although neurobrucellosis is most frequently accompanied
by subacute-chronic meningitis, it may have many different clinical
pictures. The classical triad of meningitis (fever, neck stiffness, and
unconscious state) is rarely seen in brucellosis-related meningitis.
Brucellosis should be kept in mind in patients with unexplained
neurological ﬁndings in regions where brucellosis is endemic. In
addition, a classiﬁcation of brucellosis, which reﬂects locations of
nervous system involvement, clinical picture, and pathogenesis, is
needed.
R2526 Oral candidal colonisation and oral candidiasis in the
institutionalised and non-institutionalised elderly
I. Glazar*, R. Persic, M. Jurcevic, M. Muhvic Urek, I. Brekalo Prso,
S. Pezelj-Ribaric (Rijeka, HR)
Objectives: Oral candidiasis is an opportunistic infection of the oral
cavity and it is common among the elderly. This study was carried out in
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order to evaluate colonization of the oral cavity with Candida species and
oral candidiasis in the institutionalized and non-institutionalized elderly.
Methods: A total of 341 elderly were included, 280 institutionalized
elderly in nursing home (134 males, 146 females, mean age 72.68±8.43)
and 61 non-institutionalized elderly (23 males, 38 females, mean age
70.39±6.16). Specimens were isolated from oral cavity with sterile swabs
(Copan, Zagreb, Croatia) from the surface of oral mucosa and were
inoculated on a isolation medium, Sabouraud’s dextrose agar. Cultures
were incubated at 37ºC for 48 hours. In cases of no growth, the plates
were considered negative and discarded. The count of colony-forming
units was recorded. Oral cavity is considered colonized with Candida
spp. in the case of positive microbiological analysis and normal oral
mucosal appearance. The diagnosis of oral candidiasis was established
by taking account of the clinical appearance (pseudomembranous
candidiasis, erythematous candidiasis, denture-related stomatitis or
candida-associated lesions) and positive microbiological analysis. The
diagnosis was made according to the number of the colonies described
by Budtz-Jorgensen.
Results: Altogether, 68.92% of institutionalized elderly in our study
were colonized with Candida spp. This result was statistically different
compared with the non-institutionalized elderly (50.81%; p< 0.001). The
results of our investigation also showed an increased number of the
institutionalized elderly with oral candidiasis compare with the non-
institutionalized ones (17.14% for institutionalized elderly; 9.83% for
non-institutionalized elderly; p = 0.035).
Conclusion: Results of this study showed a higher prevalence of
colonization of the oral cavity with Candida spp., as well as oral
candidiasis in the institutionalized elderly compared with the non-
institutionalized elderly.
R2527 Study of the incidence of different Corynebacterium spp.
strains among the healthy population in Romania
C.C. Dragomirescu*, E. Lupulescu, A. Stanescu, A.F. Ilie, L. Grigore,
M.I. Popa, M. Damian (Bucharest, RO)
Diphtheria is controlled in Romania by the National Program for
Communicable Diseases Surveillance. Since 1989 no diphtheria case
was recorded in our country. As a consequence, since 2002 the
disappearance of toxigenic Corynebacterium diphtheriae is declared.
At the same time, annually reports showed also a decrease of the
number of non-toxigenic C. diphtheriae strains isolated in different
districts. As members of DIPNET Diphtheria Surveillance Network, the
surveillance of Corynebacterium diphtheriae as well as C. ulcerans and
C. pseudotuberculosis strains represent an important part of our activity.
Objectives: The aim of this study was the screening of healthy target
population to identify the C. diphtheriae and other toxigenic species.
Materials and Methods: 696 pharyngeal and nasal samples were tested
in our laboratory. The target population was represented by 1−19 years
old children from care centers in 8 different geographical regions of
country. The analyses were performed according to WHO Laboratory
Diagnosis of Diphtheria protocols.
Results: No C. diphtheriae or C. ulcerans strains were isolated. A
number of 106 strains were isolated and identiﬁed as upper respiratory
tract saprophytic species belonging to the genus Corynebacterium, some
of them with pathogen potential especially in immunocompromised hosts
as follows: 56% C. pseudodiphtheriticum, 29% C. propinquum, 6%
C. striatum/amycolatum, 5% C. group C, 2% C. macginleyi and 2%
C. glucuronolyticum.
Conclusions:We can conclude that strains involved in diphtheria disease
are not circulating in Romania in the surveillance period, and that the
frequency of other species of Corynebacterium spp. isolated is low, only
16% of subjects being carriers.
R2528 Evaluation of geriatric patients hospitalised in infectious
diseases department
S. Menekse Yilmaz*, N. Baykam, T. Cirkin Guzel, M. Eroglu,
A. Kocagul Celikbas, S. Eren Gok, S. Yaprakci, H. Esener,
B. Dokuzoguz (Ankara, TR)
Introduction: Infection is a common problem in elderly patients. In
geriatric practice, infection is most frequently seen in combination with
many other problems. During the evaluation of geriatric patients, atypical
presentations are the main cause of missed diagnosis, mostly in infectious
diseases.
Method: This retrospective, cohort study identiﬁed elderly patients
(age 65 years) hospitalized in Infectious Diseases Clinic of a
tertiery hospital between January 2008 and July 2009. The initial
major symptom, co-morbidities, deﬁnite diagnosis, clinical course and
prognosis of these elderly patients were evaluated.
Results: 103 of 601 hospitalized patients in Infectious Diseases
Department were aged 65 or older.
Co-morbidities were detected in 91 of the patients as; hypertension
and coronary artery diseases (n: 60, 58.2%), neurologic disorders
(n:29, 28.1%), diabetes mellitus (n:22, 21.3%), chronic obstructive lung
disease (n:17, 16.5%), malignancy (n:9, 8.7%) and other as history
of recent surgical operation, hypothyroidism, renal insufﬁciency and
rheumatological disorders (n:18, 17.4%). The common symptom of the
patients were fever (62.1%) followed by unconsciousness (22.3%) and
cough (16.5%). The common infections were urinary tract infection
(n:37, 40%), pneumoniae (n:18, 17.4%), and sepsis (n:16, 15.5%). Four
patients had the diagnosis other than infectious diseases. The duration
for the deﬁnite diagnosis beginning from the initial symptoms was varied
from longer than 4 weeks (n:16) to less than 7 days (n:57) The mean
hospitalization day was 9.5 days (5−26 days) Following the consultations,
15 patients were transferred to other departments for the need of other
disciplines support. Nine of the patients (5 were in other departments)
died.
Conclusion: As the atypical presentations of infectious diseases are very
common in elderly patients, the most important problems are delayed
or missed diagnosis and long hospitalization periods. Data reveals that
neither the lack of fever directs the diagnosis to non-infectious disease
nor the unconsciousness is the constant symptom of CNS infection in
elderly patients. Detailed investigation of differential diagnosis is very
important in geriatric patients.
R2529 Risk factors for surgical site infections in hip and knee
arthroprosthesis: role of microbial air contamination and
adherence to guidelines for antimicrobial prophylaxis
A. Agodi*, F. Auxilia, M. Barchitta, M.L. Cristina, D. D’Alessandro,
U. Moscato, I. Mura, M. Nobile, C. Pasquarella, V. Torregrossa and
GISIO − SItI Italian Study Group on Hospital Hygiene
Objectives: The main aim of the study is to evaluate the role of microbial
air contamination on the risk of surgical site infection (SSI) in hip
and knee arthroprosthesis controlling for adherence to guidelines for
antimicrobial prophylaxis. The project has been funded by the Italian
CCM (Centro Controllo Malattie, Ministry of Health).
Methods: Hospitals were invited to join the project by GISIO members.
SSI surveillance was conducted according to the HELICS protocol
(version 9.1, 2004). Microbial air contamination was evaluated at
the patient area, once at rest and during each operation, by passive
sampling to determine the Index of microbial air contamination (IMA)
(Pasquarella et al., 2000) and in some cases also by active sampling
to determine the colony forming units (cfu)/m3. Surgical antimicrobial
prophylaxis refers to a very brief course of an antimicrobial agent
initiated just before an operation begins. A web-based data collection
procedure was adopted using three electronic data forms. The two years
project started in July 2010, preceded by a three-month pilot study to
assess the overall feasibility of the programme.
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Results: The project has included so far 8 Hospitals and 20 operating
rooms (OR). According to the OR ventilation system in place, 76.5% of
OR were with unidirectional airﬂow, 6.0% with turbulent air ventilation,
and 17.6% mixed. A total of 289 surgical procedures, 67.0% hip and
33.0% knee arthroprosthesis, were included until December 2010. Mean
duration of operations was 93 minutes for hip and 117 minutes for knee
arthroprosthesis. IMA values in OR at rest were as follows: range =
0−8, mean±SD = 0.8±2.1, median = 0; during surgical procedures the
following values were registered: range = 0–156, mean±SD = 7.2±14.7,
median = 3. A total of 99.6% of patients received antibiotic prophylaxis:
30−60 minutes (36.7%), 1−2 hours (18.5%) and >2 hours (44.8%),
before incision. The most frequently administered antimicrobial agents
were cefazolin (44.7%), tobramycin (29.1%) and teicoplanin (19.6%).
Conclusion: Although one year of follow-up after implant is requested
for SSIs surveillance, the study has depicted the epidemiological scenario
in which a complex network of risk factors for SSIs is embedded, already
highlighting potential areas for improvement both for air quality and
antibiotic prophylaxis.
R2530 Brucellosis: a ﬁve-years experience from southeastern
Anatolia
C. Ayaz*, M.K. Celen, S. Hosoglu (Diyarbakir, TR)
Brucellosis is a chronic granulomatous infection caused by intracellular
bacteria. It is an endemic disease in Mediterranean countries and Turkey.
Brucellosis shows the involvement of many systems and it seems to be
responsible for the high incidence of relapse. The aim of this study is
to analyze the clinical, laboratory ﬁndings and therapeutic features in
patients with brucellosis.
Patient and Methods: We conducted a retrospective study of
patients who developed brucellosis between 2005 to 2009 admitted in
the Department of Infectious Diseases of Dicle University Hospital,
Diyarbakir. The diagnosis was based on clinical ﬁndings compatible
with brucellosis, serological tests positive, and/or isolation of Brucella
species from blood, or other tissues.
Results: 91 cases were included. The mean age was 33 years (16−67
years). Sixty-threes of patients (69.2%) were male. An occupational
history relevant for Brucella exposure was present in 44% of the cases
and consumed contaminated animal product was noted in 93% of cases.
The mean diagnostic delay was 15 days, much longer in focal brucellosis.
Acute brucellosis was predominant, in 85% of cases. The focal
brucellosis complications were seen in 42.8%: osteoarticular involvement
(82%), epididimo-orchitis (10%), and nervous system central (8%).
Chronic brucellos occurs in 3.3% of cases. Clinical manifestations
include non-speciﬁc symptoms such as fever (95%), sweats (90%),
arthralgia and lower back pain (63%). 92% of the patient had serological
titre = 1/160. Overall, 31% of blood cultures were positive. All
of the patients were cured by antibiotherapy included Doxycycline
and rifampicin/Doxycycline, streptomycine and rifampicin/Doxycycline,
ceftiraxone and rifampicin. Relapse in follow-up period was observed in
ﬁve patients.
Conclusion: Brucellosis is an infection with multiple presentations. Its
early diagnosis was mandatory to avoid severe complications.
R2531 Boric acid for recurrent vulvovaginal candidiasis: the
clinical evidence
C. Iavazzo*, I. Gkegkes, I. Zarkada, M. Falagas (Athens, GR)
Objectives: Recurrent vulvovaginal candidiasis remains a challenge to
manage in clinical practice. Recent epidemiological studies indicate that
non-albicans Candida spp. are more resistant to conventional antifungal
treatment with azoles and are considered as causative pathogens of
vulvovaginal candidiasis.
Methods: We searched PubMed and Scopus, for studies that reported
clinical evidence on the intravaginal use of boric acid for vulvovaginal
candidiasis.
Results: We identiﬁed 14 studies (2 RCTs, 8 case series and 4 case
reports) as eligible for inclusion in this review. In 7 studies, boric acid
was compared either with nystatin, or azoles (terconazole, ﬂucytosine,
itraconazole, clotrimazole, ketoconazole, ﬂuconazole, buconazole and
miconazole), while as monotherapy boric acid was studied in 7 studies.
The mycological cure rates varied from 40% to 100% in patients treated
with boric acid. Four of the 9 included case series reported statistically
signiﬁcant outcomes regarding cure (both mycological and clinical) rates.
None of the included studies reported statistical signiﬁcant difference in
recurrence rates. Regarding the adverse effects caused by boric acid use,
vaginal burning sensation (<10% of the cases), water discharge during
treatment and vaginal erythema were identiﬁed in 7 studies.
Conclusion: Our ﬁndings suggest that boric acid is a safe, alternative,
economic option for women with recurrent and chronic symptoms of
vaginitis when conventional treatment fails due to the involvement of
non-albicans Candida species or azole-resistant strains.
R2532 Yersinia enterocolitica detection in drinking and recreational
waters
T. Kaveli, P. Gousia, V. Economou, C. Gartzonika, S. Levidiotou*,
C. Papadopoulou (Ioannina, GR)
Objectives: The objective of the present survey was the study of Yersinia
enterocolitica infestation in drinking and surface waters in Northwestern
Greece.
Methods: Over a period of 12 months (November 2008–October 2009)
a total number of 180 water samples were examined for the presence
of Y. enterocolitica. The water samples were collected from the area
of Epirus (Northwestern Greece) and included: 60 samples of drinking
water, 60 samples of lake water and 60 samples of marine water.
The drinking water samples were tap-water collected from houses from
three different municipalities of the area, the lake water samples were
collected from two lakes (Pamvotis and Voulkaria) representing two
different ecosystems (polluted/urban and rural/unpolluted) both used
for recreational activities and the marine water samples were collected
from ﬁve different point sources of Ionian Sea, including areas of
recreational activities. The APHA/AWWA, Standard Methods for the
examination of water and waste water were employed for the detection
of Y. enterocolitica and other bacterial indicators (total microbial ﬂora,
coliforms, fecal coliforms, enterococci).
Results: Y. enterocolitica was isolated from two samples of marine water
and two samples of lake water. The positive samples were isolated
from the most polluted aquatic environments (the urban lake and the
Amvrakikos Golf). The isolation of Y. enterocolitica coincided with
increased numbers of total coliforms (2500 cfu/ml) and enterococci
(2000 cfu/ml). No Y. enterocolitica strains were isolated from the
drinking water samples.
Conclusion: The ﬁndings of the present survey underline the presence
of Y. enterocolitica in marine and lake water as an indicator of
microbiological pollution and a potential threat for public health if the
contaminated aquatic environment is used for recreational activities.
Also, the absence of Y. enterocolitica in the drinking water samples
of the examined area proves the efﬁcacy of the chlorination practices.
R2533 Tick invasion in the blood transfusion unit of a general
hospital, following unusual weather conditions
C. Papadopoulou, E. Chrisostomou, H. Nita, T. Vlachou, A. Kostoula*
(Ioannina, GR)
Objectives: The aim of the present study is to report the event of tick
invasion in the premises of the blood transfusion unit (BTU) of a General
Hospital following the unusual climatic conditions of spring and summer
2010 in North-western Greece.
Methods: During the ﬁrst week of July 2010, large numbers of ticks
appeared in the external and internal walls and inside the premises
of the BTU of the “Hatzikosta” General Hospital of Ioannina, causing
uneasiness to the unit’s medical and paramedical personnel. The BTU
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is located next to the Microbiology and the Clinical Biochemistry
Laboratories and above and below the BTU there are various Clinics.
None of the surrounding laboratories and clinics reported any appearance
of any ticks, which was also conﬁrmed by in situ Inspection. Inspection
of external walls of the BTU building revealed large numbers of ticks,
the presence of a number of bird nests and many cracks on the walls.
Results: The tick specimen collected by the Microbiology Department of
the Medical School of Ioannina were identiﬁed to belong to Ixodes spp.
The Greek Ornithological society was called and there were identiﬁed
80 nests of swallows belonging mostly to the species Delichon urbica,
on the BTU building and surrounding hospital buildings. The swallow
species Delichon urbica is host of haematophagous ticks belonging to
the family of Ixodidae and apparently the nests were the source of the
ticks, which astonishingly enough, were moving only towards and into
the BTU premises and nowhere else in the Hospital buildings.
Conclusions: The swallow nests have been on the hospital buildings for
years and were re-visited every spring by their bird habitats. However, the
2010 appearance of large numbers of ticks is correlated with the earlier
spring with high temperatures and heavy rainfalls continued through
middle of July. The favorable weather conditions worked well with the
cracks on the old building walls resulting in the multiplication and
establishment of the ticks on the hospital walls of the BTU.
R2534 Clinical appearance of brucellosis in adults: are there any
changes? Response based on 14 years of experience
B. Kurtaran*, A. Candevir, A.S. Inal, S. Komur, O. Akyildiz, H.S. Aksu,
Y. Tasova (Adana, TR)
Purpose: This study has been planned to indicate the clinical course and
termination of brucellosis in our region during the recent years, and to
compare it to the literature.
Methods: The study has been based on a review of the medical records
of adult patients older than 14 years, followed with the diagnosis of
brucellosis from March 1997 to October 2010. The demographical data,
disease diagnosis, course, treatment and termination data of the patients
were recorded.
Results: 317 patients, including 136 males (43%) with average age
40±17 were included in the analysis. There was a statistically signiﬁcant
relationship between advanced age and development of spondylitis and
arthritis (respectively p = 0.000 and p = 0.028). Besides, the frequency
of splenomegaly and neurobrucellosis among the young population was
found high, which was statistically signiﬁcant (respectively p = 0.005
and p = 0.001). In cases of spondylitis, the most common (~85%)
involvement was of the lumbar vertebrae. Also there was a statistically
signiﬁcant relationship between high ESR and spondylitis, sacroilliitis
and visceral abscess (p = 0,001, 0,013 and 0,049 respectively).
Conclusion: The study is sad to see that there haven’t been any
signiﬁcant changes in the frequency of the disease and its complications
in time. Osteoarticular involvement, and particularly the presence of
spondylitis should be searched, and the advanced aged patients should be
meticulously scanned for complications. Laboratory parameters, patient’s
age and duration of symptoms may help to identify complicated cases.
R2535 Infectious diseases among EUFOR military personnel
G. Popov* (Soﬁa, BG)
Objectives: Infectious diseases and non-battle injuries has been
recognized for its impact on the combat effectiveness of military units
during operations in Bosnia and Herzegovina.
Methods: An epidemiological analysis was conducted of the impact
of infectious diseases on the European Union Force (EUFOR) troops
for the period from 02.12.2004 to 31.12.2010. Standar-dized collection
of medical data from all EUFOR medical treatment facilities (MTF)
using 14 diagnostic categories based on the International Classiﬁcation
of Diseases, 9th Revision were conducted.
Results: The average infectious diseases rate for this 6-years period
was 8.1 per 100 soldiers per week (range, 5.8–11.1/100/week). Most
frequently causes for soldier visits to MTF were respira-tory (36%),
gastrointestinal (31%), arthropod-borne (12%) and “other” infectious
diseases (21%).
Respiratory infections were the leading causes of infectious disease
morbidity among EUFOR troops showed a distinctive seasonal pattern.
Adenovirus, inﬂuenza virus, S. pyogenes and B. pertussis were
particularly problematic. It has been reported 12 outbreaks of inﬂuenza,
chicken pox, Q-fever and pertussis.
Diarrheal diseases were the most common cause of acute infections
among EUFOR troops. The primary enteropathogens identiﬁed were
norovirus, enterotoxigenic E. coli, Sh. sonnei and S. enteritidis. Five
outbreaks of norovirus and shigella were reported among EUFOR
soldiers.
From arthropod-borne infections it has been conﬁrmed cases of Lyme
disease, Mediterranean spotted fever and Q-fever. Thirty two EUFOR
soldiers were tested positive to brucellosis and four conﬁrmed cases of
hemorrhagic fever with renal syndrome have been reported. There were
a few cases of sexually transmitted diseases and viral hepatitis C but
they were not a signiﬁcant problem during this deployment.
Conclusions: The incidence rate of infectious diseases, during this
conﬂict was relatively low because of combination of factors: the
presence of a comprehensive infrastructure of medical care, extensive
preventive medicine efforts and several fortuitous circumstances.
Nevertheless EUFOR military personnel, because of crowding and
unique stressors, were subject to respiratory and diarrheal disease
outbreaks. A few diseases (brucellosis, hemorrhagic fever with renal
syndrome and Q-fever) caused by potential biological weapon agents
were prevalent.
R2536 Study of Campylobacter strains isolated in the decade
2001–2010
E. Bakali*, P. Siasios, E. Vamvaka, I. Dima, M. Gkatzima,
A. Kansouzidou (Thessaloniki, GR)
Background: Campylobacter has been recognised as a causative agent
of bacterial infectious diarrhoea and remains one of the most prevalent
bacterial enteropathogens in the industrial countries. Campylobacter
infection is generally foodborne disease.
Objectives: The aim of this report is the study of Campylobacter cases
recorded during the decade 2001–2010, as well as the susceptibility of
Campylobacter isolates to antibiotics. Also the frequency of the disease
according to age, sex and season was estimated.
Methods: A total of 898 Campylobacter strains were isolated
from patients with acute gastroenteritis hospitalized in the Infectious
Diseases Hospital of Thessaloniki. The selective Skirrow medium
was used. Skirrow medium is blood agar infused with antibiotics:
vancomycin, polymixin-B and trimethoprim. The incubation was under
microaerophilic conditions at 37ºC and 42ºC. Following isolation on
selective media, identiﬁcation was carried out using the biochemical pro-
ﬁle of each Campylobacter strain. Furthermore, Campylobacter strains
were tested for susceptibility to antibiotics (ampicillin, gentamicin,
tobramycin, cephalothin, ceftriaxone, ciproﬂoxacin, nalidixic acid, co-
trimoxazole, erythromycin) using the Kirby-Bauer method.
Results: Of the 898 strains, 846 (94.2%) were C. jejuni and 52
(5,8%) C. coli. From the total strains, 521 (58%) were isolated
from males and 377 (42%) from females. Furthermore, 704 strains
(78,4%) were isolated from children (47.4% under the age of 2 years)
and 194 (21.6%) from adults. In addition, leucocytes were found in
34.4% of the stool specimens. The peak of Campylobacter infection
in the study was in the spring months (31.4%) and in the summer
months (28.5%). An increase in ﬂuoroquinolones and co-trimoxazole
resistance (nalidixic acid 23.9%, ciproﬂoxacin 12% and cotrimoxazole
47.7% respectively) among Campylobacter isolates has been observed.
Erythromycin (macrolides) is considered the drug of choice with low
resistance.
Conclusions: Campylobacter is a major cause of bacterial enteritis,
following Salmonella in Northern Greece. Most frequently isolated was
C. jejuni. Age speciﬁc infection rate was highest in children less than
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two years old. Campylobacteriosis occurs much more frequently in the
spring and summer months. Erythromycin is still an effective antibiotic
for the therapy of Campylobacter infection.
R2537 Chlamydia pneumoniae seropositivity and its association
with carotid intima media thickness, c-reactive protein
and oxidant stress in subjects with only underlying
hypercholesterolaemia
A. Adnan*, M. Kaur, H. Mohd Nawawi (Shah Alam, MY)
Background: The association between Chlamydia pneumoniae and
atherosclerosis in hypercholesterolaemia subjects in the absence of other
conventional risk factors is unclear. This study was done to determine
whether C. pneumoniae seropositivity is associated with increase in
intima media thickness (IMT) of the carotid artery, hs-C reactive protein
(CRP) and oxidant stress in subjects with hypercholesterolaemia.
Methods: Fifty-two hypercholesterolaemic subjects were recruited
during health screening programmes organized by our institution.
Subject inclusion criteria include baseline LDL-c of 3.4mmol/l.
Subjects with diabetes, hypertension, severe obesity, smoking, primary
hypercholesterolemia and presence of acute inﬂammation (C-reactive
protein 10 units) were excluded. IgG and IgA to C. pneumoniae
were measured by microimmunoﬂuoresence test. IgG titre 64 and IgA
16 were considered to be seropositive. IMT of the far wall of carotid
artery was measured by B-mode ultrasound. hs-CRP was measured by
immunoturbidimetric method using an automated analyser. Isoprostanes
(an oxidative stress marker) was quantiﬁed by liquid chromatography
mass spectrometry.
Results: Seropositivity for C. pneumoniae was detected in 40.4% of the
hypercholesterolaemic subjects. There was no signiﬁcant difference in
the IMT in the hypercholesterolaemic subjects who were C. pneumoniae
seropositive compared to the C. pneumoniae seronegative subjects (Mean
IMT±SD mm: 0.6±0.7mm vs. 0.6±0.6mm, p> 0.05). hs-CRP did
not show a statistically signiﬁcant difference between C. pneumoniae
seropositives and seronegatives individuals (Mean hs-CRP + SD mg/dl;
1.56±0.29 vs 1.85±0.35; p> 0.05). By contrast, a signiﬁcant difference
was observed when comparing isoprostane, a marker for oxidative stress
by serostatus to C. pneumoniae (Mean + SD pg/ml; 46.2±30.6 vs
37.7±20.4; p< 0.05).
Conclusion: Our data demonstrates that seropositivity to C. pneumoniae
increases the oxidative stress but it is not associated with increase in
carotid IMT or in hs-CRP in subjects with hypercholesterolaemia in the
absence of other conventional cardiovascular risk factors.
R2538 Role of matrix assisted laser desorption/ionisation time of
ﬂight (MALDI-TOF) mass spectrometry as a tool for rapid
diagnosis of potentially toxigenic Corynebacterium species
in the laboratory management of diphtheria-associated
bacteria
R. Konrad, A. Berger, I. Huber, S. Ho¨rmansdorfer, V. Boschert,
U. Busch, M. Hogardt, S. Schubert, A. Sing* (Oberschleißheim, DE)
Objectives: The rapid and reliable identiﬁcation of the three poten-
tially toxigenic Corynebacterium species Corynebacterium diphtheriae,
C. ulcerans and C. pseudotuberculosis is usually essential for diagnosis
and treatment of diphtheria and diphtheria-like diseases. Classical
differentiation of suspected isolates is done by biochemical tests, which
are time consuming and may often give unclear results. Recently,
matrix assisted laser desorption/ionization time of ﬂight (MALDI-TOF)
mass spectrometry (MS) was shown to allow identiﬁcation of isolated
microorganisms within 15 minutes and is therefore a fast alternative for
species differentiation.
Methods: We used matrix assisted laser desorption/ionization time-
of-ﬂight mass spectrometry (MALDI-TOF MS) in comparison with
classical microbiological (API Coryne) and molecular methods (rpoB
sequencing) on 116 Corynebacterium strains.
Results: All 90 potentially toxigenic Corynebacterium spp. strains
collected by the German National Consiliary Laboratory on Diphtheria
in a period of more than ten years were correctly identiﬁed by MALDI-
TOF MS. In 103/116 strains (88.8%) biochemical identiﬁcation by
API Coryne yielded identical results as rpoB gene sequencing. Twelve
strains showing unreliable or ambiguous API results were concordantly
identiﬁed by rpoB sequencing and MALDI-TOF MS except for one
isolate of C. tuberculostearicum. In conclusion, 99.1% of the tested
Corynebacteria were correctly identiﬁed by MALDI-TOF MS when
compared to rpoB gene sequencing. Moreover, both the positive and
negative predictive values for identiﬁcation of potentially toxigenic
Corynebacterium species were 100% with MALDI-TOF, respectively.
Conclusion: In conclusion, species identiﬁcation of potentially toxigenic
Corynebacterium spp. can be accomplished by MALDI-TOF MS within
15 min. when applied to suspicious colonies. In this scenario, MALDI-
TOF MS technology might be used as a rapid screening method
helping to decide whether suspicious colonies should be analyzed for
the presence of tox by real time PCR. We propose an algorithm for
fast and reliable diagnosis of diphtheria incorporating MALDI-TOF MS,
real-time tox PCR and Elek testing.
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R2539 A case of fulminant myocarditis complicating scrub typhus
in Korea
S. Ryu*, K. Kwon, E. Choi (Daegu, KR)
Scrub typhus, which is caused by Orientia tsutsugamushi, is an
acute febrile illness characterized by fever, rash, and myalgia. Severe
complications are very rare. Recently, cases of scrub typhus with severe
complications, such as acute respiratory distress syndrome, septic shock,
acute renal failure, myocarditis and meningitis have been increasingly
reported. Fulminant myocarditis is characterized by critical illness at
presentation. However, if affected patients recover with pharmacologic
therapy and mechanical circulatory support, they may have a better
long-term prognosis than patients with other forms of myocarditis.
An adult patient with scrub typhus presented with normal EKG on
admission and no hypotensive period, subsequently developed chest
pain on 6 th hospital day. T inversion of EKG and diffuse ventricular
dyskinesia of echocardiography appeared on 6th hospital day. We report
a cases of acute fulminant myocarditis in adult with scrub typhus. This
complication led to severe cardiogenic shock and death.
R2540 Septic arthritis and bacteraemia caused by Streptococcus
suis: phenotypic and molecular conﬁrmation
H. Moon*, H. Kim, S. Lee, M. Hur, Y. Yun (Seoul, KR)
Streptococcus suis (S. suis) is a swine pathogen that is responsible for
meningitis, septicemia, pneumonia and endocarditis. Since the ﬁrst case
report of human infection in Denmark in 1968, human infection with
S. suis has been reported in many countries and especially Southeast
Asia because of its high density of pigs. We report here on a patient
with septic arthritis and bacteremia caused by S. suis. To the best of
our knowledge, a case in which S. suis is isolated from joint ﬂuid is
very rare and this is ﬁrst case report of S. suis infection in Korea.
This organism was conﬁrmed by phenotypic characterization and 16S
rRNA sequence analysis. An 81-year-old Korean female who presented
with fever, arthralgia and headache was seen in a secondary referral
center in Korea. The aspirated joint ﬂuid and the blood culture revealed
growth of S. suis biotype 2, which was identiﬁed by the Vitek 2 GPI
and API 20 Strep systems (bioMe´rieux, USA) and this organism was
susceptible to penicillin-G and vancomycin. The 16s rRNA sequences
of the blood culture isolates showed 99% homology with those of the
S. suis subsp. suis reported in GenBank. Although her fever subsided
and the subsequent blood and joint cultures were negative after antibiotic
therapy, the swelling and pain in the left knee joint persisted. She is
planning to receive total knee replacement.
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R2541 Tick-borne encephalitis: variability presentation in children
G. Nicolini*, G. Longo, A. Pasinato, G. Minardo, E. Bressan,
M. Micera, P. Peverelli, L. Memo (Belluno, Padova, IT)
Objectives: Tick-Borne Encephalitis (TBE) is an infectious zoonotic
disease present in Central Europe but rare in Italy. Over the last 30
years a continuous increase in the disease morbidity was observed in the
endemic countries, where about 13.000 cases occur each year. We report
the ﬁrst paediatric cases described in Italy.
Case reports: First: A 7 year old boy came for a remarkable involvement
of the Central Nervous System, 2 week after a ﬂu-like syndrome. Non
tick-bites were reported, daily consumption of non-pasteurized milk
was referred. Lumbar puncture revealed clear cerebrospinal ﬂuid (CSF)
with polymorphonuclear pleocytosis, glucose and protein content were
normal. The boy received treatment with dexamethasone, ceftriaxone,
ampicillin and acyclovir, with regression of symptoms within 24
hours. TBE speciﬁc serology in blood and CSF was positive while
serology for Borrelia burgdorferi revealed past infection. The diagnosis
was a meningeal form of TBE. The boy had a normal neurological
outcome. Second: A 12 year old boy came for the onset of walking
difﬁculties, myalgia, leg heaviness, fatigue and nausea, after 4 days
of fever and headache. To note the removal of two ticks on the day
before the start of symptoms. Clinically he presented only a slight
instability in the march on his heels. The blood examination revealed:
leuconeutropenia, thrombocytopenia, elevated aminotransferase levels
and signiﬁcant creatine kinase increase. Serology for common viruses
and bacteria, also Borrelia burgdorferi, were negative. A ﬁrst TBE
serology was positive only in IgM, after 15 days it was positive in IgM
and IgG. There was no need for any treatment because of spontaneous
regression of symptoms.
Conclusion: We described the ﬁrst pediatric TBE cases documented
in Italy. Generally the disease was transmitted by a tick of the genus
Ixodes, even if there have already been described sporadic cases from
non-pasteurized cow’s milk, and it manifested by the typical diphasic
febrile course (a ﬂu-like syndrome in the ﬁrst phase, involvement of the
central nervous system in the second phase).
In our ﬁrst case no tick bites were known, while the boy often fed non-
pasteurized milk and dairy products. The peculiarities of the second case
was the short incubation period and the absence of the second phase of
infection. These show that in children it is impossible to deﬁne a single
clinical picture that characterizes the TBE, because of its several clinical
forms.
R2542 A Clostridium sordellii fatal toxic shock syndrome
post-medical-abortion in Portugal
T. Reis, C. Chaves, A. Soares, M. Moreira, L. Boaventura*, G. Ribeiro
(Coimbra, PT)
Background: Clostridium sordellii (C. sordellii) is a Gram-positive
anaerobic bacillus that has been reported as a rare cause of fatal toxic
syndrome after medical abortion. Portugal’s legal therapeutic abortion,
before 10 weeks of gestation, was approved in 2007. We report a case
of a young patient who underwent a medical induced abortion and died
of a C. sordellii toxic shock syndrome.
Case summary: A 16-year-old women who underwent a medically
induced abortion by means of 200mg of oral mifepristone followed
by 800mg of vaginal misoprostol, presented to the maternity hospital’s
emergency ﬁve days after receiving mifepristone, complaining of
lipothimia in the night before and abdominal cramping. On admission,
she was conscient, afebrile and hypotense (76/35mmHg). A few hours
later she developed a rapid onset-sepsis with marked leukocitosis (83,400
white-cells/mL with 88% of neutrophils), hemoconcentration (hematocrit
of 63.4%; hemoglobin of 21.2) and severe metabolic acidosis. The
patient underwent a hysterectomy and uterus biopsy cultures and
anatomopathological analysis were requested. Patient was transferred
to intensive care unit and died 18h after presenting to emergency. At
the microbiology laboratory a direct examination by Gram-stain smear
of the uterine biopsy showed large, Gram positive rods. The biopsy was
inoculated in appropriated agar plates mediums and incubated aerobically
and anaerobically. 48 h later only the anaerobic culture was positive and
colonies were smeared by Gram stain (showing Gram positive rods)
and a C. sordellii was identiﬁed by the semi-automated system, Vitek
2 (bioMerieux®) with an ANC card (Anaerobes and Corynebacterium
card).
Discussion: This was a fatal case of pos-abortion C. sordellii sepsis. The
distinctive clinical features developed are the same reported in other
studies. Gram staining of a uterine biopsy is a good and rapid mean
of having a presumptive result and help to diagnose. C. sordellii was
identiﬁed through uterine biopsy cultures with a semi-automated system
which is different from other studies that used anti-clostridium species
immunochemical assay and PCR assays performed on formalin ﬁxed
uterine tissue pos-autopsy.
Conclusion: To improve diagnosis Gram staining and cultures of
an endometrial biopsy specimen are a good approach to an earlier
recognition of the disease’s etiology.
R2543 Tularaemia (cases from Turkey)
G. Iskender, C¸. Erbay*, C. Ogan, B. C¸elebi, S. Kilic¸ (Ankara, TR)
Objectives: The oropharyngeal form of tularemia is known to be
common particularly in Eastern European countries including Turkey.
The aim of the study was to evaluate the patients with tularemia and to
make a point for the disease.
Methods: Between February and August 2010, ﬁve patients with
unilateral cervical mass were admitted to our outpatient clinic with
the preliminary diagnosis of tularemia. The diagnosis of tularemia was
conﬁrmed by micro-agglutination test and PCR.
Results: All of the patients had oropharyngeal tularemia with the
suspicion of contaminated water ingestion. Age of the patients ranged
from 19−59, three of them were male (60%) and two were female (40%).
In initial stage of the disease, all the patients had general symptoms such
as fever, headache, malaise and sore throat which lasted about two weeks,
after that the general symptoms disappeared but the cervical lymph nodes
started swelling in all patients. b-lactam antibiotics were administered to
three of them in different centers before admission to our clinic. However
there wasn’t any response to these treatments.
At admission unilateral cervical or submandibular lymphadenopathy and
malaise were detected in all patients. One patient (20%) had suppurative
lymphadenitis with spontaneous drainage. Leukocytosis was found in
one patient (20%), elevated ESR in three (60%) and elevated CRP in
three (60%) of patients. Lymph node aspiration was performed when
ﬂuctuation was detected but F. tularensis could not be grown in the
cultures. However F. tularensis subsp. holarctica DNA was detected in
four lymph nodes aspirates by conventional PCR. Micro-agglutination
test was positive in four patients (80%) with titres of 1/640 in three
patients (60%) and 1/160 in one patient (20%).
The patients were treated with a streptomycin and doxycycline or a
ciproﬂoxacin and doxycycline combination for a 2 weeks period due to
a delay in initiation of treatment. One patient was received a second
coures of antibiotics because of insufﬁcient response to ﬁrst therapy
and continuing suppurative lymphadenitis. No severe complication was
observed.
Conclusion: Tularemia should be kept in mind in the differential
diagnosis of patients with fever, pharyngitis or tonsillitis and cervical
lymphadenopathy, especially unresponsive to b-lactam antibiotics in the
endemic regions and early treatment with proper antibiotics should be
started.
R2544 Imported malaria as a threat to Egypt
M. El Bahnasawy, H.K. Dabbous, T.A. Morsy* (Cairo, EG)
This work evaluated the clinical and parasitic status of malaria as a
cause of fever among patients admitted to the Military fever hospitals.
Thirty six patients were included twenty already diagnosed as malarial
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patients, who were recruited from Peace Keeping Mission Forces in
Africa and sixteen cases presented with prolonged fever coming from
different locations in Egypt.
The results showed that El-Gabal El-Ahmar area (Cairo) was the most
extensively infested region (37.4%). This might be due to change of its
ecolo-gical pattern since the year 2003 and the environmental conditions
favoured by breeding and ﬂaring mosquitoes. El-Sharkia and El-Fayoum
Governorates (G.) were next in order (18.7%) and (12.5%) and this
might be due to increased rural areas and agricultural projects and re-
establishment.
Plasmodium vivax was the main species among locally acquired patients
(81.25%), while the imported patients coming back to Egypt from Africa
especially (Sudan) had P. falciparum (100%). However, P. falciparum was
also present in 6.2% of cases from El Fayoum Governorate while P. ovale
and P. malariae were not encountered. Of interest, was a case recruited
from Ard-El-Golf, Heliopolis, an area with high social and hygienic
standard, and the same condition applied to that from El-Nozha El-
Gidida. Such cases included the “runway” or “airport” malaria, in which
local transmission of disease has been attributed to an infected mosquito
that was transported on a long haul ﬂight. The two locally acquired cases
were malaria positive by bone marrow smears and negative by peripheral
blood examination. However, the thick blood ﬁlm was the most sensitive
(97.2%). The patients (75%) were clinically and parasit-ologically cured,
but one patient died. The best therapeutic response for locally acquired
malaria infection was the monotherapy-based one such as Chloro-quine
or Meﬂoquine.
R2545 Abdominal lymphadenopathy and multiple splenic
micro-abscesses in an immunocompetent child with
cat-scratch disease
W. Al-Fouzan*, R. Dhar, R. Al-Bannai, B. Al-Mutairi (Farwania, KW)
Background: Cat-scratch disease (CSD),caused by Bartonella henselae,
is a benign, self-limiting disease in immunocompetent children with
history of contact with cats. The organism is commonly found in the
blood of cats and other felids. Classic presentation is tender and swollen
regional lymph nodes with or without a papule at the site of initial
infection. In immunocompromised patients, however, more severe forms
of presentation can occur. Diagnosis is usually possible by serology and
or histopathology.
Case summary: An 14-year-old Kuwaiti girl, previously healthy, was
admitted with fever, abdominal pain, nausea and generalized weakness.
She had arrived from a trip to Egypt ﬁve days earlier. There was no
history of diarrhea, vomiting, urinary symptoms or rash. On Examination
the patient looked ill & had an oral temperature of 40 ºC with abdominal
tenderness and guarding. Initial blood investigations showed a WBC
of 14.1×109, ESR 44mm/h, C-Reactive Protein (CRP) 150mg/l, urea
3.2mmol/l and creatinine 39 umol/l. Urinalysis showed presence of
RBC & WBC but the culture was negative. A diagnosis of appendicitis
was made and appendicectomy was performed. The patient, however,
continued to run high grade fever (>40ºC). Therapy with piperacillin-
tazobactam (TAZ) and metronidazole was initiated but no clinical
response was observed. CT of the abdomen showed mesenteric and
para-aortic lymphadenopathy and multiple splenic lesions. A suspicion
of enteric fever prompted changing TAZ to ceftriaxone. Blood culture,
brucella agglutination, T spot test, & Widal test were all negative. several
antibiotic courses including anti-TB & anti-fungal were tried but none
helped to improve her condition. Finally, splenectomy and lymph node
biopsy was done and the pathology report concluded multiple splenic
granulomas with a picture suggestive of CSD. Serology, however, proved
negative (IFA titre: IgG: <1:64; IgM: <1:20). History of contact with
cats in Egypt was elicited from the patient after pathology report was
available. There was a dramatic improvement in her condition following
splenectomy.
Conclusion: To the best of our knowledge this is the ﬁrst case of CSD
being reported from Kuwait. We recommend to consider CSD in the
differential diagnosis in children presenting with PUO, lymphadenopathy
and splenic involvement. Despite several antibiotic courses, which
included those recommended in CSD our patient showed defervescence
only after splenectomy was performed.
R2546 Salmonella monophasic serotype 4,[5],12:i:- in Greece
G. Mandilara*, M. Lambiri, A. Vatopoulos, M. Passiotou (Athens,
Chalkis, GR)
Objectives: Salmonella is one of the most common causes of
bacterial foodborne diseases worldwide. Recently, S. enterica serovar
4,[5],12:i:- emerged and is now among the most common serovars
isolated from humans in many countries. This serovar is considered a
monophasic variant of serovar Typhimurium (4,[5],12:i:1,2). In Greece,
this monophasic serovar was ﬁrstly recorded in human isolates in 2007
(0.3% of total isolates), increased sharply the next two years and in 2010,
it was the 3rd most frequent serotype (9.5% of total isolates).
In the present study, S. enterica 4,[5],12:i:- strains isolated from humans,
pigs and foods during 2007–2010 in Greece were examined using
phenotypic and molecular methods.
Methods: A total of 50 S. enterica 4,[5],12:i:- strains of human (29), pig
(16) and food (5) (chicken and salami) origin were included in this study.
Serotyping of isolates was performed by slide agglutination according to
White–Kauffmann–Le-Minor Scheme. Phage typing of the strains was
performed in Health Protection Agency, UK (standard HPA protocols).
Antibiotic resistance test (against 16 antibiotics) was performed by
the disk diffusion method according to NCCLS. PFGE was performed
after digestion of genomic DNA with XbaI according to the Pulse-Net
protocol.
Results: As shown in Table 1: a. Phage typing using the Typhimurium
typing phages identiﬁed 5 different PTs. The most commonly identiﬁed
PTs were DT120 (62%) and DT193 (24%), b. Eighty-six percent of the
isolates expressed resistance to ampicillin, sulphonamides, streptomycine
and tetracycline (R-type ASSuT) with or without additional resistance(s),
c. PFGE analysis identiﬁed 8 unique proﬁles (A-H). Eighty-eight percent
of strains were represented by three proﬁles (A,B,C) that shared more
than 95% similarity.
Conclusion: Combining phenotypic and genotypic characteristics, the
most frequent pattern (54%) appeared the one with phage type DT120,
R-type ASSuT (plus additional resistances) and the closely related
PFGE proﬁles (A,B,C), followed by the pattern (18%) with phage type
DT193, R-type ASSuT (with or without additional resistances) and
closely related PFGE proﬁles (A,B,C). These results are consistent with
the possible presence of two different clones of S. enterica serovar
4,[5],12:i:-, that prevail in both human and pig isolates in Greece. Similar
data have been recorded in several European countries.
R2547 First case report of pacemaker Brucella suis endocarditis
via zoonotic transmission from Canadian caribou (Rangifer
tarandus)
J.N. Kanji*, L. Saxinger (Edmonton, CA)
Background: The use of implantable cardiac devices such as permanent
pacemakers (PPMs) continues to increase, with infection complicating
up to 10% of inserted devices. Management of pacemaker endocarditis
generally requires surgical removal of the entire system. Brucella suis
is an uncommon cause of endocarditis, not previously reported in
association with a PPM.
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Case: An 81 year old gentleman from Inuvik (Nunavut, Canada) with
a PPM for 4 years was evaluated for syncope at the University of
Alberta Hospital (Edmonton, Canada). Investigation revealed evidence
of cardiac lead vegetations on a transesophageal echocardiogram. Pre-
operative blood cultures and intraoperative cultures taken during laser
lead extraction became positive for Brucella suis (with MICs of
0.25mg/L to each of ciproﬂoxacin, doxycycline, and rifampin). Upon
further questioning, the patient a subacute history of constitutional
symptoms, and reported hunting, skinning, and butchering Canadian
caribou (Rangifer tarandus). The patient’s brother, a hunting partner,
had been treated for B. suis infection 2 years previously. Our patient was
treated with laser lead extraction and combination oral antimicrobial
therapy with doxycycline and rifampin for 3 months. Follow up blood
cultures were negative.
Discussion: Brucella suis type 4 is a known pathogen of Canadian
caribou herds. It is hypothesised that cutaneous exposures when while
skinning and butchering or ingestion of undercooked meat resulted in
zoonotic transmission of the organism to our patient causing bacteraemia
and secondary seeding of his pacemaker wires. From our literature
search, this is the ﬁrst reported case of pacemaker endocarditis due to
B. suis. It is important that clinicians be aware of the possible zoonotic
transmission of B. suis to patients exposed to caribou in the Canadian
north and the risk of secondary infection of underlying foreign bodies
(such as PPMs). Clinicians are also reminded to alert microbiology
labs if Brucella is a suspect pathogen, to allow appropriate biosafety
precautions.
R2548 The ﬁrst case of Neisseria meningitidis serogroup X-caused
meningitis in Turkey
O¨. Coskun*, I. Avci, O. Bedir, U¨. Savaski, H. Gu¨l, B. Besirbellioglu,
C. Eyigu¨n (Ankara, TR)
Neisseria meningitidis, an agent of bacterial meningitis is classiﬁed
into 13 different serogroups based on immunologic reactivity of its
capsular polysaccarides. Serogroups A, B, C, W135 and Y are among
the predominant serogroups.
In Turkey, A, B, and C serogroups of N. meningitidis are encountered as
the most frequent cause of menigococcal meningitis. A meningococcal
vaccine containing serogroups A and C has been used to prevent recruits
from this fatal disease till May, 2009. From then on, administration
of the quadrivalent vaccine consisting of “A+C+W135+Y” serogroups
has been implemented because of the emergence of menigococcal
meningitis cases caused by serogroup W135. We present the ﬁrst known
menigococcal meningitis case caused by N. meningitidis serogroup X
since the start of the quadrivalent meningococcal vaccine administration
to recruits.
Serogroup X has emerged as a cause of meningococcal disease in a
susceptible population because of suppression of other serogroups not
included in the quadrivalent vaccine.
The results of mass vaccination campaigns have implied that the mass
vaccination programs solely cannot prevent the disease totally and the
improvement in environmental conditions especially in risky populations
is also essential in prevention of the disease.
R2549 A most unusual case of superinfection with Arcanobacterium
haemolyticum in a primary treated Staphylococcus aureus
mitral valve endocarditis in an intravenous drug-user
R. Sharma*, M. Przybylo, A. Guleri (Blackburn, Blackpool, UK)
Background: Arcanobacterium haemolyticum (AH) is an extremely rare
cause of infective endocarditis. We present here an unusual case of super-
infection with AH in a primary Staphylococcus aureus (SA) mitral valve
endocarditis in a Hepatitis B/C positive intravenous drug user[IVDU].
After a protracted course (with multi-organ impairment) of 3-months the
patient was successfully treated.
Case study: A 29-year-old IVDU male was transferred from emergency
unit of neighbouring hospital to intensive care of this hospital on
February 4, with signs of severe sepsis and seizures. CT head
revealed small parietal bleed; lumbar puncture was non-conclusive and
CTPA was negative for pulmonary embolism, but showed extensive
non occlusive thrombus in superior vena cava. Systolic murmur
prompted trans-esophageal echo revealing mitral regurgitation with
vegetation. Following isolation of meticillin-sensitive SA grown from
two sets of blood culture, the patients was treated with Flucloxacillin
IV 1g q6h for 4-weeks. After 3 weeks of satisfactory response,
the patient started getting intermittent pyrexia, elevation of CRP
and WCC; mild renal and hepatic impairment. Blood culture with
AH from single bottle was not considered signiﬁcant and dose of
Fluclox was increased to 2g q6h. Further pyrexia, raised inﬂammatory
markers and impairment of renal functions prompted biopsy revealing
focal necrotizing glomerulonephritis. Two sets of blood cultures grew
AH [penicillin resistant − MIC 0.5mg/L (breakpoint 0.125mg/L);
Teicoplanin MIC 0.064mg/L and Vancomycin MIC 1.0mg/L]. Reference
laboratory conﬁrmed AH and susceptibilities. The patient was started on
Teicoplanin 10mg/Kg q24h (following loading doses).
The patient responded successfully to 4-weeks of Teicoplanin with
normalization of his organ functions. Details and ECHO pictures to be
presented.
Discussion: AH infrequently causes pharyngitis and cutaneous in-
fections. Penicillin resistant AH super-infection of a primary MSSA
native mitral valve endocarditis is extremely rare. The multi-organ
impairment in this high-risk Hep B and C positive IVDU patient
complicated the course of management. Regular clinical input from
clinical microbiologist helped optimize treatment successfully. Details
to be presented.
R2550 Emerging Vibrio vulniﬁcus septicaemia associated with
environmental change
S. Heo*, J.-S. Kim, Y.K. Cho, H. Choi, Y.-R. Kim, D. Park, I. Pang,
S. Kim, J. Lee, K.H. Lee (Jeju, KR)
Vibrio vulniﬁcus is a human pathogen, frequently transmitted to humans
via raw oysters and is isolated from the majority of raw oyster and
shellﬁsh harvested from subtropical areas during summer season. A 73-
year-old woman with diabetes mellitus and liver cirrhosis presented to
the emergency department with generalized edema for one month and
mental change on a day. She was diagnosed V. vulniﬁcus septicemia
and treated ceftazidime and doxicycline. We also isolated V. vulniﬁcus
from sea water of outbreak sea and same season (summer). V. vulniﬁcus
septicemia was emerged in Jeju island associated with climate change
in island. This is the ﬁrst report about relationship between clinical and
environmental isolates according to the climate or environmental change
in Jeju island, Korea.
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R2551 CT ﬁndings in novel 2009 inﬂuenza A (H1N1) virus
infection in Isfahan, Iran
B. Ataei*, A. Adibi, M.R. Yazdani, A. Babak, M. Avijgan, A. Emami-
Naeini, A.A. Javadi, F. Khorvash, M. Meidani, K. Mostafavizadeh,
M. Rostami, H. Salehi, R. Sherkat, F. Rezaei (Isfahan, IR)
Objectives: Pandemic 2009 inﬂuenza A (H1N1) virus causes a broad
spectrum of clinical syndromes, ranging from mild to severe. The role
of radiologic imaging in detection of severity and response to therapy is
evolving. We want to ﬁnd whether CT scan of the lungs in patients with
inﬂuenza can help triage of the patients and predicts clinical outcome in
similar outbreaks.
Methods: We retrospectively reviewed the archive of all patients with
a diagnosis of H1N1 inﬂuenza A, in Saint Alzahra hospital, Isfahan,
Iran, between September23, 2009 to February 20, 2010. From 216
patients with conﬁrmed, probable, or suspected 2009 inﬂuenza A
(H1N1), 26 cases with abnormal CT were enrolled the study. Radiologic
ﬁndings were characterized by type and pattern of opacities and zonal
distribution.
Results: Patchy inﬁltration (34.6%), lobar consolidation (30.8%), and
interstitial inﬁltration (26.9%) with airbronchogram (38.5%) were the
predominant ﬁndings. Bilateral distribution was seen in 80.8% of
patients. None of our patients showed a nodular pattern on the CT.
Only one patient (3.8%) showed ground-glass opacity, the predominant
radiographic ﬁnding in the previous reports and SARS. Consolidation
was detected in 30.8% of our patients that may represent either a
severe viral infection, or a secondary bacterial infection. In patients
with a more severe clinical course of 2009 H1N1 virus infection, we
observed a radiographic pattern of areas of consolidation often associated
with patchy or interstitial inﬁltration. In fatal cases we observed
consolidation with airbronchogram and diffuse alveolar inﬁltration.
Extensive involvement of both lungs, presence of bilateral opacities,
interstitial inﬁltration, lobar consolidation, and patchy inﬁltration were
associated with poor prognosis. Patients with abnormal CT ﬁndings had
greater risk of intubation, ventilation, ICU admission and death than
those with normal CT, but some patients with similar CT ﬁndings had
various outcomes from improvement and discharge to death.
Conclusion: Chest CT ﬁndings may be signiﬁcant in prediction of
clinical outcome and management of the disease (e.g., initiation of
antibiotics) in patients with inﬂuenza infection but CT ﬁndings alone
does not exactly predict the outcome and other risk factors should be
considered.
R2552 Evaluation of epidemiological, clinical and laboratory
characteristics of pandemic inﬂuenza A (H1N1) cases in a
tertiary care hospital in Turkey
C. Ataman Hatipoglu*, Z. Kocak Tufan, C. Bulut, S. Altun, G. Tuncer
Ertem, F.S. Erdinc, S. Kinikli, N. Tulek, A.P. Demiroz (Ankara, TR)
Objectives: In April 2009, H1N1/09 virus was identiﬁed in Mexico,
spread throughout the world and caused an inﬂuenza pandemic.
Worldwide more than 214 countries and communities have reported
pandemic inﬂuenza H1N1 2009 cases, including over 18449 deaths. Our
country has also inﬂuenced from this pandemic with 656 deaths. In this
report we present the epidemiological, clinical and laboratory data of
hospitalized patients in our clinic.
Methods: Totally 117 patients were hospitalized due to the probable
pandemic inﬂuenza H1N1 between 25 October 2009 and 31 January
2010. Nasal and/or nasopharingeal samples were tested for Inﬂuenza A
(H1N1) with real-time RT-PCR in National Inﬂuenza Reference Labo-
ratory. Patients’ data were evaluated retrospectively from the records.
Results: Of the patients, 77 were female (65.8%), mean age was
44±19.4 years and the mean hospital stay was 5.8±4.6 days. Five
patients (4.3%) were vaccinated with seasonal and three (2.6%) with
pandemic ﬂu vaccine. Twenty-one patients (17.9%) had a history of close
contact with persons presenting symptoms of a respiratory infection.
38 patients (32.5%) had not have any underlying disease while 79
patients (67.5%) had one or more. Of these 25 patients were pregnant.
On admission, most common symptoms were cough, myalgia, fever
and headache (92.3%, 82.9%, 82.1% and 64.1%, respectively). Forty-
six (39.3%) had dyspnea on the admission and three of them required
mechanical ventilation. On the physical examination, 79 patients (67.5%)
were febrile. Fifty-two patients (44.4%) had crepitation on the lung.
Radiological investigations revealed bilateral extensive consolidation and
ground glass opacities. Mean SGOT, GGT, LDH, CK, creatinine and
ferritine levels were higher while mean zinc level was lower than normal
limits. Remaining routine biochemical and blood count tests were within
normal limits. Of patients, 68 (58.1%) were found to be PCR positive for
pandemic Inﬂuenza. 110 patients (94%) received oseltamivir therapy,83
(70.9%) received additional antibiotics. All pregnant patients recovered
without complications. 4 patients died, all of them had underlying
conditions and three had required mechanical ventilation.
Conclusion: During inﬂuenza pandemic, four patients died in our
hospital. Lower zinc levels may correlate with the severity of the disease,
though controlled studies are needed. We also suggest that those patients
with underlying conditions must receive a close follow-up.
R2553 High GGT levels: as a prognostic factor for surviving from
CCHF
C. Bulut*, Z. Kocak Tufan, C¸. Hatipoglu, S. Kinikli, G. Ertem,
F.S. Erdinc¸, N. Tu¨lek, A.P. Demiro¨z (Ankara, TR)
Objectives: G glutamyl transferase (GGT) is an enzyme that is present
in the cell membranes of many tissues. High GGT level is used as
a prognostic factor for alcoholic liver disease, metabolic syndrome,
cardiovascular diseases, liver cancer and liver metastasis of different
cancers. Crimean Congo Hemorrhagic Fever has been emerging in
Turkey for the last 8 years. Elevation of alanine amino transferase (ALT)
and aspartate amino trasnsferase (AST) levels are used both severity
criteria and prognostic factor for fatality in the management of CCHF.
However, we observed an association between GGT levels and the course
of the disease. In this study we aimed to ﬁgure out the relation between
serum GGT levels and CCHF and its effect on survival, if there is any.
Methods: Patients with laboratory-conﬁrmed diagnosis of CCHF
were included in to the study. Serum ALA, AST, gama glutamyl
trasnferase (GGT) were retrospectively investigated from the records.
Two parameters were used for evaluation of relation between CCHF and
GGT; serum GGT levels and serum AST-GGT ratio. Because of AST
elevation is a prominent feature of CCHF than ALT elevation, AST/GGT
ratio was chosen as a marker.
Results: Totally 126 patients were included. Of total, 71 (56.3%) were
female. The mean age was 50.2 years (15−83 years). The mean hospital
stay of the patients was 7.5 days (1−28 days). Remarkable laboratory
ﬁndings were as follows (mean, min-max); WBC: 2472/mm3 (500–
8900). Platelets: 59000/mm3 (7000–361000), AST: 291U/L (17–3060),
ALT:133U/L (9–879) and GGT: 91 U/L (6–759). Comparing the serum
levels of GGT between fatal and non fatal cases, mean GGT levels were
statistically signiﬁcantly higher in fatal cases on the 2nd and 3rd days of
admission. Serum AST levels were also found higher in those days in
the fatal group. The mean GGT level continued to increase during the
course of the disease (Figure 1). When AST/GGT ratio was investigated,
the ratio was >1 in the ﬁrst 7 days of admission but <1 after the 7th day.
Higher serum GGT level was the most prominent laboratory ﬁnding in all
non fatal cases (Figure 2). A positive correlation was detected between
higher AST/GGT ratio and mortality.
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Conclusion: Serum GGT levels can be used as a prognostic factor for
CCHF. However an increase of GGT level during the recovery period
of CCHF has not yet been fully explained. Therefore more studies are
needed in this area of research.
R2554 A retrospective study of Dengue virus infection in
northwestern Italy in travellers from endemic areas
M.G. Milia*, E. Burdino, T. Allice, G. Gregori, G. Sergi, M. Cazzato,
M. Cazzadore, G. Calleri, F. Lipani, V. Ghisetti (Turin, IT)
Background and Aim: Dengue fever is increasingly recognized to be
the most frequent agent of febrile illness in tourists returning from
dengue-endemic areas. Domestic outbreaks of dengue (DENV) fever
from imported cases have to be considered a possible risk in countries
where, even if the virus is not endemic, Dengue vectors are, such as
Italy.
Objective of this study was to review imported DENV infections in a
one-year survey in Piemonte area, North-West Italy.
Methods: From January to November 2010 we investigated 68 patients
traveling from endemic areas studied for DENV infection due to
symptoms such as fever, skin rushes and leukopenia. IgG and IgM
DENV speciﬁc serology and DENV-RNA with molecular test were
performed. Conﬁrmation of DENV IgG/IgM required a second blood
test within 15 days from the ﬁrst one.
Results: Active DENV infection was conﬁrmed in 20/68 (29%) patients
(3 IgM+/IgG−, 16 IgM+/IgG+, 1 IgM−/IgG− and DENV-RNA+) while
DENV exposure was identiﬁed in 4/68 (6%) patients.
Conclusion: Our ﬁndings outline the high rate of imported Dengue
infection and emphasize the need for a continued dengue surveillance in
non-endemic countries and a careful evaluation and follow-up of febrile
patients returning from countries in which dengue is endemic.
R2555 Vascular endothelial growth factor levels in patients with
Crimean-Congo haemorrhagic fever
Z. Ozkurt*, F. Akcay, K. Ozden, S. Erol, F. Kara, C. Karaca (Erzurum,
TR)
Background: Crimean Congo hemorrhagic fever is a serious viral
hemorrhagic fever. Immunopathogenesis of the disease is not clear
enough yet. Vasculitis due to endothelial damage is a major pathologic
component of the disease. Vasculitis may be caused by a virus and/or
cytokine and other important proteins which were released during
infﬂamatory process. Vascular endothelial growth factor (VEGF) is an
important protein on endothel functions, and it signiﬁcantly inﬂuence
vascular permeability and VEGF induces the synthesis of von Willebrand
factor in endothelial cells. Additionally, it is also a potent chemoattractant
for monocytes and thus has procoagulatory activities. In microvascular
endothelial cells VEGF induces the synthesis of plasminogen activator
and plasminogen activator inhibitor type 1.
Objective: We aimed to investigate the role of VEGF in pathogenesis
of CCHF.
Methods: Sixty CCHF patients observed between 2009–2010 years
were included in the study. Diagnosis was made by anti-CCHF IgM
and/or PCR positivity. Patients’ sera samples were obtained during
hospitaliaztion and stored at −80ºC. VEGF levels were detected by
commercial ELISA kit; and mean values were compared in severe, mild
patients and 18 healthy control.
Results: Sixty patients included in this study, and 34 of them were
male (56.7%), 26 were female (43.3%). All of the patients have
been living in rural areas, and their job was farming. Patients were
grouped according to the severity criteria, and 42 (70%) patients were
severe, 18 (30%) of them were mild cases. Mean VEGF levels were
487+422 pg/mL (range = 2–2258 pg/mL) in patients and 496+410 pg/mL
(range = 0.2–1337 pg/mL) in control group (p = 0,768). It was lower
(381+467pg/mL, range:8–1839pg/mL) in severe case than that of mild
ones (534+398pg/mL, range = 69–2258 pg/mL) (p = 0.016).
Conclusion: Low free VEGF levels may be related to vasculer
permeability, and serum VEGF levels might be a prognostic factor in
CCHF.
R2556 Interleukin-12 levels in patients with Crimean-Congo
haemorrhagic fever
Z. Ozkurt*, K. Ozden, C. Karaca, S. Iba Yilmaz, F. Akcay (Erzurum, TR)
Background: Crimean Congo hemorrhagic fever is a serious viral
hemorrhagic fever. Immunopathogenesis of the disease is not clear
enough yet. Interleukin (IL)-12 is a pivotal cytokine that strongly
stimulates Th1-associated cellular immunity, and activates humoral
immunity to both T-dependent and T-independent antigens. IL-12 has
an immunoregulatory functions which may play a role in promoting
endogenous protective responses during infections and/or contribute
to pathology resulting from unregulated cytokine expression. Pathogen
induction of IL-12 elicits interferon-g production by natural killer cells,
which contribute to early defense during certain bacterial, parasitic, and
viral infections.
Objective: We aimed to investigate the role of IL-12 in immunopatho-
genesis of CCHF.
Methods: Sixty CCHF patients observed between 2009–2010 years
were included in the study. Diagnosis was made by anti-CCHF IgM
and/or PCR positivity. Patients’ sera samples were obtained during
hospitaliaztion and stored at −80ºC. IL-12 levels were detected by
commercial ELISA kit; and mean values were compared in severe, mild
patients and 18 healthy control.
Results: Sixty patients were included in this study, and 34 of them were
male (56.7%), 26 were female (43.3%). All of the patients have been
living in rural areas, and their job was farming. Patients were grouped
according to the severity criteria, and 42 (70%) patients were severe,
18 (30%) of them were mild cases. Mean IL-12 levels were higher
in patients (200+89pg/mL range:56–459 pg/mL) than control group
(151+68pg/mL, range: 42–282pg/mL) (p = 0.009). It was 181+82pg/mL
(range: 69–336pg/mL) in severe 208+91pg/mL (range: 57–459pg/mL)
in mild cases (p = 0.206).
Conclusion: IL-12 levels have been increased during CCHF infection,
but this response is lack in severe cases compared to mild ones. It is
indicated that, low IL-12 levels may lead inadequate immune stimulation
and poor outcome in the disease.
R2557 Emergence of Clostridium difﬁcile PCR ribotype 176, highly
related to type 027 in Poland
H. Pituch, P. Obuch-Woszczatynski, C. Harmanus, D. Bakker,
D. Wultanska, J. Pawlowska, E. Skopinska, E. Ozdzenska-Milke,
P. Pruszczyk, G. Mlynarczyk*, E. Kuijper (Warsaw, PL; Leiden, NL;
Plock, PL)
Objective: The aim of this study was to establish etiological agents of
nosocomial diarrhea caused two outbreaks in two hospitals in region
Mazovia, Poland in 2008–2009.
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Methods: Subjects were 10 patients who suffered from C. difﬁcile
infection (CDI). Patients were diagnosed in the period between July
2008 and September 2009 (hospital H1) and between November 2008
and April 2009 (hospital H2); 5 patients from Infant Jesus Hospital in
Warsaw and 5 patients from Province Hospital in Plock. Faecal samples
from patients with antibiotic diarrhoea were submitted to toxigenic
culture to and toxigenicity status of C. difﬁcile strains were conﬁrmed
by using PCR for detection of tcdA, tcdB and binary toxin genes.
Susceptibility to antimicrobial agents was investigated on Brucella blood
agar using E-test method. Isolates of C. difﬁcile were typed by the PCR-
ribotyping. MLSB resistance to CM and EM carried by ermB gene, was
conﬁrmed by PCR. To investigate the relatedness of Type 176 with Type
027 isolates, MLVA was applied.
Results: Mean age of patients was 68,9 (age range 49 to 91 years) and
5 were womens. Five patients were admitted to Internal and Cardiology
Medicine Department (H1), four patients to the ward of infections
diseases (H2), and one outpatient (hospitalized before in hospital
localized in Warsaw). In the retrospective survey, PCR ribotyping in
Polish laboratory of 10 C. difﬁcile isolates shown similarity with ribotype
027 with one band in gel electrophoresis difference. All isolates were
analized in Reference Laboratory in Leiden and showed that the strains
belonged PCR ribotype 176 and shared many similarities with PCR
ribotype 027, including the presence of the binary toxin gene, an 18 bp
deletion in TcdC and a point mutation on pt 117bp. To investigate the
relatedness of Type 176 with Type 027 isolates, MLVA was applied on
59 type 027 strains collect in 14 different European countries, 10 Type
176 isolates from Poland. Type 176 isolates clearly differed from 027
isolates in 3 of the 7 loci tested with a sum tandem repeat difference
of 14, whereas tested Type 176 correlated with one another. The
strains had high level resistance to ﬂuoroquinolones and to erythromycin
(EM) and clindamycin (CM) and carried of ermB gene. Resistance to
metronidazole and vancomycin not observed.
Conclusion: A highly to 027 related new type (ribotype 176) has
emerged in Poland, underscoring the need for a local and regional
surveillance to detect and control CDI.
R2558 Mycoplasma hominis cultured from cerebrospinal ﬂuid
after subarachnoid haemorrhage
E.H.L. Lee*, H.L.J. Winter, J.P. Arends (Groningen, NL)
Introduction: Urogenital colonization with Mycoplasma hominis is
common in sexually active adolescent females. Extra-genitourinary
infections caused by this species are described in the literature. However,
it is still a rare pathogen cultured from cerebrospinal ﬂuid.
Methods: A 48 years old woman was admitted because of a subarach-
noid hemorrhage. Fever (39ºC) was noted six days after craniotomy.
On the ninth hospital day, blood cultures became positive with
Staphylococcus aureus. Flucloxacillin intravenous and a combination
of intravenous and intrathecal vancomycine were administered. This
infection responded, however, 3 days later, she again developed high
fever in spite of the antibiotics. After 6 days of incubation, small colonies
were detected on blood agar from CSF taken on day 9, 16 and 17. There
were no bacteria present on the Gram stain. No identiﬁcation could be
obtained by using MALDI-TOF MS. No growth was detected in seven
CSF cultures before day 9 and 18 cultures after day 17.
Result: M. hominis was detected from CSF by using 16S rDNA gene
ampliﬁcation. Moxiﬂoxacin (400mg daily) was given intravenous for two
weeks. Clinical conditions improved with negative repeat CSF cultures.
Conclusion: Ampliﬁcation of 16S rDNA for M. hominis in CSF
should be included in diagnostic workup of patients after subarachnoid
hemorrhage. Clinicians should consider this rarely recognised pathogen
in the differential by those not responding to standard therapy with
negative results in routine bacterial cultures.
R2559 H1N1 inﬂuenza mimicking cardiac diseases
A.R. Erbay*, A. Erbay, Y. Tezer Tekc¸e, R. Atak, A.D. Demir, E. Duru
(Yozgat, Ankara, TR)
Objectives: In early April 2009, cases of human infection with 2009
pandemic inﬂuenza A (H1N1) virus were ﬁrst identiﬁed and then H1N1
virus spread rapidly around the world. H1N1 inﬂuenza pneumonia
presents with dry cough, fever and myalgia. In this study we aimed
to call attention to H1N1 pneumonia mimicking cardiac diseases.
Methods: We report 7 cases presented with cardiac symptoms during
the H1N1 pandemic and admitted to Cardiology department of a tertiary
care superspecialty hospital. The clinical and laboratory features of these
cases were investigated through chart review.
Results: During the H1N1 pandemic, 4 patients with initial diagnosis
of pulmonary edema and 3 patients with initial diagnosis of pulmonary
emboli were admitted to cardiology department. All of these patients
had previously diagnosed cardiac diseases. After hospitalization, throat
samples were sent for H1N1 test. Polymerase-chain-reaction assay
conﬁrmed the diagnosis of H1N1. Five of them were females and mean
age was 50.4±15.8 (range 35−72). Mean duration of symptoms were
4 days before hospital admission. All of them had dyspnea and cough,
four of them had fever, only one had myalgia and one had somnolence.
None of these patients had sore throat and rhinitis. Two patients had
monocytosis. Six patients had elevated LDH levels (956±393 IU/L).
Six patients had bilateral ground glass opacities and one patient had
bilateral patchy consolidations at chest x-ray. Four patients were directly
admitted to cardiology ICU, required mechanical ventilation and had
a fatal outcome. Oseltamivir were administered to all patients after
diagnosis.
Conclusion: H1N1 inﬂuenza pneumonia can mimic cardiac diseases
especially pulmonary edema and pulmonary emboli. High level of
suspicion is required in outbreak periods.
R2560 Tick-borne infections as a cause of heart transplantation
T. Chmielewski*, I. Maczka, E. Walczak, S. Tylewska-Wierzbanowska
(Warsaw, PL)
Objectives: Infective endocarditis is a heart disease which could be
caused by many uncultured (blood-culture negative) bacteria. The aim
of presented studies was to establish if any tick-borne infection can
contribute to serious heart disorders which lead to heart transplantation.
Material and Methods: Samples of myocardium, aortic and tricuspid
valve ﬁxed in formalin of twenty three hearts removed from patients
undergoing heart transplantation between 2006 and 2009 were tested.
DNA was extracted with the QIAamp Tissue kit (QIAGEN Gmbh,
Hilden, Germany) according to the manufacturer’s recommendations.
Extracted DNA from above mentioned tissues were examined by PCR
with primers targeting following genes: OspA and 16S rRNA for
Borrelia burgdorferi sensu lato, htpAB fragment for Coxiella burnetii
and citrate synthase (gltA) for Bartonella spp. and Rickettsia spp.
Speciﬁcity of all positive results was conﬁrmed by sequencing the
amplicons with the ABI 377 DNA Analyzer (Applied Biosystem, USA)
according to the manufacturer’s recommendations. All sequences were
edited using Auto assembler software (Applied Biosystem, USA) and
identiﬁed using the BLAST software by comparison with sequences
available in GenBank.
Results: DNA of Borrelia afzelii has been found in aortic valves from
two patients. Mixed infection has been found in two patients. DNA
characteristic for Bartonella spp. were detected in valves and DNA of
C. burnetii in myocardium. DNA of Rickettsia spp. was not found.
Conclusions: Detected pathogens occurring in natural environment in
ticks have a clinical importance in heart transplantology. Obtained results
indicate that among patients with cardiac diseases, infections caused
by B. burgdorferi, C. burnetii and Bartonella spp., should be tested
routinely.
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R2561 The Q fever outbreaks in Poland
T. Chmielewski*, B. Fiecek, I. Maczka, S. Tylewska-Wierzbanowska
(Warsaw, PL)
Objectives: Q fever is a health problem affecting humans and animals
worldwide. In the last decade ﬁve outbreaks occurred occurred in cattle
farms in Poland. They occurred in southern Poland: ﬁrst one on the
border of Silesian and Malopolskie voivodships in May of 2005, the
second one in Podkarpackie voivodship in August 2008, the third one in
Opolskie voivodship in 2009 and two outbreaks in Silesian voivodship
in 2010. The aim of this study was to characterize detected foci, to
determine the number of infected animals and humans recognized with
serological and PCR methods, and describe clinical symptoms.
Methods: Serum samples were collected from: farm workers, veterinar-
ians and their family members. Blood samples were obtained from 302
persons. Levels of human serum IgM and IgG antibodies to C. burnetii
antigens phase I and II were determined. Serum titers 20 of IgM
and IgA and 64 of IgG were interpreted as positive. Blood human
and animal samples were tested for presence of C. burnetii DNA with
PCR method.
Results: Speciﬁc C. burnetii antibodies were found in 82 from 302
persons in titers ranged from 20 to 80 in phase II of IgM and from
64 to 4096 in phase II of IgG. Among all blood samples tested, 7
were positive with PCR. Three samples were positive in both methods.
The highest attack rate was revealed in groups of veterinary stuff
(63%) and farm workers (33.0%) consisting of cattlemen, milkmaids,
safeguards, mechanics and electricians. According to information on
possible exposure in the group of family members and all those
occasionally spending time on the farms an attack rate of 11.0% was
determined. Clinical symptoms presented 26 persons. There was no
correlation between level of serum antibodies and positive results in
PCR.
Conclusions: In Poland infected cattle is the main source of infections
for humans. Veterinary stuff is at the highest occupational risk to acquire
Q fever.
Table 1. Humans infected (seropositive) with C. burnetii in outbreaks in Poland.
R2562 Actinobaculum schaalii − invasive pathogen or innocent
bystander?
S. Tschudin Sutter*, R. Frei, M. Dangel, D. Goldenberger, A.F. Widmer
(Basel, CH)
Objectives: Actinobaculum schaalii is a Gram-positive, facultatively
anaerobic coccoid rod, classiﬁed as a new species in 1997, formerly
belonging to the species of Actinomyces suis. It grows slowly and
therefore is easily overgrown by other bacteria, which are often
found concomitantly. Since 1999, Actinobaculum schaalii is routinely
investigated at our hospital, whenever its presence is suspected due to
the detection of minute grey colonies on blood agar plates and negative
reactions for catalsae. The objective of this study was to determine
the clinical signiﬁcance of Actinobaculum schaalii, identiﬁed in our
microbiology laboratory over the last 11 years.
Methods: All consecutive isolates with Actinobaculum schaalii were
obtained from the computerized database of the clinical microbiology
laboratory and patients whose cultures from any body site yielded this
pathogen were analyzed. Observation of tiny colonies of Gram-positive,
catalase-negative rods triggered molecular identiﬁcation based on partial
16S rRNA gene sequencing. An infectious diseases specialist reviewed
the medical charts and collected data regarding underlying diseases,
clinical manifestations, antibiotic therapy, and clinical outcome.
Results: 27 patients with positive isolates were identiﬁed in the last 11
years. The patient’s median age was 81 (19–101) years, 25 (92.6%)
had underlying diseases and 12 (44.4%) had a genitourinary tract
pathology. Actinobaculum schaalii was isolated in 12 urine cultures,
21 blood cultures, and 7 deep tissue biopsies (n = 40). Twenty-ﬁve
(62.5%) specimens were monobacterial, the remaining 15 (37.5%) were
polybacterial (all deep tissue samples, three bloodcultures and ﬁve urine
cultures). Recovery from urine was interpreted as colonization in 5
(18.5%) cases (41.6% of all urine samples). Thirteen patients (48.1%)
suffered from genitourinary tract infections, four (14.8%) from abscesses
(skin, intraabdominal, and surgical site infections) and 5 (18.5%) from
bacteremia (associated with spondylodiscitis, intraabdominal infection
or pneumonia).
Conclusion: Actinobaculum schaalii caused an infection in 81.5% of
our patients. It is often detected together with other pathogens (37.5%),
especially in urine cultures and abscesses. Knowledge of its existence
is crucial as it can lead to serious invasive infections, as bacteremias
associated mostly with urinary tract or intra abdominal infections,
especially in patients with underlying genitourinary tract pathologies.
R2563 Implications of the detection of human inﬂuenza B virus
haemagglutination-inhibiting antibodies in unvaccinated
pigs in Ibadan, Nigeria
O. Adeola*, J. Adeniji (Ibadan, NG)
Objectives: Unlike Inﬂuenza A viruses which cause natural infection
in many species including aquatic birds, Inﬂuenza B viruses cause
inﬂuenza almost exclusively in humans. However, considering the role
of pigs in genetic reassortment of inﬂuenza viruses, using serological
survey, we investigated the possibility of human-to-swine transmission
of two inﬂuenza B virus strains, one belonging to B/Victoria/2/87 lineage
and the other belonging to B/Yamagata/16/88 lineage, which circulated
among humans in Ibadan, south-western Nigeria, in 2008 and 2009.
Methods: Serum specimens obtained from ninety-one out of one
hundred and ninety-nine (91/199) apparently healthy, unvaccinated,
Landrace pigs at three locations within Ibadan were tested for
inﬂuenza B virus Haemagglutination-inhibiting antibodies. Virus
strains used for Haemagglutination Inhibition (HI) Assay were
inﬂuenza B/Shanghai/361/2002-like (B/Yamagata/16/88 lineage) and
B/Malaysia/2506/2004-like (B/Victoria/2/87 lineage) CDC reference
antigens. HI Assay was performed according to W.H.O Protocol for
Animal Inﬂuenza Diagnoses and Surveillance Manual (2002). Results
obtained were analyzed by two-way ANOVA and Student’s t-test, using
GraphPad Prism (GraphPad Software Inc., San Diego, USA). Values of
P< 0.05 were considered signiﬁcant.
Results: Prevalence of antibodies to inﬂuenza B/Shanghai/361/2002-like
virus among pigs was 3.3% (n = 91). None of the pigs tested had HI
antibodies against inﬂuenza B/Malaysia/2506/2004-like virus. Titres of
antibodies to inﬂuenza B/Shanghai/361/2002-like virus in each of the
three pigs that were seropositive were 160, 160, and 320 HIU/25ml
respectively (mean = 213.3 HIU/25ml).
Conclusion: Considering the role of the pig as an important ‘mixing
vessel’ for inﬂuenza A viruses in which novel reassortants, which
could be highly virulent in the human population, could be generated,
detection of HI-antibodies to a human strain of inﬂuenza B virus among
pigs in Ibadan, should prompt more detailed studies to establish the
susceptibility of pigs to inﬂuenza B viruses and determine the roles of
pigs in the evolution of inﬂuenza B viruses. It should also serve as an
urgent call for effective surveillance among live pig handlers and swine
herds in south-western Nigeria, not only for inﬂuenza A viruses, but also
for inﬂuenza B viruses.
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R2564 Evaluation of predictor factors of Crimean Congo
haemorrhagic fever: new suggestions
B. Ozturk*, E. Tutuncu, F. Kuscu, Y. Gurbuz, I. Sencan, H. Tuzun
(Ankara, TR)
Objectives: Crimean-Congo hemorrhagic fever (CCHF) is one of the
viral hemorrhagic fevers caused by tick bites. Common symptoms of
the infection are fatigue, high fever, headache, and myalgia. In some
patients hemorrhage may accompany these symptoms and is a sign of
bad prognosis. The typical laboratory changes are thrombocytopenia,
leucopenia, elevation of AST, ALT, CPK, and LDH, prolongation of PT
and aPTT. Mortality rates vary between 3−30%. The aim of this study
was to determine the factors affecting the prognosis of CCHF.
Methods: A total of 70 patients who were followed with the diagnosis
of CCHF in our clinic between 2005 and 2008 were included in this
study. Besides the epidemiological history of the patients, biochemical
parameters that were tested during the ﬁrst ﬁve days and prognosis
were evaluated. Non-parametric statistical tests were used for statistical
analysis.
Results: When the laboratory parameters of patients who died and
recovered were compared, PT, aPTT, INR, AST, LDH, ﬁbrinogen, CRP,
hs-CRP, D-dimer, IgM, IgG, C3 and C4 levels and thrombocyte count
were found to be positively correlated with fatality. On the other hand,
there was no signiﬁcant difference between groups regarding ALT, CPK,
prealbumin, ceruloplasmin, protein C, protein S and antithrombin III
levels and WBC counts.
Conclusions: CCHF is an important infectious disease that may cause
loss of labour force and deaths and still an epidemic disease in our
country. Estimating the predictor factors for fatality is essential to take
possible precautions. Thus, it is important to re-evaluate the existing
parameters that were shown to be related with fatality and to suggest
new predictor factors for fatality.
NON FATAL
(n = 61), Mean (sd)
FATAL (n = 9),
Mean (sd)
p value
AST (I/U) 287 (387.48) 1727 (3513.39) 0.009
ALT (I/U) 137.2 (145.35) 428.33 (741.34) 0.107
LDH (IU/L) 821 (402.53) 2011.22 (1626.18) 0.006
CPK (I/U) 588.8 (695.31) 1307.56 (1269.74) 0.061
PT (second) 13.6 (3) 18.37 (6.61) 0.003
INR 1.7 (4.39) 1.97 (1.41) 0.005
aPTT (second) 46.8 (9.8) 81.98 (24.98) <0.001
WBC/mm3 2849.5 (1703.73) 4988 (4817.79) 0.289
Thrombocyte/mm3 37393.4 (25086.70) 11444.44 (4693.37) <0.001
Fibrinogen (mg/dl) 395.3 (159.9) 300.3 (171.9) 0.027
CRP (mg/L) 14.00 (17.1) 59.27 (60.98) 0.004
D Dimer (mg/dl) 4425.83 (3479.87) 9356.00 (1555.89) 0.002
Prealbumin (mg/dl) 0.14 (0.06) 0.10 (0.03) 0.071
HsCRP (mg/L) 16.87 (20.23) 42.32 (50.12) 0.049
Ceruloplasmin (mg/dl) 0.3 (0.08) 0.23 (0.1) 0.307
Prot C (%) 87.9 (30.9) 67.4 (28.9) 0.355
Prot S (%) 55.8 (19.1) 57.0 (4.3) 0.817
Antithrombin 3 (%) 105.4 (22.9) 83.7 (30.0) 0.176
IgM (mg/dl) 2.11 (1.05) 1.25 (0.47) 0.003
IgA (mg/dl) 2.89 (1.34) 2.98 (1.17) 0.235
IgG (mg/dl) 15.51 (3.53) 13.13 (4.72) 0.040
C3 (mg/dl) 1.43 (0.45) 1.08 (0.42) 0.048
C4 (mg/dl) 0.46 (0.43) 0.22 (0.14) 0.025
R2565 BNP, PCT and CRP as diagnostic and prognostic markers
in patients with sepsis
A. Stavrianou*, V. Kalogeri, E. Koukou, A. Tsipou, S. Pagoni (Athens,
GR)
Objectives: BNP, PCT and CRP are well known indexes in critically ill
patients such as those in sepsis and septic shock. The Purpose of our
study was to determine which of these markers’s serum levels increase
more in sepsis and if they can predict the outcome or be a valuable
prognostic marker.
Methods: We retrospectively examined 114 patients with febrile
bacterial infections admitted to our department over a period of 2 (two)
years. No one had a history of established cardiac failure. The diagnostic
of the sepsis was based on clinical and laboratory data. We measured
BNP, PCT and CRP in blood samples, taken the ﬁrst 2 (two) days
of hospitalization. The outcome was determined as survivors and non-
survivors.
Results: We had 66 female and 48 male patients. Among those patients,
68 were survivors (59,6%) and 46 (40,4%) non-survivors. There was
a signiﬁcant increase of BNP levels in non-survivors patients (1027)
vs. BNP levels in survivors patients (432,55). Also the PCT mean levels
were higher in the non-survivors’s group (20,65) vs. the survivors’s group
(3,6). Finally, the mean levels of CRP in survivors was 167,21 and in
the non-survivors was 166,4.
Conclusions: In our study BNP and PCT levels measured soon after
admission were increased signiﬁcantly in sepsis and they seem to be
a valuable prognostic marker in the outcome of these patients. The
difference of the CRP mean levels in the 2 (two) groups was not
signiﬁcant.
R2566 H1N1 pandemic inﬂuenza during pregnancy and their
newborns: risks of infection and antiviral medication
T. Cirkin Guzel*, N. Baykam, S. Menekse Yilmaz, A. Kocagul Celikbas,
S. Eren Gok, H. Esener, S. Yaprakci, B. Dokuzoguz (Ankara, TR)
Introduction: H1N1 inﬂuenza pandemic caused higher morbidity and
mortality among pregnant women than in the general population
underscores the medical community’s urgent need for data regarding
the safe and effective use of medications during pregnancy. Although the
beneﬁts of treatment appears to outweigh the theoretical risks of antiviral
use there is few data about the newborns who borned from mothers who
took medications for H1N1 during their pregnancy. In this study we
aimed to investigate the clinical characteristics of H1N1 inﬂuenza in
pregnant women and follow up the health status of newborns of these
mothers after delivery.
Methods: Twenty pregnant women with clinical symptoms and diagnosis
of inﬂuenza A (H1N1) were included in this study from October 2009 to
January 2010. All the study population were followed up until delivery
and newborns were evaluated for any complication associated with
infection or medication.
Results: Twenty of 276 hospitalized patients with pandemic H1N1
inﬂuenza were pregnant (7.2%). The mean age was 24±3 (17−30years).
Thirteen (65%) pregnant women were in 2nd trimestre, 5 (25%)
were in 3rd trimestre and 2 (10%) were in 1st trimestre when they
admitted to hospital. Although 80% of patients had pathologic respiratory
auscultation ﬁndings, only 4 pregnant patients accepted chest X-ray test
and all of them had bilateral patchy alveolar opacities. Two of them
required mechanical ventilation. One of the mechanically ventilated
pregnant woman died at the second day of hospitalization. Six of the
patients didn’t accept to get antiviral medication. Only one pregnant
women who got antiviral medication (oseltamivir) had premature birth
at 36th week. All other deliveries were in term and no complications
were detected in newborns up to 4th week of their life.
Conclusion: Although early evidence suggests that pregnant women may
be at higher risk for severe complications (including stillbirth) from novel
H1N1, the beneﬁts of treatment appears to outweigh the theoretical risks
of antiviral use. Early anti-viral therapy, may bring clinical beneﬁts to
pregnant patients.
R2567 Will Lombardia and North Italy soon begin as a new
leishmaniasis endemic area? A worrisome case report
R. Grande*, L.M. Arancio, R. Gianotti, A. Frassanito, A. Maraschini,
A. Restelli, A. Grancini, M. Colosimo, R. Colombo, E. Torresani,
M. Cusini (Milan, IT)
Background: Canine leishmaniasis (CanL) due to Leishmania infan-
tum(LI) is a veterinary disease with an heavy burden on public health.
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In humans, LI cause visceral (VL) and cutaneous (CL) leishmaniasis and
their distribution overlap that of CanL. The spreading of autochtonous
foci of CanL toward Lombardia (LO) and North Italy is well evidenced:
above all, during a 2003–2005 prospective survey were detected 5 new
foci of CanL in LO; we report a CL clinical case from a patient living
nearby the focus called PV-1.
Case report: A.C., 60 years old, male, was admitted for an evaluation of
a cutaneous lesion on the upper right wrist whit no trend to healing. The
patient was suffering of a Chronic Lymphatic Leukemia (CCL), actually
in recovering. He worked as forest warden for a natural reserve placed
nearby PV-1 area and he’s living in that area, too. The man didn’t report
travels abroad in the last years; nevertheless, because the patient lived and
worked nearby a documented new focus of CanL, was considered CL for
differential diagnosis. A biopsy of the outer rim lesion was performed: a
part of the sample was stained with Hematoxylin and Eosin (HE) stain,
the other was cultured in NNN terrain at TA for growing of Leishmania
promastigotes. A serum sample was collected for speciﬁc antibodies
assays (anti rK39 IgG antibodies Leishmaniasis Rapydtest© DID and
Leishmania Western Blot IgG WB LDBIO Diagnostic).
Results: HE stain resulted positive for intracitoplasmatic Donovan bod-
ies, diagnostics for CL. NNN culture failed because was contaminated
by cutaneous microbic ﬂora. Serological assays were negative for rK39
antibodies immunochromatographic test but a strongly positive pattern
for speciﬁc IgG was pointed out by WB. Patient’s lesion was treated
as CL by 1ml of Meglumine Antimoniate (Glucantim©) vials by local
intradermic injection in three times (1/month) with a complete lesion
recovering.
Conclusions: The reported case suggest us two important considerations:
this clinical report could be the ﬁrst case of zoonotic transmission of
CL in human being by one of the new foci of CanL identiﬁed in LO
and since now could be better for LO medical practitioners arguing that
ought to be suggested differential diagnosis for CL every time in clinical
diagnostic routine for cutaneous lesions.
R2568 Identiﬁcation and study of a cowpo virus isolated from
llama (Lama glama) farmed in central Italy
F. Carletti*, A. Brozzi, C. Eleni, N. Polici, G. D’alterio, M. Scicluna,
C. Castilletti, A. Di Caro, G. Autorino, A. Demetrio, G. Cardeti (Rome,
IT)
Objective: In July 2009, 5 llamas, farmed in Central Italy, exhibited skin
lesions at different sites evolving from nodules to crusts; some of them
had a crater morphology typical for pox lesions. On the farm, there are
present many species of birds (local and exotic) and mammals (goats,
cattle, pigs, donkeys, horses) none of which showed any of the above
mentioned symptoms.
Methods: From one moribund female which was euthanised samples
were collected for laboratory analysis. Skin lesions were processed
for electron microscopy techniques. Two mammal cell lines (Vero and
BHK21) were used for virus isolation attempts. Total viral DNA was
extracted from both homogenized crusts and Vero cells supernatant.
Real-time PCR, targeting the crmB gene, sequencing and phylogenetic
analysis were performed to identify the virus. Other viral and bacterial
diseases were considered as differential diagnosis.
Results: Transmission electron microscopy revealed brick particles
typical of orthopoxviruses. CPXV-antibodies were detected from llama
and human sera (farmers). A Real-Time PCR gave positive results for
both crust and cells supernatant. Phylogenetic analysis of two poxvirus
genes (HA and crmB) conﬁrmed a Cowpoxvirus infection, homologous
to the CPXV-GuWi strain isolated in Germany in 2007.
Conclusion: After this outbreak, no other symptoms have been described
among animals and human beings in the farm and no other news about
CPXV have been reported in Italy. About the origin of the infection, all
the llamas were born in the farm and had had no contact with exotic
mammals, as declared by the owner. we can suppose that the virus has
been introduced in the farm through bred mice, used as food for birds
of prey. Such mice came from a German farm, which had sold infected
rats to a zoo were mongooses have recently resulted affected by CPXV.
R2569 Orthopoxviruses seroprevalence among veterinarians and
cats in northeastern Italy
A. Beltrame*, C. Castilletti, A. Troi, A. Arzese, E. Ndip Nganyuo,
D. Lapa, A. Di Caro, B. Del Pin, M. Capobianchi (Udine, Rome,
Veneto, IT)
Objectives: Two cases of orthopoxviruses disease occurring in veterinary
personnel scratched by sick domestic cats from 2006 have been reported
in Friuli Venezia Giulia (FVG), Northeastern Italy. There are few studies
on seroprevalence of orthopoxviruses infection in cats from Europe (rates
from 2% to 10.1%), no one in Italy.
A surveillance program has been launched among local veterinary clinics
to identify the seroprevalence of orthopoxviruses in veterinarians and
cats to evaluate the extent of the infection in FVG.
Methods: In order to investigate the seroprevalence of orthopoxvirus
infections in veterinarians, wild and domestic cats >1 year old from 11
selected veterinary clinics of FVG, both human and animal blood sam-
ples were collected to test signs of previous exposure to orthopoxviruses.
Microneutralization assays were utilized. A standardized questionnaire
was also used to record the past history, as well as to evaluate all possible
risk factors.
Results: A total of 36 veterinarians and 85 cats were included in
the study, from February 2010 to May 2010. The median age of the
veterinarians was 41.5 years (range 25−57 years) and 17 of them
(47.2%) reported a previous smallpox vaccination. The median clinic
work experience was 15.5 years (range, 1−31 years). Twenty-four
subjects (66.7%) reported a weekly exposure to more than 10 cats. Ten
veterinarians (28.6%) reported a previous exposure to more than 10 cats
affected by ulcerative dermatitis. Only 9 (25%) of the subjects considered
the orthopoxvirus infection a professional risk.
Antibodies against orthopoxviruses were detected in 12 veterinarians
(33.3%). In particular, the seroprevalance decreased gradually for
younger age groups (Table 1).
The 85 cats analyzed have a median age of 5 years (range 1−17 years);
65 cats (77.4%) are domestics and 40 cats (48.2%) live in rural area.
The seroprevalence rate among cats was 35% (37.5% in rural area vs
38% urban area).
Conclusion: Circulation of orthopoxviruses in wild and domestic
animals, together with decreased immunity in humans, may lead to the
increased occurrence of human cowpox.
The high prevalence reported in the cats studied should alert veterinarians
and physicians to consider this infection as possible in different
diagnosis, especially with regards to potential fatal consequences for
immunosuppressed subjects as consequence of the ceasing of the
smallpox vaccination (1976 in Italy).
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R2570 Transrectal ultrasound-guided prostate biopsy. Antibiotic
prophylaxis of post-biopsy bacteraemia
R. Tomas*, A. Malet, B. Font, M. Espasa, L. Falgueras, J. Prats,
D. Fontanals (Sabadell, ES)
Introduction and Objectives: Transrectal ultrasound guided prostate
biopsy (TRUSPB) is the technique of choice in the diagnosis of prostate
cancer. There is no consensus on antibiotic, dose and duration of the
prophylaxis.
The main objectives of the study were: to calculate the incidence of
postbiopsy bacteremia (PB), to know the microorganisms and their
antibiotic susceptibility and to evaluate the effectiveness of different
antibiotic prophylaxis used in our hospital.
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Patients and Methods: The study is a retrospective revision of
patients subjected to TRUSPB between January 2005 and March 2010
in Parc Taulı´ Hospital, Spain. The information was obtained from
clinical registers and from the databases of Radiology and Microbiology
Departments. We have used the Pearson’s c2 test for statistical analysis
with signiﬁcance set at p< 0.05.
Results: The study included 2,427 TRUSPB. 1,954 procedures (80.5%)
were carried out with local anaesthesia and 1,924 (79.3%) implied the
extraction of 8 to 14 biopsic pieces. The antibiotic prophylaxis regimens
were: cotrimoxazol 1,166 (48%), ciproﬂoxacin 575 (23.7%), tobramycin
361 (14.9%), other antibiotics 68 (2.8%) and not registered 257 (10.6%).
The global incidence of PB was 2.06% (50/2427).
Escherichia coli was isolated in 98% of episodes (49/50) and Klebsiella
oxytoca in 2% (1/50). E. coli susceptibility to antibiotics used for
prophylaxis was: 81.6% for tobramycin, 73.5% for ciproﬂoxacin and
22.5% for cotrimoxazol. Susceptibility to ceftriaxone − usually proposed
in literature as prophylaxis − was of 98%. Only one strain of E. coli was
Extended-Spectrum-b-Lactamase (ESBL) producing.
The PB incidence based on the prophylaxis regimen was: ciproﬂoxacin −
1.04% (6/575); cotrimoxazol − 2.49% (29/1166) and tobramycin −
3.60% (13/361). The lower incidence of PB in ciproﬂoxacin’s group
is statistically signiﬁcant (p< 0.05 versus cotrimoxazol; p< 0.01 versus
tobramycin).
Conclusions: The global incidence of PB was 2.06%. Escherichia coli
was isolated in 98% of episodes.
Ciproﬂoxacin prophylaxis was the most effective regimen with lower PB,
however susceptibility of E. coli isolates wasn’t optimal (73.5%). Taking
into account that E. coli susceptibility to ceftriaxone was of 98%, the
use of this antibiotic as a new prophylaxis regimen could reduce PB
incidence.
R2571 Compliance, knowledge and attitudes towards hand hygiene
guidelines among healthcare workers in a tertiary hospital
in Greece
M. Mamali*, A. Skoutelis, E. Kakalou, M. Samarkos (Athens, GR)
Objectives: The objectives of the study were to evaluate healthcare
workers’ (HCWs’) compliance to the hand hygiene guidelines issued by
the World Health Organization in 2009, and to assess their knowledge
regarding and perceptions toward hand hygiene. We also searched for
associations between observed compliance and various factors.
Methods: The study was conducted in “Evaggelismos” Hospital, a
950-bed, tertiary care general hospital in Athens, Greece, between
March and June 2010. Compliance data collection was based on direct
and overt HCW observation during patient care, while anonymous,
self-administered questionnaires were used to collect information on
knowledge and perceptions. We used the data collection forms and
questionnaires provided by WHO.
Results: During 41 observation sessions with average duration of
18.6 min, we recorded 587 hand hygiene opportunities. Total average
compliance was 13.6%. Compliance was signiﬁcantly higher among
physicians than among nurses [21.6% vs. 9.5% (p< 0.001)]. Professional
category (doctor vs. nurse), type of indication (before contact vs. after
contact), day of observation (after “on take” day vs. other days) and
activity index were found to correlate strongly with compliance.
142/228 knowledge questionnaires were completed. The average number
of correct answers to the 25 knowledge questions was 12.38 (SD= 3.40)
and differed signiﬁcantly among age groups, professional categories,
departments and wards. Only 4.2% of HCWs answered correctly to more
than 19 (75%) questions.
139/228 perception questionnaires were completed. Behavioral beliefs
in favor of hand hygiene seemed to be strong and produced a positive
attitude toward the behavior. Normative beliefs were also relatively
favorable with respect to hand hygiene. As for control beliefs, most
HCWs felt that a big effort is required to perform good hand hygiene.
According to HCWs’ views, the most effective action to improve hand
hygiene in the hospital is to make alcohol-based handrub always available
at each point of care. Patient empowerment is regarded as the least
effective measure.
Conclusions: Compliance rates in “Evaggelismos” Hospital are very
low compared to those of other studies carried out in Greece or in other
countries. Doctors’ and nurses’ level of knowledge is not satisfactory,
while low perceived behavioral control seems to exert strong inﬂuence
on HCWs’ behavior. Action needs to be taken, involving a combination
of system change, education and motivation.
R2572 Does oral care with chlorhexidine inﬂuence bacterial
epidemiology or incidence of nosocomial pneumonia in the
intensive care unit?
Z.T. Yang*, Y. Chen, Y. Cai, Y.J. Yang, S.Y. Zhao, Z.Q. Che, C. Zhu,
W.J. Zhou, M. Zhong, F. Jing, E.Z. Chen (Shanghai, CN)
Objective: To investigate the effect of oral hygiene with chlorhexidine
inﬂuences bacterial epidemiology or incidence of nosocomial pneumonia
in intensive care unit.
Methods: Patients admitted and stayed for more than 48h to our 18-
bed polyvalent ICU of a Chinese tertiary care teaching hospital were
enrolled in our study. From May 2008 to April 2009, during pre-
intervention period, protocol of oral hygiene consisted of metronidazole
in the morning and boiled water in the evening and has been changed
to 0.2% chlorhexidine gluconate twice daily since May 2009. Bacterial
epidemiology of nosocomial pneumonia (NP) and ventilator associated
pneumonia (VAP) was studied. Statistical analysis was performed by
SAS 8.0.
Results: Five hundred and forty-two patients admitted in our ICU from
May 2008 to April 2010, of which four hundred and eighty-seven patients
were screened, 234 patients, 103 episodes of NP, of which 44 VAP
(21/33 for patients intubated) for 1070 device-day, occurred during the
pre-intervention period; while 253 patients, 93 NP, of which 42 VAP
(28/43 for patients intubated) for 1205 device-day during the intervention
period. There was no signiﬁcant difference between the intubated patients
for sex (60.6% vs. 78.7%, p = 0.078), age (62.6±21.3 vs. 62.2±17.7,
p = 0.968), median ICU stay (37d vs. 29d, p = 0.259) and ventilator-day
(1070d vs. 1205d, p = 0.496). Overall rate of catheter related pneumonia
(VAP) and rate of NP was 37.8 (episodes per 1000 ventilator-day) and
20.0 (episode per 1000 patient-day), 41.1 and 34.9; 24.3 and 16.7 for pre-
intervention and intervention period, respectively. Among 143 bacteria
isolated for the ﬁrst year, 32 (22.4%) were G+, of which were18 MRSA,
111 (77.6%) were G-, of which 63.1% were non-fermentive bacteria.
During the intervention period, among 113 bacteria, 28 (24.8%) were
G+ of which were 19 MRSA, 85 (75.2%) were G-, of which 72.9%
were non-fermentive bacteria. For MRSA and non fermentive bacteria
distribution, there was no signiﬁcant difference between 2 studied periods
for VAP.
Conclusions: Oral hygiene with 0.2% chlorhexidine twice daily changed
little bacterial distribution of NP in ICU compared with pre-intervention
period. However, the slightly decreased 15% (41.1 to 34.9) incidence of
VAP by episodes per 1000 catheter-day and 31% (24.3 to 16.7) incidence
of NP by 1000 patient-day were observed during the intervention period
suggests a possible beneﬁt of oral hygiene for ventilated patients in ICU.
R2573 Twenty-three years of countermeasures against all
postoperative MRSA infections
S. Kusachi*, J. Nagao, Y. Saida, M. Watanabe, Y. Nakamura, K. Asai,
T. Enomoto, T. Kiribayashi, Y. Okamoto, Y. Arima, M. Uramatsu,
T. Saito, R. Watanabe, J. Sato (Tokyo, JP)
Introduction: In a previous paper, we reported that the number of cases
of MRSA isolated from the site of postoperative infection after surgery
decreased 4.1% (34/833) to 0.3% (3/2073) of all cases of digestive
surgeries, and maintained this low rate of MRSA isolation from March
1990 to August 1997 (Kusachi S et al. Surg Today, 1999).
Patients and Methods: 8,991 cases of digestive organ surgery were
investigated for 23 years. Sparked by a increase in MRSA infections both
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Surgical Site Infections (SSI) and Remote Infections (RI), we classiﬁed
our countermeasures to class into period A (1987.9–1990.2), period B
(1990.3–1997.8), period C (1997.9–1999.2), period D (1999.3–2004.10),
and period E (2004.11–2010−8), and compared the periods. In period B,
Cefazolin and cefotiam were administered as prophylaxis. The dosing
continued for 4 days, including the day of surgery. Moreover, non-
screening pre-emptive isolation and cohorting (NSPEI&C) were applied
to the patients undergoing endotracheal intubation or tracheotomy who
were admitted to single rooms (isolation) and multiple patients with
similar conditions in one room (cohorting), regardless of whether or not
MRSA was isolated. Since August 1997, however, the idea of evidence-
based medicine (EBM) has spread over Japan so that we had no other
choice than stopping NSPEI&C because NSPEI&C had no conﬁrmed
evidence. Since then, MRSA become isolated from postoperative patients
even more often. Then, NSPEI&C was strictly instituted again, and
the dosing period of prophylactic antibiotics for postoperative infection
being shortened or extended, the isolation rate of MRSA after digestive
surgeries could be signiﬁcantly reduced. We report herein the method
to prevent the isolation of MRSA for two decades. However, NSPEI&C
was stopped in period C, but was implemented again, and prophylactic
antibiotics were administered only on the day of surgery in period D. In
period E, prophylactic antibiotics were administered for 3 days.
Results: In period A, MRSA was isolated from 4.1% (34/833). In
period B, the MRSA isolation rate decreased to 0.3% (8/2,722).
In period C, the MRSA isolation rate increased to 3.4% (23/681).
In period D, the MRSA isolate rate decreased to 2.2% (40/1807).
In period E, MRSA isolation cases signiﬁcantly decreased to 0.4%
(196/4948; p 0.002, vs. period D).
Conclusion: The comprehensive management, the 3 days administration
of prophylactic antibiotics and NSPEI&C were effective.
R2574 In vitro efﬁcacy of antibiotic supplementation in
PMMA-bone cements against staphylococci
W. Pﬁster*, A. Wagner, J. Hess, S. Eick (Jena, DE; Berne, CH)
Objectives: Infections of prostheses and surrounding tissue are one
of the most serious complications in orthopedic surgery. Most, these
infections caused by staphylococci, especially Staphylococcus aureus.
Nowadays S. aureus often has a complete resistance against b-lactams
(methicillin-resistant S. aureus (MRSA)), mostly connected with a
resistance against other antibiotics, e.g. lincosamides, quinolones.
Exchange of the implant and temporary implantation of antibiotic-
containing spacers is the mode of choice in treatment of these bioﬁlm-
associated infections. Our in vitro-study was aimed to determine the
antimicrobial activity of antibiotic-containing specimens over a time
period of up to three months.
Methods: Specimens were prepared from commercially available
bone cements (without antibiotics, with 12.5mg gentamicin/g, with
25mg gentamicin and 25mg clindamycin/g cement). Additionally the
cement containing 12.5mg gentamycin was supplemented with 25mg
and 100mg/g vancomycin. Specimens were placed in nutrient broth
with ﬁve test strains (2 methicillin-susceptible S. aureus (MSSA), 2
MRSA, 1 S. epidermidis). If bacterial growth was visible in the broth
specimens were removed and bacteria attached to the surface of the
specimens were counted. Further, specimens were soaked into nutrient
broth and phosphate buffered saline; eluates were taken for determination
of antimicrobial activity by means of agar diffusion test.
Results: Cements containing gentamicin and clindamycin showed a
higher antimicrobial activity against MSSA and S. epidermidis in
comparison to cement containing only gentamicin. All specimens were
infected 15 d after starting the experiments. Specimens with gentamicin
and clindamycin inhibited bioﬁlm formation and acted antimicrobial
against MSSA strains and S. epidermidis strain up to 84 days. Cements
with gentamicin also combined with clindamycin did not have any effect
on MRSA strains. Only supplementation of vancomycin was able to
inhibit growth of MRSA strains; concentration of 100mg was more
active up to 25 days.
Conclusions: Microbiological diagnosis should exclude as fast as
possible an infection by MRSA. If infection is caused by an MSSA,
combination of gentamicin and clindamycin can be recommended. For
treatment of MRSA, application of an vancomycin-containing cement
seems to be necessary.
R2575 Seroprevalence of antibodies against Treponema pallidum
in pregnant women
J. Lozano Serra*, J. Bartolome Alvarez, L. Robles Fonseca, S. Lorente
Ortun˜o, M. Crespo Sanchez (Albacete, ES)
Objectives: To know the prevalence of antibodies against Treponema
pallidum in pregnant women in our health area; to compare Spanish-
born women with those born abroad.
Methods: The information source used to select patients was the
Microbiology Laboratory database (Hospital de Albacete, Spain). It
included all women who applied for syphilis serology at the Obstetrics
Service (January-December 2009). Serological screening consisted in
determining antibodies against T. pallidum by chemiluminescence
enzyme immunoassay (Syphilis TP Abbott® Laboratories). Conﬁrmation
of the positive sera was done by passive hemaglutination (Kit TPHA 500,
Newmarket Laboratories Ltd.) and by determining nontreponemal anti-
bodies (Macro-Vue RPR, Beckton Dickinson®). Seropositive patients’
medical histories were consulted to know the country they were born
and if they had been previously diagnosed and treated. The Agresti-
Coull method was used to calculate 95% conﬁdence intervals (95CI) for
prevalence. Relative risk (RR) and its (95CI) were calculated by the Epi
Info 3.4.1 program, to compare proportions.
Results: 4379 women participated, with a mean age of 30.4 years
(standard deviation [SD] = 5.7 years). Of these, 3305 (75.0%) were born
in Spain, 880 (20.1%) were born abroad, and country born was not
established for 194 (4.4%). The mean age of seropositive patients was
29.5 years (SD= 4.6 years). Treponemal antibodies overall prevalence
was 0.73% (95CI: 0.52%-1.04%). Of the 32 seropositive patients, 30
were foreign (94.0%). Seroprevalence among Spanish pregnant subjects
was 0.06% (2/3305; 95CI: 0.002%-0.24%), and 3.4% among foreign
subjects (30/880; 95CI: 2.4%-4.9%). Of the 30 seropositive immigrants,
19 came from Latin America, 9 from East Europe and 1 from sub-
Saharan Africa; country born was not determined in 1 case. When
compared with Spanish pregnant subjects, seroprevalence was higher in
women born in Latin America (RR= 92; 95CI: 22–395) or East Europe
(RR= 48; 95CI: 10–220). Of the 32 seropositive pregnant women, 11
had been diagnosed and treated before pregnancy. In the remaining 21
cases, no former diagnosis was reported and women received speciﬁc
treatment. Prevalence of previously undiagnosed syphilis was 0.48%
(95CI: 0.31%-0.74%).
Conclusion: Syphilis seroprevalence is very low among Spanish
pregnant women, but high in pregnant women from Latin American and
East Europe. The strategy of prevention of congenital syphilis should
pay special attention to immigrant women.
R2576 The comparison of the sterilisation effect against
Pseudomonas aeruginosa and Acinetobacter baumannii
using the supersonic wave and plasma irradiation
Y. Nakano*, S. Fujimura, T. Sato, H. Takane, A. Watanabe (Sendai, JP)
Objectives: The nosocomial infection caused by Acinetobacter bauman-
nii and Pseudomonas aeruginosa has been problem worldwide. It is
known that these bacteria contaminate the water supply environments
such as faucet, sink and bath of the hospital for a long time. And it is
extremely difﬁcult to sanitize strains on these environments. The aim of
the present study is to evaluate the bactericidal effect against bioﬁlm-
formed these strains using the supersonic wave or plasma irradiation.
Methods: The clinical isolate of A. baumannii and the standard strain
of P. aeruginosa PAO1were used in this study. To form bioﬁlm, the
5cm square stainless steel plate was added in TSB of each bacterial
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suspension of McFarland No.0.5 and incubated at 37ºC for 24hr under
anaerobic conditions.
These stainless plates were added in water tank and irradiated a
supersonic wave of 38 kHz for 5, 10 or 30 minutes. Whereas, a plasma
ﬂow generated by a dielectric barrier discharge in air at 12 kVpp with 2
k Hz was irradiated to another plates with each bioﬁlm-formed bacteria
for 1, 10 or 30 minutes. After irradiation, each plate was cultured on the
MH agar plate at 37 oC for 24hr.
Bactericidal effect was observed using the scanning electron microscope
(SEM) and the above-mentioned cultural method.
Results: Both strains of A. baumannii and P. aeruginosa except bioﬁlm-
formed strains were sterilized by the supersonic wave for 5 minutes.
However, bioﬁlm-formed both strains were not sterilized by that of
30 minutes. On the other hand, all strains were sterilized within 10
minutes by the plasma irradiation. With or without bioﬁlm, the bursting
of bacteria by the plasma irradiation was conﬁrmed using the SEM.
Conclusion: This study results showed that the plasma irradiation is
effective for sterilization of the hospital environmental contamination by
P. aeruginosa and A. baumannii.
R2577 Evaluation of hand-hygiene compliance rate among
healthcare workers in Isfahan hospitals, 2010
A. Babak*, S.M. Zahraei, Z. Pezeshky, Z. Nokhodian, B. Ataei,
M. Ataie (Isfahan, IR)
Objectives: Nosocomial infections are those which are created during
hospitalization or as its result. The health care workers’ hands are the
main route of microorganism transmission. Hand washing is the most
important measure to prevent spread of this infection. Compliance of
hand hygiene (HH) among healthcare workers is generally low (less
than 50%). This study aimed to determine the acceptance level of hand
hygiene in Isfahan hospitals, 2010 to design interventions to increase
awareness, motivation and performance among Healthcare workers.
Methods: This cross sectional study was conducted in three large
hospitals in Isfahan (a public training medical center, a public medical
center, and a private medical center) and a total of seven trained
observers for different working shifts at three hospitals were selected.
7 working days during two different weeks and every day, eight
20-minute sessions was considered. During these sessions, observers
monitored healthcare workers during their routine activities through
a check list. Five indications (before touching a patient, before a
procedure, after a procedure or body ﬂuid exposure risk, after touching
a patient, after touching a patient surroundings) were observed based
on the World Health Organization guideline. Four different professional
groups (physician, nursing, student, others) were considered for this
study. HH compliance was calculated as “(number of positive hand
hygiene actions/number of total hand hygiene indications)× 100” based
on each indication and professional group.
Results: From the total 3097 observed indications, in general, the HH
compliance rate was 5.6% and statistically signiﬁcant between three
different hospitals (7.4%, 4.1%, and 1.4% respectively). The most rates
were observed among the nursing group (7.3%), and then the student
group (6.5%), (p-value less than 0.001). Among the various indications,
the highest rate of compliance was observed after a procedure or body
ﬂuid exposure risk (9.4%), (p-value less than 0.001).
Conclusion: In this study, the hand hygiene compliance rate in hospitals
studied was low and needs to plan for improve.
R2578 Phenotypic characterisation of gonococci isolates in an
Irish university teaching hospital
R.T. Osuntoyinbo*, D. Clancy, E. Phelan, P. Mulhare, M. Doyle,
M. Hickey, B. Carey (Waterford, IE)
Objectives: Gonorrhoea remains an important clinical and public health
problem worldwide. Neisseria gonorrhoeae infection have been shown to
increase the risk of acquiring and transmitting human immunodeﬁciency
virus (HIV) infection thereby making gonorrhoea control an important
part of HIV prevention (Barry and Klausner, 2009). This study examined
prevalent phenotypes and resistance pattern of gonococci isolates in an
Irish university teaching hospital.
Method: Thirty six Neisseria gonorrhoeae strains isolated from uro-
genital specimens adults using New York City agar (NYC, Oxoid, UK)
at Microbiology Laboratory, Waterford Regional Hospital, Waterford,
Republic of Ireland between January 2007 and June 2010 susceptibility
pattern were studied using E-test strips (Biomerieux SA, France) and
adopting the clinical laboratory standards institute (CLSI) breakpoints.
Phadebact monoclonal antibody typing (Boule Diagnostic AB, Hudding,
Sweden) was performed on these isolates. Penicillinase production was
performed using nitrocephin method.
Results: All 36 isolates were WII/WIII (IB serovars), yielded 100% in-
vitro susceptibility to ceftriaxone (MIC 0.5mg/l) and spectinomycin
(MIC 128mg/l). Three isolates (8.3%) were resistance to penicillin
(MIC 2mg/l) and were penicillinase producing strains. Twenty eight
isolates (77.8%) yielded reduced susceptibility to penicillin (MIC
0.12−1mg/l). Thirty one isolates (86%) were resistance to penicillin or
yielded reduced susceptibility to penicillin. Five isolates (13.9%) were
resistant to ciproﬂoxacin (QRNG) (MIC 1mg/l) of these ﬁve isolates
three yielded penicillin reduced susceptibility pattern while two were
resistant to penicillin. Six (16.7%) were resistant to tetracycline (MIC
2mg/l) (TRNG). All the ciproﬂoxacin resistant isolates were from
male subjects. Seven distinct antimicrobial susceptibility patterns were
observed. A 0.74% isolation rate was obtained in this study population.
Conclusion: Ciproﬂoxacin and penicillin resistance is increasing.
Cephalosporin resistance was not observed but, local continuous
antimicrobial surveillance is paramount and should be ongoing. There
was no distinct link between the phadebact monoclonal typing of these
isolates and their antimicrobial susceptibility pattern.
R2579 The incidence of infections and MDRO prevalence in
long-term-care facility in Krakow, Poland
J. Wojkowska-Mach, D. Romaniszyn*, A. Chmielarczyk, B. Wojcik-Stojek,
B. Gryglewska, T. Grodzicki, M. Pobiega, P.B. Heczko (Cracow, PL)
Nosocomial infections have been a very well-know public health
problem with many consequences like medical, economical, ethical etc.
Information about epidemiology and microbiology is used as a basis for
legislation of special programs for infection prevention and control in
hospitals and long term facilities (LTCF). Unfortunately, is not known
situation in polish LTCF.
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The aim of this work was to analyze the epidemiology of infections and
multidrug resistance organisms among 108 residents in one LTCF.
Results: 108 residents and 33 968 resident days (pds) were included in
the studied period. 61,6% of studied residents had wheelchair disability
or were bedridden, 10,6% were disoriented in time and/or space, the
average age was: 76,3. Prospective epidemiological surveillance was
carried out, with trained professionals using McGeer deﬁnitions. The
incidence density per 1000 pds was 3,6. The most common infection was
lower respiratory tract infection including pneumonia: 38 cases (31,1%
all) and skin infections − WI (lower leg ulcerations, decubitus ulcers): 26
cases (21,3%). 22 cases (18,0%) of symptomatic urinary tract infections
and 36 cases (11,5%) of other infections were reported.
The most common aetiological factor for all types of infections
were Gram negative bacteria: 75,6% with Enterobacteriaceae (46,3%).
Pseudomonas aeruginosa was resistant in 70% for ﬂuoroquinolones, in
40% for amikacin and imipenem/meropenem. 75% of isolated strains of
Klebsiella pneumoniae were ESBL+ and 80% of isolated Staphylococcus
aureus (12,2% of all bacteria) strains were MRSA.
The empirical therapy was used in 76,2% of all infections, 29 cases of
infections (23,8%) were microbiologically tested.
Conclusion: This study supports the need for screening and control
of infections and multidrug resistance organisms. Observed infections
are rarely subject to routine microbiological diagnostics. The incidence
rate and resistance of microorganisms showed importance of cooperation
between the microbiology lab and medical personnel for both: competent
diagnosis and treatment of illness as well as nosocomial infection
surveillance and control activities. Further study should examine more
risk factors in detail to identify opportunities for prevention of infections
and MDRO.
This study was supported by the grant from the Polish State Committee
for Scientiﬁc Research (No NN404 047236).
R2580 The role of silver ion coated external ﬁxators in preventing
bacterial colonisation: in vitro microbiological study
N. Kose*, E. Doyuk Kartal, A. Kiremitci, A. Dogan, S. Koparal,
C. Peksen Dogan (Eskisehir, TR)
Objectives: Foreign body (external ﬁxator, prosthesis) infections cause
a signiﬁcant morbidity and mortality in orthopedic surgery. Silver ion
coating of metal external ﬁxators can reduce bacterial colonization
consequently infections.
Methods: In the study, 66 metal external ﬁxators were used. Titanium
(22 TiA14V) external ﬁxator was coated with silver ion containing
calcium phosphate based ceramic powder by using electrospray method.
22 implants were coated with hydroxyapatite in the same way,
and the remaining 22 external ﬁxators were without any coating.
To induce experimental infection, Staphylococcus epidermidis clinical
isolate which have slime factor, was used. In the study, 1×104
CFU/mL suspension of the clinical isolate in tryptic soy broth was
prepared. Following 24 h incubation, quantitative culture of bacteria
and determination of silver ion by atomic absorption were performed
on the broth. Quantitative culture of bacteria on the external ﬁxators
was performed in addition to microscopic examination and the possible
antibacterial efﬁcacy of implants due to silver ion coating was
investigated for 8 weeks (day 2, week 2, 4, 6 and 8). Accordingly,
the implants in glass tubes (diameter 0.4 cm) were placed in shaking
incubator at 35 ºC/80 rpm. Implants were rinsed with distilled water in
aseptic conditions once a week.
Results: The bacterial growth was statistically higher in broth containing
titanium external ﬁxators compared to broth media containing silver ion-
coated and hydroxyapatite-coated external ﬁxators at 24 hours (p = 0.036
and p = 0.009, respectively). The release of bacteria from silver ion-
coated ﬁxators was statistically less compared to hydroxyapatite- and
titanium-coated ﬁxators (p = 0.039 and p = 0.002, respectively). MIC
levels for 5% silver ion powder was 8mg/mL for CNS. No free silver ions
were detected in broth media using this method which has a detection
threshold as low as 0.02 ppm. In electron microscopy, it was observed
that less bacteria adhered to silver ion-coated external ﬁxators.
Conclusion: We observed that there was no bacteria release from silver
ion-coated external ﬁxator to surrounding liquid. As a result of silver
ion coating of metal external ﬁxators, bacterial colonization reduces
signiﬁcantly. Such effect may help preventing post-operative infections
caused by external ﬁxators commonly used in orthopedic operations.
In-vivo evaluation of this effect is warranted.
R2581 An evaluation of nebulised hydrogen peroxide post routine
cleaning for environmental surface disinfection
J. Kok*, L. Thomas, J. Tallon, K. Dempsey, G. Gilbert (Westmead, AU)
Objectives: Environmental contamination with methicillin-resistant
Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci
(VRE) establishes reservoirs of infection and facilitates transmission.
Routine cleaning methods may be inadequate for environmental
disinfection and hypochlorite disinfection is time-consuming, potentially
toxic and therefore no longer widely used. This study evaluated
the efﬁcacy of nebulised hydrogen peroxide (6% H2O2; Nocospray,
OXY′PHARM) following routine cleaning, for surface disinfection.
Methods: Environmental surfaces (bed, bedside rail, bedside table, blood
pressure cuff, intravenous pump, call button, dresser, door handle, toilet
seat, toilet rail and curtain rail) in a closed room measuring 80m3
artiﬁcially contaminated with MRSA and/or VRE were sampled with
sterile swabs (Copan) prior to and after routine cleaning (using neutral
detergent and quaternary ammonium compound [Viraclean, Whiteley]);
and after further disinfection with Nocospray (delivered from a portable
aerosoliser over 18 minutes). Swabs were plated onto MRSA (Oxoid) and
VRE (bioMe´rieux) chromogenic agars and placed into enrichment broth.
After 48 hours incubation at 37ºC, the presence of MRSA and/or VRE
was noted; if absent, enrichment broth ﬂuid was plated onto chromogenic
agar and read after 48 hours incubation. RODAC plates (BD Diagnostics)
were applied to ﬁve surfaces (bed, bedside rail, blood pressure cuff,
toilet seat and toilet rail) prior to and after Viraclean and Nocospray,
and bacterial colonies counted.
Results: MRSA was detected in 22 (100%), 9 (40%), 11 (50%), 7 (32%)
and 7 (32%) and VRE in 22 (100%), 13 (59%), 17 (77%), 4 (18%) and
5 (23%) of 22 surfaces tested: pre-cleaning, post Viraclean with direct
plating, post Viraclean with enrichment, post Nocospray with direct
plating and post Nocospray with enrichment, respectively. Blood pressure
cuffs were least likely to be adequately cleaned; MRSA and VRE were
recovered after both Viraclean and Nocospray. The table below shows the
number of bacterial colonies detected on RODAC plates at each stage.
Conclusion: Nocospray further reduced environmental contamination
with MRSA and VRE following Viraclean. The process is quick,
convenient, safe and allows rapid turnaround of rooms after disinfection.
Reducing environmental reservoirs should reduce transmission of MRSA
and VRE.
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R2582 Towards European core competencies for training infection
control/hospital hygiene professionals
F. Coiz*, S. Brusaferro, B. Cookson, S. Kalenic, R. Gallagher,
G. Privitera, T. Cooper, W. Popp, J. Fabry, P. Hartemann,
K. Mannerquist, E. Fabbro, C. Ruef, K. Weist, C. Suetens, C. Varela
Santos (Italy, IT; London, UK; Zagreb, HR; Pisa, IT; Essen, DE;
Lyon, Nancy, FR; Stockholm, SE; Udine, IT; Zurich, CH)
Objective: European Centre for Disease Prevention and Control (ECDC)
commissioned the project “TRaining in Infection Control in Europe”
(TRICE) to produce a guidance document to develop and harmonize
Infection Control Professionals’ Training Programmes across Europe.
Methods: The project utilised the information in the report of
Improving Patient Safety in Europe (IPSE) project Working Pary 1
deﬁning European Core Curriculum for training for Infection Control
Practitioners and the EU council recommendations on patient safety
of June 2009. The proposed competencies resulted from the following
steps:
– the IPSE Core Curriculum for Infection Control Practitioner was
submitted to the national representatives, who were asked to score(?or
grade?) each item of the curriculum:
– in a meeting held in Udine, results, graduation and future endorsement
strategies were discussed;
– after the meeting a coordination group elaborated the ﬁnal document;
– this document was sent again to all NCPICT for their ﬁnal approval.
All 33 NCPICT participated in the process and approved the document.
Results: The proposed European Core Competencies aim to be helpful
in:
– standardizing Infection Control/Hospital Hygiene Professionals
(IC/HHPs) competencies in Europe;
– designing and implementing training courses according to different
national contexts and facilitating the mutual recognition of competence
across Europe;
– providing an opportunity for IC/HHPs to review their own perfor-
mance and to plan their professional development;
– providing an opportunity for health care institutions and organizations
to evaluate their needs in terms of professional human resources.
The document is organized into three main areas: Programme
Management, Quality Improvement and Infection Control. Each consists
of different professional tasks common to infection control doctors
and nurses (except one: related to antibiotic prescribing). For each
professional task, competencies were classiﬁed into foundation practice
(this applies to newly appointed IC/HHP staff with little or no previous
experience and expert practice (for a IC/HHP conﬁdent and experienced
in all competencies).
Conclusions: We have achieved a consensus document on European
Infection Control/Hospital Hygiene Core Competencies. However, to
ensure that they will make ae a positive impact it will be necessary
to spread and endorse them with all the relevant stakeholders.
R2583 De-escalation strategy reduces Gram-negative pathogen
resistance in infectious complications of thermal burns
D.S. Medvedev*, N.V. Zakharova (Cherepovets, Saint Petersburg, RU)
Objectives: To assess the inﬂuence of a new carbapenem-based de-
escalating strategy of antimicrobial therapy in treatment of infectious
complications of severe burn injury by resistance of nosocomial Gram-
negative bacteria.
Methods: A retrospective analysis of antibiograms from burn patients
admitted to our burn care unit (BCU) of the sensitivities to common
Gram-negative pathogens before (2007) and after de-escalation strategy
(2010) was applied. The results of microbiological analyses of wound
discharge of 100% BCU patients from January to December 2007 and
from January to November 2010 were compared. De-escalation strategy
(meropenem (MEM) in combination with vancomycin) was introduced
in January 2008. Data were collated, and statistical signiﬁcance was
assessed with the chi-square test.
Results: 302 patients in 2007 and 217 patients in 2010 with conﬁrmed
burn wound infection were analyzed. The most common Gram negative
pathogens were P. aeruginosa (20.3% of all samples) and A. baumannii
(7.1%). There was a signiﬁcant decrease of resistance to antibiotics
in 2010 as compared with resistance in 2007 for P. aeruginosa to
amikacin (AMI) (21.0% vs. 44.9%; p = 0.001), ceftazidime (CEF) (62%
vs. 78%; p = 0.022), cefoperazone/sulbactam (CFP/SUL) (67.2% vs.
85.3%; p = 0.01). There is a tendency of resistance decreasing to
ciproﬂoxacin (CIP) (65.2% vs. 75.7%; p = 0.13), MEM (52.8% vs.
61.2%; p = 0.29). The level of susceptibility of the pathogen to imipenem
(IMP) remains the same (61.4% vs. 69.3%; p = 0.47).
The amount of resistant strains of A. baumannii signiﬁcantly decreased
to AMI (23.6% vs. 62.2%; p< 0.001), CIP (36.8% vs. 69.0%; p = 0.013),
CFP/SUL (2.7% vs. 17.4%; p = 0.039). Also there is a trend to decreasing
resistance to CEF (59.0% vs. 75.8%; p = 0.083). None of the strains of
A. baumannii from the samples collected in 2010 were resistant to MEM
(0% vs. 9.7%; p = 0.093).
No difference was seen in mortality between2007 and 2010 (5.3% vs.
7.7%; p = 0.079). The rate of mean inpatient-day decreased from 19.7 in
2007 to 15.1 in 2010.
Conclusions: The implementation of a de-escalation strategy of treating
infectious complications of thermal burns in our burn care unit increased
the susceptibility of multidrug-resistance to Gram-negative pathogens.
There is a potential beneﬁt in reducing the overall costs of treatment,
due to direct costs of antibiotic treatment and shortening the length of
stay in the hospital without increasing the mortality rate.
R2584 Laboratory personnel is a high-risk group for latent tuber-
culosis infection: evaluation by interferon-g release assay
and tuberculin skin test in an intermediate incidence setting
H. Moon*, H. Kim, M. Hur, Y. Yun (Seoul, KR)
Background: This is the ﬁrst large-scale study that focused on the
prevalence of LTBI in the laboratory personnel, especially in the
intermediate incidence setting.
Methods: We recruited 173 laboratory personnel and performed
QuantiFERON-TB Gold In-Tube test (QFT-G) and tuberculin skin test
(TST). Agreement between QFT-G and TST was analyzed, and risk
factors for the positivity of each test were assessed.
Results: QFT-G was positive in 21.4% of the enrolled laboratory
personnel, and TST was positive in 33.3% with a cut-off of 10mm. The
agreement between the two tests was fair (kappa = 0.234; 95% conﬁdence
interval = 0.054–0.414). Age and duration of health care profession
were signiﬁcantly associated with positive QFT-G and TST results
by univariate analyses. With multivariate logistic regression analyses,
household contact to TB patients (P = 0.013), the laboratory sections of
microbiology (P = 0.045) and chemistry/immunology (P = 0.014) were
signiﬁcantly associated with positive QFT-G results.
Conclusions: Our data shows the high prevalence of LTBI in the
laboratory personnel, and emphasizes the importance of LTBI screening
for the health care workers. QFT-G seems to be superior to TST for the
LTBI screening.
R2585 Incidences of C. difﬁcile infections in cardiothoracic
transplant recipients
E. Ott*, C. Fegbeutel, G. Warnecke, F. Mattner (Hannover, Cologne, DE)
Background: C. difﬁcile infections (CDI) are emerging over the past
ten years. Only few data is available about incidences of CDI in
hospitalized cardiothoracic transplant recipients (CTx) in comparison
to non-transplanted hospitalized patients. Therefore, we investigate CDI
incidences in hospitalised CTx recipients in comparison to non-CTx
recipients.
Methods: In a university hospital a prospective surveillance of all
CDI patients was performed from 2007 to 2009. Psychiatric patients
were excluded. CDI was deﬁned as diarrhea with a positive toxigenic
C. difﬁcile result, or the detection of pseudomembraneous colitis
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(diagnosed by endoscopy or positive histopathology). Incidences and
incidence densities in CTx and non-CTx-patients were determined. All
C. difﬁcile isolates were typed by PFGE.
Results: CDI incidences in Ctx and non CTx recipients were depicted
in table 1. 39 (2007), 68 (2008), or 38 (2009) patients were already
admitted with CDI (all non CTx). CDI incidences and incidence densities
declined over the time in both groups (table 1). Post transplantation
CDI incidences declined signiﬁcantly in CTx patients over the observed
period (p< 0.05). CDI incidences in CTx patients were higher in 2007
than in 2009 and in comparison to the hospital-wide incidences, but
incidence densities of CDI in CTx declined remarkably over the three
years. 5 out of 366 CTx patients (1.4%) developed CDI pre-Tx. Only one
patients required a colectomy (non CTx). No NAP I strain was detected.
Conclusion: CDI occurred more frequently in patients post CTx
compared to other patients admitted to a university hospital. CDI
densities in CTx declined over a three years period. It is not clear
whether the decrease of CDI cases in CTx patients was due to more
rigorous infection control measures, a strictly targeted antibiotic therapy,
or both.
R2586 Evaluation of the antimicrobial properties of copper
against clinical isolates of carbapenamase-producing
Enterobacteriaceae
M. Souli*, Z. Chryssouli, I. Galani, T. Panayea, G. Petrikkos,
A. Armaganidis, H. Giamarellou (Chaidari, Athens, GR)
Objectives: Copper has been shown to have antimicrobial properties
and when used on hospital surfaces it minimized environmental
contamination by pathogenic bacteria. We investigated the effects of two
copper alloys on the survival of VIM and/or KPC-producing multi-drug
resistant (MDR) Enterobacteriaceae.
Methods: MDR clinical isolates were screened for the production of
VIM or KPC carbapenemase using the EDTA-imipenem or the boronic
acid-meropenem synergy test, respectively. The genes were conﬁrmed
by PCR with speciﬁc primers. To assess the antimicrobial properties of
copper, coupons (1 cm× 1 cm) of copper alloys (A and B containing
Cu99% and Cu63%Zn37%, respectively) were sterilized, inoculated
with 20ml of bacterial suspension (108 cfu/ml) and incubated at room
temperature for 0, 1, 3, 5, 6 and 24 hours. Then coupons were placed
in sterile neutralizing broth (Difco) and vortexed. The broth was serially
diluted and quantitatively cultured for recovery of viable bacteria. The
lower limit of detection was 2.6 log10 cfu/ml. Stainless steel (C) and
polyvinylchloride (D) coupons were used as controls. Mean viable counts
(log10 cfu/ml) after incubation at each time interval with each coupon
were compared for statistical analysis. Reduction of viable counts by 3
log10 from starting inoculum was characterized as bactericidal activity.
Results: Thirteen isolates including K. pneumoniae (7), E. coli (4)
and Enterobacter spp. (2) producing either VIM (2), KPC (10) or
both (1) were tested. At 3 and 5 hours, mean viable bacterial counts
on coupon A decreased by 1.2 and 3.4 log10, respectively while the
reduction produced by coupon B at 5 and 6 hours was 2.1 and 3.2
log10, respectively. Controls C and D reduced bacterial counts by 2.1
log10 at 6 and by 2.3 log10 at 24 hours, respectively. A bactericidal effect
was detected by coupons A and B at 5 and 6 hours, respectively. Viable
bacteria could not be recovered from 10/13 tested strains incubated on
coupon A after 5 hours and from 8/13 strains after 6 hours of incubation
on coupon B.
Conclusions: Copper alloys reduced the number of viable carbapenem-
ase-producing bacteria signiﬁcantly at 3 hours and produced a
bactericidal effect at 5 hours. Cu99% was more effective than CuZn.
These data suggest that the use of copper as surface material in the
hospital could aid in diminishing the environmental reservoir of MDR
Gram-negative pathogens.
R2587 Educational approach to reduce catheter-related
bloodstream infections and catheter-related urinary tract
infection rates in intensive care unit
R. Guner, I. Hasanoglu, S. Keske, M.A. Tasyaran* (Ankara, TR)
Objectives: Central venous catheter (CVC) usage is becoming more
and more frequent in intensive care units (ICU). Besides its mechanical
complications, catheter related bloodstream infections (CRBSI) are
frequent, preventable and costly with high mortality and morbidity.
Although it is essential for an ICU patient, urinary catheterisation also
brings the risk of catheter related urinary tract infection (CRUTI).
We aimed to decrease our CRBSI and CRUTI rates with observation,
education, feedback of infection rates, and reward.
Methods: We performed an observational intervention study in a 550-
bed education and training hospital in Ankara, Turkey with twelve
neurology-neurosurgery, ten coronary, six cardiovascular surgery and
nine general ICU beds. The study was carried out in three phases,
as preintervention, intervention, and postintervention. After six months
of preintervention period, we performed education meetings to all ICU
doctors and nurses. Education program highlighted prevention bundle of
urinary catheter (UC) and CVC related infections. We observed CVC and
UC with checklists and follow-up charts. CRBSI and CRUTI diagnosis
were performed according to CDC deﬁnitions.
Six months after the education, all staffs of the departments which
decreased their infection rates were promised to be awarded with 10%
pay raise.
Results: During the study period 462 CVCs and 1258 UCs were inserted
to 1075 patients and catheter days were 4313 and 6918, respectively.
Most observed indications of CVC are peripheral intravenous access
problem (41%) and haemodialysis (29%). Insertion sites were 41%
jugular and 41% subclavian. 20% of CVCs were inserted in emergency
conditions. Mean lenght of catheterisation was 11 days. Compliance to
maximum barrier precautions was 41%, but this rate was correlated with
doctors’ education years. Most common displacement reasons for CVC
were exitus (50%) and discontinuity of indication (32%). Compliance to
prevention bundle was 13%. Mean lenght of catheterisation was 13.25
days. There was a relationship between the clinic which inserted the
catheter and compliance to maximum barrier precautions for CVCs and
UCs. We decreased our CRBSI rates from 8.2 to 3.19 (61%) and CRUTI
rates from 3.7 to 2.19 (40.8%).
Conclusion: Our study showed that education, feedback of infection
rates, and reward are effective for reducing CRBSI and CRUTI rates but
continuity of education is essential for maintaining low infection rates.
R2588 Outbreak of carbapenem-resistant enterobacteria in a
Brazilian university hospital
C. Carrilho*, J.C. Pascual Garcia, R.A. Belei, N.S. Paiva, N.J. Cornetta,
R.L. Oricolli, C. Grion, M. Pelisson, S.F. Costa (Londrina, BR)
Objectives: Report an outbreak of carbapenem-resistant enterobacteria
in a university hospital, control measures and mortality associated with
these pathogens.
Methods: Retrospective observational study about the experience of
controlling an outbreak of carbapenem-resistant enterobacteria in a
Brazilian University Hospital during the period of February 2009 to
November 2010. Pathogens were isolated from vigilance cultures or
cultures from sites suspected of infections.
Results: During study period 360 patients were identiﬁed as having
positive cultures for carbapenem-resistant enterobacteria, mainly by
carbapenemase production as mechanism of resistance (KPC-2).
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Microorganisms more frequently isolated were K. pneumoniae (94.4%)
and Enterobacter spp (5%). The outbreak began on February 2009 with
nineteen cases, decreased to one case in June 2009 after control measures
that included isolation, cohort, contact precautions and decreasing
number of circulating people inside the hospital and closing of most
affected units. On July 2009 there were new cases, despite control
measures, and nowadays the number of monthly identiﬁed patients is
around 21 new cases, becoming endemic in our hospital. Most identiﬁed
cases were hospitalized (97.8%) in the following units: Intensive Care
Unit (49.0%); Wards (33.1%); Emergency Department (12.3%) and
Burn Unit (3.4%). Approximately half the patients were considered
colonization (55.2%). Infected patients were treated with polymyxin
with or without associated antibiotics. Among infected patients, more
frequently identiﬁed sites of infections were: lungs (38.0%), urinary
tract (27.7%), blood (9.0%) and catheter (5.1%). There was more than
one of site infection in 14.8% of infected patients. Hospital mortality
was 47.8% for all patients. Infected patients had higher mortality rate
(58.8%) compared with colonized patients (38.3%; p< 0.001). Patients
with positive blood cultures for these pathogens had higher mortality
(70%) compared to other patients (46.4%; p = 0.03).
Conclusions: Carbapenem-resistant enterobacteria are a great challenge
concerning control and treatment. These outbreaks take place frequently
in the Intensive Care Units, nearly half the patients manifest infections
and mortality among infected patients is high.
R2589 Incidence of nosocomial methicillin-resistant Staphylococcus
aureus after a hospital prevention and control programme
implementation
C. Farin˜as-Alvarez*, P. Rodriguez-Cundin, M.L. Fernandez-Nun˜ez,
O. Gonzalez-Martinez, I. De-Benito, A.B. Campo-Esquisabel, R. Teira,
G. Marcano (Santander, ES)
Objectives: Methicillin-resistant Staphylococcus aureus (MRSA) is one
of the most important multidrug-resistant bacteria. Its surveillance and
control must be a priority in a hospital setting. The aim of this study is to
describe the incidence of MRSA in our hospital after the implementation
of a prevention and control programme.
Methods: The programme of prevention and control was implanted in
2003 after a nosocomial MRSA outbreak, with an incidence of 0.24% in
2002. It is based in a bundle of recommendations: identiﬁcation, isolation
and control of the incidental cases, early detection of the condition of
carrier and record of incidental cases in a database. This computing
record is linked to the hospital information system (HIS) that allows us
to detect the hospital readmissions of colonized/infected patients. These
patients are isolated immediately.
Results: After the programme implementation, a gradual increase of the
incidence was observed in the last six years at expense of community-
associated MRSA (0.08% in 2003, 0.09% in 2004, 0.13% in 2005, 0.15%
in 2006, 0.16% in 2007, 0.16% in 2008 and 0.25% in 2009) while
the incidence of nosocomial MRSA has kept around 0.1% (0.15% in
2003, 0.10% in 2004, 0.11% in 2005, 0.07% in 2006, 0.14% in 2007,
0.12% in 2008 and 0.12% in 2009). The most frequent location of
infection for nosocomial MRSA during these years has been always the
low respiratory tract infection with or without pulmonary condensation
(25.0%) followed primary bacteraemia (11,8%), and for community-
associated MRSA the cutaneous infections (72,7%). All patients were
isolated after detecting the MRSA: the daily average was 5 isolated
patients which represented 2.5% of hospital bed occupancy.
Conclusions: We have not detected any nosocomial MRSA outbreak in
our hospital from 2003. The incidence of nosocomial MRSA is kept
in rates around 0.1%. It is important to emphasize the decrease of
the proportion of nosocomial MRSA isolations, whereas community-
associated MRSA have increased. A dynamic record connected to
the hospital information system allows us to identify and control the
colonized/infected patients before any entry to the hospital.
R2590 Evaluation of the use of a commercial PCR to detect
methicillin-resistant Staphylococcus aureus in screening
swabs during one year
M.E. Van De Vyvere*, M. Mollemans, K. Camps (Antwerp, BE)
Objectives: Retrospective evaluation of the results in the detection of
MRSA of a commercial PCR (Genohm®, Becton Dickinson) compared
to culture (chromID™ MRSA, Biome´rieux) after one year use (2009)
in two geriatric wards (60 beds) and an intensive care unit (8 beds) of
a 415 bed community hospital. Any impact on MRSA epidemiology is
also evaluated.
Methods: All patients were screened on admission in the geriatric wards
and in the intensive care unit. Swabs taken from nose and perineum were
pooled, tested by PCR and inoculated on chromogenic agar to detect
MRSA. No enrichment in broth culture was made. Samples arriving on
Friday evening and in the weekend were not examined by PCR. Patients
were isolated as soon as MRSA positive results of PCR or culture were
known.
Results: 1136 samples were examined by PCR. Results of PCR are
evaluated as false positive if culture was negative in primary and all
subsequent samples in the same period with a minimum of two. A PCR
negative result in combination with positive culture is regarded as false
negative. A total of 35 samples were evaluated as MRSA positive. The
results for PCR are shown in the table. The sensitivity of the PCR is
71.4%, speciﬁcity 99%, PPV 67.6% and NPV 99%.
Four patients from the involved wards screened positive in culture while
PCR was not performed because of admission in the weekend.
From 2007 until 2010 there was a decline in MRSA incidence: from
11/1000 admissions in 2007 to 8/1000 in 2009. A proportionate reduction
was seen in screening on admission (also in the geriatric wards and
ICU), in infection on admission and infection >48h after admission.
Remarkable is the decline in MRSA positivity on admission in patients
residing in a nursing home: from 61 MRSA+ patients in 2007 to 39 in
2009.
Conclusion: In our hands the Genohm® PCR test had a rather low
sensitivity and positive predictive value compared to culture even if
culture was not ideal (only two sites, no enrichment). Introduction of the
PCR was meant to reduce transmission of MRSA and hence reduction
of infection by faster isolation because of the speed of the test. We can
not deduce from our data that this policy has had any impact on the
decrease of nosocomial MRSA infection.
R2591 Turning foe into friend: an innovative multidisciplinary
Clostridium difﬁcile performance management meeting to
spearhead trust CDI programme
A. Guleri*, R. Palmer, L. Moorhouse, S. Staff, N. Harper, J. Lickiss
(Blackpool, UK)
Background: Blackpool Victoria, a large district teaching foundation
trust hospital in NW England, operates a very successful comprehensive
CDI containment programme. There is special emphasis on antibiotic
stewardship and real time programme monitoring initiatives like root
cause analysis of all CDIs in community/acute trust, multidisciplinary
audit and surveillance. We present ﬁndings from 1st 6-months
of an innovative pilot project “multidisciplinary CDI performance
management meetings [MCPM]” aimed to spearhead the trust CDI
programme in future. The aims of MCPM include team working,
problem solving, real time “shop-ﬂoor” troubleshooting, raising proﬁle
and awareness in a friendly interactive session. The results have been
used to inform a regularly monitored strategic action plan.
Methods: MCPM are scheduled with 7days of an avoidable CDI. A
rapid turnaround [within 24h] rootcause analysis is carried out jointly
by infection control and microbiologist to identify avoidable/unavoidable
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CDI. Following which MCPM is organised by DIPC/dep medical director
or Director of Nursing to which are invited divisional head nurse, matron,
staff nurse, antibiotic/ward pharmacist, consultant/s from clinical areas
during patient transfer, consultant microbiologist. Initial RCA is now
discussed in details dissecting out sequential aspects of patient care and
clinical management leading upto episode of CDI. Database review.
Results: CDI rates have consistently delined since launch of CDI pro-
gramme. An overall 58%[469/2007−08 to est 200/2010−11] reduction;
with community and acute trust CDI reductions of 41%[146/2007−08
to est 85/2010−11] and 64% [323/2007−08 to est 115/2010−11]
respectively. Key results of rootcause analysis [2009 till date] and
MDT audit/surveillance to be presented. Key outcomes from MCPM
include:inappropriate [choice, duration, dose, review/stop, guideline non-
compliance] antibiotic use; poor/missing documentation; low stafﬁng;
fall of communication between nurse/medical staff;absence of risk based
prescribing, etc. Details to be presented.
Conclusion: Trust comprehensive CDI programme is aimed at reducing
avoidable CDIs, associated morbidity, mortality & costs and increase
quality of care and patient safety. The key results of the RCAs and
MDT audit/surveillance to be presented. The MCPM have been found
to be most useful for all attendees. The results have been used to inform
regularly monitored CDI strategic action plan.
R2592 Epidemiologic survey of nosocomial infections with
molecular typing methods in haematologic patients
R. Fanci*, P. Pecile, E. Casalone, I. Giacomelli, S. Bencini,
G. Mastromei, A. Bosi (Florence, IT)
Objectives: Epidemiologic survey of infections in cancer patients is
an important tool to understand the nosocomial pattern and emerging
antibiotic resistance; in addition regular monitoring is essential to
identify outbreaks and possible transmission route. To evaluate this risk
we conducted a prospective molecular epidemiologic investigation in
hematologic patients.
Methods: From 2006 to 2009, 540 hematologic patients were monitored
employing the Vigi@ct epidemiological information system and the
f-AFLP (ﬂuorescent-ampliﬁed length fragment polymorphism) microbial
ﬁngerprinting method.
Results: Bloodstream infections (BSIs) was documented in 32% of total
study population (175/540). BSIs were present in 69% of acute leukemia,
in 16% of non-Hodgkin lymphoma, in 5% of myeloma and in 10% of
other hematologic diseases. Among the pathogens responsible for BSIs,
117 (67%) were Gram-positive: CoNS 63%, enterococci 28%, S. aureus
3%, other 6%; 53 (30%) were Gram-negative: E. coli 43%, P. aeruginosa
28%, S. maltophilia 13%, KES group 16%; 5 (3%) were fungi.
Of Gram-positive, 100% of CoNS and 59% of S. aureus were meticillin
resistant, whereas 18% and 50% of enterococci were VRE (VanA-type)
and HLAR (High-level Aminoglycoside-Resistance), respectively.
Of Gram-negative, resistance to ceftazidime occurred in 16% of E. coli,
46% of KES and 75% of P. aeruginosa; resistance to quinolones occurred
in 75% of E. coli, 53% of KES and 52% of P. aeruginosa; resistance
to b-lactamase inhibitors occurred in 20% of E. coli, 46% of KES and
33% of P. aeruginosa; resistance to carbapenems (meropenem) occurred
in 8% of KES, 14% of P. aeruginosa, while no E. coli strain was resistant.
In 2008 we recorded one P. aeruginosa PAN-R strain, sensible only
to colistin. In May-September 2008, an unexpected high incidence of
VRE was reported. AFLP analysis of these VRE strains documented a
genetic relationship between two different groups of isolates: 2 isolates
show similar AFLP patterns but different from those of the other 4
genetically related isolates. These data suggest a possible person to
person transmission. After corrective measures no other case of VRE
was documented. No Gram-negative outbreak was recorded in the same
period.
Conclusion: Our results showed a new increase of Gram-negative infec-
tions and a progressive antimicrobial resistance. The high discriminatory
AFLP method was fast enough to allow a ’real-time’ monitoring of the
outbreak, permitting additional preventive measures.
R2593 Clostridium difﬁcile detection: identiﬁcation of colonisation,
subclinical and overt disease
F.M. Awadel-Kariem*, C. Malone, H. Gough, H. O’Connor (Stevenage,
UK)
Background: Detection of C difﬁcile or its toxins has been observed
to be problematic. False negative results have meant that patients
were tested repeatedly when symptomatic. Among the reasons for
poor negative predictive value are the labile nature of the toxins and
the limitations of available technologies. Newer and more sensitive
technologies were introduced such as PCR. These technologies have
reduced the rates of false negatives and eliminated the need for multiple
samples. In recent years, and through a combination of infection
control measures, CDAD rates were reduced dramatically. However,
these successes brought to the front the signiﬁcance of high false positive
rates especially with the ultra-sensitive new technologies. It is well-
established that toxin-producing C. difﬁcile can colonise young children
and older patients with history of repeated and prolonged hospitalisation.
There is a need for a new approach to determine the clinical value of a
positive result.
Objectives: This study was designed to assess the concordance between
different toxin assays and clinical presentation in Antigen positive/Toxin
negative patients.
Methods: Twenty six Antigen positive/toxin negative stool samples
(Techlab EIA for both GDH Ag and toxin) were included in the study.
Patients with multiple samples were identiﬁed. Samples were then tested
using VIDAS EIA, culture and ribotyping, CEPHEID GeneXPert PCR
and cytotoxicity assay. Clinical presentation and follow up data were
then analysed to assess clinical signiﬁcance of each result.
Results: Patients who had alternative explanations for their transient
diarrhoea (e.g. laxatives), were found to be toxin-negative by EIA.
However, 86% of these samples were positive by PCR and all produced
cytotoxic effects following culture. Isolates were from a number of
ribotypes (001, 002, 015 and 054).
Conclusions: These results suggest that combined clinical/laboratory
interpretation is of more value at the current epidemiological setting.
Highly sensitive technologies, such as PCR, may detect the presence of
toxin genes in cases of colonisation or subclinical presence of C. difﬁcile.
Our data suggest that samples found to be Antigen positive but toxin
negative by EIA, in the presence of alternative clinical causes for
diarrhoea, should be treated as colonisation. However, these patients
should be monitored closely and should be isolated, while having
diarrhoea, to limit environmental contamination.
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R2594 Patients with chronic foot osteomyelitis: 10-year evaluation
(1999–2009) in a Greek reference clinic of a tertiary
university hospital
P. Nikou*, E. Giannitsioti, S. Athanasia, A. Drakou, E. Koratzanis,
V. Sakka, K. Kouvelas, S. Kanellaki, A. Fragkou, G.M. Gourgoulis,
G. Koukos, P. Panagopoulos, E. Paramythiotou, D. Plachouras,
V. Spyropoulos, H. Giamarellou, A. Papadopoulos, K. Kanellakopoulou
(Athens, GR)
Objectives: Chronic foot osteomyelitis (CFO) is a diagnostic and
therapeutic challenge for appropriate regimen and length of antimicrobial
therapy. Most CFO occurred on the ground of diabetic foot (DF).
This study aims to evaluate factors inﬂuencing successful outcome in
patients (pts) with CFO with or without DF.
Patients and Methods: Pts with CFO were retrieved from a data-base of
700 pts with bone and joint infections followed in our reference clinic
from 1999 to 2009. Demographics, DF, foot vascular and neurologic
complications, charcot joint and gangrene were assessed following
standard deﬁnitions. Diagnosis of CFO was based upon clinical, imaging
and laboratory/microbiological evaluation. A completely restoration of
all the above parameters was considered as cure. Chi-square and Mann
Whitney tests were applied for categorical and continuous variables
respectively. A logistic regression analysis of factors predictive of
outcome was performed.
Results: DFO pts (n = 137), were male (59%) with median age +
IQR(25−75) = 60 (52−70) and comorbidities (n = 76) including diabetes
mellitus-DM (n = 64, insulin dependent, n = 60), rheumatic arthritis
(n = 3), non DM vascular disease (n = 6), vascular (n = 44), neurological
(n = 27) DM complications, charcot joint (n = 22) and gangrene (n = 24)
with amputations (n = 25) and orthopedic device (n = 2). HbA1C was
above 7 in32 pts. Median IQR(25−75) time from infection onset to
treatment was 5 (2−12) months. Sinus tract and ulcer but no fever were
found in 71 and 49 pts respectively. Microbiological documentation of
DFO was based on intra-operative cultures (n = 83), prone to the bone
or aspiration samples (n = 21). Gram positive bacteria (86%) included
MRSA (32.5%), MRSE (17%) while Gram negative bacteria accounted
for 49%. Among 84 polymicrobial cases, 16.6% were S. aureus plus
P. aeruginosa. ESR/CRP baseline were abnormal in 90% of pts.
Combined antimicrobial therapy was given to 117/137 pts including
ﬂuoroquinolones (n = 92,67%). Only 16 fully reversible adverse events
were noted. Median IQR (25−75) treatment duration was 6 (6−8) months.
However, 34% were treated for up to 3 months, 42% up to 6 months
and 24% more than 6 months. Median follow up was 12 months. Cure
Analysis demonstrated that only HbA1C more than 7 was independently
related to adverse outcome (p = 0.0001).
Conclusions: Only normal HBA1c and n were predictive of the pts’
outcome. Strict glycemic control is mandatory in the management of pts
with DFO.
R2595 Comparison of two chromogenic media, Oxoid
Brilliance™MRSA II Agar and ChromID™MRSA, for
detection of methicillin-resistant Staphylococcus aureus
from surveillance specimens
R. Kofol*, N. Svent-Kucina (Ljubljana, SI)
Objectives: Rapid routine screening of patients for methicillin-
resistant Staphylococcus aureus − MRSA is very important. Improved
chromogenic media can detect MRSA within 18−24 hours. The purpuse
of this study was to evaluate the abillity of two chromogenic media
Oxoid Brilliance™MRSA II Agar (Oxoid, Ltd, Basingstoke, UK) and
ChromID™MRSA (bioMe´rieux, Marcy-l’Etoile, France), for detection
of MRSA from surveillance specimens.
Methods: Brilliance and ChromID were tested using six strains of
MRSA (ATCC 43300), hVISA (ATCC 700698) and hGISA (ATCC
700699), two strains of MSSA (ATCC 29213) and a strain of E. faecalis
and E. coli. The rest were strains isolated from patients (laboratory
strain collection). One to two colonies of the test strain from the third
subcultivation were inoculated on Brilliance and ChromID. 55 patient
samples were processed. Skin, nose or throat swabs were sent in an
Amies transport medium. Each sample was inoculated into Todd-Hewitt
enrichment broth (THBS), blood agar (BA), Brilliance and ChromID.
The ﬁrst 28 samples were inoculated in the following order: 1. THBS
2. BA, 3. Brilliance, 4. ChromID. The next 27 samples were inoculated
in a different order: 1. THBS 2. BA, 3. ChromID, 4. Brilliance. The
plates were inspected after 18−21h of incubation at 35ºC. The plates
were inspected after 18−21h of incubation at 35ºC. All denim-blue
colonies on Brilliance and green colonies on ChromID were processed
according to CLSI guidelines. Antimicrobial susceptibility testing was
performed for all DNAse and coagulase positive strains with positive
result of methicillin-resistance screening (MRSA strains) according to
CLSI guidelines. Denim-blue and green colonies that were DNAse and
coagulase negative (regardless of the result of methicillin-resistance
screening) were considered false positive (CNS); DNAse and coagulase
positive and oxascreen negative colonies were considered false positive
(MSSA).
Results: All MRSA strains produced denim-blue or green colonies
following 18−24 hours of incubation (Table 1). One discrepant result
was obtained from a patient sample, the colonies denim-blue were on
Brilliance, and yellow on ChromID. MRSA was conﬁrmed in both
cases. Strains of MSSA, E. faecalis and E. coli failed to grow on both
chromogenic media.
Conclusion: Both agars are fast, easy to use and reliable. They require
no additional costs and are accessible to every microbiological laboratory
in comparison with rapid PCR methods.
R2596 Cytokines in the ascitic ﬂuid of cirrhotic patients with and
without spontaneous bacterial peritonitis
M. Lagadinou*, A. Mouzaki, S. Giali, M. Marangos, H. Bassaris,
C. Gogos (Patras, GR)
Aim: The compartmental immune response of ascitic ﬂuid seems to be
important, especially in spontaneous bacterial peritonitis (SBP). The aim
of our study was to determine the pattern of cytokine synthesis in the
ascitic ﬂuid (AF) of cirrhotic patients, with or without SBP.
Patients and Methods: We prospectively studied 13 cirrhotic patients
with ascitis, who were admitted at the University Hospital of Patras
from May 2006 to December 2007. Patients were separated into
two groups: (a) group 1: patients with SBP (b) group 2: patients
without SBP. Cirrhosis was diagnosed on the basis of typical clinical,
laboratory, ultrasonographic ﬁndings and/or liver biopsy. Upon admission
a paracentesis of ascetic ﬂuid was performed. Ascitic levels of IL-1b,
IL-1ra, IL-6, IL-10, TNFa, sTNFRI and sTNFRII were measured by
using an ELISA method. Data are presented as mean±standard deviation
and were compared using t test. A P value <0.05 was considered
signiﬁcant.
Results: Characteristics of patients with SBP VS those without SBP are:
age 69±12 vs 62±15, male/female ratio 5/2 vs 5/1, ethanol use 5 vs 4,
viral hepatitis 1 vs 2, cryptogenic 1 vs noone. The ascitic concentrations
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of individual cytokines in group 1 vs group 2 are the following: IL-10:
160±142 vs 80±74, IL-6: 2413±3183 vs 2257±2478, TGF-a: 11±20
vs 0.5±1, sTNFRI: 8191±3077 vs 5618±2384, sTNFRII: 5259±2354
vs 2883±932, IL1-ra: 946±703 vs 131±84, TGF-1b: 279±681 vs
378±671.
Multivariate analysis showed signiﬁcant (P< 0,05) differences in the
levels of sTNFRII and IL-1ra between the two groups. Ascitic levels
of IL-10, IL-6, IL-1ra, TNF-a, STNFRII and STNFRI were higher,
while TGF-b1 levels were lower in the ascitic ﬂuid of patients with
SBP (differences not signiﬁcant). It is remarkable that IL-1b was
not expressed in patients either with or without spontaneous bacterial
peritonitis.
Conclusions: We demonstrated an increased cytokine production in
ascitic ﬂuid of cirrhotic patients, while the levels of anti-inﬂammatory
cytokines sTNFRII and IL-1ra are signiﬁcantly increased in patients with
SBP. It seems, therefore, that an ascitic ﬂuid anti-inﬂammatory response
is characteristic in SBP,and this might compromise the ﬁnal outocome.
R2597 Screening for extended-spectrum b-lactamase-producing
Enterobacteriaceae: which sites?
S. Tschudin Sutter*, R. Frei, M. Dangel, A.F. Widmer (Basel, CH)
Introduction: Extended-spectrum b-lactamases (ESBL)-producing or-
ganisms belong to the most important multiresistant pathogens in
hospitals. More recently, ESBLs are also spreading in the community
worldwide. Carriers of ESBL-producing Enterobacteriaceae remain
colonized for prolonged periods, possibly representing an important
source of spread. Knowledge on the body sites most commonly colonized
with these pathogens is therefore of great importance in order to develop
appropriate screening schemes. The aim of this study therefore, was to
determine the frequency of colonization for each body site.
Methods: From January 2008 to December 2010 all patients with
detection of an ESBL-producing Enterobacteriaceae in any specimen
were screened for colonization by examination of urine samples, rectal
swabs, inguinal swabs, throat swabs, as well as wound samples. ESBL
production was identiﬁed as recently described (Buehlmann M. et al.,
ICHE 2010;31: 227−8;none of these pusblised data are included in our
study sample. The frequency of detection of ESBLs was calculated for
each site.
Results: ESBL-producing Enterobacteriaceae were detected in 749
samples from 303 patients. 369 (38.6%) of all urinary samples, 219
(22.9%) of all rectal swabs, 92 (9.6%) of inguinal skin swabs, 35 (3.7%)
of all throat swabs and 34 (3.6%) of all wound samples revealed ESBL-
producing Enterobacteriaceae.
Conclusions: Urine and the rectum are the sites most commonly
colonized with ESBL-producing Enterobacteriaceae (61.5%) followed by
the inguinal fold. These three sites should therefore be considered when
screening for ESBL carriage is performed. Throat swabs and wound
samples were positive in less than 5% of all specimens, suggesting that
these sites are not useful for screening, however should be considered
in the individual patient if a decolonization regimen is performed.
R2598 Paediatric and neonatal intensive care healthcare workers:
knowledge of evidence-based guidelines for preventing
central venous catheter-related infection
M. Guembe*, A. Pe´rez-Parra, M. Sa´nchez-Luna, E. Zamora, A. Cuenca,
A. Bustinza, A´. Carrillo, E. Go´mez, B. Padilla, P. Martı´n-Rabada´n,
E. Bouza (Madrid, ES)
Assessment of knowledge of CDC guidelines for the prevention of
central venous catheter (CVC)-related infection is recommended for
healthcare workers (HCWs). Information on this knowledge in pediatric
and neonatal intensive care units (P-ICU, N-ICU) is very scarce, and
there are no comparative data on knowledge between physicians, nurses,
and medical/nursing students.
Objectives:We compared different professional groups in order to assess
HCWs knowledge of guidelines for preventing CVC-related infection in
the P-ICU and N-ICU of a large teaching institution.
Methods: We distributed a 12-question multiple-choice questionnaire to
HCWs in both units between November 2009 and May 2010. We also
recorded participants’ demographic data. Each correct answer was scored
as 1 and incorrect answers as 0. We created individual and grouped scores
of adequate responses ranging from 0 to 12.
Results: We collected 174 questionnaires from both the P-ICU and the
N-ICU (91 and 83, respectively). Of these, 6 (3.4%) were returned by
medical staff, 2 (1.1%) by medical residents, 99 (56.9%) by nurse staff,
18 (10.3%) by replacement nurses, 8 (4.6%) by nursing students, and
41 (23.6%) by nursing assistants. The overall mean score was 7.05. As
for professional category, there were statistically signiﬁcant differences
between mean scores for nursing assistants (5.9) and medical/nursing
staff (8.7 and 7.6). Moreover, years of experience were associated
with better scores (>10y, 8.1 vs. <1y, 6.9 and 1−5 y, 6.7) and those
participants who received training sessions in the last year had better
scores than those who did not (7.7 vs. 6.6).
Conclusions: Our results show that there is room for improvement
in HCWs knowledge of prevention of CVC infection. Simple, easy-
to-obtain scores can help to evaluate the impact of educational and
interventional bundles.
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R2599 Antibiotic usage and risk factors in increasing antimicrobial
resistance rates
H. Gedik* (Istanbul, TR)
Background: Aim of this study was to investigate the risk factors
associated with high antibiotic resistance rates belong to Gram positive
and negative organisms isolated in 2010 using epidemiological analysis.
Methods: A case–control study of 72 patients with Extended Spectrum
b Lactamase producing organisms and 33 patients with Amp C producing
organisms, 222 patients with non-ESBL organisms and 75 patients with
Gram positive organisms was conducted in a subsidial care hospital
of C¸anakkale province. Demographics, co-morbidities, antibiotics usage
were analysed for all patients.
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Results: ESBL and AmpC (+) producing microorganisms were more
isolated from patients that belong to over 65-year age and 0−1 age
groups (p:0,005). The risk factors including hospitalisation (OR:3,1;
1,19−8,1; p:0,018), co-morbidity (OR:2,1; 1,12−7,3, p:0,024), were
found higher in ESBL (+) group compared to ESBL(−) group.
Hospitalisation at last three months was found as a risk factor for
resistance to any 3rd generation cephalosporins (OR:2,4; 0,9−6,3;
p:0,04). There was a correlation between ESBL (+) production and
resistant to many antibiotics that are generally used for ampiric
treatment (p< 0,05, Pearson correlation r: 0,78), except for piperacillin-
tazobactam (p> 0,05). ESBL production was signiﬁcantly higher in
K. pneumoniae (p: 0,0005), E. cloacae (p:0,001), E. sakazakii (p:0,001)
and A. baumannii (p:0,005) strains more than other Gram negative strains
revealed in Table-1. Hospitalisation was single signiﬁcant risk factor for
patients with MRSA (OR:1,8, 0,7−1,2, p:0,005; Table-1). Vancomycin
resistant Enterococcus was not isolated.
Discussion: Hospitalisation and co-morbidity causing to colonisation
and impairment on immunity are the most important risk factors
for ESBL producing microorganisms related infections as our study
revealed. Although antibiotic usage including 2nd, 3rd generation
cephalosporins and quinolones was cited as a risk factor for ESBL
related infections, it was not found signiﬁcant statistically in our
study. Piperacillin-tazobactam could be thought as an option to treat
the resistant Gram negative infections associated with K. pneumoniae,
E. cloacae, E. sakazakii and A. baumannii whose ESBL rates are
frequently higher in our local settings but carbapenems, should be
opted for serious patients with co-morbidites. Consequently, immunity
and infection control programs are important factors against increasing
antibiotic resistance rates.
Table 1. Characteristics of patients and isolated microorganisms
ESBL(+)
Group,
n: 72
AmpC(+)
group,
n: 33
ESBL and AmpC (−)
Gram negative Group,
n: 222
Gram
positive
group,
n: 48
Total,
n: 375
Female/Male 42/30 18/15 150/72 33/42 243/159
AGE
Median 1 6 1 3 1
Range 0–78 0–69 0–77 0–78 0–78
0–1 age 24 9 93 33 159
1–5 age 18 6 30 9 63
5–15 6 3 42 6 57
15–65 9 6 39 24 78
>65 18 9 12 9 48
SAMPLES
Urine 51 21 68 54 194
Sputum 6 3 12 − 21
Blood 3 3 − 6 12
Wound 3 3 3 6 15
Conjunctiva − − − 15 15
Catheter 6 3 − − 9
Abscess − − 3 − 3
CO-MORBIDITY
Urinary system abnormality 9 6 45 9 69
Chronic Obstructive Lung Disease 6 6 12 9 33
Diabetes mellitus − − 12 9 21
Chronic Renal Failure − − 6 6 12
Catheter − − 6 6 12
MICROORGANISMS
E.coli 18 9 126 153
K.pneumoniae 12 3 30 45
Enterobacter cloacae 15 9 15 39
Enterobacter sakazakii 6 6 − 12
Pseudomonas aeruginosa − − 9 9
Enterobacter aerogenes 3 − 3 6
Citrobacter freundii 6 6 6 18
Morganella morganii 3 − 3 6
Providencia stuartii − − 3 3
Acinetobacter baumannii 3 − − 3
Enterobacter gergoviae − − 6 6
Klebsiella oxytoca − − 24 24
Enterococcus faecalis − − − 33 33
Enterococcus faecium − − − 3 3
Methicillin resistant S.aureus − − − 3 3
Methicillin susceptible S.aureus − − − 9 9
Methicillin resistant coagulase negative
staphylococci
− − − 15 15
Methicillin susceptible coagulase negative
staphylococci
− − − 18 18
Antibiotic usage (at last 3 months)
Ceﬁxime 45 18 123 42 228
Ceftriaxone 33 15 78 18 144
Amoxicillin-clavulanate 57 30 150 54 291
Amoxicillin 63 33 156 48 300
Cefuroxime 15 9 51 15 90
Quinolones 12 9 15 6 42
Hospitalisation 51 15 84 51 186
Resistance to any 3rd-generation cephalosporin 19 16 15 50
R2600 Infections in patients with traumatic brain injury: a 7-year
retrospective study
I. Kourbeti*, A. Vakis, J. Papadakis, D. Karabetsos, G. Bertsias,
M. Filippou, A. Ioannou, C. Neophytou, G. Samonis (Chalkida,
Heraklion, GR)
Objective: Infections in patients with traumatic brain injury (TBI) are
associated with prolonged hospitalisation and adverse outcomes. The
acknowledgement of the pre-disposing risk factors may help decrease
the morbidity and mortality. We conducted a retrospective cohort study
to determine the incidence, bacteriology and risk factors for development
of infection after TBI.
Methods: The records of patients >18 years old, admitted with head
injury in Crete Univ Med Ctr between 1999 and 2005 were abstracted.
Data were analysed with SPSS.
Results: 760 patients (75% men, median age 41) were analyzed. Two
hundred ﬁfty eight patients (33% of the admissions) underwent 342
surgical procedures. Burr-hole was the most common procedure (29.2%).
The median duration of surgery was 2 hours. In 23% of the patients there
was some kind of drain inserted.
Two hundred fourteen infections were observed. The majority were
infections of the lower respiratory tract (47%), mainly ventilator
associated pneumonia (VAP) (33%), followed by surgical site infections
(SSI) (17%). Fifty three of the admissions (6.3%) were complicated with
at least one SSI, superﬁcial or deep. The most common SSI was wound
infection (2.2% of the cohort).
The patients who underwent neurosurgery had a lower Glasgow Coma
scale (GCS) on admission, they were more prone to be admitted to
the Intensive Care Unit and bear drains. They were also more prone to
develop meningitis, SSI and had increased mortality.
Multivariate analysis showed that SSI development was independently
associated with performance of >2 procedures (p< 0.001), presence
of concomitant infections, namely VAP (p = 0.004) and urinary tract
infections (p = 0.001), insertion of lumbar (p = 0.002) and ventricular
drains (p = 0.050) and cerebrospinal ﬂuid (CSF) leak (p = 0.050).
Meningitis was independently associated with prolonged hospitalisation
(p = 0.001) and insertion of lumbar (p< 0.001) and ventricular drains
(p = 0.0017).
There was a predominance of Acinetobacter spp as a VAP
pathogen (38%) whereas Gram(+) organisms (especially coagulase-
negative staphylococci) remained the most prevalent in SSI (53%).
Conclusions: Respiratory tract infections were the most common among
patients with head injury. Device-related communication of the CSF with
the environment and prolonged hospitalisation were independent risk
factors for SSI and meningitis. The prevalence of the pathogens must
be determined upon institutional basis for the establishment of proper
treatment of these life threatening infections.
R2601 Prevalence of hospital-acquired infections at Duzce
University Hospital, Turkey
M.F. Geyik, M. Yildirim*, D. O¨zdemir, A. Sahin, S. Yener (Du¨zce, TR)
Objectives: Rates of hospital-acquired infections have varied between 5
and 10 episodes per 1000 hospital admissions and continue to be a major
problem, causing high morbidity, mortality and signiﬁcantly increasing
the length of hospitalization and cost of treatment. The purpose of
this study was to evaluate the hospital-acquired infections at Duzce
University Hospital, in Turkey.
Methods: The study was carried out at the Duzce University Hospital
(350-bed). 2009 prevalence of hospital-acquired infections in our hospital
was prospectively evaluated. A total of 11333 inpatients were searched.
Results: During one year follow up period, 384-hospital-acquired
infection episodes were detected in hospitalized patients (n = 11333). The
prevalence rates of patients with hospital-acquired infections were 3.4%.
The incidence density was 5.2/1000 patient days. The most common
hospital-acquired infections by primary site were pneumonia (47.1%),
followed by urinary tract infection (19.5%), surgical site infections
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(16.9%), bacteremia (14.8%), and other infections (1.6%). Hospital-
acquired infections were seen frequently in the department of neurology
(7.7%), internal medicine (3.3%), neurosurgery (2.9%), general surgery
(2.5%), urology (2.4%), orthopedics (1.9%), infectious disease (0.5%),
pediatrics (0.5%). Hospital-acquired infection rate in intensive care units
was 26.2%. The most prevalent microorganisms were Pseudomonas
spp. (33.5%), Escherichia coli (14.5%), Staphylococcus aureus (12.6%),
Acinetobacter spp. (9.5%), coagulase-negative staphylococci (8.1%),
Enterobacter spp (7.2%), Klebsiella spp. (6%), Enterococcus spp.
(3.1%), Stenotrophomonas spp. (2.3%), and other microorganisms
(3.1%).
Conclusion: Hospital-acquired infections in inpatients should be
screened by proper nosocomial infection control programs. The
clinical and microbiological monitoring of hospital-acquired infections
for nosocomially infected patients should be necessary. The routine
application of standard infection control practices may reduce the
incidence of hospital-acquired infections.
R2602 Twelve-year survey of severe Candida infections; results
from the Greek participation in the ARTEMIS global
antifungal surveillance study
M. Drogari-Apiranthitou*, I. Anyfantis, L. Kanioura, A. Skiada,
I. Stefanou, C. Tsoulas, A. Mitroussia-Ziouva, G. Petrikkos (Athens, GR)
Objectives: Greece has been participating in the ARTEMIS global
surveillance programme since 1997 through October 2009, in order to
study the epidemiology of Candida strains in our hospital and monitor
their susceptibility to ﬂuconazole and voriconazole using a low cost,
reproducible and accurate standard in vitro test.
Methods: Strains isolated from patients with severe Candida infections
from all body sites and all hospital locations were collected, identiﬁed
and analyzed. Susceptibility was investigated with disk diffusion testing
according to CLSI M44 method. Test results were read, interpreted and
recorded with the Biomic plate reader system.
Results: A total of 1461 Candida strains were recorded. Most prominent
species was C. albicans (63.6%), with a year-frequency ranging from
52 to 75%, followed by C. glabrata (14.5%, range 6.9–23.5%) and
C. parapsilosis (7.2%, range 0.9−9.6%, except for the years 2007 and
2009 in which a 24.1% frequency was observed). All other species
together had a frequency of 5−24%.
The sensitivity of C. albicans to ﬂuconazole equalled that to voriconazole
(92.5% versus 92.6% of strains respectively). For the C. glabrata, the
respective percentages were 72.4 and 75 and for the C. parapsilosis 85.7
and 92.8. Most of the resistant strains of all species were isolated from
miscellaneous body ﬂuids, the upper respiratory tract and blood and
derived from the ICU and the surgical wards. During the years 2006–
2009, the C. albicans strains resistant to ﬂuconazole were 13.1% and
to voriconazole 14.3%. In the previous years only 5% and 4.4% were
resistant, respectively. A comparable increase in resistant strains was
noted also for C. glabrata (47.8% versus 33.4% in previous years to
ﬂuconazole and 43.9% versus 16.9% to voriconazole) and C. parapsilosis
(11.2% versus 6.6% and 4.6% versus 2.3% respectively). The remaining
species did not show increasing rates.
Conclusions: Of the Candida species isolated in our hospital, the most
prominent was C. albicans, followed by C. glabrata and C. parapsilosis.
The frequency of isolation of these strains varied from year to year
without a clear trend. However, an increase in strains resistant to
ﬂuconazole and voriconazole was observed in the last four years.
These results conﬁrm the need for monitoring the local epidemiology
and antifungal susceptibility of Candida strains in order to optimize the
empirical or targeted therapy, especially in critically ill patients.
Travel medicine, tropical and parasitic
diseases
R2603 Ruptured hydatid cyst following minor head trauma and
few signs on presentation
T. Exiara*, A. Konstantis, A. Risggits, M. Kouroupi, E. Filippidou,
L. Mporgi, S. Papanastasiou, L. Papazoglou, D. Papadopoulou
(Komotini, Alexandroupolis, GR)
Introduction and Aim: Hydatid cyst is an infection of Echinococci
and still represents a serious problem in endemic regions, especially
in the Middle East, Mediterranean countries and Australia. Rupture of
a hydatid cyst commonly gives rise to allergic phenomena, including
anaphylactic shock. Rupture of cyst can occur spontaneously or during
surgery as well as due to trauma. We describe a patient who after trauma
presented to the emergency department with scant physical signs.
Case report: A 17-year-old girl was admitted to our emergency
department after falling down of motorcycle, 15 to 20 minutes previously.
She was only complained of pain of her head and she had two minor
traumas on her face. On presentation, her Glasgow Coma Scale was
15, blood pressure 120/80mmHg, pulse rate 110 beats per minute,
temperature was 36.8ºC and her physical examination was normal except
for mild abdominal tenderness. There was no evidence of any other
injury and the secondary survey was otherwise normal. White blood cell
count was 16,400/mm3, eosinophilia was absent and the other laboratory
tests were within normal limits. She underwent head and neck computed
tomography without sciagraphic ﬂuid and during examination general
urticaria developed and it was progressive. The examination stopped
and ﬂuid resuscitation, methyloprednisolone and diphenylhydramine
were administered intravenously. Once her condition had stabilized she
underwent abdomen computed tomography to determine the cause of
the abdomen pain. There was no free ﬂuid which usually excludes intra-
peritoneal bleeding. There was one ruptured cyst on the right lobe of the
liver and another cyst measuring 104mm with thin wall on the left lobe
of the liver. The patient turned to have a rupture of a hydatid cyst and she
was immediately taken to the operation room by the general surgeons.
Drainage and capitonage of the cysts were performed. The patient was
treated with albendazole for three months and at six months’ follow-up
she remained well without any complications.
Conclusion: Rupture of hydatid cyst is rare and can occur spontaneously
following serious injuries or even minor trauma. Anaphylaxis is the most
frequent cause of death in cases of hydatid cyst rupture. Echinococcus
liver cysts should be suspected in cases of anaphylaxis of uncertain
etiology. Acute vascular collapse, generalized cutaneous erythema,
urticaria and edema are suggestive of anaphylaxis from hydatidosis,
especially in endemic areas.
R2604 Travel: health risk perception, knowledge and prophylaxis
practices among immigrants who travel to visit friends and
relatives
A. Rodriguez Guardado*, G. Martin, L. Casado, F. Perez,
M. Rodriguez, V. Carcaba, J. Carton (Oviedo, ES)
Introduction: Travelers visiting friends or relatives (VFRs) typically
demonstrate travel and behavioural patterns which render them at high
risk for acquisition of preventable infection. Pre-travel services are rarely
sought by VFRs, whereas misconceptions that they possess life-long
immunity against malaria make them less likely to receive or adhere to
antimalarial chemoprophylaxis recommendations.
Objective: We analyzed the adherence of this group against these
measures of prophylaxis and health problems resulting from the travel.
Methods: All VFRs travellers attended in a tropical medicine referral
unit between 2007–2010 were interviewed with a questionnaire
investigating use of malaria prophylaxis, vaccination, and knowledge
of dietary and hygiene measures before and during the travel. VFR
was deﬁned as all immigrants permanently established in Spain who
temporarily travelling to their place of origin.
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Results: We analyzed 61 immigrants (mean time of travel: 91 days).
They travelled to Senegal (33%) Equatorial Guinea (25%), Ecuador
(18%), Bolivia (8%), Venezuela (5%), Brazil, Cameroon and Colombia
(3% each) and Ethiopia (2%). Only 23% patients received health’s advice
before travel, 72% of travellers didn’t received any vaccine and 78% did
not carry out antimalaria chemoprophylaxis. Only 25% used safe water.
No one use repellents. Twenty-eight patients (46%) were to be illness to
return home. Twenty-six patients had diarrhea during the trip and 20%
fever, being the most frequent reasons for consultation. In 32% of cases
the diarrhea was due to parasitic infections. Eight patients had malaria,
in 6 cases due to P. falciparum and two to P. vivax.
Conclusions: VFRs are a group of high risk for imported disease due
to poor adherence to vaccination and prophylaxis measures.
At present, immigrants visiting friends and relatives (VFRs) constitute
the most signiﬁcant group of travellers for malaria importation in
developed countries, with sub-Saharan Africa destinations carrying the
highest risk. There is an urgent need to increase health’s travel advice in
this group of travellers.
R2605 Trichinellosis in Serbia − inﬂuence of early diagnosis and
treatment on outcome and complications
N. Mitrovic*, E. Gvozdenovic, G. Stevanovic, N. Popovic, J. Stanojevic
(Belgrade, RS)
Objectives: Trichinellosis represents acute infective disease caused
by tissue nematodes Trichinella species. Despite the reduction of the
incidence of the disease resulted from obligatory meat check, this
disease still represents signiﬁcant medical and social–epidemiological
phenomena. The goal of the study was to show epidemiological
and clinical features of patients suffering from trichinellosis, and to
investigate possible inﬂuence of early diagnostic and begining of the
treatment on the outcome of the disease.
Methods: Descriptive-analytic retrospective study included 44 patients
with trichinellosis, treated at the Clinic for Infectious and Tropical
Diseases, Clinical Center of Serbia, Belgrade, from 2006 to 2010.
Statistical data analysis used descriptive and and analytic methods −
Mann–Whitney U test, Wilcoxon signed-rank test and Spearman’s rank
correlation coefﬁcient. The value of p< 0.05 was considered statistically
signiﬁcant.
Results: Within 5 years 44 patients were treated with trihinellosis.
Around 2/3 (68.18%) of them were men, average age being 41.18±14.51,
mostly from urban region (65.9%). Source of infection was known in
95% of the cases, out of which in 90% the cause was found to be
with domestic animals. Duration of the disease before making diagnosis
was on the average 11.5±6.55 days, and duration the hospitalisation
lasted 16.5±8.1 days. There were no lethal outcomes, the disease
have ended well with 39 patients, while 5 patients (11.36%) had a
disease complications-two of them hepatitis, one neurotrichinellosis with
neurological consequences, while two patients had myocarditis (one of
them developed deep venous thrombosis). Comparing groups of patients
with or without complications, the statistically signiﬁcant difference
was shown in time between the intake of food and the appearance of
symptoms (p = 0,461). Duration of the disease before the diagnostic and
treatment had no effect on the frequency of complications (p = 0,643),
while there was statistically signiﬁcant correlation between the duration
of the sickness before the diagnosis was made and duration of the
hospitalisation (p< 0.05).
Conclusion: Although trihinellosis is a rare disease, it still represents
a signiﬁcant medical problem which we need to be reminded about.
Timely diagnosis and beginning of treatment affects the shortening of
the hospitalisation and time of recovery, but has no inﬂuence on the
frequency of complications.
R2606 Clinical and epidemiological characteristics of imported
infectious diseases in immigrants
N. Moran, F. Pe´rez, M. Rodriguez, V. Ca´rcaba, J. Carton,
A. Rodrı´guez-Guardado* (Oviedo, ES)
Spain could be a potential area in Europe for the development and spread
of emerging diseases from the tropics due to its characteristics, and
their important migratory ﬂows We analyzed clinical-epidemiological
characteristics of infectious diseases imported by immigrants from
developing countries in the north of Spain.
Methods: A retrospective descriptive study of 341 immigrants from
developing countries who live in Spain was conducted. Demographic
data, details of country of origin, time on Spain, clinical syndromes, and
diagnoses were analyzed.
Results: The countries of origin were Ecuatorial Guinea (28%), Senegal
(21%), Ecuador (10%), Bolivia (7%), Nigeria (6%), Guinea-Conakry
(4%), Marruecos (4%), Brazil (3%). The mean time of Spain was
910 days. Most common syndromes were abdominal pain (25%),
diarrhea (21%), cutaneous syndrome (10%) and fever (7%). Most
frequent diagnoses were intestinal parasites (48%), ﬁlariasis (17%),
Chagas disease (5,5%), malaria (4,5%). and schistosomiasis (3.5%). The
most frequent intestinal parasites were: Entamoeba histolytica (22%),
Strongyloides spp (12.6%), Trichuris trichiura (10%) and Uncinaria
spp (5%). 70% of patients had one parasite, 17% two parasites, 9%
three parasites and 4% 4 or more parasites. 69,8% of patients were
from Subsaharian Africa. All patients diagnosed of ﬁlariasis were from
Ecuatorial Guinea. The most frequent were M. perstans (70%), ﬁlariasis
Loa loa (20%) and Onchocerca volvulus (10%).
Conclusions: Increased migratory ﬂows is a key factor for the
development and spread of emerging pathogens. Information on these
diseases is essential to early diagnostic and treatment. Intestinal parasites
were the most frequent disease following to ﬁlariasis, malaria and Chagas
disease.
R2607 Determination of visceral leishmaniasis reservoir dogs
epidemiology with real-time PCR method
Y.A. O¨ner*, S. Bayirlioglu (Istanbul, TR)
Objectives: World Health Organization (WHO) has determined that
Leishmaniasis is considered one of the most important zoonotic diseases.
Leishmaniasis consists of four main clinical syndromes: cutaneous
leishmaniasis; muco-cutaneous leishmaniasis; visceral leishmaniasis
(VL) and post-kala-azar dermal leishmaniasis. Each year, 500.000 new
cases of visceral leishmaniasis (VL) are reported worldwide. VL is a
systemic disease that is fatal if left untreated and is caused by Leishmania
infantum in Europe. VL is endemic along the tropical and subtropical
regions in the world while in Turkey VL is endemic along the Aegean
and Mediterranean coasts, it occurs sporadically in other regions. In
epidemic Mediterranean countries, prevalence is changing between
1−37% percentages. According to data from the Turkish Ministry of
Health annually 40 new cases of VL have been reported.
A relationship between canine leishmaniasis (CanL) and human visceral
leishmaniasis has been detected. Transmission of CanL is from animal to
vector to human. Humans are occasional hosts and dogs, are the reservoir
of L. infantum. In this research, dogs in two rehabilitation and treatment
centers of Istanbul Metropolitan Municipality examined with Real Time
PCR assay.
Methods: 4−5ml of venous blood samples were collected into EDTA
tubes from 93 dogs and taken to the Microbiology and Clinical
Microbiology Department. Qiagen™ (Germany) Dneasy Blood&Tissue
Kit was used for DNA extraction. Parasite DNA was examined by using
PrimerDesign™ (UK) Leishmania infantum Real Time PCR pathogen
detection kit.
Results: Bloods from 93 dogs in two rehabilitation and treatment centers
of Istanbul Metropolitan Municipality examined that whether they carry
parasites or not with the Real Time PCR assay. Two dogs (2.15%) had
a positive L. infantum DNA.
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Conclusion: Leishmaniasis is the most important zoonotic diseases in
Turkey. Transmission of L. infantum is from dog to vector to human. The
percentage of positive dogs of our study is in accordance with previous
studies performed in Turkey. Since a high proportion of infected dogs are
asymtomatic, diagnosis of Leishmania infections is an serious problem.
The parasitological methods present complex interferences, such as NNN
culture has a low sensitivity and seeing the parasites ﬁxed in glass slides
after Giemsa staining is difﬁcult. Therefore Real Time PCR is effective
for especially differential diagnosis of sub-clinical and asymptomatic
Dogs.
R2608 Clinical characteristics and aetiology of traveller’s
diarrhoea among Korean travellers visiting South-East Asia
S. Cho*, J. Chung, J. Ahn, K. Chang, M. You, J. Chai, Y. Kang, S. Kim,
H. Jeoung, D. Cheon, A. Jeoung, E. Choi (Seoul, KR)
The morbidity of travelers’ diarrhea (TD) is still high. This study
examined the incidence of common pathogens and characteristics of
TD among Korean travelers who visited South-East Asian countries.
We performed a prospective study involving 479 Korean travelers
with diarrheal disease from February 2009 to April 2009 and stool
samples were examined and questionnaires were done after arrival.
Enterotoxigenic Escherichia coli (ETEC) was found in 36.0% of TD
cases, as were the following: Enteroaggregative Escherichia coli (EAEC)
in 27.0%, Vibrio parahaemolyticus in 13.1%, and Norovirus in 11.5%.
The detected rate of classic TD was higher in men, in patients who had a
shorter duration trip and in patients who drank more than 1 liter of water
per day (P = 0.007, P = 0.023, and P = 0.037, respectively). Positive stool
culture rates were higher in men, in hospitalized patients, and in those
who consumed impure water or raw foods (P = 0.005, P = 0.013, and
P = 0.033, respectively). A higher severity of disease corresponded to a
signiﬁcantly higher culture positivity rate (P = 0.029). We should consider
the possibility of other pathogens in addition to ETEC in patients with
TD who visit South-East Asia and travelers need to educate about risk
factors associated with TD.
R2609 The aetiology of diarrhoea among primary refugee arrivals
in Timis County, Romania
I. Marincu*, L. Negrutiu, I. Iacobiciu, M. Mares, A. Neghina,
L. Marincu, R. Neghina (Timisoara, Iasi, RO)
Objectives: Diarrhea is an important cause of morbidity and mortality
worldwide, although its etiology remains unknown in many cases. The
present study aimed at establishing the etiological spectrum of pathogens
causing diarrhea in a group of refugee arrivals to Center for Immigrants
from Timisoara, Romania.
Methods: There were retrospectively analyzed the medical records
of 68 immigrants hospitalized with diarrhea at Clinic of Infectious
Diseases in Timisoara during 2008–2009. Diagnosis was established
based on the epidemiological aspects (the acute onset following
collective or individual consumption of food with inadequate physical
and organoleptic properties, stored in poor conditions or even
expired), physical examination (fever, repeated shivers, nausea, vomiting,
headache, multiple watery diarrhea, fetid stools, tenesmus, abdominal
colic, pyrosis, dizziness, paresthesias of lower limbs), laboratory
tests (erythrocyte sedimentation rate, blood counts, ﬁbrinogen, C
reactive protein, glycemia, blood cultures, lingual swabs, throat swabs,
stool cultures, stool parasitological examinations, natremia, kalemia,
calcaemia) and other medical explorations (abdominal ultrasound,
electrocardiography). Data of the epidemiological survey were collected
from the Institute of Public Health from Timisoara. The data was
statistically processed using Epi Info 3 software.
Results: Of the total number of patients, 28 (44.1%) were diagnosed
with acute enterocolitis, 5 (7.4%) had dysentery, 16 (23.5%) had
foodborne, 14 (20.6%) were diagnosed with giardiasis and 3 (4.4%)
had intestinal amoebiasis. The etiologic agent was established in 40
(58.8%) cases as follows: Staphylococcus spp. (5 cases), Salmonella
spp. (8 cases), Shigella spp. (5 cases), enterotoxigenic Escherichia coli
(5 cases), Entamoeba histolytica (3 cases), and Giardia lamblia (14
cases). Most of the patients (86.8%, p< 0.0001) required endovenous
hydroelectrolytic replacement with glucose, normal saline and lactated
Ringer solutions, along with symptomatic medication (analgesics,
antipyretics, antispasmodics, antacids). Twelve cases received antibiotics
therapy prior to hospital admission, thus complicating the detection of
the etiologic agent. All patients had favorable outcomes.
Conclusion: Knowledge of the etiology of diarrhea among immigrants
patients allows the proper implementation of targeted therapy and
prophylaxis measures in order to limit diarrheal morbidity in persons
at risk.
R2610 Clinical and epidemiological characteristics of scabies in
hospitalised patients with infectious diseases
I. Marincu*, L. Negrutiu, I. Iacobiciu, M. Mares, A. Neghina,
L. Marincu, R. Neghina (Timisoara, Iasi, RO)
Objectives: Scabies is a highly contagious parasitic dermatosis with a
worldwide distribution that may cause signiﬁcant morbidity and large
nosocomial outbreaks. The present study aimed at analyzing the clinical
and epidemiological characteristics of scabies in hospitalized patients
with infectious diseases.
Methods: Data were retrospectively collected from the medical charts of
62 patients found with scabies lesions at Clinic of Infectious Diseases,
Timisoara during 2009. The positive diagnosis was established based
on the epidemiological aspects (recent travels, family or collective
outbreaks, sex with multiple partners), physical examination (lesions
such as papules, pustules, burrows, nodules, and occasionally urticarial
papules and plaques with patognomonic distribution: interdigital web
spaces of the hands, perimalleolar and periumbilical region, ribs,
horizontal gluteal crease, radiocarpal joint) and intense generalized skin
itching at night. The diagnosis was conﬁrmed either by microscopic
identiﬁcation of mites in skin scrapings or by dermoscopy. Patients
followed treatment with precipitated sulfur apply topically to entire trunk
and extremities every 24 hours for 3 days. Disinfection was carried out
at all linen and personal items.
Results: Of the study group, 40 (64.5%) patients were rural inhabitants
and 22 (35.5%, p = 0.002) lived in urban areas. Six familial outbreaks
occured in rural regions. Scabies was mainly associated with respiratory
diseases (22.6%), liver diaseases (19.4%), intestinal diseases (12.9%),
psychiatric disorders (16.1%), urinary infections (9.7%). Scabies
lesions had the following patterns: edematous and urticariform papules
(26 cases), papulo-vesicular lesions (22 cases), escoriations due to
scratching (48 cases), and scratching related superinfected lesions with
streptococcal or staphylococcal bacteria (35 cases). Common form of
scabies was evidenced in 24 patients (38.7%) whereas 38 cases (61.3%)
had atypical course of the disease (p = 0.02). All patients had favourable
outcomes following therapy with precipitated sulfur associated with
symptomatic medication (calcium, antihistamincs, antibiotics in bacterial
superinfections), individual hygiene and disinfection.
Conclusion: The study of clinical and epidemiological characteristics
of scabies in hospitalized patients with infectious diseases allows early
diagnosis of this parasitosis as well as timely implementation of effective
prophylactic measures.
R2611 Cryptosporidium: the role of speciation in understanding
epidemiological trends
F.M. Awadel-Kariem*, J. Raghwani, H. Gough, R.N. Manzoor
(Stevenage, UK)
Background: Cryptosporidium sp taxonomy has gone through a number
of changes in the last three decades. Initially a single species, C
parvum − with a number of clonal genotypes loosely corresponding to
speciﬁc vertebrate hosts, had been proposed. The current nomenclature
suggests, for all cryptosporidial organisms with an oocyst size of
4−6 um, a number of cryptic species that are identiﬁed based on
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molecular genotyping. This is believed to facilitate better understanding
of transmission and other epidemiological factors.
Objectives: This study was designed to assess the value, to the clinician
and the epidemiologist, of the new cryptic species and whether this
information would improve practice.
Methods: Isolates that were positive for Cryptosporidium oocysts by
auramine staining were typed by PCR. The resulting molcular speciation
was then analysed with clinical data (age, travel history, contact with
animals, sporadic or part of an outbreak).
Results: In this study 27 isolates were typed, 13 C. parum, 12
C. hominis, 1 C. meleagridis and 1 C. felis. There were some trends. Two
isolates from Egypt and 1 from Greece were identiﬁed as C. hominis,
while isolates from Pakistan and St Lucia were identiﬁed as C. parvum.
This may represent epidemiological differences between the various
travel desinations. One patient has both C. parvum and Shigella
sonnei isolated, this would be strongly suggestive of a contaminated
water source of infection. A second patient had both C. felis and
Campylobacter sp isolated. This patient had recently acquired a kitten.
It is possible that both pathogens contributed to the diarrhoea, or that
the Campylobacter was the cause of the diarrhoea while the presence
C. felis oocysts (a primary pathogen of feline hosts) may represent
oocysts passing through the patient’s gut rather than tissue invasion.
Conclusions: Identiﬁcation of cryptosporidial isolates either by genotype
or as one of the cryptic species allows better understanding of potential
source. Further studies are needed to conﬁrm the trends seen in this
study.
Resistance and mechanisms of action of
antifungals
R2612 Evaluation of the Neo-Sensitabs diffusion method for
determining the antifungal susceptibilities of Candida species
D. Satana*, G. Erkose Genc, N. Sariguzel, I. Akyar, M. Uzun,
Z. Erturan (Istanbul, TR)
Objectives: The purpose of this study was to compare the Neo-Sensitabs
method with the CLSI reference broth microdilution (document M27-
A3, S3) method for testing the susceptibility of 98 Candida spp. isolates
to ﬁve antifungal agents (amphotericin B, ﬂuconazole, itraconazole,
ketoconazole, and voriconazole).
Methods: In this study, the broth microdilution method was performed
according to the CLSI recommendations. The Neo-Sensitabs method was
performed according to the manufacturer’s instructions (Neo-Sensitabs;
A/S Rosco Diagnostica, Taastrup, Denmark). C. parapsilosis ATCC
22019 was used as quality control strain.
Results: A total of 98 isolates of Candida spp.[C. albicans (n = 56),
C. tropicalis (n = 22), C. parapsilosis (n = 6), C. glabrata (n = 4),
C. dubliniensis (n = 3), C. krusei (n = 3), C. famata (n = 2), C. lusi-
taniae (n = 1), C. pelliculosa (n = 1)] were evaluated by both of the
methods. MIC ranges were found as 0.03−8.0mg/ml, 0.05−64mg/ml,
0.03−0.5mg/ml, 0.03−1.0mg/ml, and 0.03–0.12mg/ml for ampho-
tericin B, ﬂuconazole, itraconazole, ketoconazole, and voriconazole for
the microdilution method respectively. All isolates were susceptible
to voriconazole by both of the methods. Ninety one (93%) of all
isolates were determined as susceptible, two (2%) (C. albicans) were
found susceptible dose dependent (SDD), and ﬁve (5%) [C. krusei
(n = 3), C. glabrata (n = 1), C. albicans (n = 1)] were found resistant to
ﬂuconazole by both of the methods. Ninety two (94%) of all isolates were
determined as susceptible, six (6%) [C. krusei (n = 3), C. albicans (n = 3)]
were found SDD to itraconazole by both of the methods. There was
100% agreement between two of the methods for these three antifungal
agents in this study. Two (2%; C. albicans, C. glabrata) and eight [8%;
C. albicans(n = 3), C. krusei(n = 3), C. glabrata, C. tropicalis] isolates
were determined as resistant to amphotericin B and ketoconazole by both
of the methods respectively. One (C. albicans) and three [C. albicans
(n = 2), C. glabrata] isolates were intermediate to amphotericin B and
ketoconazole by Neo-Sensitabs method, but the same strains were
susceptible to these antifungals by standard method. In this situation
minor errors were calculated 0.01% for amphotericin B, and 0.03% for
ketoconazole by Neo-Sensitabs method.
Conclusion: The Neo-Sensitabs method may be an alternative and easy
method for the clinical laboratories to determine the susceptibility of
yeast isolates.
R2613 Fungistatic and fungicidal activity of antifungal agents
against Candida spp. strains isolated from patients with
invasive candidiasis
C. Tascini*, A. Leonildi, I. Ciullo, E. Tagliaferri, F. Menichetti (Pisa, IT)
Objectives: To study the activity of antifungal agents against Candida
spp strains isolated from invasive candidiasis and to assess the fungicidal
activity of amphotericin B, caspofungin and anidulafungin. Fungicidal
activity of azoles was not studied because they are considered fungistatic.
Methods: All the strains of Candida spp isolated from invasive
candidiasis in Pisa Hospital in the 2009–2010 period were studied.
MICs of all strains were performed with the Sensititre method under
manufacturer instructions. All the wells without growth of yeast
were sub-cultured in order to measure the fungicidal activity of
amphotericin B, caspofungin and anidulafungin. Minimal fungicidal
concentration (MFC) of these drugs was deﬁned by a 99,9% reduction
of the inoculum.
Results: Thirty-three Candida spp isolates were included in this study.
Thirty strains were isolated from blood, 1 from liver abscess, 1
from vertebral osteomyelitis, 1 from peritonitis. Among these strains,
C. albicans were 17 strains and Candida non-albicans 16 strains (7
C. parapsilosis, 4 C. glabrata, 3 C. tropicalis and 2 C. krusei). MIC50
and MIC90 for all strains are shown in table 1. All antifungal agents,
except amphotericin B have an increase of MIC90 for Candida non-
albicans strains, with an increase of several dilutions with respect to
those of C. albicans strains. MFC50 and MFC90 are shown in table 1.
MFC50 and MFC90 of amphotericin B were 2mg/L and between 4 and
8mg/L, instead values for echinocandins were superior especially for
Candida non-albicans.
Conclusion: Candida non-albicans strains have elevated MICs for all
antifungal agents. Amphotericin B fungicidal activity is superior to that
of echinocandins, especially among Candida non-albicans strains. If this
activity might be used in the clinical ground has to be studied.
R2614 Inﬂuence of anidulafungin or voriconazole on bioﬁlms
of various Candida species in a small tube system of
continuous ﬂow cultures
H. Bernhardt*, M. Knoke, G. Schwesinger, J. Buﬂer, J. Bernhardt
(Greifswald, Berlin, Rostock, DE)
Objectives: We investigated the antifungal effect of anidulafungin
(AND) or voriconazole (VRC) on bioﬁlms and MIC values of different
Candida species in a small tube system of continuous ﬂow culture.
Methods: We carried out 21 experiments with 23 strains. Strains
of C. albicans (Ca), C. glabrata (Cgl), C. tropicalis (Ct), C. krusei
(Ck), C. parapsilosis (Cp), C. orthopsilosis (Co), C. metapsilosis (Cm),
C. lusitaniae (Cl) and C. guilliermondii (Cgui) from blood culture
isolates were grown in small tubes (V = 0.48ml). Peptone-yeast extract
(0.5%/0.2%) + 50 mM glucose±AND (8mg/l) or VRC (16mg/l) was
supplied at very low ﬂow rates (1.3ml/h). The ﬂow in the tube was
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63-times within 24 h. Biomass production, glucose concentration as
metabolic activity, pH and planktonic CFUs were measured. MIC testing
was performed by Etest® on RPMI. Morphology of adherent fungal cells
was assessed microscopically after staining with lactophenol cotton blue.
Results: In the tube system the development of bioﬁlm varied from
species and strains and took place after 2 or 3 days. After continuous
input of AND the production stopped in case of sensible species like Ca
or Ct, but the metabolic activity measured by glucose concentration did
seldom reach the beginning concentration. This could partly be shown
after continuous input of VRC. Different strains of Cp showed different
results against AND, but there was no increase of resistance in these
long term trials up to 10 days. Bioﬁlm of strains with a low susceptibility
against AND like some Cp strains or candidaemia strains of Cl or Cgui
stopped growth after input of VRC as also metabolic activity did so.
Conclusion: The small tube system is a model to get some information
from bioﬁlms of different Candida strains under conditions of long term
cultivation with supply of low nutrition more similar to real conditions
than batch culture.
R2615 Nosocomial candidaemia: epidemiology and antifungal
susceptibility patterns at the University Hospital of Modena
A. Bedini*, C. Venturelli, C. Giovanardi, M. Venturelli, M. Leonello,
M. Codeluppi, S. Cocchi, F. Rumpianesi, R. Esposito (Modena, IT)
Objective: Aim of the present study was to evaluate the incidence
of candidemia in an Italian tertiary care hospital, and the antifungal
susceptibility patterns of isolates of Candida spp. The antifungal
agents tested were ﬂuconazole, itraconazole, voriconazole, posaonazole,
amphotericin B, caspofungin, anidulafungin and micafungin.
Materials and Methods: A retrospective, observational study was
carried out at the University Hospital of Modena. Data were collected
from January, 2007 to July, 2010. Candidemia was deﬁned as the
detection of at least two consecutive positive blood cultures yielding
Candida spp. during the same hospital admission. MICs were determined
according to the CLSI guidelines (M27A-3 protocol).
Results: During the study period a total of 142 episodes of candidemia
occurred in 129 patients, accounting for a global incidence of 12.1
episodes/10,000 in-patients. Median age of the patients was 56 years
and 58% of them were males. The most common species isolated
was C. albicans (79 episodes, 55.6%), followed by C. parapsilosis (26
episodes, 18.3%), C. glabrata (18 episodes,12.7%), C. tropicalis (10
episodes, 7.0%), C. guilliermondii (4 episodes, 2.8%), C. krusei (3
episodes, 2.1%), C. dubliniensis and C. norvegensis (1 episode, 0.8%).
During the study period the incidence of candidemia increased from 7.1
to 18.5 episodes/10,000 in-patients (p< 0,01). C. glabrata and C. krusei
fungemia occurred more frequently in patients admitted to intensive care
units (p = 0.04). All the isolates resulted susceptible to voriconazole,
posaonazole, amphotericin B and to the three echinocandins The
susceptibility rate of ﬂuconazole and itraconazole was 99.3 and 72.5%,
respectively. The antifungal agents tested had the following MICs90:
ﬂuconazole 8mg/dl, itraconazole 2mg/dl, mg/dl voriconazole 0.125,
mg/dl posaconazole 0.5, amphotericin B 1mg/dl, caspofungin 0.5mg/dl,
anidulafungin 2mg/dl, and micafungin 2mg/dl.
Conclusions: Candidemia is still a frequent complication among
hospitalized patients. We observed a progressive increase during
the study period; this trend could be due to the increase of
immunocompromised patients admitted to our institution, in particular
hematological patients, solid organ transplant recipients and surgical
patients admitted to intensive care units. Nevertheless, C. albicans
remained the prevalent species and the resistance rates to antifungal
agents were very low.
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R2616 Candidaemia in adult non-neutropenic intensive care
unit patients in 2 Turkish university hospitals: factors
associated with non-albicans Candida spp. and antifungal
susceptibility patterns
K. Serefhanoglu, F. Timurkaynak*, F. Can, O¨. Kurt Azap, H. Arslan
(Istanbul, Ankara, TR)
Objectives: The objective of this prospective, observational, multicenter
study was to describe factors associated with bloodstream infections
(BSIs) with Candida non-albicans (NAC) species, compared with
Candida albicans BSIs, and antifungal susceptibility patterns in intensive
care unit (ICU) patients.
Methods: The study was conducted in adult medical/surgical ICUs at
two university hospitals. All adult patients with ICU-acquired BSI due
to Candida, excluding patients with neutropenia, malignancy or AIDS,
between 2007–2009 were included. Potential factors occurring up to 30
days before candidemia, including demographic characteristics, comor-
bidities, exposure to antibiotics and antifungals, ICU-related factors (i.e
TPN, invasive procedures) and outcome were determined. Antifungal
susceptibility testing was performed using broth microdilution assay
method described by the Clinical Laboratory Standards Institute.
Results: Clinical characteristics of the patients were presented in the
Table. Seventy-six cases (59,4%) of candidemia were due to C. albicans
and 52 (40,6%) to NAC spp. Distribution of the ﬁrst three NAC
spp. was C. tropicalis (22/52, 42,3%), C. glabrata (12/52, 23,1%) and
C. parapsilosis (9/52, 17,3%). Multivariate logistic regression analysis
of the factors showed that presence of glucocorticosteroid treatment
and a central venous catheter were variables independently associated
with BSI due to NAC, compared with BSI due to C. albicans (P:0,001,
OR: 7,18, 95%CI: 2,22−23,22; and P0,001, OR: 20,13, 95%CI: 3,64–
111,18, respectively). A total of 65 patients died within 30 days of the
diagnosis of candidemia. The mortality rate was higher in those with
NAC than C. albicans BSI (61,5% vs 43.4%) and candidemia due to
NAC spp. was independently associated with death (P: 0.04). Except for
one C. lusitaniae strain, which was resistant to amphotericin B and four
C. glabrata strains, which were ﬂuconazole susceptible dose dependent,
all Candida species were susceptible to ﬂuconazole, caspofungin,
voriconazole and amphotericin B.
Conclusion: Presence of a central venous catheter and glucocorticos-
teroid treatment were signiﬁcantly associated with BSI due to NAC. BSI
due to NAC was signiﬁcantly associated with death, compared with BSI
due to C. albicans. The in-vitro activity of ﬂuconazole is encouraging,
and this agent, an efﬁcacious, inexpensive and safe drug, can continue
to play an important role in the management of invasive candidiasis.
S786 21st ECCMID/27th ICC, Abstracts accepted for publication only
R2617 Evaluation of candiduria in patients with neoplasia
D. Kofteridis, D. Dimopoulou*, A. Valachis, S. Maraki, A. Thanasia,
V. Theodorakopoulou, I. Aristeidou, N. Spernovasilis, G. Samonis
(Heraklion Crete, GR)
Objectives: Candiduria is encountered in cancer patients (pts) but its
signiﬁcance is not deﬁned. However, it may be indicator of urinary tract
infection (UTI) or invasive infection. The study aimed to determine the
signiﬁcance of candiduria in neoplastic pts.
Patients and Methods: Adult pts with neoplasia and positive urine
cultures for Candida, admitted to the Oncology or Haematology
department of the University Hospital of Heraklion, Greece from 2005
to 2010 were retrospectively reviewed.
Results: Seventy one pts with candiduria were identiﬁed. Of them
48 (68%) were males. The median age was 71 (range 40−88). The
underlying disease was solid tumor in 51 (72%) and hematologic
malignancy in 20 (28%). The most frequent risk factor was use of urinary
catheter or nephrostomy (69%), followed by antimicrobial treatment
(60%), corticosteroids (42%), anatomic malformations of the urinary
tract (29%), neutropenia (24%) and diabetes mellitus (21%). Fever was
present on admission in 59 (83%). Nineteen pts (27%) had dysuria.
Flank pain and vomiting were prominent clinical features in 7 (10%)
and 5 (7%) pts respectively. UTI by established criteria was present in
51 (72%). Among the 71 positive urine cultures, C. albicans was isolated
in 44 (62%), and non-albicans in 27 (38%) [C. tropicalis 9 out of 27
(33%), C. parapsilosis 7 (26%) C. glabrata 6 (22%), C. famata 3 (11%),
C. guilliermondii 1 (4%) and C. lusitaniae 1 (4%)]. Blood cultures were
obtained from 59 (83%) and were positive in 15 (21%). However, only 4
pts (6%) had Candida in their blood. Death occurred in 26 (37%) pts with
candiduria. Factors associated with death included disease progression
in 7 (27%) and sepsis syndrome in 19 (73%). Candida spp. has been
present in the blood of 2 pts who died. All pts who died had advanced
neoplasia.
Conclusions: Factors predisposing to candiduria, included urinary
catheter or nephrostomy, prior use of antimicrobial agents, corticos-
teroids, anatomic malformations of the urinary tract and diabetes
mellitus. Candiduria was rarely associated with candidemia, however,
has been associated with high mortality, probably because it occurred in
pts with advanced neoplasia.
R2618 Epidemiology of dermatophytoses in western Greece,
2003–2010
C. Gartzonika, G. Vrioni, N. Zotos, E. Kapsali, E. Priavali, H. Sakkas,
E. Papapetrou, K. Basioukas, A. Mavridis, S. Levidiotou* (Ioannina,
Athens, GR)
Objectives: Dermatophytoses are considered as one of the major public
health problems in many parts of the world which distribution varies in
different countries and geographical areas depending on several factors.
This study was conducted to investigate the aetiological agents and the
clinical variants of dermatophytoses, in Western Greece during a 8-year
period (2003–2010).
Methods: A total of 3210 samples (skin scales, nail and hair fragments)
obtained from 2616 patients with suspected dermatomycoses referred
to the laboratory of Clinical Microbiology at the University Hospital
of Ioannina, Greece. The causative agents were identiﬁed by direct
microscopy and culture.
Results: Dermatophytes were isolated from 524 patients (20.03%),
mainly adults. The most common type of infection was onychomycosis
(34.6%) followed by tinea pedis (28.5%), tinea corporis (18.5%), tinea
cruris (8.5%), tinea capitis (4.6%), tinea manum (4.0%) and tinea facei
(1.3%). In forty seven patients the same dermatophyte was isolated from
two different sites of infection. The frequency for all types of tineas
was higher in males than in females, while males exceeded females in
cases of tinea corporis and tinea facei. Trichophyton rubrum was the
most prevalent dermatophyte species isolated from 51.5% of the 607
positive samples, followed by T. mentagrophytes (20.3%), Microsporum
canis (8.2%), Epidermophyton ﬂoccosum (5.4%), T. violaceum (3.0%),
Trichophyton spp (1.8%) and M. gypseum (1.7%). Other species as
T. tonsurans, T. verrucosum and T. schoenleinii were occasionally
isolated.
Conclusion: In our region, Trichophyton rubrum is the most common
aetiological agent in all types of dermatophytoses except of tinea capitis
and tinea facei. The epidemiological data collected would serve as
reference for future research while many factors that contribute to the
change of prevalence of dermatophytoses alter to the pass of time.
R2619 In vitro combination of anidulafungin and voriconazole
against azole susceptible or resistant Aspergillus spp.
V. Planche*, S. Ducroz, A. Alanio, M. Bougnoux, O. Lortholary,
E. Dannaoui (Paris, FR)
Background: Voriconazole (VRZ) remains the ﬁrst line therapy for
invasive aspergillosis. Because some Aspergillus species are resistant
to azoles and because the prognosis or aspergillosis remains poor;
antifungal combinations could be of interest. We tested here the in vitro
combination of Anidulafungin (ANI) and VRZ against azole susceptible
or resistant Aspergillus spp by two different methods.
Methods: Thirty clinical isolates of Aspergillus spp from ﬁve various
Aspergillus species identiﬁed by b-tubulin sequencing were tested. The
ANI-VRZ combination was evaluated using checkerboard (CK) based
on the CLSI broth microdilution method M38-A3 and using an agar
diffusion technique (Etest). For CK, ﬁnal inoculums were 104/mL. After
48h at 35ºC, both MIC and MEC were recorded visually. The fractional
inhibitory concentration index (FICI) was interpreted as synergic if
FICI 0.5, no interaction if 0.5< FICI< 4 and antagonistic if FICI 4.
Tests were run in duplicates. For Etest, MIC of VRZ and ANI were
determined alone as well as in combination after 48h at 35ºC. In
combination, ANI strip was placed on agar for 1h, removed and then
VRZ strip was applied over demarcation left from previous strip. Synergy
and antagonism were deﬁned respectively as a decrease or an increase
of 3 dilutions of the resultant MIC.
Results: Using CK method, there was no interaction between VRZ and
ANI with MEC as endpoint (table) except for 1 A. nidulans isolate
for which an antagonism was shown. Using Etest, no interaction was
observed in 27 isolates. According to the endpoint used, an antagonism
or a synergism was observed for 2 and 1 A. calidoustus isolates,
respectively.
Conclusions: Overall no in vitro interaction was shown between VRZ
and ANI against most of the azole susceptible or resistant Aspergillus
isolates by using different techniques. Conﬁrmation of these results in
vivo is warranted.
R2620 Diagnostic issues, clinical characteristics and outcome for
patients with fungaemia
M. Cavling Arendrup*, S. Sulim, A. Holm, L. Nielsen, S.D. Nielsen,
J.D. Knudsen, N.E. Drenck, J.J. Christensen, H.K. Johansen
(Copenhagen, A˚rhus, Odense, Herlev, Hvidovre, Køge, DK)
Objectives: This study investigated diagnostic issues, underlying host
factors, management and outcome factors for Danish fungaemia patients.
Methods: Isolates and clinical information were collected at six
centres. 335 isolates from 319 episodes in 306 patients were included
corresponding to 2/3 of the national episodes.
Results: Species distribution varied by age, prior antifungal treatment
(more isolates with intrinsic reduced ﬂuconazole susceptibility P = 0.007)
Fungal infections S787
and clinical specialty (61% C. glabrata and C. krusei at haematology
wards versus 29%, P = 0.002). Colonisation samples were not predictive
for the invasive species in 11/100 cases with species identiﬁcation.
Blood culture positivity varied by system, species and procedure. Thus,
cultures drawn via arterial lines or with C. glabrata needed longer
incubation and cases with concomitant bacteraemia were less common
using BacT/ALERT compared to the BACTEC system (9% (11/124)
versus 28% (53/192); P< 0.0001).
56% of the patients had undergone surgery, 51% were ICU patients
and 33% had malignant disease. Mortality varied by age (increasing by
age, P = 0.009), species (numerically highest for C. krusei 36%, lowest
for C. parapsilosis 25% and other Candida species 14%), severity of
underlying disease (47% in ICU patients versus 24%; P = 0.0001), and
choice but not timing of initial therapy (12% versus 48% in patients with
C. glabrata receiving caspofungin versus ﬂuconazole, P = 0.023). Initial
antifungal choice was deemed suboptimal upon species identiﬁcation in
15% of the cases, which would have been 6.5% had current guidelines
been followed.
Conclusion: A high proportion of Danish fungaemia patients were
severely ill and received sub-optimal initial antifungal treatment.
Optimisation of diagnosis and therapy is possible.
R2621 Impact of voriconazole in fungal keratitis in eastern India
S. Saha* (Midnapore West, IN)
Aim: To describe the role of prepared voriconazole (2%) eye drop in
the management of fungal keratitis.
Methods: It is a retrospective observational case series involving patients
of culture proven fungal keratitis from April 2008 to March 2010
attending to the cornea clinic of a tertiary care eye hospital in eastern
India. Among the 144 fungal keratitis cases 66 (45.83%) cases were
identiﬁed for analysis. The ulcer size, organism, treatment modalities
and MIC value were analyzed. Voriconazole was used either topically
(2%), or in AC wash (50 mg/0.1ml),) and Intrastomally (50mg/0.1ml).
Results: Among 66 cases, 39 showed healing with corneal scar
formation while 27 underwent therapeutic keratoplasty. 25 cases
(64.10%) required topical use, 9 cases (23.07%) required intracameral
use and 5 (12.82%) cases required intrastomal administration. Among
ﬁlamentous fungi Aspergillus sp responded well (25/66;37.87%)
followed by Fusarium sp (5/66;7.57%),unidentiﬁed sp (3/66;4.54%),
and equal no of Penicillium sp, Scedosporium sp, and Cladosporium
sp (2/66;3.03%). Among the cases undergoing therapeutic keratoplasty
Candida keratitis was maximum with 11 cases followed by 7 cases
of Fusarium sp, 5 cases of Aspergillus sp and 2 case each of
Alternaria sp and Penicillium sp. In relation with ulcer size response
to voriconazole therapy obtained in (20/39;51.28%) where ulcer size is
<6mm and remaining (19/39;48.71%) cases where ulcer size is >6mm.
The minimal inhibitory concentration of voriconazole was 0.125mg/ml
against Aspergillus sp and 0.5mg/ml against Fusarium sp. Candida sp
showed resistance activity upto 2% of voriconazole.
Conclusion: Voriconazole has promising activity against ﬁlamentous
fungi and may prove useful in the management of fungal keratitis but it
shows no response in Candida keratitis from our centre.
R2622 Cerebral human pythiosis: the ﬁrst case report of Pythium
insidiosum infection presented with brain abscess
T. Narkwiboonwong*, K. Trakulhun, K. Watanakijthavonkul,
P. Paocharern, A. Singsakul, A. Wongsa, N. Woracharoensri,
N. Worasilchai, A. Chindamporn, A. Panoi, T. Methipisit,
P. Sithinamsuwan (Bangkok, TH)
We here reported a thalassemic patient suffering from cerebral pythiosis
(left common carotid pythiosis arterial aneurysms, septic embolisms
evolving to brain abscess over the left anterior cerebral artery territory).
This was the ﬁrst case in the world of Pythium insidiosum involving left
common carotid artery and producing septic emboli, causing pythiosis
brain abscess.
A 27-year-old man, developed nasal congestion with whitish discharge
from the left nostril. Three weeks before admission, he developed high
grade fever. One week later, he complained of occipital headache,
followed by a focal seizure starting at right hand, and then he developed
secondarily generalized tonic-conic seizures. Computed tomography scan
of the brain was performed. A 5x6 cm hypodensity lesion was noted
over the left frontoparietal region. Intravenous ceftriaxone 4 gm/day and
metronidazole 1,500mg/day were prescribed. One week later, fever was
still persisted and right-sided weakness was worsened.
Personal and past medical history: This patient was diagnosed with
b-thalassemia haemoglobin E disease. The pertinent physical ﬁndings
were high grade fever, signiﬁcant left carotid bruit, right facial palsy
and spastic right hemiparesis.
MRI brain showed a large rim-enhancing brain lesion over the
left hemisphere. MRA showed multiple aneurysms at left common
and internal carotid arteries. His serum was tested for antibody
against pythiosis using 3 different techniques, which were ELISA,
immunodiffusion and Western blot. The results of all the tests were
positive. We also prescribed itraconazole, terbinaﬁne and P. insidiosum
antigen immunotherapy, but the patient eventually died from brain
herniation. Autopsy revealed gross pus at left frontal area. The left
common and internal carotid arteries also found 2 cm in diameter of
aneurysm. Pus Wright’s stains showed hyphae with infrequently septate
and branching. Tissue culture from his brain was conﬁrmed the diagnosis
of pythiosis by isolation the organism and proof by Polymerase chain
reaction (PCR) with speciﬁc primers in the COX II region.
Discussion: We couldn’t eradicate infected brain tissue as well as
infected carotid arteries because of the area of brain and carotid artery
involvements were harmful to resection. Cerebral pythiosis should be
the differential diagnoses of brain abscess in thalassemic patients. Early
recognition and prompt surgical treatment should be considered to reduce
mortality or morbidity.
R2623 Bronchoscopy sampling, culture technique and real-time
PCR for Aspergillus affect diagnostic yield
M.G. Fraczek*, C.B. Moore, J. McKenna, P. Barber, J. Martin,
N.E. Duddy, M.D. Richardson, D.W. Denning (Manchester, UK)
Background: Fungal culture methods for respiratory specimens have
never been formally compared. Real time PCR for Aspergillus spp. has
recently been introduced in Europe, Africa and Canada. We compared 2
culture methods and PCR on multiple sputum and bronchoscopy samples
from 3 patients with aspergillosis.
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Method: We bronchoscoped 3 patients: ABPA, prior IA and COPD
and Aspergillus bronchitis. We compared (1) the UK standard method
for processing respiratory cultures (BSOP57) (modiﬁed to plate 10uL
instead of 1uL) with (2) high volume culture (range 20mL− 2.3mL,
avg 0.5mL) (100% plated) on Sabouraud dextrose agar (37ºC) and 3)
real time PCR (MycAssay Aspergillus) preceded by DNA extraction
using the MycXtra kit. The sensitivity of this assay is <1 genome,
following a >10% extraction efﬁciency. Sputum samples were obtained
before and after the bronchoscopy procedure. Material obtained was
split into ‘highly mucoid’ material and more liquid material, if possible.
Approximately equal volumes of material (33% each) were used for the
PCR and 2 culture methods.
Results: 21 samples were cultured. All (100%) were Aspergillus negative
by routine culture and 14 of 21 (67%) negative by high volume culture.
Only 2 (10%) were negative by PCR, 3 were below clinical cutoff (Ct
<36) and 16 (76%) positive (Ct values 28.9–35.7). Of the 6 sputum
samples (2 split), all were positive by PCR and 5 of 8 (63%) were
positive by high volume culture (1−6 CFU). BAL samples were all
Aspergillus culture negative, and 8 of 10 samples (80%) were PCR
positive. In 2 patients the highest PCR yield was the initial bronchoscopy
trap aspiration (often discarded as contains lignocaine), but not in one
patient; hyphae and Charcot-Leyden crystals were visible in this sample
from patient with ABPA and 19 CFU were grown in high volume culture.
Conclusion: The UK standard method for culture is grossly sub-optimal
for Aspergillus spp. and needs revision. Improved culture methods
may be of value for sputum but are inferior to real time PCR using
the MycXtra DNA extraction system and MycAssay Aspergillus assay.
Bronchoscopy sampling has considerable variability in diagnostic yield;
sputum may be superior.
R2624 Detection of Trichophyton rubrum by multiplex PCR and
all other dermatophytes from nails
A. Spiliopoulou*, C. Bartzavali, E.D. Anastassiou, M. Christoﬁdou
(Patras, GR)
Objectives: To evaluate the performance of a multiplex PCR (m-PCR)
method for detection of dermatophytes, in general, and speciﬁcally
T. rubrum as compared to conventional methods (microscopy and
culture) for the diagnosis of tinea unguium.
Methods: A total of 65 nail samples from clinically suspected
tinea unguium were examined by direct microscopic examination and
culture, as well as, by an m-PCR method (Dermatophyte PCR Kit −
SSI Diagnostica − Denmark). DNA from a clinical T. rubrum isolate
was used as a positive control. m-PCR includes a two step extraction, a
primer mix containing two primer pairs directed toward genes encoding
chitin synthetase 1 (chs1) for detection of dermatophytes in general
(PCR product = 366bp) and internal transcribed spacer 2 (its2) for
detection of T. rubrum (PCR product = 203 bp), an internal control
(PCR product = 660bp), and two positive controls (Dermatophyte and
T. rubrum genomic DNA). After 45 thermal cycles, PCR products are
electrophoresed in a 2% agarose gel and stained with ethidium bromide.
Results are obtained within 5 hours.
Results: Cultures of 65 nail samples, yielded growth of 2 T. rubrum, 1
of T. rubrum and Candida non-albicans, 3 of Candida non-albicans, 1 of
C. albicans, 1 of Aspergillus niger, 1 of A. fumigatus and 1 of Alternaria.
Overall 5/65 (7.7%) of samples were positive for dermatophytes by
microscopy (2) and culture (3). By m-PCR 13/65 (20%) of samples
were positive for dermatophytes, 12 for T. rubrum and 1 for another
dermatophyte. PCR results of 8 nail specimens with positive culture for
non dermatophytes showed: 1 A. niger and PCR (+) for dermatophytes,
1 A. fumigatus and PCR (+) for T. rubrum, 3 Candida non-albicans and
PCR (+) for T. rubrum. The other 3 cases, positive for C. albicans,
C. non-albicans and Alternaria, gave negative PCR results. Fifty nail
samples (77%) were negative for dermatophytes by either conventional
or PCR methods.
Conclusions: m-PCR is a rapid method with high speciﬁcity which
increases sensitivity of laboratory diagnosis of nail dermatophytosis.
R2625 Disseminated sporotrichosis in a patient with hairy cell
leukaemia treated with amphotericin B and posaconazole
P. Bunce*, L. Yang, S. Chun, S. Zhang, M. Trinkaus, L. Matukas
(Toronto, CA; Baltimore, US)
We describe a case of disseminated Sporothrix schenckii infection in a
man with underlying hairy cell leukemia.
A 44-year-old man, who was initially treated with immune suppression
for a presumed autoimmune inﬂammatory disorder, developed dissem-
inated sporotrichosis with involvement of his skin, lungs and eyes.
His immmunity was further impaired by a previously unrecognised
hematological malignancy, hairy cell leukemia.
The degree of dissemination was so severe that the organism,
S. schenckii, was isolated from blood cultures while using standard
automated culture techniques.
His infection was initially refractory to antifungal therapy with traditional
amphotericin B, in part due to drug toxicity. Treatment with liposomal
amphotericin B and oral posaconazole, along with treatment of his
underlying leukemia, resulted in dramatic clinical improvement with no
residual evidence of infection.
The immunological defects associated with this malignancy, as well as
the management of refractory sporotrichosis are reviewed.
R2626 22 months of Saccharomyces cerevisiae in Princesa
University Hospital of Madrid, Spain
M.C. Martı´nez*, A. Guiu, V. Rivera, B. Buendia (Madrid, ES)
Introduction: Saccharomyces cerevisiae is a yeast used as adjuvant
treatment and prophylaxis of diarrhea. It produces two possible
infections: superﬁcial and invasive. It can colonize the respiratory
tract, gastrointestinal tract and genitourinary tract of host. Can lead to
invasive infection: gut translocation and nosocomial. There is a possibly
environmental transmission and from person to person. Administration
of probiotic mainly in neutropenic and critical patients is the main risk
factor. Infection also may emerge without previous risk factors.
Objective: Study the prevalence of S. cerevisiae in different group of
patients: in hospital and in community, and establish a relation between
it use as treatment and infection and see another possible origin.
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Method: 4652 samples were collected from March of 2009 to
December of 2010. All of them were grown in Sabouraud dextrose
agar (SDA) for 24 and 48 hours at 30ºC. We looked for macroscopic
morphology in SDA and microscopic morphology in Corn Meal agar. We
differenced saccharomyces cerevisiae from other yeast by chromogenic
medium (CHROMagar™ Candida) and by test of assimilation of sugars
(auxacolor™, BIO-RAD). Risk factors in this study: previous use of
antibiotic/antifungal, probiotics based in S. cerevisiae, hospitalization
and immunosuppression. We followed clinical and microbiological
criterias to prove if we were in an infection or colonization.
Results: Risks factor weren’t brake down into their different headings
due to the difﬁculty of ensuring that patients received Saccharomyces
cerevisiae (Ultralevura®). Only we found that only patients admitted with
chronic diarrhea and elderly in hospital received probiotic. In community
was impossible to know. Vaginitis and cervicitis, due to S. cerevisiae,
were the main infection after using of azoles or antibiotics to treat other
infections. We had not isolated in blood or sterile samples.
Conclusions: We have not had any invasive infection. We should unify
criteria to decide which patients can be given or not Ultralevura® to
prevent infections. We should study phenotypic and genotypic factors
of yeast related to its ability to invade the host and antifungal test to
establish epidemiological criteria for treatment. It is complicated to know
the origin of S. cerevisiae.
R2627 A study of fungal keratitis cases in Sirte Province, Libya
P. Mehta*, R. Mehta, M.V. Raghavendra Rao, M. Balaramiah, A. Iban
Abdallah (Sirte, LY)
Objective: Fungal keratitis is one of the major causes of the ulcerative
and sight threatening infection of the cornea but its incidence is usually
underestimated. Such a study has never been carried in this part of the
world. The objectives of this study was to determine its incidence and
associated etiological risk factors in this region.
Materials and Methods: A prospective case study of patients presenting
with clinically suspected keratitis was conducted at Al-Rehma Hospital,
Sirte, Libya between January 2008 and November 2010. Patients
presenting with clinical features of keratitis were included in this study.
Detailed history and Ophthalmic ﬁndings were documented. Cornea
was scrapped from the edge of the base of the ulcer and smears were
examined with Gram stain, Giemsa stain and KOH and inoculated on
blood agar, chocolate agar and sabourds dextrose agar.
Results: A total of 85 patients with clinically suspected keratitis were
examined of which fungal infection was found in 28 (32.9%). Out
of them 24 (85.7%) had fungal infection alone while 4 (14.2%) had
fungus mixed with bacteria. Out of all the fungus isolated Aspergillus
was cultured in 8 (28.5%) while Fusarium was cultured in12 (42.8%).
Trauma was the major cause (n = 22,78.5%) of which vegetative injury
was found in 17 (60.7%). Associated history of diabetes mellitus was
noted in 5 (17.8%) while of contact lens in 6 (21.4%) patients. Of the
total 85 patients included in the study 62 were (72.9%) males while of
the total 28 patients diagnosed with fungal keratitis 17 (60.7%) were
males.
Conclusion: Contrary to popular perception of low incidence of fungal
keratitis in this region, high incidence has been found in this study. It can
be attributed to increasing trend towards farming activity in this region
which predisposes the people to vegetative injury. Seasonal variations
throughout the year in this region leads to altered tear ﬁlm which again
could be a major predisposing factor. Increasing use of the contact lenses
also predisposes the users to contact lens related infection.
Diabetes mellitus was found in some patients which can be a
predisposing factor.
Prevalence of individual fungi
Type of fungus No. of cases
Aspergillus spp. 14
fumigatus 8
niger 6
Fusarium 11
Penicillium 2
Sporotrichos 2
Cephalosporium 1
R2628 Candida spp. bloodstream infections: trends in
epidemiology, susceptibility and antifungal use during three
years in a French university hospital
F. Lieutier*, V. Mondain, M. Gari-Toussaint, L. Hasseine, Y. Berrouane,
T. Dantin-Delafoulhouze, S. Lucas-Daver, S. Dumas, T. Fosse,
R. Collomp (Nice, FR)
Candidaemia are an important cause of morbidity and mortality in
hospitals, especially among severe patients. Over the past decade, the
epidemiology and antifungal therapies have evolved. Our university
hospital is committed since 2005 in a multidisciplinary approach to
help diagnosis and treatment of invasive fungal infections (IFI) initially
focused on costly treatments. Our objectif was to study trends in
epidemiology, susceptibility, and antifungal use in our hospital.
Methods: All patients with a blood culture yielding yeast between
January 2007 and December 2009 were included. Patient data, epi-
demiology, susceptibility, treatments and interventions of our antifungal
team were collected from computerized patient records, the Mycology
Laboratory and the Pharmacy.
Results: 74 patients were included. During this period a diversiﬁcation
of yeast species was observed, with a signiﬁcant reduction of Candida
albicans (25% in 2009 vs 52% in 2007). The rate of resistance to
ﬂuconazole has not exceeded 6% among strains of Candida and the
ﬁrst strain of Candida parapsilosis resistant to caspofungin was isolated
in 2009. First line antifungal treatments have been established according
to local recommendations (96%). The antifungal team has intervened
for nearly 80% of patients in 2009, to continue the initial antifungal
treatment or to propose a de-escalation therapy (20%). In 2009, 45% of
patients (11/24) died, underlyng the severity of those IFI.
Conclusion: This work has underlined our local speciﬁcity both in
terms of epidemiology (most important decrease in Candida albicans
compared the litterature), and in terms of multidisciplinary management
of IFI. Among the proposals from this study include the systematic
monitoring of Candidaemia during our antifungal team meetings
wathever the drug and the search for a possible nosocomial cause of
these severe infections.
R2629 Imported histoplasmosis in a region of Spain
A. Navascue´s*, I. Rodrı´guez, J. Repa´raz, S. Salvo, A. Gil-Setas,
J.M. Martı´nez-Pen˜uela, C. Ezpeleta (Pamplona, Zaragoza, ES)
Objective: The increased presence of immigrants from Latin America
and increased travel to that continent has increased the incidence
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of Histoplasmosis in Spain. Our aim was to review the cases of
histoplasmosis diagnosed in our hospital.
Methods: Review the diagnostic methods employed and clinical
characteristics of cases of histoplasmosis diagnosed during the last six
years.
Case reports: We diagnosed 4 cases, three of whom were HIV positive
(male, 28−43 years) and one patient (female 50 years) treated with
immunosuppressive drugs. All of them were from South America. The
spectrum of disease in HIV positive patients was one liver disease, one
pulmonary and one gastrointestinal. Two had a good outcome but the
other, in spite of treatment with amphotericin B, had a rapidly progress
to a multiorganic failure and died. The female had a liver histoplasmosis
and she also had a good clinical response. The treatment in all cases
was amphotericin B 5mg/kg/day (two weeks) followed by itraconazole
200mg/12h.
The laboratory diagnosis was carried out by histological (PAS and PAS-
Diastase Stain) and microbiological study (culture and PCR directly): in
three cases, we isolated H. capsulatum var. capsulatum and in the other,
the microbiological diagnosis was thanks a direct PCR in the tissue.
Conclusion: Most infected people by histoplasmosis remain asymp-
tomatic, but they can develop serious clinical forms depending on the
level of exposure and the patient’s immune status. Usually, severe forms
are seen in HIV positive patients, but as has occurred in our series of
cases it’s also possible in patients with immunosuppressive therapy.
In our country, histoplasmosis is an imported infection and because of
this it is necessary to have a high index of suspicion and perform a
detailed history to get a diagnosis. It is an infection to be considered
in the differential diagnosis in immunosuppressed patients, both HIV
positive and immunosuppressive therapy, which originate from endemic
areas or who have a history of stay in them.
R2630 Invasive zygomycosis in Saint Petersburg, Russia
S.N. Khostelidi, Y.V. Borzova, R.A. Araviyskiy, T.S. Bogomolova,
V.A. Zinserling, I.S. Zjuzgin, N.V. Vasilyeva, N.N. Klimko* (Saint
Petersburg, RU)
Objectives: To determine risk factors, clinical features, aetiologic agents
and outcomes in patients with zygomycosis.
Methods: The diagnosis of zygomycosis was made according to
EORTC/MSG criteria (2008). Clinical materials from patients were
examined by direct microscopy, culture and histopathology.
Results: During 2002–2010 y.y. twenty one cases of zygomycosis
have been diagnosed. The mean age of patients was 37 years
(range 11−60), female − 57%, male − 43%. Risk factors were as
follows: surgery − 46%, haematological malignancies − 44%, diabetes
mellitus − 5%, tuberculosis − 5%.
Lungs and paranasal sinuses were the most common sites of infection
(38% each). Disseminated form of zygomycoses was diagnosed in 10%
of patients, as well as the disease of soft tissues (10%). Rhinocerebral
form of zygomycosis was revealed in 4% of cases.
The spectrum of aetiologic agents included: Rhizopus oryzae, Rhizopus
microsporus, Rhizomucor pusillus, Rhizomucor variabilis, Absidia
corymbifera, Syncephalastrum racemosum.
Seventeen patients were treated with antifungals: amphotericin B
deoxycholate (59%), amphotericin B lipid complex or liposomal
amphotericin B (10%), posaconazole (41%). Combined antifungal
therapy was conducted in 18% of cases. Surgical treatment was
performed in 11 patients. The six-month overall survival in all patients
was 62%, in haematological patients − 30%.
Conclusions: Early diagnosis, antifungal and surgical treatment,
elimination of immunosuppression are needed for successful treatment
of invasive zygomycosis.
R2631 Evaluation of zygomycosis patients: a retrospective
multicentre study
O. Kaya*, S. Alp-Cavus, O¨. Turhan, M. Tasbakan, H. Pullukcu,
B. Ertugrul, S. Senol, B. Cetin, B. O¨zhak-Baysan, S. Sayin-Kutlu,
D. Metin, M. Avci, G. Mermut, V. Avkan-Oguz, N. Yapar on behalf
of the West Anatolian Fungal Study Group
Objectives: The incidence of Zygomycosis has increased due to
immunosuppression in recent years. We aimed to evaluate 16 cases of
Zygomycosis from eight centers retrospectively.
Methods: Zygomycosis patients were collected between 2004 and 2010.
Zygomycosis was diagnosed by culture positivity and/or histopatholog-
ical ﬁndings in addition to clinical ﬁndings. The clinical forms of zy-
gomycosis have been described on the basis of organ involvement: rhino-
orbito-cerebral, cutaneous, pulmonary, gastrointestinal and disseminated.
Disseminated infection was deﬁned as infection at 2 non-contiguous
sites.
Results: There were 11 female and ﬁve male subjects. The mean age
was 52.50±14.55 (22−68) years. The majority of cases (15 cases, 94%)
were immunocompromised patients, mainly diabetes mellitus (10 cases,
62.5%). Seven patients had received corticosteroid treatment. The most
common symptoms and clinical signs in patients was fever (n = 9),
retroorbital pain (n = 7). The most common form was rhino-orbito-
cerebral. The mycological cultures were performed in 14 patients and
half of them had a positive culture. The isolated pathogens: Rhizopus spp.
(n = 4), Mucor spp. (n = 2) and Rhizomucor spp. (n = 1). In 2 (12.5%) of
patients the diagnosis was based on only culture positivity, in 9 (56.25%
of patients) on histopathological ﬁndings, in 5 (31.25% of patients) on
both culture positivity and histopathological ﬁndings. Aspergillus ﬂavus
was found as a second agent in two patients. The average time elapsed
for diagnosis was 14.26±13.96 (2−52) days. Antifungal therapy was
administered to 15 patients (94%). Twelve patients underwent one to
four times surgical interventions with antifungal therapy. The average
duration of antifungal therapy was 61.4±58.02 (1–180) days. On the
other hand, the median duration of treatment in survivors was 62.5 (42–
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180) days. Characteristics of underlying conditions, clinical forms and
management were given in table.
Conclusion: Diabetes mellitus and corticosteroid use are common
underlying conditions in Zygomycosis. Zygomycosis is an infectious
disease with high mortality despite antifungal therapy and surgery
interventions.
R2632 Fungemia in the intensive care unit: a ﬁve-year study in
two centres
E. Paramythiotou*, F. Frantzeskaki, A. Antoniadou, G. Kallitsi,
M. Haritidou, F. Klouva, E. Trika, H. Giamarellou, D. Plahouras,
T. Panagea, L. Zerva, G. Petrikkos, A. Armaganidis (Athens, GR)
Objectives: Candidemia is frequently encountered in the nosocomial
setting, particularly in the Intensive Care Unit (ICU) causing consider-
able morbidity and mortality. The increasing incidence of non-albicans
Candida species could also be important. The aim of the present
study was to record the epidemiology, risk factors, mortality, strains
susceptibility to antifungal drugs. This is a clinical and microbiological
retrospective study of all fungemia episodes registered in two medical–
surgical ICUs between 1/1/2005 and 31/12/2009. The records of
the research laboratory of the 4th department of Internal Medicine,
the microbiology department of Attikon university hospital and the
microbiology department of Thriassion Hospital were used in order to
identify patients. Medical records were then retrieved. Special forms
were completed for each patient including demographic information,
concomitant conditions, Apache II and Sofa severity scores the day of
ICU admission, the risk factors within the preceding 10 days, data of
colonization and candidemia related information.
Results: Attikon hospital is a 640-bed teaching tertiary care hospital
with a 25-bed medical and surgical ICU and Thriassion hospital is
a 433-bed tertiary care hospital with an ICU with 8 beds. During
the study period a total of 1663 pts were hospitalized in both ICUs.
Among them 67 patients developed fungemia. Median patients’ age was
56 years. Median ICU length of stay was 37 days. Medical cause of
admission was present in 31 cases. Species isolated were C. albicans
(38.8%), C. parapsilosis, C. tropicalis (8,9%), C.spp, C. glabrata, and
non-albicans spp. Median time elapsed between ICU admission and
candidemia was 19 days. Mean Apache II score was 19 on the day of
admission and overall mortality was 50.7%. Attributable mortality was
55,9%. Ostrosky prediction rule was positive in 41 patients. Urine or
lung colonization was present in 20.5%,and multiple site colonization in
29%. Fifteen pts were submitted to an intraabdominal operation. Fifteen
pts received TPN prior to candidemia episode. Caspofungin was the most
commonly introduced treatment.
Conclusions: Compared to other blood infections fungemias are not
common among our patients but they are often lethal. A high Apache
II score at admission, multiple site colonization in combination with
abdominal surgery should raise a high suspicion index and a prophylactic
therapy should start. Non-albicans species are on the rise.
R2633 20 months of dermatophytes onychomycosis in Princesa
University Hospital, Madrid, Spain
M.C. Martı´nez*, M. Espı´nola, J. Barba, B. Buendia (Madrid, ES)
Introduction: Onychomycosis is the mainly cause of nails disease in
developed countries. The prevalence is increases with age and in certain
conditions, such as diabetes and immunosuppression. The dermatophytes
are responsible primary of infections. The majority of cases are presented
as distal and lateral subungual onychomycosis, which has the typical
appearance in most dermatophyte infections.
Objective: Show the prevalence of onychomycosis dermatophytes in the
area of our Hospital in a period of time of twenty months.
Methods: Of 2005 samples, ﬁrstly, we looked for fungal structures by
optical microscopy using KOH 10%. We used Sabouraud agar with and
without actidione, PDA and Lactrimel agar. They were incubated at
30ºC until thirty days. We looked for typical macroscopy morphology of
dermatophytos twice a week and microscopy morphology by lactofenol-
blue from PDA or Lactrimel.
Results: Of the 2005 samples, we obtained a total of 680 samples with
growth of molds. We reported 357 (52.5%) Trichophyton rubrum and 29
(4.26%) Trichophyton mentagrophytes and 294 (43.23%) corresponded
to other molds.
In 2009 the most isolations were in May (8.53%) and August (5.00%)
and in 2010 were in July (5.44%) and in October (8.23%) as cause of
onychomycosis. No dermatophytes were isolated more than these.
Conclusions: Conﬁrmation of the diagnosis should be considered
as essential. A bad treatment predispose to advanced invasion with
dermatophytes and/or other molds. We should assay sensibility to
antifungals in our area.
R2634 Typing of the dermatophytes and yeasts detected as cause
of superﬁcial mycotic infections in diabetes patients and
antifungal sensitivity of yeasts
F. Yildiz*, Z.A. Toraman, Y. Bulut (Elazig, TR)
Objective: The present study was undertaken to determine the causative
agents of superﬁcial mycotic infections and their prevalence in diabetes
mellitus patients.
Materials and Methods: In this study, a total of 130 skin and ﬁnger
nail scratches were taken from 80 diabetes patients who had been
being followed up by Department of Internal Medicine-Endocrinology
Branch polyclinics and/or clinics between 2009–2010 and the samples
were submitted to Mycology Laboratory of Department of Medical
Microbiology, Faculty of Medicine, Firat University for mycological
analysis.
The samples were subjected to mycological direct microscopic examina-
tion with 15% KOH, and cultured in mycobiotic agar (Oxoid) medium.
In addition to conventional mycological identiﬁcation methods, API
ID32C kits (Mini API, Biomerieux, France) were used For identiﬁcation
of yeast and dermatophytes. Furthermore, Candida spp. Isolates were
subjected to disk diffusion antifungal sensitivity test using vorikonazol
and ﬂukonazole disks and using CLSI criteria.
Results: In microscopic examination, 89 (68%) of clinical specimens
were found positive while 41 (32%) was negative. In the mycological
cultures, growth was detected in 78 (60%). No growth was seen 46
(35%) while contamination was detected in 6 (5%) of the samples.
Of those 78 samples that were growth positive, 28 (36%) were
Trichophyton rubrum, 3 (4%) were Trichophyton mentagrophytes, 11
(14%) were Trichophyton rubrum + Candida spp., 2 (3%) were
Trichophyton mentagrophytes+Candida spp., 5 (6%) were Trichophyton
rubrum + Trichophyton mentagrophytes and 29 (37%) were Candida
spp. Identiﬁcation of those 29 Candida spp. revealed that 16 (55%)
were Candida albicans, 7 (24%) were Candida sake, 4 (14%) were
Candida parapsilosis, 2 (7%) were Candida krusei. Results of antifungal
sensitivity tests showed that 13 (45%) of Candida spp. were resistant to
ﬂokonazole where as 4 (14%) were resistant to vorikonazole.
R2635 A pooled analysis of 100 cases of mucormycosis from Turkey
A. Nazli*, M. Tasbakan, H. Pullukcu, O. Sipahi, T. Yamazhan, B. Arda
(Izmir, TR)
Objectives: In this study, it was aimed to review systematically the
published mucormycosis cases from Turkey.
Method: Published mucormycosis cases from Turkey in national and
international medical literature in the last ﬁfteen years were retrieved
from three national (Ulakbim, Turkish Medical Literature and Medline
Plexus) and two international databases [Pubmed and Science Citation
Index Expended (SCI)]. As keywords “mukor”, “mukormikoz” were
used in national databases and “mucor”, “mucormycosis” adding
”Turkey” in international databases. Data related to age, gender,
comorbidities, signs, diagnostic tools, therapeutic modalities, and
mortality were analysed from the retrieved articles.
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Results: Data for a total of 100 mucormycosis patients (47 female,
53 male, aged 46.1) with deﬁnitive diagnosis of invasive fungal
infections according to criteria of European Organization for Research
and Treatment of Cancer (EORTC) were obtained from 48 reports (22
international, 26 national). We could not achieve the full texts of two
reports published in international databases and three reports in national
databases. In terms of common clinical ﬁndings, the most common
symptom was swelling of eye and face (64%) followed by headache
(56%), fever (54%), opthtalmoplegia (38%), loss of vision (31%)
and other neurological signs (%27). The most common comorbidity
was diabetes (53%) followed by, hematological malignancies and
corticosteroid usage (33%). A total 40 of patients had mycological
culture and in 21 it was positive. In radiologic imaging 76% of patients
had ﬁndings in favor of fungal infection. Diagnosis was made by the
help of histopathological investigation in 83 cases. Three patients had
been diagnosed on autopsy. Both surgical debridement and antifungal
therapy were administered in 85 patients. Five patients had received only
surgical debridement and seven only antifungal therapy. Three patients
died before treatment. Total mortality rate was %57. Although all patients
treated by only surgical debridement were alive, seven patients who had
only antifungal therapy died. Patients with diabetes had tendency of
higher mortality according to others (Chi square test, p = 0.052).
Conclusion: Despite new diagnostic tools and therapeutic agents
mucormycosis has still very high mortality. Suspicion of mucormycosis
is crucial for early diagnosis. In the management, biopsy should be made
immediately.
R2636 Clinical characteristics and risk factor analysis of patients
with persistent candidaemia
S. Lim*, Y. Choi, H. Kim, S. Hwang, W. Lee, J. Choi, S. Choi (Suwon,
Seoul, KR)
Objectives: Candidemia can persist even with antifungal therapy.
However the risk factors and clinical characteristics of patients with
persistent candidemia are not well known yet.
Methods: The medical records for all patients with candidemia at
the Ajou University Hospital from August 2006 to July 2008 were
reviewed. Persistent candidemia was deﬁned as the isolation of same
species of Candida from repeated blood culture at least 72 hours after
administration of systemic antifungal agent. Cases of persistent and
non-persistent candidemia were compared and risk factor analysis was
performed. Antifungal susceptibility tests were also performed and the
relationship between laboratory susceptibility data and microbiological
failure was evaluated.
Results: Fifty-three episodes of persistent candidemia and 63 episodes of
non-persistent candidemia were identiﬁed. Male gender, high Charlson’s
comorbidity score, mechanical ventilation, antifungal treatment with
azoles, central venous catheter tip culture positivity and catheter
reinsertion the same day as catheter removal dwere identiﬁed as risk
factors by univariate analysis. Using multivariate analysis, male gender
(OR 4.72, 95%CI 1.47–15.19), antifungal treatment with azoles (OR
5.75, 95%CI 1.63–20.27) and catheter tip culture positivity (OR 4.06,
95%CI 1.03–15.99) were identiﬁed as independent risk factors. Ninety-
eight percent of Candida isolates (114 of 116) were susceptible to
the administered antifungal agents. Only one pair of isolates displayed
altered minimal inhibitory concentration value during treatment.
Conclusion: Microbiological treatment failure of patients with Candida
blood stream infections is inﬂuenced by various related factors including
host factor, efﬁcacy of antimicrobial agents and management of central
venous catheter. Antimicrobial resistance is not a major determinant to
the persistence of candidemia.
R2637 Fungicidal effect on yeasts of photodynamic therapy with
1,9-dimethylmethylene blue
A. Rezusta*, P. Martinez-Vicente, D. Royo, P. Paz-Cristobal,
M. Alejandre, M. Revillo, Y. Gilaberte (Zaragoza, Huesca, ES)
Objective: To evaluate the in-vitro fungicidal effect of PDT using
DMMB against various yeast strains.
Methods: Candida parapsilosis (ATCC 22019) Candida krusei (ATCC
6258) Candida albicans (ATCC 10231) Saccharomyces cerevisiae
(ATCC 9763) Candida albicans (CETC 1001) Saccharomyces cerevisiae
(CETC 1170) and Saccharomyces pastorianus (CETC 1970) were
included in study. Starting with 24 hour-old yeast cultures at 0.5 (± 0.05)
and 4 or 5 (+0.05) McFarland standard solutions were obtained. 90 mL
of these inocula were diluted to 100mL with different concentrations
of DMMB and incubated for 0,15,30 and 60 minutes at 35 ºC.
Yeasts were irradiated with a light-emitting diode lamp emitting at
630 nm (±10nm) with an emission power of 1,22 mW, and using
a ﬂuence of 18 J/cm2. Irradiated samples cultured on Sabouraud-
Chloramphenicol agar plates were incubated 48 h at 35ºC. Fungicidal
effect was studied combining varied incubation times with different
concentrations of DMMB. Microtiter inocculated without light exposure,
only with DMMB or none of them were used as controls.
Results: A fungicidal effect of three logarithmic units was observed irra-
diating immediately after adding the photosensitizer for C. parapsilosis
and S. cerevisiae with DMMB concentrations of 1.25 mcM; C. albicans
(CETC 1001) S. cerevisiae (CETC 1170) and S. pastorianus of 0.625
mcM; and C. albicans (ATCC 10231) and C. krusei of 2.5 mcM.
A fungicidal effect of six logarithmic units with 0 minutes of incubation
with DMMB previous to irradiation was observed for S. pastorianus
with a concentration of 5 mcM; C. krusei, C. albicans (ATCC 10231)
and C. albicans (CETC 1001) of 10 mcM; S. cerevisiae (CETC 1170)
and C. parapsilosis of 20 mcM; and S. cerevisiae of 40 mcM. Incubating
the photosensitizer for 15, 30 o 60 minutes before illumination halved
the minimal fungicidal concentration of DMMB for all of the strains
studied either to obtain 3 or 6 logarithmic units reduction.
Conclusions: PDT with DMMB has fungicidal effects in-vitro (for
three and six logarithmic reduction) on C. parapsilosis, C. albicans,
S. cerevisiae, C. krusei and S. pastorianus. 15 minutes was the optimal
time of incubation with DMMB to obtain maximum fungicidal effect
(for three and 6 logs reduction) with the minimal photosensitizer’s
concentration in all the strains. Future evaluations in vivo in animal
models, should provide a better assessment of the utility of this therapy
for yeast infections.
R2638 Posaconazole failure in a renal transplant patient with
invasive aspergillosis due to Aspergillus fumigatus with
attenuated susceptibility
S. Kuipers, R. Bruggemann*, R. de Sevaux, J. Heesakkers, W. Melchers,
J. Mouton, P. Verweij (Nijmegen, NL)
Objective: To describe the ﬁrst case of an azole-naı¨ve patient with
progressive aspergillosis around and in her renal transplant due to an
Aspergillus fumigatus isolate resistant to voriconazole and with reduced
susceptibility to posaconazole, in whom posaconazole treatment failed,
even though the posaconazole regimen had been maximized to 6 times
200mg daily with intake after high-fat-containing food. The patient
succumbed to septic emboli complicating the aspergillosis.
Methods: Antifungal susceptibility testing of A. fumigatus strains using
EUCAST methodology. Molecular identiﬁcation and sequence-analysis
of the fungal isolates. Monitoring of posaconazole concentrations by
HPLC-ﬂuorescence method.
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Results: Fungal isolates were borderline to intermediate susceptible
to posaconazole (0.25 to 0.5mg/L) according to proposed guidelines
(Verweij et al, Drug Resist Updat 2009; 12:141−7). Sequence-analysis
of the infecting fungal strains showed two mutations in the Cyp51A-
gene and a tandem repeat in the gene promoter. During treatment,
posaconazole trough levels were 0.6 microg/ml. Blood and postmortem
tissue posaconazole concentrations indicated AUC/MIC ratios of 30 to
60. Table 1. Culture results and posaconazole drug concentrations in
blood and tissue samples obtained at autopsy.
Conclusion: The efﬁcacious AUC/MIC for posaconazole is probably
above 200, but this could not be achieved in our patient. Plasma levels >4
microg/ml would have been required to achieve the pharmacodynamic
target for these A. fumigatus strains with posaconazole MIC of
0.25 and 0.5, which was impossible to achieve with the current
posaconazole formulation. Posaconazole should be used caution in
invasive aspergillosis caused by strains with attenuated posaconazole
susceptibility, as drug exposure may be inadequate resulting in
therapeutic failure.
R2639 Identiﬁcation and antifungal susceptibility of Candida
haemulonii isolates in a national reference laboratory
M.J. Mun˜oz-Davila, A. Gomez-Lopez, O. Cores, J.L. Rodriguez-Tudela,
M. Cuenca-Estrella* (Murcia, Majadahonda, ES)
Background: The list of uncommon fungal species causing human
infections is growing. Conventional methods of classiﬁcation based
on morphological, biochemical and physiological features have proven
ineffective in accurately identifying such species. Candida haemulonii
has been reported among uncommon yeasts with decreased susceptibility
to antifungal agents causing human disease. We have reviewed the
identiﬁcation and antifungal susceptibility results of a collection of
clinical isolates of C. haemulonii.
Methods: A total of 10 isolates, received in our institution over 10-year
period (2001–2010), were evaluated. One of them was isolated from
blood and the other nine strains were recovered from superﬁcial sites.
They were identiﬁed by morphology and biochemical tests. In addition,
molecular identiﬁcation was done by sequencing of ribosomal DNA (ITS
domain). Susceptibility testing followed the recommendations proposed
by the EUCAST.
Results: A total of 90% (9/10) isolates were not discriminated by
phenotyping and strains were classiﬁed as unidentiﬁable according
to their biochemical proﬁle. One strain (10%) was misidentiﬁed as
Candida sake. Sequencing-based methods were able to identify all
strains analyzed. ITS sequencing of C. haemulonii isolates resulted in
identity 97% related to the respective type/validated control strain.
Most of the isolates (90%) exhibited amphotericin B MIC 1mg/L.
In addition, azole compounds showed poor activity since all isolates
exhibited a ﬂuconazole MIC >4mg/L and eight out of 10 strains showed
itraconazole, voriconazole and posaconazole MICs >0.125mg/L. On the
other hand, echinocandins demonstrated good activity in vitro against
most of the isolates.
Conclusions: (i) Phenotyping-based methods are not useful for
C. haemulonii identiﬁcation. (ii) Molecular identiﬁcation based on ITS
sequencing shows a good performance for classifying of that species.
(iii) C. haemulonii seems to be resistant to amphotericin B and azoles,
thus its accurate identiﬁcation can be compulsory for appropriate clinical
management and treatment of infections caused by it.
R2640 Clinical and epidemiological changes in candidaemia −
a comparison of periods 1985–1990 and 2001–2005
M. Pilz*, E. Zelenka, W. Graninger, E. Presterl (Vienna, AT)
Objectives: Candida spp. is the fourth most common pathogen
causing nosocomial blood stream infections and invasive infections in
immunocompromised and seriously ill patients.
Methods: Two retrospective data sets each with 100 patients from
the time periods 1985–1990 (period 1) and 2001–2005 (period 2)
respectively were evaluated. All patients whose data were included
into this study have been diagnosed with candidemia at the University
Hospital of Vienna, a 2200-bed referral centre. The aim of the study was
to identify changes in the epidemiology, the clinical manifestation and the
outcome in these two groups. The demographic dissemination in terms
of age, gender etc. was analysed as well as differences in underlying
diseases in both periods. The duration of hospitalisation and time until
Candida albicans isolation from blood culture were determined. The
progress of candidemia, the success of therapy and the mortality rate in
these two periods were evaluated.
Results: During period 1 signiﬁcantly more patients with proven
candidemia were found at Intensive Care Units, in period 2 signiﬁcantly
more at medical wards. The main hospitalisation duration until isolation
of candida was 23 days in period 1 and 27,9 days in period 2.
In both periods two third each of the patients were diagnosed as
immunocompromised.
In period 1 60 patients died: 20 in consequence of candidemia, 10
later but from the persistent fungal infection, 16 patients from their
underlying disease and 12 from bacterial sepsis. Thirty-seven patients
received antifungal therapy, 23 remained untreated. Fifty-four percent of
the treated patients died, as opposed 74 percent of the patients without
therapy.
In period 2 51 patients died: 23 in consequence of candidemia, 2 later but
from the persistent fungal infection, 20 from their underlying disease and
6 patients from bacterial sepsis. Forty-ﬁve of the 51 deceased patients
received antifungal therapy, 6 remained untreated. Fifty-four percent died
in the treated group, 50 percent in the group without treatment.
Conclusion: Although much progress has been made in the treatment
of Candida albicans, mortality of patients is still high. For a further
decrease in candida infections better tools for diagnosis, guidelines
for management and more awareness of this pathogen are absolutely
essential.
R2641 Trends in candidaemia in one Italian region, Lombardia
A.M. Tortorano*, A. Prigitano, C. Ossi, A. Grancini, E. Casari,
G. Viola, G. Giuliani, M. Mella, M. Longo, R. Passerini, M. Facchini,
M. Tejada, M. Passera, G. Delvecchio, E. Sala, C. Sturla,
A. Ceraminiello, C. Cavanna, M. Re, C. Bezzi, D. Longo, M. Arghittu,
L. Re, M.R. Sala, P. Clerici, A. Grossi, P. Pedroni, G. Munafo`,
C. Bonetti, G. Brigante for the FIMUA Lombardia Candidemia WG
Objectives: To perform a 1-year survey on candidaemia in one Italian
region, Lombardia, to verify the epidemiological changes in comparison
with the results of a previous survey conducted ten years ago (Tortorano
et al. J. Hosp. Infect. 2002; 51: 297).
Methods: The survey was carried out prospectively during 2009
involving 30 Microbiology Laboratories of Lombardia that notiﬁed
candidaemia episodes deﬁned by at least one blood culture positive for
Candida.
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Results: A total of 354 episodes of candidaemia occurred in 344
patients accounting for an incidence of 1.19 per 1000 admissions (range
0.19−2.3) and 1.20 per 10000 patient days (range 0.2−2.2). These rates
were higher compared to those obtained in the previous ’90s survey
(0.38 per 1000 admissions, range 0.03–1.45, and 0.44 per 10000 patient
days, range 0.04–1.64). In the present survey, candidaemia occurred
more frequently in patients aged 80 years (15.4 vs 8.1% of the cases)
and remained associated mainly, even if at a reduced rate, to surgery
(45% of the cases vs 56% in the previous study) and intensive care
treatments (35% vs 45%). A shift of the species causing fungaemia was
demonstrated by the comparison of the two periods: while the proportion
due to C. albicans decreased from 58 to 52%, an increase of C. glabrata
(from 13 to 20%) and C. tropicalis (from 6 to 8%) was noted. The
proportion of C. parapsilosis remained unchanged (14.5%). A decreased
of the crude mortality at day 30 from 35 to 32% was observed. The
highest mortality rate was detected in patients with C. tropicalis (41%)
and C. albicans (33%) bloodstream infections.
Conclusion: The present study revealed an increasing incidence of
candidaemia, mainly in aged subjects, and an increasing proportion of
isolates with decreased susceptibility to ﬂuconazole.
R2642 Comparative epidemiology of Candida spp. isolated from
deep and superﬁcial sites in intensive care, haematology
and renal transplant patients during a 2-months period in
8 French hospitals
C. Lacroix, A. Gicquel, F. Morio, J. Lambert, I. Accoceberry, E. Bailly,
G. Desoubeaux, E. Collin, L. Feghoul, N. Franc¸ois, F. Gabriel, F. Gay
Andrieu, J. Guitard, C. Hennequin, C. Kauffmann Lacroix, D. Lauzin,
B. Sendid, O. Lortholary, M.E. Bougnoux* (Paris, Nantes, Bordeaux,
Tours, Lille, Poitiers, FR)
Objectives: A prospective, multicentre observational study was con-
ducted in France to compare the epidemiology of Candida spp. isolated
in high risk patients from intensive care units (ICU), haematology units
(HU) and renal transplantation units (RTU).
Methods: From January to February 2010, all Candida spp. isolated
from patients hospitalized in medical and surgical ICU, adults and
paediatrics HU and RTU from 8 French university hospitals were
collected. C. albicans was identiﬁed using chromogenic agar media,
and screened with BichroDubli® (Soﬁbel) to identify C. dubliniensis.
C. krusei and C. glabrata were identiﬁed with KruseiColor® (Soﬁbel)
and Glabrata RTT® (Soﬁbel), respectively. All other Candida spp. were
identiﬁed using ID32C® (BioMe´rieux). Unequivocal identiﬁcation using
rDNA sequencing was done for all C. glabrata, C. parapsilosis, C. kefyr,
C. inconspicua/norvegensis, and those with ID32C identiﬁcation score
<95%. In vitro antifungal susceptibility was determined by E-test®
(BioMe´rieux). First isolate of each Candida sp. from each different body
site was tested in each patient.
Results: Among the 1425 Candida spp. isolated from 537 patients,
1346 were from a superﬁcial body site and 78 from a deep one.
C. albicans was the dominant species with 60.5% of the isolates,
followed by C. glabrata (12.4%), C. tropicalis (6%), C. parapsilosis
(5.8%), C. kefyr (4.4%), C. krusei (3.3%), C. dubliniensis (2.5%) and
others (5.1%). Species distribution differed according to the clinical unit
(table) and the body site sampled. Conventional identiﬁcation methods
failed to identify recently described species or uncommon species.
ID32C frequently misidentiﬁed C. inconspicua as C. norvegensis.
Antifungal susceptibility was determined for 905 Candida isolates. None
was resistant to amphotericin B. The global rates of resistance were
8.6%, 5.2%, 2% and 0.1% for ﬂucytosin, ﬂuconazole, voriconazole and
caspofungin, respectively. Except C. krusei, 69% of ﬂuconazole resistant
isolates were C. glabrata. Among voriconazole resistant isolates, 89%
were C. glabrata. Isolates with non-susceptibility to caspofungin were
C. guilliermondii (n = 2) and C. parapsilosis (n = 1).
Conclusion: This epidemiological study conducted on a short period
of time allowed us to point out differences in Candida spp. isolated
from different clinical units and body sites. Local epidemiology must be
considered for an appropriate empirical antifungal therapy.
R2643 The incidence of Candida dubliniensis in clinical material
in Czech Republic
M. Mahelova*, F. Ruzicka, V. Hola, M. Votava (Brno, CZ)
The most commonly isolated yeats Candida albicans as well as other
yeasts can colonize the gastrointestinal tract of humans and be a reservoir
for the development of infections at other body sites. In 1995, a new
species of the Candida genus was identiﬁed and classiﬁed as Candida
dubliniensis. This species shares many phenotypic similarities with
C. albicans, which leads to its misidentiﬁcation and underestimation.
It was primarily isolated and identiﬁed from the samples of HIV-
positive individuals and AIDS patients suffering from oral candidiasis,
and many other publications reported its prevalence in the oropharynx.
The occurrence of C. dubliniensis in the human feces samples has been
tested only rarely.
C. dubliniensis is not routinely identiﬁed in most of clinical laboratories
in the Czech Republic. The aim of this study was to evaluate the
incidence of C. dubliniensis in human clinical material, especially
in stool samples. Three common phenotypic methods were used for
discriminating C. dubliniensis from C. albicans (the color of colonies
on CHROMagar Candida, the inability to grow at 42 ºC and the colony
morphology on Staib medium). The identiﬁcation of C. dubliniensis was
veriﬁed by polymerase chain reaction with the species-speciﬁc primer
pair and universal primer pair.
The experiments took place from December 2007 to December 2010.
We have collected almost 500 samples from the gastrointestinal tract and
about 1500 isolates from the airways and oropharynx, all of which were
originally identiﬁed in the laboratories as C. albicans. Two to three %
of these isolates were identiﬁed as C. dubliniensis. The incidence in the
oropharynx and airways (3%) was signiﬁcantly higher than in the stool
samples (2%).
The signiﬁcance of the ﬁnding lies primarily in the fact that only a small
number of publications deals with this particular clinical specimen and
that not many publications about the incidence of C. dubliniensis in any
other clinical materials have been published in Czech republic.
Acknowledgement: This work was supported by The Ministry of
Education, Youth and Sports, INGO-LA09032
R2644 Prophylaxis of invasive fungal diseases with posaconazole
in acute myeloid leukaemia: a real-life experience
A. Candoni*, E. Simeone, M. Caira, M. Mazzucco, R. Fanin, L. Pagano
(Udine, Rome, IT)
Background: Acute Myeloid Leukemia (AML) patients are at high risk
of Invasive Fungal Diseases (IFDs). We report our real-life experience
with POS prophylaxis in AML. We also compare the performance of
POS prophylaxis with an historical, well matched, control group of AML
pts who received prophylaxis with Fluconazole (FLUCO) or Itraconazole
(ITRA).
Patients and Results: Fifty-ﬁve unselected and consecutive AML pts
received POS prophylaxis (600mg daily) between Jan 2009 and Oct
2010. Median age of this population was 47 yrs (range 18−69). All
cases were given chemotherapy with anthracyclines and cytarabine. The
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POS was started when neutrophil (PMN) count was less than 1000mL
and was stopped at PMN recovery. The median duration of severe
neutropenia (PMN lower than 500mL) was 15 days (range 7−41); 10/55
(18%) of cases had an oral mucositis grade II-III CTC (common toxicity
criteria) and 73% (40/55) of these pts received a proton pump inhibitor.
An active diagnostic work up was made in all cases with Galactomannan
assay, standard chest X-ray and thoracic CT scan in case of fever (FUO)
lasting over 48 hours. The median duration of POS prophylaxis was 15
days (range 7 to 41). Only 4/55 (7%) of pts required parenteral empiric
or pre-emptive antimycotic therapy and only 2/55 (4%) experienced a
proven IFDs (Fusarium solani fungemia and Aspergillus sp pneumonia).
Mortality IFDs related was 0%. POS was well tolerated and only 9%
(5/55) of pts experienced mild drug related side effects. No cases of POS
discontinuation, due to the side effects or intolerance, were reported.
When we compare the 55 pts who received POS with an historical
control group of 55 AML pts who received FLUCO (45/55) or ITRA
(10/55)prophylaxis, between Jan 2008 and Jun 2009, no signiﬁcant
differences were observed for underling disease status, age, IFDs risk
factors, days of severe neutropenia and days of prophylaxis. Instead,
there were signiﬁcant differences in breakthrough IFDs (4% in POS
group vs 16% in control group; P = 0,02), and in days of parenteral
antymicotic therapyn (37 vs 163).
Conclusions: This real-life experience conﬁrms that POS prophylaxis
is feasible, safe, well tolerated and effective (prevention of IFDs) in
unselected AML patients. Only 7% of these high risk pts required
parenteral antimycotic therapy and only 4% experienced breakthrough
IFDs. We also conﬁrm that POS is more effective than FLUCO or ITRA
as antifungal prophylaxis in AML pts.
R2645 Elevated serum IgG responses against Aspergillus fumigatus
proteins prior to haematopoietic stem cell transplant
identify patients at risk for invasive aspergillosis
C. Clancy*, C. Du, J. Wingard, M. Nguyen (Pittsburgh, Gainesville, US)
Background: There is a need for screening tests that identify patients
who are at particular risk for invasive aspergillosis (IA). Patients (pts)
with elevated serum antibody responses against A. fumigatus proteins
prior to haematopoietic stem cell transplant (HSCT) may be at risk to
develop IA.
Methods: We screened A. fumigatus expression libraries with serum
from a pt who survived IA. We collected serum prior to HSCT (baseline)
from 19 pts who developed IA and 54 controls, all of whom received
ﬂuconazole prophylaxis. We also collected serum at the time of diagnosis
(acute), and, for 13 pts, 4 weeks after diagnosis. We measured serum
IgG concentrations against 6 puriﬁed recombinant proteins by ELISA.
Results: We identiﬁed 20 A. fumigatus proteins, and puriﬁed Eno1,
Ahp1, Hsp90, Pep2, Crf1 and Cdc3. Among pts with IA, 68% (13/19)
were diagnosed within 30 days of HSCT (early) and 32% after 60 days
(late). 47% (9/19) of pts with IA died. Serum IgG concentrations were
highest against Eno1 and Ahp1. Baseline IgG concentrations against
Eno1, Hsp90, Pep2, Crf1 and Cdc37 were signiﬁcantly higher among
pts with IA than controls (all p 0.05). Sensitivities and speciﬁcities
of baseline IgG in identifying pts with IA ranged from 67−84% and
52−65%, respectively. Baseline responses against Eno1, Ahp1, Hsp90,
Crf1 and Cdc37 were associated with development of IA (all p 0.05),
with best results for Eno1 (p = 0.003). Assuming 15% prevalence of IA,
PPV and NPV of baseline IgG against Eno1 would be 25% and 95%,
respectively. For the combination Eno1/Cdc37, sensitivity and speciﬁcity
of baseline IgG were both 72% (p = 0.001), and PPV and NPV would be
31% and 94%, respectively. Positive IgG responses against Hsp90, Pep2,
Crf1 and Cdc37 were speciﬁcally associated with early IA (all p 0.02).
Overall, there were no signiﬁcant differences in IgG concentrations
against any of the proteins across three time points. Pts who survived IA
were more likely to demonstrate increased IgG concentrations against
Hsp90, Pep2 and Crf1 in week 4 compared to baseline (all p 0.05).
Conclusions: Baseline IgG concentrations against Eno1 and other
proteins prior to HSCT may identify pts likely to develop IA. Our results
suggest that some pts are infected or colonized with A. fumigatus at
the time of HSCT, and IA may result from progression of infection/
colonization. At the same time, elevated IgG responses may reﬂect
defects in innate immunity that predispose to fungal infection.
R2646 Nosocomial bloodstream yeast infections in children and
adolescents in Baskent University Adana Research and
Practice Center: a 2-year retrospective study (2008–2010)
H. Aliskan*, S. Colakoglu, M. Demirbilek (Ankara, TR)
Objective: As nosocomial candidemia is one of the most important
problem of hospitalized patient, we investigated the epidemiologic
features and antimicrobial susceptibility patterns of bloodstream Candida
isolates from paediatric and adolescent patients in our centre during
2008–2010, retrospectively.
Material and Methods: Blood cultures were performed using BACTEC
9240. Candida species were identiﬁed with standard tests and API
20C AUX (bioMerieux) kit. Fluconazole, voriconazole, itraconazole
susceptibilities were investigated by ATB FUNGUS 3 (bioMerieux).
Results: During the 2 years of period total 159 Candida and 11 other
yeast species were isolated from bloodstream infections which 103
(60%) of them from pediatric and 67 (40%) of them from adolescents
patients. Clinical distributions of adolescent patients were intensive care
units (31%), oncology-haematology clinics (22%) and burn unit (16%)
and pediatric patients were from paediatric intensive care units (40%),
paediatric oncology-haematology clinics (28%) and burn unit (25%).
Species distributions were given in table.
The values of MIC50 values of Candida isolates from pediatric patients
were 1mg/L, 0.06mg/L, 0.125mg/L and MIC90 values were 16mg/L,
0.5mg/L, 0.5mg/L for ﬂuconazole, voriconazole, and itraconazol,
respectively. For adolescent patients, MIC50 values were same as
pediatric group but MIC90 values were 1mg/L, 0.125mg/L, 0.5mg/L
for ﬂuconazole, voriconazole, and itraconazol, respectively. For pediatric
patients, one of the ﬂuconazole, voriconazole and itraconazole resistance
were obtained from of C. albicans strains and nonalbicans strains were
6.9%, 11.3%, respectively.
Conclusion: Our data showed that candidemia was aserious problem
espacially in intensive care units. C. albicans was still the predominat
species. C. parapsilosis is the second most frequently reported
nosocomial bloodstream infection for candidemia agents. MIC50 values
of azoles were same in both groups, whereas MIC90 values were higher
in pediatric patients for ﬂuconazole and voriconazole.
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R2647 Aspergillus-speciﬁc immunohistochemistry and in situ
hybridisation facilitate diagnosis of aspergillosis
C. Clancy*, S. Youssem, S. Dacic, Y. Toyoda, K. Cieply, M. Nguyen
(Pittsburgh, US)
Background: The diagnosis of invasive asperigllosis (IA) is limited
by poor sensitivity and speciﬁcity of microbiologic cultures, and
the inability of conventional histopathologic tests to distinguish IA
from invasive fungal infections (IFI) caused by non-Aspergillus
moulds. Aspergillus-speciﬁc immunohistochemistry (IHC) and in situ
hybridization (ISH) could facilitate direct diagnosis of IA within tissue.
Methods: IHC and ISH were performed on deparafﬁnized, formalin-
ﬁxed sections from previously diagnosed cases of proven IFI, and slides
interpreted by pathologist blinded to diagnosis. IHC: Primary Aspergillus
antibody (Abcam, MA) and secondary anti-rabbit antibody were detected
with Avidin Biotin Complex and visualized using liquid DAB. ISH:
Commercially synthesized Locked Nucleic Acid probe for Aspergillus
was detected using antiﬂourescein AP. Poly T stained tissue section was
used to determine the area of tissue to be studied.
Results: 8 tissue sections were available from patients with IA
(A. fumigatus = 5; A. niger = 1; non-speciated = 2, and 12 sections were
available from patients with IFI due to other fungi (Zygomyces = 6;
Candida = 5; Dactylaria gallopava = 1). IA samples were obtained
from 6 tissue biopsies (3 lungs, 2 upper airways, 1 vocal cord), and
2 autopsy samples. 2 serial sections from one patient with IA due to
A. fumigatus were excluded from the study because positive control
stains were negative. The sensitivity of IHC and ISH for IA was 83%
(5/6) and 100% (6/6), respectively. IHC was falsely negative in 1 pt
with IA due to A. fumigatus. The speciﬁcity of IHC and ISH was 100%
(12/12), as the tests were each negative in all sections associated with
IFI due to non-Aspergillus fungi. IHC was associated with signiﬁcant
levels of non-speciﬁc background staining in 33% of the sections that
could be analyzed, compared to 0% for ISH.
Conclusion: Data from this pilot study suggest that Aspergillus-speciﬁc
IHC and ISH will facilitate diagnosis of IA and exclude IFI due to non-
Aspergillus fungi. ISH was superior to IHC by limiting false negative
results and non-speciﬁc background staining. We are currently assessing
IHC and ISH prospectively on non-ﬁxed tissues.
R2648 First Romanian surveillance study of fungaemia: species
distribution and antifungal susceptibility
M. Mares*, V. Nastasa, I. Marincu, R. Moraru and the Romanian
Study Group of Fungaemia
Objectives: This paper presents the preliminary results of a multicentre
study on fungaemia performed in four tertiary hospitals from Romania
between 2007 and 2009. The aim of this study was to evaluate the
species distribution and the antifungal susceptibility of fungal strains
isolated from bloodstream cultures.
Methods: The study has included a total number of 12215 blood
cultures from patients hospitalized in departments of cardiovascular
surgery, general surgery, intensive care, oncohaematology, and infectious
diseases. The range of age varied between 12 days and 86 years. The
major clinical sign that required the bloodstream cultures has been
the persistent fever. In order to detect the fungal strains we used the
Hemoline Performance Duo bottles, the BacT/ALERT FA bottles, and
the BacT/ALERT Microbial Detection System. The isolated strains have
been identiﬁed using speciﬁc tests. In vitro susceptibility was assessed
by following the guidelines of AFST-EUCAST E. Def. 7.1. Two azoles
(ﬂuconazole and voriconazole) and three echinocandins (caspofungin,
micafungin, and anidulafungin) were tested.
Results: The overall percentage of fungaemia was 1.49% (182 positive
blood cultures). Out of a total number of 182 yeast strains, 56
(30.76%) were Candida albicans, 112 (61.54%) were other Candida
species, and the rest − 14 strains (7.70%) belonged to different genera
(i.e. Cryptococcus, Geotrichum, Rhodotorula, Saccharomyces, and
Trichosporon). The distribution of minimum inhibitory concentrations
(MICs) was as follows: ﬂuconazole (MIC50: 0.5mg/L; MIC90: 32mg/L),
voriconazole ((MIC50: 0.0156mg/L; MIC90: 0.25mg/L), caspofungin
(MIC50: 0.125mg/L; MIC90: 1mg/L), micafungin (MIC50: 0.25mg/L;
MIC90: 2mg/L), and anidulafungin (MIC50: 0.0312mg/L; MIC90:
0.125mg/L).
Conclusions: The rate of positive blood cultures emphasizing fungaemia
is still low comparatively with those exhibiting bacterial infections. The
study underlines the diversity of fungal strains isolated from bloodstream
cultures. It can be noticed a relatively low frequency of Candida albicans
strains and the emergence of fungaemia due to non-albicans species
accordingly to worldwide trend. The rates of resistance to ﬂuconazole
and voriconazole were 16.49% and 12.09% respectively. The MIC90
value for all echinocandins indicates in vitro susceptibility for more
than 90% of the total strains, with no signiﬁcant differences between
caspofungin, micafungin, and anidulafungin.
R2649 Antifungal use at a tertiary care centre using only
electronic data
E. Kuo, L. Puzniak, R. Reichley, J. Doherty, B. Camins* (St. Louis, US)
Objective: There are limited data on the clinical use of antifungals,
especially the echinocandins. The objective of the study was to describe
the use of antifungals among patients admitted to a tertiary care centre
using only electronic medical data.
Methods: Patients admitted to Barnes-Jewish Hospital (BJH), a 1250-
bed tertiary care centre in the US, from 10/1/2004 to 12/31/2009, who
received systemic antifungal treatment, were included in this study.
Electronic data was collected from the Washington University and BJC
Healthcare Medical Informatics Database.
Results: There were 3229 patients in the analysis. Mean age was 56±16
years. 55% (1782/3229) were males; 74% (2401/3229) were Caucasian,
21% (668/3229) were African-Americans, 1% (25/3229) were Asians,
and 0.3% (9/3229) were of Hispanic ethnicity. Median length of stay
was 27±24 days. Median APACHE II score was 11 and median
Charlson Index of Co-Morbidity was 3. 38% (1226/3229) received
anidulafungin, 36% (1152/3229) received ﬂuconazole, 22% (729/3229)
received caspofungin, and 4% (121/3229) received amphotericin. Crude
in-hospital mortality was 27% (818/3229). 56% (1797/3229) were
admitted to the ICU during their admission. 27% (861/3229) had
neutropenia (ANC< 500). Co-morbid illnesses included malignancy
(37%; 1199/3229), heart disease (26%; 851/3229), chronic lung disease
(19%; 626/3229), diabetes (17%; 542/3229), and chronic kidney disease
(12%; 392/3229), and hepatic dysfunction (10%; 329/3229). 19%
(604/3229) had a positive blood culture for Candida species. 54%
(325/604) of the isolates collected from blood were C. albicans, 20%
(118/604) were C. glabrata, 16% (95/604) were C. parapsilosis, 6%
(37/604) were C. tropicalis, 6% (37/604) were C. lusitaniae, and 3%
(19/604) were C. krusei. An additional 16% (500/3229) were treated for
Candida species isolated from a normally sterile site. 1% (44/3229) of
patients received treatment for non-candida invasive fungal infections
with 75% (33/44) being probable or deﬁnitive aspergillus infections.
Conclusions: During the study period, the majority of patients requiring
systemic antifungal treatment were treated with echinocandins, primarily
anidulafungin and caspofungin. Less than 40% of antifungal therapy was
used to treat a probable or deﬁnitive fungal infection.
R2650 Invasive pulmonary aspergillosis in patients admitted with
acute exacerbation of chronic obstructive pulmonary disease
M. Moreno-Higueras, M. Garcı´a-Morales, C. Toma´s-Jime´nez,
L. Mun˜oz-Medina, M. Martı´nez-Pe´rez, A. Pen˜a-Monje, A. Ruiz-Sancho,
J. Parra-Ruiz*, J. Herna´ndez-Quero (Granada, Murcia, ES)
Objectives: Invasive pulmonary aspergillosis (IPA) among patients
with chronic obstructive pulmonary disease (COPD) is increasing in
frequency and associated with mortality exceeding 70% in some series.
We conducted this study to ﬁnd out the approximate incidence of IPA in
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patients hospitalized with acute exacerbation of COPD (AECOPD), its
true mortality and to identify potential factors associated with mortality.
Methods: We retrospectively included all patients admitted with
AECOPD and isolation of Aspergillus over the last 3 years. IPA was
deﬁned according to Bulpa criteria. Charts were retrospectively reviewed
and patients were classiﬁed into probable IPA and colonization.
Results: We identiﬁed 68 patients admitted in the last 3 years with
AECOPD and aspergillus isolation. Thirty-seven (54%) had COPD stage
III-IV. Forty-six (68%) were male and median age was 69 (55−90).
Fifty-ﬁve patients (81%) had increased dyspnoea and 52 (76%) had
radiological alterations, mostly new inﬁltrates in chest x-ray. Thirty-nine
(57%) received >700mg of steroids during admittance and 16 (24%)
had received >20mg/day during the past 3 months. Twenty patients
(28%) had more than one aspergillus isolation. Twenty four patients
(35%) received voriconazole for a median of 19 days (1−50 days). Crude
mortality was 21% (14/68).
Patients with COPD stage III-IV were older (71 vs 63 years, p = 0,02)
and had higher mortality, 13/37 (35%) vs 3/32 (9%) (p = 0,01, OR: 3,9
CI95: 1,8−15). Similarly, patients with COPD stage III-IV received more
frequently high dose steroids 28/37 (76%) vs 11/32 (34%), p< 0,001, and
had more frequently increased dyspnoea during admittance, 36/37 (97%)
vs 20/32 (62%), p< 0,001. Neither daily dose of steroids nor voiconazole
therapy were associated with increased mortality. In multivariate analysis,
only increase dyspnoea was signiﬁcantly associated with mortality.
Conclusion: COPD patients stage III-IV had increased mortality because
of IPA although it is lower than described by other authors. Neither
previous nor high steroid doses during admittance were associated with
mortality.
R2651 Accuracy of the b-D-glucan assay for the diagnosis of
Pneumocystis jirovecii pneumonia: a meta-analysis
D. Karageorgopoulos*, I. Korbila, V. Vasileiou, M. Falagas (Athens, GR)
Objectives: The diagnosis of Pneumocystis jirovecii pneumonia (PCP),
which affects various types of immunocompromised patients, can be
at times problematic. We sought to evaluate the diagnostic accuracy of
(1?3)-b-D-glucan (BDG) for the diagnosis of PCP.
Methods: We did a meta-analysis of relevant studies, identiﬁed through
PubMed and Scopus. Eligible studies were those that reported BDG
diagnostic data in cases with documented PCP and controls with other
conditions. We excluded cases of invasive fungal infections or healthy
controls. We performed a bivariate meta-analysis of sensitivity and
speciﬁcity and constructed a hierarchical summary receiver operating
characteristics (HSROC) curve.
Results: Twelve studies were included in the meta-analysis. BDG data
were provided for 334 PCP cases and 1663 controls. The pooled (95%
conﬁdence interval) sensitivity and speciﬁcity of BDG were 94.7%
(90.2–97.2%) and 86.6% (81.5–90.5%), respectively. The positive and
negative likelihood ratios were 7.1 (5.1−9.9) and 0.06 (0.03–0.12),
respectively. The area under the HSROC curve was 0.964 (0.944–0.977).
We did not identify the presence of a threshold effect or of substantial
statistical heterogeneity.
Conclusion: Serum BDG can be a useful test in the diagnosis of
PCP. It shows excellent sensitivity and very good speciﬁcity. Still, in
clinical practice the test results should be interpreted in the context of
the underlying clinical characteristics of the individual patient. Further
studies could determine the optimal cut-off level of the test and the
appropriate diagnostic strategy for suspected PCP.
R2652 Antifungal management strategy for high-risk neutropenic
patients based on itraconazole levels
E. Giannatou*, A. Prentice, C. Kibbler (London, UK)
Objectives: This study assessed a pilot antifungal prevention strategy
based on itraconazole levels in consecutive high risk patients with the aim
of reducing empirical treatment. The patients underwent chemotherapy
or allogeneic stem cell transplantation for haematological malignancies
and received itraconazole suspension prophylaxis. The study is ongoing.
Methods: 48 neutropenic febrile episodes, 25 of which were refractory
at 4 days to broad spectrum antibiotics initiated on day one, were studied.
All patients had serum galactomannan assays (EIA) twice a week and
trough itraconazole levels measured on day one of fever. If they were
still febrile after 4 days, HRCT scan chest was performed. Antifungal
treatment was required to be given only when well deﬁned clinical,
microbiological and radiological criteria were present. Invasive Fungal
Disease (IFD) is deﬁned according to EORTC/MSG criteria 2008.
Results: Patients with normal intraconazole levels were included in the
following groups: a. NO ACTION TAKEN (no evidence IFD) 24 patients
all alive (50%) b. TREATED DUE TO PHYSICIAN SUSPICION
(no evidence IFD) 7 alive (12.5%) c. TARGETED TREATMENT
(HRCT:IFD and or gal:pos) 5 possible alive,1 probable alive, 1 possible
dead (totally 12.5%). Patients with subtherapeutic levels were included
in the following groups: d. SWITCHED TO IV ITRACONAZOLE
(no evidence of IFD) 4 patients alive (8.3%) e. TREATED DUE TO
PHYSICIAN SUSPICION (no evidence IFD) 2 patients alive,1 dead
(totally 6.25%) f. TARGETED TREATMENT (HRCT:IFD and or
gal:pos) 1 possible alive, 1 possible dead (totally 6.25%) g. NO ACTION
TAKEN (no evidence IFD) 1 alive (2%).
Conclusions: The incidence of probable or proven IFD was 2%. Three
patients with possible IFD died (all had received iv antifungal therapy).
20% of the patients overall had subtherapeutic itraconazole levels. Our
strategy reduced the rate of antifungal use by 50%.
R2653 Efﬁcacy and safety of voriconazole and posaconazole as
second line therapy in ABPA and SAFS
L. Chishimba*, R.N. Niven, J. Cooley, D.W. Denning (Manchester, UK)
Background and Objectives: Allergic bronchopulmonary aspergillosis
(ABPA) and severe asthma with fungal sensitisation (SAFS) are
progressive allergic fungal lung diseases. Current treatment with
itraconazole (itra) is associated with a 40% failure rate and adverse
events (AEs). Very little is known about the response rates or
appropriateness of treatment with voriconazole (vori) or posaconazole
(posa). This study assessed the effect of vori or posa as second and third
line therapy.
Methods: We conducted a retrospective audit of 27 adult asthmatic
patients who fulﬁlled diagnostic criteria for either ABPA or SAFS. All
patients had previously received itraconazole. Vori (300–600mg/day) or
posa (800mg/day) (adjusted by TDM) was given for at least 6 months if
tolerated. Clinical, radiological and immunological evaluation was used
to assess response. We deﬁned response as improvement in symptoms
and either fungal serology or radiological abnormalities. The rates of
clinical response or failure and their adverse effects (AEs) after 3, 6, and
12 mos of treatment were analyzed. Co-existing diagnoses, Aspergillus
antibody titre, vori and posa levels and lung function were used as co-
variates.
Results: There were 27 patients, ABPA (n = 22) or SAFS (n = 5), 11
males, median age = 59 yrs. All patients had failed itra (n = 11) or
developed AEs (n = 12), had low serum concs (n = 2) or itra resistance
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(n = 2). There were 34 courses of therapy analysed, 25 with vori and 9
with posa; only 2 posa courses were not preceded by vori (resistance).
Clinical response to voriconazole was observed in 17/25 (68%) at 3
mos, 15/20 (75%) at 6 mos and 12/16 (75%) at 12 mos, compared to
7/9 (78%) at 3, 6 and 12 mos for posa. 6/25 (24%) vori pts had AEs
requiring discontinuation before 6 mos compared to 0/9 posa patients.
Vori AEs included GI upset (7), skin photosensitivity (11), blistering
(4), visual light ﬂashes (10), insomnia (2), visual hallucinations (2),
depression (1), adrenal suppression (2), peripheral neuropathy (4), eye
irritation (2), vivid dreams (1), dizziness (1) and headache (1) but most of
them were transient and mild. Posa AEs included insomnia (2), GI upset
and mild liver impairment. Among those who discontinued, 4 relapsed
(one at 3 mo, 3 at 12 months).
Conclusion: Both voriconazole and posaconazole are safe and effective
treatment options as second line antifungal therapy for SAFS and ABPA.
Larger prospective studies are required.
AIDS and HIV infection
R2654 Levels of HIV-1 RNA suppression in two groups of salvage
patients: relation to therapy and viral dynamics
A. Capetti, N. Zanchetta*, S. Melzi, P. Zucchi, L. Carenzi, M. Cossu,
M. Gismondo, G. Rizzardini (Milano, IT)
Background: The new methods of measuring HIV-1 RNA have lowered
the levels of detection, and not all those patients whose viremia was
classiﬁed as undetectable have levels below the new cut-offs. In this
study we tried to assess some of the factors related to deeper HIV-1
RNA suppression among subjects on rescue therapy.
Methods: The VERSANT HIV-1 RNA 1.0 Assay kit (kPCR, Siemens)
is a procedure of kinetic polymerase chain reaction (kPCR) with reverse
transcription (RT) for the direct quantiﬁcation of HIV-1 RNA, with a
range of detectability between 37 and 11.000.000 copies/mL. Below 37
copies, the system can still see some signal (SS) or no signal at all
(NS), suggesting that the virus concentration in the sample in this case
is extremely low. We selected our adherent patients on salvage therapy
with darunavir/raltegravir-based regimens (the deep salvage patients, A)
and matched each with patients on late lopinavir-based regimens (the
experienced patients, B).
Results: The two populations (A, n = 33, and B, n = 32) were
homogeneous by age (48, A, vs 45.1 years, B, P = 0,13), baseline CD4+
T-cells (292 vs 338/mmc, P = 0,4) HIV-1 RNA log10 copies/mL (4,6
vs 4,8, P = 0,6), and time on viral suppression (112,6 vs 115,1 weeks,
P = 0,77). However, group A was on average in 11th treatment line with
a mean GSS= 1,88, while group B was scattered around the 5th line,
having a GSS= 2,83, P< 0,001. 21/33 subjects in group A and 16/32
in group B reached NS viremia, p = 0.32. Reaching NS viremia does
not seem to be correlated with lower baseline viral load (4,6 in NS vs
2,9 log copies/mL in SS, P = 0,69), nor even with baseline GSS (2,3
vs 2,4, P = 0,81). Also the CD4-T cell nadir (158 vs 149, P = 0,77) and
zenith HIV-1 RNA log log10 copies/mL (5,2 vs. 5,6, P = 0,21) were not
predictive of NS response.
Conclusions: Overall, a fair proportion of subjects in rescue therapy
had NS viral loads (57%), and late treatment lines were not associated
to worse virologic outcome. The relationship between extreme viral load
suppression (NS) and the latently infected T-cell pool will be further
investigated.
R2655 Cost of antiretroviral treatment in senior naı¨ve and
experienced HIV-infected patients
G. Orlando*, P. Meraviglia, L. Valsecchi, G. Rizzardini on behalf
of the Inf Dis II working group
Introduction: Since HAART introduction, the decreased mortality rate,
the longer survival and the availability of novel drugs is accompanied to
an increase in senior HIV infected patients.
In this cross sectional study is evaluated antiretroviral (ARV) cost
according to treatment line in senior (sHIV) compared to junior (jHIV)
HIV infected pts.
Methods: ARV regimens in sHIV infected patients older than 50 years
are compared to those used in jHIV patients followed up in the II Div
Inf Dis, L Sacco Hospital, Milan − Italy.
Clinical, immunovirological and current treatment data were collected
on divisional data base on 30 November 2010. Cost of antiretroviral
treatments are based on the prices reserved to L Sacco Hospital and are
presented as mean cost/patient/day (CPD).
Results: Among 1251 HAART treated pts (404 sHIV and 847 jHIV),
534 (42.68%) were on their ﬁrst or second line treatment, and 712 pts
had experienced 3 antiretroviral regimens.
Viral load suppression <50 cp/ml was achieved in 908 (85.66%)
out of 1060 available viral load assessed within 1 month from the
enrollment with no difference between sHIV and jHIV (88.3% and
84.4% respectively; p = 0.092); no difference in rate of suppression by
treatment line (c2 p 0.74) was assessed. The two groups were comparable
for class of antiretrovirals to be included in the treatment regimen (c2
p 0.4) even if a NNRTI based regimen in sHIV and a PI based regimen
in jHIV was preferred.
Increasing proportion of rescue molecules (which include enfuvirtide,
maraviroc, raltegravir and darunavir) are included in therapeutic regimen
in multi-experienced patients associated to a proportional reduction in
NNRTI containing regimens.
Both in sHIV and jHIV patients the mean CPD of each treatment line
progressively increases from €22.02 and 23.71 in ﬁrst line treatment to
€4083 and 38.85 CPD in patients with >10 treatment lines previously
experienced respectively.
When CPD were compared in sHIV and jHIV pts according to treatment
lines a signiﬁcantly lower cost was observed in sHIV in the ﬁrst-second
line treatment while comparable costs are registered in multi experienced
patients (ﬁgure).
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Discussion: Preliminary results of this cross sectional study show a
difference in the early treatment choices in sHIV versus jHIV pts
with NNRTI based regimens preferred in the older aged group with
a comparable efﬁcacy rate. In experienced patients PI based or rescue
molecules based regimens are equally represented in the two groups.
R2656 Comparisons of three methods to estimate HIV incidence
rates among persons seeking voluntary, anonymous
counselling and testing services in Taiwan
W. Liu*, P. Wu, C. Wu, C. Yang, C. Hung, C. Fang (Taipei, TW)
Objective: The annual case number of persons who are newly diagnosed
with HIV infection continues to increase in Taiwan after successful
control of HIV outbreak among injecting drug users that took place
between 2003 and 2007. Whether the increasing case number is related
to increased awareness and HIV testing activities or increasing incidence
in high-risk populations, such as men who have sex with men (MSM),
remains to be investigated. In this study, we aimed to compare 3
methods to estimate the incidence rate of HIV infection among persons
seeking voluntary, anonymous counseling and testing services (VCT) at
a university hospital.
Methods: Between 1 May, 2006 and 30 September, 2010, 9410 persons
were tested anonymously for HIV antibodies at the National Taiwan
University Hospital. Demographics and behavioral data were obtained at
the time of the counseling. Three methods were used to estimate HIV
incidence: ﬁrst, based on self-reported dates of prior tests; second, based
on linking prior records with an unique testing code; and third, based
on the Serologic Testing Algorithm for Recent HIV Seroconversion
(STARHS).
Results: During the 4-year study period, 311 individuals (3.50%) were
diagnosed as HIV-positive. Comparable overall seroconversion rate was
found by the three methods, 5.19, 4.64, and 3.88 per 100 person-years
[PY], respectively. The incidence rate of HIV infection in MSM by the
three methods was 7.44, 6.91, and 6.22 per 100 PY, respectively, which
was signiﬁcantly higher than that in heterosexuals (0.70, 0, and 0.89
per 100 PY, respectively). Greatest variability was observed among the
3 methods in the estimation of the HIV incidence rate in non-MSM
injecting drug users (31.58, 0, and 25.95 per 100 PY, respectively). An
increasing trend of overall HIV incidence rate was observed from 2007
(3.99, 4.11, and 2.34 per 100 PY) to 2009 (7.60, 5.51, and 3.79 per 100
PY) by the three respective methods.
Conclusions: The overall incidence rate of HIV infection was increasing
among VCT clients, and MSM had a signiﬁcantly higher annual rate of
HIV infection than heterosexuals. The ﬁndings suggest that, in addition
to increased testing activities that contribute of to the increasing case
number of HIV infections in Taiwan, increased transmission of HIV
continues to occur among MSM.
R2657 Prevalence of HIV infection and the correlates among
homeless in Tehran, Iran
M. Hajizadeh, S. SeyedAlinaghi, M. Foroughi, B. Moradmand Badie,
Z. Bayat, M. Akhlaghkhah, F. Marvi* (Tehran, IR)
Objectives: This study was conducted to determine the prevalence of
HIV rate infection among homeless population and also to ﬁnd out HIV
related risk behaviors in Tehran, Iran.
Methods: Tehran municipality stacks up homeless people for assessment
HIV and began collaboration with Iranian Research Center for
HIV/AIDS (IRCHA) departments during one year, to carry out
prevalence of HIV infection among 10657 homeless people. The results
were analyzed for associations between demographic information, family
support, status of drug abuse, relation with family and friends and HIV
infection prevalence.
Results: Overall HIV prevalence was 1.7% (95% conﬁdence interval
1.4−1.9). Factors independently associated with HIV infection included
history of using drugs [AOR 8.15 (4.86–13.67)], older age [AOR
1.80 (1.08–2.99) for 40−55 yr], occupation [AOR 1.64 (1.19–2.24) for
unemployed], and no relation with family [AOR 1.82 (1.30–2.54)].
Conclusion: This study supports that using injection drug is contributing
to the increased spread of HIV. Harm reduction programs should be
urgently expanded, particularly among IDU’s homeless.
R2658 A new trend of rapid disease progression in Japanese
patients recently infected with HIV-1
S. Oka* (Tokyo, JP)
Objective: The natural course of HIV-1 infection includes 10 years
of asymptomatic period before the development of AIDS. However, in
Japan, the disease progression process seems faster in recent years. This
study is to document the natural disease progression of recently HIV-1-
infected patients in Japan.
Methods: The study subjects were all 108 new patients with primary
HIV-1 infection during the period from 1997 through 2007. We evaluated
their clinical symptoms and laboratory data, and then analyzed disease
progression in 82 eligible patients. Disease progression was deﬁned as
fall in CD4 count below 350/microliter and/or initiation of antiretroviral
therapy.
Results: Ninety percent of the patients were infected through
homosexual intercourse. All patients had at least one clinical symptom
(median; 5, range; 1−11) related to primary HIV-1 infection, with
a median duration of 20 days (4−66) and 53% of them had to be
hospitalized due to severe symptoms. The median CD4 count and viral
load at ﬁrst visit were 320/microliter (48–980) and 4.81 log10/ml (3.66–
5.71), respectively. None developed AIDS during the study period.
Estimates of risk of disease progression were 61.0% at 48 weeks and
82.2% at 144 weeks. In patients who required antiretroviral therapy,
the median CD4 count was 215/microliter (range, 52–858) at initiation
of such therapy. Among patients with CD4 count <350/microliter at
ﬁrst visit, 53% never showed recovery of CD4 count (>350/microliter)
without antiretroviral therapy.
Conclusion: Despite possible bias in patient population, disease
progression seemed faster in symptomatic Japanese patients with
recently acquired primary HIV-1 infection than the previously deﬁned
natural course of the disease.
R2659 Anti-HIV low-avidity persistence in recently infected
patients, treated and not treated with early antiretroviral
therapy (HAART)
N. Zanchetta*, C. Pagani, L. Ferraris, S. Rimoldi, M. Galli, C. Galli,
S. Rusconi, M. Gismondo (Milan, Rome, IT)
Objective: To evaluate the maturation of HIV-1 speciﬁc antibody avidity
in patients with recent HIV-1 infection and to study the early highly
active antiretroviral therapy (HAART)impact.
Methods: From May to November 2010 we collected sequential samples
(23) from 6 patients with recent HIV-1 infection (seroconversion); three
of them were treated with HAART, three were not treated. Samples
were tested with HIV Ab/Ag Combo assay (ARCHITECT, Abbott
Diagnostics), HIV 1−2 Western blot (ALFA-Biotech) and with HIV-1
RNA (RT-PCR,Siemens Healthcare). The anti-HIV avidity index (AI)
was calculated by diluting two aliquots of each sample in 1M guanidine
chlorydrate or in PBS, by using ARCHITECT HIV Ag/Ab. The S/CO
ratio values between the two aliquots was calculated according to
literature: AI <0.80 indicates a recent infection (<6 months). We assayed
AI also in three patients not recently infected (16 samples) and 42 long-
term HIV-1 infections (22 with CD4+ <200, 10 HIV-1 B and 10 HIV-1
non-B genotypes (6 C, 2 F1, 1 D, 1 CRF02_AG).
Results: AI remained low (<0.80) for the ﬁrst 6 months from
seroconversion in one patient treated very early after diagnosis (average:
0.31+0.05), while in the two patients treated later the AI reached levels
>0.80 within 4−5 months from seroconversion. Fourteen out of 16
patients not recently infected had high AI (average: 0.96+0.12). The
average AI in HIV positive subjects with low CD4+ was 0.86+0.16, and
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in three cases a low AI was detected. All other sera from long-standing
HIV infection had a high AI (average: 1.01+0.08), with no differences
between B and non-B genotypes.
Conclusions: These results may have relevant implication in understand-
ing the complex mechanism of maturation of the immune response to
HIV. We will expand our study to other patients with recent HIV-1
infection and to treated patients in order to conﬁrm this preliminary
data.
R2660 H1N1 A inﬂuenza in HIV-positive patients: a case-control
study
G. Lostaunau*, V. Abril, E. Ortega, C. Gimeno (Valencia, ES)
Objective: The aim of this study is to compare the outcome and the
presence of risk factors between HIV patients and general population
diagnosed with H1N1 inﬂuenza.
Materials and Methods: Case-control study of 12 HIV adult patients
diagnosed with H1N1 A Inﬂuenza. 2 controls were recruited for
each case, choosing in random order. Diagnosis was conﬁrmed in
all patients by identifying antigenic inﬂuenza virus A and B RNA
immunochromatography and Inﬂuenza A Virus H1N1 by Real Time PCR
in nasopharyngeal swab. The study period was July 29 to December 31,
2009 performed in a 592 beds Universitary Spanish hospital serving an
urban population around 400,000.
Statistical analysis: Descriptive statistics of quantitative variables was
calculated with the SPSS program v 15.01. The odds ratio (OR) and
conﬁdence interval (CI) were analyzed by an exact test (Mid-p).
Results: During the pandemic phase, 662 samples of symptomatic
patients resulted positive for H1N1.12 were HIV+, 2 women,10 men.
6/12 (50%) were hepatitis C virus (HCV) coinfected. Median CD4
+ count was 443/mm3 (167–1297). 6/12 had <20 copies HIV/ml.
Only 2 patients required hospitalization because of bacterial pneumonia
and exacerbation of COPD (Chronic Obstructive Pulmonary Disease).
There was no mortality in any case. 30 controls were selected: 12
men,18 women. Median age was 32.5 years (18−72). 3 controls required
hospitalization due to decompensation of underlying diseases. Outcome
was favorable in all cases. Smoking was more common in HIV patients
than in controls (OR 2.44). 1/3 patients and controls suffered from
COPD. 40% of controls had some underlying condition in contrast to
none of the HIV patients, excluded chronic liver disease and COPD.
23.3% of controls were on chronic steroid therapy for various reasons,
mainly COPD. Two of the controls were obese.
Conclusions: Although the HIV associated immunosuppression may
initially predict a more severe clinical course of inﬂuenza, our results
suggest that evolution does not differ from not HIV-infected people.
We found a higher frequency of smoking among HIV patients, with an
odds ratio of 2.4. It is striking also the high occurrence of COPD in
both groups, without differences between them. If we exclude HCV co-
infected patients with liver disease, none of the HIV patients had other
chronic diseases, unlike controls.
R2661 Mal/TIRAP S180L variant polymorphism is associated
with decreased infection risk in patients with advanced
HIV-1 infection
A.I. Papadopoulos, B. Ferwerda, V. Sakka*, L. Galani, A. Antoniadou,
D. Kavatha, P. Panagopoulos, G. Poulakou, K. Protopapas, J.W. van
der Meer, M. Netea, E.J. Giamarellos-Bourboulis (Athens, GR;
Nijmegen, NL)
Objectives: MyD88 adaptor-like (Mal/TIRAP) is an adaptor protein
bridging activation of Toll-like receptors 2 and 4 after stimulation by
exogenous and endogenous ligands. We investigated the association
between the presence of the S180L SNP of Mal and the risk of severe
infection in individuals with human immunodeﬁciency virus (HIV)-1
infection.
Methods: The SNP S180L was determined in a cohort of 179 HIV-1
infected Greek patients. Analysis of the prevalence of this SNP in relation
to the infectious complications was evaluated.
Results: One hundred and thirty two (73.3%) patients were bearing the
wild type (WT) haplotype, 43 (24%) were heterozygous (HT) for the
SNP, and four (2.2%) were homozygous (HO) for the variant allele. 39
patients carrying the WT haplotype experienced an infection (29.5%)
compared to 12 HT patients (27.3%) and one HT patient (25%) (p
ns). The individuals with a nadir CD4 count <200 cells/mm3 who
carried the S180L variant demonstrated a 4-fold decrease in the odds
ratio (OR) for any serious infection compared with those who carried
the wild-type 180S genotype (OR 0.58 vs OR 2.6, p = 0.016). Six
patients developed B-cell non-Hodgkin lymphomas: two among patients
bearing WT haplotypes (1.5%); and four among patients bearing the HT
haplotype (9.3%, p = 0.040).
Conclusions: This study suggests a protection effect of the Mal S180L
SNP against serious infections in HIV-1 infected individuals with low
CD4 cell counts.
R2662 Never ever give up until you succeed: a case report
of repeated unclear febrile episodes in a 55-year-old
HIV-infected man
H. Lederer*, Y. Achermann, M. Tinguely, F. Stenner, J. Fehr (Zurich, CH)
In February 2010, a 55 year-old man with human immunodeﬁciency
virus (HIV) infection was referred to our hospital with fever, weakness
and diarrhea. The past three months he has been suffering from several
febrile episodes. Extensive work-up during previous hospitalisations
revealed no cause. HIV was diagnosed in 2007. Despite an excellent
virological response to antiretroviral treatment with an undetectable
plasma viral load the patient remained severely immunosuppressed with
107 CD4 cells/ml (5%).
On admission he was in reduced general condition, febrile (39.5ºC),
had a normal heart rate, a low blood pressure, multiple marginally
enlarged lymph nodes and an enlarged spleen. Laboratory tests showed
pancytopenia, elevated C-reactive protein and acute renal failure. Vast
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examinations for bacteria, mycobacteria, helminths, protozoas remained
all negative. Upper and lower endoscopic bowel examination with tissue
biopsies showed no evidence of disease. Fluorodeoxyglucose (FDG)-
positron emission tomography scan revealed a pathological FDG-uptake
in lymphatic tissue. Immunohistochemical examination was positive for
human herpes virus type 8 (HHV-8) latency-associated nuclear antigen
(Figure), which allowed the diagnosis of multicentric Castleman’s disease
(MCD). A treatment with rituximab, etoposide and valganciclovir for six
cycles was started. Ten months later, the patient was free from new febrile
episodes, was working full-time and CT scan revealed a decreased size
and number of lymph nodes.
MCD is a HHV-8 associated lymphoproliferative disease and should be
considered as a possible cause of episodic fever. Disease presentation
varies widely and the optimal treatment-regime is not yet established.
Improvement of the immune system and treatment of the underlying
disease is crucial. Antiviral agents have been successfully investigated.
A promising approach for treatment in selected cases is rituximab.
Antineoplastic agents such as etoposide or vinblastine are highly active
in preventing the evolution of MCD towards lymphoma. Because of the
unspeciﬁc ﬁndings, MCD can be difﬁcult to diagnose in the setting of
episodic fever and malaise.
We present a case of MCD for which it was extremely challenging to
establish the diagnosis and assume that MCD is still underestimated even
though it is more important than ever to have MCD diagnosed timely as
new very promising therapeutical approaches exist.
R2663 Hyperhomocysteinaemia in HIV-infected patients −
An underestimated problem?
I. Raila*, S. Weidemann, N. Schmidt, K. Schreiter, C. Klein, A. Po¨ge,
T. Gru¨newald (Leipzig, DE)
Objective: HIV-infected individuals are prone to several metabolic
disturbances and are at higher risk for premature arteriosclerosis
compared to HIV-negative persons. Homocysteine is an intermediate
product of methionine metabolism; hyperhomocysteinemia may indicate
functional deﬁciency of either folate, vitamin B12 and vitamin
B6. Additionally, large population-based series have documented
hyperhomocysteinemia as an independent risk factor for atherosclerosis
and subsequent cardiovascular incidents.
Little is known about the role of hyperhomocysteinemia in individuals
with HIV infection.
Goal of this study was to describe the extent of hyperhomocysteinemia
in HIV-infected patients with or without antiretroviral treatment.
Patients and Methods: In 139 HIV-infected individuals from a single
outpatient clinic homocysteine was determined. Results were correlated
with clinical, laboratory, immunological and virological parameters. In
22 of those (15,8%) assays for folate, vitamin B12 and vitamin B6 were
done and compared to the results of homocysteine serum levels.
Results: In 98 (70.5%) patients homocysteine was elevated (median
serum levels 13.8mmol/l, range 7.6–27.2). Individuals with HIV-1
viral load below detection limit (20 copies/ml) had no difference in
homocysteine levels compared to those with detectable viral loads
(median homocysteine 13.95 vs 13.6, p> 0.9). There was a trend
towards an inverse correlation of homocysteine with the extent of
immunodeﬁciency (p = 0.148) with the highest homocysteine values in
those with CD4+ T lymphocyte counts below 0.2/nl. Also, no difference
was found in patients on antretrovirals vs. naı¨ve patients. In neither
examined case (n = 22) an association of homocysteine levels with
cobalamine, pyridoxine or folate deﬁciency was found.
Conclusions: Hyperhomocysteinemia is a common feature in HIV-
infected individuals. Elevations are not signiﬁcantly correlated to either
immunological or virological parameters although there was a trend
towards higher levels in severely immunocompromised patients neither
are there inverse correlations with folate, cobalamine or pyridoxine
plasma concentrations. If this reﬂects the signiﬁcance of homocysteine
as an independent biomarker for premature arteriosclerosis remains to
be determined.
R2664 Late diagnosis of HIV infection in Iasi County, Romania −
frequency, associated factors, therapeutical options
A. Vata*, C. Manciuc, C. Nicolau, L. Prisacariu, L. Vata, C. Dorobat
(Iasi, RO)
Late diagnosis of HIV infection has unfavorable repercussions on both
the patients themselves − due to higher morbidity and mortality rates −
and the society as a whole, given the higher infection transmission risks
and increased therapy and recovery costs.
Material and Method: Retrospective study of naı¨ve patients that have
entered the records of the Regional HIV/AIDS Center of Iasi over the
last 10 years (2001–2010), based on the initial clinical, paraclinical and
therapeutic data found in the follow-up charts of these patients. Late
diagnosis was established when the patient presented for care with a
CD4 count below 350 cells/mL or having an AIDS-deﬁning event.
Results: 73.4% of the 192 patients included in the study were considered
late presenters (58.5% with advanced HIV infection), according to the
latest consensus deﬁnition. The average age of late presenters was
23.7 years, 53.9% of them being born between 1998 and 1991; M/F
ratio − 1.3, U/R ratio − 1.14, average CD4 number − 130.8/mm3.
The factors usually associated with late diagnosis in literature (patients
over 30 years of age, males, co-infection with hepatitis viruses) had
no statistical signiﬁcance in our study group. Mortality rates were
considerably higher in late presenters (31.9 vs. 7.8%, p = 0.002) and
were correlated with a low number of CD4 (p< 0.001), younger
age (p = 0.004); 57.8% of the deaths occurred within 6 months
from diagnosis. ARV therapy was started by combining 2 INRT and
IP in 52.7% of the patients, 2 INRT and one INNRT in 32.1%
of them.
Conclusion: Late diagnosis rates were higher in Iasi County than
in literature, while the risk factors detected by other authors had no
statistical signiﬁcance, possibly due to the regional epidemiological
speciﬁcity.
R2665 Positive impact of a nurse intervention on hepatitis B
immunity in a HIV clinic
N. Boillat Blanco*, A. Probst, V. Waelti Da Costa, S. Giulieri,
E. Bernasconi, A. Calmy, L. Elzi, A. Rauch, R. Weber, P. Vernazza,
M. Cavassini, P.-Y. Bochud for the Swiss HIV Cohort Study (SHCS)
Objectives: Hepatitis B virus (HBV) infection is more frequent and
severe in HIV-infected patients than in the general population. We
assessed the impact of a 3.5-year nurse intervention to improve immunity
against HBV in patients from the Swiss HIV Cohort Study (SHCS).
The intervention was conducted in one center (intervention center) and
6 other centers were used as a comparator (control centers).
Methods: SHCS participants who were seronegative for HbsAg and anti-
HBc in January 2007 were included in the study groups and followed up
until June 2010. Non immune patients (anti-HBs <10 IU/L) and patients
with unknown immunity were eligible for nurse intervention, consisting
of (1) documenting HBV serostatus in patients with previously missing
information, (2) providing vaccination (3 doses with a minimal interval
of 1 and 6 months) to non-immune patients, (3) measuring vaccination
effectiveness 1 month after the 3rd dose and (4) providing a second
course of vaccination to non-responders.
Results: A total of 238 and 2712 patients seronegative for HbsAg
and anti-HBc were included in the intervention and control centers,
respectively (Figure 1). Between 2007 and 2010, the number of patients
with absent immunity decreased from 124 (52%) to 56 (24%) in
the intervention center, and from 1658 (61%) to 1505 (55%) in the
control centers (P< 0.001). The number of patients with undocumented
immunity decreased from 76 (32%) to 0 (0%) in the intervention
center, and from 174 (6%) to 131 (5%) in the control centers
(P< 0.001).
Conclusions: HBV immunity in the HIV population is insufﬁcient in
Switzerland and can be signiﬁcantly improved by nurse intervention.
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R2666 HIV infection is associated with reduced aortic distensibility
A. Zorbala, N.V. Sipsas, I. Moyssakis, S.P. Georgiadou*,
M. Gamaletsou, A.N. Kontos, P.D. Ziakas, T. Kordossis (Athens, GR)
Objective: Atherosclerotic cardiovascular disease is an increasing
menace for patients with HIV infection. Aortic distensibility (AD) is
an elasticity index of the aorta, and reﬂects aortic stiffness. Reduced
AD is considered as an early marker of atherosclerosis. The aim of this
study was to test the hypothesis that AD is lower in HIV-infected patients
compared to healthy controls.
Methods: One hundred and ﬁve HIV-infected patients (86 males, mean
age 41±0.92 years), including 60 patients with AIDS, and 124 age and
sex matched HIV-uninfected controls (104 males, mean age 39.2±1.03
years) were evaluated by high-resolution ultrasonography to determine
AD. Measurement of carotid intima media thickness (c-IMT) was also
performed. For all patients and controls clinical and laboratory factors
associated with atherosclerosis were recorded. For HIV-infected patients,
clinical and laboratory parameters such as the CD4(+) cell count, HIV
viral load, disease stage and exposure to HAART were recorded, as well.
Results: HIV infected patients had signiﬁcantly reduced AD in
comparison with the control subjects: 2.2±0.01 vs 2.62±0.01 10−6 cm2
dyn−1, respectively (p< 0.001). No statistically signiﬁcant difference was
found in c-IMT between the two groups. In univariate analysis obe-
sity, hypertriglyceridemia, hypercholesterolemia, systolic and diastolic
hypertension, smoking, family history of cardiovascular disease and HIV
infection were predictors for AD. In multiadjusted analysis, though, the
most inﬂuential predictor of decreased distensibility was HIV infection
(b −0.43, p< 0.001). Moreover, in multiadjusted analysis among HIV-
infected patients, only increasing age was signiﬁcant contributing factor
for decreased AD.
Conclusion: This study underscores the signiﬁcant role of HIV-
infection in the pathogenesis of early atherosclerosis, as depicted from
decreased AD. Among HIV-infected patients, increasing age is a further
contributing parameter to decreased AD.
R2667 Drug resistance mutations in HIV-1 CRF06_cpx viruses
from anti-retroviral-treated patients in Estonia
M. Pauskar*, K. Huik, R. Avi, T. Karki, T. Krispin, S. Semjonova, J. Smidt,
L. Novikova, U¨. Valvar, K. Ainsalu, I. Lutsar (Tartu, Jo˜hvi, Narva, EE)
Introduction: Development of drug resistance mutations (DRMs) is one
of the greatest challenges of the successful HIV-1 ARV therapy. There
are some studies but not all suggesting that character of DRMs might
be HIV-1 subtype speciﬁc. The Estonian concentrated HIV epidemic is
predominantly caused by the CRF06_cpx and CRF06/A viruses that are
rich of naturally occurring polymorphisms in the protease (PR) region.
Objectives: We aimed to evaluate the distribution of DRMs in HIV-1
CRF06_cpx in treatment experienced patients who have failed ARV
therapy and to compare it with subtype B viruses.
Methods: We included 97 patients sent to HIV drug resistance testing
due to failure of ARV therapy between January 2008 and November
2010. Genomic viral DNA was sequenced in PR and reverse transcriptase
(RT) region and DRMs were detected using Stanford University HIV-1
Drug Resistance Database. The data on ARV consumption in 2007 were
collected by the State Agency of Medicines.
Results: A total of 29%, 57% and 14% of patients, respectively were
treated with regimens containing 1 PI + 2 NRTI, 1 NNRTI + 2
NRTI or both. Most patients (78/97) had failed ﬁrst HAART regimen.
Median viral load was 50,586 (QR 9,514; 261,418) and median CD4+
count 170 (QR 94; 260) cells/mm3. The most frequently used ARV
agents were 3TC (0.57 DDD) followed by ddI (0.31 DDD), AZT (0.22
DDD), EFV (DDD 0.20) and LPVr (0.15 DDD). Altogether 83 viruses
were successfully sequenced; majority (79%) belonging to the HIV-1
CRF06_cpx. There were 29 wild type viruses, 31 possessing resistance
against two and 5 against three ARV classes. At least one primary DRM
was detected in 54 cases (65%) including 42/54 of NRTI, 47/54 of
NNRTI and 7/54 of PI resistance. In NRTI treated population the most
common primary DRMs were M184I/V (36/42) and L74I/V (14/42),
followed by K70E/R/Q and K219E (both 4/42) and T215Y/F (3/42). In
NNRTI treated population the DRMs were as follows: K103N (38/47),
V179E (19/47), V108I (6/47), K101E/N and G190A/S (both 5/47), others
were seen in low frequency. In PI treated population the following
primary DRMs were represented in decreasing order − L90M (3/7),
M46I, I54V, V82S/A (all three 2/7), I47V and F53L in single case only.
Conclusions: The distribution of DRMs HIV-1 CRF06_cpx viruses
corresponds to the pattern seen in subtype B viruses with similar
ARV treatment regimen in previous studies suggesting that resistance
development rather depends on the ARV agent and not on the viral
subtype.
R2668 HIV testing in patients with hepatitis B and C infection in
the United Kingdom
M. Pavlides, R. Madhotra, M.M. Raza* (Milton Keynes, UK)
Objectives: Universal HIV testing is recommended for those diagnosed
with hepatitis B and hepatitis C virus (HBV and HCV) infection
under the UK National Guidelines for HIV testing 2008. Offering
and uptake of such testing should be reviewed annually by the
Hepatology/Gastroenterology/Infectious Diseases (ID) team. The audit
was done to ascertain the practice of universal HIV testing in this setting
and to identify measures to improve things if necessary.
Methods: This audit was done in a UK district general hospital
and included all patients who tested positive for Hepatitis B surface
antigen (HBsAg) and/or hepatitis C antibody or PCR between Oct 2008
and September 2009. The pathology IT system was used to establish
whether these patients had an HIV test. In addition we looked at testing
for a second hepatitis virus (HBV/HCV) as well as other parameters in
relation to their hepatitis infection (viral load, AST, genotype).
Results: We identiﬁed 102 patients who tested positive for hepatitis C
(98 antibody positive, 4 PCR positive). The tests were requested
by specialist teams (gastroenterology/genitourinary medicine/ID) in 39
(38%) patients. 51 patients (50%) had HIV serology checked of whom 6
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(12%) were HIV antibody positive. Sixty six patients (65%) had HBsAg
checked but only one was positive. Fifty nine (58%) patients had a viral
load measured and 31 (30%) had the virus genotype checked. The AST
was measured in 75 (74%) patients.
99 patients were HBsAg positive. These tests were requested by above
specialist teams in 43 (43%) patients. HIV serology was checked in 63
(64%) patients and this was positive in 6 (10%). 52 (53%) had HCV
antibody checked. 49 (49%) patients had a HBV viral load checked and
AST was measured in 77 (78%) patients. One patient was positive for
HBV, HCV and HIV.
Conclusions: HIV testing in hepatitis B and C patients is far
from universal, however the same applies to testing for a second
blood borne hepatitis virus in these patients. The laboratory currently
recommends referral to gastroenterology services in cases of positive
viral hepatitis B&C markers on the reports. This should be extended
to include considering testing for other blood borne viruses including
HIV. The results suggest that a substantial number of requests did not
come from the specialist teams in the hospital suggesting they may not
have been involved with all patients. Further investigation is warranted
to establish the targets for further education.
R2669 A new approach for CD4 targeting and HIV-1 inhibition
by antibody therapy
A. Couto*, C. Santos, J. Gonc¸alves (Lisbon, PT)
The fusion process of the Human Immunodeﬁciency Virus type 1
(HIV-1), is mediated by the gp120 surface protein and the gp41
transmembrane protein. To facilitate viral entry, the gp120 glycoprotein
must bind to cell-surface CD4, alter its conformation to reveal a site for
co-receptor attachment, and trigger conformational rearrangements in the
gp41 glycoprotein to mediate fusion of viral and host cell membranes.
Therefore the gp120-CD4 interaction is critical for virus-cell fusion. The
gp120 region that binds CD4 is the target of the broadly neutralizing
antibody B12. The B12 antibody targets gp120 and recognizes a highly
conserved epitope overlapping the CD4-binding region of gp120. This
antibody is one of the four known human monoclonal antibodies
identiﬁed that can efﬁciently neutralize a broad array of primary isolates
of HIV-1 in vitro and can protect against viral challenge in vivo.
The goal of this project is to evaluate the potential of CD4 targeting
and virus-cell fusion inhibition of HIV-1 by a single domain antibody
grafted with the gp120 highly conserved epitope recognized by the B12
antibody.
This will be done using the 23 amino acids loop of gp120, grafted at
the CDR1 of a highly stable rabbit single domain VL antibody, and
designated VL-B12. The potential of this VL-B12 construct has been
tested for CD4 binding by ELISA assay against soluble CD4 and by
FACS analysis using HeLa, HeLa-P4, 293T and Jurkat cell lines. VL-B12
is highly speciﬁc and exhibits a high binding to CD4 in the conditions
tested.
Preliminary inhibition assays performed in Jurkat cells, a Human T
lymphocyte cell line, in the presence of the VL-B12 construct show no
apparent HIV-1NL4−3 inhibition, indicating that VL-B12–CD4 binding
alone is not sufﬁcient to block virus-cell fusion and that a steric effect
due to the presence of a larger molecule may be necessary for HIV-1
fusion inhibition. The VL-B12 is being tested in Cell-to-cell inhibition
assays and standard Jurkat cell line inhibition assays in interaction with
different molecules to further evaluate its HIV-1 inhibition potential.
In conclusion, this VL-B12 appears to be very promising for CD4
targeting and a valuable mediator of biopharmaceuticals.
Hepatitis
R2670 Incidence of and associated factor with recent hepatitis C
virus infection in patients with HIV infection in Taiwan
C. Lu*, H. Sun, H. Wu, W. Liu, C. Hsieh, C. Wu, C. Hung, S. Chang
(Hsin-Chu, Taipei, TW)
Objective: Incidence of hepatitis C virus (HCV) infection has been
increasing in HIV-infected patients in several western countries, where
clustering of HCV infection was recently detected among men who have
sex with men (MSM). The objective of this study was to investigate the
incidence of and associated factor with recent HCV infection in HIV-
infected patients in Taiwan.
Methods: From June 1994 to November 2010, HIV-positive MSM or
heterosexuals with negative anti-HCV antibody at baseline and tests for
anti-HCV at least twice within one year were included in the present
study. Serial CD4, plasma HIV RNA load (PVL), and Venereal Disease
Research laboratory (VDRL) titers were obtained at baseline and within
6 months of the last anti-HCV test. Recent syphilis was deﬁned as new
seroconversion or a 4-fold increase in VDRL titers within 6 months of
the last anti-HCV test. The HCV NS5B fragment was ampliﬁed with the
use of PCR and sequenced and the phylogenetic trees were constructed.
Results: During the 16-year study period, 854 patients (39.8%
[854/2143]), 699 MSM and 155 heterosexuals, were enrolled. After
follow-up for 4223 person-years [PY], 22 patients (2.6%) had HCV
seroconversion during follow-up, with an incidence rate of 5.210 per
1000 PY. All cases occurred during the last 5-year study period. The
median duration from the last negative to the ﬁrst positive anti-HCV
was 183 days (range, 14–350 days). 4 HCV strains clustered in the
phylogenetic analysis, and no genotype 4 or genetic relatedness with the
reported strains in the western countries was observed. Compared with
the patients without HCV seroconversion, patients with seroconversion
were more likely to have syphilis at baseline (54.5% vs. 20.8%) and
recent syphilis (40.0% [4/10] vs. 9.0% [57/631]) within 6 months
of the last anti-HCV test (both P< 0.05), while no differences were
observed between the two groups regarding age, CD4 count, or PVL.
Syphilis at baseline (odds ratio [OR] 4.660; 95%CI, 1.917–11.330,
P = 0.001) and older age (OR 1.043; 95%CI, 1.001–1.086, P = 0.001)
were independent factors associated with HCV seroconversion after
adjustment for HIV transmission routes. With age, HIV transmission
route, and recent syphilis included in the model, only recent syphilis (OR
6.236; 95%CI 1.679–23.165, P = 0.006) was independently associated
with HCV seroconversion.
Conclusion: Recent HCV infection was increasing in HIV-infected
MSM in Taiwan, which was associated with acquisition of syphilis.
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R2671 Viral shedding duration of 2009 inﬂuenza A (H1N1) in
young adults
J.H. Cho, Y.H. Park*, J.H. Lee (Seoul, KR)
The auxiliary police of Korea are a group of early 20s healthy men, who
are conscripted police as an alternative military service. They live in a
same space like military barrack, but have frequent contact with general
population. So in case of contagious disease, rapid and easy spread, and
need of isolation care can be predicted. During 2009 inﬂuenza A (H1N1)
pandemic, patients with inﬂuenza like illness (ILI) among them should
be admitted and isolated for adequate infection control and treatment.
We investigated the viral shedding duration and predictive factors of
2009 inﬂuenza A (H1N1) infection in the young adults with these data.
From 3rd November 2009 to 2nd February 2010 (prior to vaccination),
we performed daily real time reverse transcriptase polymerase chain
reaction (rRT-PCR) test (Bioneer, AccuPower®New Inf.A Real-time PCR
kit, Korea) to the all enrolled inﬂuenza patients till conﬁrming negative
result and checked the symptoms, physical ﬁndings and vital signs.
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Nasopharyngeal-swab samples for rRT-PCR were collected by a same
doctor.
During the study period, there are 62 patients were conﬁrmed 2009
inﬂuenza A (H1N1) by rRT-PCR out of 104 ILI, and negative conversions
in the serial tests were conﬁrmed in 45 patients. These 45 patients
were ﬁnally analyzed. The data were analyzed nonparametrically with
Mann-Whitney U test by Windows SPSS 13. The median age of
enrolled patients was 21 years old (19−22). The median duration of
fever (interval from the onset of fever (body temperature 37.5ºC) to
the time at which temperature <37.5ºC was attained and maintained
for >24 hours) was 42 hours (9–132). Short febrile group included
patients with shorter duration of fever than 24.5 hours (1st quartile of
distribution). Adequate antiviral treatment was deﬁned as administering
antiviral agents within 48 hours after the onset of symptoms. Symptoms
included fever (presented in 100% of patients), cough (95.6%), sputum
(73.3%), sore throat (68.9%), rhinorrhea (73.3%) and gastrointestinal
symptoms (26.7%). Viral shedding duration was deﬁned as the time
interval between the onset of symptoms and the last day of positive
result of serial rRT-PCR test.
In 2009 inﬂuenza A (H1N1) among healthy young adults, the median
viral shedding duration was 5 days (2−8). Adequately treated patients
(p = 0.002) and patients with short febrile group (p = 0.001) had
signiﬁcantly shorter infective period.
R2672 Crimean Congo haemorrhagic fever: modern approaches
to diagnostics, epidemiology, prevention, therapy and
preparedness
G. Korukluoglu, P. Leyssen, A. Papa-Konidari, D. Sondaz*, F. Weber,
M. Weidmann, J. Weinbach, A. Mirazimi on behalf of the European
Project CCH FEVER
Over the last years, large outbreaks of Crimean Congo Hemorrhagic
fever virus (CCHFV) in several European countries and neighbouring
areas are on the rise. This disease poses a great threat to public health
due to its high mortality rate, modes of transmission and geographical
distribution. Climate changes and observation of the CCHFV vector in
central Europe alarm the European Community as we cannot exclude
that future outbreaks will take place in non-endemic area of Europe. To
date, there is no vaccine available and no selective antiviral drug for
the management of the disease. The general knowledge of migration,
epidemiology, re-assortment and recombination of the virus is very
limited. To ﬁll these gaps, the CCH Fever project proposes to create
a multidisciplinary collaborative research environment by bringing
together selected competitive advantages such as: operative capacity
with appropriate high security research facilities, reference centers and
clinical samples from endemic areas and an international network of e
xperienced researchers. This multidisciplinary research consortium will
facilitate the progress in several key research areas of the ﬁeld. This
program will mainly focus on (i) developing sensitive and biosafe state-
of-art diagnostic tools for CCHFV, (ii) gathering the forces and resources
in Europe to build a Biobank of clinical samples, (iii) building a compre-
hensive database consisting in clinical, laboratory and surveillance data,
(iv) taking advantage of unique and state-of-art tools to progress towards
vaccine candidates and speciﬁc antivirals against this bio-treat and
(v) disseminating the appropriate knowledge to the health care workers
in endemic regions and contributing to capacity building. These achieve-
ments will provide tools for local and European public health authorities
to prevent or counter future outbreaks and monitor the spread of the
disease thanks to the established novel and unique tools and resources.
R2673 Herpes genitalis in women under the guise of recurrent
lower urinary tract infection
E. Dovgan*, N. Petrochenkova, A. Shevelev (Smolensk, RU)
Aim: To study the prevalence of herpes genitalis in women with
symptoms of recurrent lower urinary tract infection (LUTI).
Materials and Methods: Of 60 female patients aged 18−45 years with
symptoms of recurrent LUTI were investigated during 2006–2010 years.
All patients were examined by gynecologist. There was drawn the biopsy
material from cervical canal of uterus, the blood serum in each patient.
At the time of relapse a PCR method and a ﬂuorescence immunoassay
were used for detection of HSV2 in biopsy material and immunoglobulin
G to HSV2 in serum respectively. Also urinalysis and urine culture were
done. All patients were treated by acyclovir.
Results: All patients had a history of more than 4−8 episodes of LUTI
per year. The most common complaints were frequent and painful
urination, itch and burning. There was observed the relationship of
LUTI relapses with menstrual cycle in each woman. The gynecological
examination was displayed no abnormal changes in each patient. In the
urinalysis there was revealed the increased amount of epitheliocytes only.
All urine cultures were negative. All biopsy materials from cervical canal
of uterus were negative for HSV2, but about 75% (45/60) patients with
LUTI symptoms were found high level of immunoglobulin G to HSV2
(1:1600−1:3200) in blood serum. Three weeks later the antibody G titer
increased twice. The patients were treated by acyclovir 400mg three
times a day for ﬁve days. Then the suppressive therapy with acyclovir
400mg twice a day was given for 3−5 months. After the full course of
treatment no one patient complained of LUTI.
Conclusions: In the patients with frequent episodes (more than 4 per
year) of LUTI symptoms and normal urinalysis herpes genitalis should
be suspected. The ﬂuorescence immunoassay may be used in case of
receiving negative PCR results.
Mycobacterial infections (including
diagnosis)
R2674 Clinical manifestations of Mycobacterium marinum
infections in Taiwan
T. Wu*, C. Huang, T. Wu, H. Lai (Taoyuan Hsien, TW)
Objectives: To our knowledge, there are no standard regimens to treat
M. marinum infections to date. The role of surgery is still a controversial
issue. In Taiwan, some unsatisfactory results were observed. In this
study, we would like to unravel the optimal anti-mycobacterial regimens,
beneﬁts and risk factors inﬂuencing the outcome.
Methods: From January 1, 1999 to May 31, 2009, 27 patients
were enrolled for this study at Chang Gung Memorial Hospital −
Linkou Medical Center. Medical charts were retrospectively reviewed
for demographic data, contact history, infection sites, comorbidity,
histological results, anti-mycobacterial regimens, surgery history and
outcomes. All of them received anti-mycobacterial therapy. Ten received
surgery. The clinical outcomes are classiﬁed as: successful, remission of
lesions without any sequelae; not-successful, persistent symptoms and
signs of infection or lost to follow-up.
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Results: In our study, 27 patients were enrolled due to M. marinum
infections. Among thirty isolates, three were repetitively isolated from
two patients. According to the criteria of clinical outcomes mentioned in
methods, 18 patient’s outcomes were successful, eight were failed, and
one was lost to follow-up. Statistically, 8 failed and 1 lost to follow-
up were pooled into “not successful” group. In “successful” group, the
mean (±SD) age is 50.1 (±21.6). In “not successful” group, the mean
(±SD) age is 45.8 (±19.3). Twelve patients had either ﬁsh tank contact or
ﬁshing hobby. Two had shrimp contact, and one played in a swimming
pool. One received intra-articular steroid injection. Three patients got
minor or superﬁcial trauma on their extremities. Eight had no documents
about their contact history.
In successful group, 9 patients had ever received surgical debridement;
in not-successful group, 1 patient had received surgical debridement (2-
sided Fisher’s exact p = 0.0912).
Conclusion: In Taiwan, this is the ﬁrst study to unravel the relationship
between clinical outcome and susceptibility testing of bacterial strain.
Optimal anti-mycobacterial regimens have not well been established,
all drugs had been reported as successful agents or failed agents. In
our study, we cannot identify the risk factors of treatment failure,
but the duration of prescribing clarithromycin, rifampicin, ethambutol,
and doxycycline were different between “successful” group and “not-
successful” group.
R2675 Tuberculosis: bacteriological and epidemiological aspects
in the central region of Tunisia
M. Marzouk*, A. Ferjeni, I. Ben Kahla, W. Ben Salma, H. Tarmiz,
H. Kenani, J. Boukadida (Sousse, TN)
Objective: To present the situation of TB in the region of Sousse-TN.
Materials and Methods: A retrospective study conducted during 4 years
(2006–2009) concerning all TB cases in the region of Sousse diagnosed
according to bacteriological or histo-pathological and/or clinical criteria.
Results: The total of TB cases is 494. The incidences noted for the
period study were respectively 20.7, 20.6, 24.7 and 22.4. The mean
age was 39.7 years, the sex ratio was 1.4. Close contact with patient
was found in 29.7%. Twenty patients were prisoners. The mean delay
for TB diagnosis was 45 days. Symptoms were predominated by cough
and fever in pulmonary TB. HIV infection was noted in only 2 patients
with extrapulmonary tuberculosis. TB was 233 times pulmonary and 261
times extra pulmonary (31% lymph nodes). Bacteriology conﬁrmed the
diagnosis in 207 cases; microscopy was positive in 67.6% of pulmonary
TB cases and 15.9% of extra pulmonary TB cases. Multidrug resistance
(MDR) was observed for 8 strains/patients. Mortality attributed directly
to TB was 0.2%.
Conclusion: TB remains endemic in our region. TB location is primarily
lung and lymph nodes. TB is not related to HIV infection. MDR and
mortality attributed to TB are rare in our region.
R2676 Agreement between clinical scoring methods for the
diagnosis of childhood tuberculosis in a Venezuelan
indigenous population
J. Villalba-Nun˜ez*, L. Verhagen, R. Pereira, M. Maes, B. del Nogal,
J. de Waard (Caracas, VE; Nijmegen, NL)
Objective: Compare different scoring methods for the diagnosis of
childhood tuberculosis (TB), in Warao Amerindian children.
Methods: We selected 61 children aged <16 years, with a history of
close contact with culture-conﬁrmed TB patients. Clinical, radiological
and microbiological data (smear microscopy and culture of sputa
or gastric aspirates) were collected prospectively, previous a signed
informed consent. We calculated the number of children diagnosed
with TB according to the Fourie, Keith-Edwards, Migliori and
SATVI (The South African Trial Vaccine Initiative) diagnostic scoring
systems. Differences between case frequencies were calculated using
the McNemar test with Yates correction. The simple percent agreement
and the concordance (Cohen’s Kappa coefﬁcient) for the binary results
(TB/Not TB) were calculated. Strength of agreement was classiﬁed using
Landis and Koch categories.
Results: Childhood TB case frequency varied from 19.67% using the
Fourie scoring system to 85.25% using the SATVI scoring system.
Signiﬁcant difference in case frequency (P< 0.05) occurred in 8 of 10
pair-wise comparisons between diagnostic scoring systems. The simple
percent agreement varied from 6.93% to 78.68% (median: 68.81%).
Cohen’s kappa ranged from 0.15 to 0.48 (median: 0.34). There was
a high variability in the case frequency between the different scoring
systems. The strongest concordance (moderate) found was between
Keith-Edwards and SATVI scoring systems (Kappa: 0.48); with a
concordance median value in the fair agreement category (Kappa:
0.2−0.4).
Conclusion: Although this study doesn’t support the systematic use of
the investigated diagnostic scoring systems for the diagnosis of childhood
TB in Warao children, the criteria that showed high frequency and
moderate concordance (SATVI and Keith-Edwards) could be used as
important tools in the screening of childhood contacts of TB patients.
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R2677 Tuberculosis revisited: a 10-year experience from a tertiary
hospital outpatient infectious diseases clinic
A. Fragou*, P. Nikou, G. Poulakou, A. Oikonomou, E. Paramythiotou,
F. Kontos, L. Zerva, K. Kanellakopoulou, G. Petrikkos, A. Antoniadou
(Athens, GR)
Objectives: To evaluate deﬁnite cases of mycobacterium tuberculosis
(MTB) infections, according to ATS criteria.
Methods: Retrospective chart review of 10year outpatient visits in the
infectious diseases department of a tertiary hospital.
Results: Among 110 referred patients (pts) with suspected TB, 85
deﬁnite cases were documented and analyzed [male 39 (45.9%), age:
median 59ys, range 21−93ys, caucasian 71pts (91.2%)]. In 49 pts
(57.6%), no risk factor (RF) for TB was recognized. Among the rest,
the most prominent RF was underlying malignancy [11pts (30.6%)],
followed by diabetes mellitus [8 pts (22.2%)] and steroid use [7pts
(19.4%)]. Pulmonary TB was present in12 pts (14.1%), pleural in
4 (4.7%), extrathoracic lymphadenopathy 22 (25.9%), bone and joint
infection 9 (10.6%), spinal TB 15 (17.6%), 9 CNS (10.6%), urinary
tract 6 (7.1%), abdominal 5 pts (5.6%). Fever was present in 36.5%,
appetite and/or weight loss in 14.1%, cough in 16.5%, bone-joint pain
in 23.4% and neurological signs in 11.8% (the last two directly related
to the site of infection).
Plain chest radiography (PR) was positive in 36.5% and CT scan in 46%
of pts adding signiﬁcant diagnostic clues. Direct sputum examination
(DE) was positive in 36.5%; in 55% of them plain radiograph was
insigniﬁcant. Cultures were positive in 50pts (58.8%); in 50% of them
DE was negative. PCR was positive in 27/28 cases, contributing to the
diagnosis of 17 additional cases; the same was true for 11 biopsies.
Among 48 sensitivity tests 89.6% revealed fully sensitive MTB, whereas
only two were multidrug-resistant.
Median duration of treatment was 9 months (mo) [range 2−24]; for
pulmonary TB 6mo. Drug toxicity experienced 21/85 pts (24.7%),
mostly as liver toxicity attributed to rifampin. Successful treatment was
conﬁrmed in 73/78 (93.6%); 7 pts (8.2%) were lost to follow-up. Among
4 pts who failed treatment, 3 died (mortality 3.8%).
Conclusions: Traditional diagnostic methods (DE, cultures, PR) retain
a singiﬁcant diagnostic value, which can be signiﬁcantly augmented by
the addition of newer diagnostic techniques as CT and PCR. Molecular
methods added importantly in the diagnosis of extrapulmonary TB.
Particularities of the population served by our reference center could
probably explain the epidemiological features observed regarding risk
factors and clinical picture.
R2678 Highly individualised treatment for XDR-/MDR-
tuberculosis: case series from a single centre
T. Gru¨newald*, S. Ho¨hne, I. Raila, S. Weigold, T. Marcello, K. Schreiter,
N. Schultheis, R. Schro¨der, M. Lindner, B.R. Ruf (Leipzig, Zwickau, DE)
Objective: Treatment options for patients with extensively resistant
(XDR) or multi-drug resistant (MDR) tuberculosis (TB) are highly
limited. Individualized treatment using WHO group II, IV or V
tuberculostatic substances may improve outcomes.
Goal: To determine the clinical and microbiological outcomes of patients
with conﬁrmed MDR- or XDR-TB.
Patients and Methods: Retrospective analysis of all MDR- and
XDR-TB cases in a single tertiary referral centre. Outcomes were
correlated with underlying conditions, treatment schedules, duration of
treatment and microbiological treatment response.
Results: From 2006 to 2009 eleven patients with either XDR (n = 5) or
MDR-TB (n = 6) were recorded. Pulmonary manifestations were present
in 10/11, one patient had only extrapulmonary tuberculosis (pleural,
mammary and lymph node involvement). Disseminated disease involving
lung, liver, spleen, lymph nodes or central nervous system was found in
three patients. Eight out of eleven patients were from Eastern Europe
(Russia, Ukraine, Georgia) two from Asia (Iran, Afghanistan), and one
from Africa (Cameroon). Underlying condition were found in four (HIV
infection, n = 1; HCV infection, n = 2, HIV/HCV co-infection, n = 1).
Nearly all (10/11) had at least one incomplete tuberculostatic pre-
treatment (duration 3 months to ﬁve years, in all cases non-compliance
was documented). Isolated strains were resistant to a median of ﬁve
antituberculous drugs (range 3−8). Treatment regimens provided by DOT
in every patient included mainly WHO group IV and V drugs with
at least three drugs selected by susceptibility testing (median 3, range
3−5). Two patients underwent surgery (lung surgery, n = 1; pleurectomy,
n = 1). Microbiological, radiological and clinical cure was documented
in 10/11 (72.7%). One patient died after upper lobe resection because
of pulmonary thromboembolism.
Conclusions: Prognosis in patients having at least three effective
substances left is favourable. Complete cure can be achieved by im-
plementing DOT strategies for the long-term therapy. Drug compliance
history is crucial for estimating prognosis and directs the management
of patients especially with XDR-TB.
R2679 Rapid detection of Mycobacterium tuberculosis complex in
spinal aspirate from cases of Pott’s spine at tertiary care
hospital, North India
M. Kumar*, V. Nag, R. Kumar, S. Babu, A. Maurya, U. Singh, T. Dhole
(Lucknow, IN)
Objectives: Tuberculosis of spine causing paraplegia is common and
increasing its prevalence in developing country like India. Spinal
tuberculosis (Pott’s disease) covers 50% of the cases of skeletal
tuberculosis. 15% of the cases extra pulmonary tuberculosis and 2%
of all cases of tuberculosis. It has poor prognosis due to late diagnosis.
Therefore, rapid diagnosis is essential to decrease the morbidity and
mortality of this disease. Conventional methods are time consuming and
of low sensitivity. The polymerase chain reaction (PCR) based diagnosis
provide fast diagnostic tool and hope for early diagnosis of this disease.
The aim of the study was to compare assess the applicability of rapid
methods i.e. PCR, BACTEC culture and Microscopy for detection of
mycobacterium tuberculosis complex (MTBC) in spinal specimens from
cases of suspected Pott’s spine admitted at tertiary care hospital in North
India.
Method: Sixty two non-repeated clinical samples of suspected cases
of Pott’s disease were included. All the samples were processed for
Ziehl-Neelsen staining for acid fast bacilli (AFB) and BACTEC culture
for M. tuberculosis. All the samples were also processed for PCR
ampliﬁcation with primers targeting 123 bp fragment of insertion
element IS6110 of M. tuberculosis complex. The Sensitivity, speciﬁcity
and positive-negative predictive value were assessed for ZN stain and
PCR. Kappa coefﬁcient calculated for agreement culture between ZN
stain and PCR.
Result: Out of 62 suspected Pott’s cases 32 (51.6%) cases were male
and 28 (49.4%) cases were female. ZN staining detected AFB in 19
(30.6%); BACTEC culture was positive for MTBC in 27 (43.5%)
and PCR detected MTBC in 33 (53.2%) cases. BACTEC culture was
considered as the gold standard. The Sensitivity, speciﬁcity, positive
and negative predictive value (PPV&NPV) were 96%, 80%, 79%,
97% correspondingly. The sensitivity, speciﬁcity, PPV and NPV of ZN
staining were 52%, 91%, 82% and 71% respectively. Kappa agreement
between Culture with ZN (kappa 0.51), Culture with PCR kappa
agreement (kappa 0.75) respectively.
Conclusion: PCR disclosed good agreement with culture, hence PCR
can be used for early diagnosis of tuberculosis in spinal samples (Pott’s
disease) that can help to initiate timely anti-tubercular treatment and
prevent progression to irreversible changes.
R2680 Pulmonary infections with non-tuberculous Mycobacteria:
management under guidance of Infectious Diseases Board
B. Gru¨ner*, G. Ha¨rter, P. Kern (Ulm, DE)
Objective: In recent years pulmonary infections with nontuberculous
mycobacteria (NTM) appear to be increasing worldwide in HIV negative
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patients, although accurate data are lacking. Aim of the study was to
evaluate clinical and treatment aspects in patients with pulmonary NTM-
infections.
Methods: In our center we included all patients with pulmonary NTM-
infection without concomitant HIV-infection in the period from 2007 to
2010. All patients fulﬁlling the ATS (American Thoracic Society) criteria
for NTM pulmonary infection were evaluated, and structured treatment
recommendation was discussed in the interdisciplinary infectious
diseases board (ID-Board).
Results: Seven patients were diagnosed with pulmonary NTM-infection
meeting the criterias given by the ATS. Five were female, two male;
mean age was 55, 7 years of age (range 31−77 years).
Microbiological specimens included Mycobacterium kansasii (3),
M. xenopi (2), M. avium complex (MAC) (2).
Radiological ﬁndings included disseminated small nodules (M. xenopi,
MAC), inﬁltrates/nodules (M. kansasii, M. xenopi) and one cavitary
lesion (MAC).
Three women had malignancies: one received chemotherapy, another
the monoclonal antibody Alemtuzumab, both had a complete course of
antimycobacterial therapy for 12 or 24 month, respectively; the third with
MAC had a stable clinical course, even if treatment has been stopped
after 3 months due to side effects.
From two patients with chronic pulmonary disease, one with M. kansasii
is cured after 22 months of therapy, the other one with MAC-associated
cavitary lesion is clinically stable while still under treatment (for 6
months). In two patients (M. kansasii, M. xenopi) we could not identify
underlying risk factors.
Conclusion: Pulmonary NTM infection appears not to be a uniform
disease. The clinical and radiological presentation varies, but seems
independent of mycobacteria species involved. None of our patients
progressed or deteriorated due to NTM-infection, four patients are
cured. In our opinion this result was achieved because of thorough
interdisciplinary discussions in the ID-board considering the clinical
presentations, co-morbidities and expected drug-toxicities which led
ﬁnally to a favourable outcome of our patients.
R2681 The role of interferon gama-release assays in the diagnosis
of latent tuberculosis infection in contacts of smear-positive
pulmonary tuberculosis patients: Kuwait experience
E. Mokaddas, H. Saad Eldeen*, M. Amyl (Dasma, KW)
Introduction: Knowledge of the prevelance of latent Mycobacterium
tuberculosis (MTB) infection is crusial for effective TB control. In
contacts of smear-positive pulmonary TB cases, tracing is usually done
by tuberculin skin test (TST), chest radiography and clinical signs and
symptoms of which are either nonspeciﬁc or difﬁcult to interpret.
Objectives: This prospective survey was done to compare the new
interferon gama-release assay, T.Spot TB, (Oxford Immunotech, UK)
with the conventional tests and to evaluate its value in the decision on
administration of isoniazid (INH) chemoprophylaxis.
Methods: All contacts of smear-positive pulmonary TB cases from
November, 2008 till July, 2010 were included in the survy. They were
screened by TST, T.Spot TB and chest radiography. Their nationality,
BCG status together with the administration of INH prophylaxis were
recorded.
Results: Out of 743 contacts, 381 (51%) were Kuwaiti nationals and
691 (93%) were BCG-vaccinated. TST was above the cut off value
(10mm) in 704 (95%) of the total. Only 55 (7%) of those contacts had
abnormal chest X-ray ﬁndings. In BCG-vaccinated contacts, 660 (89%)
showed TST above 10mm while only 355 (48%) of them had reactive
T.Spot TB. Forty-four percent of the contacts with TST above 10mm had
non-reactive T.Spot TB. Furthermore, out of 68 contacts with TST above
20mm, 26 still had non-reactive T.Spot TB. In contacts with reactive
T.Spot TB, 347 (89%) had normal chest X-ray while only 42 (11%) had
abnormal chest X-ray ﬁndings. Out of the 704 contacts with TST above
10mm, 363 contacts with reactive T.Spot TB correctly received INH
prophylaxis, while 194 contacts with non-reactive T.Spot TB correctly
did not receive INH prophylaxis. Follow up of those 194 contacts is
being carried out for any possible active disease development. Till date
non developed active disease.
Conclusion: T.Spot TB, a type of interferon gama-release assay, shows
promising results in the diagnosis of latent TB infection.
R2682 Performance evaluation of an in-house interferon-g release
assay in detecting tubercular infection in HIV patients
L. Alagna, P. Scarpellini*, C. Fortis (Milan, IT)
Objectives: To evaluate the performance of interferon-g release assays
(IGRA) in relation to CD4 count in a group of patients with HIV
infection with a risk of tubercular infection.
Methods: 132 patients (pts) [M= 100, F = 32] with HIV infection, have
been tested with IGRA: 113 pts because suspected of active tuberculosis,
19 pts for screening. 91 pts were also tested with tuberculin skin test
(TST). The home-made IGRA detects the number of speciﬁc interferon-g
producing T cells by means of an enzyme-linked immunospot assay,
using a restricted pool of synthetic highly immunogenic peptides
derived from ESAT-6 and CFP-10 proteins (IGRA ESAT6-CFP10). The
interferon g response to puriﬁed protein derivative (PPD) was also
measured (IGRA PPD). IGRAs were considered positive for values
greater than 20 spot forming cells per million lymphocytes (SFCML).
CD4 cells count, collected within 3 months of IGRA, was performed
and classiﬁed using four classes: CD4 <50 cells/ml, between 50 and 200
cells/ml, between 200 and 500 cells/ml and >500 cells/ml. Chi-square,
Kruskal-Wallis, Mc Nemar test and k statistics were calculated.
Results: The four classes considered do not differ for gender and
place of birth distributions and for the median age (respectively chi
square: p = 0.7852, p = 0.5958; Kruskal Wallis test: p = 0.4638). Among
different CD4 cell count classes, no differences in the distribution
of the IGRA ESAT6-CFP10 qualitative results and in the means of
quantitative measures were found (chi square: p = 0.4412; Kruskal Wallis
test: p = 0.4458).
Considering the results of the TST and the IGRA PPD, no differences in
distribution were found among the CD4 classes (chi square: p = 0.2221
and p = 0.823).
Fair agreement was found between TST and IGRA PPD in the whole
sample (k = 0.378, McNemar p 0.0001). In particular poor agreement
was found in classes of CD4 <50 cells/ml (k = 0.111, McNemar
p = 0.0133), fair agreement between 50–200 cells/ml (k = 0.364, Mc-
Nemar p = 0.364), fair agreement between 200–500 cells/ml (k = 0.371,
McNemar p = 0.0233) and good agreement in pts with CD4 >500
cells/ml (k = 0.831, McNemar p = 1).
Conclusions: Our results show that IGRAs performance are not
inﬂuenced by a different CD4 cells count levels.
Comparison between test in vivo (TST) and in-vitro (IGRA PPD)
demostrated that IGRA performes better than TST when CD4 cells
are below 500 cells/ml; TST is not useful in detecting immunological
response to tubercular infection in case of immunodeﬁciency.
R2683 Diagnosis of tuberculosis and susceptibility testing by con-
ventional and molecular methods in Southwestern Greece
L. Gkaravela*, A. Foka, M. Sevdali, F. Kolonitsiou, A. Spiliopoulou,
E.D. Anastassiou, I. Spiliopoulou (Patras, GR)
Objective: An increase in the number of tuberculosis cases in
Southwestern Greece is observed. The re-emergence of disease combined
with isolation of multidrug-resistant strains has intensiﬁed the need for
rapid diagnostic methods for mycobacteria. The rate of mycobacteria
isolation with the Bactec/9000MB system and the Lo¨wenstein-Jensen
(LJ) medium in 2949 clinical specimens obtained from 2087 patients
during 19 months (1/1/2009−31/7/2010) was compared.
Methods: Ziehl-Neelsen (ZN) staining was performed in 2796/2949
various samples. Inoculation of 2438 samples onto Lo¨wenstein-Jensen
slants (LJ, bioMe´rieux) and 2189 into Bactec/9000MB culture vials
(Becton Dickinson) was also carried out. Among 1858 samples, real-
time PCR for Mycobacterium tuberculosis complex was applied (MTB,
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COBAS TaqMan MTB, Roche). Isolates were identiﬁed at species
level by PCR and hybridization (GenoType MycobacteriumCM, Hain).
Susceptibility testing was performed by phenotypic and genotypic
methods (MGIT, Becton Dickinson and GenoType MTBDRplus, Hain,
respectively).
Results: ZN-positive were found 30 samples (1%). Twelve out of 24
tested (50%) were MTB-positive by RT-PCR. Nine out of 30 were LJ-
positive (30%), whereas 13/25 (52%) were Bactec-positive. RT-PCR was
performed in 1819/2766 ZN-negative samples. Forty-ﬁve (2.5%) were
MTB-positive and 26/2368 (1.1%) LJ-positive. Among Bactec vials,
27/2049 (1.3%) were positive. Forty-seven patients had positive culture
by either method: 41 M. tuberculosis, three M. kansasii, and one of each
M. avium, M. simiae, M. fortuitum. Susceptibility testing of 31 MTB
showed that all were rifampicin-susceptible, while 28 were sensitive
to isoniazid, 26 to ethambutol and 20 to streptomycin. The molecular
method of 39 MTB showed 18 isoniazid-susceptible and one resistant,
while 17 more carried one mutation (14/17 phenotypically susceptible).
Furthermore, 14 were rifampicin-susceptible and 4 resistant, while 18
carried one mutation (16/18 phenotypically susceptible).
Conclusions: Sensitivity of Bactec system is higher in ZN-positive sam-
ples (100%) compared to LJ medium (66.7%). Among ZN-negative sam-
ples the sensitivity of Bactec system and LJ medium is the same (62.9%).
RT-PCR shows high sensitivity (100%) in ZN-positive and lower (68.4%)
in ZN-negative samples. It is important to apply a molecular method
for susceptibility testing, in order to discover mutated subpopulation,
avoiding the predominance of completely resistant strains.
R2684 Evaluation of the genotype microbacterium CM-Hain assay
for identiﬁcation of non-tuberculous Mycobacteria Species
from clinical specimens
M. Drago*, M.C. Sironi, C. Lacchini, D. Fanti, E. Mazzola, G. Gesu
(Milan, IT)
Although Mycobacterium tuberculosis complex is by far the most
important mycobacterial species from a public health perspective,
several non tuberculous mycobacteria (NTM) species are associated with
pulmonary disease.
NTM are ubiquitous in environmental reservoirs and sometimes
clinically insigniﬁcant colonization or contamination can be difﬁcult to
distinguish from true disease.
Detection of acid-fast bacilli (AFB) in stained smears is the ﬁrst
bacteriologic evidence of the presence of mycobacteria in a clinical
specimen, but acid-fast bacteria seen on smear may represent either
M. tuberculosis or NTM.
A positive nucleic ampliﬁcation technique (NAT) on an AFB-positive
specimen is usually taken as evidence of infection with M. tuberculosis
complex, while a negative NAT in such specimens means NTM infection.
Unfortunately, NTM species identiﬁcation still requires growth in culture
media which often requires a prolonged incubation.
We decided to test smear-positive, PCR negative respiratory specimens
with a molecular assay based on the DNA strip technology (Genotype
Mycobacterium CM-Hain®) (GMCM) aimed to identify several NTM to
a species level.
After decontamination and concentration according to standard proce-
dures, 23 AFB-positive respiratory samples which tested negative with
a commercial PCR test (Xpert MTB_RIF, Cepheid®) were submitted to
GMCM-testing. The results obtained were compared with culture results
after 56 days.
Fifteen NTM (3 M. intracellulare, 4 M. avium, 4 M. kansasii, 3
M. xenopi, 1 M. chelonae) were detected by GMCM by this procedure.
Four specimens were reported to contain M. abscessus by GMCM but
no growth was detected by culture. Three specimens grew NTM (1 each
of M. abscessus, M. intracellulare and M. avium) but were negative by
GMCM. One AFB-positive specimen was negative by both GMCM and
culture.
For the 15 concordant specimens the mean time to positivity in culture
was 11.5 days (range 5.0 to 26.0). Direct identiﬁcation of NMT from
AFB-positive specimens may be useful to reduce time to diagnosis.
R2685 Extrapulmonary tuberculosis in fever of unknown origin
G. Stevanovic*, M. Pelemis, M. Pavlovic, A. Stanojevic, L. Lavadinovic,
B. Milosevic, J. Poluga, I. Milosevic, N. Mitrovic, S. Stojakovic,
J. Nikolic (Belgrade, RS)
Objectives: The aims of this study were to determine prevalence of
extrapulmonary tuberculosis in patient with fever of unknown origin
(FOU) who was HIV negative, to show prevalence of, and types of
extrapulmonary tuberculosis (TB) and to determine trends of prevalence
among patients with FOU.
Methods and Results: During period 1995–2010, 2642 with
FUO were evaluated and treated in the Clinic for infectious and
tropical diseases, Belgrade. Extrapulmonary TB were diagnosed in
128 (4,8%) patients. Genitourinary TB in 67 patients (renal − 57,
orhiepididymitis − 3, salpingo-oophoritis − 7); TB lymphadenitis in
11, meningitis in 15, TB pericarditis in 8, spondylodiscitis in 6,
liver TB in 4, in 2 patients cerebral tuberculoma and in one patient
small intestine TB. In 14 patients we did not conﬁrm tuberculosis
and after pulmonary TB was excluded, they were treated empirically
with antituberculous drags, and had a good response. As a diagnostic
methods we used: PPD skin test, cerebrospinal ﬂuid (CSF), sputum and
urine cultivation, computed tomography, echocardiography, intravenous
pyelography, patohistological examination of lymph nodes, intestine and
liver, and gynecological laparoscopy. For urine and CSF specimens
PCR test was used after year 2001. The sensitivity of conformation
test were: CSF culture 100% (PCR 100%), urine culture 45% (PCR
68%), for histopathology lymph nodes 78%, small intestine 100%
(single patient) and liver 85%. Cerebral tuberculomas was conﬁrmed
by magnetic resonance spectroscopy and reduction of lesion dimensions
during antituberculous therapy. As a diagnostic criteria, clinical course of
the illness, radiological examination, laparoscopy and other endoscope
examinations and response to empiric therapy, were also used. Incidence
of extrapulmonary TB was in slight increasing after year 2001. Isoniazid,
rifampin, pyrazinamide, ethambutol and streptomycin were used for
treatment. Multi drug resistant TB were conﬁrmed in 4 patients
and in 7 patients (drug sensitive TB) had relapses of the illness
after treatment.
Conclusions: Extrapulmonary TB is increasing cause factor in patients
with FOU and should be always considered during evaluations of this
patients.
R2686 CD4+ T-lymphopenia in HIV-negative tuberculous patients
at the King Khalid University Hospital, Riyadh, Saudi
Arabia
A. Al Aska*, A. Al-Anazi, S. Al-Sobaei, M. Al-Hedaithy, M. Barry,
A. Al-Somily, F. Buba, U. Yusuf, N. Al Anazi (Riyadh, SA)
Objectives:
1. Compare the baseline and post treatment values of CD4 and CD8 of
patients with tuberculosis and controls.
2. To analyze the sequential CD4 counts during and after treatment.
Subjects and Methods: Twenty eight (28) consecutive adult patients
diagnosed with different clinical forms of tuberculosis were recruited.
Eligible patients were enrolled based on compatible symptoms of TB
and positive Mycobacterium tuberculosis based on Ziel-Nielsen smear
and/or culture of relevant specimens as determined by the Bactec system
and/or Lowenstein-Jensen culture methods. All controls were selected
relying on the absence of history suggestive of tuberculosis and negative
tuberculin tests. Both subjects and controls were screened for HIV and
ensured negative using Enzyme-linked immunosorbent assay (ELISA)
and Recombinant immunoblot assay (RIBA). Flow cytometry study was
done as per protocol.
Patients and controls were excluded if they have the following conditions:
any form of immunodeﬁciency syndromes, diabetes mellitus, chronic
kidney disease and concurrent use of immunosuppressant medications.
Informed consent was sought from both subjects and controls before
enrollment.
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Results: Twenty eight consecutive (28) patients with varied forms of
tuberculosis were enrolled. The baseline CD4 counts of patients (mean
±SD of 556.8±297.8) were signiﬁcantly reduced as compared with
matched controls (1132.3±259.9) at a p value of 0.000. Further the
pretreatment and post treatment values of patients were signiﬁcantly
different as recorded as follows: 556.8±297.8 versus 954.3±210.9 with
a p value 0.000.
The baseline CD8 counts were not signiﬁcantly reduced (p value
0.013) as the values were 1136.0±512.1 and 1461.9±367.0 for patients
and controls respectively. However, there were improvement of the
CD8 counts after treatment; baseline counts of 1136.0±512.1 versus
1316.5±286.2 after treatment (P value, 0.002).
Conclusion: The study showed signiﬁcantly lower baseline CD4 counts
among patients with tuberculosis as compared with the controls. Further,
the counts signiﬁcantly rose towards normalization at the end of
treatment. We therefore conclude that tuberculosis is associated with
CD4 lymphoenia independent of other notable causes. The counts are
reversible and may indicate a success of treatment.
R2687 Diagnosis of tuberculosis infection in health care workers.
Comparison of tuberculin skin test with QuantiFERON®
TB Gold In-Tube
E. Perez Escolano*, J. Gutierrez, E.M. Menor, M.I. Lopez, C. Bernal,
J.C. Alados Arboledas, M.D. Lopez-Prieto (Jerez de la Frontera, Cadiz,
ES)
Objectives: To compare the use of tuberculin skin test (TST) and
Interferon-g (IFN-g) Release Assay using three speciﬁc antigens
(ESAT-6, CFP-10 and TB7.7) (QuantiFERON®-TB Gold in tube) for
the diagnosis of tuberculosis infection (TBI) and indication of treatment
in health care workers.
Methods: We conducted a prospective transversal study of health
personnel who came for routine health care study (may 2007 to june
2010). All were screened with TST and QFT (Cellestis, Australia)
and risk factors were registered in a questionnaire. Patients with a
positive result (TST or QFT) were screened also with chest X-ray. TST
was performed by Mantoux method and a positive test was deﬁned
as an induration 5mm in non-vaccinated and 15mm in vaccinated
people. QTF was made according to the manufacturer speciﬁcations. We
considered as vaccinated persons those presenting with a suggestive scar.
CDC recommendations were followed for the interpretation of the QFT.
Agreement between TST and QFT was assessed by the Cohen kappa
coefﬁcient.
Results: We studied 316 health care workers (72.2% women) from the
General Hospital of Jerez. Average age was 43.4 years (SD: 8.8), 76.4%
had been vaccinated with BCG. TST was not done in 104 (32.9%)
persons because of a previous positive TST. TST was positive in 50
(68.5%) and QFT in 30 (41.1%) non-vaccinated people. Whereas, for
vaccinated people TST was positive in 93 (39.1%) and QFT was positive
in 53 (22.2%). Agreement between the TST and QFT was 64.4% (Kappa
0.33, CI (0.15–0.51)) among the non vaccinated group; when we deﬁned
positive test for TST as an 10mm induration, agreement was 71.2%
(Kappa 0.43, CI (0.23–0.63). Agreement was 64% (Kappa 0.18, CI
(0.06–0.30)) for the vaccinated group. Two indetermined results were
detected by QFT. The indication of TBI treatment made by TST and
risk situation was modiﬁed in 70% of cases according to QFT test. We
prescribed treatment of TBI by QFT in 13% of the patients that did not
have this indication according to the TST.
Conclusions:
1. Agreement between TST and QFT was low in vaccinated and non-
vaccinated people.
2. QFT was better than TST for recent tuberculosis infection diagnosis in
health care workers because of its high speciﬁcity and no interference
of booster
3. QFT was a better indicator for treatment of tuberculosis infection.
Further studies addressing IFN-g sero-conversion and -reversion in
health care workers for the follow-up of health care personnel are needed.
R2688 Comparison of QuantiFERON®-TB Gold In-Tube with
tuberculin skin test for the diagnosis of tuberculosis
infection among drug users
J. Gutierrez*, E. Perez Escolano, J.C. Alados Arboledas, E.M. Menor,
M.I. Lopez, F. Barrera, M.D. Lopez-Prieto (Cadiz, Jerez de la Frontera,
ES)
Objectives: To evaluate the agreement of tuberculin skin test (TST)test
and the QuantiFERON® TB Gold In Tube (QFT) for the diagnosis
of tuberculosis infection (TBI) in patients attended in Drug addicts
Rehabilitation Centers, and to establish the utility of QFT as a tool
for the indication of TBI treatment.
Methods: We studied 347 immunocompetent intravenous drug users
(92.5% men) since june 2007 to april 2010; 66% had been vaccinated
with BCG. All patients were older than 17 years (mean age 39.6
years (SD: 10.2) and came for screening of tuberculosis infection. All
were screened with chest X-ray, TST, QFT (Cellestis, Australia) and
risk factors were registered in a questionnaire. TST was performed
by Mantoux method and a positive test was deﬁned as an induration
5mm in non-vaccinated and 15mm in vaccinated people. QFT
was made according to the manufacturer speciﬁcations. We considered
as vaccinated persons those presenting with a suggestive scar. CDC
recommendations were followed for the interpretation of the QFT and the
treatment of the TBI. Agreement between TST and QFT was assessed
by the Cohen kappa coefﬁcient.
Results: Agreement between TST and the QFT among non-vaccinated
patients was 84.2% (Kappa 0.69, CI (0.56–0.82)). When we redeﬁned
positive test for TST as an induration 10mm, agreement rose to
86.8% (Kappa 0.74, CI 0.61–0.86)). Agreement for vaccinated people
was 70.7% (Kappa 0.38, CI (0.26–0.50)). QFT (−)/TST (+) results was
the most frequent disagreement in non-vaccinated people. QFT was
indeterminated for 5 patients, 4 of these were negative for TST. We
prescribed treatment of TBI by QFT in 14% of the patients that did not
have indication according to the TST. The indication of TBI treatment
made by TST and risk situation was modiﬁed in 46% of cases according
to QFT test.
Conclusions:
1. Agreement between TST and QFT was good in non vaccinated
intravenous drug users.
2. Agreement between TST and QFT was low in vaccinated intravenous
drug users even if TST was considered positive with the 15mm
criterion.
3. QFT test is a better tool to identify infected individuals and to reduce
the number of unnecessary TBI treatment.
R2689 Rapid molecular detection of tuberculosis and rifampin
resistance using Xpert-MTB/RIF
S. Al Johani* (Riyadh, SA)
Background: Global control of tuberculosis is hampered by slow,
insensitive diagnostic methods, particularly for the detection of drug-
resistant forms and in immunocompramised patient’s Early detection of
tuberculosis is essential to reduce the overall mortality and morbidity
as well as elimination of disease transmission, but the complexity and
infrastructure needs of sensitive methods limit their accessibility and
effect.
Methods: We assessed the performance of Xpert MTB/RIF, an
automated molecular test for Mycobacterium tuberculosis (MTB) and
resistance to rifampin (RIF), with fully integrated sample processing
in 40 patients with suspected pulmonary tuberculosis. Eligible patients
in from our hospital provided three sputum specimens each. Twenty
Two specimens were processed with N-acetyl-L-cysteine and sodium
hydroxide before microscopy, solid and liquid culture, and the MTB/RIF
test, and current culture conﬁrmation ProbTec PCR, the rest of 18
samples underwent direct MTB/RIF test and direct ProbTec PCR kit.
Results: Among culture-positive patients, a single, direct MTB/RIF test
identiﬁed 25 of 26 patients (96.15%). In smear-positive patient the test
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identiﬁed 15 of 16 smear positive cases (93.75%) and 6 of 24 with smear-
negative tuberculosis (25.00%). The test was speciﬁc in 38 of 40 patients
without tuberculosis (95.00%). Among patients with smear-negative,
culture-positive tuberculosis, the addition of a second MTB/RIF test
increased sensitivity to a total of 92.2%. As compared with phenotypic
drug-susceptibility testing, MTB/RIF testing correctly identiﬁed 1 of 1
patients (100%) with rifampin-resistant bacteria and 21 of 23 (91.3%)
with rifampin-sensitive bacteria.
Additional comparison between ProbTec Strand displacement ampliﬁ-
cation (our current MTB PCR) and Xpert MTB/RIF showed a total of
match of 39 of the 40 samples (97.5%) and one sample that was smear
negative were positive with ProbTec and negative with Xpert system,
subsequently culture conﬁrm it’s MTB positive.
Conclusions: The MTB/RIF test provided Simultaneous detection of
both MTB and rifampicin resistance, as a marker for MDR strains
directly from untreated sputum in less than 2 hours with minimal hands-
on time. The test has high sensitivity for detecting MTB − even in
smear negative, culture positive specimens. The test can be performed
On-demand basis enable physicians to treat rapidly and effectively.
R2690 Risk factors for long-term treatment in lymph node
tuberculosis
J.P. Lanoix*, T. Guimard, N. Ettahar, A. Grannec, C. Flateau,
C. Chapuzet, P. Tattevin, J.L. Schmit (Amiens, Rennes, Tourcoing,
Caen, Lille, Rouen, FR)
Introduction: Lymph node tuberculosis (LNTB) is the most frequent
extrapumonary tuberculosis (TB), but some authors reported huge
differences between duration of treatment instead of WHO 2003
recommendations for 6 to 9 months of antiTB therapy. We conducted
a retrospective multiple centre study in the aim to describe the clinical
factors for prolongation of antiTB drugs.
Material and Method: We included retrospectively all patients who
presented with at least LNTB during 1998–2010 periods from seven
hospitals in North of France. TB was diagnosed either by culture or
histology or clinical suspicion improving with antitubercular drugs. Five
universities hospitals participated. We excluded from treatment duration
analysis patients with bone and neurological involvement.
Results: 148 patients were included, 57 of them were men (38.5%), and
58 (41.1%) were Africa born. Median age was 43.2 years (extremes 13.2–
91.3). There were 21 (16.2%) HIV infected patients, 13 of them (54.2%)
were diagnosed HIV positive at the same time at the TB diagnosis. Mean
CD4 cell was 193.7/mm3±151. Forty two patients (28.8%) had another
TB localisation (of whom 4 had bone or neurological involvement),
91 (61.9%) had superﬁcial lymph nodes, 73 (49.6%) had cervical
localisation only. Four (2.7%) patients died, 13 (8.8%) were lost of follow
up.
Duration treatment analysis was undertaken on 126 patients: median
duration was 9 months (extremes 2−30). Treatment was signiﬁcantly
longer in HIV positive patients (p< 0.01), in patients with other
TB localisation than lymph node (p< 0.01), in patients with loss of
weight (p = 0.02), and if patient had presented new lymph node during
treatment (p = 0.023). The treatment was signiﬁcantly shorter when no
complication occurred, and the main cause for treatment prolongation
was non favourable evolution. Seven patients presented relapse, 2 have
been treated for 9 months, 2 for 6 months, 2 for 4 months, one for 30
months before relapse.
Conclusion: LNTB is treated much longer than WHO recommendations.
Only 58% of treatment length is in accordance with 2003 recommenda-
tions, and 23% with 2009 recommendations which suggest that 6 months
are sufﬁcient for all extrapulmonary TB except for bone and neurological
TB. Factors associated with treatment duration are HIV infection, loss
of weight and other tuberculosis localisation.
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R2691 Prevalence and aetiological pathogens of asymptomatic
bacteriuria in type 2 diabetic patients with and without
microalbuminuria
I. Daniil*, A. Papazaﬁropoulou, S. Konstantopoulou, A. Sotiropoulos,
E. Balampani, A. Kokolaki, S. Bousboulas, S. Pappas, D. Petropoulou
(Piraeus, GR)
Objectives: The prevalence of asymptomatic bacteriuria (ASB) in
diabetic patients is high, especially in women. The aim of this study
was to evaluate the prevalence and to identify the aetiological pathogens
of ASB in patients with type 2 diabetes mellitus (T2D) with and without
microalbuminuria (MA).
Methods: A total of 200 patients with T2D (100 with MA and 100
without MA) were recruited in the study. Patients with overt diabetic
nephropathy or nephropathy from other causes, with symptoms of
urinary track infection or use of antimicrobial drugs in the last 14 days
were excluded by the study. Microalbuminuria was diagnosed measuring
the albumin excretion rate (AER) by radioimmunoassay (RIA) method
(Pharmacia, Pharmacia and Upjon Diagnostics AB, Uppsala, Sweden).
Midstream clean voiding urinary specimens were collected for urinalysis,
examined by Gram stain and cultured on blood and MacConkey agar
for detection of uropathogens. Any isolated pathogen (after 24−48hours
incubation) was identiﬁed using BBL™ Enterotube™ II (BD Diagnostic
Systems, Germany), Api System and Vitek 2 Compact (Biomerieux,
France).
Results: The prevalence of ASB was increased in diabetic patients
with MA compared to diabetic patients without MA (21% versus
8%, P< 0.001, respectively). Escherichia coli was the most prevalent
pathogen isolated in diabetic patients with and without MA (12% versus
3.0%, P = 0.01, respectively) followed by Proteus mirabilis (6% versus
5%, P = 0.75, respectively) and Klebsiella spp (5% versus 1%, P = 0.09,
respectively).
Conclusion: ASB was more prevalent among T2D patients with MA and
the main causative agent was E. coli. Screening for ASB is warranted in
diabetic patients especially if pyuria is detected in urine analysis since
ASB has been found to be a risk factor for developing symptomatic
urinary tract infection.
R2692 Pandemic 2009 inﬂuenza A (H1N1) virus infection
coinciding with invasive pulmonary aspergillosis
J.J. Vehreschild*, P.J. Bro¨ckelmann, C. Bangard, J. Verheyen,
M.J. Vehreschild, G. Michels, H. Wisplinghoff, A. Cornely (Cologne, DE)
Introduction: Prior reports have suggested a possible association
between invasive pulmonary aspergillosis (IPA) and inﬂuenza infection
in otherwise healthy patients. In patients receiving anti-neoplastic
chemotherapy, however, the impact of inﬂuenza on the incidence of IPA
remains unknown.
Methods: We used data from the Cologne Cohort of Neutropenic
Patients to analyse the impact of the inﬂuenza A (H1N1) 2009 pandemic
on the incidence of invasive pulmonary aspergillosis among cancer
patients. We then compared our ﬁndings to historical data.
Results: During the pandemic we diagnosed inﬂuenza A (H1N1) by
PCR in ﬁve patients with malignancies and febrile neutropenia refractory
to antibiotic therapy. Probable invasive pulmonary aspergillosis was
diagnosed in three of these patients on grounds of typical CT morphology
and microbiologic results. During the pandemic, three of ﬁve patients
receiving AML induction chemotherapy developed aspergillosis although
receiving posaconazole prophylaxis. In the three years before the
inﬂuenza pandemic, only 2/77 patients of this group developed IPA (RR
23.1; 95%CI: 4.93–108.16).
Discussion: Our ﬁndings indicate that infection with inﬂuenza A (H1N1)
may increase the risk for invasive aspergillosis in neutropenic patients.
During pandemic and seasonal inﬂuenza, persistently febrile neutropenic
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patients should continue to receive standard diagnostic work-up, even
if diagnosis of inﬂuenza has been made. Pulmonary aspergillosis is
an important additional differential diagnosis in neutropenic inﬂuenza
patients with pneumonia.
R2693 Common pathogens isolated from diabetic foot infections
in a university hospital, Hungary
E. Urba´n*, G. Terhes, E. Nagy on behalf of ESGARAB
Objectives: Foot infections are the most common problems in persons
with diabetes. These individuals are predisposed to foot infections
because of a compromised vascular supply secondary to diabetes. Local
trauma and/or pressure (often in association with lack of sensation
because of neuropathy), in addition to microvascular disease, may result
in various diabetic foot infections. Infectious agents are associated with
the worst outcomes, which may ultimately lead to amputation of the
infected foot, unless prompt treatment strategies are ensued. The present
study sought to reveal bacterial etiology of diabetic foot ulcers in diabetic
patients of our region.
Methods: A retrospective review of clinical and microbiological data
of 139 diabetic patients suffered from moderate-to-severe diabetic foot
infections (DFIs), including out- and inpatients in the special wards of
our University was carried out over a 5-year period. After debridement,
investigators collected wound specimens, mostly by curettage or biopsy,
and sent them to the Hungarian Anaerobic Reference Laboratory for
aerobic and anaerobic culture.
Results: All of the samples were culture positive, only anaerobic
bacteria were present in 34 samples (24.5%). Among the cultures, 97%
were polymicrobial, 2 grew only one microorganism: C. perfringens
and C. septicum in pure culture, 43.7% had both aerobes and
anaerobes. A total of 832 bacterial strains were isolated, resulting
in an average of 5.98 organisms (range 1 to 21) per lesion: 619
anaerobic-, and 209 aerobic- or facultative bacteria and 4 yeasts were
isolated. The predominant aerobic organisms were oxacillin-susceptible
S. aureus (31.7%), b-haemolytic (mostly group B) Streptococcus
species (12.2%), Enterococcus species (16.7%), members of the family
Enterobacteriaceae: E. coli, Proteus, Klebsiella, Enterobacter, Serratia,
Citrobacter (52.3%), and P. aeruginosa (15.8%). The predominant
anaerobes were Gram-positive cocci: 103 isolates, Prevotella species:
198 isolates, Clostridium species: 50 isolates, and the members of the
Bacteroides fragilis group: 41 isolates.
Conclusion: Clinical grading and bacteriological study of 139 patients
with diabetic foot lesions revealed polymicrobial aetiology. Our ﬁndings
showed that the density of growth of anaerobes and the number of the
isolated anaerobic species were signiﬁcantly higher than that in previous
studies, due to good anaerobe laboratory practice and the adequate
sampling.
R2694 Clinical and laboratory investigation of KPC-2 Klebsiella
pneumoniae bacteraemia in patients of a haematology ward
M. Orfanidou, A. Galanopoulos, E. Vagiakou*, G. Ganteris, P. Giakoupi,
A. Vatopoulos, N. Anagnostopoulos, E. Malamou-Lada (Athens, GR)
Objectives: The present the emergence and the dissemination of
KPC-2 producers K. pneumoniae (Kp) strains from blood cultures of
hematological patients, in a tertiary hospital in Greece.
Methods: During the period October 2008-May 2010, Kp strains, that
exhibited resistance to carbapenemes, were isolated from 12 patients
of the hematology ward. Susceptibility to carbapenemes was perfomed
by the use of Kirby-Bauer method and MICs were determined by
VITEK II and E-test method, according to CLSI. KPC production
was initially investigated by Hodge test and double disk synergy test
(meropenem+boronic acid) and was conﬁrmed by molecular techniques.
Molecular typing was performed by pulse ﬁeld gel electrophoresis
(PFGE). A retrospective review of the patients’ history took place
to estimate underlying diseases, previous antibiotic usage and clinical
outcome.
Results: Kp strains revealed various susceptibility to imipenem and
meropenem. All strains were resistant to ertapenem, but most of them
were susceptible to gentamicin, tetracycline, tigecycline and colistin.
All strains were KPC-2 producers and belonged to the same clone.
Patients’ mean age was 70 years (range 25−81). Clinical diagnosis were:
nine acute leukemia, one chronic lemphogenic leukemia, one aplastic
anemia and one non Hodgkin lymphoma. The duration of patients’
hospitalization was 0−24 days, before the isolation of Kp strains. In three
patients, a simultaneous isolation of KPC strains from urine cultures
was observed. Two patients with bacteremia were found to be colonized
in the intestine with with KPC strains, while four patients developed
ﬁrst the bacteremia and intestine colonization followed. Neutropenia was
observed in eight patients, with an absolute number of neutrophils 0–
400/ml. Before the isolation of the KPC strains, all patients were treated
with a combination of a b-lactam antibiotic and an aminoglycoside, while
after the isolation the treatment changed to colistin, tigecycline and/or
gentamycin. The response was poor and ten patients out of twelve (83%)
died because of the KPC infection.
Conclusions: Bacteremia from KPC-2 producers Kp, in hematological
patients, has high mortality and consists a serious medical-nursery
problem, in addition with the already existing high bacteria resistance.
R2695 Risk factors contributing to treatment success in severe
diabetic foot infections
N. Saltoglu*, E. Zerdali, M. Altintas, Y. Aydin, Z. Osar Siva,
M. Ozyazar, H. Ilkova, T. Damci (Istanbul, TR)
Objectives: To identify risk factors contributing treatment responses and
prognoses in severe diabetic foot infections.
Material and Method: Between April 2008 and October 2010, a
prospective study was conducted by Diabetic Foot Study Group on severe
diabetic foot infections.
Results: A total of 62 patients were included in this study, the mean age
was 64.09 (range 37 to 87) years and forty three (69.4%) patients were
male. Eighty patients were diabetic for more than ten years. 56.5% of the
patient had previous hospital stay and 83.9% had previous antibiotic use
within the last three months. The duration of wound infections were more
than four weeks in 84% of the patients and 56.5% of them had purulent
discharge. Leucocytosis was found in 26 (46.8%) patients and 41 (66.1%)
patients had elevated CRP levels more than ﬁve fold. 14.5% of patients
were classiﬁed as Wagner stage 4 and 8% were Wagner stage 5. Thirty
three (53.2%) of the patients were presented with osteomyelitis. Etiology
was identiﬁed in 41 (66.1%) patients. Gram negative bacilli were isolated
in 19 (46.3%), Gram positive cocci were isolated in 10 (24.4%) and 12
(29.2%) grew mixed bacteria. Ten of 41 microorganisms isolated were
ESBL producing Gram negative bacilli, three were MRSA, nine were
MRSE, seven were multidrug resistant (MDR) P. aeruginosa and three
were MDR A. baumannii.
The mean duration of hospitalization was 38.4 days; 37 (59.7%) patients
underwent debridement and amputation was performed in 30 (48.4%)
patients. Major amputation was requ¨ired in 9% of cases.
Conclusion: Complete clinical improvement was observed in 26 (41.9%)
patients. Duration of diabetes over ten years (p = 0.017), higher fever
(38.5ºC) (p = 0.004), existance of purulent discharge (p = 0.020), higher
Wagner stage of the wound (p = 0.000), elevated CRP levels (>5 fold)
(p = 0.01), infection with MDR bacteria (p = 0.066), requirement of
amputation (p = 0.000) and prolonged hospital stay (p = 0.01) were
negative predictors of treatment success and prognosis.
R2696 The efﬁcacy of low-dose valganciclovir prophylaxis for
cytomegalovirus infection in renal transplant recipients
V. Avkan-Oguz*, A. Celik, Z. Karlibas, A. Ozbek, H. Gulay (Izmir, TR)
Objectives: Cytomegalovirus (CMV) infection is one of the most
important viral infections causing graft loss in renal transplant recipients
(RTr). The present study aims to determine the efﬁcacy of low-dose
valganciclovir (VGC) prophylaxis in CMV infection.
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Methods: 103 CMV seropositive patients over the age of 18 − and
whose donors were also seropositive − who had undergone renal
transplantation between January 2007 and June 2010 were included in
the study. The data on these patients were recorded retrospectively using
follow-up forms. The form included the following information: age,
gender, primary disease, cold ischemia time, type of transplantation,
immunosuppressive treatment scheme, duration of valganciclovir use,
adverse effects, CMV antigenemia level and whether CMV infection/
disease developed after transplantation or not. In the prophylaxis
group VGC (n = 29) was administered 450mg/day. For the other group
(n = 26) VGC was not administered only short time IV gansiklovir
was administered. If the patient received antithymocyte globulin (ATG)
treatment, IV ganciclovir was administered only during the treatment.
The patients were followed using CMV antigenemia tests (1−3 times/
month). All patients were followed for 6−30 months after transplantation.
The data were evaluated using chi-square test and t test for independent
groups on SPSS 15 software.
Results: The demographic characteristics of the RTr who did or
did not receive VGC prophylaxis were similar. Total ATG dose
was signiﬁcantly higher in the prophylaxis group than in the other
group. It was determined that, although not signiﬁcant, the rate of
CMV infection development was lower in the patients to whom
prophylaxis was administered (Table 1). All of the eight patiens were
determined CMV infection delayed-onset in the prophylaxis group
VGC. The mean time between transplantation and CMV infection were
found 242,62±141,36 (95–524) days. During the use of VGC, drug
administration was interrupted in 8.3–34.5% of the patients due to
leucopenia/thrombocytopenia.
Conclusion: The use of high-dose ATG is a risk factor for CMV
infection. Although the use of low-dose VGC decreases the rate of CMV
infection/disease, the decrease is not signiﬁcant and does not bring out
a decrease in the rate of adverse effects.
R2697 Ribavirin treatment for human metapneumovirus and
methicillin-resistant Staphylococcus aureus co-infection in
adult haematological malignancy
A. Hofmeyr*, L. Dunlop, S. Ling, E. Fiakos, M. Maley (Sydney, AU)
Objective: To report the use of intravenous ribavirin in two adult
cases of severe pneumonia demonstrating co-infection with human
metapneumovirus (HMPV) and methicillin resistant Staphylococcus
aureus (MRSA) in the setting of lymphopenia following chemotherapy
for haematological malignancy.
Method: Case report of clinical, radiological and microbiology ﬁndings
with literature review of the role of ribavirin in HMPV infection in adults
with haematological malignancy.
Results: 2 cases of HMPV pneumonia were identiﬁed in an Australian
haematology unit in spring, 2010. The cases were in separate but
adjacent rooms raising the possibility of nosocomial transmission.
Lymphopenia was present in both as a complication of chemotherapy
for anaplastic large cell lymphoma (case one) and after autologous
peripheral stem cell transplant for multiple myeloma (case two). MRSA
and HMPV were identiﬁed in bronchoalveolar lavage (BAL) ﬂuid.
Respiratory intubation, ventilation and intensive care management was
required for progressive respiratory failure whilst on maximal therapy for
MRSA infection. Bilateral ground glass inﬁltrates progressed to nodular,
conﬂuent parenchymal changes. Salvage treatment with ribavirin was
started more than a week after symptom onset. Ribavirin 25mg/kg/day
(intravenous) was followed by 15mg/kg/day (intravenous) for a total
of 7 days in both cases. One patient cleared virus from respiratory
tract, but progress was complicated by a cerebrovascular accident.
The second patient developed extensive air space consolidation and
cavitation. HMPV was detected by PCR at 6 weeks after treatment with
ribavirin.
Conclusion: HMPV infection is associated with signiﬁcant morbidity
and poor outcomes. Lymphopenia is a risk factor for infection
with HMPV in adult patients receiving treatment for hematological
malignancy. Co-infection with MRSA occurs. Neutrophil recovery
and hypogammaglobulinaemia may contribute to severity of infection.
Ribavirin was well tolerated. Late treatment with intravenous ribavirin
for seven days did not eradicate viral shedding in one patient, and may
have contributed to clinical and virological cure in the other. HMPV may
be detected in respiratory secretions for greater than 6 weeks in adult
patients with haemopoeitic malignancy, with implications for infection
control measures.
R2698 Polymicrobial bloodstream infections in patients with cancer
D. Kofteridis, D. Dimopoulou*, A. Valachis, S. Maraki, A. Christidou,
A. Thanasia, V. Theodorakopoulou, I. Aristeidou, N. Spernovasilis,
G. Samonis (Heraklion Crete, GR)
Objectives: Polymicrobial bloodstream infections (PBSIs) occur fre-
quently in patients with cancer and are associated with high mortality.
However, there are only a few reports speciﬁcally addressing PBSIs. The
aim of the present study was to compare epidemiological features and
mortality attributable to PBSIs with those attributable to monomicrobial
bloodstream infections (MBSIs) in patients with malignancy.
Methods: A retrospective matched case-control study, with 1:1 ratio was
performed. All patients with malignancy, hospitalized with bloodstream
infection in the departments of Haematology and Medical Oncology,
from 2005 to 2010, were reviewed. Each patient with PBSI was matched
to another with MBSI by age, sex and type of malignancy. Univariate
and multivariate analyses were performed.
Results: A total of 114 episodes of BSI among 110 patients were
identiﬁed. Of those, 34 patients (31%) had a PBSI. Gram-negative
organisms were predominant in 85% of the episodes, while Gram-
positive in 53% of the PBSIs. Grade 4 neutropenia was present in 6
patients with PBSI and 5 with MBSI. The presence of chronic renal
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disease (odds ratio [OR] 12.2; 95% conﬁdence interval [CI], 1.3–113.1)
was an independent risk factor for PBSI, while prior blood transfusion
was revealed as protective factor (OR 3,9; 95%CI, 1.4−11,5). Empirical
inappropriate antimicrobial treatment has been given to 20 patients
(59%) with PBSIs, and 7 (21%) with MBSIs (p = 0.003). The infection-
related mortality was 29% in patients with PBSI and 12% in those with
MBSI (p = 0.072). No differences in duration of hospitalization or overall
mortality were observed.
Conclusion: PBSIs represent a signiﬁcant percentage of BSIs among pa-
tients with malignancy. Although inappropriate empirical antimicrobial
treatment has been given in higher percentage of patients with PBSI than
those with MBSIs, no differences in duration of hospitalization or overall
mortality have been observed. Recognition of the risk factors for PBSIs
and knowledge of their microbiology are important for the selection of
appropriate empirical antimicrobial treatment that may result in improved
outcome.
R2699 Risk factors for urinary tract infections caused by
ESBL-positive E. coli in renal transplant recipients
H. Arslan*, O. O¨zalp, O¨. Azap, S. Aktas, A. Tekindal, M. Haberal
(Ankara, TR)
Objectives: Urinary tract infections (UTI) are the most common
infections in renal transplant recipients. The aim of this study is
to determine the risk factors for UTI caused by extended-spectrum
b-lactamase (ESBL) producing Escherichia coli.
Methods: Renal transplant recipients with the diagnosis of UTI during
the two year period from January 1st, 2009 to December 1st, 2010
were included in this study. Fifty-one adult patients. Demographic
charactersitics, clinical and laboratory values, antibacterial susceptibility
results were evaluated from patient records retrospectively. Risk factors
for UTI caused ESBL positive E. coli strains were determined.
Results: Sixty-one UTI episodes were diagnosed in 51 patients. Sixty-
nine percent of the patients were female. The range of the ages were
18−60 years. More than one UTI episodes were seen in 8 patients. The
three leading uropathogens were E. coli, Klebsiella spp and enterococci.
E. coli was detected in 41 (67%) episodes, Klebsiella spp. was detected
in 11 (18%) episodes and enterococci was detected in 5 (8%) episodes.
Twenty-one of the E. coli isolates (51%) were ESBL positive. The
antimicrobial resistance rates of ESBL negative and ESBL positive
E. coli isolates were shown in the Table.
The risk factors determined are hospitalization at the time of diagnosis
or hospitalization within 1 month, recent (within 1 month) antibiotic use,
urinary catheterization.
Conclusion: Risk factors for urinary tract infections caused by ESBL
producing bacteria among renal transplant recipients are similar with the
other patient groups but nearly half of the uropathogen E. coli strains
are ESBL positive in renal transplant recipients. This high percentage
of resistant pathogens causes difﬁculties in the management of these
patients.
Table. Antimicrobial resistance rates of uropathogen E. coli.
R2700 Bacterial infections in the early period after liver
transplantation
H. Arslan*, F. Timurkaynak, O¨. Azap, S. Aktas, M. Haberal (Ankara, TR)
Multidrug resistant bacteria are increasingly isolated from transplant
recipients and cause high morbidity, mortality. The aim of this study is
to determine the disribution and etiologic agents of bacterial infections
seen in the early period after liver transplantation.
A retrospective study was conducted on 90 patients who underwent
orthotopic liver transplantation consecutively from January 2008
to October 2010 at Baskent University Hospital. Microbiologically
documented bacterial infections seen during the ﬁrst month after liver
transplantation were included in this study.
A total of ninety liver transplantations were performed during the
study period. Twenty eight bacterial infection episodes were diagnosed
in 20 patients within 30 days after transplantation operation. Twelve
(13%) of the infections were intraabdominal (9 Gram negative and 3
Gram positive), 8 (9%) were catheter-related (4 Gram negative, 4 Gram
positive), 6 (6%) urinary tract infection (5 Gram negative, 1 Gram
positive), 2 ventilator associated pneumonia (1 Gram negative, 1 Gram
positive). A total of 19 episodes were caused by Gram negative bacteria
and the remaining 9 were caused by Gram positive bacteria. Strains
susceptible only to colistin and tigecycline were deﬁned as extensively
drug resistant (XDR). Seven of the isolated Gram negative strains
were Klebsiella pneumoniae (2 ESBL positive, 2 XDR strains), 6 were
Escherichia coli (4 ESBL positive strains), 4 Acinetobacter baumannii (3
XDR strains), 1 Pseudomonas aeruginosa. The distribution of the Gram
positive pathogens were 4 Enterococcus faecium (2 were vancomycin
resistant), 3 methicillin resistant coagulase negative staphylococci, 1
methicillin sensitive Staphylococcus aureus and 1 methicillin resistant
Staphylococcus aureus. A total of 20 bacteremia episodes were detected
of which 12 (60%) were secondary and 8 (40%) were primary.
The incidence of colonization and infection with multi-drug resistant
bacteria particularly Gram negative strains has been increasing
throughout the world. Data regarding the transplantation patients are
limited but common usage of extended spectrum antibiotics among
these patients both during the preoperative and postoperative phases
undoubtedly predispose to difﬁcult-to treat infections. The infection
rates seen in the early postoperative period obtained in this study are
comparable with the previous ones but the high percentages of multi-
drug resistant strain is the alarming issue.
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R2701 Urethritis epidemiology in men in central Madrid, Spain
M.A. Orellana*, M.L. Gomez-Lus (Madrid, ES)
Objective: To study the epidemiology and risk factors of urethritis in
men and compare these with the microorganisms isolated.
Methods: We conducted an epidemiological survey to 270 men with
urethral exudate petition during the years 2006−7. The parameters
obtained were: age, nationality, symptoms and risk factors (previous
STD, HSH, >1 sexual partner). To urethral exudates we performed:
GRAM stain, culture in habitual plates, study of C. trachomatis by
PCR in the COBAS AMPLICOR System (ROCHE), U. urealyticum
and M. hominis by Mycoplasma IST (Biomerieux), T. vaginalis by
microscopic examination and HSV by cellular culture.
Results: The age of patients were 33.1±10 years, the 52.6% were
Spanish, the 29.3% were HSH, the 61.8% had >1 sexual partner and the
31.8% had a previous STD. The symptoms were: pain 17%, discharge
40%, urethral itching 21.5% and dysuria 39.3%. In GRAM stain it was
observed >5 LPMN/C in 18.9%. The percentage of positive samples
was: 39.3% The isolated microorganisms were: C. trachomatis 13%,
N. gonorrhoeae 11.1%, U. urealyticum 10%, Haemophilus sp 4.8%,
S. agalactiae 1.5%, HSV 1.5%, M. hominis 0.7%, Candida sp 0.7% and
S. aureus 0.4%. The patients with urethritis compared with non-urethritis
had signiﬁcant difference for: age (31.4±8 vs 34.2±10), HSH (49.4%
vs 35.1%), >1 sexual partner (45.5% vs 29.1%), discharge (52.8% vs
31.1%) and leukocytes in GRAM stain (76.5% vs 23.5%). Depending
on isolated microorganism, we found that:
N. gonorrhoeae was signiﬁcantly most frequent isolated in HSH (27.8%
vs 4.2%), >1 sexual partner (16.2% vs 2.9%), pain (23.9% vs 8.5%),
discharge (27.8% vs 0%) and leukocytes in GRAM stain (49.0% vs
1.1%).
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C. trachomatis was signiﬁcantly most frequent isolated in: >1 sexual
partner (17.4% vs 5.8%), discharge (18.5% vs 9.3%), dysuria (18.9% vs
9.1%) and leukocytes in GRAM stain (21.6% vs 10.1%).
U. urealyticum had signiﬁcant difference for age (28.6± 7 vs 33.6±10)
and we did not ﬁnd signiﬁcant difference for the rest of issues studied.
We did not ﬁnd signiﬁcant differences for the rest of isolated
microorganisms.
Conclusions: Urethritis was most frequent in young men, with >1 sexual
partner, with discharge and leukocytes in GRAM stain. N. gonorrhoeae
was most frequently isolated in HSH, with >1 sexual partner, with
pain and discharge like symptoms and leukocytes in GRAM stain.
C. trachomatis was isolated in men with >1 sexual partner, dysuria
and leukocytes in GRAM stain and U. urealyticum was most frequent in
youngest men.
R2702 Peritoneal dialysis-related peritonitis in both a paediatric
and an adult population: a four-year retrospective analysis
B. Persy*, K. Wouters, H. Goossens, M. Ieven (Edegem, BE)
Microbial etiology of peritoneal dialysis (PD) related peritonitis seems
to vary widely in children and data for adults are scarce. The objective of
this study was to determine the microbial etiology, correlation between
leucocyte (wbc) count and culture results as well as the concordance
between culture and the Gram stain of PD related cases of peritonitis in
both children and adults.
We reviewed the records of all patients whose peritoneal dialysate
(n = 1285) was sent to the lab for microbiology of the Antwerp University
Hospital between January 2005 and August 2009. Microbial etiology,
wbc count, Gram stain and antibiotic treatment were analyzed per
episode. 142 adults and 22 children were included.
From each episode, microbial etiology was based on culture results of
the ﬁrst sample. Gram stain was performed when the leucocyte count
exceeded 200 per mm3. Logistical and linear regression were used
in addition to a mixed effects model with repeated patient effect to
determine the degree of correlation between the wbc count and positive
cultures.
In 158/39 episodes of adult/pediatric peritonitis, 70.7/70.0% of
samples were culture positive (+): 72.1/52.4% of isolates were Gram
positives (G+), 21.2/38.1% Gram negatives (G−), 1.9/0.0% anaerobes
and 4.8/9.5% yeasts. In 29.3/30.0% no etiology was found: 32.6/22.0%
of the culture − were taken during antimicrobial treatment.
Gram stain showed predominant morphotypes concordant with culture
results in 30.5/16.7%.
In adults, the G+ were mainly coagulase negative staphylococci
(CNS) (70.7%), S. aureus (8.0%) and viridans streptococci (8%); in
children, predominant pathogens were E. faecalis (27.3%), CNS (27.3%),
Coryneforms (18.2%) and S. aureus (9.1%).
The most prevalent G− pathogens in adults were E. coli (22.7%),
E. cloacae (18.2%), K. pneumoniae (18.2%), P. aeruginosa (13.6%) and
other non-fermenters (13.6%). In children, the most frequent G− were
E. cloacae (25.0%), P. aeruginosa (12.5%) and other non-fermenters
(25%).
A signiﬁcant difference in wbc count was found between culture+ and
culture− samples in adults (p = 0.001).
In conclusion, a microbial etiology was found in the majority of cases.
Gram positive related cases of peritonitis are more frequent in adults,
Gram negatives in children and the distribution of pathogens also differs.
The concordance between Gram stain and culture appears low. Finally,
there are signiﬁcantly less leucocytes in culture negative dialysates
compared to culture positive dialysates.
R2703 International PMEN clones equal or exceed the ﬁtness
of other strains despite the accumulation of antibiotic
resistance
D. Rudolf, N. Michaylov, M. van der Linden, L. Hoy, K.P. Klugman,
T. Welte, M.W. Pletz* for the CAPNETZ study group
Objectives: A small number of global pneumococcal clones deﬁned by
the Pneumococcal Molecular Epidemiology Network (PMEN) dominate
the population of antibiotic-resistant pneumococci. It remains unclear
why PMEN clones spread so successfully despite the scientiﬁc paradigm
that a loss in biological ﬁtness is the price for acquisition of resistance.
The aim of this study was to detect PMEN clone related clinical
isolates from adult patients with community-acquired pneumonia (CAP)
collected by the German CAPNETZ surveillance study during 2002–
2006 and to compare them to unrelated clones in terms of antibiotic-
resistance, biological ﬁtness and clinical parameters.
Methods: Multi-locus sequence typing (MLST) data were used to deﬁne
relatedness between PMEN clones and clinical pneumococcal isolates.
Relatedness was deﬁned by the sharing of alleles at 5 of 7 loci. Fitness
was determined by the measurement of growth curves. The bacterial
growth was measured by a microplate reader at optical density of 600 nm
at intervals of ﬁve minutes over a period of 16 hours. To compare
bacterial growth we analysed the maximum slope of each curve and the
experiment was repeated nine times. Statistical analysis were performed
by the chi-square test or Fisher’s exact test for categorial variables and
the t-test or analysis of variances (ANOVA) for continuous variables.
Results: We analysed 154 pneumococcal isolates and 46 (30%) isolates
showed a close relationship to the global PMEN clones. These isolates
were equal or exceeded the ﬁtness of isolates without relationship to
PMEN clones (1.48±0.73 vs. 1.18±0.54; P = 0.015) and constituted 80%
of antibiotic-resistant isolates. The survey of clinical parameters showed
no prominent signiﬁcant difference between both groups.
Conclusion: The success of international PMEN clones is based on the
combination of resistance and ﬁtness and may result in the endurance of
these strains despite a reduction of antibiotic usage. New vaccines can
interrupt the transmission of resistant strains, but continued attention to
the replacement of nonvaccine serotypes and development of vaccines
with a broader coverage will be necessary.
R2704 Microorganisms isolated in urethral samples in women
M.A. Orellana*, M.L. Gomez-Lus (Madrid, ES)
Objective: To study the isolated microorganisms in urethral samples in
women and to analyse the epidemiology and risk factors depending on
isolated microorganisms.
Methods: We studied 377 urethral exudates between 2003–2007. The
samples were cultured in habitual plates; C. trachomatis was performed
between January 2003 and May 2007 by ICT CHLAMY-CHECK-1
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(GRIFOLS) and between June-December 2007 by RCP by COBAS
AMPLICOR System (Roche); U. urealyticum and M. hominis by
Mycoplasma IST (Biomerieux) and HSV by cellular culture.
We performed an epidemiological survey to 90 women during the years
2006−7. The obtained parameters were: age, nationality, symptoms and
risk factors.
Results: The percentage of positive samples was 54.4%. The isolated
microorganisms were: U. urealyticum (UU) 41.1%, Candida sp 10.3%,
C. trachomatis (CT) 2.9%, M. hominis (MH) 6.4%, Enterobacteries
4.8%, S. agalactiae 2.4%, N. gonorrhoeae 0.8%, Haemophilus sp
0.5%, G. vaginalis 0.5% and SHV 1.3%. It was isolated >o= 2
microorganisms/sample in 15.1% and the most frequent associations
UU+MH 42.1%, UU+Candida sp 28.1%, UU+E. coli 8.8%, UU+CT
7% and UU+S. agalactiae 5.3%.
In the epidemiological survey we found: age 36.4±15, Spanish 52.2%,
previous STD 15.5%, >1 sexual partner 25.5%. The symptoms were:
pain 20%, discharge 37.7%, urethral itching 34.4%, dysuria 25.5% and
recurrent urinay tract infection 33.3%. The isolated microorganisms in
this group were: UU 44.4%, CT 6.7%, Enterobacteries 7.7%, Candida
sp 8.8%, GV 6.6%, S. agalactiae 2.2% and HSV 1.1%.
Among women with positive samples there were signiﬁcant differences
for discharge (79.4% vs 48.2%) and urethral itching (77.4% vs 50.8%).
Depending on isolated microorganisms, we found that:
U.U. was signiﬁcantly most frequent isolated in patients with discharge
(58.8% vs 35.7%) and >1 sexual partner (65.2% vs 37.3%).
was most frequent isolated in patients with discharge (14.7% vs 1.8%),
urethral itching (16.1% vs 1.7%), dysuria (17.4% vs 3.0%) and >1
sexual partner (17.4% vs 3.0%).
Enterobacteries were most frequently isolated when dysuria existed
(21.8% vs 3.0%).
Candida sp was not signiﬁcantly associated with none of the parameters
studied.
Conclusions: UU, Candida sp and MH were the most frequent isolated
microorganisms. Discharge and uretrhal itching were the most frequent
symptoms in women with positive culture. Discharge was present in
patiens with isolation of UU and CT and dysuria in patients with isolation
of CT and enterobacteries.
R2705 Chlamydia trachomatis, Mycoplasma hominis, Mycoplasma
genitalium and Ureaplasma urealyticum infections and
seminal quality in infertile men
N. Al-Sweih*, A. Hadad, V. Rotimi, A. Omu (Kuwait, KW)
Objective: The aim of this study was to compare the occurrence of
genital Chlamydia trachomatis, genital mycoplasmas and ureaplasmas
in semen samples of fertile and infertile men in Kuwait.
Materials and Methods: A total of non-duplicated 315 semen samples
collected from 127 infertile and 188 control men seen at the infertility
clinics in Maternity hospital were studied after informed consent.
Semen analysis was performed according to the guidelines of World
Health Organization. The specimens were examined for the presence of
Ureaplasma urealyticum, Mycoplasma hominis, Mycoplasma genitalium
and Chlamydia trachomatis by PCR using published speciﬁc primers.
Biodata, such as age, nationalities, and marital status were carefully
recorded.
Results: The frequency of genital U. urealyticum, M. hominis,
M. genitalium and C. trachomatis in all semen samples was respectively
26% (82/315), 27% (86/315), 5.4% (17/315) and 8.3% (26/315). Mixed
infections were detected in 14% (44/315). The infertile participants
positive for U. urealyticum and M. hominis, respectively had semen
samples that showed statistically signiﬁcant difference in the mean
of sperm concentration, vitality percentage, total progressive and
rapid progressive motility in comparison to control fertile participants
(P< 0.001). Similar statistical signiﬁcance difference was noted for those
infertile and fertile men positive for M. genitalium and C. trachomatis
(P< 0.001). Infections in infertile men who had been married for less
than 5 years were signiﬁcantly higher than in infected fertile men of the
same length of marriage.
Conclusion: Infections caused by these urogenital pathogens were more
common among infertile men than fertile men and may possibly play a
role, in part, in the etiology of male infertility in this part of the world.
Genital mycoplasmas and chlamydial infections may negatively inﬂuence
semen quality.
Acknowledgement: This study was supported by Kuwait University
Research Administration Grant No. YM 03/09.
R2706 Validity of hospital diagnosis of pleural empyema in 224
patients: a clinical validation study
M. Søgaard, J.B. Kornum, H.C. Schønheyder, R.W. Thomsen* (Aalborg,
Aarhus, DK)
Objective: Pleural empyema is a serious infection characterized by
accumulation of pus in the pleural space. In the US, 65,000 patients
suffer from empyema each year, with 30-day mortality up to 15%.
Many studies addressing risk factors and outcome of empyema rely on
hospital discharge diagnosis codes recorded in health care databases.
We validated the ICD-10 diagnosis of pleural empyema in the Danish
National Registry of Patients (DNRP).
Methods: We randomly selected hospitalized inpatients in the North
Denmark Region with a ﬁrst-time discharge diagnosis of pleural
empyema between 1995 and 2009. We retrieved and reviewed medical
records and estimated the positive predictive value (PPV) of the
empyema diagnosis. Deﬁnite empyema was deﬁned by frank pus
aspirated from the pleural space, a positive Gram stain/subculture for
pathogenic micro-organisms in the pleural ﬂuid, and/or an autopsy
diagnosis of empyema. Patients with clinical symptoms suggestive of
empyema in association with compatible radiographic features (e.g.
pleural thickening, loculated and/or septated pleural effusions) who did
not meet the criteria for deﬁnite empyema were classiﬁed as having
probable empyema.
Results: We could retrieve the medical records of 224/225 sampled
patients with empyema (99.6%). Of those, we classiﬁed 182 (81.3%)
as being deﬁnite empyema cases. Another 21 patients were classiﬁed
as probable empyema cases. In 21 patients whose empyema diagnosis
was rejected, eight had pneumonia, one had a pulmonary abscess, one
pulmonary tuberculosis, one had sarcoidosis, two had emphysema.
The overall PPV of the empyema diagnosis was 90.1% (95%CI 86.0–
94.1). The PPV was 81.3% (95%CI 81.3–86.1) when including deﬁnite
cases only. PPVs of empyema diagnosed in 1995–1999, 2000–2004,
and 2005–2009 were 90.7% (95%CI 81.7–96.2), 94.6% (95%CI 86.7–
98.5), and 86.7% (95%CI 76.8–93.4), respectively, indicating that no
major changes in coding validity occurred over the 15-year study period.
The PPV decreased slightly from 95.7% in patients aged 15−39 years
to 87.5% in patients aged 80 years and over but was uniformly high
regardless of study period, hospital or department type, or cause of
empyema.
Conclusion: The high overall PPV indicated good agreement between
ICD-10 codes for pleural empyema and medical records. Registry-based
discharge codes may be a suitable source of data on pleural empyema
for epidemiological research.
R2707 Pulmonary nocardiosis − clinical analysis of 21 patients
S.R. Ott, M. Kolditz, G. Rohde, D. Buchheidt, S. Vesenbeckh, A. de
Roux, T.T. Bauer, M.W. Pletz* for the OPINION Study Group
Introduction: Nocardia is a rare pathogen causing predominantly pul-
monary and/or skin and soft tissue infections. Since immunosuppression
is one main predisposing factor, nociardial infections may increase
because of the rising number of patients on immunosuppressive therapy
(e.g. solid organ or bone marrow transplantation). Data on futher risk
factors, clinical course and treatment of nocardial infections are limited
to case reports and small case series. We aim to establish a register for
nocardia infections in Germany, Switzerland and the Netherlands.
Methods: Retrospective analysis of all microbiologically proven
pulmonary Nocardia spp. infections in 4 hospitals in Germany and the
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Netherlands between 1999 and 2009, deﬁned as detection of Nocardia
spp. in respiratory samples + radiolagical changes and signs and
symptoms of pulmonary infection.
Results: Twenty-one cases of pulmonary nocardiosis could be identiﬁed
(18 male, 3 female; mean age 54.7±18.1 years). In addition to pulmonary
involvement, disseminated disease was detected in 3 patients (all with
cerebral abscess formation). Eleven of 21 patients had pulmonary
comorbidities (n = 4 COPD; n = 3 bronchiektasis, n = 2 cystic ﬁbrosis,
n = 1 asthma, n = 1 post-TB). Twelve of 18 patients had identiﬁable
causes of immunosuppression (hematological dieseases, malignancies,
drug induced immunosuppression, diabetes mellitus). All patients tested
(16/21) were HIV negative. Time from sampling to availability of
microbiological results was 9.1 days. All cases were proven by
culture and in 15 patients additional PCR-sequencing was performed
(N. farcinica n = 4; N. abscessus n = 3; N. asteroides n = 3; N. nova,
N. carnea, N. cyriacigeorgica, N. otitidiscaviarum and N. paucivorans
each n = 1) The pathogen was isolated from BAL (n = 9), sputum (n = 7),
biopsy (n = 3), tracheobronchial aspirate (n = 1), and abscess aspirate
(n = 1). Most patients received cotrimoxazol treatment (15/21), mean
duration of treatment was 12.2 weeks. One patient died.
Conclusion: Pulmonary nocardiosis remains a rare disease. Although
immunosuppression (e.g. drug induced immunosuppression or ma-
lignancies) is its major risk factor, it can also occur in patients
without obviously impaired immunocompetence. These patients most
frequently suffer from chronic pulmonary diseases such as COPD. The
delayed in vitro growth of Nocardia spp. may lead to misdiagnosis or
underestimation of nocardiosis in patients without typical risk factors.
R2708 A prospective study on predictors for early death from
bacteraemia
D.C. Lye*, S. Pada, T. Ng, R. Llorin, D. Kee, T. Lee, P. Krishnan,
T. Barkham, B. Ang (Singapore, SG)
Objective: Inactive empiric antibiotic occurred in 33% of patients with
bacteraemia, with mortality of 27% at discharge in 2006. A blood
culture service started in April 2007 to ensure active antibiotic within 2
days of blood culture collection. A prospective bacteraemia study from
February to June 2009 noted mortality at discharge decreased to 9%.
Death occurred in 2% before positive blood culture was notiﬁed. We
aim to study patients with early death for clinical predictors.
Methods: Patients who died before (early death) and after (late death)
positive blood culture was notiﬁed were compared, so was early death
with survivors. Univariate and multivariate analysis were performed for
independent predictors of early death.
Results: Of 452 patients with 467 cases of bacteraemia, 42 patients
died, and 9 were early death. Male comprised 60%, median age was
78 years and Charlson’s score 5. Staphylococcus aureus occurred in 10
(7 was methicillin-resistant [MRSA]), Escherichia coli and Klebsiella
pneumoniae 5 each (6 carried extended-spectrum b-lactamase), Proteus
mirabilis 3 and Candida species 2.
On univariate analysis of early death vs. late death, age 75 years (odds
ratio [OR] 9.14, conﬁdence interval [CI] 1.01–82.44), renal disease
(OR 0.122, CI 0.02–0.71), pneumonia (OR 28, CI 3.81–205.79) and
acute renal impairment (OR 0.17, CI 0.03–0.94) were signiﬁcant. Only
pneumonia was independent risk factor (adjusted OR [AOR] 41.2, CI
3.68–463.74, P = 0.003).
Comparison of early death vs. survivors noted signiﬁcant univariate
risk factors: age 75 years (OR 14.68, CI 1.82–118.45), intensive care
unit (OR 5.64, CI 1.35–23.42), solid tumour (OR 4.36, CI 1.05–18.06),
pneumonia (OR 26.53, CI 6.32–111.40), Acinetobacter baumannii (OR
53.38, CI 3.06–930.79), MRSA (OR 6.51, CI 1.26–33.58), inactive
empiric antibiotic (OR 4.74, CI 1.17–19.25), hypotension (OR 13.02,
CI 3.17–53.52), and ventilatory support (OR 30.29, CI 4.74–193.47).
On multivariate analysis, the independent predictors of early death
vs. survivors were: pneumonia (AOR 18.61, CI 2.68–129.53), inactive
empiric antibiotic (AOR 24.40, CI 1.57–378−23), hypotension (AOR
17.01, CI 2.29–127.78), and ventilatory support (AOR 59.59, CI 1.27–
2786.41).
Conclusion: Our study showed that hypotensive patients needing
ventilatory support for pneumonia with inactive empiric antibiotic were
more likely to die before blood culture could be notiﬁed. It is crucial to
ensure adequate empiric antibiotic in this cohort.
R2709 Evaluation of Abbott® real-time m2000 CT/GC assay, Roche
Cobas®Amplicor™ CT/GC test and SiemensVersant®
CT/GC DNA 1.0 assay (kPCR) for the detection of
Chlamydia trachomatis/Neisseria gonorrhoeae
H. Tuokko* (Oulu, FI)
Objectives: Abbott RealTime m2000 (AR) method was compared to
Roche Cobas Amplicor (RCA) for detection of Chlamydia trachomatis
(Ct) and Neisseria gonorrhoeae (Gc) in urine samples. Siemens Versant
(SV) was the third test for the minor series of the urine samples. AR
and SV are automated systems with short hands-on-time. Tecan miniprep
was used for DNA extraction for RCA.
Methods: Ct was tested in 297 urine samples and Gc in 200 urine
samples in RCA and AR. The samples were taken in the years 2008−10,
tested with RCA within 1−2 days after the collection and frozen. The
minor selection included 75 frozen urine samples for AR. Also these
were tested within 1−2 days after the collection with RCA- and SV-
methods.
Results: AR detected 170 Ct-positive while RCA 176 among 297
samples with the correlation of 0,966 for Ct-positive and of 1,05 for
negative results. In Gc-testing, RCA found 13 (conﬁrmed) positive
samples while AR 12. AR detected as Ct-positive 45 out of 75 samples
while RCA 47 with the correlation of 0,957 and SV 49 with 1,042,
respectively. All the tests gave the same 20 samples as Ct-negative and
40 as Ct-positive. RCA and SV detected the same samples negative and
SV 2 positive more than RCA, while RCA compared to AR, AR had 5
negatives and 1 positive more than RCA. SV and AR tested the same
samples Ct-negative but SV 4 Ct-positive samples more. And, RCA
detected the other 3 Ct-negative samples more than AR- and RCA. All
3 methods detected the same 4 Gc-samples as positive.
Conclusion: RCA used the DNA extractor more sensitive for
contamination than the other two. The manual pipetting may have been
the risk for false-positivity, too. There is also possibility of false-negative
samples, because of inability to detect the new variant of Ct (nvCt) unlike
AR and SV. Sample storing as frozen may have some effect on results.
AR needed sample volume less than SV. AR offers separated units for
DNA extraction and PCR itself. Gc-positive samples detected by AR
(target the opaA gene) need no conﬁrmation because of high speciﬁcity.
These make AR a suitable system for clinical microbiology laboratories.
The prevalence of nvCt needs to be tested.
R2710 Clinical manifestations of actinomycosis in a university
hospital
S. Cho*, J. Chung, S. Choi, Y. Kwak (Seoul, Gyeonggi, KR)
Objectives: Actinomycosis is a chronic infection caused by anaerobic
or microaerophilic, Gram-positive bacteria, Actinomyces spp. classically
it involves cervicofacial (55%), abdominopelvic (20%), thoracic (15%),
and mixed organs (10%), including skin, brain, pericardium, and ex-
tremities. But recent studies reveal change about types of actinomycosis.
This retrospective study describes the clinical manifestations of patients
with actinomycosis.
Methods: We retrospectively studied clinical manifestation of patients
who had diagnosed actinomycosis by histopathological methods, from
January 2001 through January 2009. The medical records were reviewed
for clinical data of the patients, including presenting symptoms,
predisposing factor, lab ﬁndings, whether surgery was performed, and
the duration of IV or oral antibiotic treatment.
Results: There were 16 cases of actinomycosis diagnosed at Chung-
Ang university Hospital in Seoul, South Korea from January 2001 to
January 2009. Three types of actinomycosis were found in this study:
thoracic (44%), abdominopelvic (31%), cervicofacial organs (25%). In
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this study, the duration of IV antibiotic treatment ranged from 10 to 30
days. 2 patients received oral antibiotic therapy without IV antibiotics.
The duration of oral antibiotic treatment ranged from 67 to 150 days.
One patient received surgical treatment only without antibiotics.
Conclusion: Over the last three decades, the incidence of actinomycosis
has declined markedly because of better oral hygiene and more extensive
use of antibiotics and clinical pictures have changed. The incidence
of cervicofacial type is declined and thoracic type is increased. The
treatments of actinomycosis are also changed, short-course chemotherapy
has recently been reported to be successful.
R2711 Comparison of the severity of invasive pneumococcal
infections between adults and children
M. Renko*, H. Kukkola, H. Kauma, T. Tapiainen, M. Uhari (Oulu, FI)
Background: Streptococcus pneumoniae is a common cause of
community acquired invasive bacterial infections both in children
and adults and infects both previously healthy and diseased subjects.
Incidence of invasive pneumococcal diseases in different age groups is
well known but the effect of age on the clinical outcome of invasive
pneumococcal diseases has not been documented. We wanted to analyze
whether our clinical impression that children recover more quickly from
invasive pneumococcal diseases than adults is true.
Methods: We reviewed the medical records of all blood culture
positive community acquired cases of pneumococcal diseases admitted
to University Hospital of Oulu in years 2000–2007. Data on clinical
symptoms, laboratory values, imaging studies, medications and outcome
were collected and compared between children and adults. During
the study period vaccination against pneumococcal diseases was
recommended only to speciﬁc risk groups (patients with immune
deﬁciencies and people older than 65 years).
Results: There were 56 paediatric (<18 years) and 229 adult cases. One
hundred and seven of the patients (26% of adults and 84% of children)
were previously healthy. None of the children died while there was a 15%
(35/229) mortality among the adults (difference 15%, 95% conﬁdence
interval, CI, 8−21%). The median length of stay at the hospital (LOS)
was 2 days in children and 9 days in adults (difference of the medians
6 days, CI 5−7). When taking account only the patients with underlying
conditions the median LOS was 2 days in children and 8 days in adults
(P< 0.001).
Conclusion: The course and outcome of invasive pneumococcal
infections are far more severe in adult patients compared to children.
This may explain the differences in the attitudes towards pneumococcal
vaccination among physicians taking care of either children or adults.
R2712 Inﬂuence of sexual intercourse on vaginal lactoﬂora
N. Borovkova, J. Stsepetova, H. Oopkaup, P. Korrovits, M. Punab,
R. Ma¨ndar* (Tartu, EE)
Under physiological conditions, the vaginal microﬂora (VMF) contains
high numbers of lactic acid bacteria which provide the colonization
resistance. At the same time VMF is an open ecosystem that can be
signiﬁcantly affected by sexual intercourse.
Our aim was to clarify the inﬂuence of sexual intercourse on partner’s
vaginal lactoﬂora.
Methods: Study group included 17 women with mean age 29.9 (21−39)
years. Two self-collected vaginal samples were taken in the follicular
phase, before intercourse and 8−12 hours after intercourse. VMF was
assessed by Nugent method. Lactobacilli were cultured on MRS agar,
typed by AP-PCR method and identiﬁed by sequencing.
Results: According to the Nugent scores, normal vaginal ﬂora (score
0−3) was found in 9 women in both specimens. Intermediate score
(4−6) was found in 3 women and bacterial vaginosis (score 7) in
1 woman. In 4 women normal microﬂora was found in the ﬁrst sample
but intermediate microﬂora in post-intercourse sample. In addition, the
score increased in two more women, and in total, the mean score was
higher after intercourse (1.94 vs 2.71).
Culturable lactobacilli were found from 15 out of 17 women. The mean
proportion of lactobacilli in total microﬂora was somewhat lower in after-
intercourse sample (49.7±33.8% vs 34.6±26.2%). All isolated strains
were identiﬁed as Lactobacillus jensenii (in 67% of women), L. crispatus
(58%) and L. gasseri (25%). In one third of women more than 1 species
was isolated. AP-PCR allowed us to conﬁrm the persistence of the same
strains in all cases though in a quarter of women strains of the same
species but different ﬁngerprints were revealed.
Conclusions: Lactobacillus species composition in Estonian women
coincides with that of described earlier. Sexual intercourse causes shifts
in vaginal lactoﬂora as revealed by increased Nugent score and decreased
lactobacillus proportion in VMF.
R2713 AQP1 and AQP4 in the CSF of bacterial meningitis patients
J. Blocher*, I. Eckert, J. Elster, J. Wiefek, H. Eiffert, H. Schmidt
(Go¨ttingen, DE)
Objectives: Aquaporins (AQP) are proteins that facilitate water transport
through cell membranes. Due to the main localization of AQP1 in the
plexus choroideus and of AQP4 in the perivascular endfeet of astrocytes
in the brain, these channels are supposed to play a pivotal role in oedema
formation. Cerebral oedema formation is one of the main contributors
of neuronal damage in bacterial meningitis (BM).
Our study aimed to determine whether AQP1 and AQP4 are present
in cerebrospinal ﬂuid (CSF) and if BM induced an increase of these
proteins in the CSF, and whether these concentrations correlated with
routine CSF parameters of inﬂammation.
Methods: CSF AQP1 and AQP4 concentrations of 35 consecutive
patients with BM treated at the Department of Neurology of the
University Medical Center and 27 healthy control persons (C) were
measured. CSF aquaporins were quantiﬁed using ELISA technique.
Results: The mean concentration of AQP1 was signiﬁcantly elevated in
patients with BM (3.8±3.4ng/ml[BM] vs. 0.8±0.5ng/ml[C]; p< 0.001).
AQP4 was also increased, however not signiﬁcantly (1.8±3.1ng/ml[BM],
0.1±0.2ng/ml[C]; p = 0.092). AQP1 and AQP4 concentrations in the CSF
of BM patients were inversely inter-correlated (R = −0.47, p = 0.004)
but we could not ﬁnd any other correlation between the concentrations
of AQP1 or AQP4 with routine CSF parameters (leukocytes, lactate,
protein, Qalbumin), age, a prediction-score, outcome-score or GCS at
admission.
Conclusion: Bacterial meningitis causes an increased release of AQP1
and AQP4 into the CSF. Whether the signiﬁcant elevation of AQP1 is due
to a higher expression on intact choroidal cells or due to the destruction
of glial cells needs to be determined.
R2714 Experience of an infectious disease ward with prosthetic
joint infections: clinical outcome and economical impact
M. Coen*, S. Passerini, R. Terzi, P. Zucchi, G. Rizzardini (Milan, IT)
Objectives: The aims of our study were: 1) to evaluate the outcome
of prosthetic joint infections (PJIs) due to different microorganisms
and treated with different options 2) to analyze the economical impact
of PJIs.
Methods: We consider retrospectively patients with PJIs from 2004 to
2009. The isolation of microorganisms was obtained from blood culture
and/or deep samples and/or intraoperatory samples. We deﬁned as cured
patients without signs of local infection and negative inﬂammatory index
>6 months after antimicrobial therapy interruption. In order to quantify
the costs of the treatment we consider the average weekly costs of
antimicrobial therapy.
Results: 50 PJIs were included in the analysis. Only in 27 (54%)
we obtained the isolation of the microrganism (9 Coagulase Negative
Staphylococci, 8 Methicillin Resistant Staphylococcus aureus, 7 Me-
thicillin Sensitive Staphylococcus aureus, 3 Gram-negative). PJIs were
cured in the 71,4% of patients; if we consider Methicillin Resistant
Staphylococcus aureus (MRSA)/Methicillin Resistant Staphylococcus
epidermidis (MRSE) infection, we achieved a positive outcome only
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in 61% of cases. Furthermore, we evaluated the importance of
the choice of the therapeutical option: with prosthetic removal and
consequent substitution we cured 89% vs 69% of patients who underwent
debridement and retention and 64% of patients treated only with long-
term suppressive antimicrobial treatment. The mean weekly cost of PJIs
in our analysis was 278€ but when the microrganism involved were
MRSA/MRSE was increased to 404€.
Conclusion: In our analysis. there is a signiﬁcant proportion of PJIs
where the pathogen remains unidentiﬁed. As previously described,
the two stages substitution of the prosthesis resulted to be the most
successful option. Taken as a whole, our data suggest the importance
of a multidisciplinary approach to the management of prosthetic
joint infections at all stages, allowing a timely identiﬁcation of the
microorganism whenever is possible and a medical and surgical approach
that allows more favourable outcome. MRSA/MRSE continue to be a
serious challenge in patients with prosthetic infections, being associated
to have a worse outcome and greater costs when compared to infections
caused by other microorganisms.
R2715 Clinical signiﬁcance of delta neutrophil index in patients
with sepsis
H.Y. Kim*, N.S. Lee, O. Kwon, Y.K. Kim, Y. Uh, J. Lee (Wonju,
Chungju, KR)
Objectives: To evaluate the clinical signiﬁcance of delta neutrophil index
(DNI), which corresponds to the immature granulocytes in the peripheral
blood, in patients with sepsis.
Methods: We reviewed medical and laboratory records of the
consecutive 116 hospitalized adult patients with sepsis from May 2007
to June 2010 in one tertiary university hospital. DNI was measured by
blood cell analyzer (ADVIA 120, Siemens, Inc.).
Results: Of a total 116 patients with sepsis, mean age was 69.3±12.0
years and mean DNI value was 5.5±7.4% (range 0–34.6%) and
mean APACHE II score was 17.8±6.9 (range 6−42). DNI values
of sepsis (n = 43), severe sepsis (n = 25) and septic shock (n = 48)
were 4.2±4.3%, 6.5±8.9% and 6.0±8.6% respectively (p = 0.34). DNI
value of bacteremic patients (n = 45) was higher than non-bacteremic
patients (n = 71) (7.9±8.6% vs 4.0±6.0%, p = 0.01). DNI values were
no signiﬁcant difference in survivors (n = 98) and non-survivors (n = 18)
(5.0±6.8% vs 7.9±9.8%, p = 0.24). But, DNI values in bacteremic
patients were signiﬁcantly higher in non-survivor (n = 7) than survivor
(n = 38) (14.2±12.1% vs 6.7±7.5%, p = 0.03).
Conclusion: The present ﬁndings indicate that DNI may be useful
prognostic marker of bacteremic sepsis.
R2716 Epidemiological characteristics of community-acquired
pneumonia among hospitalised children in the Republic of
Belarus
O. Gorbich*, G. Chistenko, Y. Gorbich (Minsk, BY)
Objective: To evaluate epidemiology of community-acquired pneumonia
(CAP) in hospitalized Belarusian children.
Methods: All consecutive immunocompetent children hospitalized in
Main city children’s infectious diseases hospital with radiographically
conﬁrmed CAP were evaluated retrospectively from January 2009
through December 2009. We analyzed age, past history, clinical
manifestations, length of hospital stay, the severity of the disease and
the inﬂuence of repeated cases of CAP in the same child.
Results: 743 patients were studied during 12 months. Ages ranged from
1 month to 17 years old (55% were boys). The majority of pneumonia
cases (34%) were registered in two-years-old children. The second place
was occupied by one-year-old children (19%), and the third place − by
three-years-old children (13%). Children younger than 1 year of age had
pneumonia only in 9% of cases.
The majority of patients were hospitalized during the ﬁrst week of their
illness (mostly on 2−4 days). In only 32.23% of cases children were
admitted with initial diagnosis of pneumonia.
Pneumonia had moderate severity level in 90% of hospitalized
children. While 10% of patients had severe CAP. The mean length of
hospitalization was 10.5±0.34 days (range 1−38 days).
686 and 183 children had the history of the acute upper respiratory tract
infection and bronchitis, respectively. 68 patients experienced one or
more CAP episodes in their past history. Inﬂuenza was registered in the
anamnesis of 53 patients. 60% of studied patients attended pre-school
and school organizations.
The analysis of the repeated cases of pneumonia among studied patients
hasn’t revealed the statistically signiﬁcant interrelation between the
severity of the disease and the presence of the pneumonia episode in
the patient’s history (odds ratio: 1.3; 95% conﬁdence interval 0.6−2.8,
p = 0.695).
CAP cases were registered round the year. The morbidity increased in
September then slightly decreased in December. Another increase was
recorded in January. The maximum levels were noted in November (101
cases) and in April (100 cases).
Conclusion: Children’s CAP is the signiﬁcant problem for Belarusian
Health System. The main group associated with CAP was children aged
from 1 to 3 years old. In the future, immunization with the use of
licensed pneumococcal and inﬂuenza vaccines may reduce the frequency
of pneumonia.
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R2717 Seroprevalence of Toxoplasma gondii among pregnant
women living in a rural northern Greek province
D. Theocharidou*, A. Theocharidis, M. Kantsadou, E. Bozi,
T. Konstantinidis (Alexandroupolis, GR)
Objectives: Purpose of this study is to evaluate toxoplasmosis
seroprevalence among pregnant women who live in a rural Province of
Northern Greece, where eating undercooked meat is quite unusual. Also,
3 toxplasmosis cases were evaluated, concerning the source of infection.
Methods: Laboratory of Hygiene in collaboration with a private
Microbiology–Virology Laboratory of Drama Province, collected blood
samples from 128 pregnant women (age range: 20−38 years old) during
the period 17/1/2007– 5/5/2010. VIDAS (BIOMERIEUX) was used to
determine IgG & IgM T. gondii levels. Statistical analysis was done
with SPSS 16.0 package. Moreover, clinical and laboratory data for 3
individuals suffering from toxoplasmosis were evaluated, and patients
were interviewed concerning the source of infection.
Results: Among 128 women, 26 (20.31%) had IgG(+) − past infection,
and 102 (79.69%) had IgG(−) − no previous contact with T. gondii. None
had recent T. gondii infection [IgM(+)].
Toxoplasmosis cases:
14 year old girl, clinical signs: fever and lemphadenopathy, IgG=
18IU/ml, IgM= 28IU/ml, her IgG and IgM titers through time is shown
on the diagram attached.
47 year old man, father of the ﬁrst patient, IgG= 140IU/ml, IgM=
1.08IU/ml. They hosted stray cats at their garden and had close and
long-term contact with them.
40 year old woman, IgG= 300IU/ml, IgM= 6.60IU/ml, infection is
attributed to eating raw meat.
Conclusions: 20.31% of women tested proved to be seropositive,
a percentage which comes in total compliance with other studies
conducted in Northern Greece (20% among women of reproductive age).
Comparing our results to previous studies we can clearly observe a
decrease in seropositivity rates during the last decades (1984: 35.6%,
1994: 25.6%). 79.69% of women tested had no previous contact with
T. gondii, and therfore are susceptible. Possible sources of infection for
susceptible individuals, taking into account people’s habits in Drama
Province:
Eating habits: low consumption of undercooked meat, high consumption
of lamp, goat, sheep, smoked pork sausages, and salads consisting
of raw and wild vegetables and fruits (well documented sources of
T. gondii)
Great number of stray cats
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Individual’s habits: close contact with cats, special attention to the cat’s
litter container.
Apart from serological testing of pregnant women, there is no further
ofﬁcial recommendation concerning toxoplasmosis management during
pregnancy, in order to prevent congenital disorders to the growing fetus.
R2718 Course and outcome of Erythema migrans in patients with
underlying rheumatological disease
V. Maraspin*, J. Cimperman, S. Lotric Furlan, E. Ruzˇic Sabljic, F. Strle
(Ljubljana, SI)
Objectives: To evaluate the course and outcome of erythema migrans
(EM) in adult patients with rheumatologic disease (RD).
Methods: Information was obtained from database on patients with EM,
examined at the University Medical Center, Department of Infectious
Diseases, Ljubljana, Slovenia, from 1992 to 2009. The data were
acquired prospectively using a structured questionnaire. EM was deﬁned
according to modiﬁed CDC criteria. During 18-year period 59 patients,
50 females and nine males, aged 58 (30−81) years, with typical EM
and pre-existent RD (arthritis and related disorders − 51 patients,
collagen vascular disorders − 8 patients), were examined. 33/59 patients
(55.9%) were receiving immunosuppressive therapy (methrotrexate,
corticosteroid, gold, leﬂonamide). Their pre-treatment characteristics and
outcome after treatment were assessed and compared with 118 previously
healthy age-, sex- and antibiotic treatment-matched persons, diagnosed
with EM in the same year.
Results: Comparison revealed analogous ﬁndings for the frequency of
tick bite, incubation, duration of EM prior to diagnosis and its largest
diameter, proportion of patients with multiple EM, seropositivity, as
well as for Borrelia skin and blood culture results. Systemic symptoms
were more common in patients with RD (51% versus 25%, p = 0.0014);
the most prominent difference was found for headache (36% versus
8%, p< 0.0001). In 2/59 (3.4%) patients with RD but in none of
the control group (p = 0.1098) objective extracutaneous manifestations
of Lyme borreliosis (monoarthritis, meningoradiculitis) were found at
presentation. Duration of EM after the beginning of antibiotic treatment
was comparable. Four (6.8%) patients with RD, and one (0.8%) in
the control group (p = 0.0429) were re-treated within 3 months due to
pronounced subjective symptoms (two patients) or persistence of EM
(two patients with and one patient without underlying RD). Nonetheless,
the clinical course was smooth and comparable in both groups.
Conclusions: Higher proportion of systemic symptoms and a tendency
for more common presence of objective extracutaneous manifestations
of Lyme borreliosis before antibiotic treatment as well as more often
need for re-treatment indicate that early Lyme borreliosis has a more
severe course in patients with RD than in immunocompetent persons.
However, the outcome one year after treatment with antibiotics as used
for immunocompetent individuals is excellent.
R2719 Neuroborreliosis in Bulgaria − Clinical manifestation and
serological ﬁndings
E. Taseva*, T. Gladnishka, I. Trifonova, V. Ivanova, I. Christova (Soﬁa,
BG)
Objectives: Lyme borreliosis is a multisystemic disease called
neuroborreliosis when neurological symptoms are pre-eminent. Bulgaria
is an endemic region for Lyme disease with increasing number of cases
reported annually. The aim of this study is to reveal clinical forms and
evaluate serological ﬁndings in patients with diagnosed neuroborreliosis
in Bulgaria.
Methods: Medical records of patients with neuroborreliosis during
2006–2010 were studied. A total of 254 paired serum/CSF samples
were collected from patients with neurological symptoms compatible
with neuroborreliosis and tested by ELISA. For detection of speciﬁc
intrathecal antibody production, antibody index towards total IgG was
calculated.
Results: Presence of IgG and IgM antibodies was detected in 39,76%
(101/254) of the patients. In 8,66% (22/254) of the patients, anti-
Borrelia IgG antibodies were found in serum samples. Anti-Borrelia
IgM antibodies were detected in 32/254 (12,5%) serum samples and
both IgM and IgG antibodies − in 9/254 (3,54%) patients. Thirty one
(12,2%) patients had intrathecal synthesis of anti-Borrelia antibodies.
Antibodies against B. burgdorferi s.l. in both serum and CSF samples
were found in only 6,69% (17/254) of the patients. IgM antibodies
were detected in 3/31 (9,68%) of the patients with intrathecal antibody
synthesis, while IgG antibodies were found in 90,32% (28/31) patients.
Various clinical manifestations of neuroborreliosis were observed −
mostly affection of the peripheral nervous system-cranial neuritis,
polyneuropathy and paresis. Encephalopathy was observed in 10 patients.
Four were misdiagnosed as multiple sclerosis.
Conclusions: Neuroborreliosis is a frequent manifestation of Lyme
borreliosis in Bulgaria. This study showed that common serological
ﬁndings included IgM anti-Borrelia antibodies in serum and IgG
antibodies in CSF samples. Polyneuropathy was the most common
clinical manifestation of neuroborreliosis.
R2720 Seroprevalence of Toxoplasmosis in HIV/AIDS Iranian
patients
M. Foroughi*, B. Moradmand Badie, S. Alinaghi, Z. Bayat,
M. Hajiabdolbaghi (Tehran, IR)
Objectives: Toxoplasma gondii has arisen as an important opportunistic
agent particularly in the central nervous system and in advanced HIV
disease; it can cause signiﬁcant morbidity and mortality. This study was
performed to determine the seroprevalence of toxoplasmosis among HIV-
positive patients in Iran.
Methods: Blood samples were collected from 201 HIV positive patients
and anti-toxoplasma antibodies were detected by using conventional
ELISA. An antibody titer of more than 3 Iu/ml was considered positive.
Results: The majority of studied patients were male (male to female
ratio: 5 to 1) with the mean age of 36±0.65 yrs. The seroprevalence
of toxoplasmosis in HIV positive patients was 49.75%. The mean
CD4 count in HIV patients with positive toxoplasma serology was
332.46±22.45/ml. Only 1% of the patients had IgM anti-toxoplasma
antibodies and 10% of the patients had clinical toxoplasma encephalitis.
The mean CD4 count in this group was 66.4±15.5/ml and there was
a signiﬁcant statistical association between CD4 count and rate of
toxoplasma encephalitis (P< 0.001).
Conclusion: In view of the relatively high prevalence of toxoplasma
infection has found among the HIV infected patients in our study
moreover a signiﬁcant proportion of HIV infected with toxoplasmosis
will be presented in future with toxoplasma encephalitis that could be
otherwise prevented by appropriate chemoprophylaxis, it can be logical
that screening for toxoplasma should be suggested for all HIV infected
patients in Iran.
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R2721 Biapenem versus meropenem: a multicentre, randomised,
single-blind, controlled clinical trial
X.J. Lu*, X.H. Wang, R.J. Yu, J.S. Liu, Z.H. Tong, Q.L. Hao, X.M. Qin,
Y. Xiong, H. Liu, G.H. Ding, C.P. Hu (Chengdu, Wuhan, Beijing,
Kunming, Guilin, Luzhou, Chongqing, Changsha, CN)
Objective: This study aimed to compare the efﬁcacy and safety of
injectable biapenem and meropenem in the treatment of bacterial lower
respiratory and urinary tract infections.
Method: A randomized, single-blind, controlled clinical trial was
performed in 9 medical centers from January 2009 to March 2010 in
mainland of China. In this phase 2 study, patients were randomly (1:1)
assigned to receive IV biapenem or meropenem for 2 weeks. The
primary efﬁcacy endpoints were clinical response at the test-of-cure visit
(7 days after therapy) for the intent-to-treat (ITT). Differences in clinical
efﬁcacy, bacteriology and safety between the two groups were subjected
to statistical analysis, including ITT analysis.
Results: A total of 272 cases received 1 dose of study drug were
enrolled and comprised the ITT population. with 241 per-protocol set
(PPS) cases (121 biapenem, 120 meropenem). A total of 272 cases (136
biapenem, 136 meropenem) were included in the safety set (SS) analysis.
Overall efﬁcacy rates of biapenem and meropenme were 94.70% and
93.94%, respectively. Overall bacterial eradication rates of the two
groups were 96.39% and 93.83%, respectively. Among the biapenem
group, 16 patients (11.76%) had probable drug-related adverse events.
Among the meropenem group, 21 patients (15.44%) had probable drug-
related adverse events. The major ones were gastro-intestinal symptoms
and rash, the elevations of AST or/and ALT and decrease of white blood
cells. All differences between the two groups were insigniﬁcant.
From the above-mentioned results of clinical efﬁcacy, bacteriological
efﬁcacy, and safety, injectable biapenem was conﬁrmed to be useful in
the treatment of moderate, severe and/or refractory infections in lower
respiratory and urinary tract infections caused by b-lactamase-producing
(including ESBL) bacterial isolates.
R2722 Microbiological analysis of a prospective, randomised,
double-blind trial comparing moxiﬂoxacin and clindamycin
in the treatment of inﬁltrates and abscesses
I. Sobottka*, K. Wegscheider, K. Balzer, R.H. Bo¨ger, O. Hallier,
I. Giersdorf, T. Streichert, M. Haddad, U. Platzer, G. Cachovan
(Geesthacht, Hamburg, Rotenburg, Berlin, DE)
Objectives: Aim of the study was the analysis of oral pathogens in
odontogenic abscesses and gingival inﬁltrates and their susceptibility to
moxiﬂoxacin (MXF), levoﬂoxacin (LVX), penicillin (PEN), amoxicillin/
clavulanic acid (AMX/CLA), doxycycline (DOX), and clindamycin
(CLI).
Patients and Methods: A prospective, randomized, double-blind,
multicenter, phase II trial compared the efﬁcacy and tolerability of MXF
and CLI in the treatment of odontogenic abscesses and inﬂammatory
inﬁltrates. The analysis of microbial parameters presented here were
part of the secondary endpoints. 71 patients with either inﬁltrates or
abscesses were enrolled into this study.
Clinical results: MXF was signiﬁcantly more effective at mean pain
reducing in patients with inﬂammatory inﬁltrates on day 2−3, compared
to CLI (61.0% vs. 23.4%, p = 0.006). Global efﬁcacy assessment at days
2−3 and 5−7 showed faster clinical responses with moxiﬂoxacin in both
abscess and inﬁltrate patients.
Microbiological results: 205 bacteria were isolated from 71 patients
(viridans streptococci 77x, Prevotella spp. 56x, Neisseria spp. 19x,
Streptococcus (S.) anginosus group and hemolytic streptococci 17x,
other anaerobes 15x, and other bacteria 21x). 98% of pathogens were
susceptible to MXF followed by AMX/CLA (96%), LVX (85%), PEN
(67%), CLI (60%), and DOX (50%). S. anginosus group and hemolytic
streptococci were detected signiﬁcantly more frequent (p = 0.04) in
patients with abscesses (12/95) compared to patients with inﬁltrates
(5/110).
Only eight patients with odontogenic infections did not recover following
surgical intervention and primary antibiotic therapy. Bacteria isolated
from patients with therapy failure and resistant against the antibiotic
given are analysed. From the abscess group a wide range of bacteria were
isolated including various kind of streptococci, E. faecalis, Neisseria
spp., and anaerobes. In contrast, from the inﬁltrate group viridans
streptococci (3x) and Neisseria spp. (3x) were isolated only.
Conclusions: In this study MXF showed a promising in vitro and in vivo
activity against odontogenic bacteria compared to CLI that justify its
use for treatment of odontogenic abscesses and inﬁltrates. Our analyses
clearly indicate that S. anginosus group and hemolytic streptococci are
associated with odontogenic abscesses and that viridans streptococci and
Neisseria spp. are involved in the pathogenesis of odontogenic inﬁltrates.
R2723 Comparative study of the antimicrobial activity of chlori-
nated and non chlorinated antiseptics against C. albicans
A.O. Atayese*, H.I. Effedua, K.I. Oritogun, K.T. Kareem, A. Oluwadun
(Abeokuta, Ibadan, NG)
Objectives: The efﬁcacy of chlorinated and non-chlorinated antiseptics
on Candida albicans is still not completely elucidated. Hence the general
objective of this study is to determine the anti-candidal efﬁcacy of six
commonly available chlorinated antiseptics with and without cetrimide
and three without chlorine and cetrimide.
Methods: The organism was challenged with diluted (according to the
manufacturers instruction) of each of the antiseptics for a period between
30 seconds and 180 seconds and the microbial cell reduction rates were
determined at every 30seconds contact by Time kill Test.
Result: The undiluted chlorinated antiseptic containing cetrimide
revealed 100% reduction in C. albicans cell count at 60secs contact
time while at 90secs undiluted chlorinated antiseptics without cetrimide
produced the same 100% lethal effect. Non chlorinated antiseptics did
not produce signiﬁcant cell reduction even at 180secs just like the
control. Chlorinated antiseptic containing cetrimide diluted according
to the manufacturer’s recommendations produced 100% cell reduction
at 120 and 150secs. Diluted chlorinated antiseptics without cetrimide
were able to produce 93.8% and 96.1% cell reduction at 180secs. Also,
the pH of the antiseptics had signiﬁcant association with their efﬁcacy
on Candida albicans (c2 = 3.54, P< 0.05).
Conclusion: Chlorination and pH of antiseptics has signiﬁcant effect on
the efﬁcacy of antiseptics against C. albicans.
R2724 A prospective, open-label, non-comparative study of anidu-
lafungin for treatment of documented candidaemia/invasive
candidiasis in selected intensive care unit patients in Europe
and Canada (ICE Study) − Focus on microbiologic efﬁcacy
M. Ruhnke*, J. Paiva, W. Meersseman, J. Pachl, I. Grigoras, G. Sganga,
F. Menichetti, P. Montravers, G. Auzinger, G. Dimopoulos, M. Borges
Sa´, P. Miller, T. Marcek, M. Kantecki (Berlin, DE; Porto, PT; Louvain,
BE; Prague, CZ; Iasi, RO; Rome, Pisa, IT; Paris, FR; London, UK;
Haidari, GR; Palma de Mallorca, ES; Sandwich, UK)
Objectives: Evaluate anidulafungin (ANI) for therapy of candidemia/
invasive candidiasis (C/IC) in selected populations of intensive care unit
(ICU) patients (pts) from Europe and Canada. Here we present detailed
results on microbiologic efﬁcacy.
Methods: Prospective, open label, multicenter, phase 3b study in adult
ICU pts (APACHE II score <25) with post-abdominal surgery, age 65
years, renal/hepatic insufﬁciency, solid organ transplant, neutropenia
and/or solid tumour. C/IC had to be conﬁrmed within 96 h before to
48 h after therapy initiation. Planned total treatment duration was 14
to 56 days: 10 days of ANI (200mg day 1, 100mg/d thereafter),
optionally followed by oral voriconazole (VOR)/ﬂuconazole (FLU).
Global response at end of all therapy (EOT) in the evaluable modiﬁed
intent-to-treat (MITT) population, i.e. excluding pts with missing/
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unknown responses, was the primary efﬁcacy endpoint. Microbiologic
response was deﬁned as eradication or presumed eradication. Secondary
endpoints were global response at end of IV therapy (EOIVT) and 2 and
6 weeks after EOT, time to negative blood culture, survival at day 90
and adverse events (AEs).
Results: 216 pts received study drug and 170 were included in the
MITT population. Most had candidemia (71%) and C albicans only
was the most common causative pathogen (56%). Common C/IC risk
factors included broad-spectrum antibiotics (90% of pts), central venous
catheter (87%), prior surgery (67%), and total parenteral nutrition (58%).
Most tested baseline isolates (153/167) were fully susceptible to all
of ANI/FLU/VOR, with the exception of: 2/96 C albicans to both
FLU and VOR; 4/27C glabrata to FLU; 1/21 C parapsilosis to ANI
and 5/21 to FLU; and 2/2 C krusei to FLU. Overall MIC90 for ANI,
FLU and VOR was 0.5mgmL, 8mgmL and 0.5mgmL, respectively.
Microbiologic and global response at different time points, across the
selected subpopulations/baseline pathogens and by infection site are
shown in the table. Mean time to ﬁrst negative blood culture was 4 days
and 90-day survival was 54%. 33/216 (15%) of patients had treatment-
related AEs, which led to study discontinuation in 5 pts. Infusion-related
AEs occurred in 6 pts.
Conclusion: In these selected ICU populations, ANI was effective,
safe and well tolerated as ﬁrst-line therapy of C/IC. EOT outcomes,
incl. microbiologic responses, were similar across baseline pathogens,
infection sites and patient populations.
R2725 Efﬁcacy and safety of probiotic in Helicobacter
pylori-positive patients with duodenal ulcer
N. Zakharova*, V. Simanenkov, A. Suvorov, G. Belov (Saint Petersburg,
RU)
Background: The Helicobacter pylori (H. pylori) eradication rate
following standard triple therapies is decreasing worldwide. The lowest
incidence of side-effects to standard therapy has been observed
when probiotics were combined with antibiotics. Because of the low
eradication rates and lack of treatment regimens alternative approaches
for H. pylori have been explored to assess the efﬁcacy and safety of
synbiotic compared with prebiotic for H. pylori eradication in duodenal
ulcer (DU) patients.
Methods: Randomized, double-blind, placebo-controlled trial lasting 8
weeks. Each of pills contained either speciﬁc synbiotic (E. faecium L-3
106−7 CFU/g, pectin and soy protein hydrolyzate, Laminaria saccharina)
or prebiotic (pectin and soy protein hydrolyzate, Laminaria saccharina)
or placebo. Pills were manufactured to conduct the trial.
81 H. pylori-positive patients in remission of DU were randomly
assigned to three groups: Group A received synbiotic, group B received
prebiotic, group C received placebo. All patients took three pills three
times daily. Gastroscopy was performed before and 6 weeks after the
end of treatment for DU activity evaluation. H. pylori detection was
carried out by rapid urease test and polymerase chain reaction (PCR)
with the primers vacA, ureaB and ureaC in gastric biopsies. Differences
between eradication frequency were evaluated by the chi-square test.
Both intention-to-treat (ITT) and per-protocol (PP) analyses were used
for the assessment of the eradication rates of H. pylori.
Results: H. pylori eradication rates for the groups A, B, and C were 38%
(11 of 29 patients), 8.7% (2 of 23 patients) and 10% (3 of 25 patients),
respectively according to PP and ITT. Synbiotic showed a higher
eradication rate than prebiotic (p = 0.0156) or placebo (p = 0.0317).
Clinical or endoscopic relapses of DU or chronic gastritis were observed
in 14 patients in group A, 6 patients in group B and 8 patients in group C.
Though H. pylori was eradicated, relapses still occurred in some cases.
Attributive relapse risk was 0.48, 0.26 and 0.28, respectively. Relapse
risk ratio was 2.45 (synbiotic vs. placebo). No cases of enterococcus
colonization of gastric mucosa were revealed by PCR with E. faecium
speciﬁc primers.
Conclusion: Monotherapy with synbiotic based on E. faecium is more
effective then prebiotic or placebo for H. pylori eradication. Monotherapy
with synbiotic increases the risk of DU relapse, indicating H. pylori is
the major cause of DU but not the only one.
R2726 Phase 2 prospective randomised study investigating dapto-
mycin 6 and 8mg/kg versus standard antibiotic therapy in
the treatment of staphylococcal prosthetic joint infections
I. Byren, A. Wheeler*, E. Campanaro, S. Yankelev, D. Anastasiou,
G. Kuropatkin, R. Evans, D. Osmon (Oxford, UK; Lexington, US;
Samara, RU; Little Rock, Rochester, US)
Objectives: Evolving resistance of Gram-positive organisms support
the investigation of higher doses of daptomycin in the management of
prosthetic joint infections (PJI).
Methods: Prospective, open-label study of 75 subjects randomised
to daptomycin (DAP) 6 or 8mg/kg, or comparator (vancomycin,
teicoplanin, or semi-synthetic penicillin) undergoing 2-stage replacement
for a hip or knee PJI. After removal of the prosthesis, subjects
received 6 weeks treatment and a 2−6 week antibiotic-free period
before implanting a new prosthesis. Test of cure (TOC) was 1−2
weeks after re-implantation. The primary objective was evaluation
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of Creatine Phosphokinase (CPK) levels. Secondary objectives were
efﬁcacy assessments by the Investigator and Sponsor.
Results: Of 73 CPK Safety Population subjects, a CPK elevation of >500
U/L occurred in 16% (4/25) DAP 6mg/kg, 22% (5/23) DAP 8mg/kg,
and 8% (2/25) comparator subjects (difference and 90% CI for DAP
8 vs. 6mg/kg was 5.7% [-17.6%, 29.4%]). Elevations were sustained
(2 consecutive values of >500 U/L) in 2 DAP 6mg/kg and 3 DAP
8mg/kg subjects. Four subjects withdrew due to increases in CPK, 1
DAP 6mg/kg and 3 DAP 8mg/kg subjects.
In the 68 modiﬁed intent-to-treat subjects, DAP had a higher blinded
Sponsor-deﬁned success rate (clinical and microbiologic response) at
TOC [Table 1]. Clinical success was also similar when assessed by
Investigators at TOC and follow-up. Microbiological failure (1 sample
positive with original organism at surgery #2) or discontinuation due to
an AE, accounted for most cases categorised as failures; only 2 subjects
(both DAP 6mg/kg) failed for an unsatisfactory clinical response.
Eradication rates at TOC for MRSA were 3/5 DAP 6mg/kg, 3/7 DAP
8mg/kg, and 2/5 comparator; MSSA 8/11, 5/9, and 5/10, respectively;
and coagulase-negative staphylococci 7/12, 7/11, and 13/15, respectively.
AE rates were similar between groups.
Conclusion: DAP at 6 and 8mg/kg, given for up to 6 weeks, was well
tolerated and appeared effective for treatment in subjects with PJI.
R2727 Treatment of chronic wounds with maggot excretion/
secretion: early clinical experience
B. Beovic*, B. Huc, K. Zupancic, L. Papst, D. Semenic,
C. Triler, D. Smrke, J. Zajc, M. Sere, S. Srcic, S. Baumgartner,
N. Gunde-Cimerman (Ljubljana, SI)
Objective: Clinical efﬁcacy and safety of hydrogels with maggot
excretion/secretion (ES) in chronic wounds was investigated.
Patients and Methods: Consecutive patients with chronic wounds were
included in the study. Lucilia sericata maggot ES was sterilized by
ﬁltration and used to prepare 60% formulation in 6% alginate hydrogel
base. Hydrogel was applied to wounds three times daily for three days.
Patients were examined at 2 to 4 days, then at 9 to 11 days and ﬁnally 3 to
4 weeks after the end of treatment Wound swabs for bacterial isolation
were taken at every patient visit. The improvement in the size of the
wound, secretion, necrosis, granulation tissue formation, epitelisation,
pain and odour was assessed by two independent investigators. A scale
from 0 to 5 was used to estimate the extent of improvement.
Results: 10 patients (6 females and 4 males) with 14 wounds in total
(8 patients with one wound, two patients with three wounds each) were
included in the study. Patients were 67,3 years old on average (range
49 to 79). Six patients suffered from diabetes mellitus, three patients
had peripheral vascular disease of other etiology and one patient had
limb trauma. Wounds were open for 20 months on average before being
inclued into the study. Seven patients ﬁnished the study per protocol,
3 patients did not attend the last visit. Improvement was observed
in all but one wound. The most prominent was the improvement in
necrosis (2,65 points), followed by epitelisation (2,1 points), granulation
tissue formation? (1,95 points), and odour (1,5 points). Seven patients
experienced 10 adverse events. Pain after application of the hydrogel was
reported most often. No patients discontinued the treatment. Maceration
of surrounding skin was observed in the patient with no improvement.
Conclusion: Maggot ES has a potential in chronic wound treatment.
Further investigations of the maggot ES pharmacodynamics, pharma-
ceutical form optimisation, and the appropriate ES dosing in chronic
wound treatment are warranted.
R2728 Tigecycline use in surgical wound infections
P. McGovern*, M. Wible, T. Babinchak (Collegeville, US)
Objective: Tigecycline (TGC) has demonstrated clinical efﬁcacy
and safety in both complicated intra-abdominal infection (cIAI) and
complicated skin and skin structure infections (cSSSI). Because cSSSI
due to prior surgery is common, TGC is a potential option for surgeons
and infectious diseases physicians who treat these infections. A pooled
analysis of phase 3−4 clinical trial subjects with cSSSI due to a surgical
infection was conducted.
Methods: Pooled data from subjects with cSSSI and a surgical etiology
from 3 double-blinded and 1 open-label study of tigecycline versus
various comparators (COM) were analyzed. The primary efﬁcacy
endpoint was the clinical cure rate at the test-of-cure assessment.
Results: A total of 200 subjects were identiﬁed (112 TGC subjects
and 88 COM subjects). TGC subjects were older (mean age 57.6
vs. 53.7) and more had diabetes (25.9% vs. 18.2%) and peripheral
vascular disease (20.5% vs. 13.6%). The abdomen and lower extremity
were the most common sites for surgical wounds and the median
therapy duration was 9 days in both treatment groups. Clinical cure
rates in the clinically evaluable population were 81.2% and 79.4% for
TGC and COM respectively (treatment difference 95%CI −11.5, 15.7).
Staphylococcus aureus was the most common pathogen with similar
cure rates for TGC and COM respectively for both MSSA (95.0% vs.
91.7%) and MRSA (82.1% vs. 76.5%). Clinical response by clinical
diagnosis, diabetes, and baseline bacteremia demonstrated no difference
between groups. Discontinuations of test article were greater in TGC
versus COM treated subjects (16.1% vs. 10.2%; p = 0.298). The number
of subjects reporting treatment-emergent adverse events were comparable
between treatment groups (p = 1.0) with signiﬁcantly more TGC subjects
experiencing nausea (43.8% vs. 21.6%) and vomiting (30.4% vs. 6.8%).
Three TGC subjects and no COM subjects had an adverse event with an
outcome of death.
Conclusion: Tigecycline appeared effective and safe in the treatment of
cSSSI due to surgical infections.
R2729 Changes in faecal ﬂora observed during a clinical trial of
linezolid or IV vancomycin for the treatment of patients
with nosocomial pneumonia caused by methicillin-resistant
Staphylococcus aureus
P. Hogan*, D. Citron, A. Baruch, A. Reisman, D. Ruzzi (New York,
Culver City, US)
Objective:We investigated the impact of linezolid (LZD) or vancomycin
(VAN) administration on the fecal ﬂora of subjects enrolled in a double-
blind randomized controlled clinical trial comparing the safety and
efﬁcacy of LZD and VAN for the treatment of nosocomial pneumonia
(NP) caused by methicillin-resistant Staphylococcus aureus (MRSA).
All patients received concomitant antibiotics with coverage for Gram
negative bacilli (GNB).
Methods: Rectal swabs were obtained at baseline, at Day 6 (± 2 days)
and at End of Treatment (EOT). Quantitative cultures and susceptibility
testing of aerobic GNB were performed to detect the emergence of
resistance of Enterobacteriaceae to ceftriaxone, ceftazidime, cefepime, or
piperacillin/tazobactam and for R of non-nonfermentative GNB (NFs) to
imipenem, aztreonam or ciproﬂoxacin. Changes in log10 number colony
forming units (cfu) for Day 6 and EOT were compared to baseline.
Results: 130 swabs were received from 69 subjects. Baseline, Day 6,
and EOT samples were available for 25 subjects, 9 in the LZD and 16 in
the VAN treatment arm. From baseline to Day 6, the median log cfu/g
of Enterobacteriaceae decreased from 106 to <102 cfu/g in LZD-treated
subjects. In VAN-treated subjects, a 2 log reduction occurred between
baseline and Day 6. At baseline, the proportion of aerobic GNB resistant
to at least 1 of the speciﬁed antibiotics for each organism group was 18%
and 14% in the LZD and VAN treatment groups, respectively. At Day
6 and EOT, the proportion of resistant GNB increased to 50% and 41%
in the LZD group compared to 17% and 22% in the VAN group. In the
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LZD arm, the average number days of GN therapy (DOT) per subject
during the pre-study period was 5.8 compared to 3.5 for subjects in the
VAN arm. The average number of DOT per subject for concomitant
antibiotics during the study period was 5 and 5.2 for LZD and VAN
treatment arms, respectively.
Conclusion: In this small study, the emergence of resistance among
GNB and changes in cfu/g during therapy was greater in the LZD arm
compared to VAN. The administration of GN active agents prior to the
study period, which was more common in LZD subjects, was likely to
have contributed to the noted changes in fecal ﬂora.
R2730 Linezolid and vancomycin in the treatment of patients with
nosocomial pneumonia proven due to methicillin-resistant
Staphylococcus aureus by body weight
L. Puzniak, D. Huang*, P. Biswas, L. Morrow (Collegeville, Omaha, US)
Objectives: The prevalence of adult obesity exceeds 30% and 20%
in adults in the USA and several European countries, respectively.
Patient body weight may need to be taken into consideration for
the optimization of drug therapy. The objective of this study was to
determine the effect of body weight on outcomes by treatment regimen
for nosocomial pneumonia (NP) due to culture proven methicillin-
resistant Staphylococcus aureus (MRSA).
Methods: Data from a prospective, double-blind, randomized clinical
trial were analyzed to examine body weight-related differences in the
efﬁcacy and safety of linezolid (LZD) 600mg IV Q12h and vancomycin
(VAN) 15mg/kg IV Q12h (adjusted for renal function) for up to 14
days. We stratiﬁed the study population into 4 weight quartiles (Q1-
Q4) (Figure). Clinical success was evaluated by weight quartiles and
treatment group at end of study (EOS = 7−30 days after last treatment
dose). We also analyzed rates of adverse events (AEs) by weight quartiles
and treatment.
Results: There were 447 patients treated with at least one dose of study
drug for MRSA NP (224 treated with LZD and 223 with VAN). The
treatment duration for all quartiles by treatment was approximately 10
days. The average maximum VAN trough was lowest in Q1 (16.2 mgml),
compared to Q2 (18.3 mgml), Q3 (18.4mgml) and Q4 (18.9 mgml). The
number of patients with AEs were similar regardless of treatment
regimen and were numerically higher in Q1 (92%) and Q2 (92%)
compared to Q3 (88%) and Q4 (85%). The rates of anemia were
highest in Q1 (16%; LNZ= 14% vs. VAN=17%) compared to Q2 (6%;
LNZ= 6% vs. VAN=5%), Q3 (11%; LNZ= 12% vs. VAN=9%) and
Q4 (9%; LNZ= 7% vs. VAN=11%). There were no differences in the
rates of thrombocytopenia among the quartiles; Q1 (6%; LNZ= 5% vs.
VAN=7%), Q2 (4%; LNZ= 4% vs. VAN=4%), Q3 (1%; LNZ= 0% vs.
VAN=2%), Q4 (0).
Conclusions: The efﬁcacy of LNZ was maintained at 600mg IV every
12 h regardless of body weight and consistently numerically higher than
weight-based VAN dosing (15mg/kg IV Q12h) for the treatment of
MRSA NP by weight quartiles. Except for higher rates of anemia in
Q1, there were no signiﬁcant differences in safety between the weight
quartiles or treatment groups.
R2731 Susceptibility patterns of baseline methicillin-resistant
Staphylococcus aureus isolates from a global clinical trial
of nosocomial pneumonia
P. Hogan*, A. Baruch (New York, US)
Objective: Methicillin-resistant Staphylococcus aureus (MRSA) is an
important cause of nosocomial pneumonia (NP) and is associated with
substantial morbidity and mortality. ZEPHYR is a randomized, double-
blind, Phase 4 study that compared linezolid (LZD) to vancomycin
(VAN) for the treatment of NP due to culture-proven MRSA. This
analysis characterizes resistance patterns in baseline MRSA isolates
collected during this recently completed trial.
Methods: 1225 patients were enrolled from Oct. 2004 to Jan. 2010.
NP was deﬁned by onset of clinical signs/symptoms and chest
radiograph consistent with pneumonia 48 hours after hospitalization.
Baseline respiratory specimens were obtained bronchoscopically, by
endotracheal aspirate or from sputum with <10 epithelial cells and >25
leukocytes/LPF. Susceptibility testing to conﬁrm MRSA presence was
performed by broth microdilution at a central laboratory according to
Clinical and Laboratory Standards Institute (CLSI) guidelines. Interim
data were previously presented at the 2009 meeting of the American
Thoracic Society.
Results: 427 baseline isolates recovered from respiratory specimens
obtained from patients with NP were conﬁrmed to be MRSA from
US (61%), Asia (15%), EU (13%), Latin America (10%) and South
Africa (1%). The in vitro activity of study drugs and other comparator
antibiotics is presented in the following table. LZD MICs ranged from
1−4mgml; 72.1% of isolates had LZD MIC = 2mgml. Mean and modal
VAN MIC = 1mgml. For 6% of isolates, VAN MIC = 2 mgml.
Conclusions: 100% of MRSA isolates from patients with NP were
susceptible to linezolid and all but 1 were susceptible to VAN. Resistance
rates were high for erythromycin, clindamycin and gatiﬂoxacin.
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R2732 Assessing the association between H. pylori infection and
the prevalence of iron deﬁciency anaemia in children, Iran,
2009–2010
M. Darvishi*, H. Mohebi, M. Forootan, M. Salehi, Z. Azizian (Tehran,
Mashad, IR)
Objectives: Iron deﬁciency, deﬁned as decreased total body iron content,
is among the most common nutritional deﬁciencies in the world.
IDA is a condition with important health consequences regarding
reproduction, immunity, work performance, and possibly cognitive
development, Emerging evidence seems to place H. pylori infection next
to helminthiasis as a communicable cause of anemia. We investigated
whether there was any correlation between H. pylori infection and iron
deﬁciency and IDA in children in Iran.
Methods: In a case-control survey, 64 patients with IDA between 3 and
8 years (median 4.5 years) were enrolled in the study and 70 matched
children as control group. Serum hemoglobin, total iron-binding capacity,
ferritin, erythrocyte mean corpuscular volume (MCV), fecal occult blood
testing, and stool for ova and immunoglobulin G antibody to H. pylori
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were measured to compare the prevalence of IDA and H. pylori infection
in the groups.
Results: 52.5% of cases were girls (53.1% of cases and 51.4% of control
group) and 47.8% were boys (46.9% of cases group and 48.6% of
controls). H. pylori serology was positive in 46.3% of cases and 19% of
control group were infected. There were a meaningful difference (p-value
>0001).
Conclusion: Our results support the proposal that H. pylori infection is
associated with IDA in children.
R2733 Inﬂuence of mother HIV and/or syphilis infection on the
outcome of newborns
A. Herrera-Martinez*, Y. Herrera-Martinez, M. Limper (Barquisimeto,
VE; Amsterdam, NL)
Background: Sexually transmitted diseases (STDs) during pregnancy
pose a major risk to the fetus due to vertical transmission. Congenital
disease still represents a signiﬁcant public health problem worldwide,
particularly in developing countries.
Methods and Materials: A retrospective investigation was performed
comprising all pregnant women with HIV and/or syphilis infections
admitted at the central hospital cof two Western Cities of Venezuela,
during January 2007-September 2010; pregnant women without STDs
served as control group. Epidemiological characteristics were reported,
anthropometrical variables in newborns were considered. Statistical
signiﬁcance was deﬁned as p< 0.05. Statistical analyses were performed
on SPSS v.17®.
Results: 76 pregnant HIV patients and 77 patients with syphilis
infection were identiﬁed, three of them being coinfected. 87 pregnant
women without STD served as controls. Mean age of infected mothers
(HIV/syphilis) was 26 years (range 14−42 yrs) with a mean of 3
pregnancies (range 1−12). In the control group, pregnancies of 38±1
weeks were observed; newborns had a mean birth weight of 3,220±524
and a mean height of 51±3cm. In HIV infected patients, mean gestation
was 36 weeks (range 26−41 weeks). Mean birth weight of newborns
was 2,829±686 g (range 510−3,900 g); 22,6% were low birth weight
newborns; mean birth height was 49±4 cm (range 30−56). In syphilis
infected patients, mean gestation was 37 weeks (range 22−41 weeks).
Mean birth weight of newborns was 3,159±649 g (range 700−4,240 g);
11,5% were low birth weight newborns, mean birth height was 51±4 cm
(range 33−59 cm).
Maternal VDRL titers were strongly associated with birth weight;
higher mother VDRL titers correlated with lower birth weight. Cephalic,
thoracic and abdominal circumference did not show considerable
differences between groups.
Conclusion: STDs cause considerable morbidity in women during the
gestational period. Congenital and perinatal infection of the newborn,
miscarriage and low birth weight have been described. In this study, both
HIV and syphilis infections resulted in lower birth weight, particularly in
newborns from HIV infected patients. Treatment of the etiologic agent
is considered effective for prevention of vertical transmission and is
recommended for STDs.
R2734 Parvo B 19 infection in children: an emerging disease
A. Kyratsa, I. Grafakos, T. Guahardo, P. Giannopoulou, F. Lykou,
A. Zabou, I. Varzakakos, A. Voyatzi, E. Trikka* (Athens, GR)
Parvo B19 is a DNA virus responsible for erythema infectiosum or
ﬁfth disease, an infectious benign rash, common in childhood. Pregnant
women may also develop Parvo B19 infection with severe conjenital
malformation.
Objectives: To study the epidemiologic proﬁle of ParvoB19 infection in
hospitalized paediatric population of Athens.
Methods: During two years period (2007–2008) IgM and IgG antibodies
against Parvo B19 virus were detected in 287 blood samples from
hospitalized children, aged 2 months till 15 years, with fever and
suspicion of parvoviral infection. Antibody titre was detected with
immunoassay and reconﬁrmed with indirect immunoﬂuorescence (Bios,
Germany).
Results: From 287 clinical samples from equal number of patients,
ParvoB19 acute infection was diagnosed in 94 patients (32,7%). IgG
antibodies were detected in 27.2% of children. A slight difference was
observed in the incidence of antibody detection between sexes. The
incidence of IgG antibody detection in children aged less than 4 years
(27,3%) was inferior in comparison with incidence in children aged
above 10 years (34,7%). Increased incidence of infection was observed
during winter and spring months.
Conclusions: Early and accurate diagnosis of Parvo B19 infection based
on IgM antibody detection or an increase of IgG antibody titre is crucial
in hospitalized children with infectious rash and leukopenia or chronic
haemolytic anaemia.
R2735 Incidence of Toxoplasma gondii infection in the paediatric
population of Athens
T. Guahardo, I. Grafakos, A. Kyratsa, F. Lykou, P. Giannopoulou,
T. Athanasopoulos, I. Varzakakos, E. Trikka*, A. Voyatzi (Athens, GR)
Toxoplasmosis is a worldwide public health disease, nowdays. Incidence
varies among different countries, depending on living standards, dietary
habits and socioeconomic status of population.
Objectives: To determine the incidence of toxoplasmosis in children
with cervical or generalized lymphadenopathy, by detection of IgM and
IgG antibodies, during ﬁve years (2004–2009).
Methods: Determination of IgM and IgG antibody titre against
Toxoplasma gondii was performed with immunoassay in 1254 sera
from children with lymphadenopathy, aged 1 till 14 years, who were
hospitalized or admitted at the emergency department. In every child
two blood samples were drawn with a distance period of 15 days and
examined for TORCH virulent agents. Reconﬁrmation of acute infection
was performed by indirect immunoﬂuorescence as well as by observation
of fourth time rise of IgG antibody titre.
Results: From 1254 children examined 85 (6.8%) were positive for
IgG and 25 (1.9%) for IgM antibodies against Toxoplasma gondii 19
(1.5%) children were positive for both IgG and IgM antibodies. Rise
of seropositivity was observed according the increase of age. Higher
incidence of infection was observed in the age group between 8 and
14yrs. There was no difference observed in the incidence of antibody
detection between sexes.
Conclusions: Toxoplasma gondii is an important cause of lym-
phadenopathy during childhood in Greece, with low incidence, probably
due to the habit of eating well-cooked meat and the good socioeconomic
status of the study population.
R2736 Candida albicans isolated from cerebrospinal ﬂuid in two
premature neonates hospitalised in neonatal unit in a
tertiary Greek hospital
F. Kouskoumpekou, I. Daniil, M. Kimouli*, M. Papadopoulou, P. Karle,
I. Labadaridis, D. Petropoulou (Piraeus, GR)
Objectives: Isolation of Candida spp. in cerebrospinal ﬂuid (CSF) in
preterm neonates is rare. We describe the clinical characteristics and
diagnosis of two cases of hospitalized premature neonates in whose
Candida albicans isolated from CSF.
Methods: The ﬁrst case was about a set of female dizygotic twins, who
were born at 32 w gestation. Twin a died within few hours, while twin b
was transferred to neonatal intensive care unit (NICU). Their mother
was treated for cervical incompetence and vaginal candidiasis during
the 2nd trimester of her pregnancy. Neonate b was started on empiric
antibiotic therapy, because of elevated CRP, and low CSF glucose level.
Blood and CSF cultures were negative. On day 8, the neonate looked
slightly unwell and lumbar puncture (LP) was repeated. The second
case was about a male neonate, who was born at 28 w gestation. The
neonate presented respiratory distress syndrome and neonatal jaundice,
and transferred to NICU. Empiric antibiotic therapy was started, although
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mechanical ventilation and phototherapy were used. On day 8, the
neonate had bradycardia and episodes of apnea with increased leycocytes
and CRP. Blood culture and CSF examination were performed.
Results: In ﬁrst case, CSF glucose remained very low, protein level
was high with 478 cells/mm3, and lymphocyte predominance, indicating
chronic meningitis. Blood and urine cultures were sterile. On day 40,
LP showed similar ﬁndings with the above results, but this time CSF
culture was positive for Candida albicans, which was sensitive in all
antifungal agents, according to RPMI method. Antifungal therapy was
given for four weeks. At the end of therapy LP were normal. The neonate
remained clinically well throughout therapy. In second case, the ﬁrst
LP and CSF culture were negative. On day 35, LP repeated cause the
neonate was still unwell. CSF glucose was normal, protein level was
high and leycocytes was 30/mm3 (47% PMNs). Blood and CSF culture
were positive for Candida albicans, which were resistant in ﬂuconazole.
Appropriate antifungal therapy was given and the neonate recovered.
Conclusion: Candida albicans isolates in CSF are very uncommon,
especially in premature neonates. As in described cases, the low
fungal load has been previously associated with false-negative results
during the ﬁrst days of Candida albicans infections. The clinical and
microbiological ﬁndings should help in diagnosis and in antifungal
treatment selection.
R2737 Newborn skin infection associated with Staphylococcus
aureus enterotoxin A production
I. Fenner*, C. Lensing, T. Fenner, F. Ahrens (Hamburg, DE)
Objective: Staphylococcal enterotoxin A (SEA) is one of the known
enterotoxins produced by Staphylococcus aureus (SA). We report about
a newborn with a persisting inﬂammatory skin infection associated with
a SAE producing methicillin sensitive SA (MSSA).
Methods: Swabs were cultured on standard media. The MALDI
Tof Biotyper System (Bruker Daltonics) was used for identiﬁcation.
Resistance testing was performed on the Microsan (Siemens). Spa-
typing, mec-A gene and the panton-valentine-leukocidine (PVL) gene
were investigated by PCR. The superantigen tests for SEA-SED and
TSST were done by agglutination (National Reference Centre for
Staphylococci, Germany).
Results: The investigation of swaps of the newborn skin at different
times showed a MSSA. The results for mecA and PVL genes were
negative as well as the results for TSST and SEB-SED. The spa-type
was t1381 and the test for SEA was positive for all investigated swabs.
Conclusions: Exotoxins especially SEB are known to play a role in
atopic dermatitis and psoriasis. The associated immune response is
a wide ﬁeld for research. To the best of our knowledge this is the
ﬁrst report of a newborn skin disease related to a MSSA positive for
SEA. After antibiotic treatment the isolated strain is still detectible. The
investigation for ﬁlaggrin defects is going on but a hyperimmunglobulin
E syndrome is excluded. In this case the colonisation or infection with
a SEA positive MSSA strain seams to play an important role in the
aetiopathology of the disease.
R2738 Detection of speciﬁc IgA antibodies in the serum of
children with Mycoplasma pneumoniae infection
M. Matsas*, G. Antonaki, A. Doudoulakakis, G. Kalogergas,
I. Paraskakis (Athens, GR)
Objectives: M. pneumoniae is a signiﬁcant cause of community
acquired pneumonia and is responsible for about 40% of atypical
pneumonias. Serology remains the most useful diagnostic tool, though
its interpretation is difﬁcult. In children detection of IgM antibodies in
serum with the absence of IgG strongly indicated acute M. pneumoniae
infection and the presence of IgM and IgG antibodies simultaneously
is associated with past infection. The aim of the present study is to
investigate the usefulness of IgA antibodies detection in serum for the
diagnosis of acute or past M. pneumoniae infection in children.
Methods: Serum samples from 184 outpatient or hospitalized children
(90 boys and 94 girls) aged 1,5−14 years old, suspected for
M. pneumoniae infection, from January 2007 to September 2010,
were tested for the determination of speciﬁc IgM and IgG antibodies
to M. pneumoniae using Platelia EIA (Biorad). IgG antibodies were
discriminated as non signiﬁcant, low, moderate and high, according to the
absorbance reading. Sera were stored at −70ºC before the determination
of IgA antibodies using ELISA (Virion/Serion).
Results: IgM antibodies were found in 167 out of 184 serum samples.
The detection rate of speciﬁc IgA antibodies in the group of IgM positive
and no signiﬁcant IgG titer was 38% (31/81), in the group of IgM
positive and low IgG titer was 48% (13/27), in the group of IgM positive
and moderate IgG titer was 45% (10/22) and in the group of IgM positive
and high IgG titer was 78% (29/37). In the group of children with IgM
negative and IgG positive, IgA antibodies were detected in 41% (7/17)
of samples, mainly with signiﬁcant IgG titer (5/7).
Conclusion: In adults, the determination of IgA antibodies is useful
for early diagnosis of acute M. pneumoniae infection considering that
IgA response is more regular than IgM response in these patients. In
contrast our results indicate that IgA speciﬁc antibodies determination
is incapable of differentiating acute or past M. pneumoniae infection in
children.
R2739 Polymicrobial otitis in childhood
E. Staikou, A. Makri*, G. Kyriakopoulou, F. Lykou, I. Varzakakos,
T. Guahardo, A. Bousmpoula, A. Voyatzi (Athens, GR)
Objectives: To evaluate the incidence of common otopathogens in
paediatric population with acute (AOM) and chronic otitis (COM).
Materials and Methods: Four hundred and eigthy ﬁve paediatric
patients were examined in our hospital with otitis symptoms during the
years 2007–2009. The samples were cultured according to conventional
methods. The identiﬁcation was performed using the API20E system.
VITEK2 automated system (BioMerieux) was used for identiﬁcation and
susceptibility testing of pathogens.
Results: Totally, 71,3% of all samples tested (346/485) were found
positive for bacteria. The most prevalent ones were: H. inﬂuenzae 27%,
S. pyogenes 20%, P. aeruginosa 20,8%, S. pneumoniae 18,5%, S. aureus
9,7%, M. catarrhalis 3% and V. alginolyticus 1%. Out of 346 positive
cultures, 19 developed fungi (5.5%). Candida spp (88%) predominated
and followed by Aspergillus spp (12%). Anaerobes were isolated mainly
in cases of chronic otitis, usually in mixed cultures with other bacteria
(Peptostreptococci and Clostridia spp). As a whole, one hundred and
four mixed polymicrobial cultures were found that developed 2
otopathogens (30%). In 4.8% of cases 3 otopathogens were recovered.
H. inﬂuenzae proved to be the most prevalent otopathogenic agent
in childhood. Nontypable H. inﬂuenzae, S. pyogenes, P. aeruginosa
and S. pneumoniae were found in culture with other otopathogens in
35%, 26%, 18% and 13% respectively. The most frequent combinations
of mixed bacterial populations were S. pyogenes+S. aureus 11,6%,
S. pyogenes+H. inﬂuenzae 8,65%, S. pneumoniae+H. inﬂuenzae 7,7%
and P. aeruginosa+S. aureus 6,8%. A seasonal variation has been also
detected in the incidence of otitis media with peaks in the fall and winter.
Conclusions: A signiﬁcant proportion of mixed microbial populations
(30%) was observed in paediatric patients suffering from otitis.
H. inﬂuenzae was the leading virulent factor in otitis media especially
with effusion, while P. aeruginosa was the dominant pathogen in external
otitis. It is worthy that S. pyogenes was encountered in high proportion
(21%) of cases and coexisted with S. aureus. An accurate differential
bacterial diagnosis is essential for ears disease ensuring appropriate
treatment.
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R2740 Retrospective study of prevalence and resistance proﬁle of
S. enteritidis and S. typhimurium in a paediatric hospital
E. Staikou, A. Makri*, M. Lampiri, M. Polemis, H. Iliadou,
G. Oikonomopoulos, A. Vatopoulos, A. Voyatzi (Athens, GR)
Objectives: To investigate the prevalence of S. enterica serovars and to
determine the antimicrobial susceptibility patterns of different S. enterica
serotypes isolated from hospitalized children with acute gastroenteritis
to current antimicrobial agents.
Materials and Methods: Out of 6800 feaces samples 550 strains
of S. enterica were isolated during a seven year period (2004–2010).
Identiﬁcation and antimicrobial susceptibility testing were performed
with automated system VITEK 2. The strains were serotyped using
speciﬁc antisera; as well serotyping was conﬁrmed in reference
laboratory. The age of patients ranged from 1 month to 14 years.
Results: Out of all samples examined 1265 were found positive for
enteropathogens (18,6%). Five hundred ﬁfty strains were identiﬁed
as S. enterica (43,5%) as follows: S. enteritidis 391 (71%), S. ty-
phimurium 86 (15,6%), and the rest Salmonella serovars 73 (13,4%).
Among 19 various Salmonella serotypes S. bovismorbiﬁcans (12,3%),
S. oranienburg (9,6%), S. hadar (8,2%), S. blockley (5,5%) and
S. abony (5,5%) were the most prevalent ones. S. enteritidis strains were
sensitive to aminoglycosides, chloramphenicol (C), ﬂuoroquinolones
(FQ), cephalosporines 3rd generation, spectinomycin (SP), streptomycin
(STR) while cotrimoxazole (SXT) showed only intermediate resistance
12,7%. S. enteritidis presented resistance to: nalidixic acid (NA) 16,5%,
ampicillin (AM) 1%, tetracycline (TE) 1% and amoxicillin/clavulanate
(AMC) 0,5%. However, higher levels of multidrug resistance was
observed in S. typhimurium strains to: TE 32,8%, AM 28%, SXT 23,7%,
STR 14,6%, C 9%, SP 9%, AMC 5,5%, NA 5.5%, cefotaxime (CTX)
3,7%, ceftazidime (CAZ) 1,9% and tobramycin (TB) 1,9%. All CTX-
resistant S. typhimurium strains were resistant to b-lactams, aztreonam,
but susceptible to CAZ and ciproﬂoxacin (CIP). Finally, the others
S. enterica serovars exhibited the following resistance proﬁles: NA 15%,
AM 10%, SXT 4%, TB 2.8%, AMC 1.5% and CIP 0.7%.
Conclusions: 1. The serovars of S. enteritidis and S. typhimurium were
susceptible to FQ. 2. S. typhimurium exhibited higher levels of resistance
to AM and SXT in relation to S. enteritidis. In this regard, treatment of
gastroenteritis in childhood might be complicated. 3. The presence of
ESBLs and cefotaximases producing S. enterica serovars emphasized
the need for strict antibiotic regimens.
R2741 Bacteraemia and fungaemia in Vilnius University
Children’s Hospital, 2007–2009
I. Narkeviciute*, G. Bernatoniene (Vilnius, LT)
Objectives: To determine the most common organisms isolated from
blood cultures in children admitted to the different hospital departments.
Methods: All positive blood cultures from the children 0−18 years
old isolated at Vilnius University Children’s Hospital which currently
possesses 469 beds, from 2007 to 2009 were included in the study. The
blood cultures were categorized according to likelihood of infection or
contamination.
Results: During the study period 6538 blood cultures were obtained
from the hospitalised children. The majority (43%) of the blood culture
samples were obtained from the oncohaematological patients and only
few samples (1.6%) were obtained from the surgical patients. In total,
there were 695 (10.6%) positive blood cultures. They were most
common from the oncohaematological patients, and least common for the
children admitted to the general paediatric wards. Different bacteria were
identiﬁed in 94.5% of the cases and 5.5% were identiﬁed as Candida
sp. Gram-positive bacteria constituted 57.6% from all positive cultures.
Of them, coagulase-negative staphylococci were found in 33.7% of the
cases and Staphylococcus aureus in 8.1%. Enterobacteria were isolated
from 26% of the children, most commonly from the oncohaematological
patients and neonates. Neisseria meningitidis isolates were identiﬁed in
24 (3.5%) children admitted to the general paediatric wards. Out of all
695 cultures, over 40% of them were considered to be either deﬁnite or
probable contamination.
Conclusion: There were approximately 10.6% positive blood cultures
obtained every year. The most common isolates were Gram positive
bacteria. Coagulase-negative staphylococci were the most common
organisms isolated in our study. The vast majority of bacterial and
Candida isolates were identiﬁed from the oncohaematological patients.
R2742 Clinical signiﬁcance and antimicrobial susceptibility of
Staphylococcus epidermidis and Staphylococcus lugdunensis
in severe infections in children
A. Makri*, H. Iliadou, A. Bousmpoula, G. Kyriakopoulou, A. Venetis,
I. Varzakakos, A. Voyatzi (Athens, GR)
Objectives: 1. To assess the prevalence and the distribution of
S. epidermidis (S.e) and S. lugdunensis (S.l) in severe diseases such
as bloodstream infections (BSI) or skin and soft tissue infections, in a
pediatric hospital. 2. To investigate S.e and S.l antimicrobial resistance
patterns.
Material and Methods: A total of 268 coagulase negative Staphylococci
(CoNS) isolated from 356 positive blood and 805 wound cultures
from hospitalized children, median age 5 years during a four year
period (2005–2008) were tested. Identiﬁcation at the species level and
susceptibility proﬁles was performed by using the Vitek II system and
E-test. All CoNS strains were investigated for the presence of bioﬁlm
formation (slime test tube adherence).
Results: Out of 19,2% (69/356) bloodstream related CoNS, the species
distribution was: S.e (39.13%), S. hominis (20.29%), S. haemolyticus
(17.40%), S. warneri (17.39%) and ﬁnally S. capitis and S. auricularis
were found in 2.90% each one. The predominant species in 25% CoNS-
wound associated isolates was S.e (61%), followed by S. warneri 7,53%,
S. hominis 7.22%, S. capitis 6,8%, S. l 6.2% and the remaining 10.89%
CoNS strains included a variety of species. The observed prevalence of
methicillin resistance (MR) among S.e strains in BSI was 68% versus
28% in wound infections (WI). A signiﬁcant proportion of MR was
found among S. hominis (60%) and S. warneri (50%) in BSI. Notable
rate of resistance (5% and 16%) was detected to teicoplanin (32mg/l)
in S.e and S. hominis sepsis related strains isolates respectively. MR
CoNS also showed multidrug resistance to antibiotics: erythromycin
65%, clindamycin 60%, tobramycin 20%, fucidic acid 35%, tetracycline
20% and sulfamethoxazole-trimethoprim 15%. In contradiction, all S.l as
well as S. haemolyticus, S. capitis and S. intermedius wound-associated
isolates were found methicillin susceptible. Bioﬁlm formation in 25 S.e
orthopedic wound-strains was also associated with multidrug resistance.
Conclusions: 1. S.e was the leading cause of BSI and WI and was
related with multiple resistance patterns and indwelling medical devices.
2. S. l, a virulent pathogen agent, was associated with severe WI.
3. Our results strongly suggest the need for the establishment of control
program measures in order to prevent and reduce the level of resistance of
S.e to methicillin. A recent concern is the upwards shift in glycopeptides
MIC for S.e strains.
R2743 Perinatal risk factors for the development of neonatal
septicaemia
M. Douraghi, M.M. Soltandallal, M. Nateghi Rostami, H. Zeraati,
R. Bakhtiari* (Tehran, IR)
Objectives: Perinatal determinants plays crucial role in the increased
incidence of bacterial sepsis. This study was undertaken to determine
whether neonatal-maternal risk factors and bacterial pathogens affect
the risk of early or late onset sepsis.
Methods: Three hundred neonates at NICU of two hospitals in Tehran,
were studied. Blood culture from neonates with suspected sepsis was
performed on BHI broth followed by identiﬁcation of isolates and testing
for their susceptibility to antimicrobial agents. Collectively, neonatal and
maternal risk factors such as birth weight, gestation age, PROM, Apgar
score, . . . were studied in the cultures proven cases of neonatal sepsis.
Immunology, host defences, immunotherapy S827
In univariate binary logistic regression models, the impact of neonatal
and maternal factors on sepsis risk was estimated in terms of odd ratio
(OR) with 95% conﬁdence interval (CI).
Results: This study revealed the impact of bacterial pathogens, neonatal
and maternal predisposing factors on sepsis as follows. Maternal
factors: PROM affect the sepsis risk to more than 3-fold (OR= 3.8;
95%CI:1.37–10.56; P< 0.05). Neonatal factors: the mean age of neonate
±SD of whom with early-onset sepsis (1.56±0.88) was lower than
that of with late-onset sepsis (10.40±5.50) and this difference was
statistically signiﬁcant (P< 0.05). Low birth weight (LBW) <2500 g
increase the risk of sepsis to more than 2-fold (OR= 2.9, 95%CI:1.17–
9.86; P< 0.01). Gestation age (GA) <29 weeks was signiﬁcantly
associated with sepsis (P< 0.01). The septicemia in turn, increase the
risk of death up to more than 5-fold (OR= 5.5; 95%CI:1.98–15.3;
P< 0.01). More than half of septic neonates had positive result for
CRP whereas only 1.9% of neonates with sepsis were CRP negative
and this difference was statistically signiﬁcant (P< 0.001). Bacterial
pathogens:14/300 (4.7%) of neonates developed septicemia. Among
infected neonates 64.3% and 35.7% were considered with early onset and
late onset sepsis respectively. The most isolated Gram negative organism
was Stenotrophomonas maltophilia (42.8%) followed by Klebsiella
pneumoniae (28.6%), Escherichia coli (21.4%) and Serratia liquefaciens
(7.2%).
Conclusion: This study reveals that speciﬁc neonatal and maternal
factors are associated with increased risk of sepsis. Among the studied
factors, prematurity of neonates explained as GA and LBW are the
most important contributors to morbidity in neonates suffered from
sepsis. Furthermore, PROM as maternal risk factor predisposes a child
to neonatal sepsis.
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R2744 Oral administration of heat-killed Lactobacillus pentosus
strain b240 augments protection against Streptococcus
pneumoniae infections in mice
H. Noguchi, A. Tanaka, M. Seki, S. Yamahira, M. Toba, K. Kosai,
Y. Morinaga, Y. Imamura, T. Miyazaki, K. Izumikawa, H. Kakeya,
Y. Yamamoto, K. Yanagihara, T. Tashiro, A. Ueda*, N. Kohda, S. Kohno
(Otsu, Nagasaki, JP)
Objectives: The fatalities caused by Streptococcus pneumoniae (S. pneu-
moniae) infection are high in the young children and the elderly.
Host-defense mechanisms against these pathogenic infections involve
both innate and acquired immune systems. In particular secretory
immunoglobulin A (IgA) and innate immunities in the airway mucosa
play a principal role in preventing these infections. Lactobacillus
pentosus ONRICb0240 (b240) has been screened as the excellent IgA-
inducing bacterium in vitro. The present study aimed to investigate
whether nonviable b240 can prevent S. pneumoniae infection in mice.
Methods: CBA/J mice were administered with b240 for 3 weeks prior to
lethal S. pneumoniae infection. The survival and body weight of the mice
were monitored daily for 2 weeks after infection. Then, isolated lungs
were evaluated the severity of pneumonia. The number of S. pneumoniae,
concentration of inﬂammatory cytokines, and expression of toll-like
receptor 2 in lung homogenate on 2days after infection were determined.
Results: In the pneumococcal pneumonia model, oral intake of b240
led to the prolongation of survival time and signiﬁcantly inhibited of
body weight loss, as well as reduced bronchitis. There were a signiﬁcant
decrease in the secretion level of inﬂammatory cytokines and toll-like
receptor 2 expression was promoted in b240-treated mice. These results
were exhibited in accordance with the alleviated pathological severity of
pneumonia.
Conclusion: These results suggest that Lactobacillus pentosus ON-
RICb0240 intake can facilitate protection against S. pneumoniae
infection via the modulation of innate immunities.
R2745 Oral administration of heat-killed Lactobacillus pentosus
strain b240 protects mice against Salmonella enterica
serovar typhimurium
T. Matsumoto*, H. Ishikawa, E. Kutsukake, T. Fukui, I. Sato, T. Shirai,
T. Kurihara, N. Okada, H. Danbara, M. Toba, Y. Maeda, N. Kohda
(Tokyo, Otsu, Uenohara, JP)
Objectives: One of the beneﬁcial effects of probiotic bacteria is
protection of the host against infection by various enteric pathogens.
Viable lactobacilli are used in most probiotic studies, while few studies
using heat-killed probiotic bacteria have been reported. The purpose
of this study was to investigate the effects of heat-killed Lactobacillus
pentosus ONRICb0240 (b240) on systemic infection by Salmonella
enterica serovar Typhimurium (S.Typhimurium) and to determine the
mechanism by which b240 protects against infection.
Methods: To determine whether oral administration of heat-killed b240
would affect the survival of mice after S. Typhimurium infection,
mice were orally administered b240 or saline daily for 3 weeks.
S. Typhimurium was orally inoculated and survival of the mice was
monitored until 20 days after inoculation. To study the effect of b240
on bacterial translocation of S. Typhimurium, mice were treated orally
with b240 or saline daily for 3 weeks. Various organs were removed 6
days after S. Typhimurium inoculation and viable numbers of bacteria
were evaluated. We also examined the effects of b240 on adhesion and
invasion of S. Typhimurium into HeLa cells by in vitro assay.
Results: The mice treated with b240 were signiﬁcantly protected against
S.Typhimurium as compared to those fed saline. Moreover, viable
numbers of S.Typhimurium in each organ in b240-treated mice tended
to be less than in the control mice. In vitro study demonstrated the
inhibitory effect of b240 on binding and invasion of S.Typhimurium
into cells.
Conclusion: The oral administration of Lactobacillus pentosus ON-
RICb0240 protected mice from S.Typhimurium infection through the
inhibition of adhesion and invasion of S.Typhimurium to intestinal
epithelial cells in association with a reduction of bacterial systemic
infection. Our results suggest that nonviable lactic acid bacteria also
play an important role in preventing infection by enteric pathogens.
R2746 Immunogenicity of the pneumococcal conjugate 7-valent
vaccine and impact on pneumococcal carriage in infants
from Venezuela with sickle cell disease or HIV infection
I.A. Rivera-Olivero*, B. del Nogal, M.C. Sisco, M. Fuentes, R. Cortez,
D. Bogaert, P.W. Hermans, J.H. de Waard (Caracas, VE; Utrecht,
Nijmegen, NL)
Objectives: To evaluate immunogenicity of the pneumococcal 7-valent
conjugate vaccine (PCV7) and the impact on pneumococcal carriage in
infants with sickle cell disease (SCD) or HIV infection.
Methods: Children with SCD (n = 25) and HIV (n = 12) listed at the
Children Hospital in Caracas, Venezuela were enrolled in this study and
vaccinated according to their age with the 7-valent conjugate vaccine
followed by a booster dose of a 23-valent pneumococcal polysaccharide
vaccine (PS-23). Blood samples and nasopharyngeal swabs for the
determination of antibody concentrations for vaccine serotypes and for
the isolation of S. pneumoniae respectively were obtained immediately
before and 1 month after the PS-23 booster.
Results: Of the 37 infants enrolled in this study, pneumococcal carriage
prior the ﬁrst immunization was found in 32% (n = 12) of the children
with 67% (n = 8) carrying non-vaccine serotypes. After boosting 100%
of the subjects had antibody titers >0.35mg/mL for all the 7 vaccine
serotypes, ranging from 0.42mg/mL (serotype 6B) to 62.21mg/mL
(serotype 14). One month after completion of the vaccination scheme
pneumococcal carriage was found in 27% (n = 10) of the children with
80% (n = 8) carrying non vaccine serotypes.
Conclusions: High antibody titers for the serotypes of the 7-valent
conjugate vaccine were obtained with this vaccination scheme in our
children. However, no signiﬁcant effect on carriage rate in general or
carriage rates for vaccine serotypes was observed.
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R2747 Clinical efﬁcacy of interferon-g (G Immunox®) in chronic
granulomatous disease
Y. Panahi*, M. Izadi, F. Beiraghdar, Z. Pourpak, M. Fazlollahi,
Y. Moharamzad (Tehran, IR)
Objectives: To evaluate clinical efﬁcacy of interferon-g (IFN-g)
(G Immunox®, Exir Co., Iran) in patients with chronic granulomatous
disease (CGD).
Methods: Twenty-eight patients with a mean (SD) age of 9.5 (8)
years with the established diagnosis of CGD (according to nitroblue-
tetrazolium (NBT) and dihydrorhodamine (DHR) tests) were included.
The patients received IFN-g for 6 months. The method of administration
consisted of a dosage of 50 micrograms/m2 of body surface area
via subcutaneous injection in deltoid muscle three times a week. The
variables documented before enrollment into the study and after 6 months
were fungal infections, respiratory infections, admission to hospital, and
primary site of infection.
Results: Mean (SD) number of fungal infections among the patients
decreased from 1.81 (0.605) times at baseline to 0.38 (0.498) after
6 months. Similarly, Mean (SD) number of respiratory infections at
baseline was 2.1 (0.68) times which decreased to 0.68 (0.86) after
receiving IFN-g. Mean (SD) number of hospital admissions decreased
from 2.95 (1.071) times at baseline to 0.512 (0.19) after 6 months. During
the study period, hepatic infections (6 cases) was the most common
primary site of infection followed by subcutaneous (3 cases), bone and/or
joint (2 cases), brain (2 cases), lymph nodes (2 cases), and respiratory
system (2 cases).
Conclusion: G Immunox® showed acceptable clinical efﬁcacy in patients
with CGD.
R2748 Phagocytic functions in patients with active brucellosis
A. Al Aska*, A. Al Tuwaijri, I. Al Orainey, A. Al Anazi, M. Al-Hedaithy,
F. Buba, U. Yusuf, N. Al Anazi (Riyadh, SA)
Objective: To evaluate phagocytic functions in Culture-proven Brucel-
losis.
Method: Eighty (80) Patients with compatible symptoms and signs and
positive blood culture for Brucellosis and forty-three normal controls
were prospectively studied at the King Khalid University Hospital,
Riyadh, Saudi Arabia. Determination of phagocytic function were
done by chemiluminesence assay of the oxidative burst, opsonized
yeast uptake and turbidimetric measurement of antibody dependent
cytotoxicity (ADCC) for whole blood, polymorphonuclear neutrophils
(PMNs)and isolated monocytes. Patients with brucellosis were divided
into three categories namely: non-complicated, complicated and post
treated patients.
Results: Luminol-enhanced chemiluminesence assay of the oxidative
burst for PMNs was signiﬁcantly increase in all patients infected with
Brucella melitensis as compared to the control group with time to
peak in minutes of non-complicated versus control of 5.82±0.03 vs
6.88 ±0.27 (p< 0.05). Speciﬁcally, the PMNs of patients in the non-
complicated group were more active than those with complication.
It has been suggested that PMNs depression may contribute to the
chronicity of Brucella in some individuals. The pattern of whole blood
chemiluminesence was found to closely parallel that of the PMNs.
The monocyte response of infected patients, however did not always
show a signiﬁcant increase in their function as the time to peak in
minutes for control, non-complicated, complicated and post treatment
were as follows: 9±0.34, 8±0.45, 7±0.50 and 8±0.50 respectively.
The oxidative burst of monocytes of patients was signiﬁcantly reduced
perhaps due to long term survival of Brucella within the monocyte.
The result demonstrated recovery of activity after treatment indicating
temporary and infection-related process. Yeast uptake was signiﬁcantly
reduced in all groups of patients. Measurement of ADCC showed a
signiﬁcant decreased in cellular cytotoxicity as measured by a decrease
in target cell elimination for all patients; non-complicated vs control
47.18±3.9 vs 55.77±2.55 (p< 0.01); complicated vs control 45.32±3.6
vs 55.77±2.55 (p< 0.05) and post treatment vs control 40.95±2.5 vs
55.77±2.55 (p< 0.05) compared to the control.
Conclusion: The PMNs and monocyte oxidation burst reaction is
dependent on the patients’ status. Target cell elimination and yeast uptake
however was signiﬁcantly reduced and did not depend on the patients’
status.
R2749 Oral intake of heat-killed Lactobacillus pentosus strain
b240 accelerates salivary immunoglobulin a secretion in the
elderly: a randomised, placebo-controlled, double-blind trial
Y. Kotani*, S. Shinkai, H. Okamatsu, M. Toba, K. Ogawa, H. Yoshida,
T. Fukaya, Y. Fujiwara, K. Kakumoto, N. Kohda (Otsu, Tokyo,
Tokushima, JP)
Objectives: Secretory immunoglobulin A (IgA) in saliva has been widely
used as an indicator of mucosal immunity. A lack of non-speciﬁc
secretory IgA at the mucosal surfaces can lead to an increased risk
of infection. Salivary IgA (SIgA) secretion decreases with age, and may
lead to an increased risk of respiratory infections because the salivary
glands are the most important source of secretory IgA in the upper
respiratory tract. The objective of this study was to demonstrate the
acceleration of SIgA secretion by oral intake of Lactobacillus pentosus
ONRICb0240 (b240) in the elderly.
Methods: A total of 80 healthy elderly individuals were randomly
allocated to either an intervention or control group. The elderly
individuals in the intervention group were given a water beverage
containing heat-killed b240 (4×109 cells), while those in the control
group were given only a water beverage; both groups received their
respective beverages once daily for 12 weeks. Saliva was collected before
initiation of the study and every 2 weeks thereafter. Saliva ﬂow rate and
SIgA concentration were determined, and the SIgA secretion rate was
calculated.
Results: Changes in SIgA secretion rate over the intervention period
were signiﬁcantly greater in the intervention group than the control group
and the mean SIgA secretion rate in the intervention group steadily
increased until week 4 (exhibiting a 20% elevation relative to that at
week 0), and then remained stable until week 12.
Conclusion: Oral intake of Lactobacillus pentosus ONRICb0240 for
12 weeks signiﬁcantly accelerated SIgA secretion, thereby indicating its
potential in the improvement of mucosal immunity and resistance against
respiratory tract infections in the elderly.
R2750 Cytokine response in patients treated with S. aureus
autovaccine
A. Szkaradkiewicz*, S. Giedrys-Kalemba, T. Tulecka, T.M. Karpinski,
A. Zeidler (Poznan, Szczecin, PL)
Objectives: Chronic infection with S. aureus creates a serious
therapeutic and epidemiological problem. In treatment of chronic
staphylococcal infections autovaccines are used, prepared from killed
S. aureus strains, isolated from the patient. The study aimed at evaluation
of serum levels of IL-1b, TNF-a and IFN-g in patients with chronic
S. aureus infections, treated with autovaccine.
Methods: The studies were conducted on two groups of patients.
Group l consisted of 20 healthy individuals of 18 to 38 years of age,
asymptomatic carriers, in whom nasal smears disclosed presence of
S. aureus. Group 2 included 16 patients, 17 to 39 years of age, with
chronic upper respiratory tract infections induced by S. aureus. Strains
of S. aureus were isolated from throat smears and identiﬁed using ID
32 STAPH tests (bioMerieux). In all patients of group 2 treatment
with autovaccine (containing 1.5×108 killed bacteria/ml) was applied,
prepared from S. aureus strains isolated from the patients. Serum IL-1b
and TNF-a cytokine levels were estimated using high sensitivity ELISA
tests (R&D), while levels of IFN-g were quantitated using high sensitivity
ELISA test (eBioscience). Estimations of serum cytokine levels were
conducted twice: before application of the autovaccine and 24−72 hours
following a series of 20 subcutaneous injections (thrice a week) of the
autovaccine.
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Results: In group 1, consisting of healthy S. aureus carriers, mean
levels of serum cytokines amounted as follows: IL-1b 0.31±0.3 pg/ml,
TNF-a 0.56±0.22 pg/ml, IFN-g 0.21±0.095 pg/ml. In group 2 at the ﬁrst
sampling levels of the cytokines were as follows: IL-1b 0.28±0.16 pg/ml,
TNF-a 0.54±0.09 pg/ml, IFN-g 2.37±1.38 pg/ml, and only the level
of IFN-g was signiﬁcantly higher (p< 0.0001) than mean level in
group 1. In turn, on the second sampling mean level of IFN-g was
signiﬁcantly higher (p = 0.0152) than the level noted upon the ﬁrst
sampling and amounted to 4.41±2.6 pg/ml. Serum levels of IL-1b
and TNF-a increased in 10 patients (2.77±2.45 pg/ml, p = 0.0005 and
1.67±0.69 pg/ml, p< 0.0001, respectively) and remained unaltered in
the 6 remaining patients. At the same time in 10 patients presence of
S. aureus could not be detected in throat smears obtained at the time of
the second sampling.
Conclusion: The effective immune response against S. aureus seems
to depend on levels of circulating cytokines IL-1b and TNF-a, the
production of which may be stimulated by S. aureus autovaccine.
R2751 Anti-cytomegalovirus Avidity Index in women with and
without recurrent pregnancy loss
R. Sherkat*, M. Meidani, B. Zarabian, A. Gholamrezaei, B. Ataei
(Isfahan, IR)
Background: Some evidence has shown a relationship between human
cytomegalovirus (CMV) infection and pregnancy loss. However, whether
recurrent or latent CMV infection or altered immune response to CMV
may relate to recurrent pregnancy loss (RPL) is unclear and few data
are available in this regard. We evaluated CMV infection and humoral
immunological response to CMV in women with RPL and compared it
to women without any history of abortion.
Methods and Materials: This cross-sectional, observational study was
conducted in Clinical Immunology outpatient clinic, Alzahra University
Hospital, Isfahan, Iran, between 2008 and 2010. Cases were 43 women
with RPL referred by Obstetric and Gynecology outpatient clinic and
controls were randomly selected from healthy age match multiparous
women without history of abortion. Inclusion criteria were at least
3 recurrent spontaneous abortions, and no history of any diagnosed
underlying diseases as etiology of RP L. Blood samples were obtained
from patients and controls to evaluate CMV IgG and IgM antibodies and
IgG avidity index by the Enzyme Linked Immunosorbant Assay Method
(ELISA). Data were analyzed with SPSS version 16.0, using Student’s
t-test, chi-squared test, and multivariate analyses.
Results: One case (2.3%) of positive IgM in each group of RPL’s and
controls was detected. Also, there were 39 (90.6%) and 30 (69.8%) cases
of positive IgG in RPL’s and controls, P< 0.05. Patients and controls
were similar regarding serum IgM titer (P> 0.05). But, IgG titer was
signiﬁcantly higher in RPL group, P< 0.05. No differences were found
between the two groups in IgG avidity index (P> 0.05). In multivariate
analyses, only IgG positivity was related to RPL (P< 0.05) and avidity
was not related to RPL (P = 0.277). Also, IgG positivity (P = 0.159), IgM
positivity (P = 0.856), or avidity index (P = 0.440) were not related to the
number of abortions in RPL patients.
Conclusions: Previous exposure to CMV detected by a positive IgG
antibody is signiﬁcantly related to RPL in the present study. However,
we found no relationship between IgG avidity index and RPL. Whether
Latent CMV infection starting an indirect process of autoimmune
etiology in RPL’s or women with RPL had recurrent or reactivation of
CMV infection but avidity index is not the best index to detect it, mostly
because of altered immune function to CMV in RPL patients need further
investigations.
R2752 Speciﬁc antibody functional activity in recipients of
one-dose vaccine contained Leningrad-3 mumps virus
strain: a 3-year follow-up
A. Atrasheuskaya*, I.A. Karpov, G.M. Ignatyev (Minsk, BY)
Mumps virus-neutralizing antibodies are believed to be the most
predictable surrogate marker of protective immunity. The remote
history of vaccination also suggests that waning immunity could
have contributed to the vaccinees’ susceptibility. Mumps outbreaks in
vaccinated populations are usually caused by the phylogenetically distinct
from the vaccine strains mumps viruses (MuV).
To examine these issues, the kinetics of titer, avidity and neutralizing
activity level and spectrum of the speciﬁc IgG were studied in 3-year
follow-up serum samples from the healthy volunteers (n = 60) with no
vaccination and mumps in the past, after the one vaccine dose contained
“Leningrad-3” (L-3) MuV strain.
Full seroconversion, conﬁrmed by ELISA and PRN against the vaccine
MuV strain, was registered in all volunteers 3 months after vaccination.
Antibodies induced by the vaccine strain effectively neutralized ﬁve
heterologous MuV strains (genotype A, B, D, and those earlier isolated
during the local mumps outbreaks, C and H) starting from month 6
after vaccination at all time points tested thereafter, albeit at levels
lower than those seen against the vaccine strain (>2-fold difference).
The speciﬁc IgG titers measured in ELISA demonstrated an “early”
decrease after 9 months post vaccination. At the same time, the speciﬁc
IgG functional activity characterized by their avidity, level and spectrum
of neutralizing activity reached its maximum within month 18 after
vaccination. Antibodies capable of neutralizing the heterologous MuV
genotypes in the absence of antigenic boosting demonstrated a decrease
to the critical levels (1:8) in a part of vaccinees after the third year
post vaccination, while the speciﬁc IgG neutralizing activity against
the vaccine strain still demonstrated a titer previously associated with
protection against MuV infection (1:8).
The current study possessing several limitations demonstrated for the
ﬁrst time a broad-spectrum neutralizing activity of the speciﬁc IgG in
recipients of one dose vaccine containing the L-3 MuV strain within 3
years after vaccination.
R2753 Screening of Lactobacillus pentosus strain b240 promoting
IgA production
K. Hamuro*, Y. Kotani, S. Inoue, Y. Ogasawara, S. Yamahira, T. Saito,
M. Toba, N. Kohda (Otsu, JP)
Objective: The foreign substances, such as pathogenic microorganisms,
usually invade internal body via mucosal surface with ingestion or
breathing. Thus, activation of mucosal immune function is essential for
maintaining and better health. Secretory immunoglobulin A (SIgA) play
a pivotal role in mucosal immune system by the multiple protective
roles. This study objective was to ﬁnd out lactic acid bacteria (LAB) for
promoting IgA.
Methods: First, we tested 150 LAB strains for IgA production capability
in vitro using a murine Peyer’s patch cell culture system and selected
Lactobacillus pentosus ONRICb0240 (b240). In addition, comparison
of cytokine proﬁle between b240 and low IgA inducible LAB was
examined. Next, we administrated heat-killed b240 to the mice for 3
weeks and investigated the intestinal IgA enhancement. Moreover, we
attempted an ex vivo study to assess the reactivity of murine Peyer’s
patch cells against b240.
Results: We found out b240 to be exhibiting excellent IgA producing
activities in 150 strains of LAB. Interestingly, plant derived LAB
including b240 tended to show higher activity than dairy LAB. After
3weeks of b240 administration, intestinal IgA signiﬁcantly increased
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comparing that of saline treated mice and the IgA production of murine
Peyer’s patch cells against stimulation of b240 was facilitated.
Conclusion: Lactobacillus pentosus ONRICb0240 would be an useful
LAB strain for promoting IgA production. Efﬁcacy of b240 ingestion to
the other mucosal immune system is expected.
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R2754 The side effects of H1N1 pandemic vaccine in pregnant
women and comparison to other healthcare workers
M. Sonmezer, G. Tuncer Ertem, S. Ucal Bakkal, C. Bulut, S. Kinikli,
N. Tulek* (Ankara, TR)
Objectives: To investigate the side effects of H1N1 vaccine in a cohort
of pregnant women and compare with in healthcare workers in 2009–
2010 pandemic season.
Methods: We recruited 26 pregnant women less than 38 gestational
weeks and 85 healthy healthcare workers who applied to our
clinic for inﬂuenza vaccination. Pregnant patients received Panenza®
(unadjuvanted H1N1 pandemic vaccine), whereas healthcare workers
received Focetria® (adjuvanted H1N1 pandemic vaccine). Pregnant
women were followed up for the entire pregnancy and the newborns were
assessed for APGAR score, while healthcare workers were monitored 14
days for the respective symptoms.
Results: The mean age of the enrolled pregnant patients and healthcare
workers were 31.7±5.5 and 33.6±6.3 years, respectively (P> 0.05).
None of the enrolled cases received seasonal vaccine. Of the enrolled
pregnant patients 26.9% were in the 1st trimester, 23,1% were in the
2nd trimester and 50% was in the 3rd trimester. The most frequent
symptom was pain in the vaccinated arm with 58.6% of the patients
being reported. When vaccine associated symptoms were assessed;
redness (34.6% vs. 3.5%; p = 0.00), sore throat (7.7% vs. 0.0%; p = 0.05),
fatigue (50.0% vs. 16.5%; p = 0.01), myalgia (50.0% vs. 9.4%; p = 0.00),
hypotension (11.5% vs. 1.2%; p = 0.03), emesis (42.3% vs. 2.4%;
p = 0.00), and dizziness (19.2% vs. 0.0%; p = 0.01) were more common
in pregnant patients compared to healthcare workers, respectively. All of
the pregnancies ended up with healthy term deliveries, but one newborn
died after premature labor in the 27th gestational week (the reason was
independent from the vaccine).
Conclusion: The frequency of H1N1 vaccine associated symptoms may
be different between pregnant patients and healthy subjects. Whether
this difference was caused by administering adjuvanted or unadjuvanted
vaccines or the presence of pregnancy − per se − confounded the results
merits further evaluation.
R2755 Evaluation of gene polymorphisms in saCOL2291 and
saCOL2581, candidate genes for a S. aureus vaccine
H. Rohaninejhad*, J.F. Mehrabadi, M. Pourmand, M. Zolfaghari
(Tehran, Qom, IR)
Objective: Staphylococcus aureus is a salient nosocomial infectious
agent. The prevalence of antibiotic resistance complicates the treatment
of staphylococcal infections. Therefore, the development of an effective
vaccine against S. aureus is important.
Materials: saCOL2291 and saCOL2581 are potential candidate genes
for vaccine development and their sequences are available in GenBank.
In this study, gene polymorphisms in saCOL2291 and saCOL2581 were
evaluated. Genomic DNA was extracted from thirty clinical S. aureus
isolates and the genes were PCR-ampliﬁed. The amplicons were
sequenced, aligned with Puls4 software and compared with saCOL2291
and saCOL2581.
Results: Nucleotide polymorphisms were detected that resulted in amino
acid sequence changes, but these polymorphisms were located in the
N-terminal domains while the C-terminal domains of these genes were
conserved.
Conclusion: Despite the identiﬁcation of polymorphisms in these
genes, both encode candidate proteins for potential use in a universal
staphylococcal vaccine. This is the ﬁrst study for assessing variation in
the saCOL2291 and saCOL2581 genes.
R2756 Projecting of rotavirus vaccine effectiveness in Ukraine,
based on the distribution of rotavirus genotypes in different
regions of the country
S. Soloviov, O. Trokhimenko, I. Dzyublyk* (Kiev, UA)
Objective: In recent years, thanks to the emprovement of laboratory
diagnosis, and especially the introduction of molecular biology study
methods, including polymerase chain reaction (PCR), it has been shown,
that rotaviruses as the etiologic agents of rotavirus infection (RVI),
dominate in the etiologic structure of acute intestinal infections of viral
etiology in infants and children under ﬁve years old worldwide. Rotavirus
is non-enveloped virus with genome, represented by 11 segments of
RNA, which makes these viruses extremely volatile, especially due
to reassortment of genes during co-infection. Detection of speciﬁc
sequences of genes, encoding protective proteins VP4 and VP7 of outer
capsid of rotaviruses (G/P-genotyping), using PCR, has become the
modern tool in the study of rotaviruses. Nowadays it is particularly
relevant in the context of the implementation of vaccination programs
aginst rotavirus infection in children. For prediction of the possible
genotype-speciﬁc effectiveness of vaccination against RVI in conditions
of limited molecular epidemiological studies, mathematical modeling
of vaccination strategies can become particularly informative, because
the distribution of pathogenic strains in children in different geographic
regions can vary signiﬁcantly.
Methods: Using PCR with reverse transcription, we demonstrated
the circulation in Ukrainian children four genotypes of group A
rotaviruses: G1P[8], G4P[8], G3P[8], G2P[4] and the dominance of
G1P[8]. The mathematical modeling method can adequately evaluate
the overall effectiveness of the vaccine, depending on the region of
its implementation. Using data of genotype-speciﬁc effectiveness of
monovalent rotavirus vaccine based on strain RIX4114 genotype G1P[8],
we estimated its expected genotype-speciﬁc effectiveness in the whole
country and, additionally, in Kiev and Odessa regions, as the most
densely populated regions with intense migration.
Results: It was shown that the expected overall effectiveness of rotavirus
vaccine, based on strain RIX4114, was 0.812 for the whole country,
0.841 for Kiev city and 0.804 for the Odessa region. These results
were comparable with the results of clinical studies of the effectiveness
of this vaccine (0.847) in Latin America and Finland. We should
therefore expect that vaccines, including attenuated or reassortant strains
of rotaviruses with genotype G1P[8], as a tool of speciﬁc prevention, will
be most effective in the territory of Ukraine.
R2757 Effect of age at immunization and quality of immune
response following multi-antigen MAP vaccination
A. Thakur*, C. Aagaard, G. Jungersen (Copenhagen, DK)
Mycobacterium avium subsp. paratuberculosis (MAP), the agent of
Johne’s disease, causes systemic infection and chronic intestinal
inﬂammation in many animal species. Neonates are more susceptible to
the infection due to high degree of exposure from their dams and possibly
less developed immune system. The only vaccines available against
MAP comprised attenuated or killed organisms. However, none of these
vaccines are able to completely prevent infection or shedding of bacteria.
Considering the fact that MAP infection occurs at a young age and
the animal remains in the subclinical phase for 2−3 years, an effective
vaccine should not only elicit strong immune response in young animals,
but also a quality of the T-cell response that correlates with long term
protection. Here we report the effect of age at immunization and quality
of immune response following immunization of calves with recombinant
MAP proteins formulated with DDA/TDB (CAF01) adjuvant. Vaccine
comprised of one heat shock protein, two ESAT-6 family members and
two secreted mycobacterial components fused with CAF01 adjuvant. A
total of 27 male jersey calves were divided into 3 groups of 9 calves each
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with ﬁrst vaccination at 2, 8 and 16 weeks of age, respectively. Vaccine
induced immune response, mainly the Th1 type cytokine secretion, was
evaluated in different age groups following booster doses at equal time
intervals. Preliminary results show higher antigen speciﬁc IFN-g levels
in response to heat shock protein and ESAT-6 family member protein
antigens. It was observed that there was no effect of age on the IFN-g
producing capacity of the animals in the different age groups after
stimulation of whole blood with SEB. However, animals in the older
age group responded well to the MAP multi-antigens and might need
only one booster compared to the younger animals. Findings from this
work could be interesting to determine the appropriate age of vaccination
so as to generate the memory T cell pool and for MAP vaccine challenge
experiments.
R2758 Characterisation of new vaccine candidates against
smallpox, attenuated and replicative-competent
J. Dimier*, A.-L. Favier, D. Gratier, D. Spehner, K. Pradeau-Aubreton,
M. Hebben, P. Schultz, R. Drillien, J.-M. Crance (La Tronche, Illkirch,
FR)
Smallpox, caused by Variola virus, is considered as a dreadful scourge for
human. Smallpox vaccination, using strains of Vaccinia virus (VACV)
has leaded to it eradication in 1980. However, adverse reaction could
result, so it was abandoned. Current bioterrorism attack threat are feared
the disease re-emergence, then new smallpox vaccines more safe but less
effective in animals have been developed.
Attenuation of our candidates have been measured in Swiss Nude or
SCID mice. Mice have been vaccinated with 105 pfu of each viruses
by tail scariﬁcation. Signs of disease and mortality were followed over
an 8 week period. Protection of BALB/c mice against a lethal challenge
have been performed, 28 days after vaccination, with 2.106 DICT50
of cowpoxvirus by intranasal route (i.n). VACV neutralizing antibodies
(Abs) in serum samples were titrated by plaque assay. Serum samples
were ﬁrst incubated at 56ºC for 30 minutes then submitted to serial
2-fold dilutions. The samples were mixed with an equal volume of VACV
containing 35 PFU in 0.1ml for one hour at 37ºC and added to Vero cell
monolayers. Two days later virus plaques were counted. To measure T
lymphocyte responses the percentage of CD4+ and CD8+ lymphocytes
expressing intracellular IFN-g was measured by ﬂow cytometry. Mature
bone marrow dendritic cells from uninfected BALB/c mice were infected
with VACV then incubated with spleen cell suspensions from infected
animals for six hours. Brefeldin A (5mg/ml) was added for the last
four hours to block cytokine secretion. Cells were stained with FITC-
coupled anti-CD8b2 and APC-coupled anti-CD4 monoclonalAbs, ﬁxed
and permeabilised. IFN-g was stained with a PE-coupled anti-IFN-g
mAb and cells were ﬁxed in 2% formaldehyde.
These vaccine candidates have been shown as protective as the traditional
vaccine (1G) against an i.n cowpox challenge in mice, and they have
been closely as safe as MVA strain in NUDE mice. The neutralizing
antibodies titration showed that every deleted viruses induced a humoral
response as strong as 1G. Finally intracellular cytokine staining showed
a similar speciﬁc CD4+ response to that of 1G and a slightly lower
speciﬁc CD8+ response than that of 1G.
Our results show that several deleted vaccines could advantageously
complete the range of the third generation vaccines already developed.
The utilisation of one of these candidates as a viral vector for a vaccine
against Ebola virus is under investigation in our laboratory.
R2759 Predictive models of adherence to seasonal and pandemic
H1N1 inﬂuenza vaccine between health care professionals
S. Luque*, S. Grau, C. Serra, P. Pi-Sunyer, J.P. Horcajada, N. Berenguer,
O. Ferra´ndez, O. Urbina, M. Espona, E. Salas (Barcelona, ES)
Objectives: Several strategies have been designed to increase adherence
to vaccination programs aimed at health-care professionals, though the
results were not always satisfactory.
Methods: The differences between adherence to seasonal and pandemic
inﬂuenza vaccination after the implementation of a vaccination program
between health-care workers were assessed and compared by age,
gender, professional category and workplace. Two different prognostic
models for predicting adherence to seasonal and pandemic inﬂuenza
were developed. In statistical analysis, univariate logistic regression
was performed to identify risk factors associated with adherence to
vaccinations. Multiple regression analysis backwards, stepwise variable
selection was used to identify independent risk factors for adherence. The
internal validation of the predictive models was evaluated by measures
of calibration and discrimination power.
Results: 7.6% of professionals were vaccinated against pandemic
inﬂuenza, and 33.7% against seasonal inﬂuenza. Statistically signiﬁcant
differences were observed for both vaccines when comparing vaccinated
to unvaccinated professionals as for age, professional category and
workplace, while sex differences were only related to pandemic
inﬂuenza. The predictive model of adherence to pandemic H1N1 vaccine,
which showed a good discriminatory power (Area under ROC curve:
0.843), included the variables age, professional category, workplace and
previous vaccination against seasonal inﬂuenza as independent predicting
factors. On the contrary, the predictive model of adherence to seasonal
vaccine, which showed a poor discriminatory power (Area under ROC
curve: 0.567), included the variables age, gender and workplace. Both
models showed a good calibration (table 1).
Conclusions: Adherence to pandemic H1N1 and seasonal inﬂuenza
vaccination program was very low, which suggests the need to
implement new strategies into vaccination programs aimed at health-
care professionals. A good model for predicting adherence to pandemic
vaccine was developed when compared with the poor discriminating
power of the predictive model for seasonal inﬂuenza vaccination.
R2760 In silico analysis of Adenovirus penton protein and
proposed vaccine using bioinformatics
S. Kaushik* (Gwalior District, IN)
Objective: Adenovirus are responsible for various diseases to humans
and many species of animals & birds. There are no antiviral drugs to
treat adenoviral infections. The use of immunoinformatics has greatly
revolutionized the ﬁeld of vaccine research, discovery and development.
Hence approach has been made to identify the relevant B-cell & T-cell
epitopes to design vaccine against adenovirus using bioinformatics.
S832 21st ECCMID/27th ICC, Abstracts accepted for publication only
Methods: Conserved regions of Penton protein of Adenovirus were
analyzed in order to assess their antigenic potential. B-cell epitope
prediction of conserved sequences was done by using BepiPred method.
The binding capacity of this conserved sequence was also assessed for
its ability to bind with MHC-I and MHC-II using the ProPred-I server.
During last step of study, this penton sequence was also analyzed for its
binding afﬁnity with T-cell receptors using the EpiJen server. Structure
prediction of this sequence was done by PSIPRED.
Results: The whole sequence of amino acid of penton protein was found
to be conserved. There are 16 B-cell epitopes, one epitope at each
conserved region. As per the results of ProPred, 32 sequences were found
to bind with MHC-I alleles. During the analysis of MHC-II binding,
total 51 alleles were analyzed for their binding efﬁciency with conserved
region of penton. The multiepitope peptide showed T-cell binding region
at a number of allele positions. Structure prediction of this sequence by
PSIPRED revealed that 16 helix are present in this sequence.
Conclusion: The present study ﬁnds that penton proteins of Adenovirus
can also be an effective candidate for the development of preventive
measures against the drastic diseases caused by this virus by blocking
its initial infection. In fact in silico approach for target prediction is
deﬁnitely reducing manpower, time and cost in relation to search for a
lead antigenic molecule against penton protein.
R2761 Immunogenicity and protective immunity of a recombinant
BCG expressing human GM-CSF and CFP10−ESAT6
fusion proteins from M. tuberculosis
X. Yang, L. Bao* (Chengdu, CN)
Objectives: Tuberculosis remains a major health threat to the people of
the world. Bacille Calmette–Guerin (BCG) is the only using vaccine and
provides dissatisfactory protection against Mycobacterium tuberculosis.
Here we constructed a trivalent recombinant BCG which encodes human
GM-CSF and immunodominant antigens CFP10 and ESAT6 fusion
protein from M. tuberculosis and detected its immune responses in mice.
Our objective is to develop a novel BCG vaccine which provides a better
immunogenicity and protective efﬁcacy against tuberculosis.
Methods: The sequence of GM-CSF and ESAT6/CFP 10 gene was
ampliﬁed by PCR respectively. GMCSF–CFP10–ESAT6 (GCE) chimeric
gene was ampliﬁed by SOE PCR and then transferred into shuttle
plasmid pMV 361. The recombinant vectors were electroporated into
M. bovis BCG. BALB/c mice were divided into seven groups and
were injected subcutaneously with BCG or rBCGs. The samples were
collected at 6, 8, 10, and 12 weeks after immunization, ELISA was
used to determine IgG antibody speciﬁcity. The proliferative response
of lymphocytes was detected by XTT assay and the lymphocyte
subpopulations were analyzed by the ﬂow cytometry. The production
of IFN-g and IL-4 in response to TB-antigen was measured.
Results: The expression of GM-CSF, CFP10, ESAT6 and GCE complex
were identiﬁed by western blotting from recombinant BCG. Stimulation
index values of rBCGs were signiﬁcantly higher than control groups.
The SI values with rBCG:GCE group was the highest in all groups.
The rBCG with GEC chimeric gene could induce more antigen speciﬁc
CD4+ and CD8+ T cells of splenocyte than BCG and single gene r
BCGs at different time points. The rBCGs were able to induce higher
levels of IFN-g and IL-4 than control groups. IFN-g production from
group of rBCG:GCE was the highest among groups. Moreover, mice
immunized with rBCG:GCE generated the strongest antigen speciﬁc
antibody responses compared to other groups.
Conclusion: The rBCG:GCE can induce intensive immune response and
could enhance the Protective efﬁcacy to M. tuberculosis. The results
indicate that this novel trivalent recombinant BCG might be a good
vaccine candidate against tuberculosis.
R2762 Serotype distribution among bacteraemic pneumococcal
pneumonia in adults in Germany
M. van der Linden*, M. Imo¨hl (Aachen, DE)
Objectives: Streptococcus pneumoniae remains a leading cause of
pneumonia, sepsis and meningitis and disproportionately affects young
children and the elderly. In July 2006, vaccination with pneumococcal
conjugate vaccine was generally recommended by the German Health
authorities for all children up to the age of 24 months. In this study,
we present the serotype distribution among adults with bacteremic
pneumococcal pneumonia before and after the start of childhood
vaccination.
Methods: The National Reference Center for Streptococci has monitored
the epidemiology of invasive pneumococcal disease (IPD) in adults
in Germany since 1992. Cases of IPD in adults are reported by
a laboratory-based surveillance system, including 265 laboratories
throughout Germany. The present analysis includes only bacteremic
pneumococcal pneumonia cases documented between 2002 and 2010.
Species conﬁrmation was done by optochin testing and bile solubility
testing. All isolates were serotyped using the Neufeld Quellung reaction.
Results: In the pneumococcal season 2006–2007 the most prevalent
serotypes among bacteremic pneumococcal pneumonia in adults were
serotypes 14 (19.1%), 3 (10.9%), 1 (8.6%), 7F (6.7%) and 9V (6.5%).
In 2009–2010 serotypes 3 (18.5%), 7F (12.4%), 19A (10.9%), 1 (9.6%)
and 22F (5.9%) were most prevalent. The coverage of the 23-valent
polysaccharide vaccine in 2009–2010 was 86.5%. The serotypes 1, 3,
4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19F, 19A and 23F cover 68.6% of all
bacteremic pneumonia cases in 2009–2010.
Conclusions: The burden of pneumococcal pneumonia among German
adults is considerably high. The most prevalent serotypes have changed
after the start of childhood vaccination and are currently serotypes 3, 7F,
19A, 1 and 22F.
R2763 Incidence and case fatality of invasive pneumococcal disease
among adults in the United Kingdom: a systematic review
A. Levy, S. Szabo, O. Eyawo, T. Huang, R. Pitman, P. Balmer,
A. Charos* (Vancouver, CA; Oxford, Walton Oaks, UK)
Objective: Pneumococcal infection is a potentially life-threatening
condition, which can also cause lifelong sequelae such as neurologic
deﬁcits. Since 2003, vaccination with a pneumococcal polysaccharide
vaccine has been recommended in the UK for those aged 65 years and
over, in addition to those in a clinically at-risk group over two years
of age (in place since 1992). A pneumococcal conjugate vaccine was
introduced into the childhood vaccination scheme in 2006. Although
many studies have estimated invasive pneumococcal disease (IPD)
incidence among various population subgroups, including adults, a
synthesis of estimates has not been performed. The objective here was
to estimate age-speciﬁc incidence and case fatality rates of IPD among
adults in the UK.
Methods: A systematic review was conducted in MEDLINE and
EMBASE in August 2010. Two independent reviewers extracted data
from articles describing adult pneumococcal disease incidence and
mortality in the UK, published from the year 2000 to present. Data
were synthesized according to clinically relevant age categories for adult
pneumococcal infection and stratiﬁed according to type of pneumococcal
disease (IPD overall, or its subgroups of bacteraemia/septicaemia or
meningitis). These data were supplemented with hand-searching of
reference lists.
Results: The search strategy identiﬁed 2,444 abstracts for screening;
20 satisﬁed the inclusion criteria, and presented estimates from 1980 to
2005. Age-speciﬁc estimates of the incidence of IPD and its subgroups
are provided in the table. Overall, incidence of IPD and its subgroups
increased with age. For IPD, incidence rates ranged from 2.7 to 10 cases
per 100,000 among those <65, to 18.8 to 70 cases per 100,000 among
those >65 years of age. Overall case fatality due to IPD and its subgroups
also generally increased with age. Four studies reported overall IPD case
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fatality rates between 21% and 34%; and age-speciﬁc estimates from 2%
to 35% among adults aged <65 years, and 30% to 43% among older
adults.
Conclusions: The epidemiologic burden of IPD is greater among older
adults. These synthesized estimates may therefore serve as a baseline
measure against which to evaluate the cost-effectiveness of new strategies
for preventing pneumococcal infection.
R2764 Immunomodulatory properties of live attenuated Bordetella
pertussis vaccine candidate BPZE1
G. Fedele*, M. Bianco, A. Debrie, C. Locht, C.M. Ausiello (Rome,
IT; Lille, FR)
Objectives: New vaccines against pertussis are needed to evoke long
lasting protection and immunological memory starting from the ﬁrst
administration in neonates. A novel live attenuated B. pertussis vaccine
strain, BPZE1, has been developed by eliminating or detoxifying three
important B. pertussis virulence factors: pertussis toxin, dermonecrotic
toxin and tracheal cytotoxin. With the aim to evaluate BPZE1
immunomodulatory properties in human pre-clinical models, we used
an ex vivo model based on monocyte-derived (MD) dendritic cells (DC)
challenged with BPZE1.
Methods: Human immature MDDC were obtained by culturing puriﬁed
monocytes in the presence of GM-CSF and IL-4 for 6 days. MDDC were
challenged with BPZE1 or its parental wild type counterpart, BPSM.
After 48 h MDDC were harvested for immunophenotypic analysis
and the supernatants collected for cytokine measurement by ELISA.
Resistance of BPZE1-challenged MDDC to apoptosis was assessed
by AnnexinV/Propidium Iodide staining. Chemokine-driven chemotaxis
was also evaluated. Co-culture experiments with T lymphocytes were
performed to assess antigen-presenting activity, T-helper cell polarizing
ability and induction of functional suppressor T cells.
Results: BPZE1 is able to induce phenotypic maturation of human
MDDC which are resistant to apoptosis. BPZE1-primed MDDC produce
a broad spectrum of proinﬂammatory and regulatory cytokines, and
very efﬁciently migrate in vitro in response to the lymphatic chemokine
CCL21, due to the inactivation of the pertussis toxin enzymatic activity.
BPZE1-primed MDDC acquire antigen-presenting capacity, drive a
mixed Th1/Th17 polarization, and induce functional suppressor T cells.
Suppressing activity requires cell contact rather than the production of
soluble factors.
Conclusion: Our ﬁndings support the potential of BPZE1 as a novel live
attenuated pertussis vaccine strongly activating the maturation of DC
with full-blown activity. BPZE1-challenged DC acquire the capacity to
survive death signals and migrate from the site of infection to the lymph
nodes. BPZE1-committed DC have the ability to orchestrate a broad
spectrum of Th1/Th17 responses, protective in experimental B. pertussis
infection, and regulatory T cell responses, likely balancing each other to
restore local homeostasis.
This work was supported by grant from EC project CHILDINNOVAC-
HEALTH-F3–2007–201502
R2765 Low immunogenicity of seasonal trivalent inﬂuenza vaccine
among patients receiving docetaxel for a solid tumour
P. Loulergue*, J. Alexandre, I. Iurisci, S. Grabar, J. Medioni, S. Ropert,
V. Dieras, S. Oudard, F. Goldwasser, P. Lebon, O. Launay (Paris, FR)
Background: Patients receiving cytotoxic therapy for solid tumors are at
increased risk of severe inﬂuenza, Data on ﬂu vaccine immunogenicity
are needed in those patients to improve the vaccine coverage.
Methods: In a multicentric prospective study, 25 patients with breast
(n = 13) or prostate (n = 12) cancer received one dose of a trivalent
inactivated inﬂuenza vaccine the same day that the IV administration
of docetaxel. Serum hemagglutination-inhibition (HI) antibody response
was assessed 21 days after vaccination.
Results: The median age of the study population was 65 years (min-max,
33−87); 52% were female. At baseline, the percentages of patients with
titers of vaccine strain-speciﬁc HI antibodies 1:50 were 100%, 72%,
and 100% against H1N1, H3N2 and B, respectively. Immunogenicity
results at day 21 show that this vaccine is poorly immunogenic (see
Table 1).
No serious adverse events (AE) have been reported during the ﬁrst 3
weeks after vaccination. All the reported AE were from mild to moderate
intensity.
Conclusions: The results show that the trivalent inactivated inﬂuenza
vaccine triggers a low immunogenicity in adults receiving docetaxel for
solid tumors, although it demonstrated a good safety proﬁle. Strategies
using more immunogenic inﬂuenza vaccines have to be evaluated in
patients with cancer.
Table 1. Immunogenicity of inﬂuenza vaccine
A/H1/Solomon Islands/3/06 A/H3/Wisconsin/67/05 B/Malaysia/2506/04
Number of tested patients 24 24 24
Geometric mean titer (GMT) (95%CI) 794.4 (609.4–1036) 257.2 (169.3–390.5) 315.2 (221.40–448.9)
Seroprotection rate (SPR) n (%) 24 (100) 19 (79) 24 (100)
Seroconversion rate (SCR), n (%) (95%CI) 7 (28) (23.1–33.3) 2 (8) (7.7–8.3) 4 (16) (7.7–25)
Geometric mean fold rise (seroconversion
factor) (95%CI)
2.16 (2.10–2.22) 1.3 (1.26–1.34) 1.58 (1.45–1.73)
SPR: percentage of patients with a post-vaccination HI titer 1:50.
SCR: percentage of patients showing a signiﬁcant increase in antibody titer deﬁned as a pre-vaccination titer 1:50 and at least a fourfold
increase in postvaccination titer.
Geometric mean fold rise: geometric mean of the within-subject ratios of the post-vaccination reciprocal HI titer to the Day 0 reciprocal HI titer.
R2766 Evaluation of cytokine proﬁle following immunisation
with Brucella abortus S99 lipopolysaccharide-Neisseria
meningitidis serogroup B outer membrane vesicle conjugate
as a new brucellosis vaccine candidate
S.D. Siadat*, H. Shirdast, S. Solaymanieh, M. Mohammadi, P. Zulﬁgar
Muraduv, M.R. Aghasadeghi, S. Javadian, S.F. Mosavi, M. Kheirandish,
M. Zangeneh, S.M. Sadat, A. Moshiri, R. Haji Abednaeini (Tehran,
IR; Baku, AZ)
Objective: The development of an efﬁcacious vaccine for brucellosis
has been a challenge for scientists for many years. Our previous studies
demonstrated that LPS+OMV conjugates was elicited high level of anti-
LPS IgG titers. In this study, the efﬁciency of LPS-OMV conjugates to
promote IFN-g and IL-4 evaluated to determine the pattern of T-helper
population activation.
Method: B. abortus LPS was extracted and used for their conjugation to
N. meningitidis serogroup B outer membrane vesicle as carrier protein
as discribed previously. Groups of ten BABL/c mice were injected
subcutaneously with 10mg of LPS alone, combine and conjugated on
0, 14 and 28 days. Sera were taken before and 14 days after each
injection. Levels of IFN-g, IL-4 and IL-10 in the sera of immunized
animals assayed by ELISA.
Results: Immunization with B. abortus LPS signiﬁcantly induced high
level of IFN-g in comparison to the other groups immunized with LPS-
OMV conjugate and LPS+adjuvant (P< 0.05. In contrast, lower levels
of IL-4 and IL-10 were elicited by LPS in all of the immunized animal
models. Although Immunization with B. abortus LPS-N. meningitidis
serogroup B OMV conjugate demonstrated signiﬁcant increase of IL-4
and IL-10 in comparison with the immunization with B. abortus LPS
(P< 0.05, the titer of IFN-g is still signiﬁcantly higher than IL-4 and
IL-10 in the sera of this group’s animal models (P< 0.05).
Conclusion: The raise of IFN-g production following the immu-
nization with all of the compounds (LPS, LPS-OMV conjugate and
LPS+adjuvant) indicates the induction of Th1-type response that would
be correlated to the clearance of the organism due to the proliferative
response of Polymorphonuclear cells. Low levels of IL-4 and IL-10
following the immunization with all compounds would be a sign of Th1
responses dominancy or inhibition of Th2-type response proliferation
and activity. Since Th1-type response would be indicated the efﬁciency
of this brucellosis conjugate vaccine, Th2 responses basically have no
role in the immune responses against brucellosis and may lead to the
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persistence of intracellular infection. These results indicate that the
conjugated LPS obtained by us, can be used as a brucellosis vaccine
after further investigation.
Internet and electronic resources
R2767 Improving empirical antibiotic therapy in orthopaedic-
related infections using ViResiST, a computerised decision
support system
J.M. Lopez-Lozano*, F. Lajara-Marco, N. Gonzalo-Gimenez,
J.A. Lozano-Requena, R. Lax-Perez, M.L. Aguilar-Martı´nez, L. Izquierdo-
Plazas, F. Navarro-Gonzalvez, A. Garcı´a-Ga´lvez (Alicante, ES)
Introduction and Objectives: Inappropriate antibiotic prescribing is
common in orthopaedic-related infections, and the consequences are
severe. Commonly used guidelines give empirical antibiotic treatment
recommendations that are general and not tailored to local prevalence
patterns. We developed a microbiologic decision support tool (ViResiST:
www.viresist.org) founded on our local bacterial susceptibility data
augmented by expert infectious disease logic. We compared the
effectiveness of current antimicrobials prescribed to the antimicrobials
recommended by the program.
Methods: We retrospectively enrolled all inpatients with a positive
culture at our institution with a surgical site infection after implantation
of a joint prosthesis or internal ﬁxation between January 2008 and
August 2009 and determined the current empiric therapy before and after
the result of culture. ViResiST incorporate the most likely infectious
organism and its antimicrobial resistance pattern using a multivariate
time-series analysis to provide treatment recommendations. A cross-table
was used to compare the effectiveness rate of empiric therapy.
Results: The microbiology laboratory recorded 19 patients/25 pathogen
related with surgical site infection over orthopaedic device during the
study period that met inclusion criteria. Physicians initiated effective
empiric therapy in 13 out of the 19 patients, for an effectiveness rate of
68%. The computer-guided therapy was effective in 19 of the 19 events
for a rate of 100% (p< 0.0001 by Fisher’s exact test).
Conclusion: We found that ViResiST would potentially improve the rate
of effectiveness of empirically chosen antimicrobials and could enhance
the current targeting of empiric antimicrobial therapy by tracking
potential pathogens and their evolving antimicrobial resistance proﬁles.
